data_2mhm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mhm _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 36.5 t80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.292 0.567 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.583 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.4 ptmt -103.53 161.32 13.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.372 -0.83 . . . . 0.0 109.215 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.88 96.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.96 . . . . 0.0 109.336 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -110.98 170.21 13.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -110.94 130.87 55.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.142 . . . . 0.0 109.238 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -74.4 -19.39 60.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.022 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.5 -49.55 74.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.093 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -63.14 -47.48 82.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.101 . . . . 0.0 109.267 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.424 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -67.66 -28.13 73.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.62 -44.73 85.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.224 . . . . 0.0 109.868 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.9 p -70.02 -38.62 75.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.153 -0.967 . . . . 0.0 109.418 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.25 -41.04 87.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.66 -46.36 88.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.79 -38.86 92.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.382 0.61 . . . . 0.0 109.967 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 p -69.31 -34.68 75.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 111.493 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -150.28 59.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.642 -1.287 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -171.18 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 0.0 109.965 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.98 -38.2 72.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 109.607 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.87 -36.09 74.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.898 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -94.53 -42.57 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.479 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.6 m-70 -107.56 124.15 49.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.598 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.9 p -84.42 -29.57 26.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.251 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 85.7 t 54.32 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.289 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.598 ' H ' ' C ' ' A' ' 19' ' ' THR . 77.8 mm-40 -62.06 141.98 57.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 24' ' ' GLY . 16.3 tttm -71.07 143.19 50.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.623 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.18 9.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 22' ' ' LYS . . . -76.17 162.65 52.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 57.0 Cg_endo -71.31 175.92 8.66 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 123.127 2.552 . . . . 0.0 111.691 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -102.42 133.49 47.28 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.254 -0.904 . . . . 0.0 109.516 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 29' ' ' GLY . 56.0 tttp -132.23 131.09 41.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.252 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.1 t 53.73 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.171 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -102.39 162.97 16.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 20.3 Cg_endo -62.03 153.01 71.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.09 2.527 . . . . 0.0 112.165 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 12.7 m120 -84.27 139.03 32.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -99.69 139.3 35.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 109.885 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.402 ' HE2' ' HE2' ' A' ' 22' ' ' LYS . 57.8 t-80 -166.56 95.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.58 7.47 78.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -58.66 -21.58 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.014 . . . . 0.0 109.613 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -64.1 133.22 52.58 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 71.13 21.39 78.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.779 ' HE ' HE21 ' A' ' 42' ' ' GLN . 68.1 mtp85 -138.57 167.04 22.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -1.15 . . . . 0.0 109.924 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -94.68 156.88 16.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.905 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.586 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 58.0 p -66.31 164.53 15.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.724 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.88 0.8 68.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.779 HE21 ' HE ' ' A' ' 38' ' ' ARG . 46.3 tt0 -60.1 -35.53 75.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.995 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.66 -34.41 69.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.3 mt-10 43.32 17.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.156 -0.965 . . . . 0.0 109.408 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -127.95 -36.42 0.47 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 47' ' ' SER . 68.5 t80 -103.67 135.52 45.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 108.815 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.436 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 54.3 p -65.93 156.57 33.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.899 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.87 150.1 42.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.559 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.1 t -54.9 149.92 10.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.863 . . . . 0.0 109.24 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.78 -35.11 65.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.877 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 76' ' ' PRO . . . -60.22 -57.58 12.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.063 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.2 t-20 -57.5 -42.8 83.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.566 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.31 -55.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.177 -0.952 . . . . 0.0 109.728 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -68.38 -54.86 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 56' ' ' ASN . 19.9 tttm -65.7 -52.23 53.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.586 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 50.91 118.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.758 0.789 . . . . 0.0 110.119 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.487 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 7.6 p -126.47 147.51 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.3 tp -75.82 134.12 40.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 108.93 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 m95 -99.6 128.41 45.71 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.337 -0.852 . . . . 0.0 110.034 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 50.3 t0 -159.12 172.98 17.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.585 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.17 -39.15 71.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.961 -1.087 . . . . 0.0 109.646 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.582 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 p-10 -74.77 -48.08 27.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.078 -1.014 . . . . 0.0 109.513 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 39.0 t30 -60.9 -38.26 85.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 110.003 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -40.12 86.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.921 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.401 ' O ' ' OG1' ' A' ' 69' ' ' THR . 94.5 p -61.49 -36.4 80.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.001 -1.062 . . . . 0.0 109.799 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.24 -36.65 77.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.019 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.628 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 81.9 t60 -61.38 -47.39 86.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.138 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 4.7 mp -71.46 -36.23 71.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.392 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.581 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 25.5 m -60.96 -39.58 90.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.623 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -152.87 68.73 6.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.585 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.15 -15.81 46.54 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.364 2.043 . . . . 0.0 112.651 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -78.87 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 110.266 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.68 -32.79 67.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.149 -0.97 . . . . 0.0 109.772 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 80.2 t80 -56.66 -49.66 74.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 2.8 mm -141.14 80.84 16.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.923 . . . . 0.0 109.113 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -84.88 149.47 10.97 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.957 2.438 . . . . 0.0 112.247 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.25 58.63 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 80' ' ' MET . 15.0 t -104.77 163.65 12.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -1.216 . . . . 0.0 109.71 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.79 -0.12 37.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.628 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 11.2 ttt -85.11 129.59 34.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 0.0 110.007 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.63 85.52 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.8 t80 -104.6 133.4 49.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.34 138.02 22.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.94 146.8 43.73 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.2 mt -95.16 125.45 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.244 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HZ1' ' CB ' ' A' ' 86' ' ' LYS . 9.3 mtmp? -65.42 -34.6 78.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 110.206 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -84.78 127.84 34.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 0.0 110.16 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -77.52 -35.54 53.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -57.75 -45.6 85.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.6 -39.54 94.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.041 . . . . 0.0 109.1 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.581 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 37.6 ttm180 -59.67 -40.47 87.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.936 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.12 -42.35 90.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.358 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -63.43 -40.06 96.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.054 -1.029 . . . . 0.0 110.14 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -59.75 -42.76 93.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.036 -1.04 . . . . 0.0 109.627 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.85 -37.41 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.972 . . . . 0.0 108.955 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -60.79 -39.58 89.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.598 -0.689 . . . . 0.0 109.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.53 -50.61 73.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.105 -0.997 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.05 -35.43 76.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.168 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.585 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 18.7 tptm -58.68 -40.56 83.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.351 -0.843 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -60.1 -40.84 91.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.529 -0.732 . . . . 0.0 109.796 -179.769 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.525 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 93.6 t80 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.4 0.619 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.712 ' HZ3' ' HZ1' ' A' ' 89' ' ' LYS . 33.5 ttpt -81.88 144.45 30.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.071 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.95 -22.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 109.564 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 42.37 94.95 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 46.0 m -63.37 153.44 35.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.111 -1.229 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -80.77 -128.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 tttm 57.64 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.057 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' ALA . 32.9 mmtp -59.29 -52.44 65.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -36.56 93.57 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.43 79.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -1.162 . . . . 0.0 109.414 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.4 p -70.43 -37.35 74.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.243 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.68 -55.98 27.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 108.816 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -62.5 -41.71 99.0 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.427 -0.796 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -61.49 -38.54 87.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 111.159 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 p -106.02 4.64 29.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.112 -0.993 . . . . 0.0 111.759 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -147.02 28.71 1.01 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.613 -1.305 . . . . 0.0 110.75 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -171.08 -24.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.723 -1.235 . . . . 0.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -59.54 -38.19 80.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.885 -1.134 . . . . 0.0 109.916 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.0 -36.53 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.018 . . . . 0.0 111.239 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.73 -50.23 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.832 -1.167 . . . . 0.0 111.202 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -101.91 126.37 48.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.065 -1.022 . . . . 0.0 110.265 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' GLU . 51.5 p -87.23 -24.28 24.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.241 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t 63.79 0.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.457 -0.777 . . . . 0.0 110.18 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.3 mt-10 -101.37 124.75 47.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -69.53 -39.22 77.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.567 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.63 87.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 154.17 44.39 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 62.1 Cg_endo -74.26 -156.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 111.733 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.403 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 98.7 m-70 -107.68 133.6 51.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.134 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -103.78 -125.07 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.31 -38.45 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.156 -0.965 . . . . 0.0 108.896 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.79 165.14 20.94 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HA ' ' HD1' ' A' ' 26' ' ' HIS . 20.9 Cg_endo -63.3 150.77 87.67 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.958 2.438 . . . . 0.0 112.37 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 2.9 m120 -80.81 141.71 34.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 108.99 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.7 mp -95.42 139.19 32.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.017 . . . . 0.0 109.861 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -172.19 90.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 0.0 109.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.583 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.05 5.02 66.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.4 tt -58.5 -22.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -1.176 . . . . 0.0 109.546 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.67 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 81.2 m-85 -68.11 135.35 52.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.8 79.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 67.8 mtt85 -142.62 166.08 25.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 110.04 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -95.77 162.57 13.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.552 ' HG ' ' ND2' ' A' ' 56' ' ' ASN . 62.0 p -66.3 166.21 12.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.816 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.28 60.89 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.407 HE22 ' HD2' ' A' ' 38' ' ' ARG . 39.0 tt0 -62.41 -38.42 89.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -1.16 . . . . 0.0 109.876 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.581 ' N ' ' OH ' ' A' ' 48' ' ' TYR . . . -71.31 66.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.98 -32.48 72.03 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.366 -0.834 . . . . 0.0 109.343 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.6 60.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -108.8 134.58 51.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -1.138 . . . . 0.0 109.153 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 m -64.47 156.32 29.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.581 ' OH ' ' N ' ' A' ' 43' ' ' ALA . 59.3 m-85 -112.14 145.32 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.306 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.4 p -76.91 161.09 28.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.456 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -58.78 -33.06 69.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.949 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.25 -70.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.216 -0.927 . . . . 0.0 110.673 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.8 t-20 -54.83 -40.62 69.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.924 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.72 -46.37 96.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.942 -1.098 . . . . 0.0 109.482 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.37 -37.06 79.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.12 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 52' ' ' ASN . 52.9 tttm -126.28 115.75 20.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' ND2' ' HG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -99.42 137.68 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.132 -0.98 . . . . 0.0 109.063 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.548 ' H ' HD21 ' A' ' 56' ' ' ASN . 14.8 p -130.9 146.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.404 -0.81 . . . . 0.0 109.975 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.14 131.05 36.09 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.401 ' HE1' ' HB3' ' A' ' 40' ' ' SER . 89.0 m95 -94.18 124.48 38.22 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -153.94 169.27 23.86 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.86 -40.0 72.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 0.0 109.559 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -69.83 -48.8 57.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.15 -41.09 92.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.544 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.67 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.0 mtt -61.45 -38.0 85.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.003 -1.061 . . . . 0.0 109.727 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -55.95 -42.0 75.52 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 108.953 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -37.01 76.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.496 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 70.4 t60 -62.92 -47.92 81.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.93 -26.79 68.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.892 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.59 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 33.8 m -84.78 126.0 33.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.952 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 69' ' ' THR . 8.2 m120 40.48 60.01 7.41 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 28.2 Cg_endo -64.52 -23.02 64.82 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.962 2.441 . . . . 0.0 112.9 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.78 81.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.061 -1.025 . . . . 0.0 109.491 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -62.67 -32.64 73.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.492 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 10.7 t80 -57.19 -55.59 32.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 109.726 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 75' ' ' ILE . 2.9 pt -141.82 73.83 22.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.0 109.779 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -60.96 -34.97 90.04 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 122.64 2.227 . . . . 0.0 112.045 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.7 75.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.0 p -75.51 158.75 32.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.236 . . . . 0.0 110.51 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -84.7 3.83 35.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 109.608 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.496 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 6.7 ttt -76.74 129.87 36.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.92 93.5 2.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.628 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 78.3 t80 -101.81 131.24 48.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.225 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -63.76 130.92 40.11 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.24 145.83 41.65 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.4 mt -94.73 125.07 39.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.979 -1.306 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -64.52 -37.96 89.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -86.98 119.49 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.826 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.03 -32.93 72.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.712 ' HZ1' ' HZ3' ' A' ' -2' ' ' LYS . 13.6 tttm -57.06 -51.46 69.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.102 -0.999 . . . . 0.0 109.641 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -60.74 -38.07 83.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.8 . . . . 0.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.59 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 55.8 ttp180 -58.09 -42.12 84.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.761 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.3 -38.77 84.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.094 -1.004 . . . . 0.0 109.972 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 2' ' ' SER . 86.0 m-20 -62.97 -40.66 98.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.19 -0.944 . . . . 0.0 109.95 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 94' ' ' LEU . 6.7 tt -57.98 -45.02 87.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 109.939 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.29 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.93 -1.106 . . . . 0.0 108.67 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 28.7 m -58.81 -39.17 80.37 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.488 -0.757 . . . . 0.0 109.469 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.06 -49.84 75.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.904 -1.122 . . . . 0.0 108.699 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.98 -33.4 75.5 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 34.3 tttm -56.5 -42.51 78.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.61 -40.25 91.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.539 -0.726 . . . . 0.0 109.627 -179.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.446 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 70.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.4 ptpt -130.89 164.03 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 109.218 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -42.02 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -66.57 134.98 33.1 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 85.2 p -64.98 -20.72 66.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 51.31 -141.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttm 55.61 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 109.725 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 3' ' ' ALA . 24.9 mttm -58.24 -45.53 87.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.033 -1.042 . . . . 0.0 109.636 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.49 -32.9 79.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.1 p -71.97 -34.82 69.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tp -57.07 -40.48 76.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.9 t80 -62.72 -47.57 83.01 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.11 -38.1 89.85 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.411 0.624 . . . . 0.0 110.033 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.4 p -69.02 -34.49 75.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 111.366 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -150.62 59.3 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.688 -1.258 . . . . 0.0 110.947 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.7 t -171.17 -50.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.82 -1.175 . . . . 0.0 110.36 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.11 -37.53 72.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.06 -1.025 . . . . 0.0 109.82 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.32 -35.98 72.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.13 -0.981 . . . . 0.0 109.827 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -95.33 -42.0 8.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.617 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -108.0 126.13 52.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' GLU . 52.7 p -86.98 -26.14 23.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.472 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t 64.02 -0.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.113 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.2 mt-10 -95.61 120.06 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -69.29 -39.74 78.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.85 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.58 -37.09 91.72 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.98 156.57 44.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.78 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.797 2.331 . . . . 0.0 111.755 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.423 ' HD1' ' H ' ' A' ' 31' ' ' ASN . 94.4 m-70 -104.89 134.5 47.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -101.37 -125.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.86 -39.62 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.05 166.03 18.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -62.06 150.5 86.29 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.879 2.386 . . . . 0.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 10.1 m120 -82.82 141.62 32.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.558 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.0 mp -99.68 137.26 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.786 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -171.71 98.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 108.907 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.11 8.56 81.79 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.45 -23.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.961 . . . . 0.0 109.535 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 86.6 m-85 -63.18 135.58 57.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 63.34 30.0 76.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.408 HH21 ' HB3' ' A' ' 42' ' ' GLN . 62.0 ttt180 -134.85 154.27 51.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -1.033 . . . . 0.0 109.843 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.64 145.94 24.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 56.9 p -67.88 163.42 21.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 0.0 110.151 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.08 -9.7 67.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HB3' HH21 ' A' ' 38' ' ' ARG . 95.5 mt-30 -96.85 6.05 49.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.92 -30.63 66.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.805 -1.185 . . . . 0.0 108.169 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 97.5 mt-10 38.05 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.431 0.634 . . . . 0.0 109.917 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.83 -26.65 2.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.94 143.31 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -1.013 . . . . 0.0 108.837 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -65.06 158.3 26.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 109.857 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 14.6 m-85 -116.65 138.3 51.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 109.713 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.0 m -74.88 144.92 43.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 108.974 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -50.56 -35.85 31.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.75 -69.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.7 t-20 -56.54 -41.41 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.086 -1.009 . . . . 0.0 110.564 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 mm -60.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.739 -1.226 . . . . 0.0 110.012 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -60.34 -33.88 73.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.205 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.4 tttm -127.26 112.65 15.33 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.593 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -100.07 137.96 37.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.589 ' H ' HD21 ' A' ' 56' ' ' ASN . 13.7 p -132.35 147.74 32.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 109.842 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.1 tp -79.04 134.22 36.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 108.811 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' GLY . 95.9 m95 -95.15 125.19 39.62 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.177 -0.952 . . . . 0.0 110.071 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 62' ' ' ASN . 46.3 p30 -155.41 -176.13 5.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -60.97 -39.59 90.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.939 -1.1 . . . . 0.0 111.013 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -74.94 -47.18 30.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.86 -1.15 . . . . 0.0 110.722 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 64.2 t30 -58.38 -42.1 86.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.499 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.645 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.3 mtt -62.41 -38.45 89.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 109.87 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.6 p -62.71 -40.82 98.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.257 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.08 -34.79 73.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.175 -0.953 . . . . 0.0 109.25 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.571 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.2 t60 -57.99 -44.15 86.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.561 -0.712 . . . . 0.0 109.471 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HB2' HH11 ' A' ' 91' ' ' ARG . 95.1 mt -67.64 -32.46 73.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -0.778 . . . . 0.0 110.597 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 m -55.77 -37.28 68.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.036 -1.04 . . . . 0.0 110.542 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.6 p-10 -167.56 69.04 0.9 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.434 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -50.15 -27.56 17.56 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.95 2.434 . . . . 0.0 112.636 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -58.44 6.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 109.321 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -61.94 -26.85 68.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.571 ' CD2' ' ND1' ' A' ' 67' ' ' HIS . 34.2 t80 -59.46 -54.78 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.631 -0.668 . . . . 0.0 109.643 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.96 70.19 35.68 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.077 -1.014 . . . . 0.0 109.97 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -52.81 135.47 57.43 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.429 2.086 . . . . 0.0 112.007 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.7 -0.55 56.65 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.847 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 80' ' ' MET . 8.4 t -89.2 161.24 16.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.653 -1.498 . . . . 0.0 109.62 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -85.66 1.41 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.424 ' H ' HG22 ' A' ' 78' ' ' THR . 15.4 ttp -77.85 125.52 29.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.002 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.3 79.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 64.4 t80 -103.21 131.68 50.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.47 -0.769 . . . . 0.0 109.68 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -71.22 144.97 38.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 147.64 34.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 55.2 mt -97.21 133.1 42.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -94.1 -9.18 37.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.929 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -99.28 128.42 45.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 110.024 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.0 -38.59 52.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -60.72 -49.64 76.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 110.21 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.76 -37.31 86.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.004 . . . . 0.0 109.444 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.8 ttm-85 -57.46 -45.3 84.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.719 . . . . 0.0 109.883 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -62.76 -39.93 95.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 85.7 m-20 -61.37 -39.64 91.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.186 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.36 -45.11 94.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 110.758 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.45 -41.8 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.008 -1.057 . . . . 0.0 109.579 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -58.15 -40.4 81.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 110.012 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -58.89 -50.88 72.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.372 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.627 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.589 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 80.6 tttt -56.72 -43.34 80.52 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -61.46 -43.58 98.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 0.0 109.4 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.673 -0.642 . . . . 0.0 109.748 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.452 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 49.9 t80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.213 0.53 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.452 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 32.9 ttpt -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.102 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.06 95.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -89.53 -176.42 45.81 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -105.86 129.47 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.165 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -68.51 -26.04 65.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -57.0 -46.97 81.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.027 -1.046 . . . . 0.0 110.15 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -66.49 -53.1 38.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.036 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.34 -28.21 72.72 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.61 -47.83 81.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.204 . . . . 0.0 109.761 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.9 p -73.65 -36.19 65.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.0 tp -58.16 -42.19 85.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -64.69 -46.67 81.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -63.43 -40.43 97.14 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.471 0.653 . . . . 0.0 110.396 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -72.5 -29.56 63.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 111.627 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.32 55.96 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.549 -1.344 . . . . 0.0 111.23 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.646 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.9 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.782 -1.199 . . . . 0.0 110.49 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.09 -37.62 69.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.54 -35.7 70.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 109.904 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -97.7 -42.6 7.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.646 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -105.31 122.69 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.144 -0.972 . . . . 0.0 110.505 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 21' ' ' GLU . 52.9 p -82.52 -18.62 40.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.8 p 39.7 21.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.701 -0.624 . . . . 0.0 110.047 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 18.8 pttm -67.2 -40.4 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.964 . . . . 0.0 109.546 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -62.62 -36.98 94.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.87 152.59 31.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.491 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 84.4 Cg_endo -77.16 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.712 2.275 . . . . 0.0 111.877 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -99.5 136.26 39.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.939 . . . . 0.0 109.258 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 36.0 tptt -106.48 -130.09 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.47 -41.1 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.58 161.96 15.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.477 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 12.2 Cg_endo -57.73 143.18 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.134 2.556 . . . . 0.0 111.938 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.5 m120 -76.43 146.31 38.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.61 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.3 mp -98.92 138.75 35.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.626 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -174.84 97.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.85 84.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 tt -58.89 -23.79 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.65 -0.912 . . . . 0.0 109.401 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -65.17 131.48 46.64 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.3 -0.875 . . . . 0.0 108.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.94 30.17 74.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -134.08 152.67 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -1.043 . . . . 0.0 109.931 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -93.37 145.23 24.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.316 -0.865 . . . . 0.0 108.999 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.579 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 53.4 p -66.79 158.52 30.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.956 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.37 -22.75 25.32 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -62.4 -36.34 82.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -1.205 . . . . 0.0 110.381 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.48 -44.86 92.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 109.892 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.12 -16.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.919 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -57.8 -34.65 71.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -123.25 143.37 50.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.597 -0.943 . . . . 0.0 109.168 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -64.76 159.39 22.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.98 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -118.41 146.52 44.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.563 -0.711 . . . . 0.0 109.554 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.9 p -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.38 -31.54 61.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 109.627 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.33 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.504 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.0 t-20 -55.8 -42.18 75.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.941 -1.1 . . . . 0.0 110.286 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.43 -45.65 96.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 120.895 -1.128 . . . . 0.0 109.519 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -60.51 -37.17 80.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.255 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 52' ' ' ASN . 40.0 tttm -128.28 118.87 24.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 14.9 t-20 -98.91 135.59 40.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 108.898 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.484 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 9.6 p -131.18 146.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.423 -0.798 . . . . 0.0 110.195 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.08 132.92 36.05 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -96.81 125.91 41.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.211 -0.931 . . . . 0.0 110.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 49.6 t0 -159.09 176.36 12.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.549 ' CD ' ' HZ1' ' A' ' 99' ' ' LYS . 97.2 mt-10 -55.35 -40.04 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.764 -1.21 . . . . 0.0 109.411 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.9 -52.22 26.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -62.85 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.611 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.5 mmt -58.75 -40.65 84.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.6 p -66.28 -37.56 85.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.19 -36.99 84.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.404 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -60.27 -45.68 92.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 109.84 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.17 -35.5 74.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.53 -0.731 . . . . 0.0 110.528 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 29.6 m -61.24 -39.2 89.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.912 -1.117 . . . . 0.0 110.829 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -152.92 67.99 6.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 109.788 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -61.96 -15.14 41.34 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.419 2.079 . . . . 0.0 112.675 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.03 -78.75 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.067 -1.021 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -57.22 -34.51 68.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.484 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 87.8 t80 -56.3 -50.34 71.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.954 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 20.7 mt -148.09 77.66 9.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.02 152.12 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 123.208 2.606 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.15 3.17 55.78 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.668 ' HG1' ' N ' ' A' ' 79' ' ' LYS . 6.2 t -104.65 174.73 5.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.154 -1.204 . . . . 0.0 109.539 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.668 ' N ' ' HG1' ' A' ' 78' ' ' THR . 47.3 mtmt -87.19 11.63 13.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.674 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.404 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -70.13 121.51 17.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.763 -1.21 . . . . 0.0 109.622 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.86 27.27 8.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.004 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 51.9 t80 -86.74 129.2 34.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.172 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -87.54 178.68 47.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.84 154.27 23.75 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.26 122.09 42.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -66.1 -36.4 83.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.87 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -92.08 128.92 38.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.02 -1.05 . . . . 0.0 110.36 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -29.59 60.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.65 -0.656 . . . . 0.0 109.91 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -55.39 -50.2 70.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -64.21 -37.94 89.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.945 . . . . 0.0 109.103 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.585 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 39.3 ttm180 -58.67 -42.47 88.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.649 -0.657 . . . . 0.0 110.116 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 88.9 m-20 -63.03 -39.51 94.96 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.055 -1.028 . . . . 0.0 110.285 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.98 -42.9 95.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.56 -38.45 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.8 m -60.7 -41.07 94.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.11 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.63 -51.88 68.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.115 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.17 -36.89 69.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HZ1' ' CD ' ' A' ' 61' ' ' GLU . 26.3 tptt -58.49 -45.68 88.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 mttm -58.78 -50.53 73.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.81 -1.181 . . . . 0.0 109.251 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 100' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 74.6 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -97.35 142.72 28.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.946 . . . . 0.0 109.154 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -60.75 138.69 58.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.203 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' -1' ' ' ALA . . . -42.46 104.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -56.82 -35.96 69.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -1.118 . . . . 0.0 109.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 173.9 -165.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 109.738 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -84.14 5.38 26.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.685 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.43 -43.31 71.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.744 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.98 -28.7 69.16 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.54 -46.4 88.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -1.044 . . . . 0.0 109.672 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.412 ' O ' ' CG2' ' A' ' 12' ' ' THR . 24.6 m -60.88 -41.47 96.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.135 -0.978 . . . . 0.0 108.694 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.48 -41.3 76.35 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -61.79 -47.13 86.53 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -64.33 -37.23 86.75 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.543 0.687 . . . . 0.0 109.697 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 8' ' ' THR . 57.2 p -66.28 -38.02 86.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 111.352 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -153.8 61.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.548 -1.345 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 5.3 t -171.48 -45.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.998 -1.064 . . . . 0.0 109.774 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.41 -37.34 75.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -58.15 -36.01 72.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.6 m -94.38 -42.8 8.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.517 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.43 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 91.4 m-70 -108.54 122.69 47.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.945 . . . . 0.0 110.023 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.501 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 30.9 p -87.8 -24.64 23.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t 51.17 36.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -103.52 148.43 25.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.9 -37.55 82.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.275 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.47 -30.6 58.96 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 64.16 58.58 10.24 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.96 -24.58 79.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.542 2.161 . . . . 0.0 111.822 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.591 ' H ' HD21 ' A' ' 31' ' ' ASN . 94.3 m-70 55.6 42.28 29.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -56.93 -36.09 69.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 108.847 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' CZ ' ' A' ' 46' ' ' TYR . 2.4 t -146.31 -76.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -0.818 . . . . 0.0 109.253 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -72.76 160.31 53.99 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.2 1.69 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.035 2.49 . . . . 0.0 112.561 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.591 HD21 ' H ' ' A' ' 26' ' ' HIS . 0.7 OUTLIER 66.56 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 109.769 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.1 mp -93.89 139.8 30.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -167.32 94.61 0.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.3 6.4 71.19 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.58 -21.3 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.984 . . . . 0.0 109.8 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.672 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 76.0 m-85 -64.44 131.47 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.93 27.99 73.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.689 ' NE ' ' NE2' ' A' ' 42' ' ' GLN . 63.4 mtp85 -144.94 168.89 19.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.948 -1.324 . . . . 0.0 110.189 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -94.21 157.76 15.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.945 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 59.5 p -67.31 163.71 20.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.69 -10.87 64.69 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.689 ' NE2' ' NE ' ' A' ' 38' ' ' ARG . 44.1 tt0 -61.65 -37.71 85.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.138 -1.213 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.62 140.19 51.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.222 -0.924 . . . . 0.0 109.715 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -126.52 148.59 49.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 109.352 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.4 -7.78 64.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CZ ' ' O ' ' A' ' 28' ' ' VAL . 73.9 t80 -129.42 134.59 47.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 109.426 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 49.8 m -67.73 156.28 37.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -111.88 140.0 46.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.775 . . . . 0.0 109.418 179.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.7 m -69.35 145.43 52.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.911 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.6 m-20 -51.66 -37.34 50.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.191 -0.943 . . . . 0.0 109.785 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -43.06 -74.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.314 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.5 t-20 -54.04 -40.9 67.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.191 -0.943 . . . . 0.0 110.744 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.83 -48.57 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.673 -1.267 . . . . 0.0 109.842 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -60.22 -33.84 72.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.7 tttm -127.53 114.88 18.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.582 -0.699 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.604 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -97.89 140.04 32.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.123 -0.986 . . . . 0.0 108.897 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.604 ' H ' HD21 ' A' ' 56' ' ' ASN . 13.2 p -132.45 147.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.435 -0.79 . . . . 0.0 110.259 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -80.78 130.0 34.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.5 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 95.6 m95 -92.44 118.46 30.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.147 -0.97 . . . . 0.0 110.31 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 59' ' ' TRP . 91.4 m-20 -140.86 -178.51 5.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -61.85 -38.3 87.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 110.033 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -76.87 -41.95 41.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.259 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.444 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 31.8 t30 -59.02 -42.51 90.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 110.249 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.672 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.4 mtt -63.11 -39.93 96.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.744 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.618 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 71.0 m -59.07 -40.51 85.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.631 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.62 -32.72 68.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.154 -0.966 . . . . 0.0 110.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -56.89 -51.17 70.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.416 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 84' ' ' GLY . 8.3 mp -71.05 -28.58 64.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.958 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.4 m -57.74 -38.12 74.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.945 . . . . 0.0 110.848 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -163.25 66.5 1.61 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.858 -1.151 . . . . 0.0 110.358 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 74' ' ' TYR . 31.7 Cg_exo -50.92 -18.88 4.78 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 C-N-CA 122.838 2.359 . . . . 0.0 112.464 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -76.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -57.95 -32.88 68.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.92 . . . . 0.0 109.467 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.507 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 50.4 t80 -79.56 126.68 31.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 108.997 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 60.1 mt 44.58 63.12 9.16 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.05 146.5 20.29 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.923 2.415 . . . . 0.0 112.451 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.19 16.41 47.29 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.762 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.9 t -106.89 151.67 24.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.064 -1.257 . . . . 0.0 109.908 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -58.78 -29.62 66.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 22.1 ttp -59.71 140.51 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.288 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.04 92.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.447 -0.783 . . . . 0.0 109.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -161.7 -46.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.592 ' N ' ' CD2' ' A' ' 82' ' ' PHE . . . -41.11 164.51 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 126.5 44.29 0.25 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -88.25 138.27 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -1.023 . . . . 0.0 109.301 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -90.34 -2.99 58.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -97.89 126.52 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.961 -1.087 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.54 -40.08 23.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.755 . . . . 0.0 110.158 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.47 -47.98 83.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.207 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.45 -42.44 95.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.618 ' NH1' ' CB ' ' A' ' 65' ' ' SER . 59.5 ttp85 -61.76 -41.55 97.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.15 -41.01 82.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 110.215 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.31 -38.26 90.45 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.137 -0.977 . . . . 0.0 109.849 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.14 -45.82 91.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 110.75 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.22 -44.35 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.894 -1.129 . . . . 0.0 109.697 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -64.35 -39.8 94.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.352 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -59.21 -43.77 92.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.05 -1.031 . . . . 0.0 110.657 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.39 -35.82 78.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.715 -1.241 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 74.0 mttt -56.94 -38.34 72.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.162 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -59.76 -45.06 93.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.338 -0.851 . . . . 0.0 109.263 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.765 . . . . 0.0 109.296 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 1' ' ' GLY . 16.0 ttmt -90.67 132.02 36.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.933 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.17 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.249 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -67.2 147.09 48.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 25.4 m -56.61 -33.19 66.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -1.162 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 2' ' ' SER . . . 75.97 -32.33 0.21 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.394 -0.816 . . . . 0.0 109.85 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 2' ' ' SER . 17.1 mttp -59.67 -51.37 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.085 -1.01 . . . . 0.0 109.203 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -65.04 -40.03 94.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.38 -34.56 89.68 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.23 89.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -1.211 . . . . 0.0 109.023 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 12' ' ' THR . 55.9 p -75.25 -38.28 60.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.89 . . . . 0.0 108.963 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -42.76 95.96 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 72.1 t80 -65.08 -46.43 81.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.4 -39.22 93.9 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.324 0.583 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 8' ' ' THR . 70.5 p -70.14 -31.27 68.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.832 . . . . 0.0 111.448 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -149.23 56.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.607 -1.308 . . . . 0.0 111.246 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.53 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.769 -1.207 . . . . 0.0 110.585 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.1 tp -56.66 -37.23 70.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.166 -0.959 . . . . 0.0 110.057 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.55 -35.29 67.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.0 m -98.31 -44.13 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 110.718 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -103.48 123.95 47.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 7.0 p -84.2 -24.6 30.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 109.28 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 19' ' ' THR . 13.9 p 42.24 41.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.351 -0.843 . . . . 0.0 110.072 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -100.53 158.27 16.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 109.187 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -68.44 143.44 55.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.403 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.87 -6.91 62.6 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 47.22 60.94 4.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 -28.05 85.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.37 2.046 . . . . 0.0 111.823 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.702 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 93.5 m-70 55.0 46.74 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -57.43 -35.11 69.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 108.652 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.96 -114.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.56 160.7 10.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.559 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 2.4 Cg_endo -53.89 137.35 68.25 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.776 1.651 . . . . 0.0 111.517 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 26' ' ' HIS . 98.2 m-20 -89.37 137.76 32.04 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -92.11 137.76 32.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 110.279 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -162.94 90.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 5.72 68.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.73 -21.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.556 -0.967 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -62.64 134.85 56.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.127 -0.983 . . . . 0.0 108.989 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 70.69 22.35 78.03 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -134.25 161.39 35.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -1.088 . . . . 0.0 110.147 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.6 153.49 18.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.595 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 26.8 p -66.09 158.39 28.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.888 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.34 -21.47 31.71 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.23 -36.08 78.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -1.157 . . . . 0.0 110.138 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.65 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -58.72 -44.81 90.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 109.606 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.68 -19.86 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.563 -0.71 . . . . 0.0 110.878 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -58.21 -34.25 73.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -124.06 142.33 51.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.962 . . . . 0.0 109.163 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -64.92 160.49 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 109.824 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 36.0 m-85 -116.44 149.93 38.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -75.47 162.01 28.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.05 -32.96 62.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.529 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.4 t-20 -54.0 -41.71 68.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.061 -1.024 . . . . 0.0 110.049 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 53' ' ' ILE . 97.4 mt -59.7 -47.19 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.869 -1.144 . . . . 0.0 109.213 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -60.99 -37.36 82.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.5 tttm -125.06 117.07 23.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.536 -0.728 . . . . 0.0 109.415 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 15.9 t-20 -100.25 137.27 38.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.953 . . . . 0.0 109.023 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.451 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 11.3 p -131.17 147.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.446 -0.783 . . . . 0.0 110.196 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 63.4 tp -77.97 132.95 38.07 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.3 m95 -96.59 126.96 42.14 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.213 -0.93 . . . . 0.0 110.133 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.403 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 51.5 t0 -156.06 171.66 19.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.58 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 97.1 mt-10 -58.07 -39.07 77.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 109.547 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -72.52 -48.04 43.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.067 -1.02 . . . . 0.0 109.256 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 35.5 t30 -60.81 -37.16 81.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.453 -0.78 . . . . 0.0 109.937 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.8 mmt -58.65 -40.68 84.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 0.0 109.702 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.6 p -64.12 -35.43 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.114 -0.991 . . . . 0.0 109.339 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.22 -35.12 78.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 0.0 109.353 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.422 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 78.3 t60 -59.05 -47.09 86.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.489 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 20.7 mt -67.97 -29.57 68.64 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.058 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -59.28 -37.91 78.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 111.024 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.53 65.49 2.0 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 110.238 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -52.44 -21.29 13.54 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -77.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.954 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -57.45 -36.11 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.451 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 74.2 t80 -57.22 -51.29 69.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 19.3 mt -148.29 76.49 10.17 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.198 -0.939 . . . . 0.0 108.621 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.9 148.81 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.103 2.535 . . . . 0.0 112.262 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.74 9.4 52.66 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.375 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 80' ' ' MET . 8.8 t -108.42 169.37 8.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 109.378 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -84.32 9.18 13.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.927 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.422 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 1.4 mtm -69.35 118.32 12.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.631 -1.293 . . . . 0.0 109.657 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.08 28.01 7.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 108.833 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.0 t80 -85.01 131.28 34.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.822 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.95 144.12 30.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 68' ' ' LEU . . . -75.9 142.86 29.22 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 mt -101.39 141.55 34.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -1.074 . . . . 0.0 108.971 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -82.64 -78.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.079 -1.013 . . . . 0.0 108.784 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -142.65 120.33 11.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 90' ' ' ASP . 82.4 tt0 -161.75 147.33 13.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -56.71 -34.58 67.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.193 -0.942 . . . . 0.0 108.657 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.402 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 90.5 m-20 -57.39 -38.21 73.91 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.308 -0.87 . . . . 0.0 108.9 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.53 -45.95 84.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 108.992 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -65.51 -43.45 90.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.466 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 2' ' ' SER . 84.7 m-20 -67.07 -39.56 86.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.334 -0.854 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.98 -45.87 78.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.737 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.16 -40.56 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.042 -1.036 . . . . 0.0 108.903 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.7 m -60.2 -39.66 87.32 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.711 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -58.66 -50.31 74.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 109.283 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.28 -31.98 70.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 108.452 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.58 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 34.4 tttt -55.99 -46.2 78.77 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.28 -46.64 85.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.67 -179.628 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -86.25 129.47 34.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.052 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.47 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.105 -0.997 . . . . 0.0 109.286 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.421 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -104.07 126.43 8.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -61.2 137.9 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -1.212 . . . . 0.0 109.296 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -78.13 -19.24 54.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.986 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -58.38 -48.75 79.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 110.066 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -65.69 -50.77 63.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.45 -32.1 83.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -56.68 -43.91 80.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.592 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.511 ' HG1' ' N ' ' A' ' 9' ' ' LEU . 52.0 p -71.87 -37.59 70.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.511 ' N ' ' HG1' ' A' ' 8' ' ' THR . 9.1 tp -58.75 -40.92 85.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.82 -47.02 85.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -63.42 -38.85 92.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.386 0.613 . . . . 0.0 109.963 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 p -69.68 -33.54 72.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 0.0 111.391 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -149.68 58.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.579 -1.326 . . . . 0.0 110.946 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.1 t -172.33 -54.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.832 -1.168 . . . . 0.0 110.291 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 -38.07 70.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.994 -1.067 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.79 -35.43 72.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.832 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m -96.07 -43.61 7.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.514 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.88 123.73 48.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.561 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 50.4 p -86.75 -23.37 25.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 0.0 109.298 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 19' ' ' THR . 16.0 t 40.37 67.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.918 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.76 143.92 40.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.782 . . . . 0.0 109.317 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -64.23 -35.1 79.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.05 49.49 0.72 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.82 166.99 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.3 Cg_endo -74.1 -171.02 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.054 2.503 . . . . 0.0 112.021 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -105.57 134.68 48.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 29' ' ' GLY . 79.7 tttt -131.35 129.72 41.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.78 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.9 t 53.81 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.222 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -101.89 161.54 17.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.24 154.16 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.151 2.567 . . . . 0.0 112.361 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.561 ' ND2' ' HG1' ' A' ' 19' ' ' THR . 13.9 m120 -84.13 133.65 34.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.255 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.8 mp -99.7 133.99 43.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 109.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -161.44 102.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 108.81 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 80.46 9.88 85.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.57 -21.32 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.599 -0.942 . . . . 0.0 109.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.71 132.98 51.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.203 -0.935 . . . . 0.0 109.495 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.04 26.11 73.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 90.2 mtt-85 -134.37 165.0 26.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -1.095 . . . . 0.0 110.021 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -100.04 147.33 25.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.582 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 9.5 m -61.3 152.89 27.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 110.118 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.51 -7.73 74.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.402 HE22 ' HD3' ' A' ' 38' ' ' ARG . 45.0 tt0 -64.03 -39.11 93.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.029 -1.277 . . . . 0.0 110.273 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.75 -45.44 92.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.0 -1.063 . . . . 0.0 109.556 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 58.97 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.659 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -60.96 -34.88 89.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 47' ' ' SER . 64.9 t80 -111.68 135.91 51.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -1.052 . . . . 0.0 109.352 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 35.0 m -62.57 153.79 30.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -116.03 148.95 39.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -76.52 164.38 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.64 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -34.28 64.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 110.147 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.095 -1.003 . . . . 0.0 110.442 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 22.8 t-20 -55.04 -41.3 71.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.971 -1.081 . . . . 0.0 110.271 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.88 -54.54 33.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.793 -1.192 . . . . 0.0 109.34 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.15 -40.39 95.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.084 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 56.4 tttm -111.43 111.96 23.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.197 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.54 136.73 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.524 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 13.4 p -131.11 147.37 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.866 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 6.2 tt -79.24 128.43 33.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.582 ' NE1' ' OG ' ' A' ' 40' ' ' SER . 87.8 m95 -91.63 108.22 19.75 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 52.4 p30 -136.49 176.25 8.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.588 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -61.91 -41.69 98.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.357 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.78 -51.69 60.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 110.333 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.489 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 38.3 t30 -61.42 -35.89 78.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.63 -41.43 77.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 109.648 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.5 m -63.24 -42.16 99.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.56 -36.9 83.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.598 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 79.6 t60 -57.76 -43.62 85.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.54 -28.84 70.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.464 -0.773 . . . . 0.0 109.68 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.551 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 10.0 m -81.89 125.37 30.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.2 m-20 37.52 61.55 3.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.718 . . . . 0.0 110.342 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.9 -21.52 73.2 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.645 2.23 . . . . 0.0 112.943 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.67 16.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -62.14 -36.32 81.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.54 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.524 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 84.0 t80 -59.9 -51.68 68.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 110.302 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 3.0 mm -141.18 79.55 17.74 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.32 152.22 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.112 2.542 . . . . 0.0 112.735 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.17 -1.82 59.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.505 ' HG1' ' H ' ' A' ' 80' ' ' MET . 15.0 p -100.57 166.54 10.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.305 . . . . 0.0 109.949 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -81.67 2.77 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 109.342 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.598 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 10.6 ttt -83.57 128.38 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.847 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.61 86.78 2.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.212 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -103.07 131.64 49.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.316 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.64 145.43 38.64 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.12 32.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 52.6 mt -95.87 124.74 40.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -65.13 -35.94 82.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.795 . . . . 0.0 110.092 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.47 129.8 39.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -74.81 -33.9 62.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.576 -0.703 . . . . 0.0 109.583 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.405 ' HG2' ' HZ1' ' A' ' -2' ' ' LYS . 18.4 mttp -57.2 -39.48 75.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.02 -38.08 81.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.253 -0.904 . . . . 0.0 108.936 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 85.5 mtt180 -61.47 -39.26 90.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -59.88 -40.5 88.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.6 m-20 -64.63 -41.36 96.21 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.088 -1.008 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.69 -43.34 99.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.787 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 95' ' ' ILE . 89.0 mt -64.78 -35.95 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 108.899 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -56.51 -41.12 76.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 109.913 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -64.07 -54.78 28.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.011 . . . . 0.0 110.299 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.08 -37.3 81.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.874 -1.141 . . . . 0.0 108.892 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.588 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 29.7 tttt -57.71 -40.03 78.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -59.65 -39.92 85.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.811 . . . . 0.0 109.413 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.439 -0.788 . . . . 0.0 109.577 -179.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 82.2 t80 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.23 0.538 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -90.48 133.12 35.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -57.11 127.69 33.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.176 -0.953 . . . . 0.0 109.387 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.465 ' CA ' ' HG1' ' A' ' 96' ' ' THR . . . -42.31 137.67 2.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -58.24 -36.71 73.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.416 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.485 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -177.24 -146.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.7 7.5 29.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 109.896 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -54.81 -43.89 73.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 108.98 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.581 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -62.17 -29.29 72.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.86 -42.82 90.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -1.094 . . . . 0.0 109.492 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.448 ' O ' ' CG2' ' A' ' 12' ' ' THR . 52.0 p -67.35 -36.9 82.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.118 -0.989 . . . . 0.0 108.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.84 -40.02 83.0 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.689 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.6 t80 -66.08 -48.55 70.59 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -62.89 -38.76 92.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 8' ' ' THR . 68.5 p -68.17 -32.7 73.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -151.27 59.2 0.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.664 -1.273 . . . . 0.0 111.014 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.689 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.06 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.755 -1.216 . . . . 0.0 110.61 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.85 -38.69 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.0 -35.94 67.36 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 109.801 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.04 -43.03 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.988 . . . . 0.0 110.985 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.465 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.0 m-70 -105.36 129.29 53.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.185 -0.947 . . . . 0.0 110.48 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' A' ' 21' ' ' GLU . 46.8 p -89.9 -19.19 24.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 0.0 109.495 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.547 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 4.3 t 60.93 20.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.55 ' H ' ' HG1' ' A' ' 19' ' ' THR . 84.4 tt0 -104.46 138.06 41.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -59.67 -39.07 83.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.935 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.3 28.78 11.79 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -61.23 154.22 37.76 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.71 -3.22 13.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.891 2.394 . . . . 0.0 112.263 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 27' ' ' LYS . 79.5 m-70 59.01 66.26 1.08 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 26' ' ' HIS . 29.9 tttp -58.04 -122.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.688 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.04 -39.78 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.929 -1.107 . . . . 0.0 109.572 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.24 162.79 14.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 18.0 Cg_endo -62.59 154.31 65.81 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.966 2.444 . . . . 0.0 112.253 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.45 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 6.8 m120 -86.22 134.19 33.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.113 -0.992 . . . . 0.0 109.122 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 33' ' ' HIS . 9.7 mp -89.58 -112.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 20' ' ' VAL . 10.6 t60 79.33 90.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.797 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.73 5.45 66.58 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -57.81 -20.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 90.4 m-85 -63.1 135.36 57.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.97 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 68.54 25.56 74.85 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HD3' HE22 ' A' ' 42' ' ' GLN . 87.2 mtt180 -135.16 157.96 45.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -1.115 . . . . 0.0 110.057 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -91.57 152.09 20.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.621 ' HG ' ' ND2' ' A' ' 56' ' ' ASN . 60.6 p -65.77 157.75 29.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.07 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.94 -13.59 67.1 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.404 HE22 ' HD3' ' A' ' 38' ' ' ARG . 48.1 tt0 -62.58 -37.51 86.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -1.192 . . . . 0.0 110.208 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.5 140.08 35.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.118 -0.988 . . . . 0.0 109.513 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.92 153.16 34.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.56 -0.713 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.81 63.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.3 t80 -140.26 168.22 20.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.215 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -111.86 150.58 30.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.0 109.956 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -109.19 151.35 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 109.513 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -75.43 157.96 33.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.08 -33.33 70.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -63.73 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.39 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.5 t-20 -55.46 -44.17 76.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.04 -1.037 . . . . 0.0 110.164 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.27 -47.11 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.948 -1.095 . . . . 0.0 110.056 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -60.04 -38.57 83.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -91.75 -66.14 0.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.623 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.621 ' ND2' ' HG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 66.1 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.32 -0.862 . . . . 0.0 108.922 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.77 149.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.36 131.55 41.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -96.79 125.69 41.42 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.167 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 50.8 p30 -152.22 179.81 8.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -59.35 -42.19 90.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.729 -1.232 . . . . 0.0 110.647 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -67.98 -49.27 62.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.024 -1.048 . . . . 0.0 110.869 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 58.3 t30 -60.34 -41.41 93.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 111.271 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.656 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 61.5 mtt -61.12 -37.62 83.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.905 -1.122 . . . . 0.0 110.276 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -60.97 -43.38 98.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.018 -1.051 . . . . 0.0 109.678 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.1 -36.7 77.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.013 -1.054 . . . . 0.0 109.169 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -60.01 -46.14 90.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.53 -31.46 72.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 110.063 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 13.1 m -85.79 127.12 34.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.943 -1.098 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.0 m120 39.8 58.61 6.91 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.429 -0.794 . . . . 0.0 110.192 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.81 -20.81 53.76 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.792 2.328 . . . . 0.0 112.959 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.87 6.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.078 -1.014 . . . . 0.0 110.083 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -61.68 -33.52 74.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 109.575 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -48.74 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.596 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.558 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 4.2 tp -152.82 82.08 5.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.271 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.91 151.34 35.44 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.314 2.009 . . . . 0.0 112.338 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.76 1.08 58.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 p -93.21 165.72 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -92.28 14.58 15.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.143 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.3 mtm -78.9 134.46 36.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 110.078 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.05 27.13 9.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.486 -0.759 . . . . 0.0 109.048 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.53 130.56 37.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 108.94 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.68 179.29 44.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.69 146.12 23.17 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -96.02 118.14 32.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -1.195 . . . . 0.0 109.338 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -64.97 -38.48 91.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.78 128.45 34.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.0 110.351 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.4 -29.27 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.895 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -55.65 -47.11 77.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.152 -0.968 . . . . 0.0 110.093 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -63.57 -38.94 93.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.907 -1.121 . . . . 0.0 108.801 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 38.5 ttm180 -60.85 -45.19 95.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.551 -0.718 . . . . 0.0 110.035 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -66.66 -48.79 68.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 45.7 t0 -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 109.869 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.8 tp -54.79 -47.03 74.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 0.0 110.108 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.35 -40.77 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.044 . . . . 0.0 109.266 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.465 ' HG1' ' CA ' ' A' ' 1' ' ' GLY . 40.1 m -59.18 -41.83 89.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.805 . . . . 0.0 110.078 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.4 -49.57 77.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.863 -1.148 . . . . 0.0 108.932 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.13 -32.06 72.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 108.562 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 41.3 tttm -54.82 -43.75 73.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -62.02 -43.22 99.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.376 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.645 -0.659 . . . . 0.0 109.899 -179.639 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -111.19 162.19 15.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.474 -0.766 . . . . 0.0 109.335 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 109.5 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.69 125.64 8.58 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 4' ' ' LYS . 86.1 p -60.98 -27.75 68.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.56 -21.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 2' ' ' SER . 33.8 tttt -58.82 -51.52 69.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.426 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -65.57 -42.23 92.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 109.201 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -61.72 -34.96 90.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.02 83.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -1.211 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.3 p -74.57 -38.65 62.61 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.05 -41.8 88.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.6 t80 -63.97 -45.91 87.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -62.78 -38.6 91.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.404 0.621 . . . . 0.0 110.267 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -72.25 -29.6 64.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 111.663 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -147.72 53.49 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.468 -1.395 . . . . 0.0 111.479 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.5 t -173.48 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.724 -1.235 . . . . 0.0 110.774 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.66 -37.55 70.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.079 -1.013 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.97 -34.8 68.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.769 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.5 m -98.14 -43.58 6.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.678 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.437 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -104.16 128.51 51.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.411 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.488 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 44.7 p -93.95 -15.71 24.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.5 t 42.26 36.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -101.16 141.06 34.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.276 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -76.15 -82.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 110.203 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.58 24.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.48 150.84 49.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 72.7 Cg_endo -76.43 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.676 2.251 . . . . 0.0 111.773 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -104.03 134.66 46.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.027 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 29' ' ' GLY . 46.1 tptt -130.51 133.01 45.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.0 109.307 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t 53.9 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.11 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -103.87 158.7 16.9 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 15.6 Cg_endo -57.01 146.78 78.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.059 2.506 . . . . 0.0 112.341 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 18.6 m120 -74.1 135.55 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.001 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.17 11.48 36.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -52.22 -32.39 36.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.197 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.42 56.05 0.68 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -111.77 2.34 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 48.7 m-85 -82.33 129.18 34.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.985 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.24 31.06 73.94 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -145.77 168.25 21.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.171 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.31 156.32 16.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.363 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.612 ' HG ' ' N ' ' A' ' 41' ' ' GLY . 59.5 p -58.71 -39.65 81.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 109.739 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' HG ' ' A' ' 40' ' ' SER . . . -65.45 -33.18 85.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.26 -36.22 72.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -1.115 . . . . 0.0 110.737 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -59.08 -32.02 69.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.892 -1.13 . . . . 0.0 109.686 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' ALA . 78.7 mm-40 42.84 -167.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.98 -41.9 2.45 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 47' ' ' SER . 71.8 t80 -123.53 136.1 54.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 109.333 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 55.1 p -69.35 159.34 33.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CZ ' ' O ' ' A' ' 40' ' ' SER . 95.4 m-85 -118.27 146.72 44.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.409 -0.807 . . . . 0.0 109.879 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 61.4 m -69.75 151.88 45.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.392 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.79 -33.27 7.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.49 -68.55 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.491 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 28.7 t-20 -56.58 -41.81 77.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.1 . . . . 0.0 110.295 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.8 -44.32 97.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.11 -37.14 76.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 108.785 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.0 tttt -127.14 112.3 15.0 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.501 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -97.95 134.79 40.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' H ' HD21 ' A' ' 56' ' ' ASN . 12.5 p -130.84 145.76 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.657 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.7 tp -79.89 132.81 36.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.243 -0.91 . . . . 0.0 108.774 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -94.98 124.74 39.2 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 109.778 -179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 55.2 t0 -148.18 163.41 37.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.4 mt-10 -52.51 -40.76 62.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.919 -1.113 . . . . 0.0 109.483 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.05 -48.19 66.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 0.0 110.164 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -61.52 -38.83 88.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 110.732 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 63.1 mtt -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.079 -1.013 . . . . 0.0 109.844 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.5 p -60.9 -40.53 93.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 108.964 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.81 -35.12 79.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.107 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.751 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 69.8 t60 -61.37 -45.66 93.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 109.868 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.536 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 17.6 m -86.01 126.15 33.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.85 -1.157 . . . . 0.0 108.725 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.569 ' N ' HD21 ' A' ' 70' ' ' ASN . 0.9 OUTLIER 41.77 59.33 9.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.272 -0.892 . . . . 0.0 109.751 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.52 -23.21 74.78 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.762 2.308 . . . . 0.0 112.747 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -60.55 -49.26 78.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.041 . . . . 0.0 109.609 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -64.16 -30.52 71.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.474 ' CG ' ' ND1' ' A' ' 67' ' ' HIS . 31.2 t80 -52.35 -46.12 66.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 108.936 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 77' ' ' GLY . 1.6 pt -141.05 153.35 66.99 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.54 -7.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.085 1.857 . . . . 0.0 112.018 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 84.02 48.41 5.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.565 ' CG2' ' H ' ' A' ' 79' ' ' LYS . 4.9 t -56.81 -118.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.007 . . . . 0.0 109.974 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.565 ' H ' ' CG2' ' A' ' 78' ' ' THR . 45.4 mtmt -89.64 1.46 55.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.188 -0.945 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.751 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 7.3 mmm -75.17 118.54 18.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 108.959 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.13 32.03 5.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.457 -0.777 . . . . 0.0 110.17 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 60.2 t80 -87.53 130.47 34.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.256 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.535 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.41 179.77 49.35 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.36 157.27 23.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.4 mt -102.46 119.03 38.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -1.14 . . . . 0.0 109.346 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -66.32 -35.72 81.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 69.0 mttm -90.32 130.76 36.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 110.294 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.03 -29.56 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.999 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.62 -52.1 66.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 91' ' ' ARG . 53.3 p30 -64.47 -30.29 71.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.639 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 39.2 ttm180 -59.45 -43.69 93.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.142 -0.974 . . . . 0.0 109.859 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -65.46 -40.5 93.26 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -0.944 . . . . 0.0 110.17 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -47.0 84.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.113 -0.992 . . . . 0.0 110.186 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.33 -36.17 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.011 -1.055 . . . . 0.0 108.684 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.6 m -57.68 -41.43 81.57 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.403 -0.811 . . . . 0.0 109.674 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -50.87 71.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 109.0 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.74 -32.77 74.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 108.384 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.471 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 19.2 tttt -57.33 -41.63 80.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.48 -40.34 90.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 0.0 109.652 -179.828 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.329 0.585 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 1' ' ' GLY . 15.5 ttmt -92.27 131.54 37.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.406 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.265 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -71.11 156.47 53.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 23.7 m -56.28 -33.26 65.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 2' ' ' SER . . . 72.05 -41.04 0.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.8 tttt -58.98 -51.21 71.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.041 -1.037 . . . . 0.0 109.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -64.0 -43.13 96.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.098 -1.001 . . . . 0.0 108.984 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.97 -32.73 85.18 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.64 -42.65 79.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.192 -1.181 . . . . 0.0 109.007 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 12' ' ' THR . 52.7 p -74.19 -33.48 63.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.34 -0.85 . . . . 0.0 109.119 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -42.18 95.2 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.685 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.0 t80 -69.07 -47.37 65.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -62.67 -39.24 93.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.67 -0.644 . . . . 0.0 110.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 8' ' ' THR . 73.3 p -69.36 -32.53 71.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 111.399 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -150.76 58.06 0.93 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.53 -1.356 . . . . 0.0 111.526 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.685 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 6.3 t -170.59 -43.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.757 -1.215 . . . . 0.0 110.128 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.54 -35.91 73.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 109.656 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.8 -37.21 73.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.5 m -93.25 -41.3 9.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.556 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 87.4 m-70 -107.73 127.08 53.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.402 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.652 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 43.2 p -87.69 -20.39 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.613 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t 57.65 29.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 110.189 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.17 149.06 25.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -60.47 -36.22 77.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 109.337 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.98 41.31 1.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -62.81 156.49 40.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -4.74 15.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.953 2.435 . . . . 0.0 112.196 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 27' ' ' LYS . 73.1 m-70 60.49 65.85 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 26' ' ' HIS . 14.6 tttt -57.04 -118.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.83 -40.36 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.68 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.76 162.86 19.91 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 16.6 Cg_endo -60.6 150.52 81.46 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.917 2.411 . . . . 0.0 111.952 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.652 ' ND2' ' HG1' ' A' ' 19' ' ' THR . 5.4 m120 -81.24 140.46 34.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.292 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.556 ' CD1' ' ND1' ' A' ' 18' ' ' HIS . 5.9 mp -98.28 140.85 31.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.024 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -171.18 97.01 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.427 -0.795 . . . . 0.0 109.064 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.29 6.76 74.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -58.81 -23.37 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.523 -0.986 . . . . 0.0 109.81 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.74 133.74 51.7 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.08 78.91 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HG3' HE22 ' A' ' 42' ' ' GLN . 64.5 mmt-85 -135.81 161.55 35.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -1.091 . . . . 0.0 109.711 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -88.78 156.69 18.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.558 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 1.8 t -61.07 149.36 37.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.81 63.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.4 HE22 ' HG3' ' A' ' 38' ' ' ARG . 51.9 tt0 -60.59 -38.34 84.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -1.218 . . . . 0.0 109.859 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.18 139.13 48.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.083 -1.01 . . . . 0.0 109.069 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -117.79 150.62 38.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 109.434 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.45 62.85 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.7 t80 -136.25 157.83 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.3 t -98.77 148.52 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -109.81 141.67 42.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.509 -0.744 . . . . 0.0 110.043 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.7 m -73.47 146.94 44.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 109.333 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.2 m-20 -51.7 -36.31 46.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.766 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -42.71 -71.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.034 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 56' ' ' ASN . 26.9 t-20 -52.88 -40.12 63.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 0.0 110.367 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.8 -54.17 32.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.862 -1.149 . . . . 0.0 109.415 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -62.47 -38.52 90.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.084 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.2 mttm -99.26 25.44 6.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.475 -0.766 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -43.64 126.55 4.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.018 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.4 ' N ' HD21 ' A' ' 56' ' ' ASN . 12.5 p -135.53 152.11 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 110.122 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -71.2 133.63 46.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.558 ' HE1' ' CB ' ' A' ' 40' ' ' SER . 98.1 m95 -96.41 123.76 40.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.229 -0.92 . . . . 0.0 110.107 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 55.1 p30 -152.93 176.66 11.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -60.11 -39.37 85.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.128 . . . . 0.0 110.665 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -70.37 -56.44 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.926 -1.109 . . . . 0.0 110.47 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.567 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 46.2 t30 -59.55 -38.8 82.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.66 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.5 mmt -59.29 -40.53 86.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.961 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 m -60.16 -40.37 89.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.17 -33.2 75.23 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.949 -1.095 . . . . 0.0 109.446 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.504 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 71.3 t60 -59.74 -47.72 84.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.376 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 8.1 mp -67.84 -30.54 69.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.584 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 28.1 m -60.74 -38.82 86.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.908 -1.12 . . . . 0.0 110.41 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -154.15 67.03 5.62 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.049 . . . . 0.0 109.796 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.27 -22.04 72.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.571 2.181 . . . . 0.0 113.061 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 -71.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.974 -1.079 . . . . 0.0 109.651 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -59.7 -24.28 63.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' ND1' ' A' ' 67' ' ' HIS . 18.6 t80 -55.36 -46.29 76.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.922 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.1 pt -142.47 78.78 16.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.155 -0.966 . . . . 0.0 109.91 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -69.25 137.42 36.9 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 C-N-CA 123.039 2.492 . . . . 0.0 111.94 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.71 2.79 62.86 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.538 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 80' ' ' MET . 8.8 t -98.6 170.4 8.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.295 . . . . 0.0 109.675 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -90.94 13.89 15.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.908 . . . . 0.0 110.603 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.504 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -74.67 122.48 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.75 30.59 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.016 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 63.9 t80 -89.69 131.15 35.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.044 -1.035 . . . . 0.0 109.406 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -85.88 176.37 49.12 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.37 159.45 25.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.98 122.98 44.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 0.0 109.293 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.49 -35.59 81.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.98 128.51 36.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 110.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -28.51 60.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 109.889 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -55.6 -47.33 76.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.185 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.32 -39.16 93.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.886 -1.134 . . . . 0.0 108.898 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.584 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.6 ttp180 -61.0 -43.41 98.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -58.63 -47.21 85.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.009 -1.057 . . . . 0.0 109.62 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 2' ' ' SER . 88.7 m-20 -66.79 -39.42 87.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' CD2' ' C ' ' A' ' 94' ' ' LEU . 6.7 tt -57.92 -45.84 85.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.12 -36.79 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.015 -1.053 . . . . 0.0 108.344 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.0 m -57.24 -41.32 79.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.594 -0.691 . . . . 0.0 109.59 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -62.29 -52.53 63.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.28 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.19 -32.92 74.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 108.495 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 13.8 tttp -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.561 -0.712 . . . . 0.0 109.091 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -61.15 -39.89 91.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.436 -0.79 . . . . 0.0 109.538 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.54 -0.725 . . . . 0.0 109.718 -179.59 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.415 0.626 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.571 ' O ' ' CB ' ' A' ' -1' ' ' ALA . 35.0 ttpt -49.97 -56.82 9.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.221 -0.924 . . . . 0.0 111.176 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' -2' ' ' LYS . . . 160.88 28.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.426 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -39.83 98.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' -1' ' ' ALA . 40.4 p -129.25 34.57 4.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.48 149.2 23.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 110.285 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -56.43 -25.73 51.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.584 -0.697 . . . . 0.0 109.762 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -45.52 -50.92 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.234 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.62 -34.83 87.76 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.7 72.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.126 . . . . 0.0 109.476 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -61.25 -39.12 89.16 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.274 -0.892 . . . . 0.0 108.761 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tp -53.98 -41.63 68.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.4 t80 -61.25 -47.04 87.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.44 -38.03 89.58 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.638 . . . . 0.0 109.933 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.4 p -68.11 -36.32 79.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.48 -0.763 . . . . 0.0 111.315 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -151.9 61.23 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.0 110.712 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -172.37 -47.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.959 -1.088 . . . . 0.0 110.161 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.21 -37.67 72.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.818 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -58.14 -35.25 71.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 109.866 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.2 m -96.57 -42.5 8.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.7 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.439 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 93.5 m-70 -109.19 124.04 50.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.947 . . . . 0.0 109.881 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.579 ' C ' ' H ' ' A' ' 21' ' ' GLU . 36.3 p -89.03 -18.18 27.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 t 61.84 -8.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 19' ' ' THR . 97.1 mt-10 -60.67 136.56 58.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.924 -1.11 . . . . 0.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -78.54 -39.67 37.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.83 -7.78 55.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.77 155.72 52.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.44 -166.52 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.723 2.282 . . . . 0.0 111.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -101.3 90.41 4.1 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -59.99 -41.7 92.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.108 -0.995 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.39 -71.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.546 -0.721 . . . . 0.0 109.153 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -76.65 159.62 49.91 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 5.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 112.834 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER 64.78 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 110.126 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.6 mp -95.92 143.48 27.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -172.51 91.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 109.045 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.38 6.35 74.28 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.73 -20.19 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.478 -1.013 . . . . 0.0 109.609 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.6 m-85 -60.4 131.31 50.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.95 29.45 73.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.416 ' HD3' HE22 ' A' ' 42' ' ' GLN . 89.6 mtt180 -140.52 164.41 30.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -1.226 . . . . 0.0 110.255 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -92.69 159.59 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 0.0 109.705 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.427 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 22.6 t -71.03 154.22 41.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.073 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.96 51.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.416 HE22 ' HD3' ' A' ' 38' ' ' ARG . 49.7 tt0 -62.54 -36.09 81.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.272 . . . . 0.0 109.95 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -58.7 -32.74 69.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 109.716 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ALA . 95.6 mt-10 42.04 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.17 -39.39 1.63 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.449 ' H ' ' C ' ' A' ' 44' ' ' GLU . 63.7 t80 -116.15 134.1 55.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.488 -1.007 . . . . 0.0 108.99 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 45.6 m -63.12 153.16 35.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.967 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -114.5 145.89 41.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.514 -0.741 . . . . 0.0 109.359 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -79.39 166.55 21.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.19 -31.7 61.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.771 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.67 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.741 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.6 t-20 -55.87 -41.33 74.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.12 -0.988 . . . . 0.0 110.79 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.44 -50.27 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.912 -1.118 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -59.89 -36.52 77.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.5 ttpp -128.01 117.43 21.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.536 -0.728 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.64 136.73 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 108.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.415 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.06 147.32 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -75.63 132.25 40.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 76.1 m95 -93.69 125.88 38.55 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.052 -1.03 . . . . 0.0 109.841 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.7 t0 -152.74 170.35 20.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -55.77 -39.93 71.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.765 -1.21 . . . . 0.0 109.498 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -66.19 -48.25 71.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -63.97 -40.41 96.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 110.791 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.9 mtt -60.79 -38.7 86.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 110.075 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -60.75 -45.48 94.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 109.216 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.69 -33.37 75.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.951 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.46 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 57.8 t60 -57.76 -44.04 85.86 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.509 -0.744 . . . . 0.0 109.158 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.43 -25.38 65.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.549 -0.719 . . . . 0.0 109.852 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.589 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 24.5 m -85.43 131.05 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.013 -1.054 . . . . 0.0 109.836 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.551 HD22 ' HZ2' ' A' ' 73' ' ' LYS . 9.9 t30 38.8 56.6 5.45 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 0.0 110.713 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.76 -14.75 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.773 2.315 . . . . 0.0 112.222 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.19 72.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 109.762 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HZ2' HD22 ' A' ' 70' ' ' ASN . 17.8 mttp -84.83 3.9 35.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.144 -0.972 . . . . 0.0 109.04 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -108.31 124.52 50.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.405 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 74' ' ' TYR . 44.7 pt 38.23 54.09 4.0 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.463 -0.773 . . . . 0.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 75' ' ' ILE . 18.2 Cg_endo -61.33 -18.65 60.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.756 2.304 . . . . 0.0 112.249 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.27 21.88 29.4 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.4 p -116.03 156.01 27.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.278 -1.131 . . . . 0.0 110.043 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 80' ' ' MET . 22.8 mttm -60.31 -29.93 69.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.46 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 4.7 ttt -38.62 115.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.43 0.633 . . . . 0.0 110.351 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.17 29.38 8.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.25 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 54.9 t80 -65.63 134.42 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.434 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.25 179.21 49.47 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.56 151.46 21.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.2 mt -105.07 121.34 43.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -1.113 . . . . 0.0 109.626 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -66.74 -34.03 76.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -84.07 116.7 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 109.994 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HB3' HH21 ' A' ' 91' ' ' ARG . 97.3 mt-10 -72.22 -35.88 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.83 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -58.43 -38.74 78.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.687 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.19 -37.27 77.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 80.6 mtm180 -60.03 -43.02 95.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -57.58 -42.61 83.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 110.828 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD1' ' CA ' ' A' ' 1' ' ' GLY . 75.2 m-20 -67.27 -39.92 86.12 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.812 -1.18 . . . . 0.0 109.95 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -61.97 -45.77 92.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.689 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.58 -42.17 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 109.618 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 43.8 m -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.435 -0.79 . . . . 0.0 110.732 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.7 -44.71 96.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.066 -1.021 . . . . 0.0 110.922 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.79 -37.68 87.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.813 -1.18 . . . . 0.0 109.874 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.523 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 9.3 mtpt -58.77 -37.0 75.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.092 -1.005 . . . . 0.0 109.188 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.5 -42.34 91.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.357 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' -2' ' ' LYS . 75.8 t80 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.345 0.593 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.598 ' O ' ' CD2' ' A' ' -3' ' ' PHE . 45.6 mtpt -83.24 172.57 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.09 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 88.02 81.47 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -120.2 142.86 48.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.454 -1.027 . . . . 0.0 109.147 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -78.2 -82.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.097 -1.002 . . . . 0.0 109.642 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 3' ' ' ALA . 47.5 tptt 42.27 -99.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.408 -0.808 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' ALA . 34.7 mttp -61.9 -42.77 99.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.63 65.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.172 -1.193 . . . . 0.0 109.785 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.8 p -71.93 -38.18 69.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.269 -0.895 . . . . 0.0 109.198 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.35 -41.01 83.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.681 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.4 t80 -63.38 -46.8 84.77 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -62.7 -38.48 90.57 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.425 0.631 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 p -71.16 -30.43 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 111.532 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -148.54 55.37 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.326 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.52 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.742 -1.224 . . . . 0.0 110.871 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -55.61 -37.12 67.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.202 -0.936 . . . . 0.0 109.984 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.36 -34.77 69.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.3 m -98.98 -43.52 6.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.896 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -104.16 130.02 51.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.579 ' C ' ' H ' ' A' ' 21' ' ' GLU . 19.6 p -91.08 -24.19 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.506 -0.746 . . . . 0.0 109.892 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.2 1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.253 -0.904 . . . . 0.0 110.054 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.4 tt0 -98.48 124.76 43.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.983 -1.073 . . . . 0.0 109.534 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -70.9 -40.23 72.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.23 -37.65 93.3 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.58 155.99 44.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 63.2 Cg_endo -74.3 -156.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.746 2.298 . . . . 0.0 111.701 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -104.03 132.28 50.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -102.09 -147.96 0.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.48 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 54.7 t -49.82 -41.43 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.894 -1.129 . . . . 0.0 109.861 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.33 159.37 14.09 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.04 152.05 67.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.84 2.36 . . . . 0.0 111.922 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.1 m120 -83.84 139.94 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 109.61 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.3 mp -96.69 139.78 32.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.664 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 52.2 p-80 -173.8 92.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.027 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.9 6.77 69.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.72 -23.3 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.989 . . . . 0.0 109.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -64.65 135.81 56.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.066 -1.021 . . . . 0.0 109.278 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.67 24.27 72.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -125.31 151.28 46.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -1.077 . . . . 0.0 109.386 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 40' ' ' SER . 1.9 t-160 -120.18 135.64 54.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.823 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER 80.52 -176.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.65 70.26 3.21 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.17 -36.68 75.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.236 . . . . 0.0 110.071 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.37 38.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.05 . . . . 0.0 109.394 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.0 164.09 20.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.589 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.96 -9.8 56.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 59.7 t80 -134.43 141.13 46.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -1.113 . . . . 0.0 109.082 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.6 p -71.62 159.32 34.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 17.6 m-85 -119.09 147.84 43.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.52 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.8 p -79.16 159.49 27.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.299 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.39 -30.78 67.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.694 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.22 -75.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.721 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.4 t-20 -55.39 -42.98 74.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.925 -1.109 . . . . 0.0 110.687 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.33 -49.35 84.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.714 -1.241 . . . . 0.0 109.271 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -60.59 -37.45 81.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 52' ' ' ASN . 16.4 tttt -125.4 113.24 17.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -103.5 143.91 32.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.41 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.448 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -132.43 149.47 32.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.611 -0.681 . . . . 0.0 109.841 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.1 tp -74.32 128.65 36.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 108.673 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -95.57 123.69 39.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 48.7 p30 -161.18 -174.43 4.34 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.51 -42.8 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.834 -1.166 . . . . 0.0 110.22 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -70.91 -53.88 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.148 -0.97 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 37.9 t30 -59.08 -38.58 79.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 110.525 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 7.8 mmt -58.87 -40.91 85.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.662 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.8 p -66.25 -34.82 78.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.28 -0.887 . . . . 0.0 109.587 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -35.7 80.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 109.496 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.04 -47.03 86.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.54 -31.44 70.68 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 0.0 109.946 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -58.61 -37.89 76.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -162.75 67.02 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.901 -1.124 . . . . 0.0 110.074 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -51.49 -19.34 6.94 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.977 2.451 . . . . 0.0 112.42 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.35 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -56.67 -34.26 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.486 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 65.6 t80 -55.22 -51.04 67.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 17.3 mt -147.66 80.14 9.14 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 108.729 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.79 149.52 12.58 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.924 2.416 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.14 0.46 55.98 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 80' ' ' MET . 9.9 t -100.57 171.25 7.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -84.65 9.37 13.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.484 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.408 ' H ' HG21 ' A' ' 78' ' ' THR . 3.1 mtm -73.83 119.68 18.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 0.0 110.011 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.13 26.97 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 59.3 t80 -76.5 133.05 39.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.572 -0.705 . . . . 0.0 109.504 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.9 175.57 50.37 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.71 147.01 18.43 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.1 mt -99.71 134.82 42.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.261 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -92.04 -4.43 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -100.93 127.59 47.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.016 . . . . 0.0 109.929 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.61 -38.23 48.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 110.132 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -60.41 -48.79 80.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.54 -40.23 95.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.682 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.93 -41.73 92.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.104 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.02 -39.8 91.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.302 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.05 -40.73 96.73 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.101 -0.999 . . . . 0.0 109.904 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.22 -43.88 98.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.57 -42.96 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -62.38 -37.75 86.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.55 -46.97 83.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.092 . . . . 0.0 110.304 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.4 mt -65.29 -38.38 90.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.104 . . . . 0.0 109.616 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.59 -36.65 79.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -59.05 -42.96 91.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.323 -0.861 . . . . 0.0 109.436 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.415 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 52.2 t80 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.52 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.8 ptmt -104.18 161.6 13.89 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.23 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.12 24.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -138.73 164.25 25.75 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -110.92 131.14 55.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -1.102 . . . . 0.0 109.295 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 100' ' ' LYS . . . -74.48 -18.27 60.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.042 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -57.52 -48.46 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.061 -1.024 . . . . 0.0 109.969 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.02 -51.92 48.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.926 -1.109 . . . . 0.0 109.748 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -65.35 -30.67 78.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -1.199 . . . . 0.0 110.054 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 12' ' ' THR . 59.6 p -72.71 -37.33 67.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.133 -0.979 . . . . 0.0 109.534 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tp -58.92 -41.63 87.73 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -62.78 -46.74 86.63 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -63.6 -38.27 90.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.421 0.629 . . . . 0.0 110.079 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.47 -34.99 75.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 111.61 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -149.94 58.17 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.525 -1.36 . . . . 0.0 111.356 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.6 t -172.97 -48.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.153 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.89 -37.22 71.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 109.6 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.39 -34.63 69.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 0.0 109.547 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.1 m -96.5 -44.21 7.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.695 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.428 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.6 m-70 -105.81 124.8 50.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.243 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.554 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 53.1 p -84.3 -27.06 28.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.695 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.9 t 64.22 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 19' ' ' THR . 78.2 mm-40 -92.48 120.98 33.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.89 -1.131 . . . . 0.0 109.622 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 55.2 pttt -69.96 -39.99 75.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.4 -36.76 90.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.43 157.25 49.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 59.1 Cg_endo -73.02 -156.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.27 134.57 48.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 29' ' ' GLY . 36.2 tttt -130.46 127.01 38.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.466 -0.771 . . . . 0.0 109.079 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t 53.42 -84.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.299 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -100.44 161.76 18.91 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.0 152.69 73.71 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.979 2.453 . . . . 0.0 112.203 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.554 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 13.1 m120 -81.71 140.52 34.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.2 mp -98.05 139.41 33.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -172.0 95.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.204 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.68 7.02 75.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.54 -23.77 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.294 -1.121 . . . . 0.0 109.565 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -70.41 132.11 45.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 75.13 20.33 79.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.66 ' CZ ' HE21 ' A' ' 42' ' ' GLN . 31.0 mtp180 -140.85 167.0 23.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -1.186 . . . . 0.0 110.015 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -93.72 156.73 16.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.707 ' HG ' ' ND2' ' A' ' 56' ' ' ASN . 24.9 p -66.15 167.1 10.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.684 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.5 -8.14 61.97 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.66 HE21 ' CZ ' ' A' ' 38' ' ' ARG . 38.9 tt0 -61.58 -38.3 87.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.424 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . . . -69.94 75.08 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.42 -31.76 73.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.47 -35.81 62.31 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 47' ' ' SER . 54.9 t80 -112.29 131.99 55.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.394 -1.063 . . . . 0.0 109.302 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -67.65 156.77 36.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.865 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.424 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 55.4 m-85 -111.21 145.39 38.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.521 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -75.74 161.65 28.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.67 -34.66 67.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -0.905 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.08 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.329 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.497 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 22.2 t-20 -52.62 -41.62 63.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.042 . . . . 0.0 110.305 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.9 mt -59.02 -55.59 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.18 -36.69 84.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ASN . 43.7 tttm -102.33 33.34 3.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.707 ' ND2' ' HG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -46.69 131.55 11.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.848 -1.157 . . . . 0.0 108.694 -179.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.449 ' H ' HD21 ' A' ' 56' ' ' ASN . 12.6 p -133.79 150.53 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.251 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.47 130.61 38.21 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.441 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.5 m95 -97.24 123.23 40.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 56.2 p30 -149.59 176.28 10.78 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.82 -40.46 88.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.061 -1.024 . . . . 0.0 111.004 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -72.29 -57.2 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.953 -1.092 . . . . 0.0 110.646 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.587 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.7 t30 -60.46 -39.66 88.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.411 -0.805 . . . . 0.0 110.799 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.413 ' SD ' ' CE3' ' A' ' 59' ' ' TRP . 42.8 tpp -59.15 -39.49 82.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.008 . . . . 0.0 109.745 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.515 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.1 m -60.76 -40.68 93.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.72 -33.54 74.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 77.9 t60 -61.26 -48.0 83.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 6.8 mp -57.81 -31.09 66.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.539 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 23.5 m -84.99 125.03 32.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.979 -1.076 . . . . 0.0 109.225 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' THR . 12.5 m120 41.75 59.6 9.29 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.69 -21.32 58.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.72 -59.1 5.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 109.981 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -62.25 -32.52 73.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.515 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.575 ' CD2' ' ND1' ' A' ' 67' ' ' HIS . 66.8 t80 -57.75 -48.73 78.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.569 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 2.7 tp -163.23 79.9 1.64 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.983 -1.073 . . . . 0.0 109.265 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.89 -21.25 7.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.823 2.349 . . . . 0.0 112.769 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.55 -27.23 54.1 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' A' ' 80' ' ' MET . 30.3 p -77.49 163.06 26.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -1.203 . . . . 0.0 110.068 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -78.47 5.36 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.542 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 11.0 ttt -79.7 141.92 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.507 -0.746 . . . . 0.0 111.145 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.79 85.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 81.7 t80 -103.36 134.89 45.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.81 . . . . 0.0 110.094 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -72.63 142.02 31.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.69 152.47 49.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.23 125.2 41.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.25 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.31 -39.75 94.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.35 128.42 35.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.984 -1.072 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.15 -34.72 61.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -58.22 -45.35 87.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.152 -0.968 . . . . 0.0 109.938 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.91 -38.66 89.23 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.128 -0.982 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.7 ttp180 -59.06 -41.39 87.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.497 -0.752 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' OD1' ' CE2' ' A' ' -3' ' ' PHE . 53.2 t30 -59.12 -41.86 89.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 110.17 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 89.1 m-20 -62.4 -39.8 94.42 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.043 -1.036 . . . . 0.0 109.964 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.0 -43.61 91.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.873 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.515 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 85.0 mt -64.65 -37.17 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 m -59.52 -40.65 87.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.459 -0.775 . . . . 0.0 109.94 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.052 . . . . 0.0 110.644 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.05 -38.45 85.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.574 ' HZ3' ' CB ' ' A' ' 99' ' ' LYS . 9.7 mtpm? -58.3 -40.54 82.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.061 . . . . 0.0 109.732 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 3' ' ' ALA . 99.2 mttt -61.64 -45.43 94.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 109.667 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 109.534 -179.742 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.9 ttpt -63.31 128.15 34.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.26 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -92.41 152.38 21.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 53.5 p -69.29 155.51 40.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.38 -10.08 21.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.785 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -59.22 -49.48 77.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.01 -46.8 79.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.387 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.87 79.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.17 89.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.891 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.9 p -72.44 -38.74 68.23 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.0 tp -59.2 -40.9 87.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.8 t80 -62.86 -46.7 86.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -63.14 -38.89 92.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.669 -0.645 . . . . 0.0 109.955 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 13' ' ' ARG . 53.0 p -69.97 -33.12 71.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 111.453 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.415 ' N ' ' HG1' ' A' ' 12' ' ' THR . 94.3 mtt-85 -148.77 57.62 1.04 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.571 -1.331 . . . . 0.0 111.14 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.667 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.2 t -172.56 -53.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.854 -1.153 . . . . 0.0 110.28 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.09 -37.63 72.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.014 -1.054 . . . . 0.0 109.811 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.33 -35.28 71.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.862 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -96.96 -43.42 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.618 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 90.6 m-70 -106.0 125.34 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 20' ' ' VAL . 52.4 p -89.52 -20.66 23.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.0 t 40.97 69.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.696 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.17 155.17 27.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -61.7 -35.72 78.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.576 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.29 20.96 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.3 166.49 50.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.62 -177.82 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.96 2.44 . . . . 0.0 112.12 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.419 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 91.1 m-70 -106.34 136.7 45.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.393 -0.817 . . . . 0.0 109.263 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 28' ' ' VAL . 51.7 tttm -105.78 -127.97 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.333 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.489 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 70.6 t -63.27 -39.71 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.081 -1.012 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.83 165.21 16.73 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 27.5 Cg_endo -63.69 150.46 88.4 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.843 2.362 . . . . 0.0 112.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.64 138.63 36.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.268 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.9 mp -97.89 137.48 36.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.134 -0.979 . . . . 0.0 109.888 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -166.35 100.24 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 108.991 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.06 7.89 79.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 tt -59.5 -22.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.555 -0.968 . . . . 0.0 109.716 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.659 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 78.7 m-85 -66.15 133.58 50.98 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.03 19.51 78.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HG3' HE22 ' A' ' 42' ' ' GLN . 32.8 mmt180 -135.66 163.29 30.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.325 -1.103 . . . . 0.0 109.826 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -90.17 161.53 15.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.42 ' OG ' ' OD1' ' A' ' 52' ' ' ASN . 24.8 t -63.17 148.71 47.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.84 . . . . 0.0 109.787 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.6 -10.07 62.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.403 HE22 ' HG3' ' A' ' 38' ' ' ARG . 52.6 tt0 -61.39 -38.35 86.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.006 -1.291 . . . . 0.0 109.722 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -61.55 -30.51 70.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.977 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 49.96 177.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 46' ' ' TYR . . . 80.61 -165.3 47.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.489 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 33.3 t80 37.07 -127.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.611 -0.935 . . . . 0.0 109.749 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 30.1 t -158.44 146.14 18.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.57 138.75 50.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.48 -0.762 . . . . 0.0 109.343 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.9 p -79.85 162.54 24.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.895 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.21 -32.73 68.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.528 -0.733 . . . . 0.0 110.071 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.59 -75.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.045 -1.034 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.2 t-20 -54.0 -41.65 68.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.933 -1.105 . . . . 0.0 110.319 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.05 -51.04 77.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.78 -1.2 . . . . 0.0 109.53 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -61.0 -38.57 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.951 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 52' ' ' ASN . 85.7 tttt -117.96 110.43 17.7 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -98.44 138.77 35.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 109.084 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 10.6 p -130.39 147.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.565 -0.71 . . . . 0.0 109.948 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -78.77 131.92 36.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 88.6 m95 -95.5 124.71 39.66 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.217 -0.927 . . . . 0.0 110.101 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.5 t0 -152.66 166.52 31.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.562 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.17 -39.7 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.69 -1.256 . . . . 0.0 109.217 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.51 -47.97 62.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -61.31 -40.71 95.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 110.712 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.5 mtt -60.21 -36.79 78.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 0.0 109.686 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -59.5 -42.97 93.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 109.156 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.18 -34.5 76.41 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.27 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.6 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 81.9 t60 -58.03 -45.46 86.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.1 -29.88 68.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.419 -0.801 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 29.1 m -57.68 -38.12 74.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.042 -1.036 . . . . 0.0 110.528 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 69' ' ' THR . 15.9 m120 -163.45 67.73 1.67 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 109.795 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -51.92 -27.74 29.04 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.975 2.45 . . . . 0.0 112.705 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.38 1.84 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 109.527 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -61.42 -29.88 70.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.246 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.563 ' CD2' ' ND1' ' A' ' 67' ' ' HIS . 40.4 t80 -58.46 -49.36 77.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.858 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.9 75.48 30.13 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.012 -1.055 . . . . 0.0 110.046 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.24 138.55 51.76 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.919 2.413 . . . . 0.0 112.576 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.41 -6.81 63.49 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.89 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -88.64 164.06 15.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.365 . . . . 0.0 110.415 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -85.12 2.02 45.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.6 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 10.9 ttt -81.77 127.74 33.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.93 87.08 2.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 69.7 t80 -103.34 131.55 50.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.335 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -67.87 142.78 40.58 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.63 145.34 31.39 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 mt -98.81 134.21 42.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -93.76 -5.81 47.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -110.32 119.27 38.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.92 -33.57 73.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 110.446 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.88 -56.27 24.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.04 . . . . 0.0 110.018 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -62.36 -38.9 91.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.57 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -58.65 -42.19 87.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.85 . . . . 0.0 109.865 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.95 -39.14 88.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.168 -0.957 . . . . 0.0 110.385 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 2' ' ' SER . 83.8 m-20 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.76 -45.17 93.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.8 mt -66.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 0.0 108.85 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.1 m -59.11 -39.01 80.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.48 -52.2 66.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.53 -32.94 74.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.067 -1.021 . . . . 0.0 108.401 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.562 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 19.1 tttp -56.65 -42.25 78.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.38 -39.08 85.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.755 . . . . 0.0 109.328 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.554 -179.775 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 68.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.358 0.599 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 1' ' ' GLY . 44.3 mtpt -87.65 172.35 9.78 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -40.57 -22.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.271 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 78.08 81.29 0.66 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.51 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.4 p -72.14 166.76 21.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.738 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.04 21.23 5.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.836 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -92.53 -70.98 0.67 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -63.86 -45.22 90.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 110.247 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.585 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -60.3 -39.39 96.01 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.997 -1.097 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.31 71.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -1.192 . . . . 0.0 109.948 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 9' ' ' LEU . 53.5 p -74.46 -35.37 63.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.452 ' N ' ' HG1' ' A' ' 8' ' ' THR . 7.3 tp -57.28 -40.86 78.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 64.4 t80 -62.88 -46.84 85.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -63.95 -39.18 93.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.742 -0.599 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -68.8 -35.01 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 111.495 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -151.77 60.53 0.87 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.628 -1.295 . . . . 0.0 110.876 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -172.84 -47.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 0.0 109.625 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.48 -37.15 77.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -58.54 -37.74 76.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.12 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.3 m -93.5 -40.85 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -106.91 132.89 52.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.099 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' A' ' 21' ' ' GLU . 30.0 p -103.41 -4.33 24.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.404 ' HA ' ' H ' ' A' ' 32' ' ' LEU . 2.8 t 45.99 16.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.999 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.52 ' H ' ' HG1' ' A' ' 19' ' ' THR . 85.0 tt0 -104.27 137.3 42.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.952 . . . . 0.0 109.465 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -76.83 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 109.891 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -51.37 -17.01 2.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' GLY . . . -41.18 164.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.16 -12.31 29.44 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.274 2.649 . . . . 0.0 112.084 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.554 ' CE1' ' H ' ' A' ' 31' ' ' ASN . 2.1 m-70 60.97 97.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.237 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -74.6 -167.8 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 110.017 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG1' ' NZ ' ' A' ' 79' ' ' LYS . 55.9 t -50.49 -45.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 109.989 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.53 149.2 22.45 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.86 148.54 91.8 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.392 2.062 . . . . 0.0 111.741 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.554 ' H ' ' CE1' ' A' ' 26' ' ' HIS . 2.8 m120 -84.35 138.73 32.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.065 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.6 mp -93.76 140.45 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.633 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 49.5 p-80 -174.07 90.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.102 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.58 4.79 65.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.19 -22.58 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -1.131 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.1 m-85 -65.62 133.99 52.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.159 -0.963 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.81 72.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.588 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 68.0 mtt85 -145.75 168.75 19.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.0 110.247 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -97.89 157.5 16.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.829 . . . . 0.0 110.119 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 2.6 m -61.33 163.91 6.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.662 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -6.08 59.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.447 ' NE2' ' CD ' ' A' ' 38' ' ' ARG . 39.6 tt0 -62.14 -38.94 90.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 0.0 110.101 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.456 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . . . -69.93 77.2 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.57 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.34 -33.05 74.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.502 -0.749 . . . . 0.0 109.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.14 -35.08 68.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 47' ' ' SER . 65.7 t80 -113.36 135.1 54.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.407 -1.055 . . . . 0.0 109.385 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 57.4 p -72.61 162.35 29.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.456 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 60.8 m-85 -114.41 148.17 38.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 109.599 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.2 p -75.26 160.65 30.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.6 -35.43 68.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.788 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 76' ' ' PRO . . . -46.56 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.4 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t-20 -52.21 -41.94 63.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.038 -1.039 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.6 mt -57.59 -53.44 44.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.843 -1.161 . . . . 0.0 109.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.88 -38.79 92.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.7 mttm -101.64 28.65 5.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 109.886 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 52' ' ' ASN . 2.6 t-20 -43.88 127.55 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 108.946 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.18 153.2 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.46 136.0 49.12 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.547 ' NE1' ' OG ' ' A' ' 40' ' ' SER . 78.8 m95 -97.75 126.59 43.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 110.34 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.9 t0 -150.9 163.82 37.77 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.543 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.5 mt-10 -54.82 -39.77 68.87 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.51 -47.66 66.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.079 -1.013 . . . . 0.0 110.251 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.24 -39.78 91.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.652 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.1 mtt -59.89 -37.96 80.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 109.807 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.5 m -58.98 -41.45 87.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.034 -1.041 . . . . 0.0 109.075 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.84 -32.77 72.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.921 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.446 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 77.1 t60 -56.87 -48.88 77.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 110.279 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 9.4 mp -73.61 -20.79 60.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.522 ' HG1' ' NH1' ' A' ' 91' ' ' ARG . 31.2 m -57.76 -36.41 72.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.687 -1.258 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.92 68.23 3.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.206 -0.934 . . . . 0.0 109.945 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.3 -18.7 64.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.577 2.185 . . . . 0.0 113.031 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.18 69.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.421 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -94.38 -5.36 46.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.446 ' CD1' ' ND1' ' A' ' 67' ' ' HIS . 28.0 t80 -63.84 -46.1 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.643 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.8 pt -136.96 72.88 53.72 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.188 -0.945 . . . . 0.0 109.923 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 18.2 Cg_exo -62.53 136.84 61.05 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.655 2.237 . . . . 0.0 111.486 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.48 15.87 48.6 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.687 -1.245 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 80' ' ' MET . 6.6 t -117.52 165.84 13.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.146 -1.208 . . . . 0.0 109.567 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.636 ' NZ ' ' CG1' ' A' ' 28' ' ' VAL . 6.4 mtmp? -86.07 6.48 28.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.284 -0.885 . . . . 0.0 111.255 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.437 ' H ' HG23 ' A' ' 78' ' ' THR . 3.4 ttt -74.95 116.67 15.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.72 31.57 6.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 86.5 t80 -84.99 131.96 34.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -82.73 176.94 53.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.36 166.55 24.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.602 -1.285 . . . . 0.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 mt -106.66 124.55 49.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -1.076 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.7 -38.13 89.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -85.28 128.17 34.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.55 -33.07 54.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 110.125 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -57.01 -50.1 73.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.004 . . . . 0.0 110.071 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.82 -39.01 92.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.174 -0.954 . . . . 0.0 108.779 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.522 ' NH1' ' HG1' ' A' ' 69' ' ' THR . 60.9 ttp180 -59.79 -40.68 89.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.756 -0.59 . . . . 0.0 109.947 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.85 -43.55 85.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.585 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 58.9 t0 -62.48 -39.25 92.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.04 -45.48 90.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.54 -38.83 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.047 . . . . 0.0 108.824 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.1 m -59.0 -39.76 82.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.562 -0.711 . . . . 0.0 109.732 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.28 -48.65 80.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 0.0 108.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.12 -31.81 70.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.543 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 20.8 tttm -56.01 -43.49 77.76 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -61.55 -43.64 98.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.783 . . . . 0.0 109.387 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.738 -179.767 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 93.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -82.87 141.95 31.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.408 -0.808 . . . . 0.0 109.172 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -44.79 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 70.14 126.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.487 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 84.2 p -63.27 -19.41 64.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.177 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 60.11 -143.55 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.401 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 56.06 -79.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.702 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 3' ' ' ALA . 65.4 mttp -58.31 -43.52 88.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.98 -33.95 76.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.86 88.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.566 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -72.54 -36.21 68.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.131 -0.981 . . . . 0.0 109.038 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.14 -40.89 82.47 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 71.2 t80 -63.46 -46.93 83.99 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -62.92 -38.18 89.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.64 -0.663 . . . . 0.0 110.133 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.7 p -70.81 -31.16 67.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 111.481 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -148.13 54.88 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.562 -1.336 . . . . 0.0 111.357 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.6 t -173.37 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 110.829 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.52 -37.07 69.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -56.3 -32.88 65.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.3 m -101.5 -44.76 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 0.0 110.838 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -103.64 121.93 43.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.073 -1.017 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.8 p -81.9 -24.64 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 t 65.55 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 19' ' ' THR . 95.8 mt-10 -98.86 120.49 39.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.075 -1.016 . . . . 0.0 109.569 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 14.5 pttp -69.85 -40.05 76.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.613 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.92 -36.55 90.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.15 155.43 49.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.54 -156.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.413 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 96.2 m-70 -109.61 137.25 47.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.276 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -110.71 -124.78 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.795 . . . . 0.0 109.114 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.63 -40.73 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.38 163.08 22.0 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HA ' ' HD1' ' A' ' 26' ' ' HIS . 17.4 Cg_endo -61.17 145.6 98.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.883 2.389 . . . . 0.0 112.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.0 145.97 53.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 109.029 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.85 119.18 38.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.168 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 35' ' ' ILE . 85.2 t60 -154.1 134.33 13.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.041 -1.037 . . . . 0.0 109.875 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.43 15.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 33' ' ' HIS . 3.7 tp -58.22 -22.49 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.427 -1.043 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.664 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 92.2 m-85 -63.64 136.77 57.74 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.172 -0.955 . . . . 0.0 109.283 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.09 32.34 72.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 36' ' ' PHE . 60.6 mmt-85 -127.29 152.06 47.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -1.14 . . . . 0.0 110.153 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.492 ' O ' ' OG ' ' A' ' 40' ' ' SER . 77.5 m80 -109.49 142.15 40.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.742 . . . . 0.0 109.933 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 39' ' ' HIS . 7.4 p 49.44 174.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.634 0.731 . . . . 0.0 110.599 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.7 72.31 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' SER . 44.0 tt0 -60.17 -35.07 74.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -1.18 . . . . 0.0 110.003 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.51 -34.78 69.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.899 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 46.54 -176.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.24 -13.05 68.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 47' ' ' SER . 85.7 t80 -136.63 146.41 45.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 108.962 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 44.1 m -62.23 147.45 47.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.744 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -119.75 142.37 48.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 109.339 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 56.9 m -72.84 143.82 47.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.95 . . . . 0.0 109.072 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -49.29 -33.73 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 109.311 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.99 -71.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 110.228 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.6 t-20 -57.51 -40.38 78.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.79 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 67.4 mt -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.867 -1.145 . . . . 0.0 109.936 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.16 -52.7 57.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.971 -1.081 . . . . 0.0 109.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 56' ' ' ASN . 32.8 tttp -67.68 -47.62 68.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.943 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 55' ' ' LYS . 1.8 m120 38.42 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.645 . . . . 0.0 109.876 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.18 149.82 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 110.172 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.574 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 49.9 tp -66.09 134.13 52.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' GLY . 92.8 m95 -98.03 130.89 44.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -156.13 164.84 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.533 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.7 mt-10 -53.89 -40.17 66.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 109.273 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -67.76 -47.98 67.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.908 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 64.7 t30 -63.75 -40.35 96.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.664 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.9 mtt -59.92 -37.9 80.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 109.688 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -60.32 -41.58 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.081 -1.012 . . . . 0.0 108.974 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.88 -34.38 77.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.189 -0.944 . . . . 0.0 109.074 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.472 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 61.8 t60 -59.57 -47.28 86.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -71.59 -34.04 69.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.039 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 30.9 m -58.66 -38.35 77.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 110.828 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -161.65 67.76 2.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.96 -1.087 . . . . 0.0 109.803 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.31 -24.71 8.83 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.144 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -63.72 -59.84 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.506 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.91 -34.12 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.028 -1.045 . . . . 0.0 109.429 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 21.6 t80 -54.97 -44.74 74.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.508 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.8 OUTLIER -139.78 154.67 71.13 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 108.885 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.24 6.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.573 2.182 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 75' ' ' ILE . . . 88.2 50.44 3.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 77' ' ' GLY . 14.6 t -55.64 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.612 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -59.57 -24.81 64.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.099 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.5 mtm -68.88 120.22 14.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 110.576 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.23 26.12 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 65.0 t80 -55.87 136.23 51.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.706 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.03 -179.68 51.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.5 146.69 17.72 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -97.22 135.96 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -91.1 -6.55 53.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.097 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -103.53 127.22 50.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.32 -38.54 55.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -60.52 -47.93 84.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.99 -39.91 95.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.55 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 61.7 ttp180 -59.58 -43.62 93.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -61.52 -37.13 82.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -0.969 . . . . 0.0 109.59 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 90.4 m-20 -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.57 -46.25 90.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 110.359 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.1 -41.0 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.048 . . . . 0.0 109.029 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 33.5 m -59.6 -39.68 85.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.825 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.74 -49.19 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.923 -1.11 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -68.18 -32.14 72.17 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 29.1 tttm -57.71 -42.84 84.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.582 -0.699 . . . . 0.0 109.284 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HZ3' ' CB ' ' A' ' 3' ' ' ALA . 21.3 mttt -61.63 -43.71 98.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.398 -0.813 . . . . 0.0 109.769 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 -179.504 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 89.7 t80 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.1 ttpt -84.08 139.95 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.15 -24.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 52.21 169.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -124.53 125.85 44.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -1.063 . . . . 0.0 109.069 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -70.24 -22.82 62.86 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.38 -53.86 53.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 110.208 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -67.3 -50.57 59.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.876 -1.14 . . . . 0.0 109.621 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.63 -31.04 78.57 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.146 . . . . 0.0 109.857 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 p -73.62 -39.77 64.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.142 -0.974 . . . . 0.0 109.42 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.8 tp -59.97 -41.23 91.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.6 t80 -62.07 -46.12 90.53 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -63.47 -37.63 88.02 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 109.967 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p -70.43 -33.9 71.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 111.74 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -149.58 56.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.519 -1.363 . . . . 0.0 111.491 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -173.06 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.74 -1.225 . . . . 0.0 110.192 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.79 -37.36 73.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.976 . . . . 0.0 109.942 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.72 -35.07 70.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.95 . . . . 0.0 109.826 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -96.73 -43.11 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.658 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -107.21 123.79 48.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.536 ' C ' ' H ' ' A' ' 21' ' ' GLU . 44.2 p -86.07 -23.9 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t 59.28 -1.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.298 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.3 tt0 -97.36 124.06 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 109.53 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 24.6 pttm -68.41 -41.4 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.885 . . . . 0.0 109.191 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -63.12 -34.84 91.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.2 157.56 51.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.74 -161.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' CD2' ' CG ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -103.64 125.24 50.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.398 -0.814 . . . . 0.0 109.106 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -101.53 -159.59 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.5 t -51.3 -41.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.13 149.98 17.13 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' CD2' ' A' ' 26' ' ' HIS . 17.5 Cg_endo -60.31 147.36 94.09 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.495 2.13 . . . . 0.0 112.6 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.74 138.71 58.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.308 -0.87 . . . . 0.0 109.111 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.6 tp -106.54 118.67 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.229 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -158.92 127.16 5.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.785 -1.197 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 55.8 12.17 4.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.07 -21.63 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.362 -1.081 . . . . 0.0 109.835 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 90.5 m-85 -62.88 139.16 58.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.055 -1.028 . . . . 0.0 109.38 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.95 22.73 77.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -136.29 160.09 39.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -1.095 . . . . 0.0 109.804 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.34 158.39 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.385 -0.822 . . . . 0.0 109.443 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.488 ' OG ' ' OD1' ' A' ' 52' ' ' ASN . 77.1 p -62.08 159.41 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.76 5.36 88.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -60.85 -35.21 75.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.46 -1.024 . . . . 0.0 110.226 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.53 -35.05 69.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.112 -0.992 . . . . 0.0 109.719 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.0 mt-10 42.2 18.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.583 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -118.65 -36.63 0.89 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.465 ' CG ' ' CD2' ' A' ' 26' ' ' HIS . 78.9 t80 -110.65 136.41 49.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.544 -0.974 . . . . 0.0 109.14 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 38.5 m -59.61 153.1 20.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.959 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -117.5 158.84 23.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.1 p -74.74 158.51 33.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.247 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.79 -30.86 67.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.67 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.532 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.5 t-20 -52.35 -44.03 64.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.71 -40.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.619 -1.301 . . . . 0.0 109.284 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.34 -37.75 84.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASN . 43.6 tttp -125.72 114.51 18.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.48 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -95.16 134.88 37.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.094 -1.004 . . . . 0.0 109.289 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' H ' HD21 ' A' ' 56' ' ' ASN . 12.2 p -131.39 146.83 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.59 133.95 35.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 108.968 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -97.95 127.57 43.98 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.195 -0.941 . . . . 0.0 110.207 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 64' ' ' MET . 53.3 t0 -151.92 167.81 27.15 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -57.47 -36.06 70.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.893 -1.13 . . . . 0.0 109.653 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -76.23 -57.5 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.895 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -63.48 -41.18 98.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.642 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 59.0 ttm -59.27 -36.31 75.31 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.542 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.4 p -62.75 -35.88 81.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.554 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.28 -35.94 82.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.45 -43.39 96.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 0.0 110.045 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 7.0 mp -62.36 -31.7 72.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.873 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.71 ' HG1' ' NH2' ' A' ' 91' ' ' ARG . 18.0 m -88.16 129.84 35.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 109.541 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 69' ' ' THR . 74.0 m-20 38.64 54.98 4.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.748 . . . . 0.0 110.496 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 9.5 Cg_endo -54.97 -14.68 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.568 2.179 . . . . 0.0 111.102 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 74' ' ' TYR . . . -63.2 154.17 32.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.2 tttt 67.23 -36.52 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.858 -0.526 . . . . 0.0 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 72' ' ' ALA . 86.5 t80 -60.25 -50.01 75.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.073 -1.017 . . . . 0.0 109.579 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 3.8 mm -140.87 77.2 21.71 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.136 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.57 151.4 11.69 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 123.095 2.53 . . . . 0.0 112.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 21.09 27.82 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 80' ' ' MET . 12.1 t -123.51 164.7 18.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.303 -1.116 . . . . 0.0 109.797 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -81.77 4.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 109.69 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.411 ' H ' HG23 ' A' ' 78' ' ' THR . 11.9 ttp -79.8 131.74 35.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.907 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.08 70.18 1.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 76.6 t80 -102.89 134.44 46.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -81.83 174.36 53.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.91 161.89 27.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 mt -102.83 128.07 49.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -1.116 . . . . 0.0 109.194 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -65.18 -44.21 89.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.951 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -90.09 129.52 36.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.483 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -73.37 -32.37 64.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 109.76 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -56.18 -48.32 76.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 0.0 109.464 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.24 -37.6 77.94 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 0.0 109.262 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.71 ' NH2' ' HG1' ' A' ' 69' ' ' THR . 34.0 ttm180 -57.81 -41.78 82.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -59.49 -40.49 87.17 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 80.1 m-20 -64.27 -40.05 95.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.169 -0.957 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.62 -44.74 95.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.02 -36.91 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.11 -0.994 . . . . 0.0 108.563 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.6 m -57.31 -40.84 78.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.552 -0.717 . . . . 0.0 109.646 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -60.06 -51.78 68.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 109.382 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.31 -35.41 80.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.444 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 12.7 tttp -57.28 -40.38 77.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -59.44 -40.3 86.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.474 -0.766 . . . . 0.0 109.466 -179.814 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 48.0 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 1' ' ' GLY . 32.7 ttpt -94.82 130.85 41.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.944 . . . . 0.0 109.267 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -48.64 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.212 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -105.53 135.19 12.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.8 p -69.58 153.54 43.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -1.226 . . . . 0.0 109.203 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.36 -10.23 36.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.797 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -59.48 -47.76 84.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.109 -0.995 . . . . 0.0 109.923 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -67.2 -50.73 59.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.48 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.59 -32.82 85.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.92 -45.26 86.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.132 -1.217 . . . . 0.0 109.639 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.8 p -71.95 -37.61 69.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -59.45 -41.35 89.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.7 t80 -63.74 -45.81 88.2 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -62.61 -39.85 95.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.661 -0.65 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 p -71.58 -37.06 71.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 111.665 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -140.49 54.38 1.61 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.775 -1.203 . . . . 0.0 110.899 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -170.95 -53.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.696 -1.252 . . . . 0.0 110.616 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.94 -37.9 72.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.034 -1.041 . . . . 0.0 109.687 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.25 -35.74 72.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.829 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.2 m -95.73 -43.18 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.57 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -105.32 129.88 53.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.345 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' GLU . 63.0 p -95.45 -8.13 36.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.01 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.7 m 32.3 36.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.209 0.528 . . . . 0.0 110.72 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -104.15 133.7 48.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -82.48 139.4 33.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.14 76.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.34 165.19 12.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.14 172.11 16.64 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.115 2.543 . . . . 0.0 111.99 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 92.7 m-70 -105.15 135.62 46.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.351 -0.843 . . . . 0.0 109.153 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 18.0 tptt -104.65 -126.48 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 109.005 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.449 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.13 -39.66 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.129 -0.982 . . . . 0.0 109.064 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.44 160.65 20.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 20.9 Cg_endo -62.34 149.43 90.78 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.035 2.49 . . . . 0.0 112.498 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.401 ' H ' ' HD1' ' A' ' 26' ' ' HIS . 2.6 m120 -77.72 126.21 30.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 8.2 mp -100.0 132.02 45.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.18 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -160.97 102.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.28 77.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.681 -1.767 . . . . 0.0 108.681 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 tt -57.7 -21.72 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.49 -1.006 . . . . 0.0 109.391 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CD2' ' OE2' ' A' ' 61' ' ' GLU . 96.0 m-85 -62.86 135.52 57.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 108.932 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.94 20.67 80.02 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -133.67 162.4 32.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -1.086 . . . . 0.0 110.035 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -94.72 168.6 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.483 ' OG ' ' OD1' ' A' ' 52' ' ' ASN . 20.8 t -83.96 146.38 28.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.63 -6.84 70.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.75 -37.62 87.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.138 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.662 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -60.21 -43.52 95.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.097 -1.002 . . . . 0.0 109.427 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 58.11 -21.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.662 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -59.91 -33.93 80.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CD2' ' O ' ' A' ' 47' ' ' SER . 76.6 t80 -115.13 140.29 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -1.011 . . . . 0.0 109.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.7 t -65.66 151.99 45.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -111.73 147.75 34.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.564 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 p -75.86 164.35 26.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.22 -31.22 61.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.392 -0.818 . . . . 0.0 109.258 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.84 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 110.638 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 23.5 t-20 -57.42 -41.56 80.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.952 -1.093 . . . . 0.0 110.641 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -60.25 -44.66 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.845 -1.16 . . . . 0.0 109.83 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -59.35 -37.54 78.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.94 . . . . 0.0 109.271 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 76.6 tttt -132.14 121.33 23.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.444 -0.785 . . . . 0.0 109.215 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.81 136.52 40.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 9.5 p -130.93 147.73 33.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.523 -0.736 . . . . 0.0 110.055 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.7 tp -77.73 133.78 38.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 108.95 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' GLY . 93.2 m95 -93.86 127.75 39.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.375 -0.828 . . . . 0.0 109.856 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.6 t0 -148.96 167.97 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' CD2' ' A' ' 36' ' ' PHE . 79.0 mm-40 -58.03 -39.36 78.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.988 -1.07 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -78.69 -48.67 14.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 33.9 t30 -59.89 -39.23 84.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.573 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 42.4 tpp -60.3 -38.92 85.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.551 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 62' ' ' ASN . 86.3 p -61.47 -33.79 74.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.801 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.51 -36.03 81.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.885 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.657 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 81.3 t60 -59.31 -43.79 92.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 5.3 mp -67.77 -27.15 66.51 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.999 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.546 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 25.5 m -81.16 128.48 33.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.973 . . . . 0.0 110.379 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 69' ' ' THR . 11.7 t-20 32.54 59.81 1.42 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.849 -0.532 . . . . 0.0 111.312 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 19.2 Cg_endo -61.8 135.65 57.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 111.699 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 71' ' ' PRO . . . 162.04 -86.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.391 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.51 -28.96 61.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.43 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 84.8 t80 -54.83 -51.98 64.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 109.53 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 9.5 mm -152.08 73.18 7.79 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.136 -0.977 . . . . 0.0 108.787 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.96 150.59 18.2 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.894 2.396 . . . . 0.0 112.34 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.01 15.29 16.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -124.17 156.99 35.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -1.083 . . . . 0.0 109.414 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -84.6 5.38 28.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 0.0 110.948 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.657 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 4.5 ttt -55.45 -40.14 71.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.793 -1.192 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 80' ' ' MET . . . 33.69 75.08 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.722 -0.611 . . . . 0.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -106.22 131.44 53.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.28 140.14 30.44 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.98 150.84 41.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.6 mt -96.19 133.67 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -1.146 . . . . 0.0 109.164 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -87.5 -12.72 45.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -101.6 126.18 48.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.83 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.12 -36.68 61.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.932 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.0 -45.06 93.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.07 -39.35 94.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.135 -0.978 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.546 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 39.1 ttm180 -59.12 -41.78 88.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.779 . . . . 0.0 109.966 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.9 -40.82 94.56 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.08 -1.013 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 84.5 m-20 -64.35 -41.27 96.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.966 -1.084 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.25 -43.1 92.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.082 -1.012 . . . . 0.0 109.376 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG2' ' OE1' ' A' ' 61' ' ' GLU . 81.0 mt -66.19 -36.15 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.186 -0.946 . . . . 0.0 108.78 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 m -57.31 -41.35 79.71 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.604 -0.685 . . . . 0.0 109.843 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -63.18 -52.94 60.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 110.306 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.02 -39.85 75.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 108.965 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.88 -40.24 83.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.716 . . . . 0.0 109.347 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -60.39 -40.15 89.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.534 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 109.667 -179.69 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 70.1 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.389 0.614 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.595 ' O ' ' CE2' ' A' ' -3' ' ' PHE . 48.5 mtmt -86.42 170.89 11.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.65 -24.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.508 -0.745 . . . . 0.0 109.798 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 101.31 97.28 2.29 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -119.72 136.93 54.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.98 . . . . 0.0 109.07 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.73 131.03 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.771 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -175.22 -91.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -63.31 -37.66 88.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 108.718 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.9 -36.73 91.05 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.81 75.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -1.134 . . . . 0.0 109.588 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.0 p -74.0 -32.27 63.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.159 -0.963 . . . . 0.0 109.126 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 tp -56.65 -41.8 77.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 68.0 t80 -63.5 -47.08 83.17 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -63.27 -38.74 92.33 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.434 0.635 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 p -70.4 -32.92 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 111.483 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -148.58 57.44 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.667 -1.271 . . . . 0.0 111.166 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -173.33 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.854 -1.153 . . . . 0.0 110.322 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.87 -37.7 71.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.799 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.52 -34.92 69.61 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.718 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -97.41 -43.67 7.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 110.681 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -105.11 124.43 49.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 110.203 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.56 ' HG1' ' H ' ' A' ' 21' ' ' GLU . 52.4 p -87.22 -18.34 30.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 109.31 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.57 19.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.56 ' H ' ' HG1' ' A' ' 19' ' ' THR . 49.0 tp10 -99.82 140.6 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.348 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -82.2 -81.7 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.14 -28.61 19.03 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.22 156.05 26.31 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.3 -174.48 1.62 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.84 2.36 . . . . 0.0 111.948 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.513 ' HD1' ' H ' ' A' ' 31' ' ' ASN . 96.4 m-70 -105.72 135.13 47.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 109.251 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -97.86 -126.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 108.908 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.34 -39.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.109 -0.995 . . . . 0.0 109.044 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 165.56 19.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 22.9 Cg_endo -62.68 148.23 93.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.968 2.445 . . . . 0.0 111.991 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.513 ' H ' ' HD1' ' A' ' 26' ' ' HIS . 9.4 m120 -80.13 137.48 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.088 -1.007 . . . . 0.0 109.46 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 7.8 mp -100.08 135.57 41.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.923 . . . . 0.0 109.835 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -164.14 98.41 0.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 108.975 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.94 8.61 82.17 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.28 -23.16 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.479 -1.012 . . . . 0.0 109.494 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.17 135.34 53.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 73.95 20.73 79.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.411 ' HD3' HE22 ' A' ' 42' ' ' GLN . 95.0 mtt180 -137.01 165.22 26.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.936 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.38 154.54 17.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.583 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 37.1 p -65.88 160.88 22.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.956 . . . . 0.0 109.899 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.61 57.18 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.411 HE22 ' HD3' ' A' ' 38' ' ' ARG . 52.0 tt0 -62.23 -36.73 82.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.262 . . . . 0.0 109.931 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.428 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . . . -56.57 140.24 47.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 109.381 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.97 153.37 41.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.786 . . . . 0.0 109.354 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.87 0.42 64.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 47' ' ' SER . 59.8 t80 -136.38 156.04 49.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.205 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.537 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.9 t -95.55 147.3 23.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.645 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.428 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 49.4 m-85 -103.21 141.99 34.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.378 -0.826 . . . . 0.0 109.785 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 m -74.4 149.98 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.479 -0.763 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.64 -33.73 23.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.809 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -73.14 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.5 t-20 -54.51 -41.0 69.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.029 . . . . 0.0 110.306 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.11 -46.4 94.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.838 -1.164 . . . . 0.0 109.456 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -60.48 -37.21 80.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 108.94 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ASN . 25.9 tttt -127.84 116.9 20.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.583 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -101.87 134.99 44.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.12 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.55 ' H ' HD21 ' A' ' 56' ' ' ASN . 8.9 p -131.99 148.24 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.438 -0.788 . . . . 0.0 109.892 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 6.5 tt -79.66 132.26 36.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.7 m95 -92.88 110.08 21.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.056 -1.027 . . . . 0.0 109.688 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 54.8 t0 -136.31 168.92 18.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.564 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.02 -37.36 69.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.902 -1.124 . . . . 0.0 109.293 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.75 -56.57 6.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.9 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.458 ' ND2' ' OH ' ' A' ' 74' ' ' TYR . 41.0 t30 -62.34 -38.96 91.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.828 . . . . 0.0 110.397 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.5 tpp -58.75 -40.56 84.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.7 m -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 109.276 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.13 -31.44 72.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.047 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.715 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 75.2 t60 -57.48 -47.49 81.75 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.439 -0.788 . . . . 0.0 109.597 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.8 mt -68.37 -30.52 69.47 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.028 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.467 ' HG1' ' CZ ' ' A' ' 91' ' ' ARG . 34.7 m -62.46 -39.81 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.015 -1.053 . . . . 0.0 110.641 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -150.95 65.93 7.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.073 -1.017 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.63 -20.74 69.76 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.572 2.181 . . . . 0.0 112.776 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.9 -50.38 64.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.652 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -86.62 -6.36 58.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 110.046 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.525 ' CE1' ' CH2' ' A' ' 59' ' ' TRP . 44.6 t80 -62.47 -49.67 74.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 pt -140.7 72.26 29.79 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.04 135.67 64.69 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.49 2.127 . . . . 0.0 112.204 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 14.62 50.09 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.15 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.626 ' HG1' ' H ' ' A' ' 79' ' ' LYS . 14.9 t -104.61 171.44 7.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.816 -1.403 . . . . 0.0 110.064 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.626 ' H ' ' HG1' ' A' ' 78' ' ' THR . 46.5 mtmt -94.61 14.06 22.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 0.0 110.318 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.715 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 2.1 mmm -67.5 135.05 52.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 0.0 109.889 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.25 26.01 10.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 57.2 t80 -91.79 130.16 37.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -85.48 177.05 50.09 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.91 158.07 30.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -102.95 135.05 45.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.0 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -92.65 -4.62 53.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.795 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -103.02 130.81 50.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.005 . . . . 0.0 109.805 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.31 -44.87 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.454 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -60.17 -48.26 82.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.018 . . . . 0.0 110.301 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.63 -39.04 93.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.467 ' CZ ' ' HG1' ' A' ' 69' ' ' THR . 40.7 ttm180 -58.92 -42.31 89.38 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.403 HD21 ' HG3' ' A' ' -2' ' ' LYS . 90.3 m-20 -61.62 -40.37 94.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.07 -1.019 . . . . 0.0 110.384 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.37 -40.08 96.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.026 -1.046 . . . . 0.0 110.001 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.0 tp -57.26 -45.75 83.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.848 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 77.3 mt -66.53 -43.64 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 m -60.71 -39.74 89.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.352 -0.843 . . . . 0.0 109.917 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -58.09 -49.18 77.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.043 . . . . 0.0 109.729 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.09 -35.59 76.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.038 . . . . 0.0 109.169 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 10.9 tptm -57.84 -43.34 85.78 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.388 -0.82 . . . . 0.0 109.517 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -61.04 -45.44 94.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.176 -0.952 . . . . 0.0 109.693 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 109.511 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' -2' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' -1' ' ' ALA . 34.6 ttpt -102.54 136.36 42.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' -1' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.99 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -98.23 134.27 11.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 4' ' ' LYS . 22.8 t -57.19 -33.48 67.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -1.123 . . . . 0.0 109.288 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . 73.32 -35.77 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.2 tttt -59.14 -48.9 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.52 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.62 -42.81 98.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.36 -32.16 81.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.9 93.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -1.17 . . . . 0.0 109.474 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -72.51 -36.38 68.35 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.33 -41.49 84.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.3 t80 -63.54 -46.85 84.11 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -63.31 -39.65 95.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -70.41 -34.43 72.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.419 -0.8 . . . . 0.0 111.7 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -150.27 59.97 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.626 -1.296 . . . . 0.0 110.933 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -173.08 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.962 -1.086 . . . . 0.0 109.997 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -36.32 72.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.967 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -56.45 -35.35 67.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.024 -1.048 . . . . 0.0 109.496 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.9 m -97.26 -48.84 5.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.263 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.3 113.43 25.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.741 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.0 p -82.58 -19.15 39.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.477 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.0 p 36.86 41.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -101.67 147.95 25.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -56.57 -36.58 69.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -30.94 56.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 25' ' ' PRO . . . 64.66 56.54 16.33 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 24' ' ' GLY . 33.1 Cg_endo -67.79 -23.78 41.35 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.787 2.325 . . . . 0.0 112.019 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 93.1 m-70 54.77 57.9 5.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.644 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' HIS . 45.1 tttm -58.98 -122.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.342 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.05 -40.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 109.883 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.52 167.47 14.95 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.29 152.29 61.49 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.004 2.469 . . . . 0.0 112.263 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 26' ' ' HIS . 16.2 m120 -89.17 140.83 29.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.273 -0.892 . . . . 0.0 109.044 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.8 mp -92.83 140.39 29.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.932 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 47.6 p-80 -176.06 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 93.98 3.8 63.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.19 -21.56 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.449 -1.03 . . . . 0.0 109.524 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -66.94 132.32 47.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.8 24.33 76.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 86.3 mtt-85 -133.12 159.1 41.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -1.133 . . . . 0.0 109.95 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -90.93 147.38 23.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.42 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 3.4 t -63.13 155.91 26.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.79 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.79 -13.92 59.08 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 44' ' ' GLU . 51.4 tt0 -62.3 -37.1 84.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 109.804 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.85 70.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.897 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLN . 97.2 mt-10 -60.51 -31.28 70.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.11 -32.84 50.64 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 47' ' ' SER . 60.3 t80 -122.3 142.03 50.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -1.04 . . . . 0.0 109.572 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 22.9 t -74.04 158.17 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 19.4 m-85 -106.12 150.27 25.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 109.835 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -63.58 155.21 30.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -55.52 -35.49 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.567 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -58.23 9.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.185 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 55' ' ' LYS . 17.5 t-20 -57.88 -40.81 81.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.922 -1.111 . . . . 0.0 109.469 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . 0.429 HG23 HD13 ' A' ' 53' ' ' ILE . 94.0 mt -62.77 -43.13 98.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.145 -0.972 . . . . 0.0 109.426 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.34 -40.99 92.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 109.331 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 52' ' ' ASN . 6.7 tptm -128.39 125.17 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.607 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -98.05 140.89 31.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 109.086 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.607 ' H ' HD21 ' A' ' 56' ' ' ASN . 14.3 p -130.94 148.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.28 130.89 35.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.4 m95 -98.95 125.15 44.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' C ' ' A' ' 60' ' ' ASP . 55.0 p30 -157.95 -170.21 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -62.31 -43.12 99.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.763 -1.21 . . . . 0.0 110.439 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -68.39 -54.1 19.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 0.0 110.714 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 40.7 t30 -57.1 -38.7 73.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.44 -0.787 . . . . 0.0 110.902 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.6 mmt -58.04 -41.99 84.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 0.0 109.425 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -65.88 -32.96 74.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.458 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.03 -37.59 84.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.148 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.512 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 79.0 t60 -59.04 -49.21 78.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.043 . . . . 0.0 109.496 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 84' ' ' GLY . 8.4 mp -72.23 -26.95 62.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 70' ' ' ASN . 27.2 m -87.51 129.66 35.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.015 . . . . 0.0 109.629 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 69' ' ' THR . 1.5 m120 38.75 55.94 5.2 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 11.1 Cg_endo -58.44 -18.49 39.16 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.84 2.36 . . . . 0.0 112.649 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.77 90.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.529 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.47 4.73 51.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 75' ' ' ILE . 50.9 t80 -116.39 119.35 35.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.275 -0.891 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 74' ' ' TYR . 45.7 mm 40.23 59.25 7.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.483 -0.761 . . . . 0.0 109.783 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.99 147.8 62.19 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.903 2.402 . . . . 0.0 112.139 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.7 2.91 57.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 p -75.48 163.59 27.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -85.07 5.99 27.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' MET . . . . . 0.512 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 69.1 mtm -86.7 126.69 34.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.371 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.65 6.87 32.38 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.83 134.07 46.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.55 -175.32 28.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 76.71 36.32 37.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 62.7 mt -82.26 143.27 31.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' LYS . 20.3 ttpp -73.3 145.64 45.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' LYS . 17.5 mttp -44.19 130.76 6.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -172.19 158.53 4.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.38 -32.3 62.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.144 -0.973 . . . . 0.0 109.231 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -56.04 -41.26 74.73 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.156 -0.965 . . . . 0.0 109.251 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.3 ttm180 -61.21 -46.46 90.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -67.25 -40.94 86.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.775 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 3' ' ' ALA . 89.2 m-20 -62.93 -40.22 96.94 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -58.18 -44.78 88.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 109.52 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 95' ' ' ILE . 80.8 mt -67.16 -40.54 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.1 m -57.99 -40.15 79.99 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.735 -0.603 . . . . 0.0 109.77 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.83 -51.36 70.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.082 -1.011 . . . . 0.0 109.687 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.92 -35.61 80.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.057 -1.027 . . . . 0.0 108.33 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 82.8 tttt -58.09 -42.39 85.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -60.79 -39.89 90.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 109.742 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.456 -0.778 . . . . 0.0 109.421 -179.673 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -5' ' ' THR . . . . . 0.457 ' H3 ' ' HG1' ' A' ' -5' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.21 -31.19 67.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 36.5 t80 -92.46 130.59 38.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.583 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.4 ptmt -103.53 161.32 13.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.372 -0.83 . . . . 0.0 109.215 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.88 96.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.96 . . . . 0.0 109.336 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -110.98 170.21 13.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -110.94 130.87 55.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.142 . . . . 0.0 109.238 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -74.4 -19.39 60.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.022 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.5 -49.55 74.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.093 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -63.14 -47.48 82.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.101 . . . . 0.0 109.267 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -67.66 -28.13 73.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.62 -44.73 85.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.224 . . . . 0.0 109.868 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.9 p -70.02 -38.62 75.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.153 -0.967 . . . . 0.0 109.418 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.3 tp -59.25 -41.04 87.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.66 -46.36 88.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.79 -38.86 92.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.382 0.61 . . . . 0.0 109.967 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.8 p -69.31 -34.68 75.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 111.493 -178.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -150.28 59.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.642 -1.287 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -171.18 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 0.0 109.965 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.98 -38.2 72.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 109.607 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.87 -36.09 74.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.898 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -94.53 -42.57 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.479 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.6 m-70 -107.56 124.15 49.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.598 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.9 p -84.42 -29.57 26.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.251 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.44 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 85.7 t 54.32 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.289 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.598 ' H ' ' C ' ' A' ' 19' ' ' THR . 77.8 mm-40 -62.06 141.98 57.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' C ' ' H ' ' A' ' 24' ' ' GLY . 16.3 tttm -71.07 143.19 50.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.623 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.18 9.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.568 ' H ' ' C ' ' A' ' 22' ' ' LYS . . . -76.17 162.65 52.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 57.0 Cg_endo -71.31 175.92 8.66 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 123.127 2.552 . . . . 0.0 111.691 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -102.42 133.49 47.28 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.254 -0.904 . . . . 0.0 109.516 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 29' ' ' GLY . 56.0 tttp -132.23 131.09 41.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.252 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 85.1 t 53.73 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.171 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -102.39 162.97 16.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 20.3 Cg_endo -62.03 153.01 71.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.09 2.527 . . . . 0.0 112.165 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.482 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 12.7 m120 -84.27 139.03 32.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.603 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -99.69 139.3 35.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 109.885 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.402 ' HE2' ' HE2' ' A' ' 22' ' ' LYS . 57.8 t-80 -166.56 95.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.58 7.47 78.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -58.66 -21.58 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.014 . . . . 0.0 109.613 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -64.1 133.22 52.58 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 71.13 21.39 78.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.779 ' HE ' HE21 ' A' ' 42' ' ' GLN . 68.1 mtp85 -138.57 167.04 22.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -1.15 . . . . 0.0 109.924 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -94.68 156.88 16.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.905 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.586 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 58.0 p -66.31 164.53 15.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.724 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.88 0.8 68.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.779 HE21 ' HE ' ' A' ' 38' ' ' ARG . 46.3 tt0 -60.1 -35.53 75.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.995 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.66 -34.41 69.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.3 mt-10 43.32 17.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.156 -0.965 . . . . 0.0 109.408 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -127.95 -36.42 0.47 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 47' ' ' SER . 68.5 t80 -103.67 135.52 45.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 108.815 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.436 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 54.3 p -65.93 156.57 33.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.899 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.87 150.1 42.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.559 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 7.1 t -54.9 149.92 10.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.863 . . . . 0.0 109.24 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.78 -35.11 65.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.877 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 76' ' ' PRO . . . -60.22 -57.58 12.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.063 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.497 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.2 t-20 -57.5 -42.8 83.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.566 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.31 -55.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.177 -0.952 . . . . 0.0 109.728 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -68.38 -54.86 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 56' ' ' ASN . 19.9 tttm -65.7 -52.23 53.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.586 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 50.91 118.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.758 0.789 . . . . 0.0 110.119 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.487 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 7.6 p -126.47 147.51 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.3 tp -75.82 134.12 40.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 108.93 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 m95 -99.6 128.41 45.71 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.337 -0.852 . . . . 0.0 110.034 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.431 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 50.3 t0 -159.12 172.98 17.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.585 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.17 -39.15 71.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.961 -1.087 . . . . 0.0 109.646 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.582 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 p-10 -74.77 -48.08 27.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.078 -1.014 . . . . 0.0 109.513 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 39.0 t30 -60.9 -38.26 85.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 110.003 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -40.12 86.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.921 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.401 ' O ' ' OG1' ' A' ' 69' ' ' THR . 94.5 p -61.49 -36.4 80.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.001 -1.062 . . . . 0.0 109.799 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.24 -36.65 77.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.019 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.628 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 81.9 t60 -61.38 -47.39 86.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.138 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 4.7 mp -71.46 -36.23 71.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.392 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.581 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 25.5 m -60.96 -39.58 90.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.623 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -152.87 68.73 6.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.585 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.15 -15.81 46.54 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.364 2.043 . . . . 0.0 112.651 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -78.87 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 110.266 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.68 -32.79 67.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.149 -0.97 . . . . 0.0 109.772 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' O ' ' NZ ' ' A' ' 55' ' ' LYS . 80.2 t80 -56.66 -49.66 74.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.448 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 2.8 mm -141.14 80.84 16.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.923 . . . . 0.0 109.113 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.434 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -84.88 149.47 10.97 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.957 2.438 . . . . 0.0 112.247 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.25 58.63 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.42 HG22 ' H ' ' A' ' 80' ' ' MET . 15.0 t -104.77 163.65 12.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -1.216 . . . . 0.0 109.71 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.79 -0.12 37.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.628 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 11.2 ttt -85.11 129.59 34.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 0.0 110.007 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.63 85.52 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.8 t80 -104.6 133.4 49.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.34 138.02 22.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.94 146.8 43.73 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.2 mt -95.16 125.45 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.244 . . . . 0.0 109.554 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.508 ' HZ1' ' CB ' ' A' ' 86' ' ' LYS . 9.3 mtmp? -65.42 -34.6 78.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 110.206 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -84.78 127.84 34.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 0.0 110.16 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -77.52 -35.54 53.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -57.75 -45.6 85.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.6 -39.54 94.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.041 . . . . 0.0 109.1 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.581 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 37.6 ttm180 -59.67 -40.47 87.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.936 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.12 -42.35 90.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.358 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.424 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -63.43 -40.06 96.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.054 -1.029 . . . . 0.0 110.14 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.5 tp -59.75 -42.76 93.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.036 -1.04 . . . . 0.0 109.627 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.85 -37.41 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.972 . . . . 0.0 108.955 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -60.79 -39.58 89.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.598 -0.689 . . . . 0.0 109.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.53 -50.61 73.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.105 -0.997 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.3 mt -69.05 -35.43 76.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.168 179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.585 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 18.7 tptm -58.68 -40.56 83.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.351 -0.843 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -60.1 -40.84 91.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.44 70.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.529 -0.732 . . . . 0.0 109.796 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 43.8 p -66.61 -23.48 66.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.414 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.99 141.35 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.525 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 93.6 t80 -99.9 130.06 46.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.924 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.712 ' HZ3' ' HZ1' ' A' ' 89' ' ' LYS . 33.5 ttpt -81.88 144.45 30.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.071 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.95 -22.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 109.564 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.588 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 42.37 94.95 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 46.0 m -63.37 153.44 35.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.111 -1.229 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -80.77 -128.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 40.8 tttm 57.64 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.057 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' ALA . 32.9 mmtp -59.29 -52.44 65.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -36.56 93.57 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.43 79.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -1.162 . . . . 0.0 109.414 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 54.4 p -70.43 -37.35 74.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.243 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.68 -55.98 27.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 108.816 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 43.2 t80 -62.5 -41.71 99.0 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.427 -0.796 . . . . 0.0 109.266 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -61.49 -38.54 87.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 111.159 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 p -106.02 4.64 29.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.112 -0.993 . . . . 0.0 111.759 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -147.02 28.71 1.01 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.613 -1.305 . . . . 0.0 110.75 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -171.08 -24.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.723 -1.235 . . . . 0.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -59.54 -38.19 80.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.885 -1.134 . . . . 0.0 109.916 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.0 -36.53 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.018 . . . . 0.0 111.239 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.73 -50.23 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.832 -1.167 . . . . 0.0 111.202 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -101.91 126.37 48.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.065 -1.022 . . . . 0.0 110.265 -178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.413 ' C ' ' H ' ' A' ' 21' ' ' GLU . 51.5 p -87.23 -24.28 24.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.241 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 t 63.79 0.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.457 -0.777 . . . . 0.0 110.18 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.3 mt-10 -101.37 124.75 47.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.436 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -69.53 -39.22 77.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.567 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.63 87.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 154.17 44.39 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 62.1 Cg_endo -74.26 -156.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 111.733 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.403 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 98.7 m-70 -107.68 133.6 51.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.134 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -103.78 -125.07 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.31 -38.45 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.156 -0.965 . . . . 0.0 108.896 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.79 165.14 20.94 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.403 ' HA ' ' HD1' ' A' ' 26' ' ' HIS . 20.9 Cg_endo -63.3 150.77 87.67 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.958 2.438 . . . . 0.0 112.37 -179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 2.9 m120 -80.81 141.71 34.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 108.99 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.519 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.7 mp -95.42 139.19 32.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.017 . . . . 0.0 109.861 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -172.19 90.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 0.0 109.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.583 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.05 5.02 66.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.4 tt -58.5 -22.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -1.176 . . . . 0.0 109.546 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.67 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 81.2 m-85 -68.11 135.35 52.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.8 79.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 67.8 mtt85 -142.62 166.08 25.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 110.04 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -95.77 162.57 13.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 110.197 -179.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.552 ' HG ' ' ND2' ' A' ' 56' ' ' ASN . 62.0 p -66.3 166.21 12.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.816 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.28 60.89 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.407 HE22 ' HD2' ' A' ' 38' ' ' ARG . 39.0 tt0 -62.41 -38.42 89.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -1.16 . . . . 0.0 109.876 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.581 ' N ' ' OH ' ' A' ' 48' ' ' TYR . . . -71.31 66.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.98 -32.48 72.03 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.366 -0.834 . . . . 0.0 109.343 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.6 60.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -108.8 134.58 51.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -1.138 . . . . 0.0 109.153 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 m -64.47 156.32 29.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.581 ' OH ' ' N ' ' A' ' 43' ' ' ALA . 59.3 m-85 -112.14 145.32 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.306 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.4 p -76.91 161.09 28.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.456 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -58.78 -33.06 69.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.949 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.25 -70.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.216 -0.927 . . . . 0.0 110.673 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.8 t-20 -54.83 -40.62 69.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.924 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.72 -46.37 96.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.942 -1.098 . . . . 0.0 109.482 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.37 -37.06 79.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.12 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 52' ' ' ASN . 52.9 tttm -126.28 115.75 20.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' ND2' ' HG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -99.42 137.68 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.132 -0.98 . . . . 0.0 109.063 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.548 ' H ' HD21 ' A' ' 56' ' ' ASN . 14.8 p -130.9 146.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.404 -0.81 . . . . 0.0 109.975 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.8 tp -79.14 131.05 36.09 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.493 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 89.0 m95 -94.18 124.48 38.22 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -153.94 169.27 23.86 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.86 -40.0 72.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 0.0 109.559 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -69.83 -48.8 57.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.15 -41.09 92.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.544 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.67 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.0 mtt -61.45 -38.0 85.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.003 -1.061 . . . . 0.0 109.727 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -55.95 -42.0 75.52 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 108.953 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -37.01 76.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.496 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 70.4 t60 -62.92 -47.92 81.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 7.4 mp -61.93 -26.79 68.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.892 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.59 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 33.8 m -84.78 126.0 33.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.952 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 69' ' ' THR . 8.2 m120 40.48 60.01 7.41 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 28.2 Cg_endo -64.52 -23.02 64.82 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.962 2.441 . . . . 0.0 112.9 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.78 81.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.061 -1.025 . . . . 0.0 109.491 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -62.67 -32.64 73.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.492 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 10.7 t80 -57.19 -55.59 32.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 109.726 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.421 HD11 HG22 ' A' ' 75' ' ' ILE . 2.9 pt -141.82 73.83 22.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.0 109.779 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -60.96 -34.97 90.04 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 122.64 2.227 . . . . 0.0 112.045 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.7 75.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.0 p -75.51 158.75 32.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.236 . . . . 0.0 110.51 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -84.7 3.83 35.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 109.608 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.496 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 6.7 ttt -76.74 129.87 36.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.92 93.5 2.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.628 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 78.3 t80 -101.81 131.24 48.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.225 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -63.76 130.92 40.11 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.24 145.83 41.65 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.4 mt -94.73 125.07 39.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.979 -1.306 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -64.52 -37.96 89.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -86.98 119.49 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.826 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.03 -32.93 72.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.712 ' HZ1' ' HZ3' ' A' ' -2' ' ' LYS . 13.6 tttm -57.06 -51.46 69.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.102 -0.999 . . . . 0.0 109.641 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -60.74 -38.07 83.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.8 . . . . 0.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.59 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 55.8 ttp180 -58.09 -42.12 84.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.761 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.3 -38.77 84.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.094 -1.004 . . . . 0.0 109.972 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 2' ' ' SER . 86.0 m-20 -62.97 -40.66 98.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.19 -0.944 . . . . 0.0 109.95 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.425 ' CD2' ' C ' ' A' ' 94' ' ' LEU . 6.7 tt -57.98 -45.02 87.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 109.939 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 70.9 mt -63.29 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.93 -1.106 . . . . 0.0 108.67 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 28.7 m -58.81 -39.17 80.37 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.488 -0.757 . . . . 0.0 109.469 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.06 -49.84 75.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.904 -1.122 . . . . 0.0 108.699 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt -66.98 -33.4 75.5 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 34.3 tttm -56.5 -42.51 78.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.61 -40.25 91.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.81 67.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.539 -0.726 . . . . 0.0 109.627 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.489 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 43.5 p -66.89 -26.47 66.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.455 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.493 ' O2A' ' NE1' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -5' ' ' THR . . . . . 0.504 ' HG1' ' H ' ' A' ' -3' ' ' PHE . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.68 -34.32 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.504 ' H ' ' HG1' ' A' ' -5' ' ' THR . 70.6 t80 -103.81 134.49 47.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.569 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.4 ptpt -130.89 164.03 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 109.218 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -42.02 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -66.57 134.98 33.1 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 85.2 p -64.98 -20.72 66.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 51.31 -141.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttm 55.61 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 109.725 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 3' ' ' ALA . 24.9 mttm -58.24 -45.53 87.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.033 -1.042 . . . . 0.0 109.636 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.49 -32.9 79.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.1 p -71.97 -34.82 69.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.321 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tp -57.07 -40.48 76.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.9 t80 -62.72 -47.57 83.01 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.11 -38.1 89.85 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.411 0.624 . . . . 0.0 110.033 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 53.4 p -69.02 -34.49 75.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 111.366 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -150.62 59.3 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.688 -1.258 . . . . 0.0 110.947 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.7 t -171.17 -50.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.82 -1.175 . . . . 0.0 110.36 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.11 -37.53 72.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.06 -1.025 . . . . 0.0 109.82 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.32 -35.98 72.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.13 -0.981 . . . . 0.0 109.827 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -95.33 -42.0 8.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.617 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -108.0 126.13 52.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -178.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.434 ' C ' ' H ' ' A' ' 21' ' ' GLU . 52.7 p -86.98 -26.14 23.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.472 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t 64.02 -0.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.113 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.2 mt-10 -95.61 120.06 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -69.29 -39.74 78.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.85 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.58 -37.09 91.72 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.98 156.57 44.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.78 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.797 2.331 . . . . 0.0 111.755 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.423 ' HD1' ' H ' ' A' ' 31' ' ' ASN . 94.4 m-70 -104.89 134.5 47.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -101.37 -125.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.86 -39.62 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.05 166.03 18.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -62.06 150.5 86.29 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.879 2.386 . . . . 0.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 10.1 m120 -82.82 141.62 32.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.558 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.495 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.0 mp -99.68 137.26 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.786 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -171.71 98.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 108.907 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.11 8.56 81.79 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.45 -23.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.961 . . . . 0.0 109.535 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 86.6 m-85 -63.18 135.58 57.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 63.34 30.0 76.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.408 HH21 ' HB3' ' A' ' 42' ' ' GLN . 62.0 ttt180 -134.85 154.27 51.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -1.033 . . . . 0.0 109.843 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.64 145.94 24.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 56.9 p -67.88 163.42 21.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 0.0 110.151 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.08 -9.7 67.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.408 ' HB3' HH21 ' A' ' 38' ' ' ARG . 95.5 mt-30 -96.85 6.05 49.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.92 -30.63 66.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.805 -1.185 . . . . 0.0 108.169 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 97.5 mt-10 38.05 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.431 0.634 . . . . 0.0 109.917 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.83 -26.65 2.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.94 143.31 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -1.013 . . . . 0.0 108.837 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -65.06 158.3 26.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 109.857 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.439 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 14.6 m-85 -116.65 138.3 51.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 109.713 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 52.0 m -74.88 144.92 43.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 108.974 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -50.56 -35.85 31.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.75 -69.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.7 t-20 -56.54 -41.41 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.086 -1.009 . . . . 0.0 110.564 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.4 mm -60.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.739 -1.226 . . . . 0.0 110.012 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -60.34 -33.88 73.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.205 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.4 tttm -127.26 112.65 15.33 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.593 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -100.07 137.96 37.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.589 ' H ' HD21 ' A' ' 56' ' ' ASN . 13.7 p -132.35 147.74 32.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 109.842 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.1 tp -79.04 134.22 36.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 108.811 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' GLY . 95.9 m95 -95.15 125.19 39.62 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.177 -0.952 . . . . 0.0 110.071 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 62' ' ' ASN . 46.3 p30 -155.41 -176.13 5.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -60.97 -39.59 90.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.939 -1.1 . . . . 0.0 111.013 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -74.94 -47.18 30.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.86 -1.15 . . . . 0.0 110.722 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 64.2 t30 -58.38 -42.1 86.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.499 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.645 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.3 mtt -62.41 -38.45 89.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 109.87 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.6 p -62.71 -40.82 98.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.257 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.08 -34.79 73.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.175 -0.953 . . . . 0.0 109.25 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.2 t60 -57.99 -44.15 86.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.561 -0.712 . . . . 0.0 109.471 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HB2' HH11 ' A' ' 91' ' ' ARG . 95.1 mt -67.64 -32.46 73.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -0.778 . . . . 0.0 110.597 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 m -55.77 -37.28 68.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.036 -1.04 . . . . 0.0 110.542 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.6 p-10 -167.56 69.04 0.9 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.434 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -50.15 -27.56 17.56 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.95 2.434 . . . . 0.0 112.636 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -58.44 6.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 109.321 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 67.5 mttt -61.94 -26.85 68.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.571 ' CD2' ' ND1' ' A' ' 67' ' ' HIS . 34.2 t80 -59.46 -54.78 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.631 -0.668 . . . . 0.0 109.643 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.8 pt -139.96 70.19 35.68 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.077 -1.014 . . . . 0.0 109.97 179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -52.81 135.47 57.43 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.429 2.086 . . . . 0.0 112.007 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.7 -0.55 56.65 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.847 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.424 HG22 ' H ' ' A' ' 80' ' ' MET . 8.4 t -89.2 161.24 16.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.653 -1.498 . . . . 0.0 109.62 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -85.66 1.41 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.424 ' H ' HG22 ' A' ' 78' ' ' THR . 15.4 ttp -77.85 125.52 29.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.002 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.3 79.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 64.4 t80 -103.21 131.68 50.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.47 -0.769 . . . . 0.0 109.68 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -71.22 144.97 38.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 147.64 34.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 55.2 mt -97.21 133.1 42.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -94.1 -9.18 37.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.929 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -99.28 128.42 45.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 110.024 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.0 -38.59 52.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -60.72 -49.64 76.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 110.21 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.76 -37.31 86.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.004 . . . . 0.0 109.444 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.477 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.8 ttm-85 -57.46 -45.3 84.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.719 . . . . 0.0 109.883 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -62.76 -39.93 95.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 85.7 m-20 -61.37 -39.64 91.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.186 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.2 tp -60.36 -45.11 94.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 110.758 -178.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.45 -41.8 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.008 -1.057 . . . . 0.0 109.579 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -58.15 -40.4 81.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 110.012 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -58.89 -50.88 72.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.372 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.6 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.627 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.589 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 80.6 tttt -56.72 -43.34 80.52 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -61.46 -43.58 98.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 0.0 109.4 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.48 68.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.673 -0.642 . . . . 0.0 109.748 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.63 -33.22 71.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 109.44 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.461 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -108.38 152.51 24.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.381 -0.824 . . . . 0.0 109.525 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.452 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 49.9 t80 -101.66 130.58 48.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 109.719 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.452 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 32.9 ttpt -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.102 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.06 95.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -89.53 -176.42 45.81 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -105.86 129.47 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.165 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -68.51 -26.04 65.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -57.0 -46.97 81.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.027 -1.046 . . . . 0.0 110.15 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -66.49 -53.1 38.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.036 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.43 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.34 -28.21 72.72 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.61 -47.83 81.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.204 . . . . 0.0 109.761 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.9 p -73.65 -36.19 65.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.427 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 20.0 tp -58.16 -42.19 85.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -64.69 -46.67 81.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -63.43 -40.43 97.14 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.471 0.653 . . . . 0.0 110.396 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 55.4 p -72.5 -29.56 63.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 111.627 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.32 55.96 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.549 -1.344 . . . . 0.0 111.23 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.646 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.9 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.782 -1.199 . . . . 0.0 110.49 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.09 -37.62 69.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.54 -35.7 70.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 109.904 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -97.7 -42.6 7.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.646 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -105.31 122.69 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.144 -0.972 . . . . 0.0 110.505 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 21' ' ' GLU . 52.9 p -82.52 -18.62 40.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.44 ' C ' ' O ' ' A' ' 19' ' ' THR . 14.8 p 39.7 21.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.701 -0.624 . . . . 0.0 110.047 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 18.8 pttm -67.2 -40.4 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.964 . . . . 0.0 109.546 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -62.62 -36.98 94.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.87 152.59 31.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 84.4 Cg_endo -77.16 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.712 2.275 . . . . 0.0 111.877 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -99.5 136.26 39.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.939 . . . . 0.0 109.258 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 36.0 tptt -106.48 -130.09 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.47 -41.1 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.58 161.96 15.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 12.2 Cg_endo -57.73 143.18 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.134 2.556 . . . . 0.0 111.938 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.5 m120 -76.43 146.31 38.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.61 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.3 mp -98.92 138.75 35.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.626 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -174.84 97.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.85 84.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 tt -58.89 -23.79 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.65 -0.912 . . . . 0.0 109.401 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -65.17 131.48 46.64 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.3 -0.875 . . . . 0.0 108.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.94 30.17 74.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -134.08 152.67 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -1.043 . . . . 0.0 109.931 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -93.37 145.23 24.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.316 -0.865 . . . . 0.0 108.999 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.579 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 53.4 p -66.79 158.52 30.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.956 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.37 -22.75 25.32 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -62.4 -36.34 82.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -1.205 . . . . 0.0 110.381 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.675 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.48 -44.86 92.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 109.892 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.12 -16.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.919 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.675 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -57.8 -34.65 71.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -123.25 143.37 50.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.597 -0.943 . . . . 0.0 109.168 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -64.76 159.39 22.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.98 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -118.41 146.52 44.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.563 -0.711 . . . . 0.0 109.554 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.456 ' N ' ' O1D' ' A' ' 201' ' ' HEC . 41.9 p -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.38 -31.54 61.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 109.627 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.33 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.504 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.0 t-20 -55.8 -42.18 75.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.941 -1.1 . . . . 0.0 110.286 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.43 -45.65 96.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 120.895 -1.128 . . . . 0.0 109.519 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -60.51 -37.17 80.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.255 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 52' ' ' ASN . 40.0 tttm -128.28 118.87 24.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 14.9 t-20 -98.91 135.59 40.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 108.898 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.484 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 9.6 p -131.18 146.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.423 -0.798 . . . . 0.0 110.195 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.08 132.92 36.05 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -96.81 125.91 41.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.211 -0.931 . . . . 0.0 110.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.413 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 49.6 t0 -159.09 176.36 12.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.549 ' CD ' ' HZ1' ' A' ' 99' ' ' LYS . 97.2 mt-10 -55.35 -40.04 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.764 -1.21 . . . . 0.0 109.411 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.9 -52.22 26.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 33.7 t30 -62.85 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.611 -179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.5 mmt -58.75 -40.65 84.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.6 p -66.28 -37.56 85.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.19 -36.99 84.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.404 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -60.27 -45.68 92.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 109.84 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 83.9 mt -70.17 -35.5 74.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.53 -0.731 . . . . 0.0 110.528 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 29.6 m -61.24 -39.2 89.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.912 -1.117 . . . . 0.0 110.829 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -152.92 67.99 6.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 109.788 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -61.96 -15.14 41.34 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.419 2.079 . . . . 0.0 112.675 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.03 -78.75 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.067 -1.021 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -57.22 -34.51 68.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.484 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 87.8 t80 -56.3 -50.34 71.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.954 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.479 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 20.7 mt -148.09 77.66 9.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.02 152.12 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 123.208 2.606 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.15 3.17 55.78 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.668 ' HG1' ' N ' ' A' ' 79' ' ' LYS . 6.2 t -104.65 174.73 5.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.154 -1.204 . . . . 0.0 109.539 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.668 ' N ' ' HG1' ' A' ' 78' ' ' THR . 47.3 mtmt -87.19 11.63 13.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.674 -178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.404 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -70.13 121.51 17.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.763 -1.21 . . . . 0.0 109.622 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.86 27.27 8.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.004 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 51.9 t80 -86.74 129.2 34.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.172 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -87.54 178.68 47.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.84 154.27 23.75 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.8 mt -100.26 122.09 42.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -66.1 -36.4 83.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.87 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -92.08 128.92 38.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.02 -1.05 . . . . 0.0 110.36 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -29.59 60.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.65 -0.656 . . . . 0.0 109.91 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -55.39 -50.2 70.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -64.21 -37.94 89.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.945 . . . . 0.0 109.103 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.585 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 39.3 ttm180 -58.67 -42.47 88.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.649 -0.657 . . . . 0.0 110.116 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.43 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 88.9 m-20 -63.03 -39.51 94.96 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.055 -1.028 . . . . 0.0 110.285 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.0 tp -59.98 -42.9 95.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.56 -38.45 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.8 m -60.7 -41.07 94.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.11 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 102' ' ' THR . 73.1 t80 -58.63 -51.88 68.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.115 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.17 -36.89 69.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.549 ' HZ1' ' CD ' ' A' ' 61' ' ' GLU . 26.3 tptt -58.49 -45.68 88.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ALA . 22.5 mttm -58.78 -50.53 73.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.81 -1.181 . . . . 0.0 109.251 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' A' ' 103' ' ' GLU . . . 154.01 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.591 ' O ' ' CE2' ' A' ' 97' ' ' TYR . 1.1 p 61.32 -2.23 0.24 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 108.909 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 101' ' ' ALA . 97.8 mt-10 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.463 -0.773 . . . . 0.0 109.44 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.456 ' O1D' ' N ' ' A' ' 49' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.74 -34.12 69.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -101.16 128.93 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -97.35 142.72 28.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.946 . . . . 0.0 109.154 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -60.75 138.69 58.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.203 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' -1' ' ' ALA . . . -42.46 104.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.3 m -56.82 -35.96 69.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -1.118 . . . . 0.0 109.58 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 173.9 -165.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 109.738 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -84.14 5.38 26.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.685 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.43 -43.31 71.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.744 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.98 -28.7 69.16 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.54 -46.4 88.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -1.044 . . . . 0.0 109.672 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.412 ' O ' ' CG2' ' A' ' 12' ' ' THR . 24.6 m -60.88 -41.47 96.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.135 -0.978 . . . . 0.0 108.694 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.48 -41.3 76.35 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -61.79 -47.13 86.53 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -64.33 -37.23 86.75 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.543 0.687 . . . . 0.0 109.697 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.412 ' CG2' ' O ' ' A' ' 8' ' ' THR . 57.2 p -66.28 -38.02 86.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 111.352 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -153.8 61.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.548 -1.345 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 5.3 t -171.48 -45.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.998 -1.064 . . . . 0.0 109.774 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.41 -37.34 75.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -58.15 -36.01 72.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.6 m -94.38 -42.8 8.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.517 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.43 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 91.4 m-70 -108.54 122.69 47.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.945 . . . . 0.0 110.023 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.501 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 30.9 p -87.8 -24.64 23.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 0.0 109.83 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t 51.17 36.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -103.52 148.43 25.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.9 -37.55 82.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.275 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.47 -30.6 58.96 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 64.16 58.58 10.24 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.96 -24.58 79.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.542 2.161 . . . . 0.0 111.822 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.591 ' H ' HD21 ' A' ' 31' ' ' ASN . 94.3 m-70 55.6 42.28 29.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -56.93 -36.09 69.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 108.847 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' CZ ' ' A' ' 46' ' ' TYR . 2.4 t -146.31 -76.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -0.818 . . . . 0.0 109.253 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -72.76 160.31 53.99 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.2 1.69 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.035 2.49 . . . . 0.0 112.561 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.591 HD21 ' H ' ' A' ' 26' ' ' HIS . 0.7 OUTLIER 66.56 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 109.769 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.1 mp -93.89 139.8 30.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -167.32 94.61 0.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.3 6.4 71.19 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.58 -21.3 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.984 . . . . 0.0 109.8 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.672 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 76.0 m-85 -64.44 131.47 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.93 27.99 73.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.689 ' NE ' ' NE2' ' A' ' 42' ' ' GLN . 63.4 mtp85 -144.94 168.89 19.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.948 -1.324 . . . . 0.0 110.189 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -94.21 157.76 15.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.945 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 59.5 p -67.31 163.71 20.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.69 -10.87 64.69 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.689 ' NE2' ' NE ' ' A' ' 38' ' ' ARG . 44.1 tt0 -61.65 -37.71 85.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.138 -1.213 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.62 140.19 51.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.222 -0.924 . . . . 0.0 109.715 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -126.52 148.59 49.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 109.352 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.4 -7.78 64.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CZ ' ' O ' ' A' ' 28' ' ' VAL . 73.9 t80 -129.42 134.59 47.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 109.426 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 49.8 m -67.73 156.28 37.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.548 ' CD2' ' O1D' ' A' ' 201' ' ' HEC . 14.0 m-85 -111.88 140.0 46.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.775 . . . . 0.0 109.418 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 40.7 m -69.35 145.43 52.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.911 . . . . 0.0 109.348 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.6 m-20 -51.66 -37.34 50.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.191 -0.943 . . . . 0.0 109.785 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -43.06 -74.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.314 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.5 t-20 -54.04 -40.9 67.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.191 -0.943 . . . . 0.0 110.744 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.83 -48.57 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.673 -1.267 . . . . 0.0 109.842 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -60.22 -33.84 72.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.7 tttm -127.53 114.88 18.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.582 -0.699 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.604 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -97.89 140.04 32.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.123 -0.986 . . . . 0.0 108.897 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.604 ' H ' HD21 ' A' ' 56' ' ' ASN . 13.2 p -132.45 147.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.435 -0.79 . . . . 0.0 110.259 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -80.78 130.0 34.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.5 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 95.6 m95 -92.44 118.46 30.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.147 -0.97 . . . . 0.0 110.31 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 59' ' ' TRP . 91.4 m-20 -140.86 -178.51 5.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.408 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -61.85 -38.3 87.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 110.033 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.468 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -76.87 -41.95 41.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.259 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.444 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 31.8 t30 -59.02 -42.51 90.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 110.249 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.672 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.4 mtt -63.11 -39.93 96.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.744 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.618 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 71.0 m -59.07 -40.51 85.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.631 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.62 -32.72 68.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.154 -0.966 . . . . 0.0 110.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -56.89 -51.17 70.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.416 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.584 ' O ' ' N ' ' A' ' 84' ' ' GLY . 8.3 mp -71.05 -28.58 64.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.958 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.4 m -57.74 -38.12 74.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.945 . . . . 0.0 110.848 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -163.25 66.5 1.61 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.858 -1.151 . . . . 0.0 110.358 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 74' ' ' TYR . 31.7 Cg_exo -50.92 -18.88 4.78 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 C-N-CA 122.838 2.359 . . . . 0.0 112.464 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -76.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -57.95 -32.88 68.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.92 . . . . 0.0 109.467 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.507 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 50.4 t80 -79.56 126.68 31.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 108.997 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.527 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 60.1 mt 44.58 63.12 9.16 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.05 146.5 20.29 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.923 2.415 . . . . 0.0 112.451 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.19 16.41 47.29 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.762 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 12.9 t -106.89 151.67 24.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.064 -1.257 . . . . 0.0 109.908 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -58.78 -29.62 66.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 22.1 ttp -59.71 140.51 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.288 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.04 92.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.447 -0.783 . . . . 0.0 109.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -161.7 -46.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.592 ' N ' ' CD2' ' A' ' 82' ' ' PHE . . . -41.11 164.51 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 126.5 44.29 0.25 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 43.6 mt -88.25 138.27 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -1.023 . . . . 0.0 109.301 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -90.34 -2.99 58.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -97.89 126.52 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.961 -1.087 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.54 -40.08 23.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.755 . . . . 0.0 110.158 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.47 -47.98 83.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.207 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.45 -42.44 95.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.618 ' NH1' ' CB ' ' A' ' 65' ' ' SER . 59.5 ttp85 -61.76 -41.55 97.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.15 -41.01 82.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 110.215 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.31 -38.26 90.45 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.137 -0.977 . . . . 0.0 109.849 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.9 tp -60.14 -45.82 91.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 110.75 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.22 -44.35 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.894 -1.129 . . . . 0.0 109.697 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 29.1 m -64.35 -39.8 94.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.352 -179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -59.21 -43.77 92.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.05 -1.031 . . . . 0.0 110.657 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.1 mt -61.39 -35.82 78.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.715 -1.241 . . . . 0.0 109.528 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.408 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 74.0 mttt -56.94 -38.34 72.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.162 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -59.76 -45.06 93.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.338 -0.851 . . . . 0.0 109.263 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.94 84.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.765 . . . . 0.0 109.296 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 103' ' ' GLU . 53.1 p -70.22 -30.88 68.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.201 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.879 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.548 ' O1D' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -110.62 154.05 24.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.96 128.36 46.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 1' ' ' GLY . 16.0 ttmt -90.67 132.02 36.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.933 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.17 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.249 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -67.2 147.09 48.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.586 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 25.4 m -56.61 -33.19 66.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -1.162 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.509 ' CB ' ' O ' ' A' ' 2' ' ' SER . . . 75.97 -32.33 0.21 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.394 -0.816 . . . . 0.0 109.85 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' H ' ' C ' ' A' ' 2' ' ' SER . 17.1 mttp -59.67 -51.37 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.085 -1.01 . . . . 0.0 109.203 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -65.04 -40.03 94.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.38 -34.56 89.68 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.23 89.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -1.211 . . . . 0.0 109.023 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.454 ' O ' ' CG2' ' A' ' 12' ' ' THR . 55.9 p -75.25 -38.28 60.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.89 . . . . 0.0 108.963 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.25 -42.76 95.96 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 72.1 t80 -65.08 -46.43 81.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.4 -39.22 93.9 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.324 0.583 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 8' ' ' THR . 70.5 p -70.14 -31.27 68.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.832 . . . . 0.0 111.448 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -149.23 56.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.607 -1.308 . . . . 0.0 111.246 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.53 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.769 -1.207 . . . . 0.0 110.585 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.1 tp -56.66 -37.23 70.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.166 -0.959 . . . . 0.0 110.057 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.55 -35.29 67.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.0 m -98.31 -44.13 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 110.718 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -103.48 123.95 47.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 7.0 p -84.2 -24.6 30.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 109.28 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.467 ' CG1' ' O ' ' A' ' 19' ' ' THR . 13.9 p 42.24 41.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.351 -0.843 . . . . 0.0 110.072 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -100.53 158.27 16.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 109.187 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -68.44 143.44 55.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.403 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.87 -6.91 62.6 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 47.22 60.94 4.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 -28.05 85.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.37 2.046 . . . . 0.0 111.823 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.702 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 93.5 m-70 55.0 46.74 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -57.43 -35.11 69.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 108.652 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.7 t -141.96 -114.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.56 160.7 10.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.559 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 2.4 Cg_endo -53.89 137.35 68.25 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.776 1.651 . . . . 0.0 111.517 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.702 ' ND2' ' H ' ' A' ' 26' ' ' HIS . 98.2 m-20 -89.37 137.76 32.04 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.574 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -92.11 137.76 32.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 110.279 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -162.94 90.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 5.72 68.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.73 -21.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.556 -0.967 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -62.64 134.85 56.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.127 -0.983 . . . . 0.0 108.989 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 70.69 22.35 78.03 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -134.25 161.39 35.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -1.088 . . . . 0.0 110.147 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.6 153.49 18.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.277 179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.595 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 26.8 p -66.09 158.39 28.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.888 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.34 -21.47 31.71 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.23 -36.08 78.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -1.157 . . . . 0.0 110.138 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.65 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -58.72 -44.81 90.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 109.606 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.68 -19.86 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.563 -0.71 . . . . 0.0 110.878 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.65 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -58.21 -34.25 73.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -124.06 142.33 51.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.962 . . . . 0.0 109.163 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -64.92 160.49 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 109.824 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.481 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 36.0 m-85 -116.44 149.93 38.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -75.47 162.01 28.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.05 -32.96 62.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.529 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.4 t-20 -54.0 -41.71 68.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.061 -1.024 . . . . 0.0 110.049 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.432 HD12 HG21 ' A' ' 53' ' ' ILE . 97.4 mt -59.7 -47.19 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.869 -1.144 . . . . 0.0 109.213 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -60.99 -37.36 82.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.5 tttm -125.06 117.07 23.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.536 -0.728 . . . . 0.0 109.415 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 15.9 t-20 -100.25 137.27 38.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.953 . . . . 0.0 109.023 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.451 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 11.3 p -131.17 147.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.446 -0.783 . . . . 0.0 110.196 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 63.4 tp -77.97 132.95 38.07 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.3 m95 -96.59 126.96 42.14 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.213 -0.93 . . . . 0.0 110.133 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.403 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 51.5 t0 -156.06 171.66 19.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.58 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 97.1 mt-10 -58.07 -39.07 77.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 109.547 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.4 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -72.52 -48.04 43.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.067 -1.02 . . . . 0.0 109.256 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.435 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 35.5 t30 -60.81 -37.16 81.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.453 -0.78 . . . . 0.0 109.937 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.8 mmt -58.65 -40.68 84.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 0.0 109.702 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 98.6 p -64.12 -35.43 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.114 -0.991 . . . . 0.0 109.339 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.22 -35.12 78.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 0.0 109.353 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.422 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 78.3 t60 -59.05 -47.09 86.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.489 ' O ' ' CA ' ' A' ' 84' ' ' GLY . 20.7 mt -67.97 -29.57 68.64 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.058 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -59.28 -37.91 78.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 111.024 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -161.53 65.49 2.0 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 110.238 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -52.44 -21.29 13.54 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -77.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.954 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -57.45 -36.11 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.451 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 74.2 t80 -57.22 -51.29 69.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.486 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 19.3 mt -148.29 76.49 10.17 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.198 -0.939 . . . . 0.0 108.621 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.9 148.81 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.103 2.535 . . . . 0.0 112.262 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.74 9.4 52.66 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.375 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.409 HG22 ' H ' ' A' ' 80' ' ' MET . 8.8 t -108.42 169.37 8.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 109.378 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -84.32 9.18 13.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.927 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.422 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 1.4 mtm -69.35 118.32 12.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.631 -1.293 . . . . 0.0 109.657 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.08 28.01 7.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 108.833 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.0 t80 -85.01 131.28 34.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.822 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.95 144.12 30.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 68' ' ' LEU . . . -75.9 142.86 29.22 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 mt -101.39 141.55 34.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -1.074 . . . . 0.0 108.971 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -82.64 -78.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.079 -1.013 . . . . 0.0 108.784 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -142.65 120.33 11.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.402 ' HG2' ' H ' ' A' ' 90' ' ' ASP . 82.4 tt0 -161.75 147.33 13.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -56.71 -34.58 67.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.193 -0.942 . . . . 0.0 108.657 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.402 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 90.5 m-20 -57.39 -38.21 73.91 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.308 -0.87 . . . . 0.0 108.9 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 64.0 ttp85 -57.53 -45.95 84.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 108.992 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -65.51 -43.45 90.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.466 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 2' ' ' SER . 84.7 m-20 -67.07 -39.56 86.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.334 -0.854 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 58.5 tp -55.98 -45.87 78.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.737 -179.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.16 -40.56 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.042 -1.036 . . . . 0.0 108.903 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.7 m -60.2 -39.66 87.32 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.711 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -58.66 -50.31 74.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 109.283 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.8 mt -69.28 -31.98 70.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 108.452 178.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.58 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 34.4 tttt -55.99 -46.2 78.77 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.28 -46.64 85.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.62 78.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.67 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 70.0 p -93.39 1.89 56.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.921 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.481 ' O2D' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.79 144.63 37.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.555 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -98.29 129.25 45.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -86.25 129.47 34.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.052 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.47 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.105 -0.997 . . . . 0.0 109.286 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -104.07 126.43 8.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -61.2 137.9 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -1.212 . . . . 0.0 109.296 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -78.13 -19.24 54.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.986 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -58.38 -48.75 79.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 110.066 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -65.69 -50.77 63.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.436 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.45 -32.1 83.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -56.68 -43.91 80.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.592 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.511 ' HG1' ' N ' ' A' ' 9' ' ' LEU . 52.0 p -71.87 -37.59 70.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.511 ' N ' ' HG1' ' A' ' 8' ' ' THR . 9.1 tp -58.75 -40.92 85.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.82 -47.02 85.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -63.42 -38.85 92.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.386 0.613 . . . . 0.0 109.963 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 59.4 p -69.68 -33.54 72.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 0.0 111.391 -178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -149.68 58.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.579 -1.326 . . . . 0.0 110.946 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.1 t -172.33 -54.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.832 -1.168 . . . . 0.0 110.291 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 -38.07 70.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.994 -1.067 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.79 -35.43 72.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.832 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m -96.07 -43.61 7.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.514 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.88 123.73 48.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.561 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 50.4 p -86.75 -23.37 25.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 0.0 109.298 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 19' ' ' THR . 16.0 t 40.37 67.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.918 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.76 143.92 40.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.782 . . . . 0.0 109.317 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -64.23 -35.1 79.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.05 49.49 0.72 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.82 166.99 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.3 Cg_endo -74.1 -171.02 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.054 2.503 . . . . 0.0 112.021 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -105.57 134.68 48.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 29' ' ' GLY . 79.7 tttt -131.35 129.72 41.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.78 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.9 t 53.81 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.222 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -101.89 161.54 17.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.24 154.16 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.151 2.567 . . . . 0.0 112.361 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.561 ' ND2' ' HG1' ' A' ' 19' ' ' THR . 13.9 m120 -84.13 133.65 34.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.255 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.8 mp -99.7 133.99 43.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 109.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -161.44 102.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 108.81 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 80.46 9.88 85.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.57 -21.32 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.599 -0.942 . . . . 0.0 109.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.71 132.98 51.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.203 -0.935 . . . . 0.0 109.495 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.04 26.11 73.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 90.2 mtt-85 -134.37 165.0 26.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -1.095 . . . . 0.0 110.021 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -100.04 147.33 25.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.582 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 9.5 m -61.3 152.89 27.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 110.118 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.51 -7.73 74.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.402 HE22 ' HD3' ' A' ' 38' ' ' ARG . 45.0 tt0 -64.03 -39.11 93.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.029 -1.277 . . . . 0.0 110.273 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.659 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.75 -45.44 92.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.0 -1.063 . . . . 0.0 109.556 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 58.97 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.659 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -60.96 -34.88 89.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 47' ' ' SER . 64.9 t80 -111.68 135.91 51.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -1.052 . . . . 0.0 109.352 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 35.0 m -62.57 153.79 30.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 87.2 m-85 -116.03 148.95 39.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 30.1 p -76.52 164.38 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.64 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -34.28 64.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 110.147 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.095 -1.003 . . . . 0.0 110.442 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 22.8 t-20 -55.04 -41.3 71.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.971 -1.081 . . . . 0.0 110.271 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 96.9 mt -59.88 -54.54 33.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.793 -1.192 . . . . 0.0 109.34 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.15 -40.39 95.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.084 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 56.4 tttm -111.43 111.96 23.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.197 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.54 136.73 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.524 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 13.4 p -131.11 147.37 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.866 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 6.2 tt -79.24 128.43 33.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.582 ' NE1' ' OG ' ' A' ' 40' ' ' SER . 87.8 m95 -91.63 108.22 19.75 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 52.4 p30 -136.49 176.25 8.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.588 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -61.91 -41.69 98.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.357 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.78 -51.69 60.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 110.333 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.489 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 38.3 t30 -61.42 -35.89 78.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.63 -41.43 77.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 109.648 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.5 m -63.24 -42.16 99.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.56 -36.9 83.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.598 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 79.6 t60 -57.76 -43.62 85.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.54 -28.84 70.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.464 -0.773 . . . . 0.0 109.68 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.551 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 10.0 m -81.89 125.37 30.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.2 m-20 37.52 61.55 3.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.718 . . . . 0.0 110.342 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.9 -21.52 73.2 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.645 2.23 . . . . 0.0 112.943 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.67 16.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -62.14 -36.32 81.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.54 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.524 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 84.0 t80 -59.9 -51.68 68.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 110.302 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.439 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 3.0 mm -141.18 79.55 17.74 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.32 152.22 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.112 2.542 . . . . 0.0 112.735 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.17 -1.82 59.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.505 ' HG1' ' H ' ' A' ' 80' ' ' MET . 15.0 p -100.57 166.54 10.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.305 . . . . 0.0 109.949 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -81.67 2.77 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 109.342 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.598 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 10.6 ttt -83.57 128.38 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.847 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.61 86.78 2.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.212 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -103.07 131.64 49.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.316 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.64 145.43 38.64 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.12 32.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 52.6 mt -95.87 124.74 40.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -65.13 -35.94 82.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.795 . . . . 0.0 110.092 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.47 129.8 39.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -74.81 -33.9 62.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.576 -0.703 . . . . 0.0 109.583 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.405 ' HG2' ' HZ1' ' A' ' -2' ' ' LYS . 18.4 mttp -57.2 -39.48 75.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 -179.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.02 -38.08 81.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.253 -0.904 . . . . 0.0 108.936 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 85.5 mtt180 -61.47 -39.26 90.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -59.88 -40.5 88.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.436 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.6 m-20 -64.63 -41.36 96.21 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.088 -1.008 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.69 -43.34 99.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.787 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.418 HG21 HD11 ' A' ' 95' ' ' ILE . 89.0 mt -64.78 -35.95 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 108.899 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 21.2 m -56.51 -41.12 76.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 109.913 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -64.07 -54.78 28.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.011 . . . . 0.0 110.299 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt -68.08 -37.3 81.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.874 -1.141 . . . . 0.0 108.892 179.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.588 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 29.7 tttt -57.71 -40.03 78.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -59.65 -39.92 85.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.811 . . . . 0.0 109.413 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.12 -32.37 68.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.439 -0.788 . . . . 0.0 109.577 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.485 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 44.0 p -66.11 -25.54 67.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 -179.895 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.492 ' O2D' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -5' ' ' THR . . . . . 0.451 ' H2 ' ' HG1' ' A' ' -5' ' ' THR . 6.2 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.74 -32.98 73.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -100.55 128.22 46.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -90.48 133.12 35.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -57.11 127.69 33.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.176 -0.953 . . . . 0.0 109.387 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.465 ' CA ' ' HG1' ' A' ' 96' ' ' THR . . . -42.31 137.67 2.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -58.24 -36.71 73.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.416 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.485 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -177.24 -146.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -87.7 7.5 29.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 109.896 -179.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -54.81 -43.89 73.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 108.98 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.581 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -62.17 -29.29 72.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.86 -42.82 90.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -1.094 . . . . 0.0 109.492 -179.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.448 ' O ' ' CG2' ' A' ' 12' ' ' THR . 52.0 p -67.35 -36.9 82.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.118 -0.989 . . . . 0.0 108.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.84 -40.02 83.0 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.689 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.6 t80 -66.08 -48.55 70.59 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -62.89 -38.76 92.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.448 ' CG2' ' O ' ' A' ' 8' ' ' THR . 68.5 p -68.17 -32.7 73.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -151.27 59.2 0.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.664 -1.273 . . . . 0.0 111.014 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.689 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.06 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.755 -1.216 . . . . 0.0 110.61 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.85 -38.69 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.0 -35.94 67.36 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 109.801 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.04 -43.03 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.988 . . . . 0.0 110.985 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.465 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.0 m-70 -105.36 129.29 53.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.185 -0.947 . . . . 0.0 110.48 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.55 ' HG1' ' H ' ' A' ' 21' ' ' GLU . 46.8 p -89.9 -19.19 24.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 0.0 109.495 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.547 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 4.3 t 60.93 20.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.55 ' H ' ' HG1' ' A' ' 19' ' ' THR . 84.4 tt0 -104.46 138.06 41.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -59.67 -39.07 83.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.935 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -107.3 28.78 11.79 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -61.23 154.22 37.76 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.71 -3.22 13.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.891 2.394 . . . . 0.0 112.263 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 27' ' ' LYS . 79.5 m-70 59.01 66.26 1.08 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 26' ' ' HIS . 29.9 tttp -58.04 -122.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.688 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.04 -39.78 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.929 -1.107 . . . . 0.0 109.572 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.24 162.79 14.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 18.0 Cg_endo -62.59 154.31 65.81 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.966 2.444 . . . . 0.0 112.253 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.45 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 6.8 m120 -86.22 134.19 33.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.113 -0.992 . . . . 0.0 109.122 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.521 ' O ' ' CB ' ' A' ' 33' ' ' HIS . 9.7 mp -89.58 -112.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 20' ' ' VAL . 10.6 t60 79.33 90.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.797 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.73 5.45 66.58 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.2 tp -57.81 -20.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 90.4 m-85 -63.1 135.36 57.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.97 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 68.54 25.56 74.85 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.404 ' HD3' HE22 ' A' ' 42' ' ' GLN . 87.2 mtt180 -135.16 157.96 45.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -1.115 . . . . 0.0 110.057 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -91.57 152.09 20.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.621 ' HG ' ' ND2' ' A' ' 56' ' ' ASN . 60.6 p -65.77 157.75 29.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.07 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.94 -13.59 67.1 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.404 HE22 ' HD3' ' A' ' 38' ' ' ARG . 48.1 tt0 -62.58 -37.51 86.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -1.192 . . . . 0.0 110.208 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.5 140.08 35.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.118 -0.988 . . . . 0.0 109.513 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.92 153.16 34.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.56 -0.713 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.81 63.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.3 t80 -140.26 168.22 20.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.215 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -111.86 150.58 30.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.0 109.956 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.474 ' CD2' ' O1D' ' A' ' 201' ' ' HEC . 10.8 m-85 -109.19 151.35 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 109.513 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -75.43 157.96 33.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.08 -33.33 70.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -63.73 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.39 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.5 t-20 -55.46 -44.17 76.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.04 -1.037 . . . . 0.0 110.164 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.27 -47.11 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.948 -1.095 . . . . 0.0 110.056 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -60.04 -38.57 83.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -91.75 -66.14 0.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.623 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.621 ' ND2' ' HG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 66.1 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.32 -0.862 . . . . 0.0 108.922 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 8.1 p -131.77 149.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -178.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.36 131.55 41.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.577 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 98.4 m95 -96.79 125.69 41.42 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.167 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 50.8 p30 -152.22 179.81 8.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -59.35 -42.19 90.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.729 -1.232 . . . . 0.0 110.647 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -67.98 -49.27 62.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.024 -1.048 . . . . 0.0 110.869 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.473 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 58.3 t30 -60.34 -41.41 93.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 111.271 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.656 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 61.5 mtt -61.12 -37.62 83.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.905 -1.122 . . . . 0.0 110.276 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -60.97 -43.38 98.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.018 -1.051 . . . . 0.0 109.678 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.1 -36.7 77.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.013 -1.054 . . . . 0.0 109.169 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -60.01 -46.14 90.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 90.1 mt -62.53 -31.46 72.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 110.063 -179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 13.1 m -85.79 127.12 34.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.943 -1.098 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.0 m120 39.8 58.61 6.91 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.429 -0.794 . . . . 0.0 110.192 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.81 -20.81 53.76 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.792 2.328 . . . . 0.0 112.959 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.87 6.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.078 -1.014 . . . . 0.0 110.083 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -61.68 -33.52 74.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 109.575 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -57.19 -48.74 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.596 -179.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.558 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 4.2 tp -152.82 82.08 5.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.271 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.91 151.34 35.44 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.314 2.009 . . . . 0.0 112.338 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.76 1.08 58.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 p -93.21 165.72 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -92.28 14.58 15.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.143 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.3 mtm -78.9 134.46 36.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 110.078 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.05 27.13 9.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.486 -0.759 . . . . 0.0 109.048 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.53 130.56 37.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 108.94 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.68 179.29 44.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.69 146.12 23.17 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -96.02 118.14 32.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -1.195 . . . . 0.0 109.338 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -64.97 -38.48 91.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.78 128.45 34.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.0 110.351 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.4 -29.27 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.895 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -55.65 -47.11 77.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.152 -0.968 . . . . 0.0 110.093 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -63.57 -38.94 93.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.907 -1.121 . . . . 0.0 108.801 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 38.5 ttm180 -60.85 -45.19 95.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.551 -0.718 . . . . 0.0 110.035 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -66.66 -48.79 68.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 45.7 t0 -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 109.869 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 47.8 tp -54.79 -47.03 74.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 0.0 110.108 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.35 -40.77 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.044 . . . . 0.0 109.266 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.465 ' HG1' ' CA ' ' A' ' 1' ' ' GLY . 40.1 m -59.18 -41.83 89.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.805 . . . . 0.0 110.078 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.4 -49.57 77.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.863 -1.148 . . . . 0.0 108.932 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 82.9 mt -68.13 -32.06 72.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 108.562 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 41.3 tttm -54.82 -43.75 73.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -62.02 -43.22 99.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.376 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.41 -25.2 65.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.645 -0.659 . . . . 0.0 109.899 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 103' ' ' GLU . 1.2 t -50.24 -39.71 45.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.578 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' N ' ' CG2' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.577 ' O2A' ' NE1' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.94 -33.21 73.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.441 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -100.19 131.23 46.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.418 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -111.19 162.19 15.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.474 -0.766 . . . . 0.0 109.335 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 109.5 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.69 125.64 8.58 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.587 ' C ' ' H ' ' A' ' 4' ' ' LYS . 86.1 p -60.98 -27.75 68.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 67.56 -21.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.587 ' H ' ' C ' ' A' ' 2' ' ' SER . 33.8 tttt -58.82 -51.52 69.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.426 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -65.57 -42.23 92.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 109.201 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -61.72 -34.96 90.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.02 83.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -1.211 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.3 p -74.57 -38.65 62.61 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.05 -41.8 88.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.6 t80 -63.97 -45.91 87.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -62.78 -38.6 91.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.404 0.621 . . . . 0.0 110.267 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 61.9 p -72.25 -29.6 64.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 111.663 -178.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -147.72 53.49 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.468 -1.395 . . . . 0.0 111.479 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.5 t -173.48 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.724 -1.235 . . . . 0.0 110.774 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.66 -37.55 70.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.079 -1.013 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.97 -34.8 68.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.769 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.5 m -98.14 -43.58 6.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.678 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.437 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -104.16 128.51 51.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.411 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.488 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 44.7 p -93.95 -15.71 24.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.5 t 42.26 36.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -101.16 141.06 34.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.276 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -76.15 -82.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 110.203 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.58 24.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.48 150.84 49.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 72.7 Cg_endo -76.43 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.676 2.251 . . . . 0.0 111.773 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -104.03 134.66 46.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.027 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 29' ' ' GLY . 46.1 tptt -130.51 133.01 45.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.0 109.307 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.6 t 53.9 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.11 -179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -103.87 158.7 16.9 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 15.6 Cg_endo -57.01 146.78 78.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.059 2.506 . . . . 0.0 112.341 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 18.6 m120 -74.1 135.55 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.001 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 6.0 mp -97.17 11.48 36.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -52.22 -32.39 36.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.197 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.42 56.05 0.68 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -111.77 2.34 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 48.7 m-85 -82.33 129.18 34.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.985 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.24 31.06 73.94 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -145.77 168.25 21.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.171 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.31 156.32 16.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.363 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.612 ' HG ' ' N ' ' A' ' 41' ' ' GLY . 59.5 p -58.71 -39.65 81.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 109.739 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.612 ' N ' ' HG ' ' A' ' 40' ' ' SER . . . -65.45 -33.18 85.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.26 -36.22 72.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -1.115 . . . . 0.0 110.737 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.494 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -59.08 -32.02 69.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.892 -1.13 . . . . 0.0 109.686 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' ALA . 78.7 mm-40 42.84 -167.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.98 -41.9 2.45 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 47' ' ' SER . 71.8 t80 -123.53 136.1 54.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 109.333 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 55.1 p -69.35 159.34 33.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.492 ' CZ ' ' O ' ' A' ' 40' ' ' SER . 95.4 m-85 -118.27 146.72 44.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.409 -0.807 . . . . 0.0 109.879 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.535 ' OG1' ' CGD' ' A' ' 201' ' ' HEC . 61.4 m -69.75 151.88 45.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.392 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.79 -33.27 7.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.49 -68.55 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.491 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 28.7 t-20 -56.58 -41.81 77.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.1 . . . . 0.0 110.295 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.8 -44.32 97.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.11 -37.14 76.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 108.785 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.0 tttt -127.14 112.3 15.0 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.501 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -97.95 134.79 40.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' H ' HD21 ' A' ' 56' ' ' ASN . 12.5 p -130.84 145.76 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.657 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.7 tp -79.89 132.81 36.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.243 -0.91 . . . . 0.0 108.774 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.589 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 99.0 m95 -94.98 124.74 39.2 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 55.2 t0 -148.18 163.41 37.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.4 mt-10 -52.51 -40.76 62.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.919 -1.113 . . . . 0.0 109.483 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.05 -48.19 66.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 0.0 110.164 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -61.52 -38.83 88.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 110.732 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 63.1 mtt -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.079 -1.013 . . . . 0.0 109.844 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 90.5 p -60.9 -40.53 93.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 108.964 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.81 -35.12 79.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.107 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.751 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 69.8 t60 -61.37 -45.66 93.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 42.0 mt -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 109.868 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.536 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 17.6 m -86.01 126.15 33.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.85 -1.157 . . . . 0.0 108.725 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.569 ' N ' HD21 ' A' ' 70' ' ' ASN . 0.9 OUTLIER 41.77 59.33 9.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.272 -0.892 . . . . 0.0 109.751 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.52 -23.21 74.78 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.762 2.308 . . . . 0.0 112.747 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -60.55 -49.26 78.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.041 . . . . 0.0 109.609 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -64.16 -30.52 71.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.474 ' CG ' ' ND1' ' A' ' 67' ' ' HIS . 31.2 t80 -52.35 -46.12 66.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 108.936 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 77' ' ' GLY . 1.6 pt -141.05 153.35 66.99 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.54 -7.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.085 1.857 . . . . 0.0 112.018 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 84.02 48.41 5.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.565 ' CG2' ' H ' ' A' ' 79' ' ' LYS . 4.9 t -56.81 -118.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.007 . . . . 0.0 109.974 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.565 ' H ' ' CG2' ' A' ' 78' ' ' THR . 45.4 mtmt -89.64 1.46 55.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.188 -0.945 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.751 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 7.3 mmm -75.17 118.54 18.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 108.959 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.13 32.03 5.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.457 -0.777 . . . . 0.0 110.17 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 60.2 t80 -87.53 130.47 34.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.256 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.535 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.41 179.77 49.35 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.36 157.27 23.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.4 mt -102.46 119.03 38.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -1.14 . . . . 0.0 109.346 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -66.32 -35.72 81.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 69.0 mttm -90.32 130.76 36.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 110.294 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.03 -29.56 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.999 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.62 -52.1 66.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 91' ' ' ARG . 53.3 p30 -64.47 -30.29 71.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.639 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 39.2 ttm180 -59.45 -43.69 93.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.142 -0.974 . . . . 0.0 109.859 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.407 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -65.46 -40.5 93.26 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -0.944 . . . . 0.0 110.17 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 54.5 tp -58.19 -47.0 84.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.113 -0.992 . . . . 0.0 110.186 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.2 mt -67.33 -36.17 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.011 -1.055 . . . . 0.0 108.684 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.6 m -57.68 -41.43 81.57 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.403 -0.811 . . . . 0.0 109.674 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -50.87 71.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 109.0 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 88.1 mt -66.74 -32.77 74.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 108.384 178.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 19.2 tttt -57.33 -41.63 80.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.48 -40.34 90.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.81 67.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 0.0 109.652 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.76 -32.04 73.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.941 . . . . 0.0 109.455 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.589 ' O2A' ' NE1' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.94 -32.73 68.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -97.89 129.03 44.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.0 109.608 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 1' ' ' GLY . 15.5 ttmt -92.27 131.54 37.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.406 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.265 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -71.11 156.47 53.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.569 ' N ' ' OD1' ' A' ' 93' ' ' ASP . 23.7 m -56.28 -33.26 65.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 2' ' ' SER . . . 72.05 -41.04 0.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.8 tttt -58.98 -51.21 71.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.041 -1.037 . . . . 0.0 109.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -64.0 -43.13 96.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.098 -1.001 . . . . 0.0 108.984 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.97 -32.73 85.18 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.64 -42.65 79.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.192 -1.181 . . . . 0.0 109.007 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 12' ' ' THR . 52.7 p -74.19 -33.48 63.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.34 -0.85 . . . . 0.0 109.119 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.35 -42.18 95.2 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.685 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.0 t80 -69.07 -47.37 65.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -62.67 -39.24 93.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.67 -0.644 . . . . 0.0 110.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.483 ' CG2' ' O ' ' A' ' 8' ' ' THR . 73.3 p -69.36 -32.53 71.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 111.399 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -150.76 58.06 0.93 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.53 -1.356 . . . . 0.0 111.526 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.685 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 6.3 t -170.59 -43.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.757 -1.215 . . . . 0.0 110.128 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.54 -35.91 73.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 109.656 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.8 -37.21 73.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.5 m -93.25 -41.3 9.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.556 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 87.4 m-70 -107.73 127.08 53.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.402 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.652 ' HG1' ' ND2' ' A' ' 31' ' ' ASN . 43.2 p -87.69 -20.39 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.613 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.7 t 57.65 29.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 110.189 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.17 149.06 25.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -60.47 -36.22 77.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 109.337 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.98 41.31 1.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -62.81 156.49 40.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -4.74 15.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.953 2.435 . . . . 0.0 112.196 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 27' ' ' LYS . 73.1 m-70 60.49 65.85 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 26' ' ' HIS . 14.6 tttt -57.04 -118.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.83 -40.36 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.68 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.76 162.86 19.91 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 16.6 Cg_endo -60.6 150.52 81.46 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.917 2.411 . . . . 0.0 111.952 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.652 ' ND2' ' HG1' ' A' ' 19' ' ' THR . 5.4 m120 -81.24 140.46 34.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.292 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.556 ' CD1' ' ND1' ' A' ' 18' ' ' HIS . 5.9 mp -98.28 140.85 31.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.024 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -171.18 97.01 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.427 -0.795 . . . . 0.0 109.064 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.29 6.76 74.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -58.81 -23.37 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.523 -0.986 . . . . 0.0 109.81 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.74 133.74 51.7 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.08 78.91 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.4 ' HG3' HE22 ' A' ' 42' ' ' GLN . 64.5 mmt-85 -135.81 161.55 35.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -1.091 . . . . 0.0 109.711 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -88.78 156.69 18.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.558 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 1.8 t -61.07 149.36 37.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.81 63.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.4 HE22 ' HG3' ' A' ' 38' ' ' ARG . 51.9 tt0 -60.59 -38.34 84.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -1.218 . . . . 0.0 109.859 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.18 139.13 48.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.083 -1.01 . . . . 0.0 109.069 -179.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -117.79 150.62 38.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 109.434 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.45 62.85 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.7 t80 -136.25 157.83 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.3 t -98.77 148.52 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -109.81 141.67 42.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.509 -0.744 . . . . 0.0 110.043 -179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.68 ' H ' ' CGD' ' A' ' 201' ' ' HEC . 51.7 m -73.47 146.94 44.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.2 m-20 -51.7 -36.31 46.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.766 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -42.71 -71.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.034 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 56' ' ' ASN . 26.9 t-20 -52.88 -40.12 63.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 0.0 110.367 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 79.2 mt -56.8 -54.17 32.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.862 -1.149 . . . . 0.0 109.415 -179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -62.47 -38.52 90.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.084 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.2 mttm -99.26 25.44 6.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.475 -0.766 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -43.64 126.55 4.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.018 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.4 ' N ' HD21 ' A' ' 56' ' ' ASN . 12.5 p -135.53 152.11 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 110.122 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -71.2 133.63 46.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.587 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 98.1 m95 -96.41 123.76 40.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.229 -0.92 . . . . 0.0 110.107 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 55.1 p30 -152.93 176.66 11.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -60.11 -39.37 85.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.128 . . . . 0.0 110.665 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -70.37 -56.44 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.926 -1.109 . . . . 0.0 110.47 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.567 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 46.2 t30 -59.55 -38.8 82.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.66 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.5 mmt -59.29 -40.53 86.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.961 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 43.1 m -60.16 -40.37 89.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.523 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.17 -33.2 75.23 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.949 -1.095 . . . . 0.0 109.446 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.504 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 71.3 t60 -59.74 -47.72 84.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.376 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.5 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 8.1 mp -67.84 -30.54 69.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.584 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 28.1 m -60.74 -38.82 86.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.908 -1.12 . . . . 0.0 110.41 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -154.15 67.03 5.62 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.049 . . . . 0.0 109.796 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.27 -22.04 72.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.571 2.181 . . . . 0.0 113.061 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 -71.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.974 -1.079 . . . . 0.0 109.651 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -59.7 -24.28 63.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.49 ' CD1' ' ND1' ' A' ' 67' ' ' HIS . 18.6 t80 -55.36 -46.29 76.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.922 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 2.1 pt -142.47 78.78 16.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.155 -0.966 . . . . 0.0 109.91 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -69.25 137.42 36.9 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 C-N-CA 123.039 2.492 . . . . 0.0 111.94 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.71 2.79 62.86 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.538 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 80' ' ' MET . 8.8 t -98.6 170.4 8.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.295 . . . . 0.0 109.675 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -90.94 13.89 15.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.908 . . . . 0.0 110.603 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.504 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 1.0 OUTLIER -74.67 122.48 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.75 30.59 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.016 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 63.9 t80 -89.69 131.15 35.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.044 -1.035 . . . . 0.0 109.406 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -85.88 176.37 49.12 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.37 159.45 25.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.98 122.98 44.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 0.0 109.293 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.49 -35.59 81.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.98 128.51 36.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 110.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -28.51 60.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 109.889 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -55.6 -47.33 76.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.185 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.32 -39.16 93.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.886 -1.134 . . . . 0.0 108.898 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.584 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.6 ttp180 -61.0 -43.41 98.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -58.63 -47.21 85.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.009 -1.057 . . . . 0.0 109.62 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 2' ' ' SER . 88.7 m-20 -66.79 -39.42 87.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' CD2' ' C ' ' A' ' 94' ' ' LEU . 6.7 tt -57.92 -45.84 85.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 75.4 mt -65.12 -36.79 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.015 -1.053 . . . . 0.0 108.344 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.0 m -57.24 -41.32 79.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.594 -0.691 . . . . 0.0 109.59 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -62.29 -52.53 63.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.28 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.19 -32.92 74.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 108.495 178.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 13.8 tttp -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.561 -0.712 . . . . 0.0 109.091 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -61.15 -39.89 91.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.436 -0.79 . . . . 0.0 109.538 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.64 64.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.54 -0.725 . . . . 0.0 109.718 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 103' ' ' GLU . 1.3 t -52.72 -39.69 62.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 109.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.68 ' CGD' ' H ' ' A' ' 49' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.8 -31.7 71.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -123.33 170.21 10.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.571 ' O ' ' CB ' ' A' ' -1' ' ' ALA . 35.0 ttpt -49.97 -56.82 9.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.221 -0.924 . . . . 0.0 111.176 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' -2' ' ' LYS . . . 160.88 28.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.426 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -39.83 98.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' -1' ' ' ALA . 40.4 p -129.25 34.57 4.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.48 149.2 23.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 110.285 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -56.43 -25.73 51.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.584 -0.697 . . . . 0.0 109.762 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -45.52 -50.92 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.234 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.62 -34.83 87.76 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.37 -49.7 72.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.126 . . . . 0.0 109.476 -179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 25.3 m -61.25 -39.12 89.16 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.274 -0.892 . . . . 0.0 108.761 179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.0 tp -53.98 -41.63 68.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.4 t80 -61.25 -47.04 87.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.44 -38.03 89.58 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.638 . . . . 0.0 109.933 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 49.4 p -68.11 -36.32 79.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.48 -0.763 . . . . 0.0 111.315 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -151.9 61.23 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.0 110.712 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -172.37 -47.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.959 -1.088 . . . . 0.0 110.161 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.21 -37.67 72.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.818 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -58.14 -35.25 71.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 109.866 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.2 m -96.57 -42.5 8.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.7 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.439 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 93.5 m-70 -109.19 124.04 50.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.947 . . . . 0.0 109.881 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.579 ' C ' ' H ' ' A' ' 21' ' ' GLU . 36.3 p -89.03 -18.18 27.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 t 61.84 -8.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 19' ' ' THR . 97.1 mt-10 -60.67 136.56 58.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.924 -1.11 . . . . 0.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -78.54 -39.67 37.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.83 -7.78 55.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.77 155.72 52.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.44 -166.52 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.723 2.282 . . . . 0.0 111.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -101.3 90.41 4.1 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -59.99 -41.7 92.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.108 -0.995 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.39 -71.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.546 -0.721 . . . . 0.0 109.153 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.539 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -76.65 159.62 49.91 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 5.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 112.834 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER 64.78 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 110.126 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.481 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.6 mp -95.92 143.48 27.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -172.51 91.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 109.045 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.38 6.35 74.28 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.73 -20.19 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.478 -1.013 . . . . 0.0 109.609 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.6 m-85 -60.4 131.31 50.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.95 29.45 73.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.416 ' HD3' HE22 ' A' ' 42' ' ' GLN . 89.6 mtt180 -140.52 164.41 30.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -1.226 . . . . 0.0 110.255 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -92.69 159.59 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 0.0 109.705 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.48 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 22.6 t -71.03 154.22 41.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.073 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.96 51.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.416 HE22 ' HD3' ' A' ' 38' ' ' ARG . 49.7 tt0 -62.54 -36.09 81.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.272 . . . . 0.0 109.95 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -58.7 -32.74 69.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 109.716 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ALA . 95.6 mt-10 42.04 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.17 -39.39 1.63 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.449 ' H ' ' C ' ' A' ' 44' ' ' GLU . 63.7 t80 -116.15 134.1 55.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.488 -1.007 . . . . 0.0 108.99 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 45.6 m -63.12 153.16 35.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.967 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -114.5 145.89 41.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.514 -0.741 . . . . 0.0 109.359 179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -79.39 166.55 21.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.19 -31.7 61.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.771 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -46.67 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.741 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.6 t-20 -55.87 -41.33 74.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.12 -0.988 . . . . 0.0 110.79 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.2 mt -59.44 -50.27 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.912 -1.118 . . . . 0.0 109.854 -179.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -59.89 -36.52 77.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.5 ttpp -128.01 117.43 21.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.536 -0.728 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.64 136.73 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 108.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.415 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.06 147.32 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -75.63 132.25 40.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.59 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 76.1 m95 -93.69 125.88 38.55 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.052 -1.03 . . . . 0.0 109.841 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.7 t0 -152.74 170.35 20.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -55.77 -39.93 71.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.765 -1.21 . . . . 0.0 109.498 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -66.19 -48.25 71.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -63.97 -40.41 96.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 110.791 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.9 mtt -60.79 -38.7 86.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 110.075 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -60.75 -45.48 94.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 109.216 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.69 -33.37 75.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.951 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.46 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 57.8 t60 -57.76 -44.04 85.86 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.509 -0.744 . . . . 0.0 109.158 -179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 93.3 mt -67.43 -25.38 65.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.549 -0.719 . . . . 0.0 109.852 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.589 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 24.5 m -85.43 131.05 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.013 -1.054 . . . . 0.0 109.836 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.551 HD22 ' HZ2' ' A' ' 73' ' ' LYS . 9.9 t30 38.8 56.6 5.45 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 0.0 110.713 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.76 -14.75 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.773 2.315 . . . . 0.0 112.222 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.19 72.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 109.762 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.551 ' HZ2' HD22 ' A' ' 70' ' ' ASN . 17.8 mttp -84.83 3.9 35.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.144 -0.972 . . . . 0.0 109.04 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.441 ' O ' ' C ' ' A' ' 75' ' ' ILE . 0.3 OUTLIER -108.31 124.52 50.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.405 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.441 ' C ' ' O ' ' A' ' 74' ' ' TYR . 44.7 pt 38.23 54.09 4.0 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.463 -0.773 . . . . 0.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 75' ' ' ILE . 18.2 Cg_endo -61.33 -18.65 60.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.756 2.304 . . . . 0.0 112.249 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.27 21.88 29.4 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.4 p -116.03 156.01 27.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.278 -1.131 . . . . 0.0 110.043 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 80' ' ' MET . 22.8 mttm -60.31 -29.93 69.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.46 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 4.7 ttt -38.62 115.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.43 0.633 . . . . 0.0 110.351 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.17 29.38 8.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.25 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 54.9 t80 -65.63 134.42 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.434 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.25 179.21 49.47 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.56 151.46 21.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.2 mt -105.07 121.34 43.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -1.113 . . . . 0.0 109.626 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -66.74 -34.03 76.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -84.07 116.7 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 109.994 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.41 ' HB3' HH21 ' A' ' 91' ' ' ARG . 97.3 mt-10 -72.22 -35.88 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.83 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -58.43 -38.74 78.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.687 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.19 -37.27 77.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 80.6 mtm180 -60.03 -43.02 95.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -57.58 -42.61 83.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 110.828 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD1' ' CA ' ' A' ' 1' ' ' GLY . 75.2 m-20 -67.27 -39.92 86.12 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.812 -1.18 . . . . 0.0 109.95 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.2 tp -61.97 -45.77 92.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.689 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.58 -42.17 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 109.618 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 43.8 m -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.435 -0.79 . . . . 0.0 110.732 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 84.0 t80 -60.7 -44.71 96.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.066 -1.021 . . . . 0.0 110.922 -178.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 80.2 mt -62.79 -37.68 87.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.813 -1.18 . . . . 0.0 109.874 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 9.3 mtpt -58.77 -37.0 75.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.092 -1.005 . . . . 0.0 109.188 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.5 -42.34 91.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.357 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.63 -33.78 75.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.48 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 52.1 p -68.67 -24.66 64.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.496 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.59 ' O2A' ' NE1' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -102.14 140.27 36.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' -2' ' ' LYS . 75.8 t80 -100.71 129.52 46.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.864 . . . . 0.0 109.685 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.598 ' O ' ' CD2' ' A' ' -3' ' ' PHE . 45.6 mtpt -83.24 172.57 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.09 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 88.02 81.47 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -120.2 142.86 48.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.454 -1.027 . . . . 0.0 109.147 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.438 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -78.2 -82.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.097 -1.002 . . . . 0.0 109.642 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 3' ' ' ALA . 47.5 tptt 42.27 -99.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.408 -0.808 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' ALA . 34.7 mttp -61.9 -42.77 99.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.39 -51.63 65.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.172 -1.193 . . . . 0.0 109.785 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.8 p -71.93 -38.18 69.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.269 -0.895 . . . . 0.0 109.198 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.0 tp -58.35 -41.01 83.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.681 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.4 t80 -63.38 -46.8 84.77 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -62.7 -38.48 90.57 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.425 0.631 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.5 p -71.16 -30.43 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 111.532 -178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -148.54 55.37 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.326 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.52 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.742 -1.224 . . . . 0.0 110.871 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -55.61 -37.12 67.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.202 -0.936 . . . . 0.0 109.984 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.36 -34.77 69.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.3 m -98.98 -43.52 6.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.896 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 -104.16 130.02 51.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.579 ' C ' ' H ' ' A' ' 21' ' ' GLU . 19.6 p -91.08 -24.19 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.506 -0.746 . . . . 0.0 109.892 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.2 1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.253 -0.904 . . . . 0.0 110.054 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.579 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.4 tt0 -98.48 124.76 43.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.983 -1.073 . . . . 0.0 109.534 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -70.9 -40.23 72.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.23 -37.65 93.3 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.58 155.99 44.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 63.2 Cg_endo -74.3 -156.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.746 2.298 . . . . 0.0 111.701 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -104.03 132.28 50.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -102.09 -147.96 0.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.48 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 54.7 t -49.82 -41.43 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.894 -1.129 . . . . 0.0 109.861 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.33 159.37 14.09 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.04 152.05 67.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.84 2.36 . . . . 0.0 111.922 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.1 m120 -83.84 139.94 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 109.61 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.541 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 5.3 mp -96.69 139.78 32.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.664 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 52.2 p-80 -173.8 92.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.027 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.9 6.77 69.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.72 -23.3 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.989 . . . . 0.0 109.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -64.65 135.81 56.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.066 -1.021 . . . . 0.0 109.278 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.67 24.27 72.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -125.31 151.28 46.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -1.077 . . . . 0.0 109.386 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 40' ' ' SER . 1.9 t-160 -120.18 135.64 54.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.823 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER 80.52 -176.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -82.65 70.26 3.21 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.17 -36.68 75.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.236 . . . . 0.0 110.071 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.66 141.37 38.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.05 . . . . 0.0 109.394 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.0 164.09 20.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.589 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.96 -9.8 56.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.48 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 59.7 t80 -134.43 141.13 46.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -1.113 . . . . 0.0 109.082 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.6 p -71.62 159.32 34.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 17.6 m-85 -119.09 147.84 43.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.52 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.8 p -79.16 159.49 27.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.299 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.39 -30.78 67.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.694 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.22 -75.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.721 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.4 t-20 -55.39 -42.98 74.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.925 -1.109 . . . . 0.0 110.687 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.33 -49.35 84.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.714 -1.241 . . . . 0.0 109.271 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -60.59 -37.45 81.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 52' ' ' ASN . 16.4 tttt -125.4 113.24 17.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -103.5 143.91 32.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.41 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.448 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -132.43 149.47 32.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.611 -0.681 . . . . 0.0 109.841 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.1 tp -74.32 128.65 36.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 108.673 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -95.57 123.69 39.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 48.7 p30 -161.18 -174.43 4.34 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.51 -42.8 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.834 -1.166 . . . . 0.0 110.22 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -70.91 -53.88 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.148 -0.97 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 37.9 t30 -59.08 -38.58 79.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 110.525 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 7.8 mmt -58.87 -40.91 85.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.662 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.8 p -66.25 -34.82 78.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.28 -0.887 . . . . 0.0 109.587 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -35.7 80.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 109.496 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.04 -47.03 86.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 87.2 mt -68.54 -31.44 70.68 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 0.0 109.946 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -58.61 -37.89 76.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -162.75 67.02 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.901 -1.124 . . . . 0.0 110.074 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -51.49 -19.34 6.94 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.977 2.451 . . . . 0.0 112.42 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.35 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -56.67 -34.26 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.486 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 65.6 t80 -55.22 -51.04 67.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.467 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 17.3 mt -147.66 80.14 9.14 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 108.729 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.79 149.52 12.58 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.924 2.416 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.14 0.46 55.98 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.408 HG21 ' H ' ' A' ' 80' ' ' MET . 9.9 t -100.57 171.25 7.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -84.65 9.37 13.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.484 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.408 ' H ' HG21 ' A' ' 78' ' ' THR . 3.1 mtm -73.83 119.68 18.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 0.0 110.011 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.13 26.97 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 59.3 t80 -76.5 133.05 39.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.572 -0.705 . . . . 0.0 109.504 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.9 175.57 50.37 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.71 147.01 18.43 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 54.1 mt -99.71 134.82 42.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.261 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -92.04 -4.43 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -100.93 127.59 47.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.016 . . . . 0.0 109.929 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.61 -38.23 48.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 110.132 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -60.41 -48.79 80.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.54 -40.23 95.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.682 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.93 -41.73 92.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.104 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -61.02 -39.8 91.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.302 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -62.05 -40.73 96.73 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.101 -0.999 . . . . 0.0 109.904 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.3 tp -61.22 -43.88 98.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.57 -42.96 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.7 m -62.38 -37.75 86.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.55 -46.97 83.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.092 . . . . 0.0 110.304 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 74.4 mt -65.29 -38.38 90.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.104 . . . . 0.0 109.616 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.434 ' O ' ' OG1' ' A' ' 102' ' ' THR . 7.8 mtpm? -60.59 -36.65 79.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -59.05 -42.96 91.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.323 -0.861 . . . . 0.0 109.436 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.21 79.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.434 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 54.0 p -70.73 -23.5 62.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.561 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.603 ' O2D' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.291 0.567 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.78 -33.41 74.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 52.2 t80 -101.98 131.24 48.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.52 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.8 ptmt -104.18 161.6 13.89 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.23 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.12 24.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -138.73 164.25 25.75 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -110.92 131.14 55.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -1.102 . . . . 0.0 109.295 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 100' ' ' LYS . . . -74.48 -18.27 60.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.042 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -57.52 -48.46 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.061 -1.024 . . . . 0.0 109.969 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.02 -51.92 48.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.926 -1.109 . . . . 0.0 109.748 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -65.35 -30.67 78.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -1.199 . . . . 0.0 110.054 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 12' ' ' THR . 59.6 p -72.71 -37.33 67.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.133 -0.979 . . . . 0.0 109.534 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 6.9 tp -58.92 -41.63 87.73 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -62.78 -46.74 86.63 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -63.6 -38.27 90.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.421 0.629 . . . . 0.0 110.079 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.422 ' CG2' ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.47 -34.99 75.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 111.61 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -149.94 58.17 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.525 -1.36 . . . . 0.0 111.356 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.6 t -172.97 -48.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.153 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.89 -37.22 71.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 109.6 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.39 -34.63 69.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 0.0 109.547 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.1 m -96.5 -44.21 7.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.695 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.428 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.6 m-70 -105.81 124.8 50.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.243 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.554 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 53.1 p -84.3 -27.06 28.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.695 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.9 t 64.22 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 19' ' ' THR . 78.2 mm-40 -92.48 120.98 33.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.89 -1.131 . . . . 0.0 109.622 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 55.2 pttt -69.96 -39.99 75.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.4 -36.76 90.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.43 157.25 49.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 59.1 Cg_endo -73.02 -156.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.27 134.57 48.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 29' ' ' GLY . 36.2 tttt -130.46 127.01 38.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.466 -0.771 . . . . 0.0 109.079 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 49.4 t 53.42 -84.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.299 -179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -100.44 161.76 18.91 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.0 152.69 73.71 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.979 2.453 . . . . 0.0 112.203 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.554 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 13.1 m120 -81.71 140.52 34.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.455 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.2 mp -98.05 139.41 33.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -172.0 95.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.204 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' H ' HG21 ' A' ' 102' ' ' THR . . . 87.68 7.02 75.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.54 -23.77 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.294 -1.121 . . . . 0.0 109.565 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -70.41 132.11 45.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 75.13 20.33 79.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.66 ' CZ ' HE21 ' A' ' 42' ' ' GLN . 31.0 mtp180 -140.85 167.0 23.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -1.186 . . . . 0.0 110.015 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -93.72 156.73 16.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.707 ' HG ' ' ND2' ' A' ' 56' ' ' ASN . 24.9 p -66.15 167.1 10.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.684 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.5 -8.14 61.97 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.66 HE21 ' CZ ' ' A' ' 38' ' ' ARG . 38.9 tt0 -61.58 -38.3 87.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.424 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . . . -69.94 75.08 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.42 -31.76 73.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.47 -35.81 62.31 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 47' ' ' SER . 54.9 t80 -112.29 131.99 55.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.394 -1.063 . . . . 0.0 109.302 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -67.65 156.77 36.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.865 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.424 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 55.4 m-85 -111.21 145.39 38.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.521 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -75.74 161.65 28.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.67 -34.66 67.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -0.905 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.08 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.329 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.497 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 22.2 t-20 -52.62 -41.62 63.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.042 . . . . 0.0 110.305 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.9 mt -59.02 -55.59 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.18 -36.69 84.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ASN . 43.7 tttm -102.33 33.34 3.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.707 ' ND2' ' HG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -46.69 131.55 11.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.848 -1.157 . . . . 0.0 108.694 -179.404 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.449 ' H ' HD21 ' A' ' 56' ' ' ASN . 12.6 p -133.79 150.53 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.251 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.47 130.61 38.21 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.482 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 97.5 m95 -97.24 123.23 40.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 56.2 p30 -149.59 176.28 10.78 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.82 -40.46 88.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.061 -1.024 . . . . 0.0 111.004 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -72.29 -57.2 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.953 -1.092 . . . . 0.0 110.646 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.587 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.7 t30 -60.46 -39.66 88.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.411 -0.805 . . . . 0.0 110.799 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.413 ' SD ' ' CE3' ' A' ' 59' ' ' TRP . 42.8 tpp -59.15 -39.49 82.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.008 . . . . 0.0 109.745 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.515 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.1 m -60.76 -40.68 93.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.72 -33.54 74.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 77.9 t60 -61.26 -48.0 83.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.513 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 6.8 mp -57.81 -31.09 66.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.539 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 23.5 m -84.99 125.03 32.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.979 -1.076 . . . . 0.0 109.225 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' THR . 12.5 m120 41.75 59.6 9.29 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.69 -21.32 58.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.72 -59.1 5.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 109.981 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -62.25 -32.52 73.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.515 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.575 ' CD2' ' ND1' ' A' ' 67' ' ' HIS . 66.8 t80 -57.75 -48.73 78.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.569 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 2.7 tp -163.23 79.9 1.64 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.983 -1.073 . . . . 0.0 109.265 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.89 -21.25 7.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.823 2.349 . . . . 0.0 112.769 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -56.55 -27.23 54.1 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.412 ' HG1' ' H ' ' A' ' 80' ' ' MET . 30.3 p -77.49 163.06 26.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -1.203 . . . . 0.0 110.068 -179.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -78.47 5.36 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.542 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 11.0 ttt -79.7 141.92 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.507 -0.746 . . . . 0.0 111.145 -178.435 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.79 85.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 81.7 t80 -103.36 134.89 45.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.81 . . . . 0.0 110.094 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -72.63 142.02 31.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.69 152.47 49.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.8 mt -97.23 125.2 41.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.25 . . . . 0.0 109.477 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.31 -39.75 94.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.35 128.42 35.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.984 -1.072 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.15 -34.72 61.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -58.22 -45.35 87.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.152 -0.968 . . . . 0.0 109.938 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.91 -38.66 89.23 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.128 -0.982 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.7 ttp180 -59.06 -41.39 87.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.497 -0.752 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' OD1' ' CE2' ' A' ' -3' ' ' PHE . 53.2 t30 -59.12 -41.86 89.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 110.17 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.423 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 89.1 m-20 -62.4 -39.8 94.42 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.043 -1.036 . . . . 0.0 109.964 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.9 tp -59.0 -43.61 91.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.873 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.515 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 85.0 mt -64.65 -37.17 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 m -59.52 -40.65 87.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.459 -0.775 . . . . 0.0 109.94 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.052 . . . . 0.0 110.644 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 89.3 mt -67.05 -38.45 85.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 -179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.574 ' HZ3' ' CB ' ' A' ' 99' ' ' LYS . 9.7 mtpm? -58.3 -40.54 82.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.061 . . . . 0.0 109.732 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 3' ' ' ALA . 99.2 mttt -61.64 -45.43 94.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 109.667 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 109.534 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 50.2 p -69.63 -21.14 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.421 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.482 ' O2A' ' NE1' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -5' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' -4' ' ' GLU . 16.9 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . 0.51 ' O ' ' O ' ' A' ' -5' ' ' THR . 84.2 tt0 57.29 150.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 109.793 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -128.91 166.29 19.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.9 ttpt -63.31 128.15 34.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.26 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -92.41 152.38 21.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 53.5 p -69.29 155.51 40.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.38 -10.08 21.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.785 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -59.22 -49.48 77.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.01 -46.8 79.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.387 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.38 -30.87 79.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.17 89.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.891 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.9 p -72.44 -38.74 68.23 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.0 tp -59.2 -40.9 87.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.8 t80 -62.86 -46.7 86.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -63.14 -38.89 92.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.669 -0.645 . . . . 0.0 109.955 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.415 ' HG1' ' N ' ' A' ' 13' ' ' ARG . 53.0 p -69.97 -33.12 71.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 111.453 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.415 ' N ' ' HG1' ' A' ' 12' ' ' THR . 94.3 mtt-85 -148.77 57.62 1.04 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.571 -1.331 . . . . 0.0 111.14 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.667 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.2 t -172.56 -53.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.854 -1.153 . . . . 0.0 110.28 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.09 -37.63 72.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.014 -1.054 . . . . 0.0 109.811 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.33 -35.28 71.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.862 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -96.96 -43.42 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.618 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 90.6 m-70 -106.0 125.34 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 20' ' ' VAL . 52.4 p -89.52 -20.66 23.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.446 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.0 t 40.97 69.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.696 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.17 155.17 27.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -61.7 -35.72 78.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.576 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.29 20.96 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.3 166.49 50.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.62 -177.82 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.96 2.44 . . . . 0.0 112.12 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.419 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 91.1 m-70 -106.34 136.7 45.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.393 -0.817 . . . . 0.0 109.263 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HG2' ' H ' ' A' ' 28' ' ' VAL . 51.7 tttm -105.78 -127.97 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.333 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.489 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 70.6 t -63.27 -39.71 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.081 -1.012 . . . . 0.0 109.565 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.83 165.21 16.73 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 27.5 Cg_endo -63.69 150.46 88.4 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.843 2.362 . . . . 0.0 112.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -80.64 138.63 36.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.268 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.518 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 6.9 mp -97.89 137.48 36.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.134 -0.979 . . . . 0.0 109.888 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -166.35 100.24 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 108.991 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.06 7.89 79.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 tt -59.5 -22.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.555 -0.968 . . . . 0.0 109.716 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.659 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 78.7 m-85 -66.15 133.58 50.98 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.03 19.51 78.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HG3' HE22 ' A' ' 42' ' ' GLN . 32.8 mmt180 -135.66 163.29 30.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.325 -1.103 . . . . 0.0 109.826 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -90.17 161.53 15.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.495 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 24.8 t -63.17 148.71 47.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.84 . . . . 0.0 109.787 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.6 -10.07 62.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.403 HE22 ' HG3' ' A' ' 38' ' ' ARG . 52.6 tt0 -61.39 -38.35 86.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.006 -1.291 . . . . 0.0 109.722 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -61.55 -30.51 70.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.977 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 49.96 177.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 46' ' ' TYR . . . 80.61 -165.3 47.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.489 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 33.3 t80 37.07 -127.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.611 -0.935 . . . . 0.0 109.749 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 30.1 t -158.44 146.14 18.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.57 138.75 50.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.48 -0.762 . . . . 0.0 109.343 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.9 p -79.85 162.54 24.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.895 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.21 -32.73 68.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.528 -0.733 . . . . 0.0 110.071 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -51.59 -75.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.045 -1.034 . . . . 0.0 110.487 -179.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.2 t-20 -54.0 -41.65 68.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.933 -1.105 . . . . 0.0 110.319 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.05 -51.04 77.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.78 -1.2 . . . . 0.0 109.53 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -61.0 -38.57 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.951 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 52' ' ' ASN . 85.7 tttt -117.96 110.43 17.7 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -98.44 138.77 35.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 109.084 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 10.6 p -130.39 147.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.565 -0.71 . . . . 0.0 109.948 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -78.77 131.92 36.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 88.6 m95 -95.5 124.71 39.66 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.217 -0.927 . . . . 0.0 110.101 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.5 t0 -152.66 166.52 31.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.562 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.17 -39.7 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.69 -1.256 . . . . 0.0 109.217 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.51 -47.97 62.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -61.31 -40.71 95.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 110.712 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.5 mtt -60.21 -36.79 78.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 0.0 109.686 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -59.5 -42.97 93.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 109.156 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.18 -34.5 76.41 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.27 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.6 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 81.9 t60 -58.03 -45.46 86.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.1 -29.88 68.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.419 -0.801 . . . . 0.0 110.212 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 29.1 m -57.68 -38.12 74.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.042 -1.036 . . . . 0.0 110.528 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 69' ' ' THR . 15.9 m120 -163.45 67.73 1.67 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 109.795 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -51.92 -27.74 29.04 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.975 2.45 . . . . 0.0 112.705 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.38 1.84 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 109.527 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -61.42 -29.88 70.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.246 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.563 ' CD2' ' ND1' ' A' ' 67' ' ' HIS . 40.4 t80 -58.46 -49.36 77.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.858 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.9 pt -139.9 75.48 30.13 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.012 -1.055 . . . . 0.0 110.046 179.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.24 138.55 51.76 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.919 2.413 . . . . 0.0 112.576 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.41 -6.81 63.49 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.89 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 71.5 p -88.64 164.06 15.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.365 . . . . 0.0 110.415 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -85.12 2.02 45.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.6 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 10.9 ttt -81.77 127.74 33.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.93 87.08 2.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 69.7 t80 -103.34 131.55 50.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.335 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -67.87 142.78 40.58 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.63 145.34 31.39 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.0 mt -98.81 134.21 42.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.468 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -93.76 -5.81 47.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -110.32 119.27 38.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.92 -33.57 73.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 110.446 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.88 -56.27 24.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.04 . . . . 0.0 110.018 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -62.36 -38.9 91.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.57 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -58.65 -42.19 87.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.85 . . . . 0.0 109.865 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.95 -39.14 88.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.168 -0.957 . . . . 0.0 110.385 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.443 ' CG ' ' O ' ' A' ' 2' ' ' SER . 83.8 m-20 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.76 -45.17 93.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.8 mt -66.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 0.0 108.85 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.1 m -59.11 -39.01 80.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.48 -52.2 66.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 87.0 mt -66.53 -32.94 74.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.067 -1.021 . . . . 0.0 108.401 178.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.562 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 19.1 tttp -56.65 -42.25 78.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.38 -39.08 85.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.755 . . . . 0.0 109.328 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.77 -31.19 68.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.554 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.488 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 44.1 p -67.33 -23.9 65.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 0.0 109.459 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.966 . . . . 0.0 109.509 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.495 ' O2A' ' OG ' ' A' ' 40' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -5' ' ' THR . . . . . 0.489 ' OG1' ' OD1' ' A' ' 62' ' ' ASN . 1.5 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -57.64 145.2 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 68.0 t80 -97.28 128.86 44.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 1' ' ' GLY . 44.3 mtpt -87.65 172.35 9.78 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -40.57 -22.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.271 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 78.08 81.29 0.66 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.51 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.4 p -72.14 166.76 21.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.738 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.04 21.23 5.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.836 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -92.53 -70.98 0.67 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -63.86 -45.22 90.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 110.247 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.585 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -60.3 -39.39 96.01 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.997 -1.097 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.31 71.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -1.192 . . . . 0.0 109.948 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.452 ' HG1' ' N ' ' A' ' 9' ' ' LEU . 53.5 p -74.46 -35.37 63.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.452 ' N ' ' HG1' ' A' ' 8' ' ' THR . 7.3 tp -57.28 -40.86 78.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 64.4 t80 -62.88 -46.84 85.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -63.95 -39.18 93.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.742 -0.599 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.4 p -68.8 -35.01 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 111.495 -178.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -151.77 60.53 0.87 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.628 -1.295 . . . . 0.0 110.876 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -172.84 -47.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 0.0 109.625 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.48 -37.15 77.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -58.54 -37.74 76.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.12 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.3 m -93.5 -40.85 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -106.91 132.89 52.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.099 -178.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.52 ' HG1' ' H ' ' A' ' 21' ' ' GLU . 30.0 p -103.41 -4.33 24.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.404 ' HA ' ' H ' ' A' ' 32' ' ' LEU . 2.8 t 45.99 16.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.999 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.52 ' H ' ' HG1' ' A' ' 19' ' ' THR . 85.0 tt0 -104.27 137.3 42.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.952 . . . . 0.0 109.465 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -76.83 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 109.891 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -51.37 -17.01 2.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' GLY . . . -41.18 164.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.16 -12.31 29.44 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.274 2.649 . . . . 0.0 112.084 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.554 ' CE1' ' H ' ' A' ' 31' ' ' ASN . 2.1 m-70 60.97 97.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.237 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mttm -74.6 -167.8 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 110.017 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG1' ' NZ ' ' A' ' 79' ' ' LYS . 55.9 t -50.49 -45.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 109.989 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.53 149.2 22.45 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.86 148.54 91.8 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.392 2.062 . . . . 0.0 111.741 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.554 ' H ' ' CE1' ' A' ' 26' ' ' HIS . 2.8 m120 -84.35 138.73 32.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.065 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.575 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.6 mp -93.76 140.45 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.633 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 49.5 p-80 -174.07 90.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.102 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.58 4.79 65.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.19 -22.58 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -1.131 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.1 m-85 -65.62 133.99 52.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.159 -0.963 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.81 72.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.588 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 68.0 mtt85 -145.75 168.75 19.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.0 110.247 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.8 m80 -97.89 157.5 16.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.829 . . . . 0.0 110.119 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 2.6 m -61.33 163.91 6.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.662 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -6.08 59.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' NE2' ' CD ' ' A' ' 38' ' ' ARG . 39.6 tt0 -62.14 -38.94 90.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 0.0 110.101 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.456 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . . . -69.93 77.2 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.57 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.34 -33.05 74.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.502 -0.749 . . . . 0.0 109.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.14 -35.08 68.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 47' ' ' SER . 65.7 t80 -113.36 135.1 54.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.407 -1.055 . . . . 0.0 109.385 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 57.4 p -72.61 162.35 29.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.456 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 60.8 m-85 -114.41 148.17 38.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 109.599 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.2 p -75.26 160.65 30.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.6 -35.43 68.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.788 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.411 ' CB ' ' O ' ' A' ' 76' ' ' PRO . . . -46.56 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.4 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t-20 -52.21 -41.94 63.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.038 -1.039 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.6 mt -57.59 -53.44 44.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.843 -1.161 . . . . 0.0 109.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.88 -38.79 92.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.7 mttm -101.64 28.65 5.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 109.886 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 52' ' ' ASN . 2.6 t-20 -43.88 127.55 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 108.946 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 14.4 p -135.18 153.2 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -178.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -70.46 136.0 49.12 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.598 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 78.8 m95 -97.75 126.59 43.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 110.34 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.9 t0 -150.9 163.82 37.77 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.543 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.5 mt-10 -54.82 -39.77 68.87 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.489 ' OD1' ' OG1' ' A' ' -5' ' ' THR . 9.1 t30 -68.51 -47.66 66.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.079 -1.013 . . . . 0.0 110.251 179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.24 -39.78 91.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.652 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.1 mtt -59.89 -37.96 80.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 109.807 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.5 m -58.98 -41.45 87.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.034 -1.041 . . . . 0.0 109.075 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.84 -32.77 72.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.921 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.446 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 77.1 t60 -56.87 -48.88 77.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 110.279 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 9.4 mp -73.61 -20.79 60.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.522 ' HG1' ' NH1' ' A' ' 91' ' ' ARG . 31.2 m -57.76 -36.41 72.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.687 -1.258 . . . . 0.0 109.307 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.92 68.23 3.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.206 -0.934 . . . . 0.0 109.945 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.3 -18.7 64.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.577 2.185 . . . . 0.0 113.031 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.18 69.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.421 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -94.38 -5.36 46.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.446 ' CD1' ' ND1' ' A' ' 67' ' ' HIS . 28.0 t80 -63.84 -46.1 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.643 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.8 pt -136.96 72.88 53.72 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.188 -0.945 . . . . 0.0 109.923 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.411 ' O ' ' CB ' ' A' ' 51' ' ' ALA . 18.2 Cg_exo -62.53 136.84 61.05 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.655 2.237 . . . . 0.0 111.486 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.48 15.87 48.6 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.687 -1.245 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 80' ' ' MET . 6.6 t -117.52 165.84 13.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.146 -1.208 . . . . 0.0 109.567 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.636 ' NZ ' ' CG1' ' A' ' 28' ' ' VAL . 6.4 mtmp? -86.07 6.48 28.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.284 -0.885 . . . . 0.0 111.255 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.437 ' H ' HG23 ' A' ' 78' ' ' THR . 3.4 ttt -74.95 116.67 15.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.72 31.57 6.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 86.5 t80 -84.99 131.96 34.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -82.73 176.94 53.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.36 166.55 24.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.602 -1.285 . . . . 0.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 63.4 mt -106.66 124.55 49.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -1.076 . . . . 0.0 109.423 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.7 -38.13 89.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -85.28 128.17 34.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.55 -33.07 54.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 110.125 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -57.01 -50.1 73.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.004 . . . . 0.0 110.071 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.82 -39.01 92.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.174 -0.954 . . . . 0.0 108.779 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.522 ' NH1' ' HG1' ' A' ' 69' ' ' THR . 60.9 ttp180 -59.79 -40.68 89.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.756 -0.59 . . . . 0.0 109.947 179.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.85 -43.55 85.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.585 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 58.9 t0 -62.48 -39.25 92.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 57.8 tp -59.04 -45.48 90.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.54 -38.83 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.047 . . . . 0.0 108.824 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.1 m -59.0 -39.76 82.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.562 -0.711 . . . . 0.0 109.732 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.28 -48.65 80.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 0.0 108.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 84.5 mt -69.12 -31.81 70.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.543 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 20.8 tttm -56.01 -43.49 77.76 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -61.55 -43.64 98.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.783 . . . . 0.0 109.387 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.89 69.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.738 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -62.23 -32.76 73.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.598 ' O2A' ' NE1' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 144.18 40.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -99.44 129.69 45.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -82.87 141.95 31.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.408 -0.808 . . . . 0.0 109.172 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -44.79 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 70.14 126.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.487 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 84.2 p -63.27 -19.41 64.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.177 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 60.11 -143.55 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.401 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 56.06 -79.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.702 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 3' ' ' ALA . 65.4 mttp -58.31 -43.52 88.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -58.98 -33.95 76.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.751 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.86 88.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.566 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.8 p -72.54 -36.21 68.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.131 -0.981 . . . . 0.0 109.038 179.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.1 tp -58.14 -40.89 82.47 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 71.2 t80 -63.46 -46.93 83.99 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -62.92 -38.18 89.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.64 -0.663 . . . . 0.0 110.133 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 51.7 p -70.81 -31.16 67.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 111.481 -178.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -148.13 54.88 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.562 -1.336 . . . . 0.0 111.357 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.6 t -173.37 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 110.829 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.52 -37.07 69.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -56.3 -32.88 65.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.3 m -101.5 -44.76 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 0.0 110.838 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -103.64 121.93 43.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.073 -1.017 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.407 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.8 p -81.9 -24.64 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 t 65.55 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 19' ' ' THR . 95.8 mt-10 -98.86 120.49 39.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.075 -1.016 . . . . 0.0 109.569 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 14.5 pttp -69.85 -40.05 76.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.613 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.92 -36.55 90.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.15 155.43 49.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.54 -156.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.413 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 96.2 m-70 -109.61 137.25 47.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.276 179.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -110.71 -124.78 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.795 . . . . 0.0 109.114 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.63 -40.73 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.38 163.08 22.0 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.413 ' HA ' ' HD1' ' A' ' 26' ' ' HIS . 17.4 Cg_endo -61.17 145.6 98.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.883 2.389 . . . . 0.0 112.353 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.0 145.97 53.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 109.029 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 13.3 tp -101.85 119.18 38.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.168 -179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 35' ' ' ILE . 85.2 t60 -154.1 134.33 13.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.041 -1.037 . . . . 0.0 109.875 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.43 15.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 33' ' ' HIS . 3.7 tp -58.22 -22.49 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.427 -1.043 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.664 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 92.2 m-85 -63.64 136.77 57.74 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.172 -0.955 . . . . 0.0 109.283 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.09 32.34 72.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.577 ' NH1' ' O ' ' A' ' 36' ' ' PHE . 60.6 mmt-85 -127.29 152.06 47.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -1.14 . . . . 0.0 110.153 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.492 ' O ' ' OG ' ' A' ' 40' ' ' SER . 77.5 m80 -109.49 142.15 40.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.742 . . . . 0.0 109.933 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 39' ' ' HIS . 7.4 p 49.44 174.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.634 0.731 . . . . 0.0 110.599 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.7 72.31 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' SER . 44.0 tt0 -60.17 -35.07 74.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -1.18 . . . . 0.0 110.003 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.51 -34.78 69.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.899 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 46.54 -176.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.24 -13.05 68.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 47' ' ' SER . 85.7 t80 -136.63 146.41 45.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 108.962 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 44.1 m -62.23 147.45 47.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.744 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -119.75 142.37 48.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 109.339 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.587 ' N ' ' O1D' ' A' ' 201' ' ' HEC . 56.9 m -72.84 143.82 47.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.95 . . . . 0.0 109.072 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -49.29 -33.73 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 109.311 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -47.99 -71.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 110.228 -179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.6 t-20 -57.51 -40.38 78.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.79 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 67.4 mt -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.867 -1.145 . . . . 0.0 109.936 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.16 -52.7 57.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.971 -1.081 . . . . 0.0 109.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 56' ' ' ASN . 32.8 tttp -67.68 -47.62 68.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.943 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 55' ' ' LYS . 1.8 m120 38.42 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.645 . . . . 0.0 109.876 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 7.1 p -123.18 149.82 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 110.172 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.574 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 49.9 tp -66.09 134.13 52.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' GLY . 92.8 m95 -98.03 130.89 44.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -156.13 164.84 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.533 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.7 mt-10 -53.89 -40.17 66.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 109.273 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -67.76 -47.98 67.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.908 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 64.7 t30 -63.75 -40.35 96.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.664 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.9 mtt -59.92 -37.9 80.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 109.688 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -60.32 -41.58 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.081 -1.012 . . . . 0.0 108.974 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.88 -34.38 77.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.189 -0.944 . . . . 0.0 109.074 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.472 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 61.8 t60 -59.57 -47.28 86.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.7 mt -71.59 -34.04 69.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.039 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 30.9 m -58.66 -38.35 77.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 110.828 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -161.65 67.76 2.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.96 -1.087 . . . . 0.0 109.803 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.31 -24.71 8.83 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.144 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -63.72 -59.84 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.506 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.91 -34.12 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.028 -1.045 . . . . 0.0 109.429 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 21.6 t80 -54.97 -44.74 74.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.508 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.606 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.8 OUTLIER -139.78 154.67 71.13 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 108.885 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.24 6.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.573 2.182 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.606 ' H ' ' C ' ' A' ' 75' ' ' ILE . . . 88.2 50.44 3.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.506 ' O ' ' O ' ' A' ' 77' ' ' GLY . 14.6 t -55.64 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.612 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -59.57 -24.81 64.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.099 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 63.5 mtm -68.88 120.22 14.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 110.576 -178.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.23 26.12 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 65.0 t80 -55.87 136.23 51.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.706 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.03 -179.68 51.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.5 146.69 17.72 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.9 mt -97.22 135.96 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 109.056 179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -91.1 -6.55 53.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.097 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -103.53 127.22 50.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.32 -38.54 55.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -60.52 -47.93 84.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.99 -39.91 95.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.55 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 61.7 ttp180 -59.58 -43.62 93.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -61.52 -37.13 82.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -0.969 . . . . 0.0 109.59 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 90.4 m-20 -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.8 tp -61.57 -46.25 90.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 110.359 -179.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.1 -41.0 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.048 . . . . 0.0 109.029 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 33.5 m -59.6 -39.68 85.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.825 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.74 -49.19 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.923 -1.11 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.0 mt -68.18 -32.14 72.17 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 29.1 tttm -57.71 -42.84 84.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.582 -0.699 . . . . 0.0 109.284 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.465 ' HZ3' ' CB ' ' A' ' 3' ' ' ALA . 21.3 mttt -61.63 -43.71 98.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.398 -0.813 . . . . 0.0 109.769 179.965 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.98 -38.93 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 103' ' ' GLU . 51.1 p -72.47 -29.03 63.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.539 -0.726 . . . . 0.0 109.831 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.587 ' O1D' ' N ' ' A' ' 49' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.82 -33.53 74.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 109.462 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 89.7 t80 -102.41 131.0 49.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.999 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.1 ttpt -84.08 139.95 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.15 -24.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 52.21 169.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -124.53 125.85 44.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -1.063 . . . . 0.0 109.069 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.498 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -70.24 -22.82 62.86 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.38 -53.86 53.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 110.208 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -67.3 -50.57 59.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.876 -1.14 . . . . 0.0 109.621 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.63 -31.04 78.57 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.498 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.146 . . . . 0.0 109.857 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.4 p -73.62 -39.77 64.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.142 -0.974 . . . . 0.0 109.42 179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.8 tp -59.97 -41.23 91.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.6 t80 -62.07 -46.12 90.53 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -63.47 -37.63 88.02 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 109.967 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.9 p -70.43 -33.9 71.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 111.74 -178.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -149.58 56.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.519 -1.363 . . . . 0.0 111.491 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -173.06 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.74 -1.225 . . . . 0.0 110.192 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.79 -37.36 73.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.976 . . . . 0.0 109.942 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.72 -35.07 70.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.95 . . . . 0.0 109.826 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -96.73 -43.11 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.658 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -107.21 123.79 48.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.536 ' C ' ' H ' ' A' ' 21' ' ' GLU . 44.2 p -86.07 -23.9 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.4 t 59.28 -1.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.298 179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.536 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.3 tt0 -97.36 124.06 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 109.53 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 24.6 pttm -68.41 -41.4 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.885 . . . . 0.0 109.191 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -63.12 -34.84 91.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.2 157.56 51.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.74 -161.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' CD2' ' CG ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -103.64 125.24 50.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.398 -0.814 . . . . 0.0 109.106 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -101.53 -159.59 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.5 t -51.3 -41.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.13 149.98 17.13 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.4 ' HA ' ' CD2' ' A' ' 26' ' ' HIS . 17.5 Cg_endo -60.31 147.36 94.09 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.495 2.13 . . . . 0.0 112.6 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.74 138.71 58.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.308 -0.87 . . . . 0.0 109.111 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.6 tp -106.54 118.67 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.229 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -158.92 127.16 5.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.785 -1.197 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 55.8 12.17 4.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.8 tp -60.07 -21.63 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.362 -1.081 . . . . 0.0 109.835 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 90.5 m-85 -62.88 139.16 58.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.055 -1.028 . . . . 0.0 109.38 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.95 22.73 77.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -136.29 160.09 39.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -1.095 . . . . 0.0 109.804 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.0 m80 -94.34 158.39 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.385 -0.822 . . . . 0.0 109.443 179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.488 ' OG ' ' OD1' ' A' ' 52' ' ' ASN . 77.1 p -62.08 159.41 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.76 5.36 88.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -60.85 -35.21 75.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.46 -1.024 . . . . 0.0 110.226 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.53 -35.05 69.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.112 -0.992 . . . . 0.0 109.719 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.0 mt-10 42.2 18.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.583 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -118.65 -36.63 0.89 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.465 ' CG ' ' CD2' ' A' ' 26' ' ' HIS . 78.9 t80 -110.65 136.41 49.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.544 -0.974 . . . . 0.0 109.14 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 38.5 m -59.61 153.1 20.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.959 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.555 ' CD2' ' O1D' ' A' ' 201' ' ' HEC . 24.2 m-85 -117.5 158.84 23.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.356 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.53 ' H ' ' CGD' ' A' ' 201' ' ' HEC . 26.1 p -74.74 158.51 33.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.247 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.79 -30.86 67.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.67 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.532 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.5 t-20 -52.35 -44.03 64.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 42.0 mm -59.71 -40.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.619 -1.301 . . . . 0.0 109.284 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.34 -37.75 84.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASN . 43.6 tttp -125.72 114.51 18.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.48 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -95.16 134.88 37.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.094 -1.004 . . . . 0.0 109.289 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' H ' HD21 ' A' ' 56' ' ' ASN . 12.2 p -131.39 146.83 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -81.59 133.95 35.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 108.968 179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -97.95 127.57 43.98 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.195 -0.941 . . . . 0.0 110.207 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.446 ' O ' ' CB ' ' A' ' 64' ' ' MET . 53.3 t0 -151.92 167.81 27.15 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.444 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -57.47 -36.06 70.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.893 -1.13 . . . . 0.0 109.653 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -76.23 -57.5 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.895 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -63.48 -41.18 98.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.642 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 59.0 ttm -59.27 -36.31 75.31 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.542 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.4 p -62.75 -35.88 81.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.554 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.28 -35.94 82.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.45 -43.39 96.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 0.0 110.045 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.478 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 7.0 mp -62.36 -31.7 72.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.873 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.71 ' HG1' ' NH2' ' A' ' 91' ' ' ARG . 18.0 m -88.16 129.84 35.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 109.541 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 69' ' ' THR . 74.0 m-20 38.64 54.98 4.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.748 . . . . 0.0 110.496 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 9.5 Cg_endo -54.97 -14.68 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.568 2.179 . . . . 0.0 111.102 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.538 ' C ' ' H ' ' A' ' 74' ' ' TYR . . . -63.2 154.17 32.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.2 tttt 67.23 -36.52 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.858 -0.526 . . . . 0.0 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.538 ' H ' ' C ' ' A' ' 72' ' ' ALA . 86.5 t80 -60.25 -50.01 75.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.073 -1.017 . . . . 0.0 109.579 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.443 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 3.8 mm -140.87 77.2 21.71 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.136 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.57 151.4 11.69 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 123.095 2.53 . . . . 0.0 112.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 21.09 27.82 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.411 HG23 ' H ' ' A' ' 80' ' ' MET . 12.1 t -123.51 164.7 18.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.303 -1.116 . . . . 0.0 109.797 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -81.77 4.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 109.69 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.411 ' H ' HG23 ' A' ' 78' ' ' THR . 11.9 ttp -79.8 131.74 35.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.907 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.08 70.18 1.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 76.6 t80 -102.89 134.44 46.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -81.83 174.36 53.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.91 161.89 27.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 mt -102.83 128.07 49.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -1.116 . . . . 0.0 109.194 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -65.18 -44.21 89.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.951 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -90.09 129.52 36.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.483 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -73.37 -32.37 64.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 109.76 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -56.18 -48.32 76.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 0.0 109.464 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.24 -37.6 77.94 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 0.0 109.262 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.71 ' NH2' ' HG1' ' A' ' 69' ' ' THR . 34.0 ttm180 -57.81 -41.78 82.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -59.49 -40.49 87.17 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.446 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 80.1 m-20 -64.27 -40.05 95.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.169 -0.957 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.6 tp -62.62 -44.74 95.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.02 -36.91 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.11 -0.994 . . . . 0.0 108.563 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.6 m -57.31 -40.84 78.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.552 -0.717 . . . . 0.0 109.646 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -60.06 -51.78 68.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 109.382 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 91.9 mt -65.31 -35.41 80.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.49 ' O ' ' OG1' ' A' ' 102' ' ' THR . 12.7 tttp -57.28 -40.38 77.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -59.44 -40.3 86.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.98 67.79 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.474 -0.766 . . . . 0.0 109.466 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 43.6 p -67.89 -23.13 65.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.324 179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.532 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.555 ' O1D' ' CD2' ' A' ' 48' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.66 -33.05 73.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -100.4 127.08 46.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 109.54 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 1' ' ' GLY . 32.7 ttpt -94.82 130.85 41.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.944 . . . . 0.0 109.267 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -48.64 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.212 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -105.53 135.19 12.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.8 p -69.58 153.54 43.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -1.226 . . . . 0.0 109.203 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -93.36 -10.23 36.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.797 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -59.48 -47.76 84.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.109 -0.995 . . . . 0.0 109.923 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -67.2 -50.73 59.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.48 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.416 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.59 -32.82 85.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -57.92 -45.26 86.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.132 -1.217 . . . . 0.0 109.639 -179.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.8 p -71.95 -37.61 69.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 9.9 tp -59.45 -41.35 89.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.7 t80 -63.74 -45.81 88.2 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -62.61 -39.85 95.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.661 -0.65 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 56.6 p -71.58 -37.06 71.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 111.665 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -140.49 54.38 1.61 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.775 -1.203 . . . . 0.0 110.899 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -170.95 -53.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.696 -1.252 . . . . 0.0 110.616 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.94 -37.9 72.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.034 -1.041 . . . . 0.0 109.687 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.25 -35.74 72.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.829 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.2 m -95.73 -43.18 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.57 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 88.4 m-70 -105.32 129.88 53.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.345 -178.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' GLU . 63.0 p -95.45 -8.13 36.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.01 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.7 m 32.3 36.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.209 0.528 . . . . 0.0 110.72 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -104.15 133.7 48.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -82.48 139.4 33.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.14 76.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.34 165.19 12.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.14 172.11 16.64 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.115 2.543 . . . . 0.0 111.99 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.422 ' HD1' ' HA ' ' A' ' 30' ' ' PRO . 92.7 m-70 -105.15 135.62 46.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.351 -0.843 . . . . 0.0 109.153 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 18.0 tptt -104.65 -126.48 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 109.005 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.449 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.13 -39.66 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.129 -0.982 . . . . 0.0 109.064 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.44 160.65 20.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 20.9 Cg_endo -62.34 149.43 90.78 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.035 2.49 . . . . 0.0 112.498 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.401 ' H ' ' HD1' ' A' ' 26' ' ' HIS . 2.6 m120 -77.72 126.21 30.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.529 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 8.2 mp -100.0 132.02 45.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.18 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -160.97 102.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.28 77.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.681 -1.767 . . . . 0.0 108.681 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 tt -57.7 -21.72 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.49 -1.006 . . . . 0.0 109.391 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CD2' ' OE2' ' A' ' 61' ' ' GLU . 96.0 m-85 -62.86 135.52 57.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 108.932 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.94 20.67 80.02 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -133.67 162.4 32.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -1.086 . . . . 0.0 110.035 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -94.72 168.6 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.613 ' HG ' ' CGA' ' A' ' 201' ' ' HEC . 20.8 t -83.96 146.38 28.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.63 -6.84 70.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.75 -37.62 87.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.138 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.662 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -60.21 -43.52 95.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.097 -1.002 . . . . 0.0 109.427 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 58.11 -21.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.662 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -59.91 -33.93 80.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CD2' ' O ' ' A' ' 47' ' ' SER . 76.6 t80 -115.13 140.29 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -1.011 . . . . 0.0 109.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.7 t -65.66 151.99 45.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.594 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 37.0 m-85 -111.73 147.75 34.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.564 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 p -75.86 164.35 26.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.22 -31.22 61.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.392 -0.818 . . . . 0.0 109.258 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -48.84 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 110.638 -179.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 23.5 t-20 -57.42 -41.56 80.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.952 -1.093 . . . . 0.0 110.641 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 84.4 mt -60.25 -44.66 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.845 -1.16 . . . . 0.0 109.83 -179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -59.35 -37.54 78.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.94 . . . . 0.0 109.271 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 76.6 tttt -132.14 121.33 23.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.444 -0.785 . . . . 0.0 109.215 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.81 136.52 40.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' CG1' ' OH ' ' A' ' 74' ' ' TYR . 9.5 p -130.93 147.73 33.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.523 -0.736 . . . . 0.0 110.055 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.7 tp -77.73 133.78 38.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 108.95 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' GLY . 93.2 m95 -93.86 127.75 39.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.375 -0.828 . . . . 0.0 109.856 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.6 t0 -148.96 167.97 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' CD2' ' A' ' 36' ' ' PHE . 79.0 mm-40 -58.03 -39.36 78.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.988 -1.07 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -78.69 -48.67 14.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 33.9 t30 -59.89 -39.23 84.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.573 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 42.4 tpp -60.3 -38.92 85.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.551 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 62' ' ' ASN . 86.3 p -61.47 -33.79 74.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.801 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.51 -36.03 81.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.885 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.657 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 81.3 t60 -59.31 -43.79 92.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 5.3 mp -67.77 -27.15 66.51 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.999 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.546 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 25.5 m -81.16 128.48 33.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.973 . . . . 0.0 110.379 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 69' ' ' THR . 11.7 t-20 32.54 59.81 1.42 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.849 -0.532 . . . . 0.0 111.312 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.542 ' O ' ' CB ' ' A' ' 72' ' ' ALA . 19.2 Cg_endo -61.8 135.65 57.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 111.699 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 71' ' ' PRO . . . 162.04 -86.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.391 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.51 -28.96 61.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.43 ' OH ' ' CG1' ' A' ' 57' ' ' VAL . 84.8 t80 -54.83 -51.98 64.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 109.53 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.476 ' O ' ' CG2' ' A' ' 75' ' ' ILE . 9.5 mm -152.08 73.18 7.79 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.136 -0.977 . . . . 0.0 108.787 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.96 150.59 18.2 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.894 2.396 . . . . 0.0 112.34 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 107.01 15.29 16.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -124.17 156.99 35.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -1.083 . . . . 0.0 109.414 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -84.6 5.38 28.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 0.0 110.948 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.657 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 4.5 ttt -55.45 -40.14 71.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.793 -1.192 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 80' ' ' MET . . . 33.69 75.08 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.722 -0.611 . . . . 0.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -106.22 131.44 53.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.28 140.14 30.44 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.98 150.84 41.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.6 mt -96.19 133.67 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -1.146 . . . . 0.0 109.164 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -87.5 -12.72 45.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -101.6 126.18 48.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.83 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.12 -36.68 61.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.932 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.0 -45.06 93.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.07 -39.35 94.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.135 -0.978 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.546 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 39.1 ttm180 -59.12 -41.78 88.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.779 . . . . 0.0 109.966 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.9 -40.82 94.56 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.08 -1.013 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.416 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 84.5 m-20 -64.35 -41.27 96.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.966 -1.084 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 50.8 tp -59.25 -43.1 92.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.082 -1.012 . . . . 0.0 109.376 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG2' ' OE1' ' A' ' 61' ' ' GLU . 81.0 mt -66.19 -36.15 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.186 -0.946 . . . . 0.0 108.78 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 m -57.31 -41.35 79.71 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.604 -0.685 . . . . 0.0 109.843 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -63.18 -52.94 60.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 110.306 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.3 mt -70.02 -39.85 75.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 108.965 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' O ' ' OG1' ' A' ' 102' ' ' THR . 84.0 tttt -58.88 -40.24 83.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.716 . . . . 0.0 109.347 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -60.39 -40.15 89.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.534 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.03 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 109.667 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.493 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 38.9 p -64.69 -25.43 67.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.464 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.613 ' CGA' ' HG ' ' A' ' 40' ' ' SER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.68 -32.96 73.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 70.1 t80 -100.61 129.03 46.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.517 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.595 ' O ' ' CE2' ' A' ' -3' ' ' PHE . 48.5 mtmt -86.42 170.89 11.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.65 -24.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.508 -0.745 . . . . 0.0 109.798 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 101.31 97.28 2.29 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -119.72 136.93 54.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.98 . . . . 0.0 109.07 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.73 131.03 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.771 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -175.22 -91.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -63.31 -37.66 88.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 108.718 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.9 -36.73 91.05 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.81 75.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -1.134 . . . . 0.0 109.588 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 52.0 p -74.0 -32.27 63.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.159 -0.963 . . . . 0.0 109.126 179.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.5 tp -56.65 -41.8 77.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 68.0 t80 -63.5 -47.08 83.17 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -63.27 -38.74 92.33 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.434 0.635 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 57.3 p -70.4 -32.92 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 111.483 -178.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -148.58 57.44 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.667 -1.271 . . . . 0.0 111.166 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -173.33 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.854 -1.153 . . . . 0.0 110.322 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.87 -37.7 71.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.799 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.52 -34.92 69.61 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.718 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -97.41 -43.67 7.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 110.681 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -105.11 124.43 49.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 110.203 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.56 ' HG1' ' H ' ' A' ' 21' ' ' GLU . 52.4 p -87.22 -18.34 30.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 109.31 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.1 t 61.57 19.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.56 ' H ' ' HG1' ' A' ' 19' ' ' THR . 49.0 tp10 -99.82 140.6 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.348 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -82.2 -81.7 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.14 -28.61 19.03 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -59.22 156.05 26.31 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.3 -174.48 1.62 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.84 2.36 . . . . 0.0 111.948 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.513 ' HD1' ' H ' ' A' ' 31' ' ' ASN . 96.4 m-70 -105.72 135.13 47.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 109.251 179.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -97.86 -126.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 108.908 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.34 -39.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.109 -0.995 . . . . 0.0 109.044 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 165.56 19.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 22.9 Cg_endo -62.68 148.23 93.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.968 2.445 . . . . 0.0 111.991 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.513 ' H ' ' HD1' ' A' ' 26' ' ' HIS . 9.4 m120 -80.13 137.48 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.088 -1.007 . . . . 0.0 109.46 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 7.8 mp -100.08 135.57 41.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.923 . . . . 0.0 109.835 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -164.14 98.41 0.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 108.975 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.94 8.61 82.17 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.28 -23.16 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.479 -1.012 . . . . 0.0 109.494 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.17 135.34 53.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 73.95 20.73 79.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.411 ' HD3' HE22 ' A' ' 42' ' ' GLN . 95.0 mtt180 -137.01 165.22 26.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.936 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.38 154.54 17.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.583 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 37.1 p -65.88 160.88 22.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.956 . . . . 0.0 109.899 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.61 57.18 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.411 HE22 ' HD3' ' A' ' 38' ' ' ARG . 52.0 tt0 -62.23 -36.73 82.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.262 . . . . 0.0 109.931 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.428 ' CB ' ' OH ' ' A' ' 48' ' ' TYR . . . -56.57 140.24 47.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 109.381 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.97 153.37 41.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.786 . . . . 0.0 109.354 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.87 0.42 64.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 47' ' ' SER . 59.8 t80 -136.38 156.04 49.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.205 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.537 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.9 t -95.55 147.3 23.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.645 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.428 ' OH ' ' CB ' ' A' ' 43' ' ' ALA . 49.4 m-85 -103.21 141.99 34.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.378 -0.826 . . . . 0.0 109.785 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 47.2 m -74.4 149.98 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.479 -0.763 . . . . 0.0 109.548 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.64 -33.73 23.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.809 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -73.14 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.5 t-20 -54.51 -41.0 69.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.029 . . . . 0.0 110.306 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.11 -46.4 94.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.838 -1.164 . . . . 0.0 109.456 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -60.48 -37.21 80.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 108.94 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ASN . 25.9 tttt -127.84 116.9 20.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.583 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -101.87 134.99 44.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.12 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.55 ' H ' HD21 ' A' ' 56' ' ' ASN . 8.9 p -131.99 148.24 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.438 -0.788 . . . . 0.0 109.892 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 58' ' ' LEU . 6.5 tt -79.66 132.26 36.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.527 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.7 m95 -92.88 110.08 21.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.056 -1.027 . . . . 0.0 109.688 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 54.8 t0 -136.31 168.92 18.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.02 -37.36 69.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.902 -1.124 . . . . 0.0 109.293 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.75 -56.57 6.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.9 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.458 ' ND2' ' OH ' ' A' ' 74' ' ' TYR . 41.0 t30 -62.34 -38.96 91.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.828 . . . . 0.0 110.397 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.5 tpp -58.75 -40.56 84.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.539 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.7 m -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 109.276 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.13 -31.44 72.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.047 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.715 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 75.2 t60 -57.48 -47.49 81.75 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.439 -0.788 . . . . 0.0 109.597 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 72.8 mt -68.37 -30.52 69.47 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.028 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.467 ' HG1' ' CZ ' ' A' ' 91' ' ' ARG . 34.7 m -62.46 -39.81 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.015 -1.053 . . . . 0.0 110.641 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -150.95 65.93 7.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.073 -1.017 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.63 -20.74 69.76 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.572 2.181 . . . . 0.0 112.776 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.9 -50.38 64.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.652 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -86.62 -6.36 58.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 110.046 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.525 ' CE1' ' CH2' ' A' ' 59' ' ' TRP . 44.6 t80 -62.47 -49.67 74.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.7 pt -140.7 72.26 29.79 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.04 135.67 64.69 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.49 2.127 . . . . 0.0 112.204 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 14.62 50.09 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.15 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.626 ' HG1' ' H ' ' A' ' 79' ' ' LYS . 14.9 t -104.61 171.44 7.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.816 -1.403 . . . . 0.0 110.064 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.626 ' H ' ' HG1' ' A' ' 78' ' ' THR . 46.5 mtmt -94.61 14.06 22.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 0.0 110.318 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.715 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 2.1 mmm -67.5 135.05 52.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 0.0 109.889 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.25 26.01 10.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 57.2 t80 -91.79 130.16 37.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -85.48 177.05 50.09 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.91 158.07 30.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -102.95 135.05 45.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.0 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -92.65 -4.62 53.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.795 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -103.02 130.81 50.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.005 . . . . 0.0 109.805 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.31 -44.87 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.454 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -60.17 -48.26 82.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.018 . . . . 0.0 110.301 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.63 -39.04 93.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.467 ' CZ ' ' HG1' ' A' ' 69' ' ' THR . 40.7 ttm180 -58.92 -42.31 89.38 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 -179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.403 HD21 ' HG3' ' A' ' -2' ' ' LYS . 90.3 m-20 -61.62 -40.37 94.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.07 -1.019 . . . . 0.0 110.384 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.37 -40.08 96.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.026 -1.046 . . . . 0.0 110.001 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.0 tp -57.26 -45.75 83.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.848 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.539 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 77.3 mt -66.53 -43.64 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 m -60.71 -39.74 89.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.352 -0.843 . . . . 0.0 109.917 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -58.09 -49.18 77.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.043 . . . . 0.0 109.729 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 85.8 mt -69.09 -35.59 76.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.038 . . . . 0.0 109.169 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 10.9 tptm -57.84 -43.34 85.78 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.388 -0.82 . . . . 0.0 109.517 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -61.04 -45.44 94.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.176 -0.952 . . . . 0.0 109.693 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.0 74.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 109.511 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 54.8 p -70.28 -21.01 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.457 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -5' ' ' THR . . . . . 0.482 ' H2 ' ' HG1' ' A' ' -5' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' -5' ' ' THR . 95.5 mt-10 41.97 -154.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.462 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -96.4 127.48 42.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' -1' ' ' ALA . 34.6 ttpt -102.54 136.36 42.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.99 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -98.23 134.27 11.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.489 ' C ' ' H ' ' A' ' 4' ' ' LYS . 22.8 t -57.19 -33.48 67.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -1.123 . . . . 0.0 109.288 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.477 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . 73.32 -35.77 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.489 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.2 tttt -59.14 -48.9 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.52 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.62 -42.81 98.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -62.36 -32.16 81.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.9 93.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -1.17 . . . . 0.0 109.474 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.4 p -72.51 -36.38 68.35 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 7.1 tp -58.33 -41.49 84.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.3 t80 -63.54 -46.85 84.11 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -63.31 -39.65 95.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 65.3 p -70.41 -34.43 72.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.419 -0.8 . . . . 0.0 111.7 -178.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -150.27 59.97 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.626 -1.296 . . . . 0.0 110.933 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -173.08 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.962 -1.086 . . . . 0.0 109.997 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -36.32 72.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.967 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -56.45 -35.35 67.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.024 -1.048 . . . . 0.0 109.496 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.9 m -97.26 -48.84 5.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.263 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -99.3 113.43 25.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.741 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.0 p -82.58 -19.15 39.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.477 ' C ' ' O ' ' A' ' 19' ' ' THR . 8.0 p 36.86 41.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -101.67 147.95 25.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -56.57 -36.58 69.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -55.44 -30.94 56.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 25' ' ' PRO . . . 64.66 56.54 16.33 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 24' ' ' GLY . 33.1 Cg_endo -67.79 -23.78 41.35 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.787 2.325 . . . . 0.0 112.019 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 93.1 m-70 54.77 57.9 5.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.644 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' HIS . 45.1 tttm -58.98 -122.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.342 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.05 -40.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 109.883 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.52 167.47 14.95 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.29 152.29 61.49 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.004 2.469 . . . . 0.0 112.263 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 26' ' ' HIS . 16.2 m120 -89.17 140.83 29.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.273 -0.892 . . . . 0.0 109.044 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 32' ' ' LEU . 4.8 mp -92.83 140.39 29.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.932 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 47.6 p-80 -176.06 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 93.98 3.8 63.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.19 -21.56 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.449 -1.03 . . . . 0.0 109.524 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -66.94 132.32 47.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.8 24.33 76.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 86.3 mtt-85 -133.12 159.1 41.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -1.133 . . . . 0.0 109.95 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -90.93 147.38 23.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.42 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 3.4 t -63.13 155.91 26.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.79 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.79 -13.92 59.08 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 44' ' ' GLU . 51.4 tt0 -62.3 -37.1 84.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 109.804 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.85 70.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.897 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLN . 97.2 mt-10 -60.51 -31.28 70.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.11 -32.84 50.64 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 47' ' ' SER . 60.3 t80 -122.3 142.03 50.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -1.04 . . . . 0.0 109.572 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 22.9 t -74.04 158.17 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.429 ' CD2' ' O1D' ' A' ' 201' ' ' HEC . 19.4 m-85 -106.12 150.27 25.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.0 t -63.58 155.21 30.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -55.52 -35.49 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.567 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -59.53 -58.23 9.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.185 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 55' ' ' LYS . 17.5 t-20 -57.88 -40.81 81.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.922 -1.111 . . . . 0.0 109.469 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . 0.429 HG23 HD13 ' A' ' 53' ' ' ILE . 94.0 mt -62.77 -43.13 98.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.145 -0.972 . . . . 0.0 109.426 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.34 -40.99 92.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 109.331 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 52' ' ' ASN . 6.7 tptm -128.39 125.17 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.607 HD21 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -98.05 140.89 31.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 109.086 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.607 ' H ' HD21 ' A' ' 56' ' ' ASN . 14.3 p -130.94 148.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.28 130.89 35.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.597 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 97.4 m95 -98.95 125.15 44.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' C ' ' A' ' 60' ' ' ASP . 55.0 p30 -157.95 -170.21 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.5 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -62.31 -43.12 99.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.763 -1.21 . . . . 0.0 110.439 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -68.39 -54.1 19.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 0.0 110.714 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 40.7 t30 -57.1 -38.7 73.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.44 -0.787 . . . . 0.0 110.902 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.6 mmt -58.04 -41.99 84.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 0.0 109.425 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -65.88 -32.96 74.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.458 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.03 -37.59 84.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.148 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.512 ' HE2' ' CE ' ' A' ' 80' ' ' MET . 79.0 t60 -59.04 -49.21 78.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.043 . . . . 0.0 109.496 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.56 ' O ' ' N ' ' A' ' 84' ' ' GLY . 8.4 mp -72.23 -26.95 62.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 70' ' ' ASN . 27.2 m -87.51 129.66 35.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.015 . . . . 0.0 109.629 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 69' ' ' THR . 1.5 m120 38.75 55.94 5.2 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 11.1 Cg_endo -58.44 -18.49 39.16 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.84 2.36 . . . . 0.0 112.649 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.77 90.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.529 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.47 4.73 51.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' TYR . . . . . 0.457 ' O ' ' C ' ' A' ' 75' ' ' ILE . 50.9 t80 -116.39 119.35 35.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.275 -0.891 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.457 ' C ' ' O ' ' A' ' 74' ' ' TYR . 45.7 mm 40.23 59.25 7.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.483 -0.761 . . . . 0.0 109.783 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.99 147.8 62.19 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.903 2.402 . . . . 0.0 112.139 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.7 2.91 57.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 51.9 p -75.48 163.59 27.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.573 ' HZ1' ' CMD' ' A' ' 201' ' ' HEC . 6.3 mtmp? -85.07 5.99 27.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' MET . . . . . 0.512 ' CE ' ' HE2' ' A' ' 67' ' ' HIS . 69.1 mtm -86.7 126.69 34.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.371 -179.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.65 6.87 32.38 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.83 134.07 46.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.55 -175.32 28.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 76.71 36.32 37.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 62.7 mt -82.26 143.27 31.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' LYS . 20.3 ttpp -73.3 145.64 45.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' LYS . 17.5 mttp -44.19 130.76 6.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -172.19 158.53 4.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 -179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.6 mttt -55.38 -32.3 62.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.144 -0.973 . . . . 0.0 109.231 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -56.04 -41.26 74.73 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.156 -0.965 . . . . 0.0 109.251 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.3 ttm180 -61.21 -46.46 90.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -67.25 -40.94 86.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.775 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.477 ' CG ' ' H ' ' A' ' 3' ' ' ALA . 89.2 m-20 -62.93 -40.22 96.94 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.5 tp -58.18 -44.78 88.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 109.52 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.463 HD13 HG22 ' A' ' 95' ' ' ILE . 80.8 mt -67.16 -40.54 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.1 m -57.99 -40.15 79.99 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.735 -0.603 . . . . 0.0 109.77 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.83 -51.36 70.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.082 -1.011 . . . . 0.0 109.687 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 92.3 mt -66.92 -35.61 80.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.057 -1.027 . . . . 0.0 108.33 178.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.5 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 82.8 tttt -58.09 -42.39 85.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -60.79 -39.89 90.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 109.742 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.55 -34.85 67.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.456 -0.778 . . . . 0.0 109.421 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.474 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 68.8 p -69.8 -22.33 63.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.468 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' HEC . . . . . 0.597 ' O2A' ' NE1' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 36.5 t80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.292 0.567 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.583 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.4 ptmt -103.53 161.32 13.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.372 -0.83 . . . . 0.0 109.215 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.88 96.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.96 . . . . 0.0 109.336 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -110.98 170.21 13.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -110.94 130.87 55.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.142 . . . . 0.0 109.238 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -74.4 -19.39 60.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.022 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.5 -49.55 74.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.093 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -63.14 -47.48 82.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.101 . . . . 0.0 109.267 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -67.66 -28.13 73.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.62 -44.73 85.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.224 . . . . 0.0 109.868 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.853 ' O ' HG23 ' A' ' 12' ' ' THR . 52.9 p -70.02 -38.62 75.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.153 -0.967 . . . . 0.0 109.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.759 HD23 HD22 ' A' ' 94' ' ' LEU . 8.3 tp -59.25 -41.04 87.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.66 -46.36 88.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.79 -38.86 92.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.382 0.61 . . . . 0.0 109.967 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' THR . 56.8 p -69.31 -34.68 75.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 111.493 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -150.28 59.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.642 -1.287 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -171.18 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 0.0 109.965 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.98 -38.2 72.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 109.607 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -58.87 -36.09 74.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.898 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -94.53 -42.57 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.479 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.6 m-70 -107.56 124.15 49.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.9 p -84.42 -29.57 26.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.251 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 20' ' ' VAL . 85.7 t 54.32 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.289 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 19' ' ' THR . 77.8 mm-40 -62.06 141.98 57.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 24' ' ' GLY . 16.3 tttm -71.07 143.19 50.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.623 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.18 9.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' LYS . . . -76.17 162.65 52.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.622 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 57.0 Cg_endo -71.31 175.92 8.66 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 123.127 2.552 . . . . 0.0 111.691 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -102.42 133.49 47.28 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.254 -0.904 . . . . 0.0 109.516 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 29' ' ' GLY . 56.0 tttp -132.23 131.09 41.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.252 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 27' ' ' LYS . 85.1 t 53.73 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.171 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -102.39 162.97 16.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 20.3 Cg_endo -62.03 153.01 71.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.09 2.527 . . . . 0.0 112.165 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 58.7 m-20 -84.27 139.03 32.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -99.69 139.3 35.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 109.885 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -166.56 95.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.58 7.47 78.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -58.66 -21.58 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.014 . . . . 0.0 109.613 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -64.1 133.22 52.58 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 71.13 21.39 78.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.536 ' NE ' ' OE1' ' A' ' 42' ' ' GLN . 68.1 mtp85 -138.57 167.04 22.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -1.15 . . . . 0.0 109.924 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -94.68 156.88 16.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.905 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 58.0 p -66.31 164.53 15.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.724 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.88 0.8 68.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.536 ' OE1' ' NE ' ' A' ' 38' ' ' ARG . 18.1 tt0 -60.1 -35.53 75.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.995 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.66 -34.41 69.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.3 mt-10 43.32 17.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.156 -0.965 . . . . 0.0 109.408 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -127.95 -36.42 0.47 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 47' ' ' SER . 68.5 t80 -103.67 135.52 45.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 108.815 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.436 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 54.3 p -65.93 156.57 33.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.899 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.87 150.1 42.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.559 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 52' ' ' ASN . 7.1 t -54.9 149.92 10.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.863 . . . . 0.0 109.24 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.78 -35.11 65.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.877 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -60.22 -57.58 12.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.063 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 49' ' ' THR . 27.2 t-20 -57.5 -42.8 83.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.566 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.31 -55.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.177 -0.952 . . . . 0.0 109.728 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -68.38 -54.86 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 56' ' ' ASN . 19.9 tttm -65.7 -52.23 53.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 55' ' ' LYS . 7.0 t-20 50.91 118.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.758 0.789 . . . . 0.0 110.119 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.715 HG11 ' OH ' ' A' ' 74' ' ' TYR . 7.6 p -126.47 147.51 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.3 tp -75.82 134.12 40.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 108.93 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 m95 -99.6 128.41 45.71 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.337 -0.852 . . . . 0.0 110.034 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 50.3 t0 -159.12 172.98 17.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.585 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.17 -39.15 71.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.961 -1.087 . . . . 0.0 109.646 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.582 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 p-10 -74.77 -48.08 27.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.078 -1.014 . . . . 0.0 109.513 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 39.0 t30 -60.9 -38.26 85.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 110.003 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -40.12 86.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.921 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -61.49 -36.4 80.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.001 -1.062 . . . . 0.0 109.799 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.24 -36.65 77.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.019 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -61.38 -47.39 86.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.138 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 4.7 mp -71.46 -36.23 71.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.392 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.581 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 25.5 m -60.96 -39.58 90.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.623 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -152.87 68.73 6.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.585 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.15 -15.81 46.54 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.364 2.043 . . . . 0.0 112.651 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -78.87 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 110.266 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.68 -32.79 67.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.149 -0.97 . . . . 0.0 109.772 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.715 ' OH ' HG11 ' A' ' 57' ' ' VAL . 80.2 t80 -56.66 -49.66 74.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 75' ' ' ILE . 2.8 mm -141.14 80.84 16.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.923 . . . . 0.0 109.113 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -84.88 149.47 10.97 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.957 2.438 . . . . 0.0 112.247 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.25 58.63 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.718 ' HB ' HG21 ' A' ' 49' ' ' THR . 15.0 t -104.77 163.65 12.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -1.216 . . . . 0.0 109.71 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.79 -0.12 37.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.519 ' H ' HG23 ' A' ' 78' ' ' THR . 11.2 ttt -85.11 129.59 34.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 0.0 110.007 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.63 85.52 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.8 t80 -104.6 133.4 49.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.34 138.02 22.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.94 146.8 43.73 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.607 HD11 HD21 ' A' ' 9' ' ' LEU . 55.2 mt -95.16 125.45 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.244 . . . . 0.0 109.554 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -65.42 -34.6 78.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 110.206 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -84.78 127.84 34.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 0.0 110.16 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -77.52 -35.54 53.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -57.75 -45.6 85.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.6 -39.54 94.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.041 . . . . 0.0 109.1 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.581 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 37.6 ttm180 -59.67 -40.47 87.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.936 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.12 -42.35 90.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.358 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -63.43 -40.06 96.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.054 -1.029 . . . . 0.0 110.14 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.759 HD22 HD23 ' A' ' 9' ' ' LEU . 48.5 tp -59.75 -42.76 93.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.036 -1.04 . . . . 0.0 109.627 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.85 -37.41 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.972 . . . . 0.0 108.955 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -60.79 -39.58 89.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.598 -0.689 . . . . 0.0 109.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.53 -50.61 73.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.105 -0.997 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.3 mt -69.05 -35.43 76.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.168 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.585 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 18.7 tptm -58.68 -40.56 83.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.351 -0.843 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -60.1 -40.84 91.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.529 -0.732 . . . . 0.0 109.796 -179.769 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.525 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 93.6 t80 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.4 0.619 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.644 ' HZ1' ' HG3' ' A' ' 89' ' ' LYS . 33.5 ttpt -81.88 144.45 30.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.071 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.95 -22.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 109.564 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.628 ' O ' HG21 ' A' ' 96' ' ' THR . . . 42.37 94.95 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 46.0 m -63.37 153.44 35.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.111 -1.229 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -80.77 -128.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' THR . 40.8 tttm 57.64 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.057 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' ALA . 32.9 mmtp -59.29 -52.44 65.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -36.56 93.57 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.43 79.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -1.162 . . . . 0.0 109.414 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 4' ' ' LYS . 54.4 p -70.43 -37.35 74.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.243 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.68 -55.98 27.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 108.816 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 98' ' ' LEU . 43.2 t80 -62.5 -41.71 99.0 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.427 -0.796 . . . . 0.0 109.266 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -61.49 -38.54 87.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 111.159 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 p -106.02 4.64 29.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.112 -0.993 . . . . 0.0 111.759 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -147.02 28.71 1.01 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.613 -1.305 . . . . 0.0 110.75 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -171.08 -24.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.723 -1.235 . . . . 0.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.6 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -59.54 -38.19 80.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.885 -1.134 . . . . 0.0 109.916 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.0 -36.53 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.018 . . . . 0.0 111.239 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.73 -50.23 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.832 -1.167 . . . . 0.0 111.202 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.645 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -101.91 126.37 48.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.065 -1.022 . . . . 0.0 110.265 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' VAL . 51.5 p -87.23 -24.28 24.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.241 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 19' ' ' THR . 2.6 t 63.79 0.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.457 -0.777 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -101.37 124.75 47.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.436 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -69.53 -39.22 77.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.567 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.63 87.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 154.17 44.39 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.634 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 62.1 Cg_endo -74.26 -156.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 111.733 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -107.68 133.6 51.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.134 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -103.78 -125.07 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.31 -38.45 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.156 -0.965 . . . . 0.0 108.896 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.79 165.14 20.94 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.3 150.77 87.67 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.958 2.438 . . . . 0.0 112.37 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.634 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 42.4 m-20 -80.81 141.71 34.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 108.99 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.7 mp -95.42 139.19 32.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.017 . . . . 0.0 109.861 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -172.19 90.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 0.0 109.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.583 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.05 5.02 66.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.4 tt -58.5 -22.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -1.176 . . . . 0.0 109.546 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.67 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 81.2 m-85 -68.11 135.35 52.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.8 79.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 67.8 mtt85 -142.62 166.08 25.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 110.04 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.402 ' CE1' HD13 ' A' ' 58' ' ' LEU . 79.0 m80 -95.77 162.57 13.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 110.197 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 62.0 p -66.3 166.21 12.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.816 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.28 60.89 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.41 -38.42 89.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -1.16 . . . . 0.0 109.876 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.723 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -71.31 66.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.98 -32.48 72.03 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.366 -0.834 . . . . 0.0 109.343 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.6 60.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -108.8 134.58 51.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -1.138 . . . . 0.0 109.153 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 m -64.47 156.32 29.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.723 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 59.3 m-85 -112.14 145.32 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.306 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.4 p -76.91 161.09 28.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.456 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -58.78 -33.06 69.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.949 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.25 -70.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.216 -0.927 . . . . 0.0 110.673 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.8 t-20 -54.83 -40.62 69.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.924 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.72 -46.37 96.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.942 -1.098 . . . . 0.0 109.482 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.37 -37.06 79.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.12 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 52' ' ' ASN . 52.9 tttm -126.28 115.75 20.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -99.42 137.68 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.132 -0.98 . . . . 0.0 109.063 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.924 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.9 146.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.404 -0.81 . . . . 0.0 109.975 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD13 ' CE1' ' A' ' 39' ' ' HIS . 62.8 tp -79.14 131.05 36.09 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.454 ' HE1' ' HB3' ' A' ' 40' ' ' SER . 89.0 m95 -94.18 124.48 38.22 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -153.94 169.27 23.86 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.86 -40.0 72.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 0.0 109.559 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -69.83 -48.8 57.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.15 -41.09 92.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.544 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.67 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.0 mtt -61.45 -38.0 85.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.003 -1.061 . . . . 0.0 109.727 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -55.95 -42.0 75.52 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 108.953 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -37.01 76.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.443 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 70.4 t60 -62.92 -47.92 81.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 94' ' ' LEU . 7.4 mp -61.93 -26.79 68.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.892 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.59 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 33.8 m -84.78 126.0 33.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.952 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 69' ' ' THR . 8.2 m120 40.48 60.01 7.41 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 28.2 Cg_endo -64.52 -23.02 64.82 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.962 2.441 . . . . 0.0 112.9 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.78 81.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.061 -1.025 . . . . 0.0 109.491 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -62.67 -32.64 73.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.924 ' OH ' HG11 ' A' ' 57' ' ' VAL . 10.7 t80 -57.19 -55.59 32.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 109.726 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.512 HG23 ' HD1' ' A' ' 74' ' ' TYR . 2.9 pt -141.82 73.83 22.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.0 109.779 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -60.96 -34.97 90.04 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 122.64 2.227 . . . . 0.0 112.045 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.7 75.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.0 p -75.51 158.75 32.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.236 . . . . 0.0 110.51 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -84.7 3.83 35.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 109.608 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 6.7 ttt -76.74 129.87 36.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.92 93.5 2.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.628 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 78.3 t80 -101.81 131.24 48.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.225 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -63.76 130.92 40.11 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.24 145.83 41.65 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.4 mt -94.73 125.07 39.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.979 -1.306 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -64.52 -37.96 89.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -86.98 119.49 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.826 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.03 -32.93 72.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.644 ' HG3' ' HZ1' ' A' ' -2' ' ' LYS . 13.6 tttm -57.06 -51.46 69.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.102 -0.999 . . . . 0.0 109.641 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -60.74 -38.07 83.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.8 . . . . 0.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.59 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 55.8 ttp180 -58.09 -42.12 84.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.761 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.3 -38.77 84.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.094 -1.004 . . . . 0.0 109.972 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 2' ' ' SER . 86.0 m-20 -62.97 -40.66 98.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.19 -0.944 . . . . 0.0 109.95 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.98 -45.02 87.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 109.939 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.455 HD12 ' HE1' ' A' ' -3' ' ' PHE . 70.9 mt -63.29 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.93 -1.106 . . . . 0.0 108.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.7 m -58.81 -39.17 80.37 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.488 -0.757 . . . . 0.0 109.469 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.06 -49.84 75.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.904 -1.122 . . . . 0.0 108.699 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 10' ' ' PHE . 91.9 mt -66.98 -33.4 75.5 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 34.3 tttm -56.5 -42.51 78.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.61 -40.25 91.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.539 -0.726 . . . . 0.0 109.627 -179.711 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.446 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 70.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.4 ptpt -130.89 164.03 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 109.218 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -42.02 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -66.57 134.98 33.1 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 85.2 p -64.98 -20.72 66.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 51.31 -141.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttm 55.61 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 109.725 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 3' ' ' ALA . 24.9 mttm -58.24 -45.53 87.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.033 -1.042 . . . . 0.0 109.636 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.49 -32.9 79.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 12' ' ' THR . 52.1 p -71.97 -34.82 69.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.321 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -57.07 -40.48 76.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.9 t80 -62.72 -47.57 83.01 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.11 -38.1 89.85 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.411 0.624 . . . . 0.0 110.033 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 8' ' ' THR . 53.4 p -69.02 -34.49 75.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 111.366 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -150.62 59.3 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.688 -1.258 . . . . 0.0 110.947 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.7 t -171.17 -50.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.82 -1.175 . . . . 0.0 110.36 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.11 -37.53 72.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.06 -1.025 . . . . 0.0 109.82 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.32 -35.98 72.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.13 -0.981 . . . . 0.0 109.827 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -95.33 -42.0 8.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.617 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' A' ' 32' ' ' LEU . 90.0 m-70 -108.0 126.13 52.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.7 p -86.98 -26.14 23.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.472 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 19' ' ' THR . 2.4 t 64.02 -0.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.113 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.2 mt-10 -95.61 120.06 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -69.29 -39.74 78.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.85 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.58 -37.09 91.72 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.98 156.57 44.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.61 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.78 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.797 2.331 . . . . 0.0 111.755 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.89 134.5 47.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -101.37 -125.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.86 -39.62 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.05 166.03 18.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -62.06 150.5 86.29 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.879 2.386 . . . . 0.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 42.8 m-20 -82.82 141.62 32.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.558 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.0 mp -99.68 137.26 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.786 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -171.71 98.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 108.907 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.11 8.56 81.79 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.45 -23.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.961 . . . . 0.0 109.535 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 86.6 m-85 -63.18 135.58 57.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 63.34 30.0 76.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 42' ' ' GLN . 62.0 ttt180 -134.85 154.27 51.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -1.033 . . . . 0.0 109.843 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.64 145.94 24.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.593 ' CB ' HD22 ' A' ' 52' ' ' ASN . 56.9 p -67.88 163.42 21.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 0.0 110.151 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.08 -9.7 67.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' HH21 ' A' ' 38' ' ' ARG . 95.5 mt-30 -96.85 6.05 49.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.92 -30.63 66.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.805 -1.185 . . . . 0.0 108.169 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 97.5 mt-10 38.05 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.431 0.634 . . . . 0.0 109.917 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.83 -26.65 2.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.94 143.31 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -1.013 . . . . 0.0 108.837 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -65.06 158.3 26.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 109.857 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CB ' HD11 ' A' ' 53' ' ' ILE . 14.6 m-85 -116.65 138.3 51.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 109.713 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 78' ' ' THR . 52.0 m -74.88 144.92 43.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 108.974 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -50.56 -35.85 31.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . . . -46.75 -69.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.593 HD22 ' CB ' ' A' ' 40' ' ' SER . 13.5 t30 -56.54 -41.41 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.086 -1.009 . . . . 0.0 110.564 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 48' ' ' TYR . 41.4 mm -60.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.739 -1.226 . . . . 0.0 110.012 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -60.34 -33.88 73.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.205 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.4 tttm -127.26 112.65 15.33 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -100.07 137.96 37.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.772 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.7 p -132.35 147.74 32.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 109.842 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.1 tp -79.04 134.22 36.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 108.811 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' GLY . 95.9 m95 -95.15 125.19 39.62 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.177 -0.952 . . . . 0.0 110.071 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 62' ' ' ASN . 46.3 p30 -155.41 -176.13 5.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.584 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -60.97 -39.59 90.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.939 -1.1 . . . . 0.0 111.013 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -74.94 -47.18 30.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.86 -1.15 . . . . 0.0 110.722 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 64.2 t30 -58.38 -42.1 86.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.499 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.645 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.3 mtt -62.41 -38.45 89.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 109.87 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.6 p -62.71 -40.82 98.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.257 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.08 -34.79 73.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.175 -0.953 . . . . 0.0 109.25 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.571 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.2 t60 -57.99 -44.15 86.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.561 -0.712 . . . . 0.0 109.471 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 94' ' ' LEU . 95.1 mt -67.64 -32.46 73.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -0.778 . . . . 0.0 110.597 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 m -55.77 -37.28 68.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.036 -1.04 . . . . 0.0 110.542 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.6 p-10 -167.56 69.04 0.9 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.434 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -50.15 -27.56 17.56 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.95 2.434 . . . . 0.0 112.636 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -58.44 6.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 109.321 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 70' ' ' ASN . 67.5 mttt -61.94 -26.85 68.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.772 ' OH ' HG11 ' A' ' 57' ' ' VAL . 34.2 t80 -59.46 -54.78 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.631 -0.668 . . . . 0.0 109.643 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.475 HG23 ' CD2' ' A' ' 74' ' ' TYR . 12.8 pt -139.96 70.19 35.68 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.077 -1.014 . . . . 0.0 109.97 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -52.81 135.47 57.43 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.429 2.086 . . . . 0.0 112.007 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.7 -0.55 56.65 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.847 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.741 ' HA ' HG21 ' A' ' 49' ' ' THR . 8.4 t -89.2 161.24 16.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.653 -1.498 . . . . 0.0 109.62 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -85.66 1.41 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.494 ' H ' HG23 ' A' ' 78' ' ' THR . 15.4 ttp -77.85 125.52 29.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.002 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.3 79.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 64.4 t80 -103.21 131.68 50.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.47 -0.769 . . . . 0.0 109.68 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -71.22 144.97 38.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 147.64 34.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 55.2 mt -97.21 133.1 42.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -94.1 -9.18 37.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.929 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -99.28 128.42 45.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 110.024 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.0 -38.59 52.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -60.72 -49.64 76.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 110.21 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.76 -37.31 86.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.004 . . . . 0.0 109.444 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.492 HH11 ' HB2' ' A' ' 68' ' ' LEU . 38.8 ttm-85 -57.46 -45.3 84.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.719 . . . . 0.0 109.883 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -62.76 -39.93 95.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 85.7 m-20 -61.37 -39.64 91.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.186 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.607 HD23 HD11 ' A' ' 68' ' ' LEU . 52.2 tp -60.36 -45.11 94.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 110.758 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.45 -41.8 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.008 -1.057 . . . . 0.0 109.579 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -58.15 -40.4 81.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 110.012 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -58.89 -50.88 72.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.372 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.509 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.6 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.627 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.584 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 80.6 tttt -56.72 -43.34 80.52 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -61.46 -43.58 98.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 0.0 109.4 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.673 -0.642 . . . . 0.0 109.748 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.452 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 49.9 t80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.213 0.53 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.452 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 32.9 ttpt -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.102 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.06 95.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -89.53 -176.42 45.81 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -105.86 129.47 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.165 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -68.51 -26.04 65.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -57.0 -46.97 81.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.027 -1.046 . . . . 0.0 110.15 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -66.49 -53.1 38.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.036 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.34 -28.21 72.72 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.61 -47.83 81.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.204 . . . . 0.0 109.761 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -73.65 -36.19 65.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 94' ' ' LEU . 20.0 tp -58.16 -42.19 85.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -64.69 -46.67 81.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -63.43 -40.43 97.14 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.471 0.653 . . . . 0.0 110.396 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 55.4 p -72.5 -29.56 63.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 111.627 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.32 55.96 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.549 -1.344 . . . . 0.0 111.23 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.646 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.9 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.782 -1.199 . . . . 0.0 110.49 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.09 -37.62 69.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.54 -35.7 70.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 109.904 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -97.7 -42.6 7.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.646 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -105.31 122.69 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.144 -0.972 . . . . 0.0 110.505 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 21' ' ' GLU . 52.9 p -82.52 -18.62 40.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 20' ' ' VAL . 14.8 p 39.7 21.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.701 -0.624 . . . . 0.0 110.047 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 18.8 pttm -67.2 -40.4 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.964 . . . . 0.0 109.546 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -62.62 -36.98 94.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.87 152.59 31.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.684 ' C ' HD22 ' A' ' 31' ' ' ASN . 84.4 Cg_endo -77.16 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.712 2.275 . . . . 0.0 111.877 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' HA ' HD22 ' A' ' 31' ' ' ASN . 86.7 m-70 -99.5 136.26 39.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.939 . . . . 0.0 109.258 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 36.0 tptt -106.48 -130.09 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.422 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.47 -41.1 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.58 161.96 15.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.477 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 12.2 Cg_endo -57.73 143.18 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.134 2.556 . . . . 0.0 111.938 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.684 HD22 ' C ' ' A' ' 25' ' ' PRO . 67.8 m-20 -76.43 146.31 38.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.3 mp -98.92 138.75 35.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.626 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -174.84 97.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.85 84.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 tt -58.89 -23.79 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.65 -0.912 . . . . 0.0 109.401 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -65.17 131.48 46.64 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.3 -0.875 . . . . 0.0 108.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.94 30.17 74.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -134.08 152.67 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -1.043 . . . . 0.0 109.931 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -93.37 145.23 24.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.316 -0.865 . . . . 0.0 108.999 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.474 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 53.4 p -66.79 158.52 30.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.956 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.37 -22.75 25.32 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -62.4 -36.34 82.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -1.205 . . . . 0.0 110.381 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.48 -44.86 92.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 109.892 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.12 -16.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.919 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -57.8 -34.65 71.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -123.25 143.37 50.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.597 -0.943 . . . . 0.0 109.168 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -64.76 159.39 22.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.98 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' O ' HD11 ' A' ' 53' ' ' ILE . 82.9 m-85 -118.41 146.52 44.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.563 -0.711 . . . . 0.0 109.554 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.9 p -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.38 -31.54 61.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 109.627 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.33 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.504 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t30 -55.8 -42.18 75.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.941 -1.1 . . . . 0.0 110.286 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.502 HD11 ' O ' ' A' ' 48' ' ' TYR . 87.9 mt -60.43 -45.65 96.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 120.895 -1.128 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -60.51 -37.17 80.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.255 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 52' ' ' ASN . 40.0 tttm -128.28 118.87 24.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 40.0 t30 -98.91 135.59 40.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 108.898 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.794 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.6 p -131.18 146.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.423 -0.798 . . . . 0.0 110.195 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.08 132.92 36.05 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -96.81 125.91 41.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.211 -0.931 . . . . 0.0 110.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 49.6 t0 -159.09 176.36 12.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.595 ' CD ' ' HZ3' ' A' ' 99' ' ' LYS . 97.2 mt-10 -55.35 -40.04 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.764 -1.21 . . . . 0.0 109.411 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.9 -52.22 26.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 33.7 t30 -62.85 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.611 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.5 mmt -58.75 -40.65 84.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.6 p -66.28 -37.56 85.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.19 -36.99 84.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.404 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -60.27 -45.68 92.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 109.84 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HD23 ' A' ' 94' ' ' LEU . 83.9 mt -70.17 -35.5 74.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.53 -0.731 . . . . 0.0 110.528 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 29.6 m -61.24 -39.2 89.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.912 -1.117 . . . . 0.0 110.829 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -152.92 67.99 6.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 109.788 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -61.96 -15.14 41.34 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.419 2.079 . . . . 0.0 112.675 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.03 -78.75 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.067 -1.021 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -57.22 -34.51 68.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.794 ' OH ' HG11 ' A' ' 57' ' ' VAL . 87.8 t80 -56.3 -50.34 71.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.954 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 75' ' ' ILE . 20.7 mt -148.09 77.66 9.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.02 152.12 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 123.208 2.606 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.15 3.17 55.78 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 80' ' ' MET . 6.2 t -104.65 174.73 5.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.154 -1.204 . . . . 0.0 109.539 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -87.19 11.63 13.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.674 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -70.13 121.51 17.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.763 -1.21 . . . . 0.0 109.622 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.86 27.27 8.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.004 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 51.9 t80 -86.74 129.2 34.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.172 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -87.54 178.68 47.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.84 154.27 23.75 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 9' ' ' LEU . 58.8 mt -100.26 122.09 42.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -66.1 -36.4 83.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.87 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -92.08 128.92 38.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.02 -1.05 . . . . 0.0 110.36 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -29.59 60.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.65 -0.656 . . . . 0.0 109.91 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -55.39 -50.2 70.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -64.21 -37.94 89.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.945 . . . . 0.0 109.103 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.585 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 39.3 ttm180 -58.67 -42.47 88.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.649 -0.657 . . . . 0.0 110.116 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 88.9 m-20 -63.03 -39.51 94.96 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.055 -1.028 . . . . 0.0 110.285 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 68' ' ' LEU . 51.0 tp -59.98 -42.9 95.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.56 -38.45 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.8 m -60.7 -41.07 94.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.11 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.63 -51.88 68.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.115 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.17 -36.89 69.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.595 ' HZ3' ' CD ' ' A' ' 61' ' ' GLU . 26.3 tptt -58.49 -45.68 88.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.738 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.5 mttm -58.78 -50.53 73.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.81 -1.181 . . . . 0.0 109.251 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 100' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 74.6 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -97.35 142.72 28.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.946 . . . . 0.0 109.154 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -60.75 138.69 58.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.203 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA3' HG21 ' A' ' 96' ' ' THR . . . -42.46 104.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 20.3 m -56.82 -35.96 69.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -1.118 . . . . 0.0 109.58 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 2' ' ' SER . . . 173.9 -165.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 109.738 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 26.4 mttm -84.14 5.38 26.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.685 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.43 -43.31 71.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.744 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.98 -28.7 69.16 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -59.54 -46.4 88.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -1.044 . . . . 0.0 109.672 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.936 ' O ' HG23 ' A' ' 12' ' ' THR . 24.6 m -60.88 -41.47 96.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.135 -0.978 . . . . 0.0 108.694 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 85' ' ' LEU . 2.1 tp -56.48 -41.3 76.35 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -61.79 -47.13 86.53 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -64.33 -37.23 86.75 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.543 0.687 . . . . 0.0 109.697 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 8' ' ' THR . 57.2 p -66.28 -38.02 86.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 111.352 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -153.8 61.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.548 -1.345 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 5.3 t -171.48 -45.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.998 -1.064 . . . . 0.0 109.774 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.41 -37.34 75.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -58.15 -36.01 72.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.6 m -94.38 -42.8 8.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.517 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.504 ' CE1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -108.54 122.69 47.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.945 . . . . 0.0 110.023 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.9 p -87.8 -24.64 23.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 0.0 109.83 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t 51.17 36.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -103.52 148.43 25.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.9 -37.55 82.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.275 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.47 -30.6 58.96 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 64.16 58.58 10.24 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.96 -24.58 79.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.542 2.161 . . . . 0.0 111.822 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 24' ' ' GLY . 94.3 m-70 55.6 42.28 29.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -56.93 -36.09 69.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 108.847 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' CZ ' ' A' ' 46' ' ' TYR . 2.4 t -146.31 -76.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -0.818 . . . . 0.0 109.253 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -72.76 160.31 53.99 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.2 1.69 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.035 2.49 . . . . 0.0 112.561 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER 66.56 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 109.769 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.824 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.1 mp -93.89 139.8 30.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -167.32 94.61 0.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.3 6.4 71.19 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.58 -21.3 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.984 . . . . 0.0 109.8 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.672 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 76.0 m-85 -64.44 131.47 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.93 27.99 73.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.54 ' NE ' ' OE1' ' A' ' 42' ' ' GLN . 63.4 mtp85 -144.94 168.89 19.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.948 -1.324 . . . . 0.0 110.189 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -94.21 157.76 15.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.945 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.464 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 59.5 p -67.31 163.71 20.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.69 -10.87 64.69 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.54 ' OE1' ' NE ' ' A' ' 38' ' ' ARG . 17.8 tt0 -61.65 -37.71 85.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.138 -1.213 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -57.62 140.19 51.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.222 -0.924 . . . . 0.0 109.715 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -126.52 148.59 49.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 109.352 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.4 -7.78 64.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CZ ' ' O ' ' A' ' 28' ' ' VAL . 73.9 t80 -129.42 134.59 47.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 109.426 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 49.8 m -67.73 156.28 37.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.748 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 14.0 m-85 -111.88 140.0 46.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.775 . . . . 0.0 109.418 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.706 HG21 ' HA ' ' A' ' 78' ' ' THR . 40.7 m -69.35 145.43 52.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.911 . . . . 0.0 109.348 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.6 m-20 -51.66 -37.34 50.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.191 -0.943 . . . . 0.0 109.785 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -43.06 -74.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.314 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 9.8 t30 -54.04 -40.9 67.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.191 -0.943 . . . . 0.0 110.744 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.83 -48.57 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.673 -1.267 . . . . 0.0 109.842 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -60.22 -33.84 72.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.7 tttm -127.53 114.88 18.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.582 -0.699 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -97.89 140.04 32.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.123 -0.986 . . . . 0.0 108.897 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.867 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.2 p -132.45 147.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.435 -0.79 . . . . 0.0 110.259 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -80.78 130.0 34.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.5 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 95.6 m95 -92.44 118.46 30.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.147 -0.97 . . . . 0.0 110.31 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 59' ' ' TRP . 91.4 m-20 -140.86 -178.51 5.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.85 -38.3 87.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 110.033 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -41.95 41.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.259 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 31.8 t30 -59.02 -42.51 90.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 110.249 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.672 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.4 mtt -63.11 -39.93 96.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.744 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.618 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 71.0 m -59.07 -40.51 85.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.631 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.62 -32.72 68.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.154 -0.966 . . . . 0.0 110.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -56.89 -51.17 70.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.416 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.68 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.3 mp -71.05 -28.58 64.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.958 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.4 m -57.74 -38.12 74.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.945 . . . . 0.0 110.848 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -163.25 66.5 1.61 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.858 -1.151 . . . . 0.0 110.358 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 74' ' ' TYR . 31.7 Cg_exo -50.92 -18.88 4.78 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 C-N-CA 122.838 2.359 . . . . 0.0 112.464 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -76.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -57.95 -32.88 68.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.92 . . . . 0.0 109.467 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.867 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.4 t80 -79.56 126.68 31.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 108.997 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 75' ' ' ILE . 60.1 mt 44.58 63.12 9.16 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.05 146.5 20.29 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.923 2.415 . . . . 0.0 112.451 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.19 16.41 47.29 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.762 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.706 ' HA ' HG21 ' A' ' 49' ' ' THR . 12.9 t -106.89 151.67 24.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.064 -1.257 . . . . 0.0 109.908 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -58.78 -29.62 66.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 22.1 ttp -59.71 140.51 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.288 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.04 92.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.447 -0.783 . . . . 0.0 109.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -161.7 -46.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.592 ' N ' ' CD2' ' A' ' 82' ' ' PHE . . . -41.11 164.51 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 126.5 44.29 0.25 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 9' ' ' LEU . 43.6 mt -88.25 138.27 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -1.023 . . . . 0.0 109.301 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -90.34 -2.99 58.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -97.89 126.52 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.961 -1.087 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.54 -40.08 23.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.755 . . . . 0.0 110.158 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.47 -47.98 83.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.207 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.45 -42.44 95.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.618 ' NH1' ' CB ' ' A' ' 65' ' ' SER . 59.5 ttp85 -61.76 -41.55 97.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.15 -41.01 82.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 110.215 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.31 -38.26 90.45 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.137 -0.977 . . . . 0.0 109.849 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD23 HD21 ' A' ' 68' ' ' LEU . 50.9 tp -60.14 -45.82 91.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 110.75 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.22 -44.35 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.894 -1.129 . . . . 0.0 109.697 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 ' HA3' ' A' ' 1' ' ' GLY . 29.1 m -64.35 -39.8 94.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.352 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.8 t80 -59.21 -43.77 92.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.05 -1.031 . . . . 0.0 110.657 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.1 mt -61.39 -35.82 78.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.715 -1.241 . . . . 0.0 109.528 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -56.94 -38.34 72.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.162 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -59.76 -45.06 93.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.338 -0.851 . . . . 0.0 109.263 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.765 . . . . 0.0 109.296 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 1' ' ' GLY . 16.0 ttmt -90.67 132.02 36.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.933 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.17 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.249 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -67.2 147.09 48.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.702 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 25.4 m -56.61 -33.19 66.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -1.162 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 75.97 -32.33 0.21 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.394 -0.816 . . . . 0.0 109.85 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 2' ' ' SER . 17.1 mttp -59.67 -51.37 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.085 -1.01 . . . . 0.0 109.203 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -65.04 -40.03 94.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.38 -34.56 89.68 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.23 89.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -1.211 . . . . 0.0 109.023 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.921 ' O ' HG23 ' A' ' 12' ' ' THR . 55.9 p -75.25 -38.28 60.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.89 . . . . 0.0 108.963 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -60.25 -42.76 95.96 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 72.1 t80 -65.08 -46.43 81.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.4 -39.22 93.9 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.324 0.583 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 8' ' ' THR . 70.5 p -70.14 -31.27 68.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.832 . . . . 0.0 111.448 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -149.23 56.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.607 -1.308 . . . . 0.0 111.246 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.53 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.769 -1.207 . . . . 0.0 110.585 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.1 tp -56.66 -37.23 70.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.166 -0.959 . . . . 0.0 110.057 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.55 -35.29 67.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.0 m -98.31 -44.13 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 110.718 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -103.48 123.95 47.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.581 HG23 HD22 ' A' ' 31' ' ' ASN . 7.0 p -84.2 -24.6 30.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 109.28 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 20' ' ' VAL . 13.9 p 42.24 41.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.351 -0.843 . . . . 0.0 110.072 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -100.53 158.27 16.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 109.187 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -68.44 143.44 55.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.403 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.87 -6.91 62.6 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 47.22 60.94 4.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 -28.05 85.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.37 2.046 . . . . 0.0 111.823 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 24' ' ' GLY . 93.5 m-70 55.0 46.74 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -57.43 -35.11 69.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 108.652 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 29' ' ' GLY . 21.7 t -141.96 -114.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 28' ' ' VAL . . . -57.56 160.7 10.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.559 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 2.4 Cg_endo -53.89 137.35 68.25 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.776 1.651 . . . . 0.0 111.517 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.581 HD22 HG23 ' A' ' 19' ' ' THR . 9.1 m120 -89.37 137.76 32.04 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.82 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -92.11 137.76 32.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 110.279 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -162.94 90.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 5.72 68.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.73 -21.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.556 -0.967 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -62.64 134.85 56.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.127 -0.983 . . . . 0.0 108.989 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 70.69 22.35 78.03 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -134.25 161.39 35.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -1.088 . . . . 0.0 110.147 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.3 m80 -97.6 153.49 18.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.277 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.595 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 26.8 p -66.09 158.39 28.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.888 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.34 -21.47 31.71 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.23 -36.08 78.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -1.157 . . . . 0.0 110.138 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -58.72 -44.81 90.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 109.606 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.68 -19.86 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.563 -0.71 . . . . 0.0 110.878 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -58.21 -34.25 73.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -124.06 142.33 51.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.962 . . . . 0.0 109.163 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -64.92 160.49 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 109.824 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' O ' HD11 ' A' ' 53' ' ' ILE . 36.0 m-85 -116.44 149.93 38.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -75.47 162.01 28.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.05 -32.96 62.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.529 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.4 t-20 -54.0 -41.71 68.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.061 -1.024 . . . . 0.0 110.049 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 48' ' ' TYR . 97.4 mt -59.7 -47.19 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.869 -1.144 . . . . 0.0 109.213 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -60.99 -37.36 82.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.5 tttm -125.06 117.07 23.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.536 -0.728 . . . . 0.0 109.415 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 15.9 t-20 -100.25 137.27 38.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.953 . . . . 0.0 109.023 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' OH ' ' A' ' 74' ' ' TYR . 11.3 p -131.17 147.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.446 -0.783 . . . . 0.0 110.196 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.4 tp -77.97 132.95 38.07 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.3 m95 -96.59 126.96 42.14 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.213 -0.93 . . . . 0.0 110.133 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 51.5 t0 -156.06 171.66 19.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 97.1 mt-10 -58.07 -39.07 77.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 109.547 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -48.04 43.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.067 -1.02 . . . . 0.0 109.256 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 11.9 t-20 -60.81 -37.16 81.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.453 -0.78 . . . . 0.0 109.937 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.8 mmt -58.65 -40.68 84.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 0.0 109.702 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.4 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 98.6 p -64.12 -35.43 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.114 -0.991 . . . . 0.0 109.339 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.22 -35.12 78.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 0.0 109.353 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -59.05 -47.09 86.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.45 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.501 HD11 HD23 ' A' ' 94' ' ' LEU . 20.7 mt -67.97 -29.57 68.64 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.058 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -59.28 -37.91 78.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 111.024 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -161.53 65.49 2.0 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 110.238 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -52.44 -21.29 13.54 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -77.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.954 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -57.45 -36.11 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.747 ' OH ' HG11 ' A' ' 57' ' ' VAL . 74.2 t80 -57.22 -51.29 69.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 75' ' ' ILE . 19.3 mt -148.29 76.49 10.17 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.198 -0.939 . . . . 0.0 108.621 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.9 148.81 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.103 2.535 . . . . 0.0 112.262 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.74 9.4 52.66 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.375 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -108.42 169.37 8.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 109.378 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -84.32 9.18 13.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.927 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.512 ' H ' HG23 ' A' ' 78' ' ' THR . 1.4 mtm -69.35 118.32 12.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.631 -1.293 . . . . 0.0 109.657 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.08 28.01 7.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 108.833 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.0 t80 -85.01 131.28 34.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.822 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.95 144.12 30.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 68' ' ' LEU . . . -75.9 142.86 29.22 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 mt -101.39 141.55 34.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -1.074 . . . . 0.0 108.971 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -82.64 -78.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.079 -1.013 . . . . 0.0 108.784 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -142.65 120.33 11.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 90' ' ' ASP . 82.4 tt0 -161.75 147.33 13.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -56.71 -34.58 67.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.193 -0.942 . . . . 0.0 108.657 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 90.5 m-20 -57.39 -38.21 73.91 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.308 -0.87 . . . . 0.0 108.9 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.449 ' HG3' HD12 ' A' ' 68' ' ' LEU . 64.0 ttp85 -57.53 -45.95 84.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -65.51 -43.45 90.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.466 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 2' ' ' SER . 84.7 m-20 -67.07 -39.56 86.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.334 -0.854 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.501 HD23 HD11 ' A' ' 68' ' ' LEU . 58.5 tp -55.98 -45.87 78.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.737 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.16 -40.56 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.042 -1.036 . . . . 0.0 108.903 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.7 m -60.2 -39.66 87.32 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.711 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -58.66 -50.31 74.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 109.283 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 10' ' ' PHE . 91.8 mt -69.28 -31.98 70.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 108.452 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 34.4 tttt -55.99 -46.2 78.77 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.28 -46.64 85.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.67 -179.628 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -86.25 129.47 34.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.052 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.47 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.105 -0.997 . . . . 0.0 109.286 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.421 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -104.07 126.43 8.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -61.2 137.9 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -1.212 . . . . 0.0 109.296 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -78.13 -19.24 54.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.986 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -58.38 -48.75 79.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 110.066 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -65.69 -50.77 63.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.533 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.45 -32.1 83.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -56.68 -43.91 80.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.592 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -71.87 -37.59 70.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD23 HD22 ' A' ' 94' ' ' LEU . 9.1 tp -58.75 -40.92 85.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.82 -47.02 85.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -63.42 -38.85 92.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.386 0.613 . . . . 0.0 109.963 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 8' ' ' THR . 59.4 p -69.68 -33.54 72.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 0.0 111.391 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -149.68 58.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.579 -1.326 . . . . 0.0 110.946 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.1 t -172.33 -54.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.832 -1.168 . . . . 0.0 110.291 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 -38.07 70.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.994 -1.067 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -58.79 -35.43 72.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.832 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m -96.07 -43.61 7.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.514 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.88 123.73 48.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.4 p -86.75 -23.37 25.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 0.0 109.298 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 32' ' ' LEU . 16.0 t 40.37 67.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.918 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.76 143.92 40.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.782 . . . . 0.0 109.317 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -64.23 -35.1 79.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.05 49.49 0.72 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.82 166.99 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.625 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.3 Cg_endo -74.1 -171.02 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.054 2.503 . . . . 0.0 112.021 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -105.57 134.68 48.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 29' ' ' GLY . 79.7 tttt -131.35 129.72 41.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.78 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.9 t 53.81 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.222 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -101.89 161.54 17.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.24 154.16 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.151 2.567 . . . . 0.0 112.361 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.625 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 58.5 m-20 -84.13 133.65 34.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.255 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 20' ' ' VAL . 6.8 mp -99.7 133.99 43.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 109.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -161.44 102.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 108.81 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 80.46 9.88 85.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.57 -21.32 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.599 -0.942 . . . . 0.0 109.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.71 132.98 51.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.203 -0.935 . . . . 0.0 109.495 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.04 26.11 73.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 90.2 mtt-85 -134.37 165.0 26.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -1.095 . . . . 0.0 110.021 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -100.04 147.33 25.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.582 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 9.5 m -61.3 152.89 27.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 110.118 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.51 -7.73 74.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.444 HE22 HH11 ' A' ' 38' ' ' ARG . 45.0 tt0 -64.03 -39.11 93.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.029 -1.277 . . . . 0.0 110.273 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.75 -45.44 92.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.0 -1.063 . . . . 0.0 109.556 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 58.97 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -60.96 -34.88 89.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 47' ' ' SER . 64.9 t80 -111.68 135.91 51.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -1.052 . . . . 0.0 109.352 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 35.0 m -62.57 153.79 30.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' O ' HD11 ' A' ' 53' ' ' ILE . 87.2 m-85 -116.03 148.95 39.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.417 ' OG1' HG22 ' A' ' 78' ' ' THR . 30.1 p -76.52 164.38 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.64 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -34.28 64.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 110.147 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.095 -1.003 . . . . 0.0 110.442 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 22.8 t-20 -55.04 -41.3 71.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.971 -1.081 . . . . 0.0 110.271 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.552 HD11 ' O ' ' A' ' 48' ' ' TYR . 96.9 mt -59.88 -54.54 33.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.793 -1.192 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.15 -40.39 95.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.084 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 56.4 tttm -111.43 111.96 23.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.197 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.54 136.73 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.848 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.4 p -131.11 147.37 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.866 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.2 tt -79.24 128.43 33.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.765 ' N ' HD23 ' A' ' 58' ' ' LEU . 87.8 m95 -91.63 108.22 19.75 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 52.4 p30 -136.49 176.25 8.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.574 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -61.91 -41.69 98.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.357 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.78 -51.69 60.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 110.333 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.489 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 11.7 t-20 -61.42 -35.89 78.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.63 -41.43 77.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 109.648 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 95' ' ' ILE . 35.5 m -63.24 -42.16 99.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.56 -36.9 83.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.471 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.6 t60 -57.76 -43.62 85.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 94' ' ' LEU . 86.2 mt -63.54 -28.84 70.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.464 -0.773 . . . . 0.0 109.68 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.551 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 10.0 m -81.89 125.37 30.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.2 m-20 37.52 61.55 3.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.718 . . . . 0.0 110.342 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.9 -21.52 73.2 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.645 2.23 . . . . 0.0 112.943 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.67 16.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -62.14 -36.32 81.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.54 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.848 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.0 t80 -59.9 -51.68 68.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 110.302 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 75' ' ' ILE . 3.0 mm -141.18 79.55 17.74 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.32 152.22 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.112 2.542 . . . . 0.0 112.735 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.17 -1.82 59.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.531 HG21 ' CG2' ' A' ' 75' ' ' ILE . 15.0 p -100.57 166.54 10.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.305 . . . . 0.0 109.949 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -81.67 2.77 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 109.342 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.6 ttt -83.57 128.38 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.847 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.61 86.78 2.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.212 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -103.07 131.64 49.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.316 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.64 145.43 38.64 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.12 32.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 52.6 mt -95.87 124.74 40.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -65.13 -35.94 82.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.795 . . . . 0.0 110.092 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.47 129.8 39.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -74.81 -33.9 62.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.576 -0.703 . . . . 0.0 109.583 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -57.2 -39.48 75.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.02 -38.08 81.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.253 -0.904 . . . . 0.0 108.936 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 85.5 mtt180 -61.47 -39.26 90.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -59.88 -40.5 88.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.6 m-20 -64.63 -41.36 96.21 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.088 -1.008 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 68' ' ' LEU . 55.3 tp -61.69 -43.34 99.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.787 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 ' OG ' ' A' ' 65' ' ' SER . 89.0 mt -64.78 -35.95 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 108.899 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 3' ' ' ALA . 21.2 m -56.51 -41.12 76.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 109.913 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -64.07 -54.78 28.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.011 . . . . 0.0 110.299 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 98' ' ' LEU . 91.9 mt -68.08 -37.3 81.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.874 -1.141 . . . . 0.0 108.892 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.574 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 29.7 tttt -57.71 -40.03 78.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -59.65 -39.92 85.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.811 . . . . 0.0 109.413 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.439 -0.788 . . . . 0.0 109.577 -179.737 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 82.2 t80 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.23 0.538 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -90.48 133.12 35.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -57.11 127.69 33.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.176 -0.953 . . . . 0.0 109.387 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' -1' ' ' ALA . . . -42.31 137.67 2.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -58.24 -36.71 73.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.416 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.485 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -177.24 -146.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 88.3 mttt -87.7 7.5 29.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 109.896 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -54.81 -43.89 73.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 108.98 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -62.17 -29.29 72.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -58.86 -42.82 90.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -1.094 . . . . 0.0 109.492 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -67.35 -36.9 82.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.118 -0.989 . . . . 0.0 108.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -58.84 -40.02 83.0 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.6 t80 -66.08 -48.55 70.59 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -62.89 -38.76 92.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.928 HG23 ' O ' ' A' ' 8' ' ' THR . 68.5 p -68.17 -32.7 73.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -151.27 59.2 0.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.664 -1.273 . . . . 0.0 111.014 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.06 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.755 -1.216 . . . . 0.0 110.61 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.85 -38.69 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.0 -35.94 67.36 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 109.801 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.04 -43.03 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.988 . . . . 0.0 110.985 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.465 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.0 m-70 -105.36 129.29 53.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.185 -0.947 . . . . 0.0 110.48 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.45 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 46.8 p -89.9 -19.19 24.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 0.0 109.495 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.547 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 4.3 t 60.93 20.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.4 tt0 -104.46 138.06 41.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -59.67 -39.07 83.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.935 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -107.3 28.78 11.79 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -61.23 154.22 37.76 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.71 -3.22 13.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.891 2.394 . . . . 0.0 112.263 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 27' ' ' LYS . 79.5 m-70 59.01 66.26 1.08 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 26' ' ' HIS . 29.9 tttp -58.04 -122.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.688 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.04 -39.78 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.929 -1.107 . . . . 0.0 109.572 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.24 162.79 14.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 18.0 Cg_endo -62.59 154.31 65.81 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.966 2.444 . . . . 0.0 112.253 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.45 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 6.8 m120 -86.22 134.19 33.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.113 -0.992 . . . . 0.0 109.122 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 35' ' ' ILE . 9.7 mp -89.58 -112.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 20' ' ' VAL . 10.6 t60 79.33 90.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.797 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.73 5.45 66.58 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.61 HG21 HD23 ' A' ' 32' ' ' LEU . 3.2 tp -57.81 -20.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 90.4 m-85 -63.1 135.36 57.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.97 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 68.54 25.56 74.85 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD3' HE22 ' A' ' 42' ' ' GLN . 87.2 mtt180 -135.16 157.96 45.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -1.115 . . . . 0.0 110.057 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -91.57 152.09 20.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.464 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 60.6 p -65.77 157.75 29.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.07 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.94 -13.59 67.1 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.434 HE22 ' HD3' ' A' ' 38' ' ' ARG . 48.1 tt0 -62.58 -37.51 86.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -1.192 . . . . 0.0 110.208 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -54.5 140.08 35.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.118 -0.988 . . . . 0.0 109.513 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.92 153.16 34.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.56 -0.713 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.81 63.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.3 t80 -140.26 168.22 20.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.215 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -111.86 150.58 30.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.0 109.956 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 10.8 m-85 -109.19 151.35 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 109.513 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -75.43 157.96 33.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.08 -33.33 70.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -63.73 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.39 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.5 t-20 -55.46 -44.17 76.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.04 -1.037 . . . . 0.0 110.164 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.27 -47.11 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.948 -1.095 . . . . 0.0 110.056 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -60.04 -38.57 83.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -91.75 -66.14 0.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.623 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.582 ' N ' ' O ' ' A' ' 52' ' ' ASN . 5.6 t30 66.1 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.32 -0.862 . . . . 0.0 108.922 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.819 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.1 p -131.77 149.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.36 131.55 41.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -96.79 125.69 41.42 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.167 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.454 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 50.8 p30 -152.22 179.81 8.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -59.35 -42.19 90.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.729 -1.232 . . . . 0.0 110.647 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -67.98 -49.27 62.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.024 -1.048 . . . . 0.0 110.869 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.454 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 58.3 t30 -60.34 -41.41 93.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 111.271 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.656 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 61.5 mtt -61.12 -37.62 83.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.905 -1.122 . . . . 0.0 110.276 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -60.97 -43.38 98.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.018 -1.051 . . . . 0.0 109.678 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.1 -36.7 77.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.013 -1.054 . . . . 0.0 109.169 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -60.01 -46.14 90.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' CD1' HD23 ' A' ' 94' ' ' LEU . 90.1 mt -62.53 -31.46 72.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 110.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 13.1 m -85.79 127.12 34.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.943 -1.098 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' THR . 30.3 m-20 39.8 58.61 6.91 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.429 -0.794 . . . . 0.0 110.192 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.81 -20.81 53.76 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.792 2.328 . . . . 0.0 112.959 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.87 6.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.078 -1.014 . . . . 0.0 110.083 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -61.68 -33.52 74.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 109.575 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.819 ' OH ' HG11 ' A' ' 57' ' ' VAL . 71.5 t80 -57.19 -48.74 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.596 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 75' ' ' ILE . 4.2 tp -152.82 82.08 5.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.271 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.91 151.34 35.44 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.314 2.009 . . . . 0.0 112.338 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.76 1.08 58.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 p -93.21 165.72 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -92.28 14.58 15.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.143 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.3 mtm -78.9 134.46 36.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 110.078 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.05 27.13 9.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.486 -0.759 . . . . 0.0 109.048 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.53 130.56 37.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 108.94 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.68 179.29 44.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.69 146.12 23.17 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -96.02 118.14 32.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -1.195 . . . . 0.0 109.338 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -64.97 -38.48 91.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.78 128.45 34.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.0 110.351 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.4 -29.27 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.895 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -55.65 -47.11 77.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.152 -0.968 . . . . 0.0 110.093 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -63.57 -38.94 93.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.907 -1.121 . . . . 0.0 108.801 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 38.5 ttm180 -60.85 -45.19 95.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.551 -0.718 . . . . 0.0 110.035 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -66.66 -48.79 68.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.659 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 45.7 t0 -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 109.869 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 68' ' ' LEU . 47.8 tp -54.79 -47.03 74.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 0.0 110.108 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.35 -40.77 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.044 . . . . 0.0 109.266 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.1 m -59.18 -41.83 89.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.805 . . . . 0.0 110.078 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.721 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.2 t80 -60.4 -49.57 77.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.863 -1.148 . . . . 0.0 108.932 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 98' ' ' LEU . 82.9 mt -68.13 -32.06 72.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 108.562 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 41.3 tttm -54.82 -43.75 73.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -62.02 -43.22 99.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.376 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.645 -0.659 . . . . 0.0 109.899 -179.639 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -111.19 162.19 15.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.474 -0.766 . . . . 0.0 109.335 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 109.5 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.69 125.64 8.58 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 86.1 p -60.98 -27.75 68.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 67.56 -21.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 2' ' ' SER . 33.8 tttt -58.82 -51.52 69.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.426 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -65.57 -42.23 92.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 109.201 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -61.72 -34.96 90.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.02 83.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -1.211 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 52.3 p -74.57 -38.65 62.61 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.05 -41.8 88.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.6 t80 -63.97 -45.91 87.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -62.78 -38.6 91.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.404 0.621 . . . . 0.0 110.267 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 61.9 p -72.25 -29.6 64.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 111.663 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -147.72 53.49 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.468 -1.395 . . . . 0.0 111.479 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.5 t -173.48 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.724 -1.235 . . . . 0.0 110.774 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.66 -37.55 70.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.079 -1.013 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.97 -34.8 68.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.769 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.5 m -98.14 -43.58 6.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.678 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.437 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -104.16 128.51 51.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.411 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 20' ' ' VAL . 44.7 p -93.95 -15.71 24.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.5 t 42.26 36.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLY . 85.3 tt0 -101.16 141.06 34.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.276 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -76.15 -82.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 110.203 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.58 24.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.48 150.84 49.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.612 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 72.7 Cg_endo -76.43 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.676 2.251 . . . . 0.0 111.773 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -104.03 134.66 46.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.027 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 29' ' ' GLY . 46.1 tptt -130.51 133.01 45.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.0 109.307 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' HG3' ' A' ' 27' ' ' LYS . 91.6 t 53.9 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.11 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -103.87 158.7 16.9 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 15.6 Cg_endo -57.01 146.78 78.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.059 2.506 . . . . 0.0 112.341 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 70.8 m-20 -74.1 135.55 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.001 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.0 mp -97.17 11.48 36.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -52.22 -32.39 36.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.197 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.42 56.05 0.68 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -111.77 2.34 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 48.7 m-85 -82.33 129.18 34.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.985 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.24 31.06 73.94 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -145.77 168.25 21.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.171 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.31 156.32 16.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.363 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 48' ' ' TYR . 59.5 p -58.71 -39.65 81.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 109.739 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.18 85.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.26 -36.22 72.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -1.115 . . . . 0.0 110.737 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -59.08 -32.02 69.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.892 -1.13 . . . . 0.0 109.686 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' ALA . 78.7 mm-40 42.84 -167.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.98 -41.9 2.45 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 47' ' ' SER . 71.8 t80 -123.53 136.1 54.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 109.333 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 55.1 p -69.35 159.34 33.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.638 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 95.4 m-85 -118.27 146.72 44.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.409 -0.807 . . . . 0.0 109.879 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.574 HG21 ' OG1' ' A' ' 78' ' ' THR . 61.4 m -69.75 151.88 45.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.392 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.79 -33.27 7.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.49 -68.55 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.7 t-20 -56.58 -41.81 77.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.1 . . . . 0.0 110.295 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.8 -44.32 97.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.11 -37.14 76.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 108.785 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.0 tttt -127.14 112.3 15.0 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -97.95 134.79 40.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.79 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -130.84 145.76 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.657 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.7 tp -79.89 132.81 36.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.243 -0.91 . . . . 0.0 108.774 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.45 ' HE1' ' HB3' ' A' ' 40' ' ' SER . 99.0 m95 -94.98 124.74 39.2 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 55.2 t0 -148.18 163.41 37.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.4 mt-10 -52.51 -40.76 62.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.919 -1.113 . . . . 0.0 109.483 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.05 -48.19 66.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 0.0 110.164 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -61.52 -38.83 88.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 110.732 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 63.1 mtt -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.079 -1.013 . . . . 0.0 109.844 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' HD11 ' A' ' 95' ' ' ILE . 90.5 p -60.9 -40.53 93.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 108.964 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.81 -35.12 79.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.107 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.474 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 69.8 t60 -61.37 -45.66 93.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.63 HD13 HD23 ' A' ' 94' ' ' LEU . 42.0 mt -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 109.868 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.536 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 17.6 m -86.01 126.15 33.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.85 -1.157 . . . . 0.0 108.725 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.8 m-20 41.77 59.33 9.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.272 -0.892 . . . . 0.0 109.751 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.52 -23.21 74.78 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.762 2.308 . . . . 0.0 112.747 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -60.55 -49.26 78.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.041 . . . . 0.0 109.609 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -64.16 -30.52 71.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.79 ' OH ' HG11 ' A' ' 57' ' ' VAL . 31.2 t80 -52.35 -46.12 66.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 108.936 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 77' ' ' GLY . 1.6 pt -141.05 153.35 66.99 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.54 -7.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.085 1.857 . . . . 0.0 112.018 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 84.02 48.41 5.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.671 HG23 ' N ' ' A' ' 79' ' ' LYS . 4.9 t -56.81 -118.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.007 . . . . 0.0 109.974 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 78' ' ' THR . 45.4 mtmt -89.64 1.46 55.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.188 -0.945 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.3 mmm -75.17 118.54 18.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 108.959 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.13 32.03 5.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.457 -0.777 . . . . 0.0 110.17 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 60.2 t80 -87.53 130.47 34.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.256 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.535 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.41 179.77 49.35 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.36 157.27 23.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.4 mt -102.46 119.03 38.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -1.14 . . . . 0.0 109.346 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -66.32 -35.72 81.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 69.0 mttm -90.32 130.76 36.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 110.294 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.03 -29.56 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.999 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.62 -52.1 66.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 91' ' ' ARG . 53.3 p30 -64.47 -30.29 71.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.639 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 39.2 ttm180 -59.45 -43.69 93.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.142 -0.974 . . . . 0.0 109.859 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -65.46 -40.5 93.26 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -0.944 . . . . 0.0 110.17 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD23 HD13 ' A' ' 68' ' ' LEU . 54.5 tp -58.19 -47.0 84.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.113 -0.992 . . . . 0.0 110.186 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.48 HD11 ' HA ' ' A' ' 65' ' ' SER . 63.2 mt -67.33 -36.17 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.011 -1.055 . . . . 0.0 108.684 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.6 m -57.68 -41.43 81.57 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.403 -0.811 . . . . 0.0 109.674 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -50.87 71.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 109.0 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.607 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.1 mt -66.74 -32.77 74.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 108.384 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.471 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 19.2 tttt -57.33 -41.63 80.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.48 -40.34 90.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 0.0 109.652 -179.828 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.329 0.585 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 1' ' ' GLY . 15.5 ttmt -92.27 131.54 37.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.406 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.265 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -71.11 156.47 53.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 23.7 m -56.28 -33.26 65.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 72.05 -41.04 0.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.8 tttt -58.98 -51.21 71.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.041 -1.037 . . . . 0.0 109.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -64.0 -43.13 96.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.098 -1.001 . . . . 0.0 108.984 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.97 -32.73 85.18 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.64 -42.65 79.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.192 -1.181 . . . . 0.0 109.007 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 12' ' ' THR . 52.7 p -74.19 -33.48 63.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.34 -0.85 . . . . 0.0 109.119 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -60.35 -42.18 95.2 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.0 t80 -69.07 -47.37 65.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -62.67 -39.24 93.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.67 -0.644 . . . . 0.0 110.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 8' ' ' THR . 73.3 p -69.36 -32.53 71.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 111.399 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -150.76 58.06 0.93 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.53 -1.356 . . . . 0.0 111.526 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 6.3 t -170.59 -43.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.757 -1.215 . . . . 0.0 110.128 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.54 -35.91 73.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 109.656 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.8 -37.21 73.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.5 m -93.25 -41.3 9.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.646 ' ND1' HD11 ' A' ' 32' ' ' LEU . 87.4 m-70 -107.73 127.08 53.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.402 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 43.2 p -87.69 -20.39 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.613 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 20' ' ' VAL . 5.7 t 57.65 29.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 110.189 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.17 149.06 25.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -60.47 -36.22 77.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 109.337 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.98 41.31 1.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -62.81 156.49 40.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -4.74 15.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.953 2.435 . . . . 0.0 112.196 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 27' ' ' LYS . 73.1 m-70 60.49 65.85 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 26' ' ' HIS . 14.6 tttt -57.04 -118.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.83 -40.36 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.68 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.76 162.86 19.91 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 16.6 Cg_endo -60.6 150.52 81.46 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.917 2.411 . . . . 0.0 111.952 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.443 ' OD1' ' C ' ' A' ' 24' ' ' GLY . 5.4 m120 -81.24 140.46 34.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.292 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.9 mp -98.28 140.85 31.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.024 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -171.18 97.01 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.427 -0.795 . . . . 0.0 109.064 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.29 6.76 74.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -58.81 -23.37 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.523 -0.986 . . . . 0.0 109.81 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.74 133.74 51.7 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.08 78.91 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -135.81 161.55 35.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -1.091 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -88.78 156.69 18.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 1.8 t -61.07 149.36 37.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.81 63.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -60.59 -38.34 84.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -1.218 . . . . 0.0 109.859 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.752 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.18 139.13 48.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.083 -1.01 . . . . 0.0 109.069 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -117.79 150.62 38.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 109.434 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.45 62.85 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.7 t80 -136.25 157.83 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.3 t -98.77 148.52 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.752 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 m-85 -109.81 141.67 42.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.509 -0.744 . . . . 0.0 110.043 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 51' ' ' ALA . 51.7 m -73.47 146.94 44.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 53' ' ' ILE . 92.2 m-20 -51.7 -36.31 46.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.766 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -42.71 -71.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.034 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 56' ' ' ASN . 26.9 t-20 -52.88 -40.12 63.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 0.0 110.367 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 50' ' ' ASP . 79.2 mt -56.8 -54.17 32.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.862 -1.149 . . . . 0.0 109.415 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -62.47 -38.52 90.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.084 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.2 mttm -99.26 25.44 6.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.475 -0.766 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 52' ' ' ASN . 36.7 t-20 -43.64 126.55 4.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.018 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.854 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -135.53 152.11 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 110.122 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -71.2 133.63 46.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 40' ' ' SER . 98.1 m95 -96.41 123.76 40.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.229 -0.92 . . . . 0.0 110.107 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 55.1 p30 -152.93 176.66 11.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -60.11 -39.37 85.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.128 . . . . 0.0 110.665 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -70.37 -56.44 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.926 -1.109 . . . . 0.0 110.47 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.567 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 46.2 t30 -59.55 -38.8 82.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.66 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.5 mmt -59.29 -40.53 86.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.961 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 95' ' ' ILE . 43.1 m -60.16 -40.37 89.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.523 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.17 -33.2 75.23 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.949 -1.095 . . . . 0.0 109.446 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.49 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 71.3 t60 -59.74 -47.72 84.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.376 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.1 mp -67.84 -30.54 69.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.584 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 28.1 m -60.74 -38.82 86.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.908 -1.12 . . . . 0.0 110.41 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -154.15 67.03 5.62 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.049 . . . . 0.0 109.796 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.27 -22.04 72.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.571 2.181 . . . . 0.0 113.061 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 -71.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.974 -1.079 . . . . 0.0 109.651 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -59.7 -24.28 63.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.854 ' OH ' HG11 ' A' ' 57' ' ' VAL . 18.6 t80 -55.36 -46.29 76.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.922 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.67 HD12 HG21 ' A' ' 78' ' ' THR . 2.1 pt -142.47 78.78 16.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.155 -0.966 . . . . 0.0 109.91 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -69.25 137.42 36.9 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 C-N-CA 123.039 2.492 . . . . 0.0 111.94 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.71 2.79 62.86 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.538 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -98.6 170.4 8.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.295 . . . . 0.0 109.675 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -90.94 13.89 15.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.908 . . . . 0.0 110.603 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.818 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -74.67 122.48 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.75 30.59 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.016 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 63.9 t80 -89.69 131.15 35.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.044 -1.035 . . . . 0.0 109.406 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -85.88 176.37 49.12 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.37 159.45 25.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.98 122.98 44.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 0.0 109.293 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.49 -35.59 81.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.98 128.51 36.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 110.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -28.51 60.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 109.889 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -55.6 -47.33 76.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.185 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.32 -39.16 93.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.886 -1.134 . . . . 0.0 108.898 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.584 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.6 ttp180 -61.0 -43.41 98.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -58.63 -47.21 85.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.009 -1.057 . . . . 0.0 109.62 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 2' ' ' SER . 88.7 m-20 -66.79 -39.42 87.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.92 -45.84 85.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 65' ' ' SER . 75.4 mt -65.12 -36.79 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.015 -1.053 . . . . 0.0 108.344 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.0 m -57.24 -41.32 79.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.594 -0.691 . . . . 0.0 109.59 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -62.29 -52.53 63.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.28 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.4 mt -66.19 -32.92 74.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 108.495 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 13.8 tttp -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.561 -0.712 . . . . 0.0 109.091 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -61.15 -39.89 91.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.436 -0.79 . . . . 0.0 109.538 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.54 -0.725 . . . . 0.0 109.718 -179.59 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.415 0.626 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.752 ' O ' ' HB2' ' A' ' -1' ' ' ALA . 35.0 ttpt -49.97 -56.82 9.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.221 -0.924 . . . . 0.0 111.176 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' -2' ' ' LYS . . . 160.88 28.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.426 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -39.83 98.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' -1' ' ' ALA . 40.4 p -129.25 34.57 4.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.48 149.2 23.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 110.285 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -56.43 -25.73 51.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.584 -0.697 . . . . 0.0 109.762 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -45.52 -50.92 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.234 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.62 -34.83 87.76 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -63.37 -49.7 72.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.126 . . . . 0.0 109.476 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' THR . 25.3 m -61.25 -39.12 89.16 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.274 -0.892 . . . . 0.0 108.761 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.679 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -53.98 -41.63 68.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.4 t80 -61.25 -47.04 87.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.44 -38.03 89.58 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.638 . . . . 0.0 109.933 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 8' ' ' THR . 49.4 p -68.11 -36.32 79.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.48 -0.763 . . . . 0.0 111.315 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -151.9 61.23 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.0 110.712 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -172.37 -47.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.959 -1.088 . . . . 0.0 110.161 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.21 -37.67 72.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.818 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -58.14 -35.25 71.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 109.866 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.2 m -96.57 -42.5 8.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.7 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.462 ' CE1' HD11 ' A' ' 32' ' ' LEU . 93.5 m-70 -109.19 124.04 50.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.947 . . . . 0.0 109.881 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' GLU . 36.3 p -89.03 -18.18 27.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 t 61.84 -8.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' THR . 97.1 mt-10 -60.67 136.56 58.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.924 -1.11 . . . . 0.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -78.54 -39.67 37.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.83 -7.78 55.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.77 155.72 52.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.44 -166.52 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.723 2.282 . . . . 0.0 111.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -101.3 90.41 4.1 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -59.99 -41.7 92.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.108 -0.995 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.39 -71.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.546 -0.721 . . . . 0.0 109.153 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -76.65 159.62 49.91 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 5.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 112.834 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER 64.78 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 110.126 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.6 mp -95.92 143.48 27.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -172.51 91.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 109.045 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.38 6.35 74.28 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.73 -20.19 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.478 -1.013 . . . . 0.0 109.609 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.6 m-85 -60.4 131.31 50.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.95 29.45 73.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HD3' HE22 ' A' ' 42' ' ' GLN . 89.6 mtt180 -140.52 164.41 30.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -1.226 . . . . 0.0 110.255 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -92.69 159.59 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 0.0 109.705 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 22.6 t -71.03 154.22 41.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.073 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.96 51.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.438 HE22 ' HD3' ' A' ' 38' ' ' ARG . 49.7 tt0 -62.54 -36.09 81.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.272 . . . . 0.0 109.95 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -58.7 -32.74 69.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 109.716 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ALA . 95.6 mt-10 42.04 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.17 -39.39 1.63 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 44' ' ' GLU . 63.7 t80 -116.15 134.1 55.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.488 -1.007 . . . . 0.0 108.99 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 45.6 m -63.12 153.16 35.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.967 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' O ' HD11 ' A' ' 53' ' ' ILE . 66.5 m-85 -114.5 145.89 41.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.514 -0.741 . . . . 0.0 109.359 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -79.39 166.55 21.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.19 -31.7 61.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.771 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 75' ' ' ILE . . . -46.67 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.741 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.6 t-20 -55.87 -41.33 74.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.12 -0.988 . . . . 0.0 110.79 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 48' ' ' TYR . 80.2 mt -59.44 -50.27 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.912 -1.118 . . . . 0.0 109.854 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -59.89 -36.52 77.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.5 ttpp -128.01 117.43 21.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.536 -0.728 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.64 136.73 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 108.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.938 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.06 147.32 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -75.63 132.25 40.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 76.1 m95 -93.69 125.88 38.55 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.052 -1.03 . . . . 0.0 109.841 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.7 t0 -152.74 170.35 20.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -55.77 -39.93 71.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.765 -1.21 . . . . 0.0 109.498 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -66.19 -48.25 71.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -63.97 -40.41 96.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 110.791 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.9 mtt -60.79 -38.7 86.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 110.075 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -60.75 -45.48 94.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 109.216 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.69 -33.37 75.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.951 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -57.76 -44.04 85.86 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.509 -0.744 . . . . 0.0 109.158 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 HD23 ' A' ' 94' ' ' LEU . 93.3 mt -67.43 -25.38 65.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.549 -0.719 . . . . 0.0 109.852 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.589 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 24.5 m -85.43 131.05 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.013 -1.054 . . . . 0.0 109.836 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 69' ' ' THR . 3.2 t-20 38.8 56.6 5.45 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 0.0 110.713 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.76 -14.75 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.773 2.315 . . . . 0.0 112.222 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.19 72.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 109.762 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -84.83 3.9 35.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.144 -0.972 . . . . 0.0 109.04 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.938 ' OH ' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -108.31 124.52 50.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.405 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.596 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 44.7 pt 38.23 54.09 4.0 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.463 -0.773 . . . . 0.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 75' ' ' ILE . 18.2 Cg_endo -61.33 -18.65 60.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.756 2.304 . . . . 0.0 112.249 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.27 21.88 29.4 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.4 p -116.03 156.01 27.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.278 -1.131 . . . . 0.0 110.043 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 80' ' ' MET . 22.8 mttm -60.31 -29.93 69.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 79' ' ' LYS . 4.7 ttt -38.62 115.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.43 0.633 . . . . 0.0 110.351 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.17 29.38 8.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.25 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 54.9 t80 -65.63 134.42 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.434 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.25 179.21 49.47 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.56 151.46 21.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.507 HD11 HD21 ' A' ' 9' ' ' LEU . 57.2 mt -105.07 121.34 43.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -1.113 . . . . 0.0 109.626 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -66.74 -34.03 76.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -84.07 116.7 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 109.994 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 97.3 mt-10 -72.22 -35.88 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.83 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -58.43 -38.74 78.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.687 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.19 -37.27 77.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 80.6 mtm180 -60.03 -43.02 95.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -57.58 -42.61 83.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 110.828 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD1' ' CA ' ' A' ' 1' ' ' GLY . 75.2 m-20 -67.27 -39.92 86.12 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.812 -1.18 . . . . 0.0 109.95 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.679 HD22 HD23 ' A' ' 9' ' ' LEU . 55.2 tp -61.97 -45.77 92.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.689 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.58 -42.17 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 109.618 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 43.8 m -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.435 -0.79 . . . . 0.0 110.732 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 84.0 t80 -60.7 -44.71 96.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.066 -1.021 . . . . 0.0 110.922 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.444 HD21 ' CE1' ' A' ' 10' ' ' PHE . 80.2 mt -62.79 -37.68 87.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.813 -1.18 . . . . 0.0 109.874 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.523 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 9.3 mtpt -58.77 -37.0 75.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.092 -1.005 . . . . 0.0 109.188 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.5 -42.34 91.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.357 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' -2' ' ' LYS . 75.8 t80 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.345 0.593 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.598 ' O ' ' CD2' ' A' ' -3' ' ' PHE . 45.6 mtpt -83.24 172.57 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.09 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.625 ' C ' HG21 ' A' ' 96' ' ' THR . . . 88.02 81.47 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -120.2 142.86 48.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.454 -1.027 . . . . 0.0 109.147 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 7' ' ' ALA . . . -78.2 -82.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.097 -1.002 . . . . 0.0 109.642 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 3' ' ' ALA . 47.5 tptt 42.27 -99.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.408 -0.808 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' ALA . 34.7 mttp -61.9 -42.77 99.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . . . -63.39 -51.63 65.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.172 -1.193 . . . . 0.0 109.785 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 12' ' ' THR . 52.8 p -71.93 -38.18 69.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.269 -0.895 . . . . 0.0 109.198 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 85' ' ' LEU . 8.0 tp -58.35 -41.01 83.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.4 t80 -63.38 -46.8 84.77 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -62.7 -38.48 90.57 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.425 0.631 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 8' ' ' THR . 57.5 p -71.16 -30.43 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 111.532 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -148.54 55.37 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.326 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.52 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.742 -1.224 . . . . 0.0 110.871 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -55.61 -37.12 67.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.202 -0.936 . . . . 0.0 109.984 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.36 -34.77 69.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.3 m -98.98 -43.52 6.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.896 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.595 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -104.16 130.02 51.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 21' ' ' GLU . 19.6 p -91.08 -24.19 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.506 -0.746 . . . . 0.0 109.892 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.2 1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.253 -0.904 . . . . 0.0 110.054 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.4 tt0 -98.48 124.76 43.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.983 -1.073 . . . . 0.0 109.534 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -70.9 -40.23 72.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.23 -37.65 93.3 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.58 155.99 44.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.622 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 63.2 Cg_endo -74.3 -156.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.746 2.298 . . . . 0.0 111.701 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.406 ' HA ' HD22 ' A' ' 31' ' ' ASN . 78.8 m-70 -104.03 132.28 50.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 19' ' ' THR . 26.0 mttt -102.09 -147.96 0.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 54.7 t -49.82 -41.43 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.894 -1.129 . . . . 0.0 109.861 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.33 159.37 14.09 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.04 152.05 67.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.84 2.36 . . . . 0.0 111.922 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 67.4 m-20 -83.84 139.94 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 109.61 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.3 mp -96.69 139.78 32.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.664 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 52.2 p-80 -173.8 92.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.027 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.9 6.77 69.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.72 -23.3 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.989 . . . . 0.0 109.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -64.65 135.81 56.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.066 -1.021 . . . . 0.0 109.278 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.67 24.27 72.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -125.31 151.28 46.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -1.077 . . . . 0.0 109.386 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 40' ' ' SER . 1.9 t-160 -120.18 135.64 54.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.823 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER 80.52 -176.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' A' ' 48' ' ' TYR . . . -82.65 70.26 3.21 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.17 -36.68 75.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.236 . . . . 0.0 110.071 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -55.66 141.37 38.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.05 . . . . 0.0 109.394 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.0 164.09 20.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.589 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.96 -9.8 56.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 59.7 t80 -134.43 141.13 46.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -1.113 . . . . 0.0 109.082 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.6 p -71.62 159.32 34.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 17.6 m-85 -119.09 147.84 43.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.52 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.8 p -79.16 159.49 27.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.299 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.39 -30.78 67.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.694 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.22 -75.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.721 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.4 t-20 -55.39 -42.98 74.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.925 -1.109 . . . . 0.0 110.687 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.33 -49.35 84.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.714 -1.241 . . . . 0.0 109.271 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -60.59 -37.45 81.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 52' ' ' ASN . 16.4 tttt -125.4 113.24 17.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -103.5 143.91 32.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.41 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.831 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -132.43 149.47 32.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.611 -0.681 . . . . 0.0 109.841 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.1 tp -74.32 128.65 36.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 108.673 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -95.57 123.69 39.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 48.7 p30 -161.18 -174.43 4.34 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.51 -42.8 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.834 -1.166 . . . . 0.0 110.22 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -70.91 -53.88 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.148 -0.97 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 37.9 t30 -59.08 -38.58 79.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 110.525 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 7.8 mmt -58.87 -40.91 85.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.662 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.8 p -66.25 -34.82 78.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.28 -0.887 . . . . 0.0 109.587 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -35.7 80.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 109.496 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.04 -47.03 86.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' CD1' HD23 ' A' ' 94' ' ' LEU . 87.2 mt -68.54 -31.44 70.68 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -58.61 -37.89 76.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -162.75 67.02 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.901 -1.124 . . . . 0.0 110.074 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -51.49 -19.34 6.94 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.977 2.451 . . . . 0.0 112.42 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.35 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -56.67 -34.26 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.831 ' OH ' HG11 ' A' ' 57' ' ' VAL . 65.6 t80 -55.22 -51.04 67.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 75' ' ' ILE . 17.3 mt -147.66 80.14 9.14 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 108.729 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.79 149.52 12.58 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.924 2.416 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.14 0.46 55.98 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 80' ' ' MET . 9.9 t -100.57 171.25 7.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -84.65 9.37 13.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.484 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.522 ' H ' HG23 ' A' ' 78' ' ' THR . 3.1 mtm -73.83 119.68 18.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 0.0 110.011 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.13 26.97 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 59.3 t80 -76.5 133.05 39.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.572 -0.705 . . . . 0.0 109.504 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.9 175.57 50.37 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.71 147.01 18.43 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.404 HD11 HD21 ' A' ' 9' ' ' LEU . 54.1 mt -99.71 134.82 42.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.261 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -92.04 -4.43 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -100.93 127.59 47.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.016 . . . . 0.0 109.929 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.61 -38.23 48.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 110.132 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -60.41 -48.79 80.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.54 -40.23 95.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.682 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.93 -41.73 92.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.104 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.7 m-20 -61.02 -39.8 91.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.302 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 91.1 m-20 -62.05 -40.73 96.73 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.101 -0.999 . . . . 0.0 109.904 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 68' ' ' LEU . 55.3 tp -61.22 -43.88 98.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.57 -42.96 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.625 HG21 ' C ' ' A' ' 1' ' ' GLY . 26.7 m -62.38 -37.75 86.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.55 -46.97 83.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.092 . . . . 0.0 110.304 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.666 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.4 mt -65.29 -38.38 90.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.104 . . . . 0.0 109.616 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.59 -36.65 79.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -59.05 -42.96 91.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.323 -0.861 . . . . 0.0 109.436 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.415 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.56 ' CE2' ' ND2' ' A' ' 92' ' ' ASN . 52.2 t80 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.52 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.8 ptmt -104.18 161.6 13.89 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.23 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.12 24.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -138.73 164.25 25.75 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -110.92 131.14 55.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -1.102 . . . . 0.0 109.295 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 100' ' ' LYS . . . -74.48 -18.27 60.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.042 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -57.52 -48.46 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.061 -1.024 . . . . 0.0 109.969 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.02 -51.92 48.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.926 -1.109 . . . . 0.0 109.748 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -65.35 -30.67 78.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -1.199 . . . . 0.0 110.054 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.916 ' O ' HG23 ' A' ' 12' ' ' THR . 59.6 p -72.71 -37.33 67.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.133 -0.979 . . . . 0.0 109.534 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 94' ' ' LEU . 6.9 tp -58.92 -41.63 87.73 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -62.78 -46.74 86.63 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -63.6 -38.27 90.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.421 0.629 . . . . 0.0 110.079 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.47 -34.99 75.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 111.61 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -149.94 58.17 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.525 -1.36 . . . . 0.0 111.356 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.6 t -172.97 -48.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.153 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.89 -37.22 71.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 109.6 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.39 -34.63 69.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 0.0 109.547 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.1 m -96.5 -44.21 7.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.695 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.637 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -105.81 124.8 50.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.243 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.531 ' C ' HG23 ' A' ' 20' ' ' VAL . 53.1 p -84.3 -27.06 28.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.695 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' C ' ' A' ' 19' ' ' THR . 1.9 t 64.22 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' THR . 78.2 mm-40 -92.48 120.98 33.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.89 -1.131 . . . . 0.0 109.622 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 55.2 pttt -69.96 -39.99 75.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.4 -36.76 90.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.43 157.25 49.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.625 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 59.1 Cg_endo -73.02 -156.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.27 134.57 48.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 29' ' ' GLY . 36.2 tttt -130.46 127.01 38.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.466 -0.771 . . . . 0.0 109.079 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 29' ' ' GLY . 49.4 t 53.42 -84.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.299 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -100.44 161.76 18.91 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.0 152.69 73.71 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.979 2.453 . . . . 0.0 112.203 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.625 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 59.6 m-20 -81.71 140.52 34.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.2 mp -98.05 139.41 33.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -172.0 95.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.204 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.68 7.02 75.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.54 -23.77 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.294 -1.121 . . . . 0.0 109.565 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -70.41 132.11 45.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 75.13 20.33 79.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 31.0 mtp180 -140.85 167.0 23.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -1.186 . . . . 0.0 110.015 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -93.72 156.73 16.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 24.9 p -66.15 167.1 10.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.684 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.5 -8.14 61.97 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 38' ' ' ARG . 19.7 tt0 -61.58 -38.3 87.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.676 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.94 75.08 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.42 -31.76 73.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.47 -35.81 62.31 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 47' ' ' SER . 54.9 t80 -112.29 131.99 55.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.394 -1.063 . . . . 0.0 109.302 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -67.65 156.77 36.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.865 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.676 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 55.4 m-85 -111.21 145.39 38.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.521 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -75.74 161.65 28.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.67 -34.66 67.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -0.905 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . -48.08 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.329 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 22.2 t-20 -52.62 -41.62 63.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.042 . . . . 0.0 110.305 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.9 mt -59.02 -55.59 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.18 -36.69 84.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ASN . 43.7 tttm -102.33 33.34 3.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 52' ' ' ASN . 24.0 t-20 -46.69 131.55 11.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.848 -1.157 . . . . 0.0 108.694 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.927 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.6 p -133.79 150.53 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.251 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.47 130.61 38.21 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.469 ' HE1' ' HB3' ' A' ' 40' ' ' SER . 97.5 m95 -97.24 123.23 40.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 56.2 p30 -149.59 176.28 10.78 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.82 -40.46 88.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.061 -1.024 . . . . 0.0 111.004 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -72.29 -57.2 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.953 -1.092 . . . . 0.0 110.646 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.587 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 13.7 t-20 -60.46 -39.66 88.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.411 -0.805 . . . . 0.0 110.799 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.413 ' SD ' ' CE3' ' A' ' 59' ' ' TRP . 42.8 tpp -59.15 -39.49 82.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.008 . . . . 0.0 109.745 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.515 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.1 m -60.76 -40.68 93.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.72 -33.54 74.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 77.9 t60 -61.26 -48.0 83.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD2' HD23 ' A' ' 94' ' ' LEU . 6.8 mp -57.81 -31.09 66.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.539 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 23.5 m -84.99 125.03 32.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.979 -1.076 . . . . 0.0 109.225 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' THR . 12.5 m120 41.75 59.6 9.29 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.69 -21.32 58.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.72 -59.1 5.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 109.981 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -62.25 -32.52 73.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.515 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.927 ' OH ' HG11 ' A' ' 57' ' ' VAL . 66.8 t80 -57.75 -48.73 78.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 75' ' ' ILE . 2.7 tp -163.23 79.9 1.64 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.983 -1.073 . . . . 0.0 109.265 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.89 -21.25 7.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.823 2.349 . . . . 0.0 112.769 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -56.55 -27.23 54.1 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 p -77.49 163.06 26.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -1.203 . . . . 0.0 110.068 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -78.47 5.36 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.0 ttt -79.7 141.92 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.507 -0.746 . . . . 0.0 111.145 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.79 85.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 81.7 t80 -103.36 134.89 45.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.81 . . . . 0.0 110.094 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -72.63 142.02 31.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.69 152.47 49.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HD21 ' A' ' 9' ' ' LEU . 56.8 mt -97.23 125.2 41.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.25 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.31 -39.75 94.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.35 128.42 35.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.984 -1.072 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.15 -34.72 61.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -58.22 -45.35 87.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.152 -0.968 . . . . 0.0 109.938 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.91 -38.66 89.23 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.128 -0.982 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.7 ttp180 -59.06 -41.39 87.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.497 -0.752 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' -3' ' ' PHE . 1.3 t-20 -59.12 -41.86 89.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 110.17 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 89.1 m-20 -62.4 -39.8 94.42 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.043 -1.036 . . . . 0.0 109.964 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.662 HD22 HD23 ' A' ' 9' ' ' LEU . 51.9 tp -59.0 -43.61 91.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.873 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.515 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 85.0 mt -64.65 -37.17 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 m -59.52 -40.65 87.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.459 -0.775 . . . . 0.0 109.94 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.052 . . . . 0.0 110.644 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.626 HD21 ' CE1' ' A' ' 10' ' ' PHE . 89.3 mt -67.05 -38.45 85.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 9.7 mtpm? -58.3 -40.54 82.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.061 . . . . 0.0 109.732 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 3' ' ' ALA . 99.2 mttt -61.64 -45.43 94.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 109.667 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 109.534 -179.742 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.9 ttpt -63.31 128.15 34.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.26 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -92.41 152.38 21.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 53.5 p -69.29 155.51 40.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.38 -10.08 21.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.785 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -59.22 -49.48 77.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.01 -46.8 79.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.387 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.38 -30.87 79.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.17 89.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.891 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -72.44 -38.74 68.23 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 94' ' ' LEU . 9.0 tp -59.2 -40.9 87.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.8 t80 -62.86 -46.7 86.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -63.14 -38.89 92.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.669 -0.645 . . . . 0.0 109.955 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.97 -33.12 71.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 111.453 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.77 57.62 1.04 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.571 -1.331 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.2 t -172.56 -53.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.854 -1.153 . . . . 0.0 110.28 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.09 -37.63 72.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.014 -1.054 . . . . 0.0 109.811 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.33 -35.28 71.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.862 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -96.96 -43.42 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.618 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 90.6 m-70 -106.0 125.34 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 20' ' ' VAL . 52.4 p -89.52 -20.66 23.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 32' ' ' LEU . 8.0 t 40.97 69.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.696 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.17 155.17 27.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -61.7 -35.72 78.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.576 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.29 20.96 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.3 166.49 50.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 55.3 Cg_endo -70.62 -177.82 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.96 2.44 . . . . 0.0 112.12 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -106.34 136.7 45.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.393 -0.817 . . . . 0.0 109.263 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -105.78 -127.97 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.333 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.27 -39.71 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.081 -1.012 . . . . 0.0 109.565 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.83 165.21 16.73 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 27.5 Cg_endo -63.69 150.46 88.4 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.843 2.362 . . . . 0.0 112.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 37.5 m-20 -80.64 138.63 36.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.268 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.9 mp -97.89 137.48 36.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.134 -0.979 . . . . 0.0 109.888 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -166.35 100.24 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 108.991 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.06 7.89 79.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 tt -59.5 -22.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.555 -0.968 . . . . 0.0 109.716 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.659 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 78.7 m-85 -66.15 133.58 50.98 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.03 19.51 78.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.533 ' HG3' HE22 ' A' ' 42' ' ' GLN . 32.8 mmt180 -135.66 163.29 30.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.325 -1.103 . . . . 0.0 109.826 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -90.17 161.53 15.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.417 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 24.8 t -63.17 148.71 47.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.84 . . . . 0.0 109.787 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.6 -10.07 62.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.533 HE22 ' HG3' ' A' ' 38' ' ' ARG . 10.0 tt0 -61.39 -38.35 86.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.006 -1.291 . . . . 0.0 109.722 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -61.55 -30.51 70.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.977 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 49.96 177.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 46' ' ' TYR . . . 80.61 -165.3 47.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 45' ' ' GLY . 33.3 t80 37.07 -127.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.611 -0.935 . . . . 0.0 109.749 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 30.1 t -158.44 146.14 18.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.57 138.75 50.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.48 -0.762 . . . . 0.0 109.343 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 78' ' ' THR . 41.9 p -79.85 162.54 24.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.895 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.21 -32.73 68.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.528 -0.733 . . . . 0.0 110.071 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' A' ' 78' ' ' THR . . . -51.59 -75.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.045 -1.034 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.2 t-20 -54.0 -41.65 68.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.933 -1.105 . . . . 0.0 110.319 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.05 -51.04 77.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.78 -1.2 . . . . 0.0 109.53 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -61.0 -38.57 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.951 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 52' ' ' ASN . 85.7 tttt -117.96 110.43 17.7 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -98.44 138.77 35.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 109.084 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.743 HG11 ' OH ' ' A' ' 74' ' ' TYR . 10.6 p -130.39 147.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.565 -0.71 . . . . 0.0 109.948 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -78.77 131.92 36.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 88.6 m95 -95.5 124.71 39.66 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.217 -0.927 . . . . 0.0 110.101 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.5 t0 -152.66 166.52 31.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.562 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.17 -39.7 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.69 -1.256 . . . . 0.0 109.217 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.51 -47.97 62.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -61.31 -40.71 95.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 110.712 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.5 mtt -60.21 -36.79 78.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 0.0 109.686 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -59.5 -42.97 93.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 109.156 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.18 -34.5 76.41 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.27 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.563 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 81.9 t60 -58.03 -45.46 86.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.541 ' CD1' HD23 ' A' ' 94' ' ' LEU . 79.9 mt -68.1 -29.88 68.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.419 -0.801 . . . . 0.0 110.212 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 29.1 m -57.68 -38.12 74.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.042 -1.036 . . . . 0.0 110.528 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 69' ' ' THR . 15.9 m120 -163.45 67.73 1.67 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 109.795 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -51.92 -27.74 29.04 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.975 2.45 . . . . 0.0 112.705 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.38 1.84 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 109.527 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -61.42 -29.88 70.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.246 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.743 ' OH ' HG11 ' A' ' 57' ' ' VAL . 40.4 t80 -58.46 -49.36 77.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.858 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 74' ' ' TYR . 7.9 pt -139.9 75.48 30.13 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.012 -1.055 . . . . 0.0 110.046 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.24 138.55 51.76 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.919 2.413 . . . . 0.0 112.576 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.41 -6.81 63.49 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.89 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 51' ' ' ALA . 71.5 p -88.64 164.06 15.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.365 . . . . 0.0 110.415 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -85.12 2.02 45.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.9 ttt -81.77 127.74 33.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.951 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.93 87.08 2.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 69.7 t80 -103.34 131.55 50.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.335 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -67.87 142.78 40.58 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.63 145.34 31.39 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 9' ' ' LEU . 55.0 mt -98.81 134.21 42.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.468 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -93.76 -5.81 47.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -110.32 119.27 38.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.92 -33.57 73.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 110.446 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.88 -56.27 24.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.04 . . . . 0.0 110.018 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -62.36 -38.9 91.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.57 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -58.65 -42.19 87.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.85 . . . . 0.0 109.865 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.95 -39.14 88.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.168 -0.957 . . . . 0.0 110.385 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 83.8 m-20 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.541 HD23 ' CD1' ' A' ' 68' ' ' LEU . 56.1 tp -59.76 -45.17 93.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.8 mt -66.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 0.0 108.85 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.1 m -59.11 -39.01 80.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.48 -52.2 66.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.546 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.0 mt -66.53 -32.94 74.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.067 -1.021 . . . . 0.0 108.401 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.562 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 19.1 tttp -56.65 -42.25 78.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.38 -39.08 85.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.755 . . . . 0.0 109.328 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.554 -179.775 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 68.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.358 0.599 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 1' ' ' GLY . 44.3 mtpt -87.65 172.35 9.78 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -40.57 -22.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.271 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 78.08 81.29 0.66 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.51 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.4 p -72.14 166.76 21.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.738 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.04 21.23 5.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.836 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -92.53 -70.98 0.67 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -63.86 -45.22 90.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 110.247 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.669 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -60.3 -39.39 96.01 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.997 -1.097 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.31 71.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -1.192 . . . . 0.0 109.948 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 12' ' ' THR . 53.5 p -74.46 -35.37 63.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 85' ' ' LEU . 7.3 tp -57.28 -40.86 78.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 64.4 t80 -62.88 -46.84 85.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -63.95 -39.18 93.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.742 -0.599 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' THR . 57.4 p -68.8 -35.01 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 111.495 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -151.77 60.53 0.87 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.628 -1.295 . . . . 0.0 110.876 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -172.84 -47.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 0.0 109.625 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.48 -37.15 77.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -58.54 -37.74 76.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.12 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.3 m -93.5 -40.85 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 32' ' ' LEU . 88.4 m-70 -106.91 132.89 52.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.099 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 21' ' ' GLU . 30.0 p -103.41 -4.33 24.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' H ' ' A' ' 32' ' ' LEU . 2.8 t 45.99 16.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.999 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.61 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 85.0 tt0 -104.27 137.3 42.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.952 . . . . 0.0 109.465 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -76.83 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 109.891 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -51.37 -17.01 2.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' GLY . . . -41.18 164.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.16 -12.31 29.44 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.274 2.649 . . . . 0.0 112.084 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.3 m80 60.97 97.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.237 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' HG21 ' A' ' 19' ' ' THR . 51.5 mttm -74.6 -167.8 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 110.017 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG1' ' NZ ' ' A' ' 79' ' ' LYS . 55.9 t -50.49 -45.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 109.989 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.53 149.2 22.45 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.86 148.54 91.8 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.392 2.062 . . . . 0.0 111.741 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 21' ' ' GLU . 36.2 m-20 -84.35 138.73 32.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.065 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.6 mp -93.76 140.45 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.633 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 49.5 p-80 -174.07 90.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.102 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.58 4.79 65.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.19 -22.58 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -1.131 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.1 m-85 -65.62 133.99 52.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.159 -0.963 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.81 72.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.588 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 68.0 mtt85 -145.75 168.75 19.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.0 110.247 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.8 m80 -97.89 157.5 16.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.829 . . . . 0.0 110.119 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 2.6 m -61.33 163.91 6.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.662 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -6.08 59.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.14 -38.94 90.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 0.0 110.101 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.93 77.2 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.57 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.34 -33.05 74.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.502 -0.749 . . . . 0.0 109.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.14 -35.08 68.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 47' ' ' SER . 65.7 t80 -113.36 135.1 54.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.407 -1.055 . . . . 0.0 109.385 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 57.4 p -72.61 162.35 29.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.636 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 60.8 m-85 -114.41 148.17 38.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 109.599 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.2 p -75.26 160.65 30.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.6 -35.43 68.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.788 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -46.56 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.4 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t-20 -52.21 -41.94 63.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.038 -1.039 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.6 mt -57.59 -53.44 44.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.843 -1.161 . . . . 0.0 109.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.88 -38.79 92.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.7 mttm -101.64 28.65 5.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 109.886 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 52' ' ' ASN . 60.5 t30 -43.88 127.55 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 108.946 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.898 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.4 p -135.18 153.2 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -70.46 136.0 49.12 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.547 ' NE1' ' OG ' ' A' ' 40' ' ' SER . 78.8 m95 -97.75 126.59 43.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 110.34 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.9 t0 -150.9 163.82 37.77 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.543 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.5 mt-10 -54.82 -39.77 68.87 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.51 -47.66 66.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.079 -1.013 . . . . 0.0 110.251 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.24 -39.78 91.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.652 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.1 mtt -59.89 -37.96 80.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 109.807 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.5 m -58.98 -41.45 87.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.034 -1.041 . . . . 0.0 109.075 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.84 -32.77 72.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.921 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.446 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 77.1 t60 -56.87 -48.88 77.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 110.279 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.681 ' CD2' HD23 ' A' ' 94' ' ' LEU . 9.4 mp -73.61 -20.79 60.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -57.76 -36.41 72.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.687 -1.258 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.92 68.23 3.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.206 -0.934 . . . . 0.0 109.945 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.3 -18.7 64.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.577 2.185 . . . . 0.0 113.031 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.18 69.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.421 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -94.38 -5.36 46.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.898 ' OH ' HG11 ' A' ' 57' ' ' VAL . 28.0 t80 -63.84 -46.1 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.643 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.921 HD12 HG21 ' A' ' 78' ' ' THR . 1.8 pt -136.96 72.88 53.72 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.188 -0.945 . . . . 0.0 109.923 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 18.2 Cg_exo -62.53 136.84 61.05 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.655 2.237 . . . . 0.0 111.486 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.48 15.87 48.6 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.687 -1.245 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.921 HG21 HD12 ' A' ' 75' ' ' ILE . 6.6 t -117.52 165.84 13.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.146 -1.208 . . . . 0.0 109.567 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.636 ' NZ ' ' CG1' ' A' ' 28' ' ' VAL . 6.4 mtmp? -86.07 6.48 28.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.284 -0.885 . . . . 0.0 111.255 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.734 ' H ' HG23 ' A' ' 78' ' ' THR . 3.4 ttt -74.95 116.67 15.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.72 31.57 6.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 86.5 t80 -84.99 131.96 34.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -82.73 176.94 53.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.36 166.55 24.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.602 -1.285 . . . . 0.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 HD21 ' A' ' 9' ' ' LEU . 63.4 mt -106.66 124.55 49.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -1.076 . . . . 0.0 109.423 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.7 -38.13 89.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -85.28 128.17 34.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.55 -33.07 54.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 110.125 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -57.01 -50.1 73.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.004 . . . . 0.0 110.071 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.82 -39.01 92.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.174 -0.954 . . . . 0.0 108.779 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -59.79 -40.68 89.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.756 -0.59 . . . . 0.0 109.947 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.85 -43.55 85.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 58.9 t0 -62.48 -39.25 92.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 68' ' ' LEU . 57.8 tp -59.04 -45.48 90.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.54 -38.83 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.047 . . . . 0.0 108.824 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.1 m -59.0 -39.76 82.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.562 -0.711 . . . . 0.0 109.732 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.28 -48.65 80.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 0.0 108.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 10' ' ' PHE . 84.5 mt -69.12 -31.81 70.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.543 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 20.8 tttm -56.01 -43.49 77.76 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -61.55 -43.64 98.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.783 . . . . 0.0 109.387 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.738 -179.767 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 93.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -82.87 141.95 31.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.408 -0.808 . . . . 0.0 109.172 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -44.79 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 70.14 126.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' A' ' 93' ' ' ASP . 84.2 p -63.27 -19.41 64.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.177 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 60.11 -143.55 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.401 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 56.06 -79.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.702 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 3' ' ' ALA . 65.4 mttp -58.31 -43.52 88.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -58.98 -33.95 76.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.86 88.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.566 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 12' ' ' THR . 58.8 p -72.54 -36.21 68.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.131 -0.981 . . . . 0.0 109.038 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 85' ' ' LEU . 8.1 tp -58.14 -40.89 82.47 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 71.2 t80 -63.46 -46.93 83.99 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -62.92 -38.18 89.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.64 -0.663 . . . . 0.0 110.133 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 8' ' ' THR . 51.7 p -70.81 -31.16 67.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 111.481 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -148.13 54.88 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.562 -1.336 . . . . 0.0 111.357 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.6 t -173.37 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 110.829 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.52 -37.07 69.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -56.3 -32.88 65.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.3 m -101.5 -44.76 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 0.0 110.838 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -103.64 121.93 43.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.073 -1.017 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.535 ' C ' HG23 ' A' ' 20' ' ' VAL . 47.8 p -81.9 -24.64 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 65.55 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -98.86 120.49 39.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.075 -1.016 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 14.5 pttp -69.85 -40.05 76.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.613 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.92 -36.55 90.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.15 155.43 49.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.54 -156.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.61 137.25 47.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.276 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -110.71 -124.78 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.795 . . . . 0.0 109.114 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.63 -40.73 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.38 163.08 22.0 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -61.17 145.6 98.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.883 2.389 . . . . 0.0 112.353 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 42.1 m-20 -68.0 145.97 53.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 109.029 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.834 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.3 tp -101.85 119.18 38.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.168 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 35' ' ' ILE . 85.2 t60 -154.1 134.33 13.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.041 -1.037 . . . . 0.0 109.875 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.43 15.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 33' ' ' HIS . 3.7 tp -58.22 -22.49 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.427 -1.043 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.664 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 92.2 m-85 -63.64 136.77 57.74 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.172 -0.955 . . . . 0.0 109.283 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.09 32.34 72.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 58' ' ' LEU . 60.6 mmt-85 -127.29 152.06 47.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -1.14 . . . . 0.0 110.153 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.913 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.5 m80 -109.49 142.15 40.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.742 . . . . 0.0 109.933 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 39' ' ' HIS . 7.4 p 49.44 174.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.634 0.731 . . . . 0.0 110.599 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.7 72.31 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' SER . 44.0 tt0 -60.17 -35.07 74.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -1.18 . . . . 0.0 110.003 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.51 -34.78 69.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.899 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 46.54 -176.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.24 -13.05 68.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 47' ' ' SER . 85.7 t80 -136.63 146.41 45.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 108.962 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 44.1 m -62.23 147.45 47.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.744 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -119.75 142.37 48.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 109.339 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 51' ' ' ALA . 56.9 m -72.84 143.82 47.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.95 . . . . 0.0 109.072 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -49.29 -33.73 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 109.311 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 49' ' ' THR . . . -47.99 -71.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 110.228 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.6 t-20 -57.51 -40.38 78.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.79 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.645 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 67.4 mt -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.867 -1.145 . . . . 0.0 109.936 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.16 -52.7 57.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.971 -1.081 . . . . 0.0 109.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 56' ' ' ASN . 32.8 tttp -67.68 -47.62 68.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.943 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 53' ' ' ILE . 37.0 m-20 38.42 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.645 . . . . 0.0 109.876 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 74' ' ' TYR . 7.1 p -123.18 149.82 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 110.172 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.913 HD13 ' CE1' ' A' ' 39' ' ' HIS . 49.9 tp -66.09 134.13 52.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' GLY . 92.8 m95 -98.03 130.89 44.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -156.13 164.84 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.533 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.7 mt-10 -53.89 -40.17 66.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 109.273 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -67.76 -47.98 67.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.908 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 64.7 t30 -63.75 -40.35 96.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.664 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.9 mtt -59.92 -37.9 80.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 109.688 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -60.32 -41.58 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.081 -1.012 . . . . 0.0 108.974 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.88 -34.38 77.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.189 -0.944 . . . . 0.0 109.074 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.472 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 61.8 t60 -59.57 -47.28 86.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 94' ' ' LEU . 71.7 mt -71.59 -34.04 69.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 30.9 m -58.66 -38.35 77.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 110.828 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -161.65 67.76 2.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.96 -1.087 . . . . 0.0 109.803 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.31 -24.71 8.83 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.144 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -63.72 -59.84 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.506 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.91 -34.12 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.028 -1.045 . . . . 0.0 109.429 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 21.6 t80 -54.97 -44.74 74.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.508 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.8 OUTLIER -139.78 154.67 71.13 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 108.885 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.24 6.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.573 2.182 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 75' ' ' ILE . . . 88.2 50.44 3.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.883 HG23 ' H ' ' A' ' 80' ' ' MET . 14.6 t -55.64 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.612 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -59.57 -24.81 64.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.099 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.883 ' H ' HG23 ' A' ' 78' ' ' THR . 63.5 mtm -68.88 120.22 14.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.23 26.12 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 65.0 t80 -55.87 136.23 51.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.706 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.03 -179.68 51.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.5 146.69 17.72 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 9' ' ' LEU . 55.9 mt -97.22 135.96 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 109.056 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -91.1 -6.55 53.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.097 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -103.53 127.22 50.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.32 -38.54 55.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -60.52 -47.93 84.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.99 -39.91 95.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.55 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 61.7 ttp180 -59.58 -43.62 93.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -61.52 -37.13 82.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -0.969 . . . . 0.0 109.59 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' A' ' 2' ' ' SER . 90.4 m-20 -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 68' ' ' LEU . 51.8 tp -61.57 -46.25 90.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 110.359 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.1 -41.0 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.048 . . . . 0.0 109.029 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 33.5 m -59.6 -39.68 85.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.825 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.74 -49.19 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.923 -1.11 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 32' ' ' LEU . 94.0 mt -68.18 -32.14 72.17 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 29.1 tttm -57.71 -42.84 84.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.582 -0.699 . . . . 0.0 109.284 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -61.63 -43.71 98.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.398 -0.813 . . . . 0.0 109.769 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 -179.504 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 89.7 t80 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.1 ttpt -84.08 139.95 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.15 -24.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 52.21 169.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -124.53 125.85 44.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -1.063 . . . . 0.0 109.069 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -70.24 -22.82 62.86 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.38 -53.86 53.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 110.208 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -67.3 -50.57 59.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.876 -1.14 . . . . 0.0 109.621 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.525 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.63 -31.04 78.57 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.146 . . . . 0.0 109.857 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.887 ' O ' HG23 ' A' ' 12' ' ' THR . 66.4 p -73.62 -39.77 64.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.142 -0.974 . . . . 0.0 109.42 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 HD13 ' A' ' 94' ' ' LEU . 8.8 tp -59.97 -41.23 91.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.664 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.6 t80 -62.07 -46.12 90.53 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -63.47 -37.63 88.02 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 109.967 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 8' ' ' THR . 56.9 p -70.43 -33.9 71.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 111.74 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -149.58 56.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.519 -1.363 . . . . 0.0 111.491 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -173.06 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.74 -1.225 . . . . 0.0 110.192 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.79 -37.36 73.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.976 . . . . 0.0 109.942 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.72 -35.07 70.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.95 . . . . 0.0 109.826 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -96.73 -43.11 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.658 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -107.21 123.79 48.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' GLU . 44.2 p -86.07 -23.9 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' LEU . 2.4 t 59.28 -1.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.298 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.3 tt0 -97.36 124.06 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 109.53 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 24.6 pttm -68.41 -41.4 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.885 . . . . 0.0 109.191 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -63.12 -34.84 91.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.2 157.56 51.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.74 -161.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' CD2' ' CG ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -103.64 125.24 50.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.398 -0.814 . . . . 0.0 109.106 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -101.53 -159.59 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.5 t -51.3 -41.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.13 149.98 17.13 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.31 147.36 94.09 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.495 2.13 . . . . 0.0 112.6 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -61.74 138.71 58.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.308 -0.87 . . . . 0.0 109.111 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.793 ' CD2' HD13 ' A' ' 98' ' ' LEU . 14.6 tp -106.54 118.67 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.229 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -158.92 127.16 5.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.785 -1.197 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 55.8 12.17 4.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.66 HG21 HD11 ' A' ' 32' ' ' LEU . 2.8 tp -60.07 -21.63 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.362 -1.081 . . . . 0.0 109.835 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 90.5 m-85 -62.88 139.16 58.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.055 -1.028 . . . . 0.0 109.38 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.95 22.73 77.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -136.29 160.09 39.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -1.095 . . . . 0.0 109.804 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' CE1' HD13 ' A' ' 58' ' ' LEU . 78.0 m80 -94.34 158.39 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.385 -0.822 . . . . 0.0 109.443 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.438 ' OG ' ' OD1' ' A' ' 52' ' ' ASN . 77.1 p -62.08 159.41 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.76 5.36 88.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -60.85 -35.21 75.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.46 -1.024 . . . . 0.0 110.226 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.53 -35.05 69.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.112 -0.992 . . . . 0.0 109.719 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.0 mt-10 42.2 18.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.583 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -118.65 -36.63 0.89 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.465 ' CG ' ' CD2' ' A' ' 26' ' ' HIS . 78.9 t80 -110.65 136.41 49.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.544 -0.974 . . . . 0.0 109.14 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 38.5 m -59.61 153.1 20.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.959 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -117.5 158.84 23.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.1 p -74.74 158.51 33.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.247 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.79 -30.86 67.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.67 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.532 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.5 t-20 -52.35 -44.03 64.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 53' ' ' ILE . 42.0 mm -59.71 -40.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.619 -1.301 . . . . 0.0 109.284 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.34 -37.75 84.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASN . 43.6 tttp -125.72 114.51 18.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -95.16 134.88 37.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.094 -1.004 . . . . 0.0 109.289 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.849 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.2 p -131.39 146.83 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -81.59 133.95 35.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 108.968 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -97.95 127.57 43.98 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.195 -0.941 . . . . 0.0 110.207 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.3 t0 -151.92 167.81 27.15 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -57.47 -36.06 70.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.893 -1.13 . . . . 0.0 109.653 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -76.23 -57.5 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.895 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -63.48 -41.18 98.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.642 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 59.0 ttm -59.27 -36.31 75.31 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.542 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.4 p -62.75 -35.88 81.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.554 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.28 -35.94 82.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.45 -43.39 96.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 0.0 110.045 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.609 ' CD2' HD23 ' A' ' 94' ' ' LEU . 7.0 mp -62.36 -31.7 72.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.873 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 18.0 m -88.16 129.84 35.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 109.541 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 69' ' ' THR . 74.0 m-20 38.64 54.98 4.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.748 . . . . 0.0 110.496 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 9.5 Cg_endo -54.97 -14.68 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.568 2.179 . . . . 0.0 111.102 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 74' ' ' TYR . . . -63.2 154.17 32.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.2 tttt 67.23 -36.52 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.858 -0.526 . . . . 0.0 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.849 ' OH ' HG11 ' A' ' 57' ' ' VAL . 86.5 t80 -60.25 -50.01 75.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.073 -1.017 . . . . 0.0 109.579 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 75' ' ' ILE . 3.8 mm -140.87 77.2 21.71 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.136 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.57 151.4 11.69 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 123.095 2.53 . . . . 0.0 112.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 21.09 27.82 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 80' ' ' MET . 12.1 t -123.51 164.7 18.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.303 -1.116 . . . . 0.0 109.797 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -81.77 4.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 109.69 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.506 ' H ' HG23 ' A' ' 78' ' ' THR . 11.9 ttp -79.8 131.74 35.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.907 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.08 70.18 1.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 76.6 t80 -102.89 134.44 46.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -81.83 174.36 53.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.91 161.89 27.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 mt -102.83 128.07 49.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -1.116 . . . . 0.0 109.194 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -65.18 -44.21 89.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.951 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -90.09 129.52 36.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.483 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -73.37 -32.37 64.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 109.76 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -56.18 -48.32 76.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 0.0 109.464 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.24 -37.6 77.94 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 0.0 109.262 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.55 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 34.0 ttm180 -57.81 -41.78 82.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -59.49 -40.49 87.17 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 80.1 m-20 -64.27 -40.05 95.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.169 -0.957 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.609 HD23 ' CD2' ' A' ' 68' ' ' LEU . 46.6 tp -62.62 -44.74 95.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.02 -36.91 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.11 -0.994 . . . . 0.0 108.563 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.6 m -57.31 -40.84 78.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.552 -0.717 . . . . 0.0 109.646 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -60.06 -51.78 68.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 109.382 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' CD2' ' A' ' 32' ' ' LEU . 91.9 mt -65.31 -35.41 80.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 12.7 tttp -57.28 -40.38 77.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -59.44 -40.3 86.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.474 -0.766 . . . . 0.0 109.466 -179.814 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 48.0 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 1' ' ' GLY . 32.7 ttpt -94.82 130.85 41.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.944 . . . . 0.0 109.267 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -48.64 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.212 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -105.53 135.19 12.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.8 p -69.58 153.54 43.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -1.226 . . . . 0.0 109.203 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -93.36 -10.23 36.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.797 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -59.48 -47.76 84.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.109 -0.995 . . . . 0.0 109.923 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -67.2 -50.73 59.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.48 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.59 -32.82 85.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -57.92 -45.26 86.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.132 -1.217 . . . . 0.0 109.639 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 12' ' ' THR . 51.8 p -71.95 -37.61 69.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 94' ' ' LEU . 9.9 tp -59.45 -41.35 89.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.7 t80 -63.74 -45.81 88.2 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -62.61 -39.85 95.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.661 -0.65 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 8' ' ' THR . 56.6 p -71.58 -37.06 71.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 111.665 -178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -140.49 54.38 1.61 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.775 -1.203 . . . . 0.0 110.899 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -170.95 -53.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.696 -1.252 . . . . 0.0 110.616 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.94 -37.9 72.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.034 -1.041 . . . . 0.0 109.687 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.25 -35.74 72.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.829 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.2 m -95.73 -43.18 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.57 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.473 ' ND1' HD13 ' A' ' 32' ' ' LEU . 88.4 m-70 -105.32 129.88 53.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.345 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' GLU . 63.0 p -95.45 -8.13 36.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.01 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' LEU . 2.7 m 32.3 36.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.209 0.528 . . . . 0.0 110.72 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -104.15 133.7 48.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -82.48 139.4 33.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.14 76.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.34 165.19 12.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.14 172.11 16.64 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.115 2.543 . . . . 0.0 111.99 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -105.15 135.62 46.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.351 -0.843 . . . . 0.0 109.153 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 18.0 tptt -104.65 -126.48 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 109.005 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.13 -39.66 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.129 -0.982 . . . . 0.0 109.064 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.44 160.65 20.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 20.9 Cg_endo -62.34 149.43 90.78 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.035 2.49 . . . . 0.0 112.498 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.54 ' C ' HD12 ' A' ' 32' ' ' LEU . 36.6 m-20 -77.72 126.21 30.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 32' ' ' LEU . 8.2 mp -100.0 132.02 45.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.18 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -160.97 102.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.28 77.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.681 -1.767 . . . . 0.0 108.681 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 tt -57.7 -21.72 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.49 -1.006 . . . . 0.0 109.391 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CD2' ' OE2' ' A' ' 61' ' ' GLU . 96.0 m-85 -62.86 135.52 57.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 108.932 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.94 20.67 80.02 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -133.67 162.4 32.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -1.086 . . . . 0.0 110.035 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -94.72 168.6 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 20.8 t -83.96 146.38 28.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.63 -6.84 70.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.75 -37.62 87.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.138 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -60.21 -43.52 95.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.097 -1.002 . . . . 0.0 109.427 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 58.11 -21.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -59.91 -33.93 80.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CD2' ' O ' ' A' ' 47' ' ' SER . 76.6 t80 -115.13 140.29 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -1.011 . . . . 0.0 109.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.7 t -65.66 151.99 45.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' O ' HD11 ' A' ' 53' ' ' ILE . 37.0 m-85 -111.73 147.75 34.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.564 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 p -75.86 164.35 26.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.22 -31.22 61.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.392 -0.818 . . . . 0.0 109.258 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' C ' ' A' ' 77' ' ' GLY . . . -48.84 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 110.638 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.606 ' HA ' HD12 ' A' ' 75' ' ' ILE . 23.5 t-20 -57.42 -41.56 80.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.952 -1.093 . . . . 0.0 110.641 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 48' ' ' TYR . 84.4 mt -60.25 -44.66 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.845 -1.16 . . . . 0.0 109.83 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -59.35 -37.54 78.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.94 . . . . 0.0 109.271 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 76.6 tttt -132.14 121.33 23.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.444 -0.785 . . . . 0.0 109.215 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.81 136.52 40.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.724 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.5 p -130.93 147.73 33.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.523 -0.736 . . . . 0.0 110.055 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.7 tp -77.73 133.78 38.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 108.95 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' GLY . 93.2 m95 -93.86 127.75 39.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.375 -0.828 . . . . 0.0 109.856 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.6 t0 -148.96 167.97 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' CD2' ' A' ' 36' ' ' PHE . 79.0 mm-40 -58.03 -39.36 78.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.988 -1.07 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -78.69 -48.67 14.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 14.7 t-20 -59.89 -39.23 84.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.573 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 42.4 tpp -60.3 -38.92 85.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.551 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -61.47 -33.79 74.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.801 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.51 -36.03 81.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.885 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.408 ' NE2' ' CE ' ' A' ' 80' ' ' MET . 81.3 t60 -59.31 -43.79 92.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 5.3 mp -67.77 -27.15 66.51 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.999 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.546 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 25.5 m -81.16 128.48 33.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.973 . . . . 0.0 110.379 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 69' ' ' THR . 11.7 t-20 32.54 59.81 1.42 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.849 -0.532 . . . . 0.0 111.312 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.2 Cg_endo -61.8 135.65 57.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 111.699 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 71' ' ' PRO . . . 162.04 -86.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.391 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.51 -28.96 61.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.724 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.8 t80 -54.83 -51.98 64.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 109.53 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 75' ' ' ILE . 9.5 mm -152.08 73.18 7.79 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.136 -0.977 . . . . 0.0 108.787 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.96 150.59 18.2 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.894 2.396 . . . . 0.0 112.34 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 107.01 15.29 16.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -124.17 156.99 35.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -1.083 . . . . 0.0 109.414 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -84.6 5.38 28.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 0.0 110.948 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.474 ' O ' ' C ' ' A' ' 81' ' ' ALA . 4.5 ttt -55.45 -40.14 71.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.793 -1.192 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 80' ' ' MET . . . 33.69 75.08 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.722 -0.611 . . . . 0.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -106.22 131.44 53.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.28 140.14 30.44 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.98 150.84 41.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.6 mt -96.19 133.67 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -1.146 . . . . 0.0 109.164 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -87.5 -12.72 45.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -101.6 126.18 48.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.83 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.12 -36.68 61.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.932 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.0 -45.06 93.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.07 -39.35 94.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.135 -0.978 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.546 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 39.1 ttm180 -59.12 -41.78 88.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.779 . . . . 0.0 109.966 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.9 -40.82 94.56 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.08 -1.013 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 84.5 m-20 -64.35 -41.27 96.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.966 -1.084 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD22 HD23 ' A' ' 9' ' ' LEU . 50.8 tp -59.25 -43.1 92.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.082 -1.012 . . . . 0.0 109.376 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG2' ' OE1' ' A' ' 61' ' ' GLU . 81.0 mt -66.19 -36.15 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.186 -0.946 . . . . 0.0 108.78 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 m -57.31 -41.35 79.71 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.604 -0.685 . . . . 0.0 109.843 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -63.18 -52.94 60.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 110.306 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 10' ' ' PHE . 94.3 mt -70.02 -39.85 75.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 108.965 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.88 -40.24 83.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.716 . . . . 0.0 109.347 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -60.39 -40.15 89.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.534 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 109.667 -179.69 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' -3' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 70.1 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.389 0.614 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.595 ' O ' ' CE2' ' A' ' -3' ' ' PHE . 48.5 mtmt -86.42 170.89 11.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.65 -24.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.508 -0.745 . . . . 0.0 109.798 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 101.31 97.28 2.29 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -119.72 136.93 54.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.98 . . . . 0.0 109.07 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.73 131.03 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.771 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -175.22 -91.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -63.31 -37.66 88.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 108.718 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.9 -36.73 91.05 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.81 75.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -1.134 . . . . 0.0 109.588 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -74.0 -32.27 63.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.159 -0.963 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -56.65 -41.8 77.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 68.0 t80 -63.5 -47.08 83.17 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -63.27 -38.74 92.33 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.434 0.635 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 8' ' ' THR . 57.3 p -70.4 -32.92 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 111.483 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -148.58 57.44 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.667 -1.271 . . . . 0.0 111.166 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -173.33 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.854 -1.153 . . . . 0.0 110.322 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.87 -37.7 71.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.799 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.52 -34.92 69.61 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.718 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -97.41 -43.67 7.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 110.681 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -105.11 124.43 49.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 110.203 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.4 p -87.22 -18.34 30.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 109.31 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 61.57 19.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 24' ' ' GLY . 49.0 tp10 -99.82 140.6 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.348 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -82.2 -81.7 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.14 -28.61 19.03 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 21' ' ' GLU . . . -59.22 156.05 26.31 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.618 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.3 -174.48 1.62 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.84 2.36 . . . . 0.0 111.948 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -105.72 135.13 47.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 109.251 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -97.86 -126.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 108.908 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.34 -39.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.109 -0.995 . . . . 0.0 109.044 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 165.56 19.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 22.9 Cg_endo -62.68 148.23 93.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.968 2.445 . . . . 0.0 111.991 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 38.6 m-20 -80.13 137.48 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.088 -1.007 . . . . 0.0 109.46 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 32' ' ' LEU . 7.8 mp -100.08 135.57 41.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.923 . . . . 0.0 109.835 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -164.14 98.41 0.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 108.975 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.94 8.61 82.17 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.28 -23.16 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.479 -1.012 . . . . 0.0 109.494 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.17 135.34 53.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 73.95 20.73 79.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HD3' HE22 ' A' ' 42' ' ' GLN . 95.0 mtt180 -137.01 165.22 26.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.936 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.38 154.54 17.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.523 ' CB ' HD22 ' A' ' 52' ' ' ASN . 37.1 p -65.88 160.88 22.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.956 . . . . 0.0 109.899 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.61 57.18 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.432 HE22 ' HD3' ' A' ' 38' ' ' ARG . 52.0 tt0 -62.23 -36.73 82.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.262 . . . . 0.0 109.931 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.818 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.57 140.24 47.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 109.381 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.97 153.37 41.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.786 . . . . 0.0 109.354 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.87 0.42 64.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 47' ' ' SER . 59.8 t80 -136.38 156.04 49.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.205 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.537 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.9 t -95.55 147.3 23.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.645 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.818 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 49.4 m-85 -103.21 141.99 34.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.378 -0.826 . . . . 0.0 109.785 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 78' ' ' THR . 47.2 m -74.4 149.98 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.479 -0.763 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.64 -33.73 23.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.809 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -73.14 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.523 HD22 ' CB ' ' A' ' 40' ' ' SER . 14.2 t30 -54.51 -41.0 69.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.029 . . . . 0.0 110.306 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.11 -46.4 94.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.838 -1.164 . . . . 0.0 109.456 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -60.48 -37.21 80.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 108.94 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ASN . 25.9 tttt -127.84 116.9 20.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -101.87 134.99 44.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.12 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.65 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -131.99 148.24 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.438 -0.788 . . . . 0.0 109.892 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.5 tt -79.66 132.26 36.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.794 ' N ' HD23 ' A' ' 58' ' ' LEU . 99.7 m95 -92.88 110.08 21.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.056 -1.027 . . . . 0.0 109.688 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 54.8 t0 -136.31 168.92 18.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.564 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.02 -37.36 69.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.902 -1.124 . . . . 0.0 109.293 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.75 -56.57 6.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.9 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -62.34 -38.96 91.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.828 . . . . 0.0 110.397 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.5 tpp -58.75 -40.56 84.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.691 ' HA ' HD11 ' A' ' 95' ' ' ILE . 19.7 m -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 109.276 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.13 -31.44 72.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.047 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.474 ' CE1' ' CD1' ' A' ' 74' ' ' TYR . 75.2 t60 -57.48 -47.49 81.75 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.439 -0.788 . . . . 0.0 109.597 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.523 ' CD1' HD23 ' A' ' 94' ' ' LEU . 72.8 mt -68.37 -30.52 69.47 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.7 m -62.46 -39.81 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.015 -1.053 . . . . 0.0 110.641 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -150.95 65.93 7.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.073 -1.017 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.63 -20.74 69.76 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.572 2.181 . . . . 0.0 112.776 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.9 -50.38 64.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.652 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -86.62 -6.36 58.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 110.046 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.65 ' OH ' HG11 ' A' ' 57' ' ' VAL . 44.6 t80 -62.47 -49.67 74.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 ' CD1' ' A' ' 74' ' ' TYR . 6.7 pt -140.7 72.26 29.79 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.04 135.67 64.69 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.49 2.127 . . . . 0.0 112.204 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 14.62 50.09 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.15 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.721 ' HA ' HG21 ' A' ' 49' ' ' THR . 14.9 t -104.61 171.44 7.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.816 -1.403 . . . . 0.0 110.064 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -94.61 14.06 22.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 0.0 110.318 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' MET . . . . . 0.625 ' H ' HG23 ' A' ' 78' ' ' THR . 2.1 mmm -67.5 135.05 52.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 0.0 109.889 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.25 26.01 10.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 57.2 t80 -91.79 130.16 37.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -85.48 177.05 50.09 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.91 158.07 30.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -102.95 135.05 45.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.0 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -92.65 -4.62 53.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.795 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -103.02 130.81 50.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.005 . . . . 0.0 109.805 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.31 -44.87 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.454 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -60.17 -48.26 82.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.018 . . . . 0.0 110.301 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.63 -39.04 93.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -58.92 -42.31 89.38 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.3 m-20 -61.62 -40.37 94.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.07 -1.019 . . . . 0.0 110.384 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.37 -40.08 96.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.026 -1.046 . . . . 0.0 110.001 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.644 HD22 HD23 ' A' ' 9' ' ' LEU . 59.0 tp -57.26 -45.75 83.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 65' ' ' SER . 77.3 mt -66.53 -43.64 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 m -60.71 -39.74 89.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.352 -0.843 . . . . 0.0 109.917 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -58.09 -49.18 77.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.043 . . . . 0.0 109.729 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 98' ' ' LEU . 85.8 mt -69.09 -35.59 76.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.038 . . . . 0.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 10.9 tptm -57.84 -43.34 85.78 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.388 -0.82 . . . . 0.0 109.517 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -61.04 -45.44 94.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.176 -0.952 . . . . 0.0 109.693 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 109.511 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' -2' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' -1' ' ' ALA . 34.6 ttpt -102.54 136.36 42.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' -1' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.99 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -98.23 134.27 11.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 22.8 t -57.19 -33.48 67.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -1.123 . . . . 0.0 109.288 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 73.32 -35.77 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.2 tttt -59.14 -48.9 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.52 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.62 -42.81 98.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.36 -32.16 81.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.9 93.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -1.17 . . . . 0.0 109.474 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 12' ' ' THR . 47.4 p -72.51 -36.38 68.35 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.572 HD23 HD13 ' A' ' 94' ' ' LEU . 7.1 tp -58.33 -41.49 84.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.3 t80 -63.54 -46.85 84.11 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -63.31 -39.65 95.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 8' ' ' THR . 65.3 p -70.41 -34.43 72.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.419 -0.8 . . . . 0.0 111.7 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -150.27 59.97 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.626 -1.296 . . . . 0.0 110.933 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -173.08 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.962 -1.086 . . . . 0.0 109.997 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -36.32 72.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.967 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -56.45 -35.35 67.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.024 -1.048 . . . . 0.0 109.496 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.9 m -97.26 -48.84 5.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.263 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.2 m-70 -99.3 113.43 25.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.741 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.0 p -82.58 -19.15 39.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 20' ' ' VAL . 8.0 p 36.86 41.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.6 tt0 -101.67 147.95 25.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -56.57 -36.58 69.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -55.44 -30.94 56.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 25' ' ' PRO . . . 64.66 56.54 16.33 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 24' ' ' GLY . 33.1 Cg_endo -67.79 -23.78 41.35 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.787 2.325 . . . . 0.0 112.019 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 93.1 m-70 54.77 57.9 5.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.644 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' HIS . 45.1 tttm -58.98 -122.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.342 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.05 -40.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 109.883 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.52 167.47 14.95 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.29 152.29 61.49 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.004 2.469 . . . . 0.0 112.263 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 26' ' ' HIS . 16.2 m120 -89.17 140.83 29.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.273 -0.892 . . . . 0.0 109.044 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.817 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.8 mp -92.83 140.39 29.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.932 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 47.6 p-80 -176.06 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 93.98 3.8 63.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.19 -21.56 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.449 -1.03 . . . . 0.0 109.524 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -66.94 132.32 47.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.8 24.33 76.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 86.3 mtt-85 -133.12 159.1 41.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -1.133 . . . . 0.0 109.95 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -90.93 147.38 23.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 3.4 t -63.13 155.91 26.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.79 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.79 -13.92 59.08 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 44' ' ' GLU . 51.4 tt0 -62.3 -37.1 84.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 109.804 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -64.85 70.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.897 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLN . 97.2 mt-10 -60.51 -31.28 70.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.11 -32.84 50.64 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 47' ' ' SER . 60.3 t80 -122.3 142.03 50.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -1.04 . . . . 0.0 109.572 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 22.9 t -74.04 158.17 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 19.4 m-85 -106.12 150.27 25.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 51' ' ' ALA . 2.0 t -63.58 155.21 30.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.258 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -55.52 -35.49 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.567 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' N ' HG23 ' A' ' 49' ' ' THR . . . -59.53 -58.23 9.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.185 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 55' ' ' LYS . 17.5 t-20 -57.88 -40.81 81.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.922 -1.111 . . . . 0.0 109.469 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.77 -43.13 98.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.145 -0.972 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.34 -40.99 92.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 109.331 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 52' ' ' ASN . 6.7 tptm -128.39 125.17 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -98.05 140.89 31.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 109.086 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.806 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.3 p -130.94 148.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.28 130.89 35.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.4 m95 -98.95 125.15 44.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' C ' ' A' ' 60' ' ' ASP . 55.0 p30 -157.95 -170.21 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -62.31 -43.12 99.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.763 -1.21 . . . . 0.0 110.439 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -68.39 -54.1 19.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 0.0 110.714 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 40.7 t30 -57.1 -38.7 73.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.44 -0.787 . . . . 0.0 110.902 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.6 mmt -58.04 -41.99 84.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 0.0 109.425 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -65.88 -32.96 74.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.458 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.03 -37.59 84.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.148 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.04 -49.21 78.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.043 . . . . 0.0 109.496 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.4 mp -72.23 -26.95 62.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 70' ' ' ASN . 27.2 m -87.51 129.66 35.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.015 . . . . 0.0 109.629 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 69' ' ' THR . 17.6 m-20 38.75 55.94 5.2 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 11.1 Cg_endo -58.44 -18.49 39.16 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.84 2.36 . . . . 0.0 112.649 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.77 90.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.529 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.47 4.73 51.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' TYR . . . . . 0.806 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.9 t80 -116.39 119.35 35.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.275 -0.891 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 78' ' ' THR . 45.7 mm 40.23 59.25 7.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.483 -0.761 . . . . 0.0 109.783 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.99 147.8 62.19 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.903 2.402 . . . . 0.0 112.139 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.7 2.91 57.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 75' ' ' ILE . 51.9 p -75.48 163.59 27.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -85.07 5.99 27.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -86.7 126.69 34.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.371 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.65 6.87 32.38 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.83 134.07 46.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.55 -175.32 28.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 76.71 36.32 37.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 62.7 mt -82.26 143.27 31.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' LYS . 20.3 ttpp -73.3 145.64 45.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' LYS . 17.5 mttp -44.19 130.76 6.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 89' ' ' LYS . 85.6 tt0 -172.19 158.53 4.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 88' ' ' GLU . 18.6 mttt -55.38 -32.3 62.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.144 -0.973 . . . . 0.0 109.231 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -56.04 -41.26 74.73 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.156 -0.965 . . . . 0.0 109.251 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.3 ttm180 -61.21 -46.46 90.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -67.25 -40.94 86.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.775 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 3' ' ' ALA . 89.2 m-20 -62.93 -40.22 96.94 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 68' ' ' LEU . 53.5 tp -58.18 -44.78 88.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 109.52 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.16 -40.54 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 3' ' ' ALA . 14.1 m -57.99 -40.15 79.99 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.735 -0.603 . . . . 0.0 109.77 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.83 -51.36 70.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.082 -1.011 . . . . 0.0 109.687 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 10' ' ' PHE . 92.3 mt -66.92 -35.61 80.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.057 -1.027 . . . . 0.0 108.33 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 82.8 tttt -58.09 -42.39 85.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -60.79 -39.89 90.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 109.742 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.456 -0.778 . . . . 0.0 109.421 -179.673 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.21 -31.19 67.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 36.5 t80 -92.46 130.59 38.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.583 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.4 ptmt -103.53 161.32 13.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.372 -0.83 . . . . 0.0 109.215 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.88 96.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.96 . . . . 0.0 109.336 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -110.98 170.21 13.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -110.94 130.87 55.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.142 . . . . 0.0 109.238 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -74.4 -19.39 60.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.022 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.5 -49.55 74.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.093 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -63.14 -47.48 82.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.101 . . . . 0.0 109.267 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -67.66 -28.13 73.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.62 -44.73 85.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.224 . . . . 0.0 109.868 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.853 ' O ' HG23 ' A' ' 12' ' ' THR . 52.9 p -70.02 -38.62 75.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.153 -0.967 . . . . 0.0 109.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.759 HD23 HD22 ' A' ' 94' ' ' LEU . 8.3 tp -59.25 -41.04 87.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.66 -46.36 88.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.79 -38.86 92.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.382 0.61 . . . . 0.0 109.967 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' THR . 56.8 p -69.31 -34.68 75.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 111.493 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -150.28 59.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.642 -1.287 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -171.18 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 0.0 109.965 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.98 -38.2 72.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 109.607 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -58.87 -36.09 74.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.898 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -94.53 -42.57 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.479 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.6 m-70 -107.56 124.15 49.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.9 p -84.42 -29.57 26.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.251 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 20' ' ' VAL . 85.7 t 54.32 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.289 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 19' ' ' THR . 77.8 mm-40 -62.06 141.98 57.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 24' ' ' GLY . 16.3 tttm -71.07 143.19 50.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.623 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.18 9.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' LYS . . . -76.17 162.65 52.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.622 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 57.0 Cg_endo -71.31 175.92 8.66 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 123.127 2.552 . . . . 0.0 111.691 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -102.42 133.49 47.28 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.254 -0.904 . . . . 0.0 109.516 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 29' ' ' GLY . 56.0 tttp -132.23 131.09 41.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.252 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 27' ' ' LYS . 85.1 t 53.73 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.171 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -102.39 162.97 16.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 20.3 Cg_endo -62.03 153.01 71.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.09 2.527 . . . . 0.0 112.165 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 58.7 m-20 -84.27 139.03 32.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.837 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -99.69 139.3 35.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 109.885 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -166.56 95.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.58 7.47 78.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -58.66 -21.58 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.014 . . . . 0.0 109.613 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 102' ' ' THR . 81.9 m-85 -64.1 133.22 52.58 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 71.13 21.39 78.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.536 ' NE ' ' OE1' ' A' ' 42' ' ' GLN . 68.1 mtp85 -138.57 167.04 22.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -1.15 . . . . 0.0 109.924 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -94.68 156.88 16.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.905 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.447 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 58.0 p -66.31 164.53 15.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.724 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.88 0.8 68.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.536 ' OE1' ' NE ' ' A' ' 38' ' ' ARG . 18.1 tt0 -60.1 -35.53 75.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.995 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.66 -34.41 69.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.3 mt-10 43.32 17.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.156 -0.965 . . . . 0.0 109.408 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -127.95 -36.42 0.47 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 47' ' ' SER . 68.5 t80 -103.67 135.52 45.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 108.815 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.436 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 54.3 p -65.93 156.57 33.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.899 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.87 150.1 42.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.559 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 52' ' ' ASN . 7.1 t -54.9 149.92 10.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.863 . . . . 0.0 109.24 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.78 -35.11 65.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.877 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -60.22 -57.58 12.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.063 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 49' ' ' THR . 27.2 t-20 -57.5 -42.8 83.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.566 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.31 -55.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.177 -0.952 . . . . 0.0 109.728 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -68.38 -54.86 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 56' ' ' ASN . 19.9 tttm -65.7 -52.23 53.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.578 ' O ' ' O ' ' A' ' 55' ' ' LYS . 7.0 t-20 50.91 118.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.758 0.789 . . . . 0.0 110.119 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.715 HG11 ' OH ' ' A' ' 74' ' ' TYR . 7.6 p -126.47 147.51 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.3 tp -75.82 134.12 40.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 108.93 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 m95 -99.6 128.41 45.71 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.337 -0.852 . . . . 0.0 110.034 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 50.3 t0 -159.12 172.98 17.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.585 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.17 -39.15 71.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.961 -1.087 . . . . 0.0 109.646 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.582 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 p-10 -74.77 -48.08 27.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.078 -1.014 . . . . 0.0 109.513 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 39.0 t30 -60.9 -38.26 85.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 110.003 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -40.12 86.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.921 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -61.49 -36.4 80.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.001 -1.062 . . . . 0.0 109.799 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.24 -36.65 77.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.019 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -61.38 -47.39 86.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.138 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 4.7 mp -71.46 -36.23 71.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.392 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.581 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 25.5 m -60.96 -39.58 90.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.623 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -152.87 68.73 6.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.585 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.15 -15.81 46.54 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.364 2.043 . . . . 0.0 112.651 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -78.87 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 110.266 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.68 -32.79 67.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.149 -0.97 . . . . 0.0 109.772 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.715 ' OH ' HG11 ' A' ' 57' ' ' VAL . 80.2 t80 -56.66 -49.66 74.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.707 HG22 ' O ' ' A' ' 75' ' ' ILE . 2.8 mm -141.14 80.84 16.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.923 . . . . 0.0 109.113 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -84.88 149.47 10.97 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.957 2.438 . . . . 0.0 112.247 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.25 58.63 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.718 ' HB ' HG21 ' A' ' 49' ' ' THR . 15.0 t -104.77 163.65 12.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -1.216 . . . . 0.0 109.71 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.79 -0.12 37.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.519 ' H ' HG23 ' A' ' 78' ' ' THR . 11.2 ttt -85.11 129.59 34.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 0.0 110.007 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.63 85.52 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.8 t80 -104.6 133.4 49.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.34 138.02 22.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.94 146.8 43.73 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.607 HD11 HD21 ' A' ' 9' ' ' LEU . 55.2 mt -95.16 125.45 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.244 . . . . 0.0 109.554 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -65.42 -34.6 78.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 110.206 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -84.78 127.84 34.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 0.0 110.16 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -77.52 -35.54 53.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -57.75 -45.6 85.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.6 -39.54 94.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.041 . . . . 0.0 109.1 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.581 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 37.6 ttm180 -59.67 -40.47 87.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.936 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.12 -42.35 90.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.358 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -63.43 -40.06 96.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.054 -1.029 . . . . 0.0 110.14 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.765 HD21 ' CBB' ' A' ' 201' ' ' HEC . 48.5 tp -59.75 -42.76 93.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.036 -1.04 . . . . 0.0 109.627 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.85 -37.41 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.972 . . . . 0.0 108.955 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -60.79 -39.58 89.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.598 -0.689 . . . . 0.0 109.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.53 -50.61 73.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.105 -0.997 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.3 mt -69.05 -35.43 76.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.168 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.585 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 18.7 tptm -58.68 -40.56 83.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.351 -0.843 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -60.1 -40.84 91.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.44 70.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.529 -0.732 . . . . 0.0 109.796 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.426 HG21 ' CD1' ' A' ' 36' ' ' PHE . 43.8 p -66.61 -23.48 66.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.414 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.765 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.99 141.35 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.525 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 93.6 t80 -99.9 130.06 46.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.924 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.644 ' HZ1' ' HG3' ' A' ' 89' ' ' LYS . 33.5 ttpt -81.88 144.45 30.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.071 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.95 -22.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 109.564 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' O ' HG21 ' A' ' 96' ' ' THR . . . 42.37 94.95 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 46.0 m -63.37 153.44 35.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.111 -1.229 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -80.77 -128.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' THR . 40.8 tttm 57.64 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.057 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' ALA . 32.9 mmtp -59.29 -52.44 65.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -36.56 93.57 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.43 79.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -1.162 . . . . 0.0 109.414 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 4' ' ' LYS . 54.4 p -70.43 -37.35 74.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.243 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.68 -55.98 27.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 108.816 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 98' ' ' LEU . 43.2 t80 -62.5 -41.71 99.0 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.427 -0.796 . . . . 0.0 109.266 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -61.49 -38.54 87.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 111.159 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 p -106.02 4.64 29.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.112 -0.993 . . . . 0.0 111.759 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -147.02 28.71 1.01 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.613 -1.305 . . . . 0.0 110.75 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -171.08 -24.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.723 -1.235 . . . . 0.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.6 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -59.54 -38.19 80.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.885 -1.134 . . . . 0.0 109.916 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.0 -36.53 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.018 . . . . 0.0 111.239 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' HMC1 ' A' ' 201' ' ' HEC . 92.4 m -95.73 -50.23 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.832 -1.167 . . . . 0.0 111.202 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.645 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -101.91 126.37 48.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.065 -1.022 . . . . 0.0 110.265 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' VAL . 51.5 p -87.23 -24.28 24.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.241 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 19' ' ' THR . 2.6 t 63.79 0.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.457 -0.777 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -101.37 124.75 47.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.436 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -69.53 -39.22 77.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.567 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.63 87.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 154.17 44.39 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.634 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 62.1 Cg_endo -74.26 -156.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 111.733 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -107.68 133.6 51.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.134 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -103.78 -125.07 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.31 -38.45 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.156 -0.965 . . . . 0.0 108.896 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.79 165.14 20.94 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.3 150.77 87.67 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.958 2.438 . . . . 0.0 112.37 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.634 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 42.4 m-20 -80.81 141.71 34.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 108.99 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.7 mp -95.42 139.19 32.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.017 . . . . 0.0 109.861 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -172.19 90.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 0.0 109.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.583 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.05 5.02 66.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.4 tt -58.5 -22.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -1.176 . . . . 0.0 109.546 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.67 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 81.2 m-85 -68.11 135.35 52.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.8 79.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 67.8 mtt85 -142.62 166.08 25.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 110.04 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.402 ' CE1' HD13 ' A' ' 58' ' ' LEU . 79.0 m80 -95.77 162.57 13.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 110.197 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 62.0 p -66.3 166.21 12.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.816 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.28 60.89 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.9 tt0 -62.41 -38.42 89.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -1.16 . . . . 0.0 109.876 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.723 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -71.31 66.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.98 -32.48 72.03 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.366 -0.834 . . . . 0.0 109.343 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.6 60.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -108.8 134.58 51.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -1.138 . . . . 0.0 109.153 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 m -64.47 156.32 29.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.723 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 59.3 m-85 -112.14 145.32 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.306 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.4 p -76.91 161.09 28.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.456 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -58.78 -33.06 69.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.949 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.25 -70.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.216 -0.927 . . . . 0.0 110.673 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.8 t-20 -54.83 -40.62 69.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.924 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.72 -46.37 96.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.942 -1.098 . . . . 0.0 109.482 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.37 -37.06 79.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.12 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 52' ' ' ASN . 52.9 tttm -126.28 115.75 20.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.8 t-20 -99.42 137.68 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.132 -0.98 . . . . 0.0 109.063 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.924 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.9 146.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.404 -0.81 . . . . 0.0 109.975 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD13 ' CE1' ' A' ' 39' ' ' HIS . 62.8 tp -79.14 131.05 36.09 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.493 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 89.0 m95 -94.18 124.48 38.22 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -153.94 169.27 23.86 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.86 -40.0 72.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 0.0 109.559 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -69.83 -48.8 57.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.15 -41.09 92.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.544 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.67 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.0 mtt -61.45 -38.0 85.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.003 -1.061 . . . . 0.0 109.727 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -55.95 -42.0 75.52 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 108.953 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -37.01 76.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.443 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 70.4 t60 -62.92 -47.92 81.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.664 HD11 ' CMB' ' A' ' 201' ' ' HEC . 7.4 mp -61.93 -26.79 68.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.892 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.59 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 33.8 m -84.78 126.0 33.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.952 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 69' ' ' THR . 8.2 m120 40.48 60.01 7.41 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 28.2 Cg_endo -64.52 -23.02 64.82 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.962 2.441 . . . . 0.0 112.9 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.78 81.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.061 -1.025 . . . . 0.0 109.491 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -62.67 -32.64 73.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.924 ' OH ' HG11 ' A' ' 57' ' ' VAL . 10.7 t80 -57.19 -55.59 32.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 109.726 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.512 HG23 ' HD1' ' A' ' 74' ' ' TYR . 2.9 pt -141.82 73.83 22.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.0 109.779 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -60.96 -34.97 90.04 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 122.64 2.227 . . . . 0.0 112.045 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.7 75.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.0 p -75.51 158.75 32.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.236 . . . . 0.0 110.51 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -84.7 3.83 35.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 109.608 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 6.7 ttt -76.74 129.87 36.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.92 93.5 2.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.628 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 78.3 t80 -101.81 131.24 48.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.225 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -63.76 130.92 40.11 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.24 145.83 41.65 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.4 mt -94.73 125.07 39.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.979 -1.306 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -64.52 -37.96 89.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -86.98 119.49 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.826 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.03 -32.93 72.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.644 ' HG3' ' HZ1' ' A' ' -2' ' ' LYS . 13.6 tttm -57.06 -51.46 69.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.102 -0.999 . . . . 0.0 109.641 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -60.74 -38.07 83.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.8 . . . . 0.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.59 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 55.8 ttp180 -58.09 -42.12 84.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.761 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.3 -38.77 84.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.094 -1.004 . . . . 0.0 109.972 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 2' ' ' SER . 86.0 m-20 -62.97 -40.66 98.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.19 -0.944 . . . . 0.0 109.95 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.98 -45.02 87.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 109.939 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.455 HD12 ' HE1' ' A' ' -3' ' ' PHE . 70.9 mt -63.29 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.93 -1.106 . . . . 0.0 108.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.7 m -58.81 -39.17 80.37 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.488 -0.757 . . . . 0.0 109.469 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.06 -49.84 75.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.904 -1.122 . . . . 0.0 108.699 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 10' ' ' PHE . 91.9 mt -66.98 -33.4 75.5 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 34.3 tttm -56.5 -42.51 78.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.61 -40.25 91.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.81 67.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.539 -0.726 . . . . 0.0 109.627 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 43.5 p -66.89 -26.47 66.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.455 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.781 HBB2 HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.68 -34.32 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.446 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 70.6 t80 -103.81 134.49 47.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.569 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.4 ptpt -130.89 164.03 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 109.218 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -42.02 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -66.57 134.98 33.1 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 85.2 p -64.98 -20.72 66.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 51.31 -141.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttm 55.61 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 109.725 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 3' ' ' ALA . 24.9 mttm -58.24 -45.53 87.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.033 -1.042 . . . . 0.0 109.636 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.49 -32.9 79.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 12' ' ' THR . 52.1 p -71.97 -34.82 69.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.321 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -57.07 -40.48 76.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.9 t80 -62.72 -47.57 83.01 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.11 -38.1 89.85 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.411 0.624 . . . . 0.0 110.033 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 8' ' ' THR . 53.4 p -69.02 -34.49 75.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 111.366 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -150.62 59.3 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.688 -1.258 . . . . 0.0 110.947 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.7 t -171.17 -50.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.82 -1.175 . . . . 0.0 110.36 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.11 -37.53 72.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.06 -1.025 . . . . 0.0 109.82 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.32 -35.98 72.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.13 -0.981 . . . . 0.0 109.827 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -95.33 -42.0 8.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.617 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' A' ' 32' ' ' LEU . 90.0 m-70 -108.0 126.13 52.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.7 p -86.98 -26.14 23.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.472 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 19' ' ' THR . 2.4 t 64.02 -0.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.113 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.2 mt-10 -95.61 120.06 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -69.29 -39.74 78.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.85 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.58 -37.09 91.72 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.98 156.57 44.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.61 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.78 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.797 2.331 . . . . 0.0 111.755 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.89 134.5 47.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -101.37 -125.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.86 -39.62 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.05 166.03 18.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -62.06 150.5 86.29 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.879 2.386 . . . . 0.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 42.8 m-20 -82.82 141.62 32.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.558 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.0 mp -99.68 137.26 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.786 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -171.71 98.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 108.907 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.11 8.56 81.79 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.45 -23.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.961 . . . . 0.0 109.535 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 86.6 m-85 -63.18 135.58 57.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 63.34 30.0 76.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 42' ' ' GLN . 62.0 ttt180 -134.85 154.27 51.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -1.033 . . . . 0.0 109.843 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.64 145.94 24.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.593 ' CB ' HD22 ' A' ' 52' ' ' ASN . 56.9 p -67.88 163.42 21.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 0.0 110.151 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.08 -9.7 67.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' HH21 ' A' ' 38' ' ' ARG . 95.5 mt-30 -96.85 6.05 49.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.92 -30.63 66.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.805 -1.185 . . . . 0.0 108.169 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 97.5 mt-10 38.05 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.431 0.634 . . . . 0.0 109.917 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.83 -26.65 2.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.94 143.31 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -1.013 . . . . 0.0 108.837 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -65.06 158.3 26.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 109.857 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CB ' HD11 ' A' ' 53' ' ' ILE . 14.6 m-85 -116.65 138.3 51.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 109.713 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 78' ' ' THR . 52.0 m -74.88 144.92 43.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 108.974 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -50.56 -35.85 31.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . . . -46.75 -69.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.593 HD22 ' CB ' ' A' ' 40' ' ' SER . 13.5 t30 -56.54 -41.41 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.086 -1.009 . . . . 0.0 110.564 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 48' ' ' TYR . 41.4 mm -60.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.739 -1.226 . . . . 0.0 110.012 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -60.34 -33.88 73.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.205 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.4 tttm -127.26 112.65 15.33 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -100.07 137.96 37.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.772 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.7 p -132.35 147.74 32.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 109.842 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.1 tp -79.04 134.22 36.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 108.811 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' GLY . 95.9 m95 -95.15 125.19 39.62 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.177 -0.952 . . . . 0.0 110.071 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 62' ' ' ASN . 46.3 p30 -155.41 -176.13 5.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.584 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -60.97 -39.59 90.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.939 -1.1 . . . . 0.0 111.013 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -74.94 -47.18 30.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.86 -1.15 . . . . 0.0 110.722 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 64.2 t30 -58.38 -42.1 86.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.499 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.645 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.3 mtt -62.41 -38.45 89.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 109.87 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.6 p -62.71 -40.82 98.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.257 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.08 -34.79 73.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.175 -0.953 . . . . 0.0 109.25 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.2 t60 -57.99 -44.15 86.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.561 -0.712 . . . . 0.0 109.471 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 94' ' ' LEU . 95.1 mt -67.64 -32.46 73.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -0.778 . . . . 0.0 110.597 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 m -55.77 -37.28 68.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.036 -1.04 . . . . 0.0 110.542 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.6 p-10 -167.56 69.04 0.9 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.434 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -50.15 -27.56 17.56 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.95 2.434 . . . . 0.0 112.636 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -58.44 6.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 109.321 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 70' ' ' ASN . 67.5 mttt -61.94 -26.85 68.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.772 ' OH ' HG11 ' A' ' 57' ' ' VAL . 34.2 t80 -59.46 -54.78 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.631 -0.668 . . . . 0.0 109.643 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.475 HG23 ' CD2' ' A' ' 74' ' ' TYR . 12.8 pt -139.96 70.19 35.68 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.077 -1.014 . . . . 0.0 109.97 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -52.81 135.47 57.43 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.429 2.086 . . . . 0.0 112.007 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.7 -0.55 56.65 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.847 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.741 ' HA ' HG21 ' A' ' 49' ' ' THR . 8.4 t -89.2 161.24 16.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.653 -1.498 . . . . 0.0 109.62 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -85.66 1.41 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.494 ' H ' HG23 ' A' ' 78' ' ' THR . 15.4 ttp -77.85 125.52 29.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.002 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.3 79.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 64.4 t80 -103.21 131.68 50.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.47 -0.769 . . . . 0.0 109.68 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -71.22 144.97 38.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 147.64 34.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 55.2 mt -97.21 133.1 42.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -94.1 -9.18 37.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.929 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -99.28 128.42 45.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 110.024 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.0 -38.59 52.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -60.72 -49.64 76.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 110.21 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.76 -37.31 86.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.004 . . . . 0.0 109.444 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.492 HH11 ' HB2' ' A' ' 68' ' ' LEU . 38.8 ttm-85 -57.46 -45.3 84.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.719 . . . . 0.0 109.883 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -62.76 -39.93 95.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 85.7 m-20 -61.37 -39.64 91.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.186 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.685 HD21 ' CBB' ' A' ' 201' ' ' HEC . 52.2 tp -60.36 -45.11 94.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 110.758 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.45 -41.8 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.008 -1.057 . . . . 0.0 109.579 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -58.15 -40.4 81.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 110.012 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -58.89 -50.88 72.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.372 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.509 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.6 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.627 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.584 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 80.6 tttt -56.72 -43.34 80.52 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -61.46 -43.58 98.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 0.0 109.4 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.48 68.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.673 -0.642 . . . . 0.0 109.748 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -59.63 -33.22 71.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 109.44 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.461 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.685 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -108.38 152.51 24.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.381 -0.824 . . . . 0.0 109.525 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.452 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 49.9 t80 -101.66 130.58 48.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 109.719 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.452 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 32.9 ttpt -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.102 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.06 95.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -89.53 -176.42 45.81 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -105.86 129.47 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.165 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -68.51 -26.04 65.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -57.0 -46.97 81.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.027 -1.046 . . . . 0.0 110.15 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -66.49 -53.1 38.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.036 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.34 -28.21 72.72 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.61 -47.83 81.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.204 . . . . 0.0 109.761 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -73.65 -36.19 65.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 94' ' ' LEU . 20.0 tp -58.16 -42.19 85.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -64.69 -46.67 81.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -63.43 -40.43 97.14 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.471 0.653 . . . . 0.0 110.396 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 55.4 p -72.5 -29.56 63.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 111.627 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.32 55.96 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.549 -1.344 . . . . 0.0 111.23 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.646 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.9 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.782 -1.199 . . . . 0.0 110.49 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.09 -37.62 69.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.54 -35.7 70.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 109.904 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -97.7 -42.6 7.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.646 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -105.31 122.69 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.144 -0.972 . . . . 0.0 110.505 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 21' ' ' GLU . 52.9 p -82.52 -18.62 40.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.671 HG22 ' O ' ' A' ' 20' ' ' VAL . 14.8 p 39.7 21.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.701 -0.624 . . . . 0.0 110.047 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 18.8 pttm -67.2 -40.4 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.964 . . . . 0.0 109.546 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -62.62 -36.98 94.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.87 152.59 31.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.684 ' C ' HD22 ' A' ' 31' ' ' ASN . 84.4 Cg_endo -77.16 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.712 2.275 . . . . 0.0 111.877 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' HA ' HD22 ' A' ' 31' ' ' ASN . 86.7 m-70 -99.5 136.26 39.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.939 . . . . 0.0 109.258 179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 36.0 tptt -106.48 -130.09 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.422 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.47 -41.1 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.58 161.96 15.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 12.2 Cg_endo -57.73 143.18 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.134 2.556 . . . . 0.0 111.938 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.684 HD22 ' C ' ' A' ' 25' ' ' PRO . 67.8 m-20 -76.43 146.31 38.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.86 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.3 mp -98.92 138.75 35.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.626 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -174.84 97.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.85 84.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 tt -58.89 -23.79 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.65 -0.912 . . . . 0.0 109.401 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -65.17 131.48 46.64 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.3 -0.875 . . . . 0.0 108.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.94 30.17 74.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -134.08 152.67 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -1.043 . . . . 0.0 109.931 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -93.37 145.23 24.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.316 -0.865 . . . . 0.0 108.999 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.474 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 53.4 p -66.79 158.52 30.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.956 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.37 -22.75 25.32 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -62.4 -36.34 82.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -1.205 . . . . 0.0 110.381 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.48 -44.86 92.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 109.892 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.12 -16.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.919 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -57.8 -34.65 71.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -123.25 143.37 50.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.597 -0.943 . . . . 0.0 109.168 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -64.76 159.39 22.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.98 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' O ' HD11 ' A' ' 53' ' ' ILE . 82.9 m-85 -118.41 146.52 44.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.563 -0.711 . . . . 0.0 109.554 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.724 HG23 HBD2 ' A' ' 201' ' ' HEC . 41.9 p -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.38 -31.54 61.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 109.627 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.33 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.504 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 55' ' ' LYS . 15.1 t30 -55.8 -42.18 75.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.941 -1.1 . . . . 0.0 110.286 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.502 HD11 ' O ' ' A' ' 48' ' ' TYR . 87.9 mt -60.43 -45.65 96.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 120.895 -1.128 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -60.51 -37.17 80.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.255 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 52' ' ' ASN . 40.0 tttm -128.28 118.87 24.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.411 ' OD1' ' OG ' ' A' ' 40' ' ' SER . 40.0 t30 -98.91 135.59 40.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 108.898 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.794 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.6 p -131.18 146.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.423 -0.798 . . . . 0.0 110.195 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.08 132.92 36.05 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.552 ' CZ2' HMA2 ' A' ' 201' ' ' HEC . 98.4 m95 -96.81 125.91 41.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.211 -0.931 . . . . 0.0 110.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 49.6 t0 -159.09 176.36 12.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.595 ' CD ' ' HZ3' ' A' ' 99' ' ' LYS . 97.2 mt-10 -55.35 -40.04 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.764 -1.21 . . . . 0.0 109.411 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.9 -52.22 26.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 33.7 t30 -62.85 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.611 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.5 mmt -58.75 -40.65 84.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.6 p -66.28 -37.56 85.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.19 -36.99 84.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.404 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -60.27 -45.68 92.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 109.84 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HD23 ' A' ' 94' ' ' LEU . 83.9 mt -70.17 -35.5 74.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.53 -0.731 . . . . 0.0 110.528 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 29.6 m -61.24 -39.2 89.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.912 -1.117 . . . . 0.0 110.829 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -152.92 67.99 6.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 109.788 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -61.96 -15.14 41.34 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.419 2.079 . . . . 0.0 112.675 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.03 -78.75 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.067 -1.021 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -57.22 -34.51 68.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.794 ' OH ' HG11 ' A' ' 57' ' ' VAL . 87.8 t80 -56.3 -50.34 71.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.954 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.75 HG22 ' O ' ' A' ' 75' ' ' ILE . 20.7 mt -148.09 77.66 9.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.02 152.12 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 123.208 2.606 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.15 3.17 55.78 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 80' ' ' MET . 6.2 t -104.65 174.73 5.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.154 -1.204 . . . . 0.0 109.539 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -87.19 11.63 13.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.674 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -70.13 121.51 17.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.763 -1.21 . . . . 0.0 109.622 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.86 27.27 8.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.004 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 51.9 t80 -86.74 129.2 34.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.172 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -87.54 178.68 47.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.84 154.27 23.75 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 9' ' ' LEU . 58.8 mt -100.26 122.09 42.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -66.1 -36.4 83.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.87 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -92.08 128.92 38.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.02 -1.05 . . . . 0.0 110.36 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -29.59 60.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.65 -0.656 . . . . 0.0 109.91 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -55.39 -50.2 70.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -64.21 -37.94 89.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.945 . . . . 0.0 109.103 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.585 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 39.3 ttm180 -58.67 -42.47 88.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.649 -0.657 . . . . 0.0 110.116 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 88.9 m-20 -63.03 -39.51 94.96 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.055 -1.028 . . . . 0.0 110.285 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.744 HD21 ' CBB' ' A' ' 201' ' ' HEC . 51.0 tp -59.98 -42.9 95.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.56 -38.45 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.8 m -60.7 -41.07 94.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.11 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 102' ' ' THR . 73.1 t80 -58.63 -51.88 68.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.115 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.17 -36.89 69.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.595 ' HZ3' ' CD ' ' A' ' 61' ' ' GLU . 26.3 tptt -58.49 -45.68 88.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.738 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.5 mttm -58.78 -50.53 73.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.81 -1.181 . . . . 0.0 109.251 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 100' ' ' LYS . . . 154.01 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 101' ' ' ALA . 1.1 p 61.32 -2.23 0.24 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 108.909 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.546 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 97.8 mt-10 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.463 -0.773 . . . . 0.0 109.44 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.744 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.74 -34.12 69.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -101.16 128.93 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -97.35 142.72 28.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.946 . . . . 0.0 109.154 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -60.75 138.69 58.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.203 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA3' HG21 ' A' ' 96' ' ' THR . . . -42.46 104.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 20.3 m -56.82 -35.96 69.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -1.118 . . . . 0.0 109.58 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 2' ' ' SER . . . 173.9 -165.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 109.738 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 26.4 mttm -84.14 5.38 26.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.685 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.43 -43.31 71.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.744 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.98 -28.7 69.16 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -59.54 -46.4 88.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -1.044 . . . . 0.0 109.672 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.936 ' O ' HG23 ' A' ' 12' ' ' THR . 24.6 m -60.88 -41.47 96.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.135 -0.978 . . . . 0.0 108.694 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 85' ' ' LEU . 2.1 tp -56.48 -41.3 76.35 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -61.79 -47.13 86.53 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -64.33 -37.23 86.75 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.543 0.687 . . . . 0.0 109.697 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 8' ' ' THR . 57.2 p -66.28 -38.02 86.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 111.352 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -153.8 61.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.548 -1.345 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 5.3 t -171.48 -45.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.998 -1.064 . . . . 0.0 109.774 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.41 -37.34 75.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -58.15 -36.01 72.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.6 m -94.38 -42.8 8.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.517 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.504 ' CE1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -108.54 122.69 47.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.945 . . . . 0.0 110.023 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.9 p -87.8 -24.64 23.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 0.0 109.83 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t 51.17 36.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -103.52 148.43 25.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.9 -37.55 82.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.275 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.47 -30.6 58.96 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 64.16 58.58 10.24 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.96 -24.58 79.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.542 2.161 . . . . 0.0 111.822 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 24' ' ' GLY . 94.3 m-70 55.6 42.28 29.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -56.93 -36.09 69.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 108.847 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' CZ ' ' A' ' 46' ' ' TYR . 2.4 t -146.31 -76.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -0.818 . . . . 0.0 109.253 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -72.76 160.31 53.99 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.2 1.69 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.035 2.49 . . . . 0.0 112.561 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.1 OUTLIER 66.56 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 109.769 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.824 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.1 mp -93.89 139.8 30.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -167.32 94.61 0.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.3 6.4 71.19 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.58 -21.3 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.984 . . . . 0.0 109.8 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.672 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 76.0 m-85 -64.44 131.47 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.93 27.99 73.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.54 ' NE ' ' OE1' ' A' ' 42' ' ' GLN . 63.4 mtp85 -144.94 168.89 19.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.948 -1.324 . . . . 0.0 110.189 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -94.21 157.76 15.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.945 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.464 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 59.5 p -67.31 163.71 20.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.69 -10.87 64.69 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.54 ' OE1' ' NE ' ' A' ' 38' ' ' ARG . 17.8 tt0 -61.65 -37.71 85.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.138 -1.213 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -57.62 140.19 51.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.222 -0.924 . . . . 0.0 109.715 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -126.52 148.59 49.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 109.352 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.4 -7.78 64.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CZ ' ' O ' ' A' ' 28' ' ' VAL . 73.9 t80 -129.42 134.59 47.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 109.426 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 49.8 m -67.73 156.28 37.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.748 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 14.0 m-85 -111.88 140.0 46.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.775 . . . . 0.0 109.418 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.706 HG21 ' HA ' ' A' ' 78' ' ' THR . 40.7 m -69.35 145.43 52.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.911 . . . . 0.0 109.348 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.6 m-20 -51.66 -37.34 50.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.191 -0.943 . . . . 0.0 109.785 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -43.06 -74.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.314 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 9.8 t30 -54.04 -40.9 67.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.191 -0.943 . . . . 0.0 110.744 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.83 -48.57 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.673 -1.267 . . . . 0.0 109.842 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -60.22 -33.84 72.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.7 tttm -127.53 114.88 18.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.582 -0.699 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -97.89 140.04 32.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.123 -0.986 . . . . 0.0 108.897 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.867 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.2 p -132.45 147.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.435 -0.79 . . . . 0.0 110.259 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -80.78 130.0 34.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.5 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 95.6 m95 -92.44 118.46 30.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.147 -0.97 . . . . 0.0 110.31 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 59' ' ' TRP . 91.4 m-20 -140.86 -178.51 5.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.85 -38.3 87.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 110.033 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -76.87 -41.95 41.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.259 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 31.8 t30 -59.02 -42.51 90.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 110.249 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.672 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.4 mtt -63.11 -39.93 96.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.744 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.618 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 71.0 m -59.07 -40.51 85.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.631 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.62 -32.72 68.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.154 -0.966 . . . . 0.0 110.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -56.89 -51.17 70.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.416 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.68 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.3 mp -71.05 -28.58 64.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.958 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.4 m -57.74 -38.12 74.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.945 . . . . 0.0 110.848 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -163.25 66.5 1.61 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.858 -1.151 . . . . 0.0 110.358 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 74' ' ' TYR . 31.7 Cg_exo -50.92 -18.88 4.78 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 C-N-CA 122.838 2.359 . . . . 0.0 112.464 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -76.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -57.95 -32.88 68.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.92 . . . . 0.0 109.467 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.867 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.4 t80 -79.56 126.68 31.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 108.997 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.78 HG22 ' O ' ' A' ' 75' ' ' ILE . 60.1 mt 44.58 63.12 9.16 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.05 146.5 20.29 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.923 2.415 . . . . 0.0 112.451 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.19 16.41 47.29 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.762 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.706 ' HA ' HG21 ' A' ' 49' ' ' THR . 12.9 t -106.89 151.67 24.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.064 -1.257 . . . . 0.0 109.908 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -58.78 -29.62 66.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 22.1 ttp -59.71 140.51 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.288 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.04 92.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.447 -0.783 . . . . 0.0 109.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -161.7 -46.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.592 ' N ' ' CD2' ' A' ' 82' ' ' PHE . . . -41.11 164.51 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 126.5 44.29 0.25 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 9' ' ' LEU . 43.6 mt -88.25 138.27 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -1.023 . . . . 0.0 109.301 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -90.34 -2.99 58.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -97.89 126.52 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.961 -1.087 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.54 -40.08 23.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.755 . . . . 0.0 110.158 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.47 -47.98 83.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.207 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.45 -42.44 95.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.618 ' NH1' ' CB ' ' A' ' 65' ' ' SER . 59.5 ttp85 -61.76 -41.55 97.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.15 -41.01 82.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 110.215 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.31 -38.26 90.45 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.137 -0.977 . . . . 0.0 109.849 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.854 HD21 ' CBB' ' A' ' 201' ' ' HEC . 50.9 tp -60.14 -45.82 91.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 110.75 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.22 -44.35 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.894 -1.129 . . . . 0.0 109.697 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 ' HA3' ' A' ' 1' ' ' GLY . 29.1 m -64.35 -39.8 94.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.352 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.8 t80 -59.21 -43.77 92.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.05 -1.031 . . . . 0.0 110.657 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.1 mt -61.39 -35.82 78.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.715 -1.241 . . . . 0.0 109.528 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -56.94 -38.34 72.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.162 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -59.76 -45.06 93.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.338 -0.851 . . . . 0.0 109.263 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.94 84.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.765 . . . . 0.0 109.296 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 103' ' ' GLU . 53.1 p -70.22 -30.88 68.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.201 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.879 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.854 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -110.62 154.05 24.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.96 128.36 46.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 1' ' ' GLY . 16.0 ttmt -90.67 132.02 36.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.933 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.17 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.249 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -67.2 147.09 48.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.702 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 25.4 m -56.61 -33.19 66.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -1.162 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 75.97 -32.33 0.21 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.394 -0.816 . . . . 0.0 109.85 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 2' ' ' SER . 17.1 mttp -59.67 -51.37 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.085 -1.01 . . . . 0.0 109.203 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -65.04 -40.03 94.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.38 -34.56 89.68 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.23 89.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -1.211 . . . . 0.0 109.023 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.921 ' O ' HG23 ' A' ' 12' ' ' THR . 55.9 p -75.25 -38.28 60.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.89 . . . . 0.0 108.963 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.2 OUTLIER -60.25 -42.76 95.96 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 72.1 t80 -65.08 -46.43 81.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.4 -39.22 93.9 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.324 0.583 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 8' ' ' THR . 70.5 p -70.14 -31.27 68.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.832 . . . . 0.0 111.448 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -149.23 56.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.607 -1.308 . . . . 0.0 111.246 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.53 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.769 -1.207 . . . . 0.0 110.585 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.1 tp -56.66 -37.23 70.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.166 -0.959 . . . . 0.0 110.057 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.55 -35.29 67.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.0 m -98.31 -44.13 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 110.718 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -103.48 123.95 47.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.581 HG23 HD22 ' A' ' 31' ' ' ASN . 7.0 p -84.2 -24.6 30.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 109.28 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 20' ' ' VAL . 13.9 p 42.24 41.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.351 -0.843 . . . . 0.0 110.072 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -100.53 158.27 16.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 109.187 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -68.44 143.44 55.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.403 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.87 -6.91 62.6 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 47.22 60.94 4.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 -28.05 85.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.37 2.046 . . . . 0.0 111.823 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.471 ' CD2' ' O ' ' A' ' 24' ' ' GLY . 93.5 m-70 55.0 46.74 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -57.43 -35.11 69.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 108.652 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 29' ' ' GLY . 21.7 t -141.96 -114.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 28' ' ' VAL . . . -57.56 160.7 10.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.559 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 2.4 Cg_endo -53.89 137.35 68.25 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.776 1.651 . . . . 0.0 111.517 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.581 HD22 HG23 ' A' ' 19' ' ' THR . 9.1 m120 -89.37 137.76 32.04 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.82 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.9 mp -92.11 137.76 32.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 110.279 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -162.94 90.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' H ' HG22 ' A' ' 102' ' ' THR . . . 90.58 5.72 68.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.73 -21.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.556 -0.967 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -62.64 134.85 56.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.127 -0.983 . . . . 0.0 108.989 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 70.69 22.35 78.03 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -134.25 161.39 35.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -1.088 . . . . 0.0 110.147 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.3 m80 -97.6 153.49 18.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.277 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.595 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 26.8 p -66.09 158.39 28.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.888 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.34 -21.47 31.71 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.23 -36.08 78.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -1.157 . . . . 0.0 110.138 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -58.72 -44.81 90.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 109.606 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.68 -19.86 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.563 -0.71 . . . . 0.0 110.878 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -58.21 -34.25 73.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -124.06 142.33 51.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.962 . . . . 0.0 109.163 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -64.92 160.49 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 109.824 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' O ' HD11 ' A' ' 53' ' ' ILE . 36.0 m-85 -116.44 149.93 38.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.645 HG23 HBD2 ' A' ' 201' ' ' HEC . 34.9 p -75.47 162.01 28.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.05 -32.96 62.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.529 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.4 t-20 -54.0 -41.71 68.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.061 -1.024 . . . . 0.0 110.049 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 48' ' ' TYR . 97.4 mt -59.7 -47.19 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.869 -1.144 . . . . 0.0 109.213 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -60.99 -37.36 82.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.5 tttm -125.06 117.07 23.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.536 -0.728 . . . . 0.0 109.415 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 15.9 t-20 -100.25 137.27 38.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.953 . . . . 0.0 109.023 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' OH ' ' A' ' 74' ' ' TYR . 11.3 p -131.17 147.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.446 -0.783 . . . . 0.0 110.196 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.42 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.4 tp -77.97 132.95 38.07 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.3 m95 -96.59 126.96 42.14 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.213 -0.93 . . . . 0.0 110.133 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 51.5 t0 -156.06 171.66 19.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 97.1 mt-10 -58.07 -39.07 77.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 109.547 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -72.52 -48.04 43.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.067 -1.02 . . . . 0.0 109.256 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 11.9 t-20 -60.81 -37.16 81.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.453 -0.78 . . . . 0.0 109.937 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.8 mmt -58.65 -40.68 84.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 0.0 109.702 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.4 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 98.6 p -64.12 -35.43 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.114 -0.991 . . . . 0.0 109.339 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.22 -35.12 78.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 0.0 109.353 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -59.05 -47.09 86.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.45 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.501 HD11 HD23 ' A' ' 94' ' ' LEU . 20.7 mt -67.97 -29.57 68.64 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.058 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -59.28 -37.91 78.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 111.024 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -161.53 65.49 2.0 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 110.238 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -52.44 -21.29 13.54 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -77.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.954 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.5 tttt -57.45 -36.11 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.747 ' OH ' HG11 ' A' ' 57' ' ' VAL . 74.2 t80 -57.22 -51.29 69.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.746 HG22 ' O ' ' A' ' 75' ' ' ILE . 19.3 mt -148.29 76.49 10.17 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.198 -0.939 . . . . 0.0 108.621 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.9 148.81 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.103 2.535 . . . . 0.0 112.262 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.74 9.4 52.66 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.375 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -108.42 169.37 8.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 109.378 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -84.32 9.18 13.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.927 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.512 ' H ' HG23 ' A' ' 78' ' ' THR . 1.4 mtm -69.35 118.32 12.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.631 -1.293 . . . . 0.0 109.657 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.08 28.01 7.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 108.833 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.0 t80 -85.01 131.28 34.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.822 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.95 144.12 30.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 68' ' ' LEU . . . -75.9 142.86 29.22 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 mt -101.39 141.55 34.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -1.074 . . . . 0.0 108.971 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -82.64 -78.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.079 -1.013 . . . . 0.0 108.784 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -142.65 120.33 11.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 90' ' ' ASP . 82.4 tt0 -161.75 147.33 13.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -56.71 -34.58 67.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.193 -0.942 . . . . 0.0 108.657 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 90.5 m-20 -57.39 -38.21 73.91 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.308 -0.87 . . . . 0.0 108.9 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.449 ' HG3' HD12 ' A' ' 68' ' ' LEU . 64.0 ttp85 -57.53 -45.95 84.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -65.51 -43.45 90.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.466 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 2' ' ' SER . 84.7 m-20 -67.07 -39.56 86.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.334 -0.854 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.501 HD23 HD11 ' A' ' 68' ' ' LEU . 58.5 tp -55.98 -45.87 78.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.737 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.16 -40.56 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.042 -1.036 . . . . 0.0 108.903 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.7 m -60.2 -39.66 87.32 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.711 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -58.66 -50.31 74.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 109.283 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 10' ' ' PHE . 91.8 mt -69.28 -31.98 70.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 108.452 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 34.4 tttt -55.99 -46.2 78.77 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.28 -46.64 85.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.62 78.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.67 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 34' ' ' GLY . 70.0 p -93.39 1.89 56.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.921 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.661 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.79 144.63 37.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.555 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -98.29 129.25 45.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -86.25 129.47 34.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.052 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.47 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.105 -0.997 . . . . 0.0 109.286 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -104.07 126.43 8.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -61.2 137.9 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -1.212 . . . . 0.0 109.296 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -78.13 -19.24 54.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.986 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -58.38 -48.75 79.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 110.066 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -65.69 -50.77 63.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.45 -32.1 83.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -56.68 -43.91 80.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.592 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -71.87 -37.59 70.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.454 HD23 HD22 ' A' ' 94' ' ' LEU . 9.1 tp -58.75 -40.92 85.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.82 -47.02 85.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -63.42 -38.85 92.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.386 0.613 . . . . 0.0 109.963 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 8' ' ' THR . 59.4 p -69.68 -33.54 72.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 0.0 111.391 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -149.68 58.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.579 -1.326 . . . . 0.0 110.946 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.1 t -172.33 -54.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.832 -1.168 . . . . 0.0 110.291 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 -38.07 70.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.994 -1.067 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -58.79 -35.43 72.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.832 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m -96.07 -43.61 7.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.514 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.88 123.73 48.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.4 p -86.75 -23.37 25.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 0.0 109.298 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 32' ' ' LEU . 16.0 t 40.37 67.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.918 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.76 143.92 40.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.782 . . . . 0.0 109.317 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -64.23 -35.1 79.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.05 49.49 0.72 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.82 166.99 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.625 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.3 Cg_endo -74.1 -171.02 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.054 2.503 . . . . 0.0 112.021 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -105.57 134.68 48.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 29' ' ' GLY . 79.7 tttt -131.35 129.72 41.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.78 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.9 t 53.81 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.222 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -101.89 161.54 17.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.24 154.16 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.151 2.567 . . . . 0.0 112.361 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.625 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 58.5 m-20 -84.13 133.65 34.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.255 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 20' ' ' VAL . 6.8 mp -99.7 133.99 43.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 109.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -161.44 102.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 108.81 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 80.46 9.88 85.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.57 -21.32 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.599 -0.942 . . . . 0.0 109.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 102' ' ' THR . 90.4 m-85 -64.71 132.98 51.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.203 -0.935 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.04 26.11 73.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 90.2 mtt-85 -134.37 165.0 26.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -1.095 . . . . 0.0 110.021 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -100.04 147.33 25.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.582 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 9.5 m -61.3 152.89 27.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 110.118 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.51 -7.73 74.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.444 HE22 HH11 ' A' ' 38' ' ' ARG . 45.0 tt0 -64.03 -39.11 93.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.029 -1.277 . . . . 0.0 110.273 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.75 -45.44 92.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.0 -1.063 . . . . 0.0 109.556 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 58.97 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -60.96 -34.88 89.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 47' ' ' SER . 64.9 t80 -111.68 135.91 51.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -1.052 . . . . 0.0 109.352 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 35.0 m -62.57 153.79 30.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' O ' HD11 ' A' ' 53' ' ' ILE . 87.2 m-85 -116.03 148.95 39.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.417 ' OG1' HG22 ' A' ' 78' ' ' THR . 30.1 p -76.52 164.38 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.64 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -34.28 64.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 110.147 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.095 -1.003 . . . . 0.0 110.442 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 22.8 t-20 -55.04 -41.3 71.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.971 -1.081 . . . . 0.0 110.271 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.552 HD11 ' O ' ' A' ' 48' ' ' TYR . 96.9 mt -59.88 -54.54 33.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.793 -1.192 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.15 -40.39 95.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.084 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 56.4 tttm -111.43 111.96 23.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.197 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.54 136.73 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.848 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.4 p -131.11 147.37 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.866 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.2 tt -79.24 128.43 33.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.765 ' N ' HD23 ' A' ' 58' ' ' LEU . 87.8 m95 -91.63 108.22 19.75 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 52.4 p30 -136.49 176.25 8.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.574 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -61.91 -41.69 98.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.357 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.78 -51.69 60.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 110.333 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.489 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 11.7 t-20 -61.42 -35.89 78.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.63 -41.43 77.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 109.648 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 95' ' ' ILE . 35.5 m -63.24 -42.16 99.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.56 -36.9 83.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.471 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.6 t60 -57.76 -43.62 85.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 94' ' ' LEU . 86.2 mt -63.54 -28.84 70.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.464 -0.773 . . . . 0.0 109.68 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.551 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 10.0 m -81.89 125.37 30.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.2 m-20 37.52 61.55 3.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.718 . . . . 0.0 110.342 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.9 -21.52 73.2 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.645 2.23 . . . . 0.0 112.943 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.67 16.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -62.14 -36.32 81.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.54 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.848 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.0 t80 -59.9 -51.68 68.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 110.302 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.694 HG22 ' O ' ' A' ' 75' ' ' ILE . 3.0 mm -141.18 79.55 17.74 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.32 152.22 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.112 2.542 . . . . 0.0 112.735 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.17 -1.82 59.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.531 HG21 ' CG2' ' A' ' 75' ' ' ILE . 15.0 p -100.57 166.54 10.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.305 . . . . 0.0 109.949 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -81.67 2.77 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 109.342 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.6 ttt -83.57 128.38 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.847 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.61 86.78 2.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.212 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -103.07 131.64 49.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.316 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.64 145.43 38.64 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.12 32.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 52.6 mt -95.87 124.74 40.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -65.13 -35.94 82.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.795 . . . . 0.0 110.092 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.47 129.8 39.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -74.81 -33.9 62.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.576 -0.703 . . . . 0.0 109.583 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -57.2 -39.48 75.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.02 -38.08 81.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.253 -0.904 . . . . 0.0 108.936 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 85.5 mtt180 -61.47 -39.26 90.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -59.88 -40.5 88.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.6 m-20 -64.63 -41.36 96.21 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.088 -1.008 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.822 HD21 ' CBB' ' A' ' 201' ' ' HEC . 55.3 tp -61.69 -43.34 99.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.787 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 ' OG ' ' A' ' 65' ' ' SER . 89.0 mt -64.78 -35.95 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 108.899 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 3' ' ' ALA . 21.2 m -56.51 -41.12 76.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 109.913 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -64.07 -54.78 28.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.011 . . . . 0.0 110.299 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 98' ' ' LEU . 91.9 mt -68.08 -37.3 81.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.874 -1.141 . . . . 0.0 108.892 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.574 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 29.7 tttt -57.71 -40.03 78.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -59.65 -39.92 85.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.811 . . . . 0.0 109.413 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.12 -32.37 68.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.439 -0.788 . . . . 0.0 109.577 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.402 HG21 ' CD1' ' A' ' 36' ' ' PHE . 44.0 p -66.11 -25.54 67.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 -179.895 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.822 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.74 -32.98 73.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -100.55 128.22 46.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -90.48 133.12 35.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -57.11 127.69 33.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.176 -0.953 . . . . 0.0 109.387 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' -1' ' ' ALA . . . -42.31 137.67 2.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -58.24 -36.71 73.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.416 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.485 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -177.24 -146.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 88.3 mttt -87.7 7.5 29.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 109.896 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -54.81 -43.89 73.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 108.98 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -62.17 -29.29 72.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -58.86 -42.82 90.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -1.094 . . . . 0.0 109.492 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -67.35 -36.9 82.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.118 -0.989 . . . . 0.0 108.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.589 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -58.84 -40.02 83.0 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.689 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.6 t80 -66.08 -48.55 70.59 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -62.89 -38.76 92.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.928 HG23 ' O ' ' A' ' 8' ' ' THR . 68.5 p -68.17 -32.7 73.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -151.27 59.2 0.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.664 -1.273 . . . . 0.0 111.014 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.689 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.06 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.755 -1.216 . . . . 0.0 110.61 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.85 -38.69 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.0 -35.94 67.36 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 109.801 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.04 -43.03 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.988 . . . . 0.0 110.985 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.465 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.0 m-70 -105.36 129.29 53.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.185 -0.947 . . . . 0.0 110.48 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.45 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 46.8 p -89.9 -19.19 24.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 0.0 109.495 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.547 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 4.3 t 60.93 20.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.4 tt0 -104.46 138.06 41.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -59.67 -39.07 83.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.935 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -107.3 28.78 11.79 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -61.23 154.22 37.76 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.71 -3.22 13.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.891 2.394 . . . . 0.0 112.263 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 27' ' ' LYS . 79.5 m-70 59.01 66.26 1.08 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 26' ' ' HIS . 29.9 tttp -58.04 -122.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.688 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.04 -39.78 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.929 -1.107 . . . . 0.0 109.572 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.24 162.79 14.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 18.0 Cg_endo -62.59 154.31 65.81 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.966 2.444 . . . . 0.0 112.253 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.45 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 6.8 m120 -86.22 134.19 33.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.113 -0.992 . . . . 0.0 109.122 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 35' ' ' ILE . 9.7 mp -89.58 -112.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 20' ' ' VAL . 10.6 t60 79.33 90.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.797 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.73 5.45 66.58 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.61 HG21 HD23 ' A' ' 32' ' ' LEU . 3.2 tp -57.81 -20.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 90.4 m-85 -63.1 135.36 57.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.97 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 68.54 25.56 74.85 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD3' HE22 ' A' ' 42' ' ' GLN . 87.2 mtt180 -135.16 157.96 45.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -1.115 . . . . 0.0 110.057 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -91.57 152.09 20.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.499 ' CB ' ' O2A' ' A' ' 201' ' ' HEC . 60.6 p -65.77 157.75 29.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.07 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.94 -13.59 67.1 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.434 HE22 ' HD3' ' A' ' 38' ' ' ARG . 48.1 tt0 -62.58 -37.51 86.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -1.192 . . . . 0.0 110.208 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -54.5 140.08 35.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.118 -0.988 . . . . 0.0 109.513 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.92 153.16 34.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.56 -0.713 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.81 63.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.3 t80 -140.26 168.22 20.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.215 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -111.86 150.58 30.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.0 109.956 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 10.8 m-85 -109.19 151.35 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 109.513 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.705 HG23 HBD2 ' A' ' 201' ' ' HEC . 33.6 p -75.43 157.96 33.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.08 -33.33 70.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -63.73 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.39 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.5 t-20 -55.46 -44.17 76.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.04 -1.037 . . . . 0.0 110.164 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.27 -47.11 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.948 -1.095 . . . . 0.0 110.056 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -60.04 -38.57 83.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -91.75 -66.14 0.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.623 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.582 ' N ' ' O ' ' A' ' 52' ' ' ASN . 5.6 t30 66.1 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.32 -0.862 . . . . 0.0 108.922 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.819 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.1 p -131.77 149.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.36 131.55 41.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.801 ' CE2' HMA2 ' A' ' 201' ' ' HEC . 98.4 m95 -96.79 125.69 41.42 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.167 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.454 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 50.8 p30 -152.22 179.81 8.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -59.35 -42.19 90.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.729 -1.232 . . . . 0.0 110.647 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -67.98 -49.27 62.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.024 -1.048 . . . . 0.0 110.869 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.454 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 58.3 t30 -60.34 -41.41 93.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 111.271 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.656 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 61.5 mtt -61.12 -37.62 83.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.905 -1.122 . . . . 0.0 110.276 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -60.97 -43.38 98.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.018 -1.051 . . . . 0.0 109.678 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.1 -36.7 77.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.013 -1.054 . . . . 0.0 109.169 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -60.01 -46.14 90.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' CD1' HD23 ' A' ' 94' ' ' LEU . 90.1 mt -62.53 -31.46 72.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 110.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 13.1 m -85.79 127.12 34.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.943 -1.098 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' THR . 30.3 m-20 39.8 58.61 6.91 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.429 -0.794 . . . . 0.0 110.192 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.81 -20.81 53.76 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.792 2.328 . . . . 0.0 112.959 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.87 6.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.078 -1.014 . . . . 0.0 110.083 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -61.68 -33.52 74.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 109.575 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.819 ' OH ' HG11 ' A' ' 57' ' ' VAL . 71.5 t80 -57.19 -48.74 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.596 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 75' ' ' ILE . 4.2 tp -152.82 82.08 5.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.271 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.91 151.34 35.44 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.314 2.009 . . . . 0.0 112.338 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.76 1.08 58.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 p -93.21 165.72 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -92.28 14.58 15.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.143 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.3 mtm -78.9 134.46 36.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 110.078 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.05 27.13 9.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.486 -0.759 . . . . 0.0 109.048 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.53 130.56 37.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 108.94 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.68 179.29 44.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.69 146.12 23.17 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -96.02 118.14 32.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -1.195 . . . . 0.0 109.338 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -64.97 -38.48 91.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.78 128.45 34.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.0 110.351 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.4 -29.27 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.895 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -55.65 -47.11 77.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.152 -0.968 . . . . 0.0 110.093 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -63.57 -38.94 93.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.907 -1.121 . . . . 0.0 108.801 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 38.5 ttm180 -60.85 -45.19 95.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.551 -0.718 . . . . 0.0 110.035 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -66.66 -48.79 68.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.659 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 45.7 t0 -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 109.869 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 68' ' ' LEU . 47.8 tp -54.79 -47.03 74.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 0.0 110.108 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.35 -40.77 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.044 . . . . 0.0 109.266 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.1 m -59.18 -41.83 89.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.805 . . . . 0.0 110.078 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.721 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.2 t80 -60.4 -49.57 77.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.863 -1.148 . . . . 0.0 108.932 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 98' ' ' LEU . 82.9 mt -68.13 -32.06 72.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 108.562 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 41.3 tttm -54.82 -43.75 73.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -62.02 -43.22 99.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.376 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.41 -25.2 65.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.645 -0.659 . . . . 0.0 109.899 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 103' ' ' GLU . 1.2 t -50.24 -39.71 45.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.578 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' N ' ' CG2' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.801 HMA2 ' CE2' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.94 -33.21 73.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.441 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -100.19 131.23 46.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.418 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -111.19 162.19 15.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.474 -0.766 . . . . 0.0 109.335 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 109.5 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.69 125.64 8.58 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 86.1 p -60.98 -27.75 68.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 67.56 -21.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 2' ' ' SER . 33.8 tttt -58.82 -51.52 69.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.426 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -65.57 -42.23 92.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 109.201 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -61.72 -34.96 90.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.02 83.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -1.211 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 52.3 p -74.57 -38.65 62.61 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.05 -41.8 88.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.6 t80 -63.97 -45.91 87.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -62.78 -38.6 91.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.404 0.621 . . . . 0.0 110.267 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 61.9 p -72.25 -29.6 64.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 111.663 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -147.72 53.49 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.468 -1.395 . . . . 0.0 111.479 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.5 t -173.48 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.724 -1.235 . . . . 0.0 110.774 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.66 -37.55 70.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.079 -1.013 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.97 -34.8 68.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.769 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.5 m -98.14 -43.58 6.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.678 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.437 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -104.16 128.51 51.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.411 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 20' ' ' VAL . 44.7 p -93.95 -15.71 24.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.5 t 42.26 36.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLY . 85.3 tt0 -101.16 141.06 34.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.276 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -76.15 -82.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 110.203 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.58 24.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.48 150.84 49.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.612 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 72.7 Cg_endo -76.43 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.676 2.251 . . . . 0.0 111.773 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -104.03 134.66 46.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.027 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 29' ' ' GLY . 46.1 tptt -130.51 133.01 45.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.0 109.307 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' HG3' ' A' ' 27' ' ' LYS . 91.6 t 53.9 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.11 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -103.87 158.7 16.9 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 15.6 Cg_endo -57.01 146.78 78.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.059 2.506 . . . . 0.0 112.341 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.612 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 70.8 m-20 -74.1 135.55 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.001 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.443 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.0 mp -97.17 11.48 36.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -52.22 -32.39 36.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.197 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.42 56.05 0.68 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -111.77 2.34 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 48.7 m-85 -82.33 129.18 34.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.985 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.24 31.06 73.94 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -145.77 168.25 21.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.171 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.31 156.32 16.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.363 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 48' ' ' TYR . 59.5 p -58.71 -39.65 81.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 109.739 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.18 85.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.26 -36.22 72.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -1.115 . . . . 0.0 110.737 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -59.08 -32.02 69.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.892 -1.13 . . . . 0.0 109.686 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' ALA . 78.7 mm-40 42.84 -167.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.98 -41.9 2.45 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 47' ' ' SER . 71.8 t80 -123.53 136.1 54.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 109.333 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 55.1 p -69.35 159.34 33.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.638 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 95.4 m-85 -118.27 146.72 44.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.409 -0.807 . . . . 0.0 109.879 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.574 HG21 ' OG1' ' A' ' 78' ' ' THR . 61.4 m -69.75 151.88 45.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.392 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.79 -33.27 7.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.49 -68.55 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.7 t-20 -56.58 -41.81 77.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.1 . . . . 0.0 110.295 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.8 -44.32 97.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.11 -37.14 76.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 108.785 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.0 tttt -127.14 112.3 15.0 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 35.2 t-20 -97.95 134.79 40.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.79 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -130.84 145.76 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.657 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.7 tp -79.89 132.81 36.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.243 -0.91 . . . . 0.0 108.774 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.589 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 99.0 m95 -94.98 124.74 39.2 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 55.2 t0 -148.18 163.41 37.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.4 mt-10 -52.51 -40.76 62.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.919 -1.113 . . . . 0.0 109.483 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.05 -48.19 66.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 0.0 110.164 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -61.52 -38.83 88.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 110.732 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 63.1 mtt -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.079 -1.013 . . . . 0.0 109.844 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' HD11 ' A' ' 95' ' ' ILE . 90.5 p -60.9 -40.53 93.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 108.964 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.81 -35.12 79.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.107 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.474 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 69.8 t60 -61.37 -45.66 93.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.63 HD13 HD23 ' A' ' 94' ' ' LEU . 42.0 mt -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 109.868 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.536 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 17.6 m -86.01 126.15 33.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.85 -1.157 . . . . 0.0 108.725 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.434 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.8 m-20 41.77 59.33 9.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.272 -0.892 . . . . 0.0 109.751 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.52 -23.21 74.78 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.762 2.308 . . . . 0.0 112.747 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -60.55 -49.26 78.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.041 . . . . 0.0 109.609 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -64.16 -30.52 71.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.79 ' OH ' HG11 ' A' ' 57' ' ' VAL . 31.2 t80 -52.35 -46.12 66.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 108.936 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 77' ' ' GLY . 1.6 pt -141.05 153.35 66.99 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.54 -7.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.085 1.857 . . . . 0.0 112.018 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 84.02 48.41 5.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.671 HG23 ' N ' ' A' ' 79' ' ' LYS . 4.9 t -56.81 -118.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.007 . . . . 0.0 109.974 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 78' ' ' THR . 45.4 mtmt -89.64 1.46 55.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.188 -0.945 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.3 mmm -75.17 118.54 18.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 108.959 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.13 32.03 5.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.457 -0.777 . . . . 0.0 110.17 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 60.2 t80 -87.53 130.47 34.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.256 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.535 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.41 179.77 49.35 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.36 157.27 23.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.4 mt -102.46 119.03 38.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -1.14 . . . . 0.0 109.346 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -66.32 -35.72 81.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 69.0 mttm -90.32 130.76 36.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 110.294 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.03 -29.56 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.999 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.62 -52.1 66.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 91' ' ' ARG . 53.3 p30 -64.47 -30.29 71.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.639 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 39.2 ttm180 -59.45 -43.69 93.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.142 -0.974 . . . . 0.0 109.859 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -65.46 -40.5 93.26 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -0.944 . . . . 0.0 110.17 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD23 HD13 ' A' ' 68' ' ' LEU . 54.5 tp -58.19 -47.0 84.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.113 -0.992 . . . . 0.0 110.186 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.48 HD11 ' HA ' ' A' ' 65' ' ' SER . 63.2 mt -67.33 -36.17 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.011 -1.055 . . . . 0.0 108.684 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.6 m -57.68 -41.43 81.57 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.403 -0.811 . . . . 0.0 109.674 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -50.87 71.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 109.0 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.607 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.1 mt -66.74 -32.77 74.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 108.384 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 19.2 tttt -57.33 -41.63 80.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.48 -40.34 90.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.81 67.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 0.0 109.652 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -63.76 -32.04 73.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.941 . . . . 0.0 109.455 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.642 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.94 -32.73 68.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -97.89 129.03 44.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.0 109.608 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 1' ' ' GLY . 15.5 ttmt -92.27 131.54 37.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.406 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.265 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -71.11 156.47 53.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 23.7 m -56.28 -33.26 65.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 72.05 -41.04 0.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.8 tttt -58.98 -51.21 71.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.041 -1.037 . . . . 0.0 109.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -64.0 -43.13 96.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.098 -1.001 . . . . 0.0 108.984 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.97 -32.73 85.18 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.64 -42.65 79.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.192 -1.181 . . . . 0.0 109.007 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 12' ' ' THR . 52.7 p -74.19 -33.48 63.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.34 -0.85 . . . . 0.0 109.119 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.606 HD13 ' O ' ' A' ' 9' ' ' LEU . 0.3 OUTLIER -60.35 -42.18 95.2 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.685 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.0 t80 -69.07 -47.37 65.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -62.67 -39.24 93.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.67 -0.644 . . . . 0.0 110.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 8' ' ' THR . 73.3 p -69.36 -32.53 71.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 111.399 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -150.76 58.06 0.93 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.53 -1.356 . . . . 0.0 111.526 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.685 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 6.3 t -170.59 -43.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.757 -1.215 . . . . 0.0 110.128 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.54 -35.91 73.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 109.656 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.8 -37.21 73.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.5 m -93.25 -41.3 9.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.646 ' ND1' HD11 ' A' ' 32' ' ' LEU . 87.4 m-70 -107.73 127.08 53.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.402 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 43.2 p -87.69 -20.39 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.613 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 20' ' ' VAL . 5.7 t 57.65 29.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 110.189 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.17 149.06 25.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -60.47 -36.22 77.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 109.337 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.98 41.31 1.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -62.81 156.49 40.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -4.74 15.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.953 2.435 . . . . 0.0 112.196 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 27' ' ' LYS . 73.1 m-70 60.49 65.85 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 26' ' ' HIS . 14.6 tttt -57.04 -118.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.83 -40.36 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.68 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.76 162.86 19.91 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 16.6 Cg_endo -60.6 150.52 81.46 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.917 2.411 . . . . 0.0 111.952 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.443 ' OD1' ' C ' ' A' ' 24' ' ' GLY . 5.4 m120 -81.24 140.46 34.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.292 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.676 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.9 mp -98.28 140.85 31.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.024 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -171.18 97.01 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.427 -0.795 . . . . 0.0 109.064 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.29 6.76 74.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -58.81 -23.37 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.523 -0.986 . . . . 0.0 109.81 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.74 133.74 51.7 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.08 78.91 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 64.5 mmt-85 -135.81 161.55 35.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -1.091 . . . . 0.0 109.711 -179.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -88.78 156.69 18.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 1.8 t -61.07 149.36 37.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.81 63.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -60.59 -38.34 84.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -1.218 . . . . 0.0 109.859 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.752 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.18 139.13 48.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.083 -1.01 . . . . 0.0 109.069 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -117.79 150.62 38.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 109.434 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.45 62.85 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.7 t80 -136.25 157.83 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.3 t -98.77 148.52 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.752 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 m-85 -109.81 141.67 42.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.509 -0.744 . . . . 0.0 110.043 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.704 ' H ' ' CGD' ' A' ' 201' ' ' HEC . 51.7 m -73.47 146.94 44.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 53' ' ' ILE . 92.2 m-20 -51.7 -36.31 46.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.766 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -42.71 -71.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.034 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 56' ' ' ASN . 26.9 t-20 -52.88 -40.12 63.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 0.0 110.367 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 50' ' ' ASP . 79.2 mt -56.8 -54.17 32.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.862 -1.149 . . . . 0.0 109.415 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -62.47 -38.52 90.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.084 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.2 mttm -99.26 25.44 6.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.475 -0.766 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 52' ' ' ASN . 36.7 t-20 -43.64 126.55 4.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.018 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.854 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -135.53 152.11 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 110.122 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -71.2 133.63 46.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 40' ' ' SER . 98.1 m95 -96.41 123.76 40.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.229 -0.92 . . . . 0.0 110.107 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 55.1 p30 -152.93 176.66 11.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -60.11 -39.37 85.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.128 . . . . 0.0 110.665 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -70.37 -56.44 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.926 -1.109 . . . . 0.0 110.47 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.567 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 46.2 t30 -59.55 -38.8 82.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.66 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.5 mmt -59.29 -40.53 86.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.961 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 95' ' ' ILE . 43.1 m -60.16 -40.37 89.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.523 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.17 -33.2 75.23 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.949 -1.095 . . . . 0.0 109.446 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.49 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 71.3 t60 -59.74 -47.72 84.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.376 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.1 mp -67.84 -30.54 69.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.584 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 28.1 m -60.74 -38.82 86.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.908 -1.12 . . . . 0.0 110.41 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -154.15 67.03 5.62 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.049 . . . . 0.0 109.796 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.27 -22.04 72.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.571 2.181 . . . . 0.0 113.061 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 -71.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.974 -1.079 . . . . 0.0 109.651 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -59.7 -24.28 63.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.854 ' OH ' HG11 ' A' ' 57' ' ' VAL . 18.6 t80 -55.36 -46.29 76.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.922 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.67 HD12 HG21 ' A' ' 78' ' ' THR . 2.1 pt -142.47 78.78 16.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.155 -0.966 . . . . 0.0 109.91 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -69.25 137.42 36.9 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 C-N-CA 123.039 2.492 . . . . 0.0 111.94 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.71 2.79 62.86 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.538 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -98.6 170.4 8.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.295 . . . . 0.0 109.675 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -90.94 13.89 15.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.908 . . . . 0.0 110.603 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.818 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -74.67 122.48 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.75 30.59 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.016 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 63.9 t80 -89.69 131.15 35.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.044 -1.035 . . . . 0.0 109.406 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -85.88 176.37 49.12 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.37 159.45 25.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.98 122.98 44.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 0.0 109.293 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.49 -35.59 81.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.98 128.51 36.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 110.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -28.51 60.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 109.889 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -55.6 -47.33 76.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.185 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.32 -39.16 93.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.886 -1.134 . . . . 0.0 108.898 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.584 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.6 ttp180 -61.0 -43.41 98.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -58.63 -47.21 85.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.009 -1.057 . . . . 0.0 109.62 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 2' ' ' SER . 88.7 m-20 -66.79 -39.42 87.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.92 -45.84 85.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 65' ' ' SER . 75.4 mt -65.12 -36.79 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.015 -1.053 . . . . 0.0 108.344 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.0 m -57.24 -41.32 79.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.594 -0.691 . . . . 0.0 109.59 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -62.29 -52.53 63.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.28 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.4 mt -66.19 -32.92 74.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 108.495 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 13.8 tttp -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.561 -0.712 . . . . 0.0 109.091 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -61.15 -39.89 91.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.436 -0.79 . . . . 0.0 109.538 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.64 64.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.54 -0.725 . . . . 0.0 109.718 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 103' ' ' GLU . 1.3 t -52.72 -39.69 62.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 109.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.704 ' CGD' ' H ' ' A' ' 49' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.8 -31.7 71.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -123.33 170.21 10.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.752 ' O ' ' HB2' ' A' ' -1' ' ' ALA . 35.0 ttpt -49.97 -56.82 9.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.221 -0.924 . . . . 0.0 111.176 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' -2' ' ' LYS . . . 160.88 28.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.426 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -39.83 98.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' -1' ' ' ALA . 40.4 p -129.25 34.57 4.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.48 149.2 23.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 110.285 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -56.43 -25.73 51.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.584 -0.697 . . . . 0.0 109.762 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -45.52 -50.92 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.234 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.62 -34.83 87.76 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -63.37 -49.7 72.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.126 . . . . 0.0 109.476 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' THR . 25.3 m -61.25 -39.12 89.16 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.274 -0.892 . . . . 0.0 108.761 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.679 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -53.98 -41.63 68.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.4 t80 -61.25 -47.04 87.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.44 -38.03 89.58 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.638 . . . . 0.0 109.933 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 8' ' ' THR . 49.4 p -68.11 -36.32 79.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.48 -0.763 . . . . 0.0 111.315 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -151.9 61.23 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.0 110.712 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -172.37 -47.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.959 -1.088 . . . . 0.0 110.161 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.21 -37.67 72.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.818 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -58.14 -35.25 71.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 109.866 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.2 m -96.57 -42.5 8.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.7 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.462 ' CE1' HD11 ' A' ' 32' ' ' LEU . 93.5 m-70 -109.19 124.04 50.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.947 . . . . 0.0 109.881 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' GLU . 36.3 p -89.03 -18.18 27.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 t 61.84 -8.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' THR . 97.1 mt-10 -60.67 136.56 58.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.924 -1.11 . . . . 0.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -78.54 -39.67 37.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.83 -7.78 55.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.77 155.72 52.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.44 -166.52 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.723 2.282 . . . . 0.0 111.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -101.3 90.41 4.1 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -59.99 -41.7 92.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.108 -0.995 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.39 -71.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.546 -0.721 . . . . 0.0 109.153 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -76.65 159.62 49.91 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 5.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 112.834 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.7 OUTLIER 64.78 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 110.126 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.71 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.6 mp -95.92 143.48 27.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -172.51 91.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 109.045 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.38 6.35 74.28 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.73 -20.19 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.478 -1.013 . . . . 0.0 109.609 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.6 m-85 -60.4 131.31 50.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.95 29.45 73.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HD3' HE22 ' A' ' 42' ' ' GLN . 89.6 mtt180 -140.52 164.41 30.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -1.226 . . . . 0.0 110.255 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -92.69 159.59 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 0.0 109.705 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.48 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 22.6 t -71.03 154.22 41.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.073 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.96 51.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.438 HE22 ' HD3' ' A' ' 38' ' ' ARG . 49.7 tt0 -62.54 -36.09 81.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.272 . . . . 0.0 109.95 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -58.7 -32.74 69.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 109.716 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ALA . 95.6 mt-10 42.04 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.17 -39.39 1.63 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 44' ' ' GLU . 63.7 t80 -116.15 134.1 55.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.488 -1.007 . . . . 0.0 108.99 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 45.6 m -63.12 153.16 35.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.967 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' O ' HD11 ' A' ' 53' ' ' ILE . 66.5 m-85 -114.5 145.89 41.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.514 -0.741 . . . . 0.0 109.359 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -79.39 166.55 21.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.19 -31.7 61.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.771 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 75' ' ' ILE . . . -46.67 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.741 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.6 t-20 -55.87 -41.33 74.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.12 -0.988 . . . . 0.0 110.79 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 48' ' ' TYR . 80.2 mt -59.44 -50.27 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.912 -1.118 . . . . 0.0 109.854 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -59.89 -36.52 77.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.5 ttpp -128.01 117.43 21.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.536 -0.728 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.64 136.73 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 108.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.938 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.06 147.32 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -75.63 132.25 40.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.59 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 76.1 m95 -93.69 125.88 38.55 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.052 -1.03 . . . . 0.0 109.841 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.7 t0 -152.74 170.35 20.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -55.77 -39.93 71.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.765 -1.21 . . . . 0.0 109.498 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -66.19 -48.25 71.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -63.97 -40.41 96.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 110.791 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.9 mtt -60.79 -38.7 86.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 110.075 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -60.75 -45.48 94.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 109.216 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.69 -33.37 75.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.951 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -57.76 -44.04 85.86 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.509 -0.744 . . . . 0.0 109.158 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 HD23 ' A' ' 94' ' ' LEU . 93.3 mt -67.43 -25.38 65.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.549 -0.719 . . . . 0.0 109.852 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.589 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 24.5 m -85.43 131.05 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.013 -1.054 . . . . 0.0 109.836 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 69' ' ' THR . 3.2 t-20 38.8 56.6 5.45 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 0.0 110.713 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.76 -14.75 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.773 2.315 . . . . 0.0 112.222 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.19 72.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 109.762 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -84.83 3.9 35.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.144 -0.972 . . . . 0.0 109.04 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.938 ' OH ' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -108.31 124.52 50.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.405 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.596 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 44.7 pt 38.23 54.09 4.0 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.463 -0.773 . . . . 0.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 75' ' ' ILE . 18.2 Cg_endo -61.33 -18.65 60.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.756 2.304 . . . . 0.0 112.249 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.27 21.88 29.4 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.4 p -116.03 156.01 27.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.278 -1.131 . . . . 0.0 110.043 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 80' ' ' MET . 22.8 mttm -60.31 -29.93 69.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 79' ' ' LYS . 4.7 ttt -38.62 115.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.43 0.633 . . . . 0.0 110.351 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.17 29.38 8.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.25 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 54.9 t80 -65.63 134.42 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.434 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.25 179.21 49.47 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.56 151.46 21.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.507 HD11 HD21 ' A' ' 9' ' ' LEU . 57.2 mt -105.07 121.34 43.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -1.113 . . . . 0.0 109.626 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -66.74 -34.03 76.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -84.07 116.7 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 109.994 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 97.3 mt-10 -72.22 -35.88 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.83 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -58.43 -38.74 78.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.687 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.19 -37.27 77.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 80.6 mtm180 -60.03 -43.02 95.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -57.58 -42.61 83.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 110.828 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD1' ' CA ' ' A' ' 1' ' ' GLY . 75.2 m-20 -67.27 -39.92 86.12 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.812 -1.18 . . . . 0.0 109.95 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.84 HD21 ' CBB' ' A' ' 201' ' ' HEC . 55.2 tp -61.97 -45.77 92.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.689 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.58 -42.17 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 109.618 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 43.8 m -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.435 -0.79 . . . . 0.0 110.732 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 84.0 t80 -60.7 -44.71 96.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.066 -1.021 . . . . 0.0 110.922 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.444 HD21 ' CE1' ' A' ' 10' ' ' PHE . 80.2 mt -62.79 -37.68 87.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.813 -1.18 . . . . 0.0 109.874 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 9.3 mtpt -58.77 -37.0 75.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.092 -1.005 . . . . 0.0 109.188 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.5 -42.34 91.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.357 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.63 -33.78 75.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 52.1 p -68.67 -24.66 64.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.496 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.84 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -102.14 140.27 36.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' -2' ' ' LYS . 75.8 t80 -100.71 129.52 46.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.864 . . . . 0.0 109.685 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.598 ' O ' ' CD2' ' A' ' -3' ' ' PHE . 45.6 mtpt -83.24 172.57 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.09 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.625 ' C ' HG21 ' A' ' 96' ' ' THR . . . 88.02 81.47 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -120.2 142.86 48.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.454 -1.027 . . . . 0.0 109.147 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 7' ' ' ALA . . . -78.2 -82.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.097 -1.002 . . . . 0.0 109.642 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 3' ' ' ALA . 47.5 tptt 42.27 -99.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.408 -0.808 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' ALA . 34.7 mttp -61.9 -42.77 99.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . . . -63.39 -51.63 65.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.172 -1.193 . . . . 0.0 109.785 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 12' ' ' THR . 52.8 p -71.93 -38.18 69.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.269 -0.895 . . . . 0.0 109.198 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 85' ' ' LEU . 8.0 tp -58.35 -41.01 83.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.681 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.4 t80 -63.38 -46.8 84.77 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -62.7 -38.48 90.57 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.425 0.631 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 8' ' ' THR . 57.5 p -71.16 -30.43 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 111.532 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -148.54 55.37 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.326 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.52 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.742 -1.224 . . . . 0.0 110.871 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -55.61 -37.12 67.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.202 -0.936 . . . . 0.0 109.984 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.36 -34.77 69.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.3 m -98.98 -43.52 6.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.896 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.595 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -104.16 130.02 51.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.528 ' C ' ' H ' ' A' ' 21' ' ' GLU . 19.6 p -91.08 -24.19 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.506 -0.746 . . . . 0.0 109.892 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.2 1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.253 -0.904 . . . . 0.0 110.054 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.4 tt0 -98.48 124.76 43.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.983 -1.073 . . . . 0.0 109.534 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -70.9 -40.23 72.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.23 -37.65 93.3 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.58 155.99 44.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.622 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 63.2 Cg_endo -74.3 -156.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.746 2.298 . . . . 0.0 111.701 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.406 ' HA ' HD22 ' A' ' 31' ' ' ASN . 78.8 m-70 -104.03 132.28 50.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 19' ' ' THR . 26.0 mttt -102.09 -147.96 0.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 54.7 t -49.82 -41.43 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.894 -1.129 . . . . 0.0 109.861 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.33 159.37 14.09 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.04 152.05 67.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.84 2.36 . . . . 0.0 111.922 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.622 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 67.4 m-20 -83.84 139.94 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 109.61 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 32' ' ' LEU . 5.3 mp -96.69 139.78 32.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.664 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 52.2 p-80 -173.8 92.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.027 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.9 6.77 69.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.72 -23.3 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.989 . . . . 0.0 109.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -64.65 135.81 56.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.066 -1.021 . . . . 0.0 109.278 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.67 24.27 72.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -125.31 151.28 46.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -1.077 . . . . 0.0 109.386 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 40' ' ' SER . 1.9 t-160 -120.18 135.64 54.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.823 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER 80.52 -176.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' A' ' 48' ' ' TYR . . . -82.65 70.26 3.21 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.17 -36.68 75.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.236 . . . . 0.0 110.071 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -55.66 141.37 38.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.05 . . . . 0.0 109.394 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.0 164.09 20.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.589 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.96 -9.8 56.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 59.7 t80 -134.43 141.13 46.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -1.113 . . . . 0.0 109.082 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.6 p -71.62 159.32 34.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 17.6 m-85 -119.09 147.84 43.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.52 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.664 HG23 HBD2 ' A' ' 201' ' ' HEC . 51.8 p -79.16 159.49 27.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.299 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.39 -30.78 67.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.694 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.22 -75.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.721 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.4 t-20 -55.39 -42.98 74.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.925 -1.109 . . . . 0.0 110.687 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.33 -49.35 84.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.714 -1.241 . . . . 0.0 109.271 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -60.59 -37.45 81.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 52' ' ' ASN . 16.4 tttt -125.4 113.24 17.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.8 m-20 -103.5 143.91 32.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.41 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.831 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -132.43 149.47 32.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.611 -0.681 . . . . 0.0 109.841 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.1 tp -74.32 128.65 36.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 108.673 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.426 ' CH2' HMA2 ' A' ' 201' ' ' HEC . 97.0 m95 -95.57 123.69 39.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 48.7 p30 -161.18 -174.43 4.34 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.51 -42.8 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.834 -1.166 . . . . 0.0 110.22 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -70.91 -53.88 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.148 -0.97 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 37.9 t30 -59.08 -38.58 79.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 110.525 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 7.8 mmt -58.87 -40.91 85.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.662 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.8 p -66.25 -34.82 78.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.28 -0.887 . . . . 0.0 109.587 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -35.7 80.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 109.496 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.04 -47.03 86.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' CD1' HD23 ' A' ' 94' ' ' LEU . 87.2 mt -68.54 -31.44 70.68 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -58.61 -37.89 76.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -162.75 67.02 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.901 -1.124 . . . . 0.0 110.074 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -51.49 -19.34 6.94 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.977 2.451 . . . . 0.0 112.42 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.35 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -56.67 -34.26 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.831 ' OH ' HG11 ' A' ' 57' ' ' VAL . 65.6 t80 -55.22 -51.04 67.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.729 HG22 ' O ' ' A' ' 75' ' ' ILE . 17.3 mt -147.66 80.14 9.14 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 108.729 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.79 149.52 12.58 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.924 2.416 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.14 0.46 55.98 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 80' ' ' MET . 9.9 t -100.57 171.25 7.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -84.65 9.37 13.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.484 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.522 ' H ' HG23 ' A' ' 78' ' ' THR . 3.1 mtm -73.83 119.68 18.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 0.0 110.011 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.13 26.97 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 59.3 t80 -76.5 133.05 39.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.572 -0.705 . . . . 0.0 109.504 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.9 175.57 50.37 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.71 147.01 18.43 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.404 HD11 HD21 ' A' ' 9' ' ' LEU . 54.1 mt -99.71 134.82 42.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.261 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -92.04 -4.43 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -100.93 127.59 47.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.016 . . . . 0.0 109.929 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.61 -38.23 48.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 110.132 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -60.41 -48.79 80.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.54 -40.23 95.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.682 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.93 -41.73 92.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.104 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.7 m-20 -61.02 -39.8 91.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.302 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 91.1 m-20 -62.05 -40.73 96.73 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.101 -0.999 . . . . 0.0 109.904 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 ' CBB' ' A' ' 201' ' ' HEC . 55.3 tp -61.22 -43.88 98.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.57 -42.96 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.625 HG21 ' C ' ' A' ' 1' ' ' GLY . 26.7 m -62.38 -37.75 86.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.55 -46.97 83.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.092 . . . . 0.0 110.304 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.666 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.4 mt -65.29 -38.38 90.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.104 . . . . 0.0 109.616 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.59 -36.65 79.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -59.05 -42.96 91.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.323 -0.861 . . . . 0.0 109.436 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.21 79.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 p -70.73 -23.5 62.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.666 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.291 0.567 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.78 -33.41 74.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.56 ' CE2' ' ND2' ' A' ' 92' ' ' ASN . 52.2 t80 -101.98 131.24 48.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.52 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.8 ptmt -104.18 161.6 13.89 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.23 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.12 24.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -138.73 164.25 25.75 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -110.92 131.14 55.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -1.102 . . . . 0.0 109.295 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 100' ' ' LYS . . . -74.48 -18.27 60.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.042 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -57.52 -48.46 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.061 -1.024 . . . . 0.0 109.969 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.02 -51.92 48.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.926 -1.109 . . . . 0.0 109.748 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -65.35 -30.67 78.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -1.199 . . . . 0.0 110.054 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.916 ' O ' HG23 ' A' ' 12' ' ' THR . 59.6 p -72.71 -37.33 67.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.133 -0.979 . . . . 0.0 109.534 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 94' ' ' LEU . 6.9 tp -58.92 -41.63 87.73 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -62.78 -46.74 86.63 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -63.6 -38.27 90.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.421 0.629 . . . . 0.0 110.079 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.47 -34.99 75.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 111.61 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -149.94 58.17 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.525 -1.36 . . . . 0.0 111.356 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.6 t -172.97 -48.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.153 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.89 -37.22 71.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 109.6 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.39 -34.63 69.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 0.0 109.547 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.1 m -96.5 -44.21 7.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.695 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.637 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -105.81 124.8 50.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.243 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.531 ' C ' HG23 ' A' ' 20' ' ' VAL . 53.1 p -84.3 -27.06 28.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.695 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' C ' ' A' ' 19' ' ' THR . 1.9 t 64.22 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' THR . 78.2 mm-40 -92.48 120.98 33.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.89 -1.131 . . . . 0.0 109.622 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 55.2 pttt -69.96 -39.99 75.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.4 -36.76 90.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.43 157.25 49.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.625 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 59.1 Cg_endo -73.02 -156.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.27 134.57 48.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 29' ' ' GLY . 36.2 tttt -130.46 127.01 38.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.466 -0.771 . . . . 0.0 109.079 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 29' ' ' GLY . 49.4 t 53.42 -84.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.299 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -100.44 161.76 18.91 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.0 152.69 73.71 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.979 2.453 . . . . 0.0 112.203 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.625 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 59.6 m-20 -81.71 140.52 34.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.69 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.2 mp -98.05 139.41 33.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -172.0 95.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.204 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.68 7.02 75.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.54 -23.77 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.294 -1.121 . . . . 0.0 109.565 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CD1' HG21 ' A' ' 102' ' ' THR . 96.2 m-85 -70.41 132.11 45.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 75.13 20.33 79.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.482 ' CZ ' ' OE1' ' A' ' 42' ' ' GLN . 31.0 mtp180 -140.85 167.0 23.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -1.186 . . . . 0.0 110.015 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -93.72 156.73 16.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.469 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 24.9 p -66.15 167.1 10.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.684 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.5 -8.14 61.97 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.482 ' OE1' ' CZ ' ' A' ' 38' ' ' ARG . 19.7 tt0 -61.58 -38.3 87.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.676 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.94 75.08 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.42 -31.76 73.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.47 -35.81 62.31 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 47' ' ' SER . 54.9 t80 -112.29 131.99 55.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.394 -1.063 . . . . 0.0 109.302 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -67.65 156.77 36.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.865 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.676 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 55.4 m-85 -111.21 145.39 38.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.521 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -75.74 161.65 28.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.67 -34.66 67.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -0.905 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . -48.08 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.329 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 22.2 t-20 -52.62 -41.62 63.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.042 . . . . 0.0 110.305 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.9 mt -59.02 -55.59 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.18 -36.69 84.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ASN . 43.7 tttm -102.33 33.34 3.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.484 ' N ' ' O ' ' A' ' 52' ' ' ASN . 24.0 t-20 -46.69 131.55 11.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.848 -1.157 . . . . 0.0 108.694 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.927 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.6 p -133.79 150.53 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.251 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.47 130.61 38.21 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.488 ' CH2' HMA2 ' A' ' 201' ' ' HEC . 97.5 m95 -97.24 123.23 40.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 56.2 p30 -149.59 176.28 10.78 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.82 -40.46 88.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.061 -1.024 . . . . 0.0 111.004 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -72.29 -57.2 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.953 -1.092 . . . . 0.0 110.646 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.587 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 13.7 t-20 -60.46 -39.66 88.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.411 -0.805 . . . . 0.0 110.799 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.413 ' SD ' ' CE3' ' A' ' 59' ' ' TRP . 42.8 tpp -59.15 -39.49 82.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.008 . . . . 0.0 109.745 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.515 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.1 m -60.76 -40.68 93.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.72 -33.54 74.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 77.9 t60 -61.26 -48.0 83.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD2' HD23 ' A' ' 94' ' ' LEU . 6.8 mp -57.81 -31.09 66.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.539 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 23.5 m -84.99 125.03 32.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.979 -1.076 . . . . 0.0 109.225 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' THR . 12.5 m120 41.75 59.6 9.29 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.69 -21.32 58.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.72 -59.1 5.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 109.981 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -62.25 -32.52 73.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.515 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.927 ' OH ' HG11 ' A' ' 57' ' ' VAL . 66.8 t80 -57.75 -48.73 78.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 75' ' ' ILE . 2.7 tp -163.23 79.9 1.64 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.983 -1.073 . . . . 0.0 109.265 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.89 -21.25 7.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.823 2.349 . . . . 0.0 112.769 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -56.55 -27.23 54.1 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 p -77.49 163.06 26.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -1.203 . . . . 0.0 110.068 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -78.47 5.36 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.0 ttt -79.7 141.92 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.507 -0.746 . . . . 0.0 111.145 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.79 85.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 81.7 t80 -103.36 134.89 45.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.81 . . . . 0.0 110.094 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -72.63 142.02 31.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.69 152.47 49.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HD21 ' A' ' 9' ' ' LEU . 56.8 mt -97.23 125.2 41.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.25 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.31 -39.75 94.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.35 128.42 35.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.984 -1.072 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.15 -34.72 61.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -58.22 -45.35 87.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.152 -0.968 . . . . 0.0 109.938 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.91 -38.66 89.23 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.128 -0.982 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.7 ttp180 -59.06 -41.39 87.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.497 -0.752 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' -3' ' ' PHE . 1.3 t-20 -59.12 -41.86 89.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 110.17 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 89.1 m-20 -62.4 -39.8 94.42 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.043 -1.036 . . . . 0.0 109.964 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.762 HD21 ' CBB' ' A' ' 201' ' ' HEC . 51.9 tp -59.0 -43.61 91.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.873 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.515 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 85.0 mt -64.65 -37.17 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 m -59.52 -40.65 87.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.459 -0.775 . . . . 0.0 109.94 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.052 . . . . 0.0 110.644 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 102' ' ' THR . 89.3 mt -67.05 -38.45 85.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 9.7 mtpm? -58.3 -40.54 82.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.061 . . . . 0.0 109.732 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 3' ' ' ALA . 99.2 mttt -61.64 -45.43 94.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 109.667 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 109.534 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 98' ' ' LEU . 50.2 p -69.63 -21.14 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.421 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.762 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -5' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' -4' ' ' GLU . 16.9 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -4' ' ' GLU . . . . . 0.51 ' O ' ' O ' ' A' ' -5' ' ' THR . 84.2 tt0 57.29 150.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 109.793 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -128.91 166.29 19.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.9 ttpt -63.31 128.15 34.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.26 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -92.41 152.38 21.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 53.5 p -69.29 155.51 40.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.38 -10.08 21.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.785 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -59.22 -49.48 77.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.01 -46.8 79.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.387 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.38 -30.87 79.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.17 89.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.891 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -72.44 -38.74 68.23 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 94' ' ' LEU . 9.0 tp -59.2 -40.9 87.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.8 t80 -62.86 -46.7 86.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -63.14 -38.89 92.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.669 -0.645 . . . . 0.0 109.955 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.97 -33.12 71.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 111.453 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.77 57.62 1.04 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.571 -1.331 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.667 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.2 t -172.56 -53.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.854 -1.153 . . . . 0.0 110.28 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.09 -37.63 72.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.014 -1.054 . . . . 0.0 109.811 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.33 -35.28 71.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.862 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -96.96 -43.42 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.618 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 90.6 m-70 -106.0 125.34 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 20' ' ' VAL . 52.4 p -89.52 -20.66 23.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 32' ' ' LEU . 8.0 t 40.97 69.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.696 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.17 155.17 27.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -61.7 -35.72 78.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.576 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.29 20.96 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.3 166.49 50.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 55.3 Cg_endo -70.62 -177.82 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.96 2.44 . . . . 0.0 112.12 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -106.34 136.7 45.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.393 -0.817 . . . . 0.0 109.263 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -105.78 -127.97 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.333 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.27 -39.71 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.081 -1.012 . . . . 0.0 109.565 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.83 165.21 16.73 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 27.5 Cg_endo -63.69 150.46 88.4 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.843 2.362 . . . . 0.0 112.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.48 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 37.5 m-20 -80.64 138.63 36.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.268 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.733 HD12 ' N ' ' A' ' 32' ' ' LEU . 6.9 mp -97.89 137.48 36.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.134 -0.979 . . . . 0.0 109.888 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -166.35 100.24 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 108.991 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.06 7.89 79.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 tt -59.5 -22.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.555 -0.968 . . . . 0.0 109.716 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.659 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 78.7 m-85 -66.15 133.58 50.98 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.03 19.51 78.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.533 ' HG3' HE22 ' A' ' 42' ' ' GLN . 32.8 mmt180 -135.66 163.29 30.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.325 -1.103 . . . . 0.0 109.826 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -90.17 161.53 15.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.495 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 24.8 t -63.17 148.71 47.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.84 . . . . 0.0 109.787 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.6 -10.07 62.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.533 HE22 ' HG3' ' A' ' 38' ' ' ARG . 10.0 tt0 -61.39 -38.35 86.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.006 -1.291 . . . . 0.0 109.722 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -61.55 -30.51 70.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.977 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 49.96 177.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 46' ' ' TYR . . . 80.61 -165.3 47.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 45' ' ' GLY . 33.3 t80 37.07 -127.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.611 -0.935 . . . . 0.0 109.749 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 30.1 t -158.44 146.14 18.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.57 138.75 50.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.48 -0.762 . . . . 0.0 109.343 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 78' ' ' THR . 41.9 p -79.85 162.54 24.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.895 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.21 -32.73 68.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.528 -0.733 . . . . 0.0 110.071 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' A' ' 78' ' ' THR . . . -51.59 -75.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.045 -1.034 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.2 t-20 -54.0 -41.65 68.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.933 -1.105 . . . . 0.0 110.319 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.05 -51.04 77.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.78 -1.2 . . . . 0.0 109.53 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -61.0 -38.57 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.951 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 52' ' ' ASN . 85.7 tttt -117.96 110.43 17.7 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -98.44 138.77 35.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 109.084 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.743 HG11 ' OH ' ' A' ' 74' ' ' TYR . 10.6 p -130.39 147.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.565 -0.71 . . . . 0.0 109.948 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -78.77 131.92 36.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.59 ' CZ2' HMA2 ' A' ' 201' ' ' HEC . 88.6 m95 -95.5 124.71 39.66 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.217 -0.927 . . . . 0.0 110.101 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.5 t0 -152.66 166.52 31.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.562 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.17 -39.7 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.69 -1.256 . . . . 0.0 109.217 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.51 -47.97 62.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -61.31 -40.71 95.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 110.712 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.5 mtt -60.21 -36.79 78.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 0.0 109.686 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -59.5 -42.97 93.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 109.156 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.18 -34.5 76.41 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.27 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.563 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 81.9 t60 -58.03 -45.46 86.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.541 ' CD1' HD23 ' A' ' 94' ' ' LEU . 79.9 mt -68.1 -29.88 68.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.419 -0.801 . . . . 0.0 110.212 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 29.1 m -57.68 -38.12 74.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.042 -1.036 . . . . 0.0 110.528 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 69' ' ' THR . 15.9 m120 -163.45 67.73 1.67 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 109.795 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -51.92 -27.74 29.04 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.975 2.45 . . . . 0.0 112.705 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.38 1.84 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 109.527 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -61.42 -29.88 70.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.246 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.743 ' OH ' HG11 ' A' ' 57' ' ' VAL . 40.4 t80 -58.46 -49.36 77.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.858 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 74' ' ' TYR . 7.9 pt -139.9 75.48 30.13 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.012 -1.055 . . . . 0.0 110.046 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.24 138.55 51.76 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.919 2.413 . . . . 0.0 112.576 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.41 -6.81 63.49 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.89 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 51' ' ' ALA . 71.5 p -88.64 164.06 15.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.365 . . . . 0.0 110.415 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -85.12 2.02 45.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.9 ttt -81.77 127.74 33.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.951 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.93 87.08 2.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 69.7 t80 -103.34 131.55 50.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.335 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -67.87 142.78 40.58 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.63 145.34 31.39 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 9' ' ' LEU . 55.0 mt -98.81 134.21 42.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.468 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -93.76 -5.81 47.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -110.32 119.27 38.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.92 -33.57 73.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 110.446 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.88 -56.27 24.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.04 . . . . 0.0 110.018 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -62.36 -38.9 91.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.57 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -58.65 -42.19 87.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.85 . . . . 0.0 109.865 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.95 -39.14 88.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.168 -0.957 . . . . 0.0 110.385 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 83.8 m-20 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.737 HD21 ' CBB' ' A' ' 201' ' ' HEC . 56.1 tp -59.76 -45.17 93.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.8 mt -66.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 0.0 108.85 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.1 m -59.11 -39.01 80.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.48 -52.2 66.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.546 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.0 mt -66.53 -32.94 74.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.067 -1.021 . . . . 0.0 108.401 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.562 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 19.1 tttp -56.65 -42.25 78.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.38 -39.08 85.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.755 . . . . 0.0 109.328 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.77 -31.19 68.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.554 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.1 p -67.33 -23.9 65.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.966 . . . . 0.0 109.509 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.737 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -57.64 145.2 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 68.0 t80 -97.28 128.86 44.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 1' ' ' GLY . 44.3 mtpt -87.65 172.35 9.78 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -40.57 -22.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.271 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 78.08 81.29 0.66 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.51 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.4 p -72.14 166.76 21.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.738 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.04 21.23 5.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.836 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -92.53 -70.98 0.67 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -63.86 -45.22 90.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 110.247 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.669 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -60.3 -39.39 96.01 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.997 -1.097 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.31 71.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -1.192 . . . . 0.0 109.948 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 12' ' ' THR . 53.5 p -74.46 -35.37 63.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 85' ' ' LEU . 7.3 tp -57.28 -40.86 78.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 64.4 t80 -62.88 -46.84 85.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -63.95 -39.18 93.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.742 -0.599 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' THR . 57.4 p -68.8 -35.01 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 111.495 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -151.77 60.53 0.87 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.628 -1.295 . . . . 0.0 110.876 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -172.84 -47.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 0.0 109.625 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.48 -37.15 77.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -58.54 -37.74 76.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.12 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.3 m -93.5 -40.85 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 32' ' ' LEU . 88.4 m-70 -106.91 132.89 52.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.099 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 21' ' ' GLU . 30.0 p -103.41 -4.33 24.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' H ' ' A' ' 32' ' ' LEU . 2.8 t 45.99 16.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.999 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.61 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 85.0 tt0 -104.27 137.3 42.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.952 . . . . 0.0 109.465 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -76.83 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 109.891 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -51.37 -17.01 2.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' GLY . . . -41.18 164.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.16 -12.31 29.44 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.274 2.649 . . . . 0.0 112.084 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 1.3 m80 60.97 97.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.237 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' HG21 ' A' ' 19' ' ' THR . 51.5 mttm -74.6 -167.8 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 110.017 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG1' ' NZ ' ' A' ' 79' ' ' LYS . 55.9 t -50.49 -45.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 109.989 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.53 149.2 22.45 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.86 148.54 91.8 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.392 2.062 . . . . 0.0 111.741 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.61 ' ND2' ' O ' ' A' ' 21' ' ' GLU . 36.2 m-20 -84.35 138.73 32.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.065 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.83 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.6 mp -93.76 140.45 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.633 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.583 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 49.5 p-80 -174.07 90.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.102 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.58 4.79 65.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.19 -22.58 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -1.131 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.1 m-85 -65.62 133.99 52.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.159 -0.963 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.81 72.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.588 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 68.0 mtt85 -145.75 168.75 19.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.0 110.247 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.8 m80 -97.89 157.5 16.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.829 . . . . 0.0 110.119 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 2.6 m -61.33 163.91 6.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.662 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -6.08 59.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 19.4 tt0 -62.14 -38.94 90.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 0.0 110.101 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.93 77.2 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.57 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.34 -33.05 74.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.502 -0.749 . . . . 0.0 109.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.14 -35.08 68.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 47' ' ' SER . 65.7 t80 -113.36 135.1 54.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.407 -1.055 . . . . 0.0 109.385 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 57.4 p -72.61 162.35 29.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.636 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 60.8 m-85 -114.41 148.17 38.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 109.599 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.2 p -75.26 160.65 30.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.6 -35.43 68.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.788 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -46.56 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.4 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t-20 -52.21 -41.94 63.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.038 -1.039 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.6 mt -57.59 -53.44 44.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.843 -1.161 . . . . 0.0 109.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.88 -38.79 92.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.7 mttm -101.64 28.65 5.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 109.886 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 52' ' ' ASN . 60.5 t30 -43.88 127.55 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 108.946 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.898 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.4 p -135.18 153.2 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -70.46 136.0 49.12 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.598 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 78.8 m95 -97.75 126.59 43.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 110.34 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.9 t0 -150.9 163.82 37.77 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.543 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.5 mt-10 -54.82 -39.77 68.87 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.51 -47.66 66.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.079 -1.013 . . . . 0.0 110.251 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.24 -39.78 91.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.652 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.1 mtt -59.89 -37.96 80.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 109.807 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.5 m -58.98 -41.45 87.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.034 -1.041 . . . . 0.0 109.075 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.84 -32.77 72.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.921 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.446 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 77.1 t60 -56.87 -48.88 77.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 110.279 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.681 ' CD2' HD23 ' A' ' 94' ' ' LEU . 9.4 mp -73.61 -20.79 60.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -57.76 -36.41 72.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.687 -1.258 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.92 68.23 3.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.206 -0.934 . . . . 0.0 109.945 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.3 -18.7 64.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.577 2.185 . . . . 0.0 113.031 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.18 69.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.421 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -94.38 -5.36 46.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.898 ' OH ' HG11 ' A' ' 57' ' ' VAL . 28.0 t80 -63.84 -46.1 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.643 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.921 HD12 HG21 ' A' ' 78' ' ' THR . 1.8 pt -136.96 72.88 53.72 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.188 -0.945 . . . . 0.0 109.923 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 18.2 Cg_exo -62.53 136.84 61.05 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.655 2.237 . . . . 0.0 111.486 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.48 15.87 48.6 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.687 -1.245 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.921 HG21 HD12 ' A' ' 75' ' ' ILE . 6.6 t -117.52 165.84 13.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.146 -1.208 . . . . 0.0 109.567 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.636 ' NZ ' ' CG1' ' A' ' 28' ' ' VAL . 6.4 mtmp? -86.07 6.48 28.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.284 -0.885 . . . . 0.0 111.255 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.734 ' H ' HG23 ' A' ' 78' ' ' THR . 3.4 ttt -74.95 116.67 15.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.72 31.57 6.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 86.5 t80 -84.99 131.96 34.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -82.73 176.94 53.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.36 166.55 24.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.602 -1.285 . . . . 0.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 HD21 ' A' ' 9' ' ' LEU . 63.4 mt -106.66 124.55 49.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -1.076 . . . . 0.0 109.423 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.7 -38.13 89.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -85.28 128.17 34.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.55 -33.07 54.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 110.125 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -57.01 -50.1 73.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.004 . . . . 0.0 110.071 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.82 -39.01 92.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.174 -0.954 . . . . 0.0 108.779 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -59.79 -40.68 89.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.756 -0.59 . . . . 0.0 109.947 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.85 -43.55 85.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 58.9 t0 -62.48 -39.25 92.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.878 HD21 ' CBB' ' A' ' 201' ' ' HEC . 57.8 tp -59.04 -45.48 90.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.54 -38.83 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.047 . . . . 0.0 108.824 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.1 m -59.0 -39.76 82.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.562 -0.711 . . . . 0.0 109.732 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.28 -48.65 80.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 0.0 108.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 10' ' ' PHE . 84.5 mt -69.12 -31.81 70.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.543 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 20.8 tttm -56.01 -43.49 77.76 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -61.55 -43.64 98.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.783 . . . . 0.0 109.387 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.89 69.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.738 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -62.23 -32.76 73.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.878 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 144.18 40.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -99.44 129.69 45.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -82.87 141.95 31.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.408 -0.808 . . . . 0.0 109.172 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -44.79 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 70.14 126.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' A' ' 93' ' ' ASP . 84.2 p -63.27 -19.41 64.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.177 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 60.11 -143.55 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.401 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 56.06 -79.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.702 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 3' ' ' ALA . 65.4 mttp -58.31 -43.52 88.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -58.98 -33.95 76.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.86 88.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.566 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 12' ' ' THR . 58.8 p -72.54 -36.21 68.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.131 -0.981 . . . . 0.0 109.038 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 85' ' ' LEU . 8.1 tp -58.14 -40.89 82.47 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 71.2 t80 -63.46 -46.93 83.99 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -62.92 -38.18 89.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.64 -0.663 . . . . 0.0 110.133 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 8' ' ' THR . 51.7 p -70.81 -31.16 67.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 111.481 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -148.13 54.88 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.562 -1.336 . . . . 0.0 111.357 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.6 t -173.37 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 110.829 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.52 -37.07 69.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 83.4 mt-30 -56.3 -32.88 65.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.3 m -101.5 -44.76 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 0.0 110.838 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -103.64 121.93 43.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.073 -1.017 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.535 ' C ' HG23 ' A' ' 20' ' ' VAL . 47.8 p -81.9 -24.64 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 65.55 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -98.86 120.49 39.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.075 -1.016 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 14.5 pttp -69.85 -40.05 76.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.613 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.92 -36.55 90.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.15 155.43 49.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.476 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.54 -156.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.61 137.25 47.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.276 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -110.71 -124.78 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.795 . . . . 0.0 109.114 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.63 -40.73 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.38 163.08 22.0 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -61.17 145.6 98.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.883 2.389 . . . . 0.0 112.353 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.476 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 42.1 m-20 -68.0 145.97 53.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 109.029 179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.834 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.3 tp -101.85 119.18 38.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.168 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 35' ' ' ILE . 85.2 t60 -154.1 134.33 13.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.041 -1.037 . . . . 0.0 109.875 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 102' ' ' THR . . . 44.43 15.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 33' ' ' HIS . 3.7 tp -58.22 -22.49 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.427 -1.043 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.664 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 92.2 m-85 -63.64 136.77 57.74 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.172 -0.955 . . . . 0.0 109.283 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.09 32.34 72.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 58' ' ' LEU . 60.6 mmt-85 -127.29 152.06 47.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -1.14 . . . . 0.0 110.153 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.913 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.5 m80 -109.49 142.15 40.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.742 . . . . 0.0 109.933 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 39' ' ' HIS . 7.4 p 49.44 174.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.634 0.731 . . . . 0.0 110.599 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.7 72.31 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' SER . 44.0 tt0 -60.17 -35.07 74.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -1.18 . . . . 0.0 110.003 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.51 -34.78 69.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.899 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 46.54 -176.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.24 -13.05 68.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 47' ' ' SER . 85.7 t80 -136.63 146.41 45.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 108.962 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 44.1 m -62.23 147.45 47.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.744 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -119.75 142.37 48.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 109.339 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.587 ' N ' ' O1D' ' A' ' 201' ' ' HEC . 56.9 m -72.84 143.82 47.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.95 . . . . 0.0 109.072 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -49.29 -33.73 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 109.311 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 49' ' ' THR . . . -47.99 -71.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 110.228 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.6 t-20 -57.51 -40.38 78.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.79 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.645 ' O ' ' ND2' ' A' ' 56' ' ' ASN . 67.4 mt -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.867 -1.145 . . . . 0.0 109.936 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.16 -52.7 57.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.971 -1.081 . . . . 0.0 109.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 56' ' ' ASN . 32.8 tttp -67.68 -47.62 68.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.943 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.645 ' ND2' ' O ' ' A' ' 53' ' ' ILE . 37.0 m-20 38.42 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.645 . . . . 0.0 109.876 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 74' ' ' TYR . 7.1 p -123.18 149.82 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 110.172 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.913 HD13 ' CE1' ' A' ' 39' ' ' HIS . 49.9 tp -66.09 134.13 52.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.572 ' CZ2' HMA2 ' A' ' 201' ' ' HEC . 92.8 m95 -98.03 130.89 44.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -156.13 164.84 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.533 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.7 mt-10 -53.89 -40.17 66.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 109.273 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -67.76 -47.98 67.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.908 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 64.7 t30 -63.75 -40.35 96.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.664 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.9 mtt -59.92 -37.9 80.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 109.688 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -60.32 -41.58 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.081 -1.012 . . . . 0.0 108.974 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.88 -34.38 77.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.189 -0.944 . . . . 0.0 109.074 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.472 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 61.8 t60 -59.57 -47.28 86.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 94' ' ' LEU . 71.7 mt -71.59 -34.04 69.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 30.9 m -58.66 -38.35 77.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 110.828 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -161.65 67.76 2.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.96 -1.087 . . . . 0.0 109.803 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.31 -24.71 8.83 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.144 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -63.72 -59.84 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.506 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.91 -34.12 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.028 -1.045 . . . . 0.0 109.429 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 21.6 t80 -54.97 -44.74 74.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.508 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.8 OUTLIER -139.78 154.67 71.13 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 108.885 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.24 6.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.573 2.182 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 75' ' ' ILE . . . 88.2 50.44 3.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.883 HG23 ' H ' ' A' ' 80' ' ' MET . 14.6 t -55.64 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.612 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -59.57 -24.81 64.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.099 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.883 ' H ' HG23 ' A' ' 78' ' ' THR . 63.5 mtm -68.88 120.22 14.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.23 26.12 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 65.0 t80 -55.87 136.23 51.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.706 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.03 -179.68 51.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.5 146.69 17.72 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 9' ' ' LEU . 55.9 mt -97.22 135.96 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 109.056 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -91.1 -6.55 53.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.097 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -103.53 127.22 50.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.32 -38.54 55.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -60.52 -47.93 84.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.99 -39.91 95.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.55 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 61.7 ttp180 -59.58 -43.62 93.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -61.52 -37.13 82.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -0.969 . . . . 0.0 109.59 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' A' ' 2' ' ' SER . 90.4 m-20 -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 68' ' ' LEU . 51.8 tp -61.57 -46.25 90.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 110.359 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.1 -41.0 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.048 . . . . 0.0 109.029 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 33.5 m -59.6 -39.68 85.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.825 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.74 -49.19 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.923 -1.11 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 32' ' ' LEU . 94.0 mt -68.18 -32.14 72.17 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 29.1 tttm -57.71 -42.84 84.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.582 -0.699 . . . . 0.0 109.284 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -61.63 -43.71 98.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.398 -0.813 . . . . 0.0 109.769 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.98 -38.93 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 36' ' ' PHE . 51.1 p -72.47 -29.03 63.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.539 -0.726 . . . . 0.0 109.831 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.641 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.82 -33.53 74.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 109.462 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 89.7 t80 -102.41 131.0 49.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.999 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.1 ttpt -84.08 139.95 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.15 -24.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 52.21 169.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -124.53 125.85 44.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -1.063 . . . . 0.0 109.069 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -70.24 -22.82 62.86 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.38 -53.86 53.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 110.208 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -67.3 -50.57 59.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.876 -1.14 . . . . 0.0 109.621 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.525 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.63 -31.04 78.57 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.146 . . . . 0.0 109.857 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.887 ' O ' HG23 ' A' ' 12' ' ' THR . 66.4 p -73.62 -39.77 64.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.142 -0.974 . . . . 0.0 109.42 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 HD13 ' A' ' 94' ' ' LEU . 8.8 tp -59.97 -41.23 91.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.6 t80 -62.07 -46.12 90.53 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -63.47 -37.63 88.02 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 109.967 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 8' ' ' THR . 56.9 p -70.43 -33.9 71.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 111.74 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -149.58 56.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.519 -1.363 . . . . 0.0 111.491 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -173.06 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.74 -1.225 . . . . 0.0 110.192 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.79 -37.36 73.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.976 . . . . 0.0 109.942 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.72 -35.07 70.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.95 . . . . 0.0 109.826 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -96.73 -43.11 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.658 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -107.21 123.79 48.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' GLU . 44.2 p -86.07 -23.9 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' LEU . 2.4 t 59.28 -1.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.298 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.3 tt0 -97.36 124.06 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 109.53 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 24.6 pttm -68.41 -41.4 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.885 . . . . 0.0 109.191 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -63.12 -34.84 91.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.2 157.56 51.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.74 -161.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' CD2' ' CG ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -103.64 125.24 50.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.398 -0.814 . . . . 0.0 109.106 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -101.53 -159.59 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.5 t -51.3 -41.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.13 149.98 17.13 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.31 147.36 94.09 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.495 2.13 . . . . 0.0 112.6 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -61.74 138.71 58.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.308 -0.87 . . . . 0.0 109.111 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.793 ' CD2' HD13 ' A' ' 98' ' ' LEU . 14.6 tp -106.54 118.67 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.229 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -158.92 127.16 5.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.785 -1.197 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 55.8 12.17 4.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.66 HG21 HD11 ' A' ' 32' ' ' LEU . 2.8 tp -60.07 -21.63 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.362 -1.081 . . . . 0.0 109.835 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 90.5 m-85 -62.88 139.16 58.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.055 -1.028 . . . . 0.0 109.38 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.95 22.73 77.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -136.29 160.09 39.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -1.095 . . . . 0.0 109.804 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' CE1' HD13 ' A' ' 58' ' ' LEU . 78.0 m80 -94.34 158.39 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.385 -0.822 . . . . 0.0 109.443 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.454 ' CB ' ' O2A' ' A' ' 201' ' ' HEC . 77.1 p -62.08 159.41 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.76 5.36 88.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -60.85 -35.21 75.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.46 -1.024 . . . . 0.0 110.226 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.53 -35.05 69.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.112 -0.992 . . . . 0.0 109.719 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.0 mt-10 42.2 18.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.583 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -118.65 -36.63 0.89 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.465 ' CG ' ' CD2' ' A' ' 26' ' ' HIS . 78.9 t80 -110.65 136.41 49.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.544 -0.974 . . . . 0.0 109.14 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 38.5 m -59.61 153.1 20.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.959 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.555 ' CD2' ' O1D' ' A' ' 201' ' ' HEC . 24.2 m-85 -117.5 158.84 23.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.356 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.56 ' H ' ' CGD' ' A' ' 201' ' ' HEC . 26.1 p -74.74 158.51 33.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.247 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.79 -30.86 67.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.67 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.532 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.5 t-20 -52.35 -44.03 64.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 53' ' ' ILE . 42.0 mm -59.71 -40.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.619 -1.301 . . . . 0.0 109.284 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.34 -37.75 84.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASN . 43.6 tttp -125.72 114.51 18.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 31.2 t-20 -95.16 134.88 37.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.094 -1.004 . . . . 0.0 109.289 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.849 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.2 p -131.39 146.83 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -81.59 133.95 35.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 108.968 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -97.95 127.57 43.98 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.195 -0.941 . . . . 0.0 110.207 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.3 t0 -151.92 167.81 27.15 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -57.47 -36.06 70.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.893 -1.13 . . . . 0.0 109.653 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -76.23 -57.5 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.895 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -63.48 -41.18 98.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.642 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 59.0 ttm -59.27 -36.31 75.31 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.542 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.4 p -62.75 -35.88 81.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.554 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.28 -35.94 82.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.45 -43.39 96.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 0.0 110.045 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.609 ' CD2' HD23 ' A' ' 94' ' ' LEU . 7.0 mp -62.36 -31.7 72.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.873 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 18.0 m -88.16 129.84 35.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 109.541 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 69' ' ' THR . 74.0 m-20 38.64 54.98 4.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.748 . . . . 0.0 110.496 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 9.5 Cg_endo -54.97 -14.68 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.568 2.179 . . . . 0.0 111.102 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 74' ' ' TYR . . . -63.2 154.17 32.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.2 tttt 67.23 -36.52 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.858 -0.526 . . . . 0.0 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.849 ' OH ' HG11 ' A' ' 57' ' ' VAL . 86.5 t80 -60.25 -50.01 75.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.073 -1.017 . . . . 0.0 109.579 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.683 HG22 ' O ' ' A' ' 75' ' ' ILE . 3.8 mm -140.87 77.2 21.71 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.136 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.57 151.4 11.69 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 123.095 2.53 . . . . 0.0 112.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 21.09 27.82 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 80' ' ' MET . 12.1 t -123.51 164.7 18.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.303 -1.116 . . . . 0.0 109.797 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -81.77 4.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 109.69 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.506 ' H ' HG23 ' A' ' 78' ' ' THR . 11.9 ttp -79.8 131.74 35.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.907 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.08 70.18 1.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 76.6 t80 -102.89 134.44 46.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -81.83 174.36 53.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.91 161.89 27.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 mt -102.83 128.07 49.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -1.116 . . . . 0.0 109.194 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -65.18 -44.21 89.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.951 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -90.09 129.52 36.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.483 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -73.37 -32.37 64.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 109.76 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -56.18 -48.32 76.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 0.0 109.464 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.24 -37.6 77.94 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 0.0 109.262 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.55 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 34.0 ttm180 -57.81 -41.78 82.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -59.49 -40.49 87.17 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 80.1 m-20 -64.27 -40.05 95.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.169 -0.957 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.716 HD21 ' CBB' ' A' ' 201' ' ' HEC . 46.6 tp -62.62 -44.74 95.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.02 -36.91 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.11 -0.994 . . . . 0.0 108.563 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.6 m -57.31 -40.84 78.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.552 -0.717 . . . . 0.0 109.646 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -60.06 -51.78 68.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 109.382 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' CD2' ' A' ' 32' ' ' LEU . 91.9 mt -65.31 -35.41 80.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 12.7 tttp -57.28 -40.38 77.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -59.44 -40.3 86.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.98 67.79 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.474 -0.766 . . . . 0.0 109.466 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.6 p -67.89 -23.13 65.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.532 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.716 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.66 -33.05 73.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -100.4 127.08 46.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 109.54 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 1' ' ' GLY . 32.7 ttpt -94.82 130.85 41.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.944 . . . . 0.0 109.267 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -48.64 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.212 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -105.53 135.19 12.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.8 p -69.58 153.54 43.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -1.226 . . . . 0.0 109.203 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -93.36 -10.23 36.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.797 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -59.48 -47.76 84.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.109 -0.995 . . . . 0.0 109.923 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -67.2 -50.73 59.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.48 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.59 -32.82 85.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -57.92 -45.26 86.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.132 -1.217 . . . . 0.0 109.639 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 12' ' ' THR . 51.8 p -71.95 -37.61 69.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 94' ' ' LEU . 9.9 tp -59.45 -41.35 89.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.7 t80 -63.74 -45.81 88.2 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -62.61 -39.85 95.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.661 -0.65 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 8' ' ' THR . 56.6 p -71.58 -37.06 71.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 111.665 -178.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -140.49 54.38 1.61 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.775 -1.203 . . . . 0.0 110.899 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -170.95 -53.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.696 -1.252 . . . . 0.0 110.616 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.94 -37.9 72.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.034 -1.041 . . . . 0.0 109.687 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.25 -35.74 72.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.829 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.2 m -95.73 -43.18 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.57 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.473 ' ND1' HD13 ' A' ' 32' ' ' LEU . 88.4 m-70 -105.32 129.88 53.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.345 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' GLU . 63.0 p -95.45 -8.13 36.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.01 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' LEU . 2.7 m 32.3 36.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.209 0.528 . . . . 0.0 110.72 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -104.15 133.7 48.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -82.48 139.4 33.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.14 76.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.34 165.19 12.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.14 172.11 16.64 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.115 2.543 . . . . 0.0 111.99 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -105.15 135.62 46.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.351 -0.843 . . . . 0.0 109.153 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 18.0 tptt -104.65 -126.48 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 109.005 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.13 -39.66 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.129 -0.982 . . . . 0.0 109.064 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.44 160.65 20.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 20.9 Cg_endo -62.34 149.43 90.78 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.035 2.49 . . . . 0.0 112.498 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.54 ' C ' HD12 ' A' ' 32' ' ' LEU . 36.6 m-20 -77.72 126.21 30.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 32' ' ' LEU . 8.2 mp -100.0 132.02 45.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.18 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -160.97 102.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.28 77.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.681 -1.767 . . . . 0.0 108.681 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 tt -57.7 -21.72 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.49 -1.006 . . . . 0.0 109.391 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CD2' ' OE2' ' A' ' 61' ' ' GLU . 96.0 m-85 -62.86 135.52 57.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 108.932 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.94 20.67 80.02 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -133.67 162.4 32.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -1.086 . . . . 0.0 110.035 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -94.72 168.6 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.499 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 20.8 t -83.96 146.38 28.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.63 -6.84 70.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.75 -37.62 87.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.138 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -60.21 -43.52 95.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.097 -1.002 . . . . 0.0 109.427 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 58.11 -21.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -59.91 -33.93 80.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CD2' ' O ' ' A' ' 47' ' ' SER . 76.6 t80 -115.13 140.29 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -1.011 . . . . 0.0 109.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.7 t -65.66 151.99 45.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.594 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 37.0 m-85 -111.73 147.75 34.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.564 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 p -75.86 164.35 26.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.22 -31.22 61.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.392 -0.818 . . . . 0.0 109.258 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' C ' ' A' ' 77' ' ' GLY . . . -48.84 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 110.638 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.606 ' HA ' HD12 ' A' ' 75' ' ' ILE . 23.5 t-20 -57.42 -41.56 80.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.952 -1.093 . . . . 0.0 110.641 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 48' ' ' TYR . 84.4 mt -60.25 -44.66 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.845 -1.16 . . . . 0.0 109.83 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -59.35 -37.54 78.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.94 . . . . 0.0 109.271 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 76.6 tttt -132.14 121.33 23.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.444 -0.785 . . . . 0.0 109.215 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.81 136.52 40.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.724 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.5 p -130.93 147.73 33.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.523 -0.736 . . . . 0.0 110.055 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.7 tp -77.73 133.78 38.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 108.95 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' GLY . 93.2 m95 -93.86 127.75 39.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.375 -0.828 . . . . 0.0 109.856 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.6 t0 -148.96 167.97 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' CD2' ' A' ' 36' ' ' PHE . 79.0 mm-40 -58.03 -39.36 78.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.988 -1.07 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -78.69 -48.67 14.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 14.7 t-20 -59.89 -39.23 84.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.573 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 42.4 tpp -60.3 -38.92 85.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.551 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -61.47 -33.79 74.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.801 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.51 -36.03 81.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.885 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.408 ' NE2' ' CE ' ' A' ' 80' ' ' MET . 81.3 t60 -59.31 -43.79 92.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 68' ' ' LEU . 5.3 mp -67.77 -27.15 66.51 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.999 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.546 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 25.5 m -81.16 128.48 33.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.973 . . . . 0.0 110.379 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 69' ' ' THR . 11.7 t-20 32.54 59.81 1.42 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.849 -0.532 . . . . 0.0 111.312 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.2 Cg_endo -61.8 135.65 57.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 111.699 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 71' ' ' PRO . . . 162.04 -86.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.391 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.51 -28.96 61.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.724 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.8 t80 -54.83 -51.98 64.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 109.53 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.749 HG22 ' O ' ' A' ' 75' ' ' ILE . 9.5 mm -152.08 73.18 7.79 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.136 -0.977 . . . . 0.0 108.787 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.96 150.59 18.2 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.894 2.396 . . . . 0.0 112.34 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 107.01 15.29 16.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -124.17 156.99 35.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -1.083 . . . . 0.0 109.414 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -84.6 5.38 28.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 0.0 110.948 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.474 ' O ' ' C ' ' A' ' 81' ' ' ALA . 4.5 ttt -55.45 -40.14 71.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.793 -1.192 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 80' ' ' MET . . . 33.69 75.08 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.722 -0.611 . . . . 0.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -106.22 131.44 53.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.28 140.14 30.44 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.98 150.84 41.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.6 mt -96.19 133.67 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -1.146 . . . . 0.0 109.164 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -87.5 -12.72 45.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -101.6 126.18 48.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.83 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.12 -36.68 61.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.932 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.0 -45.06 93.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.07 -39.35 94.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.135 -0.978 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.546 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 39.1 ttm180 -59.12 -41.78 88.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.779 . . . . 0.0 109.966 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.9 -40.82 94.56 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.08 -1.013 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 84.5 m-20 -64.35 -41.27 96.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.966 -1.084 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.752 HD21 ' CBB' ' A' ' 201' ' ' HEC . 50.8 tp -59.25 -43.1 92.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.082 -1.012 . . . . 0.0 109.376 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG2' ' OE1' ' A' ' 61' ' ' GLU . 81.0 mt -66.19 -36.15 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.186 -0.946 . . . . 0.0 108.78 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 m -57.31 -41.35 79.71 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.604 -0.685 . . . . 0.0 109.843 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -63.18 -52.94 60.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 110.306 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 10' ' ' PHE . 94.3 mt -70.02 -39.85 75.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 108.965 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' O ' ' OG1' ' A' ' 102' ' ' THR . 84.0 tttt -58.88 -40.24 83.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.716 . . . . 0.0 109.347 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -60.39 -40.15 89.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.534 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.03 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 109.667 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 38.9 p -64.69 -25.43 67.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.464 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.752 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.68 -32.96 73.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -3' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 70.1 t80 -100.61 129.03 46.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.517 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.595 ' O ' ' CE2' ' A' ' -3' ' ' PHE . 48.5 mtmt -86.42 170.89 11.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.65 -24.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.508 -0.745 . . . . 0.0 109.798 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 101.31 97.28 2.29 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -119.72 136.93 54.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.98 . . . . 0.0 109.07 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.73 131.03 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.771 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -175.22 -91.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -63.31 -37.66 88.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 108.718 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.9 -36.73 91.05 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.81 75.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -1.134 . . . . 0.0 109.588 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -74.0 -32.27 63.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.159 -0.963 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -56.65 -41.8 77.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 68.0 t80 -63.5 -47.08 83.17 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -63.27 -38.74 92.33 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.434 0.635 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 8' ' ' THR . 57.3 p -70.4 -32.92 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 111.483 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -148.58 57.44 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.667 -1.271 . . . . 0.0 111.166 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -173.33 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.854 -1.153 . . . . 0.0 110.322 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.87 -37.7 71.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.799 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.52 -34.92 69.61 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.718 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -97.41 -43.67 7.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 110.681 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -105.11 124.43 49.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 110.203 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.4 p -87.22 -18.34 30.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 109.31 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 61.57 19.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 24' ' ' GLY . 49.0 tp10 -99.82 140.6 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.348 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -82.2 -81.7 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.14 -28.61 19.03 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 21' ' ' GLU . . . -59.22 156.05 26.31 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.618 ' O ' ' ND2' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.3 -174.48 1.62 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.84 2.36 . . . . 0.0 111.948 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -105.72 135.13 47.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 109.251 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -97.86 -126.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 108.908 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.34 -39.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.109 -0.995 . . . . 0.0 109.044 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 165.56 19.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 22.9 Cg_endo -62.68 148.23 93.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.968 2.445 . . . . 0.0 111.991 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.618 ' ND2' ' O ' ' A' ' 25' ' ' PRO . 38.6 m-20 -80.13 137.48 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.088 -1.007 . . . . 0.0 109.46 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.679 HD12 ' N ' ' A' ' 32' ' ' LEU . 7.8 mp -100.08 135.57 41.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.923 . . . . 0.0 109.835 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -164.14 98.41 0.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 108.975 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.94 8.61 82.17 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.28 -23.16 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.479 -1.012 . . . . 0.0 109.494 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 102' ' ' THR . 96.2 m-85 -67.17 135.34 53.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 73.95 20.73 79.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HD3' HE22 ' A' ' 42' ' ' GLN . 95.0 mtt180 -137.01 165.22 26.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.936 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.38 154.54 17.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.523 ' CB ' HD22 ' A' ' 52' ' ' ASN . 37.1 p -65.88 160.88 22.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.956 . . . . 0.0 109.899 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.61 57.18 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.432 HE22 ' HD3' ' A' ' 38' ' ' ARG . 52.0 tt0 -62.23 -36.73 82.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.262 . . . . 0.0 109.931 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.818 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.57 140.24 47.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 109.381 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.97 153.37 41.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.786 . . . . 0.0 109.354 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.87 0.42 64.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 47' ' ' SER . 59.8 t80 -136.38 156.04 49.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.205 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.537 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.9 t -95.55 147.3 23.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.645 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.818 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 49.4 m-85 -103.21 141.99 34.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.378 -0.826 . . . . 0.0 109.785 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 78' ' ' THR . 47.2 m -74.4 149.98 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.479 -0.763 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.64 -33.73 23.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.809 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -73.14 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.523 HD22 ' CB ' ' A' ' 40' ' ' SER . 14.2 t30 -54.51 -41.0 69.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.029 . . . . 0.0 110.306 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.11 -46.4 94.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.838 -1.164 . . . . 0.0 109.456 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -60.48 -37.21 80.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 108.94 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ASN . 25.9 tttt -127.84 116.9 20.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 32.7 t-20 -101.87 134.99 44.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.12 179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.65 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -131.99 148.24 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.438 -0.788 . . . . 0.0 109.892 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.5 tt -79.66 132.26 36.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.794 ' N ' HD23 ' A' ' 58' ' ' LEU . 99.7 m95 -92.88 110.08 21.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.056 -1.027 . . . . 0.0 109.688 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 54.8 t0 -136.31 168.92 18.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.02 -37.36 69.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.902 -1.124 . . . . 0.0 109.293 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.75 -56.57 6.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.9 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -62.34 -38.96 91.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.828 . . . . 0.0 110.397 -179.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.5 tpp -58.75 -40.56 84.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.691 ' HA ' HD11 ' A' ' 95' ' ' ILE . 19.7 m -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 109.276 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.13 -31.44 72.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.047 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.474 ' CE1' ' CD1' ' A' ' 74' ' ' TYR . 75.2 t60 -57.48 -47.49 81.75 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.439 -0.788 . . . . 0.0 109.597 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.523 ' CD1' HD23 ' A' ' 94' ' ' LEU . 72.8 mt -68.37 -30.52 69.47 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.7 m -62.46 -39.81 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.015 -1.053 . . . . 0.0 110.641 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -150.95 65.93 7.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.073 -1.017 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.63 -20.74 69.76 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.572 2.181 . . . . 0.0 112.776 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.9 -50.38 64.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.652 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -86.62 -6.36 58.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 110.046 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.65 ' OH ' HG11 ' A' ' 57' ' ' VAL . 44.6 t80 -62.47 -49.67 74.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 ' CD1' ' A' ' 74' ' ' TYR . 6.7 pt -140.7 72.26 29.79 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.04 135.67 64.69 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.49 2.127 . . . . 0.0 112.204 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 14.62 50.09 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.15 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.721 ' HA ' HG21 ' A' ' 49' ' ' THR . 14.9 t -104.61 171.44 7.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.816 -1.403 . . . . 0.0 110.064 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -94.61 14.06 22.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 0.0 110.318 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' MET . . . . . 0.625 ' H ' HG23 ' A' ' 78' ' ' THR . 2.1 mmm -67.5 135.05 52.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 0.0 109.889 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.25 26.01 10.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 57.2 t80 -91.79 130.16 37.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -85.48 177.05 50.09 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.91 158.07 30.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -102.95 135.05 45.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.0 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -92.65 -4.62 53.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.795 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -103.02 130.81 50.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.005 . . . . 0.0 109.805 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.31 -44.87 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.454 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -60.17 -48.26 82.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.018 . . . . 0.0 110.301 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.63 -39.04 93.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -58.92 -42.31 89.38 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.3 m-20 -61.62 -40.37 94.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.07 -1.019 . . . . 0.0 110.384 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.37 -40.08 96.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.026 -1.046 . . . . 0.0 110.001 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.644 HD22 HD23 ' A' ' 9' ' ' LEU . 59.0 tp -57.26 -45.75 83.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 65' ' ' SER . 77.3 mt -66.53 -43.64 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 m -60.71 -39.74 89.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.352 -0.843 . . . . 0.0 109.917 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -58.09 -49.18 77.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.043 . . . . 0.0 109.729 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.733 ' O ' HG23 ' A' ' 102' ' ' THR . 85.8 mt -69.09 -35.59 76.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.038 . . . . 0.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 10.9 tptm -57.84 -43.34 85.78 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.388 -0.82 . . . . 0.0 109.517 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -61.04 -45.44 94.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.176 -0.952 . . . . 0.0 109.693 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.0 74.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 109.511 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 98' ' ' LEU . 54.8 p -70.28 -21.01 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.457 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.656 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -5' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' -4' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -4' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' -5' ' ' THR . 95.5 mt-10 41.97 -154.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.462 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -96.4 127.48 42.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' -1' ' ' ALA . 34.6 ttpt -102.54 136.36 42.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.99 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -98.23 134.27 11.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 22.8 t -57.19 -33.48 67.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -1.123 . . . . 0.0 109.288 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 73.32 -35.77 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.2 tttt -59.14 -48.9 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.52 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.62 -42.81 98.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.36 -32.16 81.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.9 93.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -1.17 . . . . 0.0 109.474 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 12' ' ' THR . 47.4 p -72.51 -36.38 68.35 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.572 HD23 HD13 ' A' ' 94' ' ' LEU . 7.1 tp -58.33 -41.49 84.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.3 t80 -63.54 -46.85 84.11 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -63.31 -39.65 95.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 8' ' ' THR . 65.3 p -70.41 -34.43 72.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.419 -0.8 . . . . 0.0 111.7 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -150.27 59.97 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.626 -1.296 . . . . 0.0 110.933 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -173.08 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.962 -1.086 . . . . 0.0 109.997 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -36.32 72.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.967 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -56.45 -35.35 67.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.024 -1.048 . . . . 0.0 109.496 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.9 m -97.26 -48.84 5.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.263 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.2 m-70 -99.3 113.43 25.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.741 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.0 p -82.58 -19.15 39.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.73 HG22 ' O ' ' A' ' 20' ' ' VAL . 8.0 p 36.86 41.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.6 tt0 -101.67 147.95 25.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -56.57 -36.58 69.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -55.44 -30.94 56.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 25' ' ' PRO . . . 64.66 56.54 16.33 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 24' ' ' GLY . 33.1 Cg_endo -67.79 -23.78 41.35 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.787 2.325 . . . . 0.0 112.019 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 93.1 m-70 54.77 57.9 5.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.644 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' HIS . 45.1 tttm -58.98 -122.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.342 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.05 -40.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 109.883 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.52 167.47 14.95 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.29 152.29 61.49 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.004 2.469 . . . . 0.0 112.263 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 26' ' ' HIS . 16.2 m120 -89.17 140.83 29.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.273 -0.892 . . . . 0.0 109.044 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.817 HD12 ' N ' ' A' ' 32' ' ' LEU . 4.8 mp -92.83 140.39 29.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.932 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 33' ' ' HIS . 47.6 p-80 -176.06 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 93.98 3.8 63.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.19 -21.56 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.449 -1.03 . . . . 0.0 109.524 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 102' ' ' THR . 82.3 m-85 -66.94 132.32 47.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.8 24.33 76.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 86.3 mtt-85 -133.12 159.1 41.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -1.133 . . . . 0.0 109.95 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -90.93 147.38 23.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 3.4 t -63.13 155.91 26.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.79 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.79 -13.92 59.08 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 44' ' ' GLU . 51.4 tt0 -62.3 -37.1 84.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 109.804 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -64.85 70.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.897 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLN . 97.2 mt-10 -60.51 -31.28 70.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.11 -32.84 50.64 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 47' ' ' SER . 60.3 t80 -122.3 142.03 50.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -1.04 . . . . 0.0 109.572 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 22.9 t -74.04 158.17 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 19.4 m-85 -106.12 150.27 25.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 51' ' ' ALA . 2.0 t -63.58 155.21 30.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.258 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -55.52 -35.49 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.567 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.44 ' N ' HG23 ' A' ' 49' ' ' THR . . . -59.53 -58.23 9.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.185 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 55' ' ' LYS . 17.5 t-20 -57.88 -40.81 81.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.922 -1.111 . . . . 0.0 109.469 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.77 -43.13 98.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.145 -0.972 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.34 -40.99 92.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 109.331 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 52' ' ' ASN . 6.7 tptm -128.39 125.17 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -98.05 140.89 31.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 109.086 179.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.806 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.3 p -130.94 148.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.28 130.89 35.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.597 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 97.4 m95 -98.95 125.15 44.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' C ' ' A' ' 60' ' ' ASP . 55.0 p30 -157.95 -170.21 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -62.31 -43.12 99.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.763 -1.21 . . . . 0.0 110.439 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -68.39 -54.1 19.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 0.0 110.714 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 40.7 t30 -57.1 -38.7 73.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.44 -0.787 . . . . 0.0 110.902 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.6 mmt -58.04 -41.99 84.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 0.0 109.425 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -65.88 -32.96 74.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.458 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.03 -37.59 84.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.148 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.04 -49.21 78.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.043 . . . . 0.0 109.496 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.4 mp -72.23 -26.95 62.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 70' ' ' ASN . 27.2 m -87.51 129.66 35.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.015 . . . . 0.0 109.629 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 69' ' ' THR . 17.6 m-20 38.75 55.94 5.2 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 11.1 Cg_endo -58.44 -18.49 39.16 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.84 2.36 . . . . 0.0 112.649 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.77 90.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.529 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.47 4.73 51.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' TYR . . . . . 0.806 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.9 t80 -116.39 119.35 35.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.275 -0.891 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 78' ' ' THR . 45.7 mm 40.23 59.25 7.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.483 -0.761 . . . . 0.0 109.783 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.99 147.8 62.19 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.903 2.402 . . . . 0.0 112.139 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.7 2.91 57.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 75' ' ' ILE . 51.9 p -75.48 163.59 27.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -85.07 5.99 27.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -86.7 126.69 34.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.371 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.65 6.87 32.38 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.83 134.07 46.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.55 -175.32 28.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 76.71 36.32 37.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 62.7 mt -82.26 143.27 31.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' LYS . 20.3 ttpp -73.3 145.64 45.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' LYS . 17.5 mttp -44.19 130.76 6.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 89' ' ' LYS . 85.6 tt0 -172.19 158.53 4.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 88' ' ' GLU . 18.6 mttt -55.38 -32.3 62.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.144 -0.973 . . . . 0.0 109.231 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -56.04 -41.26 74.73 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.156 -0.965 . . . . 0.0 109.251 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.3 ttm180 -61.21 -46.46 90.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -67.25 -40.94 86.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.775 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 3' ' ' ALA . 89.2 m-20 -62.93 -40.22 96.94 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 68' ' ' LEU . 53.5 tp -58.18 -44.78 88.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 109.52 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.16 -40.54 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.505 HG21 ' HB2' ' A' ' 3' ' ' ALA . 14.1 m -57.99 -40.15 79.99 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.735 -0.603 . . . . 0.0 109.77 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.83 -51.36 70.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.082 -1.011 . . . . 0.0 109.687 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 10' ' ' PHE . 92.3 mt -66.92 -35.61 80.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.057 -1.027 . . . . 0.0 108.33 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 82.8 tttt -58.09 -42.39 85.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -60.79 -39.89 90.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 109.742 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.55 -34.85 67.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.456 -0.778 . . . . 0.0 109.421 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.401 HG21 ' CD1' ' A' ' 36' ' ' PHE . 68.8 p -69.8 -22.33 63.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.468 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 201' ' ' HEC . . . . . 0.645 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 36.5 t80 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.292 0.567 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.583 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.4 ptmt -103.53 161.32 13.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.372 -0.83 . . . . 0.0 109.215 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.88 96.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.96 . . . . 0.0 109.336 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -110.98 170.21 13.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -110.94 130.87 55.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.142 . . . . 0.0 109.238 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -74.4 -19.39 60.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.022 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.5 -49.55 74.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.093 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -63.14 -47.48 82.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.101 . . . . 0.0 109.267 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -67.66 -28.13 73.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.62 -44.73 85.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.224 . . . . 0.0 109.868 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.853 ' O ' HG23 ' A' ' 12' ' ' THR . 52.9 p -70.02 -38.62 75.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.153 -0.967 . . . . 0.0 109.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.759 HD23 HD22 ' A' ' 94' ' ' LEU . 8.3 tp -59.25 -41.04 87.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.66 -46.36 88.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.79 -38.86 92.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.382 0.61 . . . . 0.0 109.967 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' THR . 56.8 p -69.31 -34.68 75.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 111.493 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -150.28 59.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.642 -1.287 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -171.18 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 0.0 109.965 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.98 -38.2 72.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 109.607 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.87 -36.09 74.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.898 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -94.53 -42.57 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.479 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.6 m-70 -107.56 124.15 49.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.9 p -84.42 -29.57 26.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.251 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 20' ' ' VAL . 85.7 t 54.32 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.289 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 19' ' ' THR . 77.8 mm-40 -62.06 141.98 57.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 24' ' ' GLY . 16.3 tttm -71.07 143.19 50.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.623 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.18 9.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' LYS . . . -76.17 162.65 52.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 57.0 Cg_endo -71.31 175.92 8.66 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 123.127 2.552 . . . . 0.0 111.691 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -102.42 133.49 47.28 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.254 -0.904 . . . . 0.0 109.516 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 29' ' ' GLY . 56.0 tttp -132.23 131.09 41.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.252 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 27' ' ' LYS . 85.1 t 53.73 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.171 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -102.39 162.97 16.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 20.3 Cg_endo -62.03 153.01 71.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.09 2.527 . . . . 0.0 112.165 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.534 ' C ' HD12 ' A' ' 32' ' ' LEU . 12.7 m120 -84.27 139.03 32.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -99.69 139.3 35.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 109.885 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -166.56 95.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.58 7.47 78.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -58.66 -21.58 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.014 . . . . 0.0 109.613 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -64.1 133.22 52.58 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 71.13 21.39 78.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.804 ' HE ' HE21 ' A' ' 42' ' ' GLN . 68.1 mtp85 -138.57 167.04 22.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -1.15 . . . . 0.0 109.924 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -94.68 156.88 16.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.905 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.586 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 58.0 p -66.31 164.53 15.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.724 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.88 0.8 68.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.804 HE21 ' HE ' ' A' ' 38' ' ' ARG . 46.3 tt0 -60.1 -35.53 75.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.995 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.66 -34.41 69.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.3 mt-10 43.32 17.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.156 -0.965 . . . . 0.0 109.408 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -127.95 -36.42 0.47 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 47' ' ' SER . 68.5 t80 -103.67 135.52 45.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 108.815 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.436 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 54.3 p -65.93 156.57 33.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.899 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.87 150.1 42.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.559 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 52' ' ' ASN . 7.1 t -54.9 149.92 10.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.863 . . . . 0.0 109.24 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.78 -35.11 65.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.877 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -60.22 -57.58 12.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.063 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 49' ' ' THR . 27.2 t-20 -57.5 -42.8 83.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.566 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.31 -55.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.177 -0.952 . . . . 0.0 109.728 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -68.38 -54.86 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 56' ' ' ASN . 19.9 tttm -65.7 -52.23 53.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.586 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 50.91 118.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.758 0.789 . . . . 0.0 110.119 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.715 HG11 ' OH ' ' A' ' 74' ' ' TYR . 7.6 p -126.47 147.51 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.533 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.3 tp -75.82 134.12 40.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 108.93 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 m95 -99.6 128.41 45.71 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.337 -0.852 . . . . 0.0 110.034 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 50.3 t0 -159.12 172.98 17.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.585 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.17 -39.15 71.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.961 -1.087 . . . . 0.0 109.646 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.582 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 p-10 -74.77 -48.08 27.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.078 -1.014 . . . . 0.0 109.513 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 39.0 t30 -60.9 -38.26 85.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 110.003 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -40.12 86.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.921 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -61.49 -36.4 80.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.001 -1.062 . . . . 0.0 109.799 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.24 -36.65 77.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.019 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -61.38 -47.39 86.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.138 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.578 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 4.7 mp -71.46 -36.23 71.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.392 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.581 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 25.5 m -60.96 -39.58 90.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.623 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -152.87 68.73 6.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.585 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.15 -15.81 46.54 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.364 2.043 . . . . 0.0 112.651 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -78.87 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 110.266 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.68 -32.79 67.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.149 -0.97 . . . . 0.0 109.772 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.715 ' OH ' HG11 ' A' ' 57' ' ' VAL . 80.2 t80 -56.66 -49.66 74.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.707 ' O ' HG22 ' A' ' 75' ' ' ILE . 2.8 mm -141.14 80.84 16.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.923 . . . . 0.0 109.113 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -84.88 149.47 10.97 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.957 2.438 . . . . 0.0 112.247 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.25 58.63 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.718 ' HB ' HG21 ' A' ' 49' ' ' THR . 15.0 t -104.77 163.65 12.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -1.216 . . . . 0.0 109.71 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.79 -0.12 37.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.519 ' H ' HG23 ' A' ' 78' ' ' THR . 11.2 ttt -85.11 129.59 34.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 0.0 110.007 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.63 85.52 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.8 t80 -104.6 133.4 49.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.34 138.02 22.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.94 146.8 43.73 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.607 HD11 HD21 ' A' ' 9' ' ' LEU . 55.2 mt -95.16 125.45 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.244 . . . . 0.0 109.554 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -65.42 -34.6 78.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 110.206 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -84.78 127.84 34.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 0.0 110.16 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -77.52 -35.54 53.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -57.75 -45.6 85.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.6 -39.54 94.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.041 . . . . 0.0 109.1 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.581 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 37.6 ttm180 -59.67 -40.47 87.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.936 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.12 -42.35 90.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.358 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -63.43 -40.06 96.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.054 -1.029 . . . . 0.0 110.14 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.759 HD22 HD23 ' A' ' 9' ' ' LEU . 48.5 tp -59.75 -42.76 93.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.036 -1.04 . . . . 0.0 109.627 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.85 -37.41 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.972 . . . . 0.0 108.955 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -60.79 -39.58 89.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.598 -0.689 . . . . 0.0 109.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.53 -50.61 73.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.105 -0.997 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.3 mt -69.05 -35.43 76.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.168 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.585 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 18.7 tptm -58.68 -40.56 83.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.351 -0.843 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -60.1 -40.84 91.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.529 -0.732 . . . . 0.0 109.796 -179.769 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.525 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 93.6 t80 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.4 0.619 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.644 ' HZ1' ' HG3' ' A' ' 89' ' ' LYS . 33.5 ttpt -81.88 144.45 30.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.071 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.95 -22.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 109.564 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.628 ' O ' HG21 ' A' ' 96' ' ' THR . . . 42.37 94.95 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 46.0 m -63.37 153.44 35.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.111 -1.229 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -80.77 -128.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' THR . 40.8 tttm 57.64 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.057 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' ALA . 32.9 mmtp -59.29 -52.44 65.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -36.56 93.57 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.43 79.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -1.162 . . . . 0.0 109.414 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 4' ' ' LYS . 54.4 p -70.43 -37.35 74.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.243 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.68 -55.98 27.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 108.816 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 98' ' ' LEU . 43.2 t80 -62.5 -41.71 99.0 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.427 -0.796 . . . . 0.0 109.266 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -61.49 -38.54 87.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 111.159 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 p -106.02 4.64 29.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.112 -0.993 . . . . 0.0 111.759 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -147.02 28.71 1.01 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.613 -1.305 . . . . 0.0 110.75 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -171.08 -24.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.723 -1.235 . . . . 0.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.6 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -59.54 -38.19 80.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.885 -1.134 . . . . 0.0 109.916 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.0 -36.53 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.018 . . . . 0.0 111.239 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -95.73 -50.23 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.832 -1.167 . . . . 0.0 111.202 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.645 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -101.91 126.37 48.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.065 -1.022 . . . . 0.0 110.265 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' VAL . 51.5 p -87.23 -24.28 24.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.241 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 19' ' ' THR . 2.6 t 63.79 0.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.457 -0.777 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -101.37 124.75 47.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.436 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -69.53 -39.22 77.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.567 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.63 87.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 154.17 44.39 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 62.1 Cg_endo -74.26 -156.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 111.733 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -107.68 133.6 51.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.134 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -103.78 -125.07 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.31 -38.45 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.156 -0.965 . . . . 0.0 108.896 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.79 165.14 20.94 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.3 150.77 87.67 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.958 2.438 . . . . 0.0 112.37 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 2.9 m120 -80.81 141.71 34.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 108.99 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -95.42 139.19 32.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.017 . . . . 0.0 109.861 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -172.19 90.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 0.0 109.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.583 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.05 5.02 66.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.4 tt -58.5 -22.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -1.176 . . . . 0.0 109.546 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.67 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 81.2 m-85 -68.11 135.35 52.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.8 79.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 67.8 mtt85 -142.62 166.08 25.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 110.04 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.402 ' CE1' HD13 ' A' ' 58' ' ' LEU . 79.0 m80 -95.77 162.57 13.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 110.197 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 62.0 p -66.3 166.21 12.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.816 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.28 60.89 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.459 HE22 ' HD2' ' A' ' 38' ' ' ARG . 39.0 tt0 -62.41 -38.42 89.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -1.16 . . . . 0.0 109.876 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.723 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -71.31 66.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.98 -32.48 72.03 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.366 -0.834 . . . . 0.0 109.343 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.6 60.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -108.8 134.58 51.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -1.138 . . . . 0.0 109.153 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 m -64.47 156.32 29.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.723 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 59.3 m-85 -112.14 145.32 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.306 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.4 p -76.91 161.09 28.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.456 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -58.78 -33.06 69.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.949 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.25 -70.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.216 -0.927 . . . . 0.0 110.673 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.8 t-20 -54.83 -40.62 69.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.924 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.72 -46.37 96.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.942 -1.098 . . . . 0.0 109.482 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.37 -37.06 79.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.12 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 52' ' ' ASN . 52.9 tttm -126.28 115.75 20.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -99.42 137.68 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.132 -0.98 . . . . 0.0 109.063 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.924 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.9 146.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.404 -0.81 . . . . 0.0 109.975 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.402 HD13 ' CE1' ' A' ' 39' ' ' HIS . 62.8 tp -79.14 131.05 36.09 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.454 ' HE1' ' HB3' ' A' ' 40' ' ' SER . 89.0 m95 -94.18 124.48 38.22 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -153.94 169.27 23.86 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.86 -40.0 72.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 0.0 109.559 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -69.83 -48.8 57.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.15 -41.09 92.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.544 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.67 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.0 mtt -61.45 -38.0 85.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.003 -1.061 . . . . 0.0 109.727 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -55.95 -42.0 75.52 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 108.953 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -37.01 76.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.443 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 70.4 t60 -62.92 -47.92 81.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.583 HD21 HD22 ' A' ' 94' ' ' LEU . 7.4 mp -61.93 -26.79 68.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.892 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.59 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 33.8 m -84.78 126.0 33.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.952 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 69' ' ' THR . 8.2 m120 40.48 60.01 7.41 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 28.2 Cg_endo -64.52 -23.02 64.82 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.962 2.441 . . . . 0.0 112.9 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.78 81.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.061 -1.025 . . . . 0.0 109.491 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -62.67 -32.64 73.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.924 ' OH ' HG11 ' A' ' 57' ' ' VAL . 10.7 t80 -57.19 -55.59 32.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 109.726 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.512 HG23 ' HD1' ' A' ' 74' ' ' TYR . 2.9 pt -141.82 73.83 22.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.0 109.779 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -60.96 -34.97 90.04 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 122.64 2.227 . . . . 0.0 112.045 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.7 75.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.0 p -75.51 158.75 32.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.236 . . . . 0.0 110.51 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -84.7 3.83 35.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 109.608 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 6.7 ttt -76.74 129.87 36.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.92 93.5 2.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.628 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 78.3 t80 -101.81 131.24 48.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.225 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -63.76 130.92 40.11 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.24 145.83 41.65 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.4 mt -94.73 125.07 39.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.979 -1.306 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -64.52 -37.96 89.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -86.98 119.49 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.826 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.03 -32.93 72.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.644 ' HG3' ' HZ1' ' A' ' -2' ' ' LYS . 13.6 tttm -57.06 -51.46 69.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.102 -0.999 . . . . 0.0 109.641 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -60.74 -38.07 83.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.8 . . . . 0.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.59 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 55.8 ttp180 -58.09 -42.12 84.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.761 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.3 -38.77 84.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.094 -1.004 . . . . 0.0 109.972 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 2' ' ' SER . 86.0 m-20 -62.97 -40.66 98.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.19 -0.944 . . . . 0.0 109.95 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.98 -45.02 87.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 109.939 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.455 HD12 ' HE1' ' A' ' -3' ' ' PHE . 70.9 mt -63.29 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.93 -1.106 . . . . 0.0 108.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.7 m -58.81 -39.17 80.37 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.488 -0.757 . . . . 0.0 109.469 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.06 -49.84 75.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.904 -1.122 . . . . 0.0 108.699 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 10' ' ' PHE . 91.9 mt -66.98 -33.4 75.5 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 34.3 tttm -56.5 -42.51 78.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.61 -40.25 91.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.539 -0.726 . . . . 0.0 109.627 -179.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.446 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 70.6 t80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.4 ptpt -130.89 164.03 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 109.218 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -42.02 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -66.57 134.98 33.1 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 85.2 p -64.98 -20.72 66.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 51.31 -141.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttm 55.61 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 109.725 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 3' ' ' ALA . 24.9 mttm -58.24 -45.53 87.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.033 -1.042 . . . . 0.0 109.636 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.49 -32.9 79.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 12' ' ' THR . 52.1 p -71.97 -34.82 69.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.321 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -57.07 -40.48 76.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.9 t80 -62.72 -47.57 83.01 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.11 -38.1 89.85 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.411 0.624 . . . . 0.0 110.033 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 8' ' ' THR . 53.4 p -69.02 -34.49 75.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 111.366 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -150.62 59.3 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.688 -1.258 . . . . 0.0 110.947 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.7 t -171.17 -50.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.82 -1.175 . . . . 0.0 110.36 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.11 -37.53 72.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.06 -1.025 . . . . 0.0 109.82 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.32 -35.98 72.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.13 -0.981 . . . . 0.0 109.827 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -95.33 -42.0 8.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.617 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' A' ' 32' ' ' LEU . 90.0 m-70 -108.0 126.13 52.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.7 p -86.98 -26.14 23.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.472 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 19' ' ' THR . 2.4 t 64.02 -0.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.113 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.2 mt-10 -95.61 120.06 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -69.29 -39.74 78.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.85 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.58 -37.09 91.72 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.98 156.57 44.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.78 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.797 2.331 . . . . 0.0 111.755 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.89 134.5 47.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -101.37 -125.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.86 -39.62 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.05 166.03 18.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -62.06 150.5 86.29 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.879 2.386 . . . . 0.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 10.1 m120 -82.82 141.62 32.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.558 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.0 mp -99.68 137.26 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.786 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -171.71 98.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 108.907 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.11 8.56 81.79 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.45 -23.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.961 . . . . 0.0 109.535 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 86.6 m-85 -63.18 135.58 57.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 63.34 30.0 76.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 42' ' ' GLN . 62.0 ttt180 -134.85 154.27 51.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -1.033 . . . . 0.0 109.843 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.64 145.94 24.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 56.9 p -67.88 163.42 21.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 0.0 110.151 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.08 -9.7 67.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' HH21 ' A' ' 38' ' ' ARG . 95.5 mt-30 -96.85 6.05 49.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.92 -30.63 66.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.805 -1.185 . . . . 0.0 108.169 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 97.5 mt-10 38.05 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.431 0.634 . . . . 0.0 109.917 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.83 -26.65 2.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.94 143.31 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -1.013 . . . . 0.0 108.837 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -65.06 158.3 26.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 109.857 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CB ' HD11 ' A' ' 53' ' ' ILE . 14.6 m-85 -116.65 138.3 51.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 109.713 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 78' ' ' THR . 52.0 m -74.88 144.92 43.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 108.974 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -50.56 -35.85 31.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . . . -46.75 -69.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.7 t-20 -56.54 -41.41 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.086 -1.009 . . . . 0.0 110.564 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 48' ' ' TYR . 41.4 mm -60.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.739 -1.226 . . . . 0.0 110.012 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -60.34 -33.88 73.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.205 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.4 tttm -127.26 112.65 15.33 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.596 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -100.07 137.96 37.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.772 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.7 p -132.35 147.74 32.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 109.842 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.1 tp -79.04 134.22 36.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 108.811 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' GLY . 95.9 m95 -95.15 125.19 39.62 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.177 -0.952 . . . . 0.0 110.071 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 62' ' ' ASN . 46.3 p30 -155.41 -176.13 5.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.584 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -60.97 -39.59 90.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.939 -1.1 . . . . 0.0 111.013 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -74.94 -47.18 30.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.86 -1.15 . . . . 0.0 110.722 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 64.2 t30 -58.38 -42.1 86.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.499 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.645 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.3 mtt -62.41 -38.45 89.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 109.87 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.6 p -62.71 -40.82 98.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.257 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.08 -34.79 73.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.175 -0.953 . . . . 0.0 109.25 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.571 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.2 t60 -57.99 -44.15 86.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.561 -0.712 . . . . 0.0 109.471 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 94' ' ' LEU . 95.1 mt -67.64 -32.46 73.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -0.778 . . . . 0.0 110.597 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 m -55.77 -37.28 68.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.036 -1.04 . . . . 0.0 110.542 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.6 p-10 -167.56 69.04 0.9 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.434 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -50.15 -27.56 17.56 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.95 2.434 . . . . 0.0 112.636 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -58.44 6.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 109.321 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 70' ' ' ASN . 67.5 mttt -61.94 -26.85 68.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.772 ' OH ' HG11 ' A' ' 57' ' ' VAL . 34.2 t80 -59.46 -54.78 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.631 -0.668 . . . . 0.0 109.643 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.475 HG23 ' CD2' ' A' ' 74' ' ' TYR . 12.8 pt -139.96 70.19 35.68 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.077 -1.014 . . . . 0.0 109.97 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -52.81 135.47 57.43 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.429 2.086 . . . . 0.0 112.007 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.7 -0.55 56.65 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.847 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.741 ' HA ' HG21 ' A' ' 49' ' ' THR . 8.4 t -89.2 161.24 16.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.653 -1.498 . . . . 0.0 109.62 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -85.66 1.41 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.494 ' H ' HG23 ' A' ' 78' ' ' THR . 15.4 ttp -77.85 125.52 29.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.002 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.3 79.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 64.4 t80 -103.21 131.68 50.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.47 -0.769 . . . . 0.0 109.68 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -71.22 144.97 38.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 147.64 34.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 55.2 mt -97.21 133.1 42.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -94.1 -9.18 37.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.929 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -99.28 128.42 45.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 110.024 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.0 -38.59 52.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -60.72 -49.64 76.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 110.21 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.76 -37.31 86.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.004 . . . . 0.0 109.444 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.492 HH11 ' HB2' ' A' ' 68' ' ' LEU . 38.8 ttm-85 -57.46 -45.3 84.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.719 . . . . 0.0 109.883 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -62.76 -39.93 95.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 85.7 m-20 -61.37 -39.64 91.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.186 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.607 HD23 HD11 ' A' ' 68' ' ' LEU . 52.2 tp -60.36 -45.11 94.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 110.758 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.45 -41.8 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.008 -1.057 . . . . 0.0 109.579 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -58.15 -40.4 81.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 110.012 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -58.89 -50.88 72.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.372 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.509 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.6 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.627 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.584 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 80.6 tttt -56.72 -43.34 80.52 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -61.46 -43.58 98.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 0.0 109.4 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.673 -0.642 . . . . 0.0 109.748 -179.82 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.452 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 49.9 t80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.213 0.53 . . . . 0.0 109.719 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.452 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 32.9 ttpt -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.102 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.06 95.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -89.53 -176.42 45.81 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -105.86 129.47 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.165 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -68.51 -26.04 65.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -57.0 -46.97 81.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.027 -1.046 . . . . 0.0 110.15 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -66.49 -53.1 38.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.036 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.34 -28.21 72.72 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.61 -47.83 81.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.204 . . . . 0.0 109.761 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -73.65 -36.19 65.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 94' ' ' LEU . 20.0 tp -58.16 -42.19 85.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -64.69 -46.67 81.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -63.43 -40.43 97.14 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.471 0.653 . . . . 0.0 110.396 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 55.4 p -72.5 -29.56 63.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 111.627 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.32 55.96 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.549 -1.344 . . . . 0.0 111.23 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.646 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.9 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.782 -1.199 . . . . 0.0 110.49 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.09 -37.62 69.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.54 -35.7 70.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 109.904 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -97.7 -42.6 7.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.646 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -105.31 122.69 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.144 -0.972 . . . . 0.0 110.505 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 21' ' ' GLU . 52.9 p -82.52 -18.62 40.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 20' ' ' VAL . 14.8 p 39.7 21.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.701 -0.624 . . . . 0.0 110.047 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 18.8 pttm -67.2 -40.4 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.964 . . . . 0.0 109.546 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -62.62 -36.98 94.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.87 152.59 31.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.491 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 84.4 Cg_endo -77.16 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.712 2.275 . . . . 0.0 111.877 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -99.5 136.26 39.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.939 . . . . 0.0 109.258 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 36.0 tptt -106.48 -130.09 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.422 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.47 -41.1 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.58 161.96 15.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.477 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 12.2 Cg_endo -57.73 143.18 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.134 2.556 . . . . 0.0 111.938 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.5 m120 -76.43 146.31 38.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.3 mp -98.92 138.75 35.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.626 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -174.84 97.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.85 84.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 tt -58.89 -23.79 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.65 -0.912 . . . . 0.0 109.401 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -65.17 131.48 46.64 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.3 -0.875 . . . . 0.0 108.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.94 30.17 74.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -134.08 152.67 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -1.043 . . . . 0.0 109.931 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -93.37 145.23 24.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.316 -0.865 . . . . 0.0 108.999 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.579 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 53.4 p -66.79 158.52 30.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.956 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.37 -22.75 25.32 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -62.4 -36.34 82.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -1.205 . . . . 0.0 110.381 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.48 -44.86 92.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 109.892 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.12 -16.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.919 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -57.8 -34.65 71.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -123.25 143.37 50.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.597 -0.943 . . . . 0.0 109.168 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -64.76 159.39 22.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.98 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.502 ' O ' HD11 ' A' ' 53' ' ' ILE . 82.9 m-85 -118.41 146.52 44.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.563 -0.711 . . . . 0.0 109.554 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.9 p -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.38 -31.54 61.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 109.627 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.33 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.504 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.0 t-20 -55.8 -42.18 75.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.941 -1.1 . . . . 0.0 110.286 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.502 HD11 ' O ' ' A' ' 48' ' ' TYR . 87.9 mt -60.43 -45.65 96.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 120.895 -1.128 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -60.51 -37.17 80.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.255 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 52' ' ' ASN . 40.0 tttm -128.28 118.87 24.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 14.9 t-20 -98.91 135.59 40.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 108.898 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.794 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.6 p -131.18 146.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.423 -0.798 . . . . 0.0 110.195 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.08 132.92 36.05 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.488 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -96.81 125.91 41.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.211 -0.931 . . . . 0.0 110.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 49.6 t0 -159.09 176.36 12.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.595 ' CD ' ' HZ3' ' A' ' 99' ' ' LYS . 97.2 mt-10 -55.35 -40.04 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.764 -1.21 . . . . 0.0 109.411 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.9 -52.22 26.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 33.7 t30 -62.85 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.611 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.5 mmt -58.75 -40.65 84.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.6 p -66.28 -37.56 85.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.19 -36.99 84.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.404 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -60.27 -45.68 92.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 109.84 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HD23 ' A' ' 94' ' ' LEU . 83.9 mt -70.17 -35.5 74.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.53 -0.731 . . . . 0.0 110.528 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 29.6 m -61.24 -39.2 89.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.912 -1.117 . . . . 0.0 110.829 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -152.92 67.99 6.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 109.788 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -61.96 -15.14 41.34 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.419 2.079 . . . . 0.0 112.675 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.03 -78.75 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.067 -1.021 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -57.22 -34.51 68.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.794 ' OH ' HG11 ' A' ' 57' ' ' VAL . 87.8 t80 -56.3 -50.34 71.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.954 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.75 ' O ' HG22 ' A' ' 75' ' ' ILE . 20.7 mt -148.09 77.66 9.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.02 152.12 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 123.208 2.606 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.15 3.17 55.78 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 80' ' ' MET . 6.2 t -104.65 174.73 5.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.154 -1.204 . . . . 0.0 109.539 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -87.19 11.63 13.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.674 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -70.13 121.51 17.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.763 -1.21 . . . . 0.0 109.622 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.86 27.27 8.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.004 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 51.9 t80 -86.74 129.2 34.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.172 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -87.54 178.68 47.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.84 154.27 23.75 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 9' ' ' LEU . 58.8 mt -100.26 122.09 42.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -66.1 -36.4 83.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.87 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -92.08 128.92 38.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.02 -1.05 . . . . 0.0 110.36 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -29.59 60.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.65 -0.656 . . . . 0.0 109.91 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -55.39 -50.2 70.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -64.21 -37.94 89.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.945 . . . . 0.0 109.103 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.585 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 39.3 ttm180 -58.67 -42.47 88.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.649 -0.657 . . . . 0.0 110.116 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 88.9 m-20 -63.03 -39.51 94.96 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.055 -1.028 . . . . 0.0 110.285 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 68' ' ' LEU . 51.0 tp -59.98 -42.9 95.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.56 -38.45 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.8 m -60.7 -41.07 94.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.11 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.63 -51.88 68.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.115 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.17 -36.89 69.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.595 ' HZ3' ' CD ' ' A' ' 61' ' ' GLU . 26.3 tptt -58.49 -45.68 88.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.738 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.5 mttm -58.78 -50.53 73.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.81 -1.181 . . . . 0.0 109.251 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 100' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 74.6 t80 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -97.35 142.72 28.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.946 . . . . 0.0 109.154 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -60.75 138.69 58.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.203 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA3' HG21 ' A' ' 96' ' ' THR . . . -42.46 104.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 20.3 m -56.82 -35.96 69.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -1.118 . . . . 0.0 109.58 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 2' ' ' SER . . . 173.9 -165.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 109.738 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 26.4 mttm -84.14 5.38 26.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.685 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.43 -43.31 71.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.744 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.98 -28.7 69.16 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -59.54 -46.4 88.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -1.044 . . . . 0.0 109.672 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.936 ' O ' HG23 ' A' ' 12' ' ' THR . 24.6 m -60.88 -41.47 96.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.135 -0.978 . . . . 0.0 108.694 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 85' ' ' LEU . 2.1 tp -56.48 -41.3 76.35 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -61.79 -47.13 86.53 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -64.33 -37.23 86.75 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.543 0.687 . . . . 0.0 109.697 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 8' ' ' THR . 57.2 p -66.28 -38.02 86.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 111.352 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -153.8 61.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.548 -1.345 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 5.3 t -171.48 -45.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.998 -1.064 . . . . 0.0 109.774 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.41 -37.34 75.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -58.15 -36.01 72.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.6 m -94.38 -42.8 8.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.517 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.504 ' CE1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -108.54 122.69 47.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.945 . . . . 0.0 110.023 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.9 p -87.8 -24.64 23.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 0.0 109.83 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t 51.17 36.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -103.52 148.43 25.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.9 -37.55 82.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.275 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.47 -30.6 58.96 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 64.16 58.58 10.24 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.96 -24.58 79.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.542 2.161 . . . . 0.0 111.822 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.69 ' H ' HD22 ' A' ' 31' ' ' ASN . 94.3 m-70 55.6 42.28 29.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -56.93 -36.09 69.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 108.847 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' CZ ' ' A' ' 46' ' ' TYR . 2.4 t -146.31 -76.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -0.818 . . . . 0.0 109.253 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -72.76 160.31 53.99 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.2 1.69 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.035 2.49 . . . . 0.0 112.561 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.69 HD22 ' H ' ' A' ' 26' ' ' HIS . 0.7 OUTLIER 66.56 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 109.769 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.824 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -93.89 139.8 30.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -167.32 94.61 0.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.3 6.4 71.19 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.58 -21.3 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.984 . . . . 0.0 109.8 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.672 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 76.0 m-85 -64.44 131.47 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.93 27.99 73.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.689 ' NE ' ' NE2' ' A' ' 42' ' ' GLN . 63.4 mtp85 -144.94 168.89 19.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.948 -1.324 . . . . 0.0 110.189 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -94.21 157.76 15.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.945 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.464 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 59.5 p -67.31 163.71 20.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.69 -10.87 64.69 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.689 ' NE2' ' NE ' ' A' ' 38' ' ' ARG . 44.1 tt0 -61.65 -37.71 85.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.138 -1.213 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -57.62 140.19 51.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.222 -0.924 . . . . 0.0 109.715 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -126.52 148.59 49.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 109.352 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.4 -7.78 64.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CZ ' ' O ' ' A' ' 28' ' ' VAL . 73.9 t80 -129.42 134.59 47.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 109.426 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 49.8 m -67.73 156.28 37.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.748 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 14.0 m-85 -111.88 140.0 46.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.775 . . . . 0.0 109.418 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.706 HG21 ' HA ' ' A' ' 78' ' ' THR . 40.7 m -69.35 145.43 52.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.911 . . . . 0.0 109.348 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.6 m-20 -51.66 -37.34 50.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.191 -0.943 . . . . 0.0 109.785 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -43.06 -74.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.314 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.5 t-20 -54.04 -40.9 67.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.191 -0.943 . . . . 0.0 110.744 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.83 -48.57 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.673 -1.267 . . . . 0.0 109.842 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -60.22 -33.84 72.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.7 tttm -127.53 114.88 18.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.582 -0.699 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.613 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -97.89 140.04 32.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.123 -0.986 . . . . 0.0 108.897 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.867 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.2 p -132.45 147.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.435 -0.79 . . . . 0.0 110.259 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -80.78 130.0 34.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.5 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 95.6 m95 -92.44 118.46 30.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.147 -0.97 . . . . 0.0 110.31 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 59' ' ' TRP . 91.4 m-20 -140.86 -178.51 5.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.85 -38.3 87.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 110.033 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -76.87 -41.95 41.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.259 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 31.8 t30 -59.02 -42.51 90.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 110.249 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.672 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.4 mtt -63.11 -39.93 96.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.744 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.618 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 71.0 m -59.07 -40.51 85.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.631 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.62 -32.72 68.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.154 -0.966 . . . . 0.0 110.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -56.89 -51.17 70.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.416 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.68 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.3 mp -71.05 -28.58 64.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.958 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.4 m -57.74 -38.12 74.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.945 . . . . 0.0 110.848 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -163.25 66.5 1.61 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.858 -1.151 . . . . 0.0 110.358 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 74' ' ' TYR . 31.7 Cg_exo -50.92 -18.88 4.78 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 C-N-CA 122.838 2.359 . . . . 0.0 112.464 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -76.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -57.95 -32.88 68.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.92 . . . . 0.0 109.467 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.867 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.4 t80 -79.56 126.68 31.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 108.997 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 75' ' ' ILE . 60.1 mt 44.58 63.12 9.16 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.05 146.5 20.29 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.923 2.415 . . . . 0.0 112.451 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.19 16.41 47.29 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.762 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.706 ' HA ' HG21 ' A' ' 49' ' ' THR . 12.9 t -106.89 151.67 24.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.064 -1.257 . . . . 0.0 109.908 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -58.78 -29.62 66.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 22.1 ttp -59.71 140.51 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.288 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.04 92.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.447 -0.783 . . . . 0.0 109.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -161.7 -46.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.592 ' N ' ' CD2' ' A' ' 82' ' ' PHE . . . -41.11 164.51 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 126.5 44.29 0.25 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 9' ' ' LEU . 43.6 mt -88.25 138.27 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -1.023 . . . . 0.0 109.301 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -90.34 -2.99 58.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -97.89 126.52 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.961 -1.087 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.54 -40.08 23.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.755 . . . . 0.0 110.158 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.47 -47.98 83.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.207 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.45 -42.44 95.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.618 ' NH1' ' CB ' ' A' ' 65' ' ' SER . 59.5 ttp85 -61.76 -41.55 97.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.15 -41.01 82.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 110.215 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.31 -38.26 90.45 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.137 -0.977 . . . . 0.0 109.849 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.638 HD23 HD21 ' A' ' 68' ' ' LEU . 50.9 tp -60.14 -45.82 91.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 110.75 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.22 -44.35 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.894 -1.129 . . . . 0.0 109.697 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 ' HA3' ' A' ' 1' ' ' GLY . 29.1 m -64.35 -39.8 94.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.352 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.8 t80 -59.21 -43.77 92.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.05 -1.031 . . . . 0.0 110.657 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.1 mt -61.39 -35.82 78.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.715 -1.241 . . . . 0.0 109.528 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -56.94 -38.34 72.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.162 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -59.76 -45.06 93.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.338 -0.851 . . . . 0.0 109.263 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.765 . . . . 0.0 109.296 179.964 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.293 0.568 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 1' ' ' GLY . 16.0 ttmt -90.67 132.02 36.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.933 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.17 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.249 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -67.2 147.09 48.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.702 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 25.4 m -56.61 -33.19 66.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -1.162 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 75.97 -32.33 0.21 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.394 -0.816 . . . . 0.0 109.85 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 2' ' ' SER . 17.1 mttp -59.67 -51.37 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.085 -1.01 . . . . 0.0 109.203 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -65.04 -40.03 94.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.38 -34.56 89.68 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.23 89.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -1.211 . . . . 0.0 109.023 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.921 ' O ' HG23 ' A' ' 12' ' ' THR . 55.9 p -75.25 -38.28 60.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.89 . . . . 0.0 108.963 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -60.25 -42.76 95.96 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.659 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 72.1 t80 -65.08 -46.43 81.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.4 -39.22 93.9 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.324 0.583 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 8' ' ' THR . 70.5 p -70.14 -31.27 68.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.832 . . . . 0.0 111.448 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -149.23 56.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.607 -1.308 . . . . 0.0 111.246 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.659 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.53 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.769 -1.207 . . . . 0.0 110.585 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.1 tp -56.66 -37.23 70.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.166 -0.959 . . . . 0.0 110.057 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.55 -35.29 67.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.0 m -98.31 -44.13 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 110.718 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -103.48 123.95 47.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 7.0 p -84.2 -24.6 30.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 109.28 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.9 p 42.24 41.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.351 -0.843 . . . . 0.0 110.072 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -100.53 158.27 16.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 109.187 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -68.44 143.44 55.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.403 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.87 -6.91 62.6 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 47.22 60.94 4.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 -28.05 85.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.37 2.046 . . . . 0.0 111.823 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.769 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 93.5 m-70 55.0 46.74 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -57.43 -35.11 69.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 108.652 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 29' ' ' GLY . 21.7 t -141.96 -114.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 28' ' ' VAL . . . -57.56 160.7 10.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.559 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 2.4 Cg_endo -53.89 137.35 68.25 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.776 1.651 . . . . 0.0 111.517 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.769 ' ND2' ' H ' ' A' ' 26' ' ' HIS . 98.2 m-20 -89.37 137.76 32.04 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -92.11 137.76 32.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 110.279 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -162.94 90.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.58 5.72 68.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.73 -21.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.556 -0.967 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -62.64 134.85 56.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.127 -0.983 . . . . 0.0 108.989 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 70.69 22.35 78.03 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -134.25 161.39 35.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -1.088 . . . . 0.0 110.147 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.3 m80 -97.6 153.49 18.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.277 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.595 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 26.8 p -66.09 158.39 28.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.888 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.34 -21.47 31.71 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.23 -36.08 78.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -1.157 . . . . 0.0 110.138 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -58.72 -44.81 90.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 109.606 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.68 -19.86 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.563 -0.71 . . . . 0.0 110.878 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -58.21 -34.25 73.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -124.06 142.33 51.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.962 . . . . 0.0 109.163 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -64.92 160.49 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 109.824 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.511 ' O ' HD11 ' A' ' 53' ' ' ILE . 36.0 m-85 -116.44 149.93 38.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 34.9 p -75.47 162.01 28.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.05 -32.96 62.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.529 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.4 t-20 -54.0 -41.71 68.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.061 -1.024 . . . . 0.0 110.049 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 48' ' ' TYR . 97.4 mt -59.7 -47.19 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.869 -1.144 . . . . 0.0 109.213 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -60.99 -37.36 82.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.5 tttm -125.06 117.07 23.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.536 -0.728 . . . . 0.0 109.415 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 15.9 t-20 -100.25 137.27 38.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.953 . . . . 0.0 109.023 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' OH ' ' A' ' 74' ' ' TYR . 11.3 p -131.17 147.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.446 -0.783 . . . . 0.0 110.196 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.435 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 63.4 tp -77.97 132.95 38.07 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.3 m95 -96.59 126.96 42.14 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.213 -0.93 . . . . 0.0 110.133 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 51.5 t0 -156.06 171.66 19.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 97.1 mt-10 -58.07 -39.07 77.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 109.547 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -72.52 -48.04 43.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.067 -1.02 . . . . 0.0 109.256 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 35.5 t30 -60.81 -37.16 81.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.453 -0.78 . . . . 0.0 109.937 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.8 mmt -58.65 -40.68 84.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 0.0 109.702 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.4 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 98.6 p -64.12 -35.43 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.114 -0.991 . . . . 0.0 109.339 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.22 -35.12 78.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 0.0 109.353 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -59.05 -47.09 86.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.45 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.501 HD11 HD23 ' A' ' 94' ' ' LEU . 20.7 mt -67.97 -29.57 68.64 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.058 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -59.28 -37.91 78.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 111.024 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -161.53 65.49 2.0 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 110.238 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -52.44 -21.29 13.54 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -77.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.954 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.417 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 17.5 tttt -57.45 -36.11 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.747 ' OH ' HG11 ' A' ' 57' ' ' VAL . 74.2 t80 -57.22 -51.29 69.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 75' ' ' ILE . 19.3 mt -148.29 76.49 10.17 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.198 -0.939 . . . . 0.0 108.621 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.9 148.81 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.103 2.535 . . . . 0.0 112.262 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.74 9.4 52.66 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.375 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -108.42 169.37 8.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 109.378 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -84.32 9.18 13.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.927 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.512 ' H ' HG23 ' A' ' 78' ' ' THR . 1.4 mtm -69.35 118.32 12.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.631 -1.293 . . . . 0.0 109.657 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.08 28.01 7.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 108.833 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.0 t80 -85.01 131.28 34.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.822 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.95 144.12 30.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 68' ' ' LEU . . . -75.9 142.86 29.22 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 mt -101.39 141.55 34.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -1.074 . . . . 0.0 108.971 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -82.64 -78.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.079 -1.013 . . . . 0.0 108.784 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -142.65 120.33 11.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 90' ' ' ASP . 82.4 tt0 -161.75 147.33 13.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -56.71 -34.58 67.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.193 -0.942 . . . . 0.0 108.657 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.434 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 90.5 m-20 -57.39 -38.21 73.91 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.308 -0.87 . . . . 0.0 108.9 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.449 ' HG3' HD12 ' A' ' 68' ' ' LEU . 64.0 ttp85 -57.53 -45.95 84.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -65.51 -43.45 90.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.466 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 2' ' ' SER . 84.7 m-20 -67.07 -39.56 86.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.334 -0.854 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.501 HD23 HD11 ' A' ' 68' ' ' LEU . 58.5 tp -55.98 -45.87 78.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.737 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.16 -40.56 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.042 -1.036 . . . . 0.0 108.903 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.7 m -60.2 -39.66 87.32 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.711 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -58.66 -50.31 74.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 109.283 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 10' ' ' PHE . 91.8 mt -69.28 -31.98 70.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 108.452 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 34.4 tttt -55.99 -46.2 78.77 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.28 -46.64 85.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.67 -179.628 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -86.25 129.47 34.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.052 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.47 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.105 -0.997 . . . . 0.0 109.286 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.421 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -104.07 126.43 8.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -61.2 137.9 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -1.212 . . . . 0.0 109.296 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -78.13 -19.24 54.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.986 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -58.38 -48.75 79.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 110.066 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -65.69 -50.77 63.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.533 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.45 -32.1 83.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -56.68 -43.91 80.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.592 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -71.87 -37.59 70.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD23 HD22 ' A' ' 94' ' ' LEU . 9.1 tp -58.75 -40.92 85.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.82 -47.02 85.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -63.42 -38.85 92.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.386 0.613 . . . . 0.0 109.963 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 8' ' ' THR . 59.4 p -69.68 -33.54 72.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 0.0 111.391 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -149.68 58.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.579 -1.326 . . . . 0.0 110.946 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.1 t -172.33 -54.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.832 -1.168 . . . . 0.0 110.291 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 -38.07 70.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.994 -1.067 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.79 -35.43 72.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.832 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m -96.07 -43.61 7.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.514 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.88 123.73 48.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.4 p -86.75 -23.37 25.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 0.0 109.298 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 32' ' ' LEU . 16.0 t 40.37 67.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.918 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.76 143.92 40.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.782 . . . . 0.0 109.317 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -64.23 -35.1 79.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.05 49.49 0.72 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.82 166.99 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.3 Cg_endo -74.1 -171.02 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.054 2.503 . . . . 0.0 112.021 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -105.57 134.68 48.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 29' ' ' GLY . 79.7 tttt -131.35 129.72 41.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.78 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.9 t 53.81 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.222 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -101.89 161.54 17.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.24 154.16 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.151 2.567 . . . . 0.0 112.361 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 13.9 m120 -84.13 133.65 34.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.255 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 20' ' ' VAL . 6.8 mp -99.7 133.99 43.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 109.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -161.44 102.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 108.81 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 80.46 9.88 85.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.57 -21.32 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.599 -0.942 . . . . 0.0 109.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -64.71 132.98 51.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.203 -0.935 . . . . 0.0 109.495 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.04 26.11 73.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 90.2 mtt-85 -134.37 165.0 26.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -1.095 . . . . 0.0 110.021 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -100.04 147.33 25.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.582 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 9.5 m -61.3 152.89 27.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 110.118 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.51 -7.73 74.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.444 HE22 HH11 ' A' ' 38' ' ' ARG . 45.0 tt0 -64.03 -39.11 93.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.029 -1.277 . . . . 0.0 110.273 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.75 -45.44 92.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.0 -1.063 . . . . 0.0 109.556 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 58.97 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -60.96 -34.88 89.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 47' ' ' SER . 64.9 t80 -111.68 135.91 51.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -1.052 . . . . 0.0 109.352 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 35.0 m -62.57 153.79 30.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.552 ' O ' HD11 ' A' ' 53' ' ' ILE . 87.2 m-85 -116.03 148.95 39.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.417 ' OG1' HG22 ' A' ' 78' ' ' THR . 30.1 p -76.52 164.38 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.64 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -34.28 64.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 110.147 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.095 -1.003 . . . . 0.0 110.442 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 22.8 t-20 -55.04 -41.3 71.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.971 -1.081 . . . . 0.0 110.271 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.552 HD11 ' O ' ' A' ' 48' ' ' TYR . 96.9 mt -59.88 -54.54 33.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.793 -1.192 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.15 -40.39 95.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.084 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 56.4 tttm -111.43 111.96 23.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.197 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.54 136.73 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.848 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.4 p -131.11 147.37 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.866 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.2 tt -79.24 128.43 33.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.765 ' N ' HD23 ' A' ' 58' ' ' LEU . 87.8 m95 -91.63 108.22 19.75 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 52.4 p30 -136.49 176.25 8.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.574 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -61.91 -41.69 98.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.357 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.78 -51.69 60.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 110.333 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.489 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 38.3 t30 -61.42 -35.89 78.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.63 -41.43 77.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 109.648 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 95' ' ' ILE . 35.5 m -63.24 -42.16 99.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.56 -36.9 83.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.471 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.6 t60 -57.76 -43.62 85.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 94' ' ' LEU . 86.2 mt -63.54 -28.84 70.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.464 -0.773 . . . . 0.0 109.68 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.551 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 10.0 m -81.89 125.37 30.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.2 m-20 37.52 61.55 3.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.718 . . . . 0.0 110.342 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.9 -21.52 73.2 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.645 2.23 . . . . 0.0 112.943 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.67 16.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -62.14 -36.32 81.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.54 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.848 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.0 t80 -59.9 -51.68 68.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 110.302 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.694 ' O ' HG22 ' A' ' 75' ' ' ILE . 3.0 mm -141.18 79.55 17.74 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.32 152.22 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.112 2.542 . . . . 0.0 112.735 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.17 -1.82 59.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.531 HG21 ' CG2' ' A' ' 75' ' ' ILE . 15.0 p -100.57 166.54 10.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.305 . . . . 0.0 109.949 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -81.67 2.77 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 109.342 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.6 ttt -83.57 128.38 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.847 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.61 86.78 2.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.212 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -103.07 131.64 49.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.316 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.64 145.43 38.64 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.12 32.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 52.6 mt -95.87 124.74 40.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -65.13 -35.94 82.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.795 . . . . 0.0 110.092 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.47 129.8 39.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -74.81 -33.9 62.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.576 -0.703 . . . . 0.0 109.583 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -57.2 -39.48 75.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.02 -38.08 81.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.253 -0.904 . . . . 0.0 108.936 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 85.5 mtt180 -61.47 -39.26 90.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -59.88 -40.5 88.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.6 m-20 -64.63 -41.36 96.21 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.088 -1.008 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.487 HD23 HD11 ' A' ' 68' ' ' LEU . 55.3 tp -61.69 -43.34 99.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.787 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 ' OG ' ' A' ' 65' ' ' SER . 89.0 mt -64.78 -35.95 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 108.899 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 3' ' ' ALA . 21.2 m -56.51 -41.12 76.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 109.913 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -64.07 -54.78 28.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.011 . . . . 0.0 110.299 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 98' ' ' LEU . 91.9 mt -68.08 -37.3 81.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.874 -1.141 . . . . 0.0 108.892 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.574 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 29.7 tttt -57.71 -40.03 78.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -59.65 -39.92 85.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.811 . . . . 0.0 109.413 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.439 -0.788 . . . . 0.0 109.577 -179.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 82.2 t80 . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.23 0.538 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -90.48 133.12 35.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -57.11 127.69 33.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.176 -0.953 . . . . 0.0 109.387 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' -1' ' ' ALA . . . -42.31 137.67 2.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -58.24 -36.71 73.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.416 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.485 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -177.24 -146.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 88.3 mttt -87.7 7.5 29.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 109.896 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -54.81 -43.89 73.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 108.98 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -62.17 -29.29 72.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -58.86 -42.82 90.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -1.094 . . . . 0.0 109.492 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -67.35 -36.9 82.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.118 -0.989 . . . . 0.0 108.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -58.84 -40.02 83.0 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.6 t80 -66.08 -48.55 70.59 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -62.89 -38.76 92.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.928 HG23 ' O ' ' A' ' 8' ' ' THR . 68.5 p -68.17 -32.7 73.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -151.27 59.2 0.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.664 -1.273 . . . . 0.0 111.014 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.06 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.755 -1.216 . . . . 0.0 110.61 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.85 -38.69 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.0 -35.94 67.36 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 109.801 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.04 -43.03 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.988 . . . . 0.0 110.985 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.465 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.0 m-70 -105.36 129.29 53.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.185 -0.947 . . . . 0.0 110.48 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.45 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 46.8 p -89.9 -19.19 24.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 0.0 109.495 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.547 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 4.3 t 60.93 20.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.4 tt0 -104.46 138.06 41.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -59.67 -39.07 83.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.935 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -107.3 28.78 11.79 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -61.23 154.22 37.76 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.71 -3.22 13.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.891 2.394 . . . . 0.0 112.263 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 27' ' ' LYS . 79.5 m-70 59.01 66.26 1.08 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 26' ' ' HIS . 29.9 tttp -58.04 -122.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.688 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.04 -39.78 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.929 -1.107 . . . . 0.0 109.572 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.24 162.79 14.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 18.0 Cg_endo -62.59 154.31 65.81 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.966 2.444 . . . . 0.0 112.253 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.45 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 6.8 m120 -86.22 134.19 33.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.113 -0.992 . . . . 0.0 109.122 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 35' ' ' ILE . 9.7 mp -89.58 -112.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 20' ' ' VAL . 10.6 t60 79.33 90.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.797 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.73 5.45 66.58 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.61 HG21 HD23 ' A' ' 32' ' ' LEU . 3.2 tp -57.81 -20.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 90.4 m-85 -63.1 135.36 57.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.97 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 68.54 25.56 74.85 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD3' HE22 ' A' ' 42' ' ' GLN . 87.2 mtt180 -135.16 157.96 45.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -1.115 . . . . 0.0 110.057 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -91.57 152.09 20.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 60.6 p -65.77 157.75 29.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.07 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.94 -13.59 67.1 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.434 HE22 ' HD3' ' A' ' 38' ' ' ARG . 48.1 tt0 -62.58 -37.51 86.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -1.192 . . . . 0.0 110.208 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -54.5 140.08 35.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.118 -0.988 . . . . 0.0 109.513 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.92 153.16 34.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.56 -0.713 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.81 63.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.3 t80 -140.26 168.22 20.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.215 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -111.86 150.58 30.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.0 109.956 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 10.8 m-85 -109.19 151.35 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 109.513 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.6 p -75.43 157.96 33.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.08 -33.33 70.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -63.73 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.39 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.5 t-20 -55.46 -44.17 76.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.04 -1.037 . . . . 0.0 110.164 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.27 -47.11 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.948 -1.095 . . . . 0.0 110.056 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -60.04 -38.57 83.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -91.75 -66.14 0.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.623 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.59 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 66.1 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.32 -0.862 . . . . 0.0 108.922 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.819 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.1 p -131.77 149.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.36 131.55 41.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.487 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -96.79 125.69 41.42 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.167 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.454 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 50.8 p30 -152.22 179.81 8.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -59.35 -42.19 90.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.729 -1.232 . . . . 0.0 110.647 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -67.98 -49.27 62.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.024 -1.048 . . . . 0.0 110.869 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.454 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 58.3 t30 -60.34 -41.41 93.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 111.271 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.656 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 61.5 mtt -61.12 -37.62 83.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.905 -1.122 . . . . 0.0 110.276 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -60.97 -43.38 98.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.018 -1.051 . . . . 0.0 109.678 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.1 -36.7 77.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.013 -1.054 . . . . 0.0 109.169 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -60.01 -46.14 90.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.503 ' CD1' HD23 ' A' ' 94' ' ' LEU . 90.1 mt -62.53 -31.46 72.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 110.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 13.1 m -85.79 127.12 34.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.943 -1.098 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.0 m120 39.8 58.61 6.91 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.429 -0.794 . . . . 0.0 110.192 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.81 -20.81 53.76 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.792 2.328 . . . . 0.0 112.959 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.87 6.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.078 -1.014 . . . . 0.0 110.083 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -61.68 -33.52 74.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 109.575 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.819 ' OH ' HG11 ' A' ' 57' ' ' VAL . 71.5 t80 -57.19 -48.74 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.596 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 75' ' ' ILE . 4.2 tp -152.82 82.08 5.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.271 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.91 151.34 35.44 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.314 2.009 . . . . 0.0 112.338 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.76 1.08 58.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 p -93.21 165.72 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -92.28 14.58 15.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.143 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.3 mtm -78.9 134.46 36.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 110.078 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.05 27.13 9.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.486 -0.759 . . . . 0.0 109.048 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.53 130.56 37.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 108.94 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.68 179.29 44.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.69 146.12 23.17 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -96.02 118.14 32.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -1.195 . . . . 0.0 109.338 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -64.97 -38.48 91.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.78 128.45 34.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.0 110.351 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.4 -29.27 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.895 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -55.65 -47.11 77.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.152 -0.968 . . . . 0.0 110.093 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -63.57 -38.94 93.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.907 -1.121 . . . . 0.0 108.801 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 38.5 ttm180 -60.85 -45.19 95.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.551 -0.718 . . . . 0.0 110.035 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -66.66 -48.79 68.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.659 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 45.7 t0 -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 109.869 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 68' ' ' LEU . 47.8 tp -54.79 -47.03 74.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 0.0 110.108 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.35 -40.77 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.044 . . . . 0.0 109.266 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.1 m -59.18 -41.83 89.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.805 . . . . 0.0 110.078 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.721 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.2 t80 -60.4 -49.57 77.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.863 -1.148 . . . . 0.0 108.932 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 98' ' ' LEU . 82.9 mt -68.13 -32.06 72.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 108.562 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 41.3 tttm -54.82 -43.75 73.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -62.02 -43.22 99.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.376 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.645 -0.659 . . . . 0.0 109.899 -179.639 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -111.19 162.19 15.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.474 -0.766 . . . . 0.0 109.335 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 109.5 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.69 125.64 8.58 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 86.1 p -60.98 -27.75 68.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 67.56 -21.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 2' ' ' SER . 33.8 tttt -58.82 -51.52 69.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.426 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -65.57 -42.23 92.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 109.201 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.509 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -61.72 -34.96 90.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.02 83.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -1.211 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 52.3 p -74.57 -38.65 62.61 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.05 -41.8 88.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.6 t80 -63.97 -45.91 87.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -62.78 -38.6 91.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.404 0.621 . . . . 0.0 110.267 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 61.9 p -72.25 -29.6 64.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 111.663 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -147.72 53.49 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.468 -1.395 . . . . 0.0 111.479 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.5 t -173.48 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.724 -1.235 . . . . 0.0 110.774 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.66 -37.55 70.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.079 -1.013 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.97 -34.8 68.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.769 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.5 m -98.14 -43.58 6.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.678 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.437 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -104.16 128.51 51.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.411 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 20' ' ' VAL . 44.7 p -93.95 -15.71 24.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.5 t 42.26 36.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLY . 85.3 tt0 -101.16 141.06 34.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.276 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -76.15 -82.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 110.203 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.58 24.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.48 150.84 49.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 72.7 Cg_endo -76.43 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.676 2.251 . . . . 0.0 111.773 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -104.03 134.66 46.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.027 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 29' ' ' GLY . 46.1 tptt -130.51 133.01 45.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.0 109.307 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' HG3' ' A' ' 27' ' ' LYS . 91.6 t 53.9 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.11 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -103.87 158.7 16.9 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 15.6 Cg_endo -57.01 146.78 78.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.059 2.506 . . . . 0.0 112.341 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 18.6 m120 -74.1 135.55 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.001 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.0 mp -97.17 11.48 36.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -52.22 -32.39 36.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.197 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.42 56.05 0.68 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -111.77 2.34 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 48.7 m-85 -82.33 129.18 34.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.985 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.24 31.06 73.94 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -145.77 168.25 21.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.171 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.31 156.32 16.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.363 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 48' ' ' TYR . 59.5 p -58.71 -39.65 81.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 109.739 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.18 85.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.26 -36.22 72.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -1.115 . . . . 0.0 110.737 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -59.08 -32.02 69.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.892 -1.13 . . . . 0.0 109.686 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' ALA . 78.7 mm-40 42.84 -167.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.98 -41.9 2.45 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 47' ' ' SER . 71.8 t80 -123.53 136.1 54.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 109.333 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 55.1 p -69.35 159.34 33.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.638 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 95.4 m-85 -118.27 146.72 44.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.409 -0.807 . . . . 0.0 109.879 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.574 HG21 ' OG1' ' A' ' 78' ' ' THR . 61.4 m -69.75 151.88 45.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.392 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.79 -33.27 7.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.49 -68.55 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.7 t-20 -56.58 -41.81 77.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.1 . . . . 0.0 110.295 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.8 -44.32 97.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.11 -37.14 76.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 108.785 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.0 tttt -127.14 112.3 15.0 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.502 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -97.95 134.79 40.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.79 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -130.84 145.76 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.657 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.7 tp -79.89 132.81 36.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.243 -0.91 . . . . 0.0 108.774 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.45 ' HE1' ' HB3' ' A' ' 40' ' ' SER . 99.0 m95 -94.98 124.74 39.2 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 55.2 t0 -148.18 163.41 37.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.471 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.4 mt-10 -52.51 -40.76 62.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.919 -1.113 . . . . 0.0 109.483 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.05 -48.19 66.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 0.0 110.164 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -61.52 -38.83 88.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 110.732 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 63.1 mtt -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.079 -1.013 . . . . 0.0 109.844 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' HD11 ' A' ' 95' ' ' ILE . 90.5 p -60.9 -40.53 93.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 108.964 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.81 -35.12 79.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.107 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.474 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 69.8 t60 -61.37 -45.66 93.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.63 HD13 HD23 ' A' ' 94' ' ' LEU . 42.0 mt -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 109.868 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.536 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 17.6 m -86.01 126.15 33.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.85 -1.157 . . . . 0.0 108.725 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.599 HD22 ' N ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER 41.77 59.33 9.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.272 -0.892 . . . . 0.0 109.751 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.52 -23.21 74.78 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.762 2.308 . . . . 0.0 112.747 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -60.55 -49.26 78.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.041 . . . . 0.0 109.609 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -64.16 -30.52 71.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.79 ' OH ' HG11 ' A' ' 57' ' ' VAL . 31.2 t80 -52.35 -46.12 66.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 108.936 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 77' ' ' GLY . 1.6 pt -141.05 153.35 66.99 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.54 -7.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.085 1.857 . . . . 0.0 112.018 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 84.02 48.41 5.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.671 HG23 ' N ' ' A' ' 79' ' ' LYS . 4.9 t -56.81 -118.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.007 . . . . 0.0 109.974 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 78' ' ' THR . 45.4 mtmt -89.64 1.46 55.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.188 -0.945 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.3 mmm -75.17 118.54 18.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 108.959 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.13 32.03 5.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.457 -0.777 . . . . 0.0 110.17 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 60.2 t80 -87.53 130.47 34.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.256 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.535 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.41 179.77 49.35 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.36 157.27 23.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.4 mt -102.46 119.03 38.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -1.14 . . . . 0.0 109.346 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -66.32 -35.72 81.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 69.0 mttm -90.32 130.76 36.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 110.294 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.03 -29.56 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.999 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.62 -52.1 66.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 91' ' ' ARG . 53.3 p30 -64.47 -30.29 71.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.639 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 39.2 ttm180 -59.45 -43.69 93.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.142 -0.974 . . . . 0.0 109.859 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -65.46 -40.5 93.26 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -0.944 . . . . 0.0 110.17 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.63 HD23 HD13 ' A' ' 68' ' ' LEU . 54.5 tp -58.19 -47.0 84.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.113 -0.992 . . . . 0.0 110.186 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.48 HD11 ' HA ' ' A' ' 65' ' ' SER . 63.2 mt -67.33 -36.17 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.011 -1.055 . . . . 0.0 108.684 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.6 m -57.68 -41.43 81.57 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.403 -0.811 . . . . 0.0 109.674 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -50.87 71.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 109.0 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.607 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.1 mt -66.74 -32.77 74.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 108.384 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.471 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 19.2 tttt -57.33 -41.63 80.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.48 -40.34 90.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 0.0 109.652 -179.828 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 73.8 t80 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.329 0.585 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 1' ' ' GLY . 15.5 ttmt -92.27 131.54 37.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.406 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.265 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -71.11 156.47 53.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 23.7 m -56.28 -33.26 65.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 72.05 -41.04 0.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.8 tttt -58.98 -51.21 71.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.041 -1.037 . . . . 0.0 109.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -64.0 -43.13 96.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.098 -1.001 . . . . 0.0 108.984 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.97 -32.73 85.18 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.64 -42.65 79.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.192 -1.181 . . . . 0.0 109.007 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 12' ' ' THR . 52.7 p -74.19 -33.48 63.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.34 -0.85 . . . . 0.0 109.119 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.606 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -60.35 -42.18 95.2 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.0 t80 -69.07 -47.37 65.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -62.67 -39.24 93.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.67 -0.644 . . . . 0.0 110.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 8' ' ' THR . 73.3 p -69.36 -32.53 71.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 111.399 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -150.76 58.06 0.93 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.53 -1.356 . . . . 0.0 111.526 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 6.3 t -170.59 -43.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.757 -1.215 . . . . 0.0 110.128 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.54 -35.91 73.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 109.656 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.8 -37.21 73.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.5 m -93.25 -41.3 9.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.646 ' ND1' HD11 ' A' ' 32' ' ' LEU . 87.4 m-70 -107.73 127.08 53.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.402 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 43.2 p -87.69 -20.39 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.613 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 20' ' ' VAL . 5.7 t 57.65 29.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 110.189 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.17 149.06 25.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -60.47 -36.22 77.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 109.337 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.98 41.31 1.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -62.81 156.49 40.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -4.74 15.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.953 2.435 . . . . 0.0 112.196 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 27' ' ' LYS . 73.1 m-70 60.49 65.85 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 26' ' ' HIS . 14.6 tttt -57.04 -118.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.83 -40.36 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.68 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.76 162.86 19.91 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 16.6 Cg_endo -60.6 150.52 81.46 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.917 2.411 . . . . 0.0 111.952 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.443 ' OD1' ' C ' ' A' ' 24' ' ' GLY . 5.4 m120 -81.24 140.46 34.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.292 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.9 mp -98.28 140.85 31.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.024 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -171.18 97.01 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.427 -0.795 . . . . 0.0 109.064 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.29 6.76 74.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -58.81 -23.37 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.523 -0.986 . . . . 0.0 109.81 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.74 133.74 51.7 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.08 78.91 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HG3' HE22 ' A' ' 42' ' ' GLN . 64.5 mmt-85 -135.81 161.55 35.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -1.091 . . . . 0.0 109.711 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -88.78 156.69 18.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 1.8 t -61.07 149.36 37.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.81 63.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.405 HE22 ' HG3' ' A' ' 38' ' ' ARG . 51.9 tt0 -60.59 -38.34 84.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -1.218 . . . . 0.0 109.859 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.752 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.18 139.13 48.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.083 -1.01 . . . . 0.0 109.069 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -117.79 150.62 38.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 109.434 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.45 62.85 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.7 t80 -136.25 157.83 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.3 t -98.77 148.52 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.752 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 m-85 -109.81 141.67 42.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.509 -0.744 . . . . 0.0 110.043 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.412 HG22 ' H ' ' A' ' 51' ' ' ALA . 51.7 m -73.47 146.94 44.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 53' ' ' ILE . 92.2 m-20 -51.7 -36.31 46.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.766 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -42.71 -71.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.034 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 56' ' ' ASN . 26.9 t-20 -52.88 -40.12 63.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 0.0 110.367 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 50' ' ' ASP . 79.2 mt -56.8 -54.17 32.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.862 -1.149 . . . . 0.0 109.415 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -62.47 -38.52 90.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.084 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.2 mttm -99.26 25.44 6.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.475 -0.766 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -43.64 126.55 4.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.018 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.854 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -135.53 152.11 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 110.122 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -71.2 133.63 46.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 40' ' ' SER . 98.1 m95 -96.41 123.76 40.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.229 -0.92 . . . . 0.0 110.107 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 55.1 p30 -152.93 176.66 11.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -60.11 -39.37 85.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.128 . . . . 0.0 110.665 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -70.37 -56.44 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.926 -1.109 . . . . 0.0 110.47 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.567 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 46.2 t30 -59.55 -38.8 82.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.66 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.5 mmt -59.29 -40.53 86.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.961 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 95' ' ' ILE . 43.1 m -60.16 -40.37 89.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.523 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.17 -33.2 75.23 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.949 -1.095 . . . . 0.0 109.446 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.49 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 71.3 t60 -59.74 -47.72 84.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.376 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.1 mp -67.84 -30.54 69.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.584 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 28.1 m -60.74 -38.82 86.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.908 -1.12 . . . . 0.0 110.41 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -154.15 67.03 5.62 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.049 . . . . 0.0 109.796 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.27 -22.04 72.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.571 2.181 . . . . 0.0 113.061 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 -71.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.974 -1.079 . . . . 0.0 109.651 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -59.7 -24.28 63.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.854 ' OH ' HG11 ' A' ' 57' ' ' VAL . 18.6 t80 -55.36 -46.29 76.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.922 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.67 HD12 HG21 ' A' ' 78' ' ' THR . 2.1 pt -142.47 78.78 16.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.155 -0.966 . . . . 0.0 109.91 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -69.25 137.42 36.9 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 C-N-CA 123.039 2.492 . . . . 0.0 111.94 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.71 2.79 62.86 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.538 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -98.6 170.4 8.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.295 . . . . 0.0 109.675 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -90.94 13.89 15.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.908 . . . . 0.0 110.603 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.818 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -74.67 122.48 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.75 30.59 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.016 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 63.9 t80 -89.69 131.15 35.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.044 -1.035 . . . . 0.0 109.406 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -85.88 176.37 49.12 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.37 159.45 25.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.98 122.98 44.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 0.0 109.293 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.49 -35.59 81.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.98 128.51 36.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 110.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -28.51 60.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 109.889 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -55.6 -47.33 76.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.185 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.32 -39.16 93.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.886 -1.134 . . . . 0.0 108.898 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.584 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.6 ttp180 -61.0 -43.41 98.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -58.63 -47.21 85.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.009 -1.057 . . . . 0.0 109.62 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 2' ' ' SER . 88.7 m-20 -66.79 -39.42 87.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.92 -45.84 85.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 65' ' ' SER . 75.4 mt -65.12 -36.79 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.015 -1.053 . . . . 0.0 108.344 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.0 m -57.24 -41.32 79.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.594 -0.691 . . . . 0.0 109.59 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -62.29 -52.53 63.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.28 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.4 mt -66.19 -32.92 74.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 108.495 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 13.8 tttp -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.561 -0.712 . . . . 0.0 109.091 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -61.15 -39.89 91.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.436 -0.79 . . . . 0.0 109.538 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.54 -0.725 . . . . 0.0 109.718 -179.59 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.415 0.626 . . . . 0.0 109.823 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.752 ' O ' ' HB2' ' A' ' -1' ' ' ALA . 35.0 ttpt -49.97 -56.82 9.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.221 -0.924 . . . . 0.0 111.176 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' -2' ' ' LYS . . . 160.88 28.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.426 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -39.83 98.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' -1' ' ' ALA . 40.4 p -129.25 34.57 4.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.48 149.2 23.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 110.285 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -56.43 -25.73 51.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.584 -0.697 . . . . 0.0 109.762 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -45.52 -50.92 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.234 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.62 -34.83 87.76 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -63.37 -49.7 72.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.126 . . . . 0.0 109.476 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' THR . 25.3 m -61.25 -39.12 89.16 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.274 -0.892 . . . . 0.0 108.761 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.679 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -53.98 -41.63 68.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.4 t80 -61.25 -47.04 87.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.44 -38.03 89.58 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.638 . . . . 0.0 109.933 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 8' ' ' THR . 49.4 p -68.11 -36.32 79.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.48 -0.763 . . . . 0.0 111.315 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -151.9 61.23 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.0 110.712 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -172.37 -47.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.959 -1.088 . . . . 0.0 110.161 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.21 -37.67 72.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.818 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -58.14 -35.25 71.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 109.866 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.2 m -96.57 -42.5 8.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.7 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.462 ' CE1' HD11 ' A' ' 32' ' ' LEU . 93.5 m-70 -109.19 124.04 50.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.947 . . . . 0.0 109.881 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' GLU . 36.3 p -89.03 -18.18 27.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 t 61.84 -8.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' THR . 97.1 mt-10 -60.67 136.56 58.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.924 -1.11 . . . . 0.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -78.54 -39.67 37.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.83 -7.78 55.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.77 155.72 52.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.44 -166.52 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.723 2.282 . . . . 0.0 111.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -101.3 90.41 4.1 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -59.99 -41.7 92.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.108 -0.995 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.39 -71.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.546 -0.721 . . . . 0.0 109.153 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -76.65 159.62 49.91 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 5.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 112.834 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER 64.78 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 110.126 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -95.92 143.48 27.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -172.51 91.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 109.045 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.38 6.35 74.28 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.73 -20.19 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.478 -1.013 . . . . 0.0 109.609 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.6 m-85 -60.4 131.31 50.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.95 29.45 73.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HD3' HE22 ' A' ' 42' ' ' GLN . 89.6 mtt180 -140.52 164.41 30.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -1.226 . . . . 0.0 110.255 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -92.69 159.59 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 0.0 109.705 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 22.6 t -71.03 154.22 41.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.073 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.96 51.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.438 HE22 ' HD3' ' A' ' 38' ' ' ARG . 49.7 tt0 -62.54 -36.09 81.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.272 . . . . 0.0 109.95 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -58.7 -32.74 69.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 109.716 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ALA . 95.6 mt-10 42.04 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.17 -39.39 1.63 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 44' ' ' GLU . 63.7 t80 -116.15 134.1 55.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.488 -1.007 . . . . 0.0 108.99 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 45.6 m -63.12 153.16 35.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.967 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.426 ' O ' HD11 ' A' ' 53' ' ' ILE . 66.5 m-85 -114.5 145.89 41.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.514 -0.741 . . . . 0.0 109.359 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -79.39 166.55 21.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.19 -31.7 61.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.771 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 75' ' ' ILE . . . -46.67 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.741 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.6 t-20 -55.87 -41.33 74.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.12 -0.988 . . . . 0.0 110.79 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 48' ' ' TYR . 80.2 mt -59.44 -50.27 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.912 -1.118 . . . . 0.0 109.854 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -59.89 -36.52 77.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.5 ttpp -128.01 117.43 21.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.536 -0.728 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.64 136.73 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 108.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.938 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.06 147.32 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -75.63 132.25 40.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 76.1 m95 -93.69 125.88 38.55 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.052 -1.03 . . . . 0.0 109.841 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.7 t0 -152.74 170.35 20.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -55.77 -39.93 71.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.765 -1.21 . . . . 0.0 109.498 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -66.19 -48.25 71.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -63.97 -40.41 96.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 110.791 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.9 mtt -60.79 -38.7 86.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 110.075 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -60.75 -45.48 94.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 109.216 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.69 -33.37 75.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.951 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -57.76 -44.04 85.86 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.509 -0.744 . . . . 0.0 109.158 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 HD23 ' A' ' 94' ' ' LEU . 93.3 mt -67.43 -25.38 65.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.549 -0.719 . . . . 0.0 109.852 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.589 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 24.5 m -85.43 131.05 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.013 -1.054 . . . . 0.0 109.836 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 69' ' ' THR . 9.9 t30 38.8 56.6 5.45 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 0.0 110.713 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.76 -14.75 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.773 2.315 . . . . 0.0 112.222 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.19 72.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 109.762 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -84.83 3.9 35.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.144 -0.972 . . . . 0.0 109.04 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.938 ' OH ' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -108.31 124.52 50.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.405 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.596 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 44.7 pt 38.23 54.09 4.0 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.463 -0.773 . . . . 0.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 75' ' ' ILE . 18.2 Cg_endo -61.33 -18.65 60.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.756 2.304 . . . . 0.0 112.249 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.27 21.88 29.4 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.4 p -116.03 156.01 27.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.278 -1.131 . . . . 0.0 110.043 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 80' ' ' MET . 22.8 mttm -60.31 -29.93 69.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 79' ' ' LYS . 4.7 ttt -38.62 115.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.43 0.633 . . . . 0.0 110.351 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.17 29.38 8.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.25 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 54.9 t80 -65.63 134.42 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.434 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.25 179.21 49.47 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.56 151.46 21.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.507 HD11 HD21 ' A' ' 9' ' ' LEU . 57.2 mt -105.07 121.34 43.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -1.113 . . . . 0.0 109.626 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -66.74 -34.03 76.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -84.07 116.7 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 109.994 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 97.3 mt-10 -72.22 -35.88 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.83 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -58.43 -38.74 78.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.687 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.19 -37.27 77.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 80.6 mtm180 -60.03 -43.02 95.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -57.58 -42.61 83.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 110.828 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD1' ' CA ' ' A' ' 1' ' ' GLY . 75.2 m-20 -67.27 -39.92 86.12 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.812 -1.18 . . . . 0.0 109.95 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.679 HD22 HD23 ' A' ' 9' ' ' LEU . 55.2 tp -61.97 -45.77 92.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.689 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.58 -42.17 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 109.618 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 43.8 m -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.435 -0.79 . . . . 0.0 110.732 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 84.0 t80 -60.7 -44.71 96.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.066 -1.021 . . . . 0.0 110.922 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.444 HD21 ' CE1' ' A' ' 10' ' ' PHE . 80.2 mt -62.79 -37.68 87.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.813 -1.18 . . . . 0.0 109.874 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.523 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 9.3 mtpt -58.77 -37.0 75.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.092 -1.005 . . . . 0.0 109.188 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.5 -42.34 91.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.357 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 -179.997 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' -2' ' ' LYS . 75.8 t80 . . . . . 0 N--CA 1.488 1.47 0 CA-C-O 121.345 0.593 . . . . 0.0 109.685 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.598 ' O ' ' CD2' ' A' ' -3' ' ' PHE . 45.6 mtpt -83.24 172.57 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.09 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.625 ' C ' HG21 ' A' ' 96' ' ' THR . . . 88.02 81.47 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -120.2 142.86 48.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.454 -1.027 . . . . 0.0 109.147 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 7' ' ' ALA . . . -78.2 -82.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.097 -1.002 . . . . 0.0 109.642 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 3' ' ' ALA . 47.5 tptt 42.27 -99.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.408 -0.808 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' ALA . 34.7 mttp -61.9 -42.77 99.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . . . -63.39 -51.63 65.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.172 -1.193 . . . . 0.0 109.785 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 12' ' ' THR . 52.8 p -71.93 -38.18 69.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.269 -0.895 . . . . 0.0 109.198 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 85' ' ' LEU . 8.0 tp -58.35 -41.01 83.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.4 t80 -63.38 -46.8 84.77 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -62.7 -38.48 90.57 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.425 0.631 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 8' ' ' THR . 57.5 p -71.16 -30.43 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 111.532 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -148.54 55.37 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.326 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.52 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.742 -1.224 . . . . 0.0 110.871 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -55.61 -37.12 67.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.202 -0.936 . . . . 0.0 109.984 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.36 -34.77 69.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.3 m -98.98 -43.52 6.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.896 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.595 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -104.16 130.02 51.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 19.6 p -91.08 -24.19 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.506 -0.746 . . . . 0.0 109.892 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.2 1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.253 -0.904 . . . . 0.0 110.054 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.4 tt0 -98.48 124.76 43.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.983 -1.073 . . . . 0.0 109.534 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -70.9 -40.23 72.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.23 -37.65 93.3 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.58 155.99 44.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 63.2 Cg_endo -74.3 -156.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.746 2.298 . . . . 0.0 111.701 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -104.03 132.28 50.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 19' ' ' THR . 26.0 mttt -102.09 -147.96 0.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 54.7 t -49.82 -41.43 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.894 -1.129 . . . . 0.0 109.861 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.33 159.37 14.09 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.04 152.05 67.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.84 2.36 . . . . 0.0 111.922 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.1 m120 -83.84 139.94 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 109.61 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.776 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.3 mp -96.69 139.78 32.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.664 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 52.2 p-80 -173.8 92.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.027 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.9 6.77 69.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.72 -23.3 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.989 . . . . 0.0 109.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -64.65 135.81 56.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.066 -1.021 . . . . 0.0 109.278 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.67 24.27 72.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -125.31 151.28 46.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -1.077 . . . . 0.0 109.386 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 40' ' ' SER . 1.9 t-160 -120.18 135.64 54.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.823 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER 80.52 -176.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' A' ' 48' ' ' TYR . . . -82.65 70.26 3.21 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.17 -36.68 75.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.236 . . . . 0.0 110.071 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -55.66 141.37 38.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.05 . . . . 0.0 109.394 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.0 164.09 20.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.589 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.96 -9.8 56.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 59.7 t80 -134.43 141.13 46.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -1.113 . . . . 0.0 109.082 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.6 p -71.62 159.32 34.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.509 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 17.6 m-85 -119.09 147.84 43.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.52 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 51.8 p -79.16 159.49 27.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.299 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.39 -30.78 67.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.694 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.22 -75.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.721 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.4 t-20 -55.39 -42.98 74.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.925 -1.109 . . . . 0.0 110.687 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.33 -49.35 84.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.714 -1.241 . . . . 0.0 109.271 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -60.59 -37.45 81.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 52' ' ' ASN . 16.4 tttt -125.4 113.24 17.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -103.5 143.91 32.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.41 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.831 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -132.43 149.47 32.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.611 -0.681 . . . . 0.0 109.841 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.437 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.1 tp -74.32 128.65 36.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 108.673 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -95.57 123.69 39.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 48.7 p30 -161.18 -174.43 4.34 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.51 -42.8 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.834 -1.166 . . . . 0.0 110.22 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -70.91 -53.88 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.148 -0.97 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 37.9 t30 -59.08 -38.58 79.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 110.525 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 7.8 mmt -58.87 -40.91 85.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.662 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.8 p -66.25 -34.82 78.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.28 -0.887 . . . . 0.0 109.587 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -35.7 80.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 109.496 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.04 -47.03 86.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.536 ' CD1' HD23 ' A' ' 94' ' ' LEU . 87.2 mt -68.54 -31.44 70.68 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -58.61 -37.89 76.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -162.75 67.02 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.901 -1.124 . . . . 0.0 110.074 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -51.49 -19.34 6.94 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.977 2.451 . . . . 0.0 112.42 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.35 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -56.67 -34.26 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.831 ' OH ' HG11 ' A' ' 57' ' ' VAL . 65.6 t80 -55.22 -51.04 67.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.729 ' O ' HG22 ' A' ' 75' ' ' ILE . 17.3 mt -147.66 80.14 9.14 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 108.729 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.79 149.52 12.58 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.924 2.416 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.14 0.46 55.98 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 80' ' ' MET . 9.9 t -100.57 171.25 7.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -84.65 9.37 13.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.484 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.522 ' H ' HG23 ' A' ' 78' ' ' THR . 3.1 mtm -73.83 119.68 18.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 0.0 110.011 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.13 26.97 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 59.3 t80 -76.5 133.05 39.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.572 -0.705 . . . . 0.0 109.504 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.9 175.57 50.37 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.71 147.01 18.43 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.404 HD11 HD21 ' A' ' 9' ' ' LEU . 54.1 mt -99.71 134.82 42.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.261 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -92.04 -4.43 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -100.93 127.59 47.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.016 . . . . 0.0 109.929 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.61 -38.23 48.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 110.132 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -60.41 -48.79 80.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.54 -40.23 95.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.682 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.93 -41.73 92.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.104 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.7 m-20 -61.02 -39.8 91.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.302 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 91.1 m-20 -62.05 -40.73 96.73 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.101 -0.999 . . . . 0.0 109.904 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.536 HD23 ' CD1' ' A' ' 68' ' ' LEU . 55.3 tp -61.22 -43.88 98.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.57 -42.96 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.625 HG21 ' C ' ' A' ' 1' ' ' GLY . 26.7 m -62.38 -37.75 86.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.55 -46.97 83.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.092 . . . . 0.0 110.304 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.666 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.4 mt -65.29 -38.38 90.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.104 . . . . 0.0 109.616 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.59 -36.65 79.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -59.05 -42.96 91.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.323 -0.861 . . . . 0.0 109.436 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.415 179.946 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 52.2 t80 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.52 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.8 ptmt -104.18 161.6 13.89 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.23 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.12 24.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -138.73 164.25 25.75 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -110.92 131.14 55.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -1.102 . . . . 0.0 109.295 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 100' ' ' LYS . . . -74.48 -18.27 60.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.042 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -57.52 -48.46 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.061 -1.024 . . . . 0.0 109.969 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.02 -51.92 48.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.926 -1.109 . . . . 0.0 109.748 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -65.35 -30.67 78.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -1.199 . . . . 0.0 110.054 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.916 ' O ' HG23 ' A' ' 12' ' ' THR . 59.6 p -72.71 -37.33 67.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.133 -0.979 . . . . 0.0 109.534 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 94' ' ' LEU . 6.9 tp -58.92 -41.63 87.73 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -62.78 -46.74 86.63 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -63.6 -38.27 90.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.421 0.629 . . . . 0.0 110.079 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.47 -34.99 75.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 111.61 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -149.94 58.17 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.525 -1.36 . . . . 0.0 111.356 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.6 t -172.97 -48.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.153 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.89 -37.22 71.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 109.6 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.39 -34.63 69.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 0.0 109.547 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.1 m -96.5 -44.21 7.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.695 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.637 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -105.81 124.8 50.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.243 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.554 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 53.1 p -84.3 -27.06 28.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.695 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' C ' ' A' ' 19' ' ' THR . 1.9 t 64.22 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' THR . 78.2 mm-40 -92.48 120.98 33.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.89 -1.131 . . . . 0.0 109.622 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 55.2 pttt -69.96 -39.99 75.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.4 -36.76 90.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.43 157.25 49.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 59.1 Cg_endo -73.02 -156.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.27 134.57 48.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 29' ' ' GLY . 36.2 tttt -130.46 127.01 38.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.466 -0.771 . . . . 0.0 109.079 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 29' ' ' GLY . 49.4 t 53.42 -84.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.299 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -100.44 161.76 18.91 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.0 152.69 73.71 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.979 2.453 . . . . 0.0 112.203 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.554 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 13.1 m120 -81.71 140.52 34.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.69 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.2 mp -98.05 139.41 33.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -172.0 95.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.204 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.68 7.02 75.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.54 -23.77 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.294 -1.121 . . . . 0.0 109.565 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -70.41 132.11 45.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 75.13 20.33 79.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.678 ' CZ ' HE21 ' A' ' 42' ' ' GLN . 31.0 mtp180 -140.85 167.0 23.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -1.186 . . . . 0.0 110.015 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -93.72 156.73 16.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.589 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 24.9 p -66.15 167.1 10.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.684 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.5 -8.14 61.97 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.678 HE21 ' CZ ' ' A' ' 38' ' ' ARG . 38.9 tt0 -61.58 -38.3 87.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.676 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.94 75.08 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.42 -31.76 73.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.47 -35.81 62.31 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 47' ' ' SER . 54.9 t80 -112.29 131.99 55.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.394 -1.063 . . . . 0.0 109.302 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -67.65 156.77 36.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.865 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.676 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 55.4 m-85 -111.21 145.39 38.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.521 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -75.74 161.65 28.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.67 -34.66 67.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -0.905 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . -48.08 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.329 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 22.2 t-20 -52.62 -41.62 63.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.042 . . . . 0.0 110.305 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.9 mt -59.02 -55.59 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.18 -36.69 84.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ASN . 43.7 tttm -102.33 33.34 3.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.589 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -46.69 131.55 11.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.848 -1.157 . . . . 0.0 108.694 -179.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.927 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.6 p -133.79 150.53 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.251 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.47 130.61 38.21 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.469 ' HE1' ' HB3' ' A' ' 40' ' ' SER . 97.5 m95 -97.24 123.23 40.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 56.2 p30 -149.59 176.28 10.78 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.82 -40.46 88.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.061 -1.024 . . . . 0.0 111.004 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -72.29 -57.2 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.953 -1.092 . . . . 0.0 110.646 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.587 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.7 t30 -60.46 -39.66 88.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.411 -0.805 . . . . 0.0 110.799 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.413 ' SD ' ' CE3' ' A' ' 59' ' ' TRP . 42.8 tpp -59.15 -39.49 82.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.008 . . . . 0.0 109.745 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.515 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.1 m -60.76 -40.68 93.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.72 -33.54 74.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 77.9 t60 -61.26 -48.0 83.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD2' HD23 ' A' ' 94' ' ' LEU . 6.8 mp -57.81 -31.09 66.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.539 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 23.5 m -84.99 125.03 32.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.979 -1.076 . . . . 0.0 109.225 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' THR . 12.5 m120 41.75 59.6 9.29 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.69 -21.32 58.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.72 -59.1 5.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 109.981 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -62.25 -32.52 73.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.515 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.927 ' OH ' HG11 ' A' ' 57' ' ' VAL . 66.8 t80 -57.75 -48.73 78.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 75' ' ' ILE . 2.7 tp -163.23 79.9 1.64 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.983 -1.073 . . . . 0.0 109.265 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.89 -21.25 7.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.823 2.349 . . . . 0.0 112.769 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -56.55 -27.23 54.1 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 p -77.49 163.06 26.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -1.203 . . . . 0.0 110.068 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -78.47 5.36 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.0 ttt -79.7 141.92 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.507 -0.746 . . . . 0.0 111.145 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.79 85.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 81.7 t80 -103.36 134.89 45.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.81 . . . . 0.0 110.094 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -72.63 142.02 31.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.69 152.47 49.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HD21 ' A' ' 9' ' ' LEU . 56.8 mt -97.23 125.2 41.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.25 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.31 -39.75 94.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.35 128.42 35.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.984 -1.072 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.15 -34.72 61.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -58.22 -45.35 87.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.152 -0.968 . . . . 0.0 109.938 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.91 -38.66 89.23 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.128 -0.982 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.539 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.7 ttp180 -59.06 -41.39 87.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.497 -0.752 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.41 ' OD1' ' CE2' ' A' ' -3' ' ' PHE . 53.2 t30 -59.12 -41.86 89.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 110.17 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 89.1 m-20 -62.4 -39.8 94.42 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.043 -1.036 . . . . 0.0 109.964 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.662 HD22 HD23 ' A' ' 9' ' ' LEU . 51.9 tp -59.0 -43.61 91.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.873 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.515 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 85.0 mt -64.65 -37.17 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 m -59.52 -40.65 87.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.459 -0.775 . . . . 0.0 109.94 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.052 . . . . 0.0 110.644 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.626 HD21 ' CE1' ' A' ' 10' ' ' PHE . 89.3 mt -67.05 -38.45 85.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 9.7 mtpm? -58.3 -40.54 82.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.061 . . . . 0.0 109.732 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 3' ' ' ALA . 99.2 mttt -61.64 -45.43 94.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 109.667 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 109.534 -179.742 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.9 ttpt -63.31 128.15 34.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.26 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -92.41 152.38 21.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 53.5 p -69.29 155.51 40.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.38 -10.08 21.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.785 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -59.22 -49.48 77.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.01 -46.8 79.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.387 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.38 -30.87 79.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.17 89.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.891 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -72.44 -38.74 68.23 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 94' ' ' LEU . 9.0 tp -59.2 -40.9 87.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.8 t80 -62.86 -46.7 86.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -63.14 -38.89 92.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.669 -0.645 . . . . 0.0 109.955 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.97 -33.12 71.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 111.453 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.77 57.62 1.04 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.571 -1.331 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.2 t -172.56 -53.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.854 -1.153 . . . . 0.0 110.28 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.09 -37.63 72.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.014 -1.054 . . . . 0.0 109.811 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.33 -35.28 71.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.862 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -96.96 -43.42 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.618 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 90.6 m-70 -106.0 125.34 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 20' ' ' VAL . 52.4 p -89.52 -20.66 23.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 32' ' ' LEU . 8.0 t 40.97 69.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.696 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.17 155.17 27.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -61.7 -35.72 78.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.576 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.29 20.96 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.3 166.49 50.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.62 -177.82 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.96 2.44 . . . . 0.0 112.12 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -106.34 136.7 45.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.393 -0.817 . . . . 0.0 109.263 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -105.78 -127.97 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.333 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.27 -39.71 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.081 -1.012 . . . . 0.0 109.565 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.83 165.21 16.73 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.433 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 27.5 Cg_endo -63.69 150.46 88.4 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.843 2.362 . . . . 0.0 112.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.426 ' C ' HD12 ' A' ' 32' ' ' LEU . 8.7 m120 -80.64 138.63 36.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.268 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.733 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -97.89 137.48 36.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.134 -0.979 . . . . 0.0 109.888 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -166.35 100.24 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 108.991 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.06 7.89 79.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 tt -59.5 -22.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.555 -0.968 . . . . 0.0 109.716 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.659 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 78.7 m-85 -66.15 133.58 50.98 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.03 19.51 78.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' CD ' HE22 ' A' ' 42' ' ' GLN . 32.8 mmt180 -135.66 163.29 30.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.325 -1.103 . . . . 0.0 109.826 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -90.17 161.53 15.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.417 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 24.8 t -63.17 148.71 47.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.84 . . . . 0.0 109.787 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.6 -10.07 62.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.409 HE22 ' CD ' ' A' ' 38' ' ' ARG . 52.6 tt0 -61.39 -38.35 86.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.006 -1.291 . . . . 0.0 109.722 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -61.55 -30.51 70.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.977 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 49.96 177.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 46' ' ' TYR . . . 80.61 -165.3 47.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 45' ' ' GLY . 33.3 t80 37.07 -127.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.611 -0.935 . . . . 0.0 109.749 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 30.1 t -158.44 146.14 18.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.57 138.75 50.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.48 -0.762 . . . . 0.0 109.343 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 78' ' ' THR . 41.9 p -79.85 162.54 24.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.895 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.21 -32.73 68.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.528 -0.733 . . . . 0.0 110.071 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' A' ' 78' ' ' THR . . . -51.59 -75.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.045 -1.034 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.2 t-20 -54.0 -41.65 68.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.933 -1.105 . . . . 0.0 110.319 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.05 -51.04 77.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.78 -1.2 . . . . 0.0 109.53 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -61.0 -38.57 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.951 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 52' ' ' ASN . 85.7 tttt -117.96 110.43 17.7 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -98.44 138.77 35.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 109.084 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.743 HG11 ' OH ' ' A' ' 74' ' ' TYR . 10.6 p -130.39 147.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.565 -0.71 . . . . 0.0 109.948 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -78.77 131.92 36.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.419 ' O ' ' N ' ' A' ' 37' ' ' GLY . 88.6 m95 -95.5 124.71 39.66 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.217 -0.927 . . . . 0.0 110.101 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.5 t0 -152.66 166.52 31.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.562 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.17 -39.7 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.69 -1.256 . . . . 0.0 109.217 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.51 -47.97 62.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -61.31 -40.71 95.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 110.712 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.5 mtt -60.21 -36.79 78.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 0.0 109.686 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -59.5 -42.97 93.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 109.156 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.18 -34.5 76.41 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.27 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.563 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 81.9 t60 -58.03 -45.46 86.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.541 ' CD1' HD23 ' A' ' 94' ' ' LEU . 79.9 mt -68.1 -29.88 68.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.419 -0.801 . . . . 0.0 110.212 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 29.1 m -57.68 -38.12 74.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.042 -1.036 . . . . 0.0 110.528 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 69' ' ' THR . 15.9 m120 -163.45 67.73 1.67 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 109.795 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -51.92 -27.74 29.04 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.975 2.45 . . . . 0.0 112.705 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.38 1.84 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 109.527 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -61.42 -29.88 70.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.246 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.743 ' OH ' HG11 ' A' ' 57' ' ' VAL . 40.4 t80 -58.46 -49.36 77.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.858 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 74' ' ' TYR . 7.9 pt -139.9 75.48 30.13 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.012 -1.055 . . . . 0.0 110.046 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.24 138.55 51.76 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.919 2.413 . . . . 0.0 112.576 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.41 -6.81 63.49 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.89 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 51' ' ' ALA . 71.5 p -88.64 164.06 15.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.365 . . . . 0.0 110.415 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -85.12 2.02 45.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.9 ttt -81.77 127.74 33.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.951 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.93 87.08 2.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 69.7 t80 -103.34 131.55 50.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.335 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -67.87 142.78 40.58 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.63 145.34 31.39 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 9' ' ' LEU . 55.0 mt -98.81 134.21 42.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.468 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -93.76 -5.81 47.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -110.32 119.27 38.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.92 -33.57 73.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 110.446 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.88 -56.27 24.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.04 . . . . 0.0 110.018 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -62.36 -38.9 91.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.57 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -58.65 -42.19 87.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.85 . . . . 0.0 109.865 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.95 -39.14 88.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.168 -0.957 . . . . 0.0 110.385 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 83.8 m-20 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.541 HD23 ' CD1' ' A' ' 68' ' ' LEU . 56.1 tp -59.76 -45.17 93.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.8 mt -66.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 0.0 108.85 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.1 m -59.11 -39.01 80.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.48 -52.2 66.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.546 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.0 mt -66.53 -32.94 74.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.067 -1.021 . . . . 0.0 108.401 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.562 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 19.1 tttp -56.65 -42.25 78.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.38 -39.08 85.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.755 . . . . 0.0 109.328 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.554 -179.775 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 68.0 t80 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.358 0.599 . . . . 0.0 109.563 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 1' ' ' GLY . 44.3 mtpt -87.65 172.35 9.78 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -40.57 -22.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.271 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 78.08 81.29 0.66 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.51 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.4 p -72.14 166.76 21.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.738 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.04 21.23 5.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.836 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -92.53 -70.98 0.67 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -63.86 -45.22 90.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 110.247 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.669 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -60.3 -39.39 96.01 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.997 -1.097 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.31 71.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -1.192 . . . . 0.0 109.948 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 12' ' ' THR . 53.5 p -74.46 -35.37 63.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 85' ' ' LEU . 7.3 tp -57.28 -40.86 78.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.661 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 64.4 t80 -62.88 -46.84 85.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -63.95 -39.18 93.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.742 -0.599 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' THR . 57.4 p -68.8 -35.01 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 111.495 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -151.77 60.53 0.87 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.628 -1.295 . . . . 0.0 110.876 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.661 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -172.84 -47.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 0.0 109.625 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.48 -37.15 77.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -58.54 -37.74 76.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.12 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.3 m -93.5 -40.85 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 32' ' ' LEU . 88.4 m-70 -106.91 132.89 52.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.099 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 21' ' ' GLU . 30.0 p -103.41 -4.33 24.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' H ' ' A' ' 32' ' ' LEU . 2.8 t 45.99 16.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.999 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' THR . 85.0 tt0 -104.27 137.3 42.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.952 . . . . 0.0 109.465 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -76.83 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 109.891 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -51.37 -17.01 2.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' GLY . . . -41.18 164.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.16 -12.31 29.44 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.274 2.649 . . . . 0.0 112.084 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.614 ' CE1' ' H ' ' A' ' 31' ' ' ASN . 2.1 m-70 60.97 97.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.237 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' HG21 ' A' ' 19' ' ' THR . 51.5 mttm -74.6 -167.8 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 110.017 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG1' ' NZ ' ' A' ' 79' ' ' LYS . 55.9 t -50.49 -45.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 109.989 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.53 149.2 22.45 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.86 148.54 91.8 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.392 2.062 . . . . 0.0 111.741 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.614 ' H ' ' CE1' ' A' ' 26' ' ' HIS . 2.8 m120 -84.35 138.73 32.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.065 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -93.76 140.45 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.633 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.583 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 49.5 p-80 -174.07 90.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.102 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.58 4.79 65.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.19 -22.58 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -1.131 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.1 m-85 -65.62 133.99 52.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.159 -0.963 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.81 72.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.588 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 68.0 mtt85 -145.75 168.75 19.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.0 110.247 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.8 m80 -97.89 157.5 16.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.829 . . . . 0.0 110.119 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.547 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 2.6 m -61.33 163.91 6.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.662 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -6.08 59.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.464 HE22 ' HD2' ' A' ' 38' ' ' ARG . 39.6 tt0 -62.14 -38.94 90.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 0.0 110.101 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.93 77.2 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.57 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.34 -33.05 74.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.502 -0.749 . . . . 0.0 109.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.14 -35.08 68.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 47' ' ' SER . 65.7 t80 -113.36 135.1 54.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.407 -1.055 . . . . 0.0 109.385 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 57.4 p -72.61 162.35 29.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.636 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 60.8 m-85 -114.41 148.17 38.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 109.599 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.2 p -75.26 160.65 30.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.6 -35.43 68.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.788 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -46.56 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.4 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t-20 -52.21 -41.94 63.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.038 -1.039 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.6 mt -57.59 -53.44 44.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.843 -1.161 . . . . 0.0 109.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.88 -38.79 92.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.7 mttm -101.64 28.65 5.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 109.886 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 52' ' ' ASN . 2.6 t-20 -43.88 127.55 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 108.946 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.898 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.4 p -135.18 153.2 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -70.46 136.0 49.12 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.547 ' NE1' ' OG ' ' A' ' 40' ' ' SER . 78.8 m95 -97.75 126.59 43.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 110.34 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.9 t0 -150.9 163.82 37.77 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.543 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.5 mt-10 -54.82 -39.77 68.87 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.51 -47.66 66.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.079 -1.013 . . . . 0.0 110.251 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.24 -39.78 91.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.652 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.1 mtt -59.89 -37.96 80.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 109.807 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.5 m -58.98 -41.45 87.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.034 -1.041 . . . . 0.0 109.075 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.84 -32.77 72.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.921 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.446 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 77.1 t60 -56.87 -48.88 77.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 110.279 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.681 ' CD2' HD23 ' A' ' 94' ' ' LEU . 9.4 mp -73.61 -20.79 60.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -57.76 -36.41 72.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.687 -1.258 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.92 68.23 3.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.206 -0.934 . . . . 0.0 109.945 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.3 -18.7 64.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.577 2.185 . . . . 0.0 113.031 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.18 69.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.421 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -94.38 -5.36 46.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.898 ' OH ' HG11 ' A' ' 57' ' ' VAL . 28.0 t80 -63.84 -46.1 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.643 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.921 HD12 HG21 ' A' ' 78' ' ' THR . 1.8 pt -136.96 72.88 53.72 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.188 -0.945 . . . . 0.0 109.923 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 18.2 Cg_exo -62.53 136.84 61.05 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.655 2.237 . . . . 0.0 111.486 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.48 15.87 48.6 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.687 -1.245 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.921 HG21 HD12 ' A' ' 75' ' ' ILE . 6.6 t -117.52 165.84 13.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.146 -1.208 . . . . 0.0 109.567 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.636 ' NZ ' ' CG1' ' A' ' 28' ' ' VAL . 6.4 mtmp? -86.07 6.48 28.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.284 -0.885 . . . . 0.0 111.255 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.734 ' H ' HG23 ' A' ' 78' ' ' THR . 3.4 ttt -74.95 116.67 15.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.72 31.57 6.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 86.5 t80 -84.99 131.96 34.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -82.73 176.94 53.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.36 166.55 24.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.602 -1.285 . . . . 0.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 HD21 ' A' ' 9' ' ' LEU . 63.4 mt -106.66 124.55 49.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -1.076 . . . . 0.0 109.423 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.7 -38.13 89.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -85.28 128.17 34.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.55 -33.07 54.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 110.125 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -57.01 -50.1 73.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.004 . . . . 0.0 110.071 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.82 -39.01 92.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.174 -0.954 . . . . 0.0 108.779 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -59.79 -40.68 89.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.756 -0.59 . . . . 0.0 109.947 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.85 -43.55 85.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 58.9 t0 -62.48 -39.25 92.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.681 HD23 ' CD2' ' A' ' 68' ' ' LEU . 57.8 tp -59.04 -45.48 90.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.54 -38.83 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.047 . . . . 0.0 108.824 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.1 m -59.0 -39.76 82.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.562 -0.711 . . . . 0.0 109.732 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.28 -48.65 80.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 0.0 108.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 10' ' ' PHE . 84.5 mt -69.12 -31.81 70.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.543 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 20.8 tttm -56.01 -43.49 77.76 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -61.55 -43.64 98.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.783 . . . . 0.0 109.387 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.738 -179.767 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 93.1 t80 . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.244 0.545 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -82.87 141.95 31.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.408 -0.808 . . . . 0.0 109.172 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -44.79 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 70.14 126.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' A' ' 93' ' ' ASP . 84.2 p -63.27 -19.41 64.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.177 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 60.11 -143.55 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.401 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 56.06 -79.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.702 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 3' ' ' ALA . 65.4 mttp -58.31 -43.52 88.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -58.98 -33.95 76.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.86 88.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.566 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 12' ' ' THR . 58.8 p -72.54 -36.21 68.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.131 -0.981 . . . . 0.0 109.038 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 85' ' ' LEU . 8.1 tp -58.14 -40.89 82.47 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 71.2 t80 -63.46 -46.93 83.99 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -62.92 -38.18 89.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.64 -0.663 . . . . 0.0 110.133 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 8' ' ' THR . 51.7 p -70.81 -31.16 67.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 111.481 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -148.13 54.88 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.562 -1.336 . . . . 0.0 111.357 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.6 t -173.37 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 110.829 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.52 -37.07 69.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -56.3 -32.88 65.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.3 m -101.5 -44.76 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 0.0 110.838 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -103.64 121.93 43.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.073 -1.017 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.535 ' C ' HG23 ' A' ' 20' ' ' VAL . 47.8 p -81.9 -24.64 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 65.55 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -98.86 120.49 39.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.075 -1.016 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 14.5 pttp -69.85 -40.05 76.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.613 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.92 -36.55 90.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.15 155.43 49.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.54 -156.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.61 137.25 47.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.276 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -110.71 -124.78 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.795 . . . . 0.0 109.114 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.63 -40.73 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.38 163.08 22.0 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -61.17 145.6 98.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.883 2.389 . . . . 0.0 112.353 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.0 145.97 53.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 109.029 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.834 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.3 tp -101.85 119.18 38.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.168 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 35' ' ' ILE . 85.2 t60 -154.1 134.33 13.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.041 -1.037 . . . . 0.0 109.875 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 44.43 15.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 33' ' ' HIS . 3.7 tp -58.22 -22.49 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.427 -1.043 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.664 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 92.2 m-85 -63.64 136.77 57.74 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.172 -0.955 . . . . 0.0 109.283 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.09 32.34 72.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 58' ' ' LEU . 60.6 mmt-85 -127.29 152.06 47.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -1.14 . . . . 0.0 110.153 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.913 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.5 m80 -109.49 142.15 40.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.742 . . . . 0.0 109.933 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 39' ' ' HIS . 7.4 p 49.44 174.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.634 0.731 . . . . 0.0 110.599 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.7 72.31 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' SER . 44.0 tt0 -60.17 -35.07 74.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -1.18 . . . . 0.0 110.003 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.51 -34.78 69.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.899 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 46.54 -176.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.24 -13.05 68.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 47' ' ' SER . 85.7 t80 -136.63 146.41 45.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 108.962 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 44.1 m -62.23 147.45 47.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.744 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -119.75 142.37 48.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 109.339 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 51' ' ' ALA . 56.9 m -72.84 143.82 47.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.95 . . . . 0.0 109.072 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -49.29 -33.73 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 109.311 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 49' ' ' THR . . . -47.99 -71.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 110.228 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.6 t-20 -57.51 -40.38 78.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.79 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 67.4 mt -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.867 -1.145 . . . . 0.0 109.936 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.16 -52.7 57.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.971 -1.081 . . . . 0.0 109.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 56' ' ' ASN . 32.8 tttp -67.68 -47.62 68.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.943 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 55' ' ' LYS . 1.8 m120 38.42 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.645 . . . . 0.0 109.876 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 74' ' ' TYR . 7.1 p -123.18 149.82 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 110.172 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.913 HD13 ' CE1' ' A' ' 39' ' ' HIS . 49.9 tp -66.09 134.13 52.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 37' ' ' GLY . 92.8 m95 -98.03 130.89 44.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -156.13 164.84 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.533 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.7 mt-10 -53.89 -40.17 66.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 109.273 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -67.76 -47.98 67.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.908 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 64.7 t30 -63.75 -40.35 96.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.664 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.9 mtt -59.92 -37.9 80.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 109.688 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -60.32 -41.58 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.081 -1.012 . . . . 0.0 108.974 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.88 -34.38 77.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.189 -0.944 . . . . 0.0 109.074 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.472 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 61.8 t60 -59.57 -47.28 86.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 94' ' ' LEU . 71.7 mt -71.59 -34.04 69.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 30.9 m -58.66 -38.35 77.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 110.828 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -161.65 67.76 2.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.96 -1.087 . . . . 0.0 109.803 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.31 -24.71 8.83 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.144 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -63.72 -59.84 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.506 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.91 -34.12 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.028 -1.045 . . . . 0.0 109.429 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.512 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 21.6 t80 -54.97 -44.74 74.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.508 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.8 OUTLIER -139.78 154.67 71.13 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 108.885 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.24 6.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.573 2.182 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 75' ' ' ILE . . . 88.2 50.44 3.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.883 HG23 ' H ' ' A' ' 80' ' ' MET . 14.6 t -55.64 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.612 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -59.57 -24.81 64.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.099 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.883 ' H ' HG23 ' A' ' 78' ' ' THR . 63.5 mtm -68.88 120.22 14.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.23 26.12 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 65.0 t80 -55.87 136.23 51.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.706 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.03 -179.68 51.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.5 146.69 17.72 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 9' ' ' LEU . 55.9 mt -97.22 135.96 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 109.056 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -91.1 -6.55 53.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.097 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -103.53 127.22 50.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.32 -38.54 55.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -60.52 -47.93 84.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.99 -39.91 95.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.55 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 61.7 ttp180 -59.58 -43.62 93.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -61.52 -37.13 82.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -0.969 . . . . 0.0 109.59 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' A' ' 2' ' ' SER . 90.4 m-20 -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 68' ' ' LEU . 51.8 tp -61.57 -46.25 90.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 110.359 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.1 -41.0 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.048 . . . . 0.0 109.029 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 33.5 m -59.6 -39.68 85.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.825 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.74 -49.19 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.923 -1.11 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 32' ' ' LEU . 94.0 mt -68.18 -32.14 72.17 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 29.1 tttm -57.71 -42.84 84.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.582 -0.699 . . . . 0.0 109.284 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -61.63 -43.71 98.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.398 -0.813 . . . . 0.0 109.769 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 -179.504 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 89.7 t80 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.397 0.617 . . . . 0.0 109.999 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.1 ttpt -84.08 139.95 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.15 -24.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 52.21 169.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -124.53 125.85 44.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -1.063 . . . . 0.0 109.069 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -70.24 -22.82 62.86 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.38 -53.86 53.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 110.208 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -67.3 -50.57 59.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.876 -1.14 . . . . 0.0 109.621 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.525 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.63 -31.04 78.57 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.146 . . . . 0.0 109.857 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.887 ' O ' HG23 ' A' ' 12' ' ' THR . 66.4 p -73.62 -39.77 64.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.142 -0.974 . . . . 0.0 109.42 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 HD13 ' A' ' 94' ' ' LEU . 8.8 tp -59.97 -41.23 91.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.664 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.6 t80 -62.07 -46.12 90.53 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -63.47 -37.63 88.02 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 109.967 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 8' ' ' THR . 56.9 p -70.43 -33.9 71.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 111.74 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -149.58 56.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.519 -1.363 . . . . 0.0 111.491 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.664 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -173.06 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.74 -1.225 . . . . 0.0 110.192 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.79 -37.36 73.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.976 . . . . 0.0 109.942 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.72 -35.07 70.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.95 . . . . 0.0 109.826 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -96.73 -43.11 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.658 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -107.21 123.79 48.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' GLU . 44.2 p -86.07 -23.9 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' LEU . 2.4 t 59.28 -1.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.298 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.3 tt0 -97.36 124.06 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 109.53 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 24.6 pttm -68.41 -41.4 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.885 . . . . 0.0 109.191 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -63.12 -34.84 91.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.2 157.56 51.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.74 -161.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' CD2' ' CG ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -103.64 125.24 50.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.398 -0.814 . . . . 0.0 109.106 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -101.53 -159.59 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.5 t -51.3 -41.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.13 149.98 17.13 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.31 147.36 94.09 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.495 2.13 . . . . 0.0 112.6 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.74 138.71 58.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.308 -0.87 . . . . 0.0 109.111 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.793 ' CD2' HD13 ' A' ' 98' ' ' LEU . 14.6 tp -106.54 118.67 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.229 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -158.92 127.16 5.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.785 -1.197 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 55.8 12.17 4.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.66 HG21 HD11 ' A' ' 32' ' ' LEU . 2.8 tp -60.07 -21.63 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.362 -1.081 . . . . 0.0 109.835 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 90.5 m-85 -62.88 139.16 58.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.055 -1.028 . . . . 0.0 109.38 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.95 22.73 77.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -136.29 160.09 39.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -1.095 . . . . 0.0 109.804 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' CE1' HD13 ' A' ' 58' ' ' LEU . 78.0 m80 -94.34 158.39 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.385 -0.822 . . . . 0.0 109.443 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.449 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 77.1 p -62.08 159.41 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.76 5.36 88.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -60.85 -35.21 75.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.46 -1.024 . . . . 0.0 110.226 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.53 -35.05 69.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.112 -0.992 . . . . 0.0 109.719 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.0 mt-10 42.2 18.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.583 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -118.65 -36.63 0.89 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.465 ' CG ' ' CD2' ' A' ' 26' ' ' HIS . 78.9 t80 -110.65 136.41 49.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.544 -0.974 . . . . 0.0 109.14 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 38.5 m -59.61 153.1 20.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.959 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -117.5 158.84 23.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.356 179.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 26.1 p -74.74 158.51 33.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.247 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.79 -30.86 67.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.67 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.532 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.5 t-20 -52.35 -44.03 64.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 53' ' ' ILE . 42.0 mm -59.71 -40.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.619 -1.301 . . . . 0.0 109.284 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.34 -37.75 84.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASN . 43.6 tttp -125.72 114.51 18.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.486 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -95.16 134.88 37.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.094 -1.004 . . . . 0.0 109.289 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.849 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.2 p -131.39 146.83 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -81.59 133.95 35.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 108.968 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -97.95 127.57 43.98 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.195 -0.941 . . . . 0.0 110.207 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.3 t0 -151.92 167.81 27.15 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -57.47 -36.06 70.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.893 -1.13 . . . . 0.0 109.653 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -76.23 -57.5 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.895 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -63.48 -41.18 98.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.642 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 59.0 ttm -59.27 -36.31 75.31 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.542 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.4 p -62.75 -35.88 81.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.554 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.28 -35.94 82.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.45 -43.39 96.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 0.0 110.045 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.609 ' CD2' HD23 ' A' ' 94' ' ' LEU . 7.0 mp -62.36 -31.7 72.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.873 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 18.0 m -88.16 129.84 35.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 109.541 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 69' ' ' THR . 74.0 m-20 38.64 54.98 4.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.748 . . . . 0.0 110.496 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 9.5 Cg_endo -54.97 -14.68 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.568 2.179 . . . . 0.0 111.102 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 74' ' ' TYR . . . -63.2 154.17 32.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.2 tttt 67.23 -36.52 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.858 -0.526 . . . . 0.0 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.849 ' OH ' HG11 ' A' ' 57' ' ' VAL . 86.5 t80 -60.25 -50.01 75.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.073 -1.017 . . . . 0.0 109.579 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.683 ' O ' HG22 ' A' ' 75' ' ' ILE . 3.8 mm -140.87 77.2 21.71 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.136 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.57 151.4 11.69 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 123.095 2.53 . . . . 0.0 112.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 21.09 27.82 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 80' ' ' MET . 12.1 t -123.51 164.7 18.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.303 -1.116 . . . . 0.0 109.797 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -81.77 4.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 109.69 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.506 ' H ' HG23 ' A' ' 78' ' ' THR . 11.9 ttp -79.8 131.74 35.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.907 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.08 70.18 1.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 76.6 t80 -102.89 134.44 46.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -81.83 174.36 53.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.91 161.89 27.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 mt -102.83 128.07 49.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -1.116 . . . . 0.0 109.194 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -65.18 -44.21 89.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.951 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -90.09 129.52 36.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.483 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -73.37 -32.37 64.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 109.76 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -56.18 -48.32 76.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 0.0 109.464 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.24 -37.6 77.94 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 0.0 109.262 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.55 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 34.0 ttm180 -57.81 -41.78 82.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -59.49 -40.49 87.17 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 80.1 m-20 -64.27 -40.05 95.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.169 -0.957 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.609 HD23 ' CD2' ' A' ' 68' ' ' LEU . 46.6 tp -62.62 -44.74 95.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.02 -36.91 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.11 -0.994 . . . . 0.0 108.563 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.6 m -57.31 -40.84 78.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.552 -0.717 . . . . 0.0 109.646 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -60.06 -51.78 68.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 109.382 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' CD2' ' A' ' 32' ' ' LEU . 91.9 mt -65.31 -35.41 80.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 12.7 tttp -57.28 -40.38 77.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -59.44 -40.3 86.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.301 -1.539 0 O-C-N 121.474 -0.766 . . . . 0.0 109.466 -179.814 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 48.0 t80 . . . . . 0 N--CA 1.491 1.578 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 1' ' ' GLY . 32.7 ttpt -94.82 130.85 41.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.944 . . . . 0.0 109.267 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -48.64 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.212 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -105.53 135.19 12.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.8 p -69.58 153.54 43.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -1.226 . . . . 0.0 109.203 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -93.36 -10.23 36.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.797 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -59.48 -47.76 84.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.109 -0.995 . . . . 0.0 109.923 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -67.2 -50.73 59.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.48 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.59 -32.82 85.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -57.92 -45.26 86.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.132 -1.217 . . . . 0.0 109.639 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 12' ' ' THR . 51.8 p -71.95 -37.61 69.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 94' ' ' LEU . 9.9 tp -59.45 -41.35 89.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.7 t80 -63.74 -45.81 88.2 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -62.61 -39.85 95.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.661 -0.65 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 8' ' ' THR . 56.6 p -71.58 -37.06 71.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 111.665 -178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -140.49 54.38 1.61 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.775 -1.203 . . . . 0.0 110.899 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -170.95 -53.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.696 -1.252 . . . . 0.0 110.616 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.94 -37.9 72.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.034 -1.041 . . . . 0.0 109.687 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.25 -35.74 72.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.829 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.2 m -95.73 -43.18 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.57 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.473 ' ND1' HD13 ' A' ' 32' ' ' LEU . 88.4 m-70 -105.32 129.88 53.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.345 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' GLU . 63.0 p -95.45 -8.13 36.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.01 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' LEU . 2.7 m 32.3 36.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.209 0.528 . . . . 0.0 110.72 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -104.15 133.7 48.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -82.48 139.4 33.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.14 76.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.34 165.19 12.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.14 172.11 16.64 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.115 2.543 . . . . 0.0 111.99 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -105.15 135.62 46.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.351 -0.843 . . . . 0.0 109.153 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.41 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 18.0 tptt -104.65 -126.48 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 109.005 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.13 -39.66 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.129 -0.982 . . . . 0.0 109.064 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.44 160.65 20.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 20.9 Cg_endo -62.34 149.43 90.78 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.035 2.49 . . . . 0.0 112.498 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.54 ' C ' HD12 ' A' ' 32' ' ' LEU . 2.6 m120 -77.72 126.21 30.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 32' ' ' LEU . 8.2 mp -100.0 132.02 45.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.18 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -160.97 102.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.28 77.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.681 -1.767 . . . . 0.0 108.681 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 tt -57.7 -21.72 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.49 -1.006 . . . . 0.0 109.391 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CD2' ' OE2' ' A' ' 61' ' ' GLU . 96.0 m-85 -62.86 135.52 57.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 108.932 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.94 20.67 80.02 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -133.67 162.4 32.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -1.086 . . . . 0.0 110.035 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -94.72 168.6 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.463 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 20.8 t -83.96 146.38 28.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.63 -6.84 70.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.75 -37.62 87.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.138 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -60.21 -43.52 95.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.097 -1.002 . . . . 0.0 109.427 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 58.11 -21.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -59.91 -33.93 80.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CD2' ' O ' ' A' ' 47' ' ' SER . 76.6 t80 -115.13 140.29 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -1.011 . . . . 0.0 109.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.7 t -65.66 151.99 45.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.518 ' O ' HD11 ' A' ' 53' ' ' ILE . 37.0 m-85 -111.73 147.75 34.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.564 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 p -75.86 164.35 26.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.22 -31.22 61.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.392 -0.818 . . . . 0.0 109.258 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' C ' ' A' ' 77' ' ' GLY . . . -48.84 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 110.638 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.606 ' HA ' HD12 ' A' ' 75' ' ' ILE . 23.5 t-20 -57.42 -41.56 80.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.952 -1.093 . . . . 0.0 110.641 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 48' ' ' TYR . 84.4 mt -60.25 -44.66 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.845 -1.16 . . . . 0.0 109.83 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -59.35 -37.54 78.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.94 . . . . 0.0 109.271 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 76.6 tttt -132.14 121.33 23.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.444 -0.785 . . . . 0.0 109.215 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.81 136.52 40.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.724 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.5 p -130.93 147.73 33.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.523 -0.736 . . . . 0.0 110.055 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.7 tp -77.73 133.78 38.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 108.95 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' GLY . 93.2 m95 -93.86 127.75 39.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.375 -0.828 . . . . 0.0 109.856 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.6 t0 -148.96 167.97 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' CD2' ' A' ' 36' ' ' PHE . 79.0 mm-40 -58.03 -39.36 78.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.988 -1.07 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -78.69 -48.67 14.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 33.9 t30 -59.89 -39.23 84.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.573 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 42.4 tpp -60.3 -38.92 85.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.551 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -61.47 -33.79 74.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.801 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.51 -36.03 81.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.885 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.408 ' NE2' ' CE ' ' A' ' 80' ' ' MET . 81.3 t60 -59.31 -43.79 92.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 5.3 mp -67.77 -27.15 66.51 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.999 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.546 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 25.5 m -81.16 128.48 33.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.973 . . . . 0.0 110.379 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 69' ' ' THR . 11.7 t-20 32.54 59.81 1.42 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.849 -0.532 . . . . 0.0 111.312 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.2 Cg_endo -61.8 135.65 57.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 111.699 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 71' ' ' PRO . . . 162.04 -86.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.391 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.51 -28.96 61.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.724 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.8 t80 -54.83 -51.98 64.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 109.53 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 75' ' ' ILE . 9.5 mm -152.08 73.18 7.79 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.136 -0.977 . . . . 0.0 108.787 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.96 150.59 18.2 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.894 2.396 . . . . 0.0 112.34 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 107.01 15.29 16.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -124.17 156.99 35.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -1.083 . . . . 0.0 109.414 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -84.6 5.38 28.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 0.0 110.948 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.474 ' O ' ' C ' ' A' ' 81' ' ' ALA . 4.5 ttt -55.45 -40.14 71.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.793 -1.192 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 80' ' ' MET . . . 33.69 75.08 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.722 -0.611 . . . . 0.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -106.22 131.44 53.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.28 140.14 30.44 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.98 150.84 41.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.6 mt -96.19 133.67 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -1.146 . . . . 0.0 109.164 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -87.5 -12.72 45.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -101.6 126.18 48.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.83 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.12 -36.68 61.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.932 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.0 -45.06 93.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.07 -39.35 94.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.135 -0.978 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.546 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 39.1 ttm180 -59.12 -41.78 88.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.779 . . . . 0.0 109.966 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.9 -40.82 94.56 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.08 -1.013 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 84.5 m-20 -64.35 -41.27 96.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.966 -1.084 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.489 HD22 HD23 ' A' ' 9' ' ' LEU . 50.8 tp -59.25 -43.1 92.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.082 -1.012 . . . . 0.0 109.376 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG2' ' OE1' ' A' ' 61' ' ' GLU . 81.0 mt -66.19 -36.15 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.186 -0.946 . . . . 0.0 108.78 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 m -57.31 -41.35 79.71 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.604 -0.685 . . . . 0.0 109.843 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -63.18 -52.94 60.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 110.306 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 10' ' ' PHE . 94.3 mt -70.02 -39.85 75.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 108.965 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -58.88 -40.24 83.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.716 . . . . 0.0 109.347 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -60.39 -40.15 89.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.534 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 109.667 -179.69 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 70.1 t80 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 121.389 0.614 . . . . 0.0 109.517 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.595 ' O ' ' CE2' ' A' ' -3' ' ' PHE . 48.5 mtmt -86.42 170.89 11.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.65 -24.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.508 -0.745 . . . . 0.0 109.798 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 101.31 97.28 2.29 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -119.72 136.93 54.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.98 . . . . 0.0 109.07 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.73 131.03 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.771 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -175.22 -91.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -63.31 -37.66 88.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 108.718 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.9 -36.73 91.05 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.81 75.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -1.134 . . . . 0.0 109.588 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -74.0 -32.27 63.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.159 -0.963 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -56.65 -41.8 77.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 68.0 t80 -63.5 -47.08 83.17 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -63.27 -38.74 92.33 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.434 0.635 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 8' ' ' THR . 57.3 p -70.4 -32.92 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 111.483 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -148.58 57.44 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.667 -1.271 . . . . 0.0 111.166 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -173.33 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.854 -1.153 . . . . 0.0 110.322 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.87 -37.7 71.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.799 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.52 -34.92 69.61 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.718 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -97.41 -43.67 7.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 110.681 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -105.11 124.43 49.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 110.203 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.4 p -87.22 -18.34 30.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 109.31 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 61.57 19.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 24' ' ' GLY . 49.0 tp10 -99.82 140.6 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.348 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -82.2 -81.7 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.14 -28.61 19.03 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 21' ' ' GLU . . . -59.22 156.05 26.31 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.3 -174.48 1.62 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.84 2.36 . . . . 0.0 111.948 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -105.72 135.13 47.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 109.251 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -97.86 -126.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 108.908 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.34 -39.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.109 -0.995 . . . . 0.0 109.044 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 165.56 19.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 22.9 Cg_endo -62.68 148.23 93.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.968 2.445 . . . . 0.0 111.991 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 9.4 m120 -80.13 137.48 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.088 -1.007 . . . . 0.0 109.46 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.679 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.8 mp -100.08 135.57 41.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.923 . . . . 0.0 109.835 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -164.14 98.41 0.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 108.975 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.94 8.61 82.17 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.28 -23.16 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.479 -1.012 . . . . 0.0 109.494 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -67.17 135.34 53.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 73.95 20.73 79.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HD3' HE22 ' A' ' 42' ' ' GLN . 95.0 mtt180 -137.01 165.22 26.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.936 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.38 154.54 17.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.583 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 37.1 p -65.88 160.88 22.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.956 . . . . 0.0 109.899 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.61 57.18 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.432 HE22 ' HD3' ' A' ' 38' ' ' ARG . 52.0 tt0 -62.23 -36.73 82.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.262 . . . . 0.0 109.931 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.818 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.57 140.24 47.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 109.381 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.97 153.37 41.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.786 . . . . 0.0 109.354 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.87 0.42 64.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 47' ' ' SER . 59.8 t80 -136.38 156.04 49.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.205 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.537 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.9 t -95.55 147.3 23.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.645 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.818 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 49.4 m-85 -103.21 141.99 34.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.378 -0.826 . . . . 0.0 109.785 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 78' ' ' THR . 47.2 m -74.4 149.98 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.479 -0.763 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.64 -33.73 23.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.809 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -73.14 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.5 t-20 -54.51 -41.0 69.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.029 . . . . 0.0 110.306 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.11 -46.4 94.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.838 -1.164 . . . . 0.0 109.456 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -60.48 -37.21 80.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 108.94 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ASN . 25.9 tttt -127.84 116.9 20.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.583 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -101.87 134.99 44.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.12 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.65 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -131.99 148.24 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.438 -0.788 . . . . 0.0 109.892 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.5 tt -79.66 132.26 36.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.794 ' N ' HD23 ' A' ' 58' ' ' LEU . 99.7 m95 -92.88 110.08 21.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.056 -1.027 . . . . 0.0 109.688 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 54.8 t0 -136.31 168.92 18.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.564 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.02 -37.36 69.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.902 -1.124 . . . . 0.0 109.293 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.75 -56.57 6.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.9 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.458 ' ND2' ' OH ' ' A' ' 74' ' ' TYR . 41.0 t30 -62.34 -38.96 91.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.828 . . . . 0.0 110.397 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.5 tpp -58.75 -40.56 84.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.691 ' HA ' HD11 ' A' ' 95' ' ' ILE . 19.7 m -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 109.276 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.13 -31.44 72.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.047 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.474 ' CE1' ' CD1' ' A' ' 74' ' ' TYR . 75.2 t60 -57.48 -47.49 81.75 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.439 -0.788 . . . . 0.0 109.597 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.523 ' CD1' HD23 ' A' ' 94' ' ' LEU . 72.8 mt -68.37 -30.52 69.47 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.7 m -62.46 -39.81 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.015 -1.053 . . . . 0.0 110.641 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -150.95 65.93 7.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.073 -1.017 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.63 -20.74 69.76 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.572 2.181 . . . . 0.0 112.776 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.9 -50.38 64.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.652 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -86.62 -6.36 58.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 110.046 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.65 ' OH ' HG11 ' A' ' 57' ' ' VAL . 44.6 t80 -62.47 -49.67 74.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 ' CD1' ' A' ' 74' ' ' TYR . 6.7 pt -140.7 72.26 29.79 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.04 135.67 64.69 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.49 2.127 . . . . 0.0 112.204 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 14.62 50.09 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.15 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.721 ' HA ' HG21 ' A' ' 49' ' ' THR . 14.9 t -104.61 171.44 7.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.816 -1.403 . . . . 0.0 110.064 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -94.61 14.06 22.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 0.0 110.318 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . 0.625 ' H ' HG23 ' A' ' 78' ' ' THR . 2.1 mmm -67.5 135.05 52.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 0.0 109.889 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.25 26.01 10.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 57.2 t80 -91.79 130.16 37.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -85.48 177.05 50.09 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.91 158.07 30.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -102.95 135.05 45.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.0 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -92.65 -4.62 53.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.795 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -103.02 130.81 50.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.005 . . . . 0.0 109.805 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.31 -44.87 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.454 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -60.17 -48.26 82.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.018 . . . . 0.0 110.301 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.63 -39.04 93.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -58.92 -42.31 89.38 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.3 m-20 -61.62 -40.37 94.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.07 -1.019 . . . . 0.0 110.384 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.37 -40.08 96.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.026 -1.046 . . . . 0.0 110.001 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.644 HD22 HD23 ' A' ' 9' ' ' LEU . 59.0 tp -57.26 -45.75 83.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 65' ' ' SER . 77.3 mt -66.53 -43.64 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 m -60.71 -39.74 89.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.352 -0.843 . . . . 0.0 109.917 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -58.09 -49.18 77.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.043 . . . . 0.0 109.729 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 98' ' ' LEU . 85.8 mt -69.09 -35.59 76.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.038 . . . . 0.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.564 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 10.9 tptm -57.84 -43.34 85.78 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.388 -0.82 . . . . 0.0 109.517 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -61.04 -45.44 94.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.176 -0.952 . . . . 0.0 109.693 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 109.511 -179.886 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' -2' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' -1' ' ' ALA . 34.6 ttpt -102.54 136.36 42.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' -1' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.99 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -98.23 134.27 11.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 22.8 t -57.19 -33.48 67.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -1.123 . . . . 0.0 109.288 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 73.32 -35.77 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.2 tttt -59.14 -48.9 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.52 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.62 -42.81 98.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.36 -32.16 81.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.9 93.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -1.17 . . . . 0.0 109.474 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 12' ' ' THR . 47.4 p -72.51 -36.38 68.35 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.572 HD23 HD13 ' A' ' 94' ' ' LEU . 7.1 tp -58.33 -41.49 84.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.3 t80 -63.54 -46.85 84.11 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -63.31 -39.65 95.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 8' ' ' THR . 65.3 p -70.41 -34.43 72.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.419 -0.8 . . . . 0.0 111.7 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -150.27 59.97 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.626 -1.296 . . . . 0.0 110.933 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -173.08 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.962 -1.086 . . . . 0.0 109.997 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -36.32 72.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.967 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -56.45 -35.35 67.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.024 -1.048 . . . . 0.0 109.496 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.9 m -97.26 -48.84 5.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.263 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . 0.574 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.2 m-70 -99.3 113.43 25.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.741 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.0 p -82.58 -19.15 39.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.73 ' O ' HG22 ' A' ' 20' ' ' VAL . 8.0 p 36.86 41.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.6 tt0 -101.67 147.95 25.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -56.57 -36.58 69.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -55.44 -30.94 56.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 25' ' ' PRO . . . 64.66 56.54 16.33 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 24' ' ' GLY . 33.1 Cg_endo -67.79 -23.78 41.35 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.787 2.325 . . . . 0.0 112.019 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 93.1 m-70 54.77 57.9 5.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.644 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' HIS . 45.1 tttm -58.98 -122.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.342 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.05 -40.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 109.883 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.52 167.47 14.95 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.29 152.29 61.49 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.004 2.469 . . . . 0.0 112.263 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 26' ' ' HIS . 16.2 m120 -89.17 140.83 29.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.273 -0.892 . . . . 0.0 109.044 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.817 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.8 mp -92.83 140.39 29.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.932 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 47.6 p-80 -176.06 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 93.98 3.8 63.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.19 -21.56 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.449 -1.03 . . . . 0.0 109.524 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -66.94 132.32 47.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.8 24.33 76.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 86.3 mtt-85 -133.12 159.1 41.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -1.133 . . . . 0.0 109.95 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -90.93 147.38 23.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 3.4 t -63.13 155.91 26.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.79 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.79 -13.92 59.08 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 44' ' ' GLU . 51.4 tt0 -62.3 -37.1 84.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 109.804 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -64.85 70.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.897 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLN . 97.2 mt-10 -60.51 -31.28 70.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.11 -32.84 50.64 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 47' ' ' SER . 60.3 t80 -122.3 142.03 50.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -1.04 . . . . 0.0 109.572 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 22.9 t -74.04 158.17 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 19.4 m-85 -106.12 150.27 25.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 51' ' ' ALA . 2.0 t -63.58 155.21 30.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.258 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -55.52 -35.49 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.567 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' N ' HG23 ' A' ' 49' ' ' THR . . . -59.53 -58.23 9.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.185 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 55' ' ' LYS . 17.5 t-20 -57.88 -40.81 81.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.922 -1.111 . . . . 0.0 109.469 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.77 -43.13 98.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.145 -0.972 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.34 -40.99 92.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 109.331 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 52' ' ' ASN . 6.7 tptm -128.39 125.17 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.621 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -98.05 140.89 31.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 109.086 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.806 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.3 p -130.94 148.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.28 130.89 35.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TRP . . . . . 0.451 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.4 m95 -98.95 125.15 44.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 p30 -157.95 -170.21 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -62.31 -43.12 99.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.763 -1.21 . . . . 0.0 110.439 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -68.39 -54.1 19.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 0.0 110.714 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 40.7 t30 -57.1 -38.7 73.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.44 -0.787 . . . . 0.0 110.902 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.6 mmt -58.04 -41.99 84.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 0.0 109.425 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -65.88 -32.96 74.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.458 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.03 -37.59 84.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.148 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.04 -49.21 78.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.043 . . . . 0.0 109.496 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.4 mp -72.23 -26.95 62.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 70' ' ' ASN . 27.2 m -87.51 129.66 35.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.015 . . . . 0.0 109.629 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 69' ' ' THR . 1.5 m120 38.75 55.94 5.2 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 11.1 Cg_endo -58.44 -18.49 39.16 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.84 2.36 . . . . 0.0 112.649 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.77 90.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.529 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.47 4.73 51.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' TYR . . . . . 0.806 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.9 t80 -116.39 119.35 35.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.275 -0.891 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 78' ' ' THR . 45.7 mm 40.23 59.25 7.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.483 -0.761 . . . . 0.0 109.783 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.99 147.8 62.19 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.903 2.402 . . . . 0.0 112.139 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.7 2.91 57.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 75' ' ' ILE . 51.9 p -75.48 163.59 27.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -85.07 5.99 27.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -86.7 126.69 34.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.371 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.65 6.87 32.38 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.83 134.07 46.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.55 -175.32 28.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 76.71 36.32 37.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 62.7 mt -82.26 143.27 31.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' LYS . 20.3 ttpp -73.3 145.64 45.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' LYS . 17.5 mttp -44.19 130.76 6.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 89' ' ' LYS . 85.6 tt0 -172.19 158.53 4.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 88' ' ' GLU . 18.6 mttt -55.38 -32.3 62.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.144 -0.973 . . . . 0.0 109.231 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -56.04 -41.26 74.73 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.156 -0.965 . . . . 0.0 109.251 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.3 ttm180 -61.21 -46.46 90.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -67.25 -40.94 86.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.775 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 3' ' ' ALA . 89.2 m-20 -62.93 -40.22 96.94 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 68' ' ' LEU . 53.5 tp -58.18 -44.78 88.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 109.52 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.16 -40.54 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 14.1 m -57.99 -40.15 79.99 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.735 -0.603 . . . . 0.0 109.77 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.83 -51.36 70.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.082 -1.011 . . . . 0.0 109.687 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 10' ' ' PHE . 92.3 mt -66.92 -35.61 80.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.057 -1.027 . . . . 0.0 108.33 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 82.8 tttt -58.09 -42.39 85.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -60.79 -39.89 90.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 109.742 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.456 -0.778 . . . . 0.0 109.421 -179.673 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.21 -31.19 67.09 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.927 . . . . 0.0 109.523 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.583 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 36.5 t80 -92.46 130.59 38.09 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.215 -0.928 . . . . 0.0 109.517 -179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.583 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.4 ptmt -103.53 161.32 13.97 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.372 -0.83 . . . . 0.0 109.215 179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -62.88 96.43 0.09 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.96 . . . . 0.0 109.336 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -110.98 170.21 13.73 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.3 t -110.94 130.87 55.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.259 -1.142 . . . . 0.0 109.238 179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -74.4 -19.39 60.44 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.296 -0.878 . . . . 0.0 110.022 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -56.5 -49.55 74.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.17 -0.956 . . . . 0.0 110.093 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 65.1 mttt -63.14 -47.48 82.56 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.938 -1.101 . . . . 0.0 109.267 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -67.66 -28.13 73.56 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 179.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.469 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.62 -44.73 85.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.118 -1.224 . . . . 0.0 109.868 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.853 ' O ' HG23 ' A' ' 12' ' ' THR . 52.9 p -70.02 -38.62 75.97 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.153 -0.967 . . . . 0.0 109.418 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.759 HD23 HD22 ' A' ' 94' ' ' LEU . 8.3 tp -59.25 -41.04 87.85 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.676 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.66 -46.36 88.54 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.517 -0.92 . . . . 0.0 108.517 179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 tttm -63.79 -38.86 92.68 Favored 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.382 0.61 . . . . 0.0 109.967 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 8' ' ' THR . 56.8 p -69.31 -34.68 75.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.471 -0.768 . . . . 0.0 111.493 -178.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 80.8 mtp180 -150.28 59.38 0.96 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.642 -1.287 . . . . 0.0 110.952 -178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -171.18 -51.98 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.895 -1.128 . . . . 0.0 109.965 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.98 -38.2 72.67 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.135 -0.978 . . . . 0.0 109.607 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.87 -36.09 74.06 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.167 -0.958 . . . . 0.0 109.898 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.1 m -94.53 -42.57 8.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 110.479 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.434 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.6 m-70 -107.56 124.15 49.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.331 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 21' ' ' GLU . 47.9 p -84.42 -29.57 26.04 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 0.0 109.251 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 20' ' ' VAL . 85.7 t 54.32 -0.23 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.397 -0.815 . . . . 0.0 110.289 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.567 ' H ' ' C ' ' A' ' 19' ' ' THR . 77.8 mm-40 -62.06 141.98 57.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.002 -1.061 . . . . 0.0 109.416 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.563 ' O ' ' N ' ' A' ' 24' ' ' GLY . 16.3 tttm -71.07 143.19 50.77 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.166 -0.959 . . . . 0.0 109.623 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 48.18 9.98 0.09 OUTLIER Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 -179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 22' ' ' LYS . . . -76.17 162.65 52.69 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 57.0 Cg_endo -71.31 175.92 8.66 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 123.127 2.552 . . . . 0.0 111.691 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -102.42 133.49 47.28 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.254 -0.904 . . . . 0.0 109.516 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.582 ' O ' ' N ' ' A' ' 29' ' ' GLY . 56.0 tttp -132.23 131.09 41.78 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.399 -0.813 . . . . 0.0 109.252 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.43 HG23 ' HG2' ' A' ' 27' ' ' LYS . 85.1 t 53.73 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.201 -0.937 . . . . 0.0 109.171 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.582 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -102.39 162.97 16.69 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.434 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 20.3 Cg_endo -62.03 153.01 71.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 123.09 2.527 . . . . 0.0 112.165 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.534 ' C ' HD12 ' A' ' 32' ' ' LEU . 12.7 m120 -84.27 139.03 32.61 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 109.431 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -99.69 139.3 35.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.168 -0.957 . . . . 0.0 109.885 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 57.8 t-80 -166.56 95.24 0.53 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.22 -0.925 . . . . 0.0 109.213 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.58 7.47 78.85 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.007 -1.637 . . . . 0.0 109.007 -179.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.8 tt -58.66 -21.58 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.477 -1.014 . . . . 0.0 109.613 -179.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' CD1' HG21 ' A' ' 102' ' ' THR . 81.9 m-85 -64.1 133.22 52.58 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.244 -0.91 . . . . 0.0 109.514 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 71.13 21.39 78.41 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.804 ' HE ' HE21 ' A' ' 42' ' ' GLN . 68.1 mtp85 -138.57 167.04 22.8 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.245 -1.15 . . . . 0.0 109.924 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.6 m80 -94.68 156.88 16.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.29 -0.881 . . . . 0.0 109.905 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.586 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 58.0 p -66.31 164.53 15.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 109.724 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 92.88 0.8 68.3 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.804 HE21 ' HE ' ' A' ' 38' ' ' ARG . 46.3 tt0 -60.1 -35.53 75.41 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -1.166 . . . . 0.0 109.995 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.601 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.66 -34.41 69.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.921 . . . . 0.0 109.712 -179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.427 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.3 mt-10 43.32 17.31 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.156 -0.965 . . . . 0.0 109.408 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.601 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -127.95 -36.42 0.47 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 47' ' ' SER . 68.5 t80 -103.67 135.52 45.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.364 -1.08 . . . . 0.0 108.815 179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.436 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 54.3 p -65.93 156.57 33.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.118 -0.989 . . . . 0.0 109.899 -179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -121.87 150.1 42.43 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.521 -0.737 . . . . 0.0 109.559 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.775 HG23 ' H ' ' A' ' 52' ' ' ASN . 7.1 t -54.9 149.92 10.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.318 -0.863 . . . . 0.0 109.24 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -55.78 -35.11 65.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.276 -0.89 . . . . 0.0 109.877 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.551 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -60.22 -57.58 12.21 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.164 -0.96 . . . . 0.0 110.063 -179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.775 ' H ' HG23 ' A' ' 49' ' ' THR . 27.2 t-20 -57.5 -42.8 83.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.048 -1.032 . . . . 0.0 109.566 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 88.4 mt -62.31 -55.25 25.16 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.425 0 O-C-N 121.177 -0.952 . . . . 0.0 109.728 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -68.38 -54.86 14.39 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.814 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' O ' ' O ' ' A' ' 56' ' ' ASN . 19.9 tttm -65.7 -52.23 53.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.305 -0.872 . . . . 0.0 109.822 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.586 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.2 OUTLIER 50.91 118.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.758 0.789 . . . . 0.0 110.119 -179.829 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.715 HG11 ' OH ' ' A' ' 74' ' ' TYR . 7.6 p -126.47 147.51 31.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 110.254 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.533 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.3 tp -75.82 134.12 40.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 108.93 179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.496 ' O ' ' N ' ' A' ' 37' ' ' GLY . 99.0 m95 -99.6 128.41 45.71 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.337 -0.852 . . . . 0.0 110.034 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.463 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 50.3 t0 -159.12 172.98 17.12 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.585 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.17 -39.15 71.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.961 -1.087 . . . . 0.0 109.646 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.582 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.5 p-10 -74.77 -48.08 27.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.078 -1.014 . . . . 0.0 109.513 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.582 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 39.0 t30 -60.9 -38.26 85.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 110.003 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -59.53 -40.12 86.16 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.207 -0.933 . . . . 0.0 109.921 -179.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 94.5 p -61.49 -36.4 80.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.001 -1.062 . . . . 0.0 109.799 -179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.24 -36.65 77.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 110.019 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -61.38 -47.39 86.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.946 . . . . 0.0 110.138 -179.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.578 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 4.7 mp -71.46 -36.23 71.13 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.345 -0.847 . . . . 0.0 110.392 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.581 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 25.5 m -60.96 -39.58 90.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.078 -1.014 . . . . 0.0 110.623 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -152.87 68.73 6.88 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.065 -1.022 . . . . 0.0 109.585 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -62.15 -15.81 46.54 Favored 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 122.364 2.043 . . . . 0.0 112.651 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -78.87 0.07 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.139 -0.976 . . . . 0.0 110.266 -179.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -57.68 -32.79 67.7 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.149 -0.97 . . . . 0.0 109.772 -179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.715 ' OH ' HG11 ' A' ' 57' ' ' VAL . 80.2 t80 -56.66 -49.66 74.4 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.3 -0.875 . . . . 0.0 110.117 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.707 ' O ' HG22 ' A' ' 75' ' ' ILE . 2.8 mm -141.14 80.84 16.46 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.222 -0.923 . . . . 0.0 109.113 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.551 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 72.9 Cg_endo -84.88 149.47 10.97 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 C-N-CA 122.957 2.438 . . . . 0.0 112.247 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.5 6.25 58.63 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.903 -1.142 . . . . 0.0 110.382 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.718 ' HB ' HG21 ' A' ' 49' ' ' THR . 15.0 t -104.77 163.65 12.35 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.132 -1.216 . . . . 0.0 109.71 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.4 mtmp? -80.79 -0.12 37.28 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.127 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.519 ' H ' HG23 ' A' ' 78' ' ' THR . 11.2 ttt -85.11 129.59 34.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.363 -0.835 . . . . 0.0 110.007 -179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -133.63 85.52 2.21 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.421 -0.799 . . . . 0.0 109.2 179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.457 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.8 t80 -104.6 133.4 49.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.541 -0.724 . . . . 0.0 109.588 -179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.457 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.34 138.02 22.73 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.317 -1.513 . . . . 0.0 109.317 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -69.94 146.8 43.73 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.607 HD11 HD21 ' A' ' 9' ' ' LEU . 55.2 mt -95.16 125.45 39.82 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.084 -1.244 . . . . 0.0 109.554 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -65.42 -34.6 78.68 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.439 -0.788 . . . . 0.0 110.206 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.9 mttt -84.78 127.84 34.32 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.081 -1.012 . . . . 0.0 110.16 -179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -77.52 -35.54 53.34 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.582 -0.699 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 45.5 mttt -57.75 -45.6 85.67 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.29 -0.881 . . . . 0.0 110.124 -178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.6 -39.54 94.08 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.035 -1.041 . . . . 0.0 109.1 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.581 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 37.6 ttm180 -59.67 -40.47 87.9 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.524 -0.735 . . . . 0.0 109.936 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.12 -42.35 90.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.251 -0.906 . . . . 0.0 110.358 -179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -63.43 -40.06 96.15 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.054 -1.029 . . . . 0.0 110.14 -179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.765 HD21 ' CBB' ' A' ' 201' ' ' HEC . 48.5 tp -59.75 -42.76 93.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.036 -1.04 . . . . 0.0 109.627 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 82.6 mt -64.85 -37.41 80.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.144 -0.972 . . . . 0.0 108.955 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 14.8 m -60.79 -39.58 89.41 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.598 -0.689 . . . . 0.0 109.989 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -59.53 -50.61 73.23 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.105 -0.997 . . . . 0.0 110.032 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.536 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.3 mt -69.05 -35.43 76.56 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.02 -1.05 . . . . 0.0 109.168 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.585 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 18.7 tptm -58.68 -40.56 83.93 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.351 -0.843 . . . . 0.0 108.866 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -60.1 -40.84 91.04 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.332 -0.855 . . . . 0.0 109.414 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.79 -30.44 70.05 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.529 -0.732 . . . . 0.0 109.796 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.426 HG21 ' CD1' ' A' ' 36' ' ' PHE . 43.8 p -66.61 -23.48 66.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 109.414 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.24 -0.912 . . . . 0.0 109.486 -179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.765 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 31.1 p . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -102.99 141.35 35.93 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.454 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.525 ' CD2' ' OE1' ' A' ' 61' ' ' GLU . 93.6 t80 -99.9 130.06 46.04 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.155 -0.966 . . . . 0.0 109.924 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.644 ' HZ1' ' HG3' ' A' ' 89' ' ' LYS . 33.5 ttpt -81.88 144.45 30.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.071 179.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.95 -22.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.331 -0.856 . . . . 0.0 109.564 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.628 ' O ' HG21 ' A' ' 96' ' ' THR . . . 42.37 94.95 0.01 OUTLIER Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.445 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 46.0 m -63.37 153.44 35.09 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.111 -1.229 . . . . 0.0 109.122 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . -80.77 -128.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.247 -0.908 . . . . 0.0 109.464 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 8' ' ' THR . 40.8 tttm 57.64 -84.19 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 0.0 110.057 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 3' ' ' ALA . 32.9 mmtp -59.29 -52.44 65.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.056 -1.027 . . . . 0.0 109.805 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -63.35 -36.56 93.57 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -58.45 -39.43 79.84 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.225 -1.162 . . . . 0.0 109.414 -179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 4' ' ' LYS . 54.4 p -70.43 -37.35 74.38 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.275 -0.89 . . . . 0.0 109.243 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -57.68 -55.98 27.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -0.874 . . . . 0.0 108.816 179.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.505 ' CE2' HD21 ' A' ' 98' ' ' LEU . 43.2 t80 -62.5 -41.71 99.0 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.427 -0.796 . . . . 0.0 109.266 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -61.49 -38.54 87.68 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.51 -0.744 . . . . 0.0 111.159 -178.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 p -106.02 4.64 29.54 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.112 -0.993 . . . . 0.0 111.759 -177.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 44.8 mtp180 -147.02 28.71 1.01 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.613 -1.305 . . . . 0.0 110.75 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -171.08 -24.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.723 -1.235 . . . . 0.0 110.802 179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.6 HD13 ' O ' ' A' ' 15' ' ' LEU . 0.2 OUTLIER -59.54 -38.19 80.4 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.885 -1.134 . . . . 0.0 109.916 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -57.0 -36.53 70.5 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.07 -1.018 . . . . 0.0 111.239 -178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.403 ' SG ' HMC1 ' A' ' 201' ' ' HEC . 92.4 m -95.73 -50.23 5.01 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.832 -1.167 . . . . 0.0 111.202 -178.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.645 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -101.91 126.37 48.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.065 -1.022 . . . . 0.0 110.265 -178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.405 ' C ' HG23 ' A' ' 20' ' ' VAL . 51.5 p -87.23 -24.28 24.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.337 -0.852 . . . . 0.0 109.241 179.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.405 HG23 ' C ' ' A' ' 19' ' ' THR . 2.6 t 63.79 0.76 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.457 -0.777 . . . . 0.0 110.18 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -101.37 124.75 47.54 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.154 -0.966 . . . . 0.0 109.436 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -69.53 -39.22 77.64 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.567 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -58.78 -36.63 87.67 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.681 -1.367 . . . . 0.0 109.681 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.07 154.17 44.39 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 62.1 Cg_endo -74.26 -156.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.656 2.237 . . . . 0.0 111.733 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -107.68 133.6 51.87 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.134 179.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -103.78 -125.07 0.21 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 108.809 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 89.4 t -64.31 -38.45 82.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.156 -0.965 . . . . 0.0 108.896 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -127.79 165.14 20.94 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -63.3 150.77 87.67 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 C-N-CA 122.958 2.438 . . . . 0.0 112.37 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.486 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 2.9 m120 -80.81 141.71 34.44 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.174 -0.954 . . . . 0.0 108.99 179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.766 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.7 mp -95.42 139.19 32.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.074 -1.017 . . . . 0.0 109.861 -179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -172.19 90.8 0.11 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.409 -0.807 . . . . 0.0 109.159 179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.583 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.05 5.02 66.35 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.276 -1.53 . . . . 0.0 109.276 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.4 tt -58.5 -22.15 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.201 -1.176 . . . . 0.0 109.546 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.67 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 81.2 m-85 -68.11 135.35 52.03 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.254 -0.904 . . . . 0.0 109.711 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.33 21.8 79.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.583 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 67.8 mtt85 -142.62 166.08 25.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.252 -1.146 . . . . 0.0 110.04 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.402 ' CE1' HD13 ' A' ' 58' ' ' LEU . 79.0 m80 -95.77 162.57 13.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.27 -0.893 . . . . 0.0 110.197 -179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 62.0 p -66.3 166.21 12.56 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.491 -0.756 . . . . 0.0 109.816 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.61 -10.28 60.89 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.459 HE22 ' HD2' ' A' ' 38' ' ' ARG . 39.0 tt0 -62.41 -38.42 89.59 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.227 -1.16 . . . . 0.0 109.876 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.723 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -71.31 66.59 0.45 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.241 -0.912 . . . . 0.0 109.594 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.98 -32.48 72.03 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.366 -0.834 . . . . 0.0 109.343 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.96 -33.6 60.68 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.736 -1.345 . . . . 0.0 109.736 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 48.9 t80 -108.8 134.58 51.31 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.265 -1.138 . . . . 0.0 109.153 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 46.1 m -64.47 156.32 29.94 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.313 -0.867 . . . . 0.0 110.089 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.723 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 59.3 m-85 -112.14 145.32 40.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.593 -0.692 . . . . 0.0 109.306 179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.4 p -76.91 161.09 28.68 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.219 -0.925 . . . . 0.0 109.456 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -58.78 -33.06 69.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.949 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.25 -70.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.216 -0.927 . . . . 0.0 110.673 -179.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.492 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.8 t-20 -54.83 -40.62 69.77 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.966 -1.084 . . . . 0.0 109.924 -179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 87.0 mt -60.72 -46.37 96.06 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.942 -1.098 . . . . 0.0 109.482 179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -60.37 -37.06 79.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.891 . . . . 0.0 109.12 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.492 ' O ' ' O ' ' A' ' 52' ' ' ASN . 52.9 tttm -126.28 115.75 20.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.551 -0.718 . . . . 0.0 109.219 179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -99.42 137.68 37.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.132 -0.98 . . . . 0.0 109.063 179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.924 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.9 146.89 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.404 -0.81 . . . . 0.0 109.975 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.402 HD13 ' CE1' ' A' ' 39' ' ' HIS . 62.8 tp -79.14 131.05 36.09 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.493 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 89.0 m95 -94.18 124.48 38.22 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.076 -1.015 . . . . 0.0 109.949 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -153.94 169.27 23.86 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.86 -40.0 72.28 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 0.0 109.559 -179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -69.83 -48.8 57.61 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.24 -0.912 . . . . 0.0 110.33 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.15 -41.09 92.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.23 -0.919 . . . . 0.0 110.544 -179.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.67 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.0 mtt -61.45 -38.0 85.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.003 -1.061 . . . . 0.0 109.727 -179.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 48.0 m -55.95 -42.0 75.52 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.964 -1.085 . . . . 0.0 108.953 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.66 -37.01 76.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.918 . . . . 0.0 109.456 179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.443 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 70.4 t60 -62.92 -47.92 81.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.232 -0.918 . . . . 0.0 110.124 -179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.664 HD11 ' CMB' ' A' ' 201' ' ' HEC . 7.4 mp -61.93 -26.79 68.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.252 -0.905 . . . . 0.0 109.892 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.59 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 33.8 m -84.78 126.0 33.05 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.962 -1.086 . . . . 0.0 108.952 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 69' ' ' THR . 8.2 m120 40.48 60.01 7.41 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.352 -0.842 . . . . 0.0 109.704 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' CG ' ' O ' ' A' ' 82' ' ' PHE . 28.2 Cg_endo -64.52 -23.02 64.82 Favored 'Trans proline' 0 N--CA 1.495 1.602 0 C-N-CA 122.962 2.441 . . . . 0.0 112.9 -179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.73 -47.78 81.46 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.061 -1.025 . . . . 0.0 109.491 -179.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -62.67 -32.64 73.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.247 -0.908 . . . . 0.0 109.369 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.924 ' OH ' HG11 ' A' ' 57' ' ' VAL . 10.7 t80 -57.19 -55.59 32.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.395 -0.815 . . . . 0.0 109.726 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.512 HG23 ' HD1' ' A' ' 74' ' ' TYR . 2.9 pt -141.82 73.83 22.99 Favored Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.127 -0.983 . . . . 0.0 109.779 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -60.96 -34.97 90.04 Favored 'Trans proline' 0 C--N 1.301 -1.973 0 C-N-CA 122.64 2.227 . . . . 0.0 112.045 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -64.66 -29.7 75.93 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.643 -0.983 . . . . 0.0 110.643 -179.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.0 p -75.51 158.75 32.13 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.098 -1.236 . . . . 0.0 110.51 -179.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 pttp -84.7 3.83 35.44 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.665 -0.647 . . . . 0.0 109.608 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 6.7 ttt -76.74 129.87 36.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.728 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.92 93.5 2.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.243 -0.911 . . . . 0.0 109.628 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.422 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 78.3 t80 -101.81 131.24 48.23 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 0.0 109.225 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.422 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -63.76 130.92 40.11 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.646 -1.382 . . . . 0.0 109.646 -179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -70.24 145.83 41.65 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 108.965 -1.654 . . . . 0.0 108.965 179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 55.4 mt -94.73 125.07 39.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.979 -1.306 . . . . 0.0 109.529 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -64.52 -37.96 89.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.342 -0.849 . . . . 0.0 110.255 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 34.0 tttt -86.98 119.49 27.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.176 -0.952 . . . . 0.0 109.826 -179.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -69.03 -32.93 72.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.392 -0.818 . . . . 0.0 110.045 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.644 ' HG3' ' HZ1' ' A' ' -2' ' ' LYS . 13.6 tttm -57.06 -51.46 69.2 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.102 -0.999 . . . . 0.0 109.641 -179.163 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -60.74 -38.07 83.9 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.421 -0.8 . . . . 0.0 109.296 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.59 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 55.8 ttp180 -58.09 -42.12 84.93 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.761 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.3 -38.77 84.68 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.094 -1.004 . . . . 0.0 109.972 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' CG ' ' O ' ' A' ' 2' ' ' SER . 86.0 m-20 -62.97 -40.66 98.4 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.19 -0.944 . . . . 0.0 109.95 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.685 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.98 -45.02 87.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.997 -1.064 . . . . 0.0 109.939 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.455 HD12 ' HE1' ' A' ' -3' ' ' PHE . 70.9 mt -63.29 -40.5 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 120.93 -1.106 . . . . 0.0 108.67 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.628 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.7 m -58.81 -39.17 80.37 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.488 -0.757 . . . . 0.0 109.469 179.672 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -58.06 -49.84 75.51 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.904 -1.122 . . . . 0.0 108.699 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.505 HD21 ' CE2' ' A' ' 10' ' ' PHE . 91.9 mt -66.98 -33.4 75.5 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 178.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 34.3 tttm -56.5 -42.51 78.48 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -60.61 -40.25 91.14 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.471 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.34 -30.81 67.02 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.539 -0.726 . . . . 0.0 109.627 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.402 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 43.5 p -66.89 -26.47 66.89 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.16 -0.962 . . . . 0.0 109.427 -179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.266 -0.896 . . . . 0.0 109.455 -179.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.781 HMB1 HBB2 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.68 -34.32 75.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.188 -0.945 . . . . 0.0 109.434 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.446 ' CG ' ' OE1' ' A' ' 61' ' ' GLU . 70.6 t80 -103.81 134.49 47.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.346 -0.846 . . . . 0.0 109.569 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.4 ptpt -130.89 164.03 26.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.416 -0.802 . . . . 0.0 109.218 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -42.02 98.73 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.457 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -66.57 134.98 33.1 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.492 ' OG ' ' OD2' ' A' ' 93' ' ' ASP . 85.2 p -64.98 -20.72 66.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.352 -1.087 . . . . 0.0 109.267 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.58 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 51.31 -141.58 0.78 Allowed 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.261 -0.9 . . . . 0.0 109.301 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.7 tttm 55.61 -80.5 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.328 -0.857 . . . . 0.0 109.725 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.58 ' N ' ' O ' ' A' ' 3' ' ' ALA . 24.9 mttm -58.24 -45.53 87.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.033 -1.042 . . . . 0.0 109.636 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.49 -32.9 79.36 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.23 -45.56 94.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.257 -1.143 . . . . 0.0 109.795 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.83 ' O ' HG23 ' A' ' 12' ' ' THR . 52.1 p -71.97 -34.82 69.27 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.218 -0.926 . . . . 0.0 109.321 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.517 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -57.07 -40.48 76.96 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.9 t80 -62.72 -47.57 83.01 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 179.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.11 -38.1 89.85 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.411 0.624 . . . . 0.0 110.033 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.83 HG23 ' O ' ' A' ' 8' ' ' THR . 53.4 p -69.02 -34.49 75.34 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.512 -0.742 . . . . 0.0 111.366 -178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.1 mtt-85 -150.62 59.3 0.94 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.688 -1.258 . . . . 0.0 110.947 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.7 t -171.17 -50.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.82 -1.175 . . . . 0.0 110.36 179.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -57.11 -37.53 72.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.06 -1.025 . . . . 0.0 109.82 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -58.32 -35.98 72.69 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.13 -0.981 . . . . 0.0 109.827 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 94.2 m -95.33 -42.0 8.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.118 -0.989 . . . . 0.0 110.617 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.545 ' ND1' HD11 ' A' ' 32' ' ' LEU . 90.0 m-70 -108.0 126.13 52.35 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.261 -0.899 . . . . 0.0 110.38 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.436 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.7 p -86.98 -26.14 23.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.344 -0.847 . . . . 0.0 109.472 179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.436 HG23 ' C ' ' A' ' 19' ' ' THR . 2.4 t 64.02 -0.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.354 -0.842 . . . . 0.0 110.113 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 19' ' ' THR . 96.2 mt-10 -95.61 120.06 35.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.011 -1.056 . . . . 0.0 109.556 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 18.5 pttp -69.29 -39.74 78.13 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.85 . . . . 0.0 109.459 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -59.58 -37.09 91.72 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.98 156.57 44.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.494 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.78 -159.95 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.797 2.331 . . . . 0.0 111.755 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -104.89 134.5 47.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.362 -0.836 . . . . 0.0 109.192 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.6 tttt -101.37 -125.94 0.19 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.204 -0.935 . . . . 0.0 109.142 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 68.9 t -62.86 -39.62 85.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.178 -0.951 . . . . 0.0 109.268 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.05 166.03 18.98 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_endo -62.06 150.5 86.29 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 C-N-CA 122.879 2.386 . . . . 0.0 112.161 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 10.1 m120 -82.82 141.62 32.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.125 -0.984 . . . . 0.0 109.558 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.738 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.0 mp -99.68 137.26 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.164 -0.96 . . . . 0.0 109.786 179.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -171.71 98.26 0.18 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 0.0 108.907 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 85.11 8.56 81.79 Favored Glycine 0 N--CA 1.488 2.127 0 N-CA-C 108.651 -1.779 . . . . 0.0 108.651 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.2 tt -59.45 -23.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.566 -0.961 . . . . 0.0 109.535 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.645 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 86.6 m-85 -63.18 135.58 57.23 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.217 -0.927 . . . . 0.0 109.204 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 63.34 30.0 76.22 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 -179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.438 HH21 ' HB3' ' A' ' 42' ' ' GLN . 62.0 ttt180 -134.85 154.27 51.71 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.444 -1.033 . . . . 0.0 109.843 -179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.64 145.94 24.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.319 -0.863 . . . . 0.0 109.628 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.593 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 56.9 p -67.88 163.42 21.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.446 -0.784 . . . . 0.0 110.151 -179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.08 -9.7 67.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.819 -1.312 . . . . 0.0 109.819 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HB3' HH21 ' A' ' 38' ' ' ARG . 95.5 mt-30 -96.85 6.05 49.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.214 -1.168 . . . . 0.0 110.528 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.92 -30.63 66.08 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.805 -1.185 . . . . 0.0 108.169 179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 97.5 mt-10 38.05 94.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.431 0.634 . . . . 0.0 109.917 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 143.83 -26.65 2.07 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -125.94 143.31 51.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -1.013 . . . . 0.0 108.837 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.3 p -65.06 158.3 26.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.195 -0.941 . . . . 0.0 109.857 -179.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.48 ' CB ' HD11 ' A' ' 53' ' ' ILE . 14.6 m-85 -116.65 138.3 51.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.477 -0.764 . . . . 0.0 109.713 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.741 HG21 ' HA ' ' A' ' 78' ' ' THR . 52.0 m -74.88 144.92 43.13 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.306 -0.871 . . . . 0.0 108.974 179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -50.56 -35.85 31.81 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.187 -0.945 . . . . 0.0 109.782 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.41 ' H ' HG22 ' A' ' 49' ' ' THR . . . -46.75 -69.74 0.12 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.503 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.7 t-20 -56.54 -41.41 76.74 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.086 -1.009 . . . . 0.0 110.564 -179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.48 HD11 ' CB ' ' A' ' 48' ' ' TYR . 41.4 mm -60.52 -49.6 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 120.739 -1.226 . . . . 0.0 110.012 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -60.34 -33.88 73.04 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.053 -1.03 . . . . 0.0 109.205 179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.503 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.4 tttm -127.26 112.65 15.33 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.596 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -100.07 137.96 37.8 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.218 -0.926 . . . . 0.0 109.3 -179.951 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.772 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.7 p -132.35 147.74 32.02 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 O-C-N 121.544 -0.722 . . . . 0.0 109.842 -179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.511 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.1 tp -79.04 134.22 36.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.318 -0.863 . . . . 0.0 108.811 179.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.531 ' O ' ' N ' ' A' ' 37' ' ' GLY . 95.9 m95 -95.15 125.19 39.62 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.177 -0.952 . . . . 0.0 110.071 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' OD2' ' OD1' ' A' ' 62' ' ' ASN . 46.3 p30 -155.41 -176.13 5.79 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.584 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -60.97 -39.59 90.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.939 -1.1 . . . . 0.0 111.013 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.56 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 0.7 OUTLIER -74.94 -47.18 30.93 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.86 -1.15 . . . . 0.0 110.722 -178.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.56 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 64.2 t30 -58.38 -42.1 86.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.183 -0.948 . . . . 0.0 110.499 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.645 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.3 mtt -62.41 -38.45 89.74 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 109.87 -179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 83.6 p -62.71 -40.82 98.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.123 -0.985 . . . . 0.0 109.257 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -70.08 -34.79 73.62 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.175 -0.953 . . . . 0.0 109.25 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.571 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.2 t60 -57.99 -44.15 86.99 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.561 -0.712 . . . . 0.0 109.471 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.607 HD11 HD23 ' A' ' 94' ' ' LEU . 95.1 mt -67.64 -32.46 73.17 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.455 -0.778 . . . . 0.0 110.597 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 27.5 m -55.77 -37.28 68.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.036 -1.04 . . . . 0.0 110.542 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.509 ' N ' ' OD1' ' A' ' 70' ' ' ASN . 7.6 p-10 -167.56 69.04 0.9 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 120.959 -1.088 . . . . 0.0 109.434 -179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -50.15 -27.56 17.56 Favored 'Trans proline' 0 C--N 1.301 -1.938 0 C-N-CA 122.95 2.434 . . . . 0.0 112.636 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.79 -58.44 6.82 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.042 -1.036 . . . . 0.0 109.321 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HD2' HD22 ' A' ' 70' ' ' ASN . 67.5 mttt -61.94 -26.85 68.44 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.281 -0.887 . . . . 0.0 108.844 179.279 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.772 ' OH ' HG11 ' A' ' 57' ' ' VAL . 34.2 t80 -59.46 -54.78 42.7 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.631 -0.668 . . . . 0.0 109.643 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.475 HG23 ' CD2' ' A' ' 74' ' ' TYR . 12.8 pt -139.96 70.19 35.68 Favored Pre-proline 0 N--CA 1.499 1.977 0 O-C-N 121.077 -1.014 . . . . 0.0 109.97 179.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -52.81 135.47 57.43 Favored 'Trans proline' 0 C--N 1.296 -2.197 0 C-N-CA 122.429 2.086 . . . . 0.0 112.007 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 99.7 -0.55 56.65 Favored Glycine 0 N--CA 1.489 2.184 0 C-N-CA 120.095 -1.05 . . . . 0.0 110.847 179.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.741 ' HA ' HG21 ' A' ' 49' ' ' THR . 8.4 t -89.2 161.24 16.55 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.653 -1.498 . . . . 0.0 109.62 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -85.66 1.41 49.44 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.249 -0.907 . . . . 0.0 109.982 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.494 ' H ' HG23 ' A' ' 78' ' ' THR . 15.4 ttp -77.85 125.52 29.46 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.137 -0.977 . . . . 0.0 110.002 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -120.3 79.09 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 179.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.523 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 64.4 t80 -103.21 131.68 50.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.47 -0.769 . . . . 0.0 109.68 -179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.523 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -71.22 144.97 38.53 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.356 -1.498 . . . . 0.0 109.356 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.35 147.64 34.66 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.477 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 55.2 mt -97.21 133.1 42.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.354 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 30.0 mtmm -94.1 -9.18 37.43 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.146 -0.971 . . . . 0.0 109.929 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.2 mttm -99.28 128.42 45.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.004 -1.06 . . . . 0.0 110.024 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -77.0 -38.59 52.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.516 -0.74 . . . . 0.0 110.116 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 19.8 mttp -60.72 -49.64 76.67 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.098 -1.001 . . . . 0.0 110.21 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.76 -37.31 86.88 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.093 -1.004 . . . . 0.0 109.444 179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.492 HH11 ' HB2' ' A' ' 68' ' ' LEU . 38.8 ttm-85 -57.46 -45.3 84.92 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.549 -0.719 . . . . 0.0 109.883 -179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -62.76 -39.93 95.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.917 . . . . 0.0 110.112 -179.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.492 ' OD2' ' OG ' ' A' ' 2' ' ' SER . 85.7 m-20 -61.37 -39.64 91.38 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.212 -0.93 . . . . 0.0 110.186 -179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.685 HD21 ' CBB' ' A' ' 201' ' ' HEC . 52.2 tp -60.36 -45.11 94.65 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.163 -0.961 . . . . 0.0 110.758 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.3 mt -66.45 -41.8 89.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.008 -1.057 . . . . 0.0 109.579 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 27.3 m -58.15 -40.4 81.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 110.012 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 76.0 t80 -58.89 -50.88 72.35 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.899 -1.126 . . . . 0.0 109.372 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.509 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.6 mt -68.36 -31.18 70.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.627 178.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.584 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 80.6 tttt -56.72 -43.34 80.52 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.537 -0.727 . . . . 0.0 109.041 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -61.46 -43.58 98.62 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.344 -0.847 . . . . 0.0 109.4 179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.31 -28.48 68.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.673 -0.642 . . . . 0.0 109.748 -179.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.41 HG22 ' O ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -59.63 -33.22 71.23 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.176 -0.952 . . . . 0.0 109.44 -179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.184 -0.948 . . . . 0.0 109.461 -179.971 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.685 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.9 p . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -108.38 152.51 24.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.381 -0.824 . . . . 0.0 109.525 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.452 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 49.9 t80 -101.66 130.58 48.05 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 0.0 109.719 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.452 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 32.9 ttpt -86.34 127.83 34.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.187 -0.945 . . . . 0.0 109.102 179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -63.06 95.64 0.08 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.146 -0.971 . . . . 0.0 109.245 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -89.53 -176.42 45.81 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.8 t -105.86 129.47 54.02 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -1.142 . . . . 0.0 109.165 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.475 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -68.51 -26.04 65.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.124 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -57.0 -46.97 81.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.027 -1.046 . . . . 0.0 110.15 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 49.0 mttt -66.49 -53.1 38.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.042 -1.036 . . . . 0.0 109.455 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.515 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.34 -28.21 72.72 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.807 -1.317 . . . . 0.0 109.807 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.475 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -57.61 -47.83 81.09 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.152 -1.204 . . . . 0.0 109.761 -179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -73.65 -36.19 65.36 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.427 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.442 HD23 ' HB2' ' A' ' 94' ' ' LEU . 20.0 tp -58.16 -42.19 85.42 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.646 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -64.69 -46.67 81.37 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.002 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.9 tttt -63.43 -40.43 97.14 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.471 0.653 . . . . 0.0 110.396 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 55.4 p -72.5 -29.56 63.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.352 -0.842 . . . . 0.0 111.627 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 78.9 mtt85 -148.32 55.96 1.04 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.549 -1.344 . . . . 0.0 111.23 -178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.646 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.9 -52.91 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.782 -1.199 . . . . 0.0 110.49 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.09 -37.62 69.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.174 -0.954 . . . . 0.0 109.954 -179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.54 -35.7 70.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.052 -1.03 . . . . 0.0 109.904 -179.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.9 m -97.7 -42.6 7.55 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.21 -0.931 . . . . 0.0 110.646 -179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.477 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -105.31 122.69 46.47 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.144 -0.972 . . . . 0.0 110.505 -178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 21' ' ' GLU . 52.9 p -82.52 -18.62 40.87 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.671 ' O ' HG22 ' A' ' 20' ' ' VAL . 14.8 p 39.7 21.48 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.701 -0.624 . . . . 0.0 110.047 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.583 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -109.46 126.56 53.62 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.105 179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.408 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 18.8 pttm -67.2 -40.4 86.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.158 -0.964 . . . . 0.0 109.546 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.408 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -62.62 -36.98 94.01 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -81.87 152.59 31.8 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.841 -1.304 . . . . 0.0 109.841 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.491 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 84.4 Cg_endo -77.16 -153.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.45 0 C-N-CA 122.712 2.275 . . . . 0.0 111.877 179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -99.5 136.26 39.7 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.197 -0.939 . . . . 0.0 109.258 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 36.0 tptt -106.48 -130.09 0.28 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.292 -0.88 . . . . 0.0 109.175 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.422 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.47 -41.1 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.168 -0.958 . . . . 0.0 109.391 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.58 161.96 15.49 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 12.2 Cg_endo -57.73 143.18 95.8 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 123.134 2.556 . . . . 0.0 111.938 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.495 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.5 m120 -76.43 146.31 38.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.141 -0.974 . . . . 0.0 109.87 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.86 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.3 mp -98.92 138.75 35.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.152 -0.968 . . . . 0.0 109.626 179.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -174.84 97.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 82.37 9.85 84.36 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 -178.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 tt -58.89 -23.79 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.65 -0.912 . . . . 0.0 109.401 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -65.17 131.48 46.64 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.3 -0.875 . . . . 0.0 108.965 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.488 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.94 30.17 74.04 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 108.753 -1.739 . . . . 0.0 108.753 -179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 34.2 ttm180 -134.08 152.67 51.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.428 -1.043 . . . . 0.0 109.931 -179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -93.37 145.23 24.62 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.316 -0.865 . . . . 0.0 108.999 179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.579 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 53.4 p -66.79 158.52 30.18 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.187 -0.945 . . . . 0.0 109.956 -179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.37 -22.75 25.32 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 110.07 -1.212 . . . . 0.0 110.07 179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -62.4 -36.34 82.04 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.151 -1.205 . . . . 0.0 110.381 -179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.648 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.48 -44.86 92.94 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.978 -1.076 . . . . 0.0 109.892 -179.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 57.12 -16.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.536 -0.728 . . . . 0.0 110.919 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.648 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -57.8 -34.65 71.71 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.717 -1.353 . . . . 0.0 109.717 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -123.25 143.37 50.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.597 -0.943 . . . . 0.0 109.168 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.1 p -64.76 159.39 22.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.319 -0.863 . . . . 0.0 109.98 -179.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.502 ' O ' HD11 ' A' ' 53' ' ' ILE . 82.9 m-85 -118.41 146.52 44.37 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.563 -0.711 . . . . 0.0 109.554 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.724 HG23 HBD2 ' A' ' 201' ' ' HEC . 41.9 p -76.57 164.74 25.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.238 -0.914 . . . . 0.0 109.626 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -55.38 -31.54 61.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.384 -0.822 . . . . 0.0 109.627 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.33 -75.96 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.239 -0.913 . . . . 0.0 110.504 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.479 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.0 t-20 -55.8 -42.18 75.23 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.941 -1.1 . . . . 0.0 110.286 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.502 HD11 ' O ' ' A' ' 48' ' ' TYR . 87.9 mt -60.43 -45.65 96.43 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 O-C-N 120.895 -1.128 . . . . 0.0 109.519 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -60.51 -37.17 80.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.372 -0.83 . . . . 0.0 109.255 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' O ' ' O ' ' A' ' 52' ' ' ASN . 40.0 tttm -128.28 118.87 24.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.566 -0.709 . . . . 0.0 109.371 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.579 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 14.9 t-20 -98.91 135.59 40.12 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.23 -0.919 . . . . 0.0 108.898 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.794 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.6 p -131.18 146.97 33.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.423 -0.798 . . . . 0.0 110.195 -179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 64.8 tp -80.08 132.92 36.05 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.552 ' CZ2' HMA2 ' A' ' 201' ' ' HEC . 98.4 m95 -96.81 125.91 41.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.211 -0.931 . . . . 0.0 110.028 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.417 ' H ' ' HB3' ' A' ' 63' ' ' ASN . 49.6 t0 -159.09 176.36 12.35 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.595 ' CD ' ' HZ3' ' A' ' 99' ' ' LYS . 97.2 mt-10 -55.35 -40.04 70.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.764 -1.21 . . . . 0.0 109.411 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.4 t30 -69.9 -52.22 26.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.257 -0.902 . . . . 0.0 110.024 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.417 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 33.7 t30 -62.85 -38.98 92.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 110.611 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.5 mmt -58.75 -40.65 84.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.127 -0.983 . . . . 0.0 109.955 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 88.6 p -66.28 -37.56 85.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.095 -1.003 . . . . 0.0 109.716 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -66.19 -36.99 84.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 0.0 109.404 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -60.27 -45.68 92.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.423 -0.798 . . . . 0.0 109.84 -179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.542 HD11 HD23 ' A' ' 94' ' ' LEU . 83.9 mt -70.17 -35.5 74.04 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.53 -0.731 . . . . 0.0 110.528 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.585 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 29.6 m -61.24 -39.2 89.44 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.912 -1.117 . . . . 0.0 110.829 -178.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -152.92 67.99 6.62 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.943 -1.098 . . . . 0.0 109.788 -179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -61.96 -15.14 41.34 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.419 2.079 . . . . 0.0 112.675 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.03 -78.75 0.07 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.067 -1.021 . . . . 0.0 110.248 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 57.6 tttp -57.22 -34.51 68.63 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.186 -0.946 . . . . 0.0 109.841 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.794 ' OH ' HG11 ' A' ' 57' ' ' VAL . 87.8 t80 -56.3 -50.34 71.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -0.871 . . . . 0.0 109.954 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.75 ' O ' HG22 ' A' ' 75' ' ' ILE . 20.7 mt -148.09 77.66 9.91 Favored Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.007 -1.058 . . . . 0.0 108.928 178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -87.02 152.12 8.33 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 C-N-CA 123.208 2.606 . . . . 0.0 112.438 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.15 3.17 55.78 Favored Glycine 0 N--CA 1.491 2.336 0 C-N-CA 119.947 -1.121 . . . . 0.0 110.354 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 80' ' ' MET . 6.2 t -104.65 174.73 5.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.154 -1.204 . . . . 0.0 109.539 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -87.19 11.63 13.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.199 -0.938 . . . . 0.0 110.674 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.471 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -70.13 121.51 17.65 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.763 -1.21 . . . . 0.0 109.622 -179.861 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -104.86 27.27 8.24 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.41 -0.806 . . . . 0.0 109.004 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 51.9 t80 -86.74 129.2 34.96 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.172 -179.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.549 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -87.54 178.68 47.49 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.84 154.27 23.75 Favored Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.436 HD11 HD21 ' A' ' 9' ' ' LEU . 58.8 mt -100.26 122.09 42.51 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.08 -1.247 . . . . 0.0 109.371 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.2 mtmt -66.1 -36.4 83.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.307 -0.87 . . . . 0.0 110.164 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -92.08 128.92 38.1 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.02 -1.05 . . . . 0.0 110.36 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -29.59 60.77 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.65 -0.656 . . . . 0.0 109.91 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -55.39 -50.2 70.35 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.135 -0.978 . . . . 0.0 110.066 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -64.21 -37.94 89.28 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.187 -0.945 . . . . 0.0 109.103 179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.585 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 39.3 ttm180 -58.67 -42.47 88.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.649 -0.657 . . . . 0.0 110.116 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 29.8 m120 -61.49 -38.96 89.23 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 110.311 -179.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.515 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 88.9 m-20 -63.03 -39.51 94.96 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.055 -1.028 . . . . 0.0 110.285 -179.434 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.744 HD21 ' CBB' ' A' ' 201' ' ' HEC . 51.0 tp -59.98 -42.9 95.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.098 -1.001 . . . . 0.0 109.882 -179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.0 mt -66.56 -38.45 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.139 -0.976 . . . . 0.0 109.724 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 28.8 m -60.7 -41.07 94.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.31 -0.869 . . . . 0.0 110.11 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.591 ' CE2' ' O ' ' A' ' 102' ' ' THR . 73.1 t80 -58.63 -51.88 68.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.139 -0.976 . . . . 0.0 110.115 -179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 94.1 mt -72.17 -36.89 69.42 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.06 -1.025 . . . . 0.0 109.985 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.595 ' HZ3' ' CD ' ' A' ' 61' ' ' GLU . 26.3 tptt -58.49 -45.68 88.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.519 -0.738 . . . . 0.0 110.344 -179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.738 ' O ' ' HB2' ' A' ' 101' ' ' ALA . 22.5 mttm -58.78 -50.53 73.6 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.81 -1.181 . . . . 0.0 109.251 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.738 ' HB2' ' O ' ' A' ' 100' ' ' LYS . . . 154.01 66.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.593 HG23 ' C ' ' A' ' 101' ' ' ALA . 1.1 p 61.32 -2.23 0.24 Allowed 'General case' 0 C--N 1.297 -1.702 0 O-C-N 121.155 -0.965 . . . . 0.0 108.909 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.546 ' C ' ' CD1' ' A' ' 97' ' ' TYR . 97.8 mt-10 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.463 -0.773 . . . . 0.0 109.44 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.744 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 61.8 p . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.74 -34.12 69.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.886 . . . . 0.0 109.519 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -101.16 128.93 47.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.447 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -97.35 142.72 28.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.187 -0.946 . . . . 0.0 109.154 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -60.75 138.69 58.08 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.203 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.534 ' HA3' HG21 ' A' ' 96' ' ' THR . . . -42.46 104.64 0.05 OUTLIER Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.557 ' O ' ' HB2' ' A' ' 3' ' ' ALA . 20.3 m -56.82 -35.96 69.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -1.118 . . . . 0.0 109.58 -179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 2' ' ' SER . . . 173.9 -165.84 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.195 -0.94 . . . . 0.0 109.738 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.473 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 26.4 mttm -84.14 5.38 26.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.391 -0.818 . . . . 0.0 109.685 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -54.43 -43.31 71.46 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.116 -0.99 . . . . 0.0 108.744 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.98 -28.7 69.16 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.651 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -59.54 -46.4 88.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.426 -1.044 . . . . 0.0 109.672 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.936 ' O ' HG23 ' A' ' 12' ' ' THR . 24.6 m -60.88 -41.47 96.03 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.135 -0.978 . . . . 0.0 108.694 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.528 HD21 HD11 ' A' ' 85' ' ' LEU . 2.1 tp -56.48 -41.3 76.35 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.856 -1.164 . . . . 0.0 107.856 179.016 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.688 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -61.79 -47.13 86.53 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.6 tttm -64.33 -37.23 86.75 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 121.543 0.687 . . . . 0.0 109.697 179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.936 HG23 ' O ' ' A' ' 8' ' ' THR . 57.2 p -66.28 -38.02 86.8 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.431 -0.793 . . . . 0.0 111.352 -178.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.0 mtt85 -153.8 61.97 0.73 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.548 -1.345 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 5.3 t -171.48 -45.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.998 -1.064 . . . . 0.0 109.774 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 20.8 tp -58.41 -37.34 75.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.19 -0.944 . . . . 0.0 109.665 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -58.15 -36.01 72.37 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.143 -0.973 . . . . 0.0 109.747 -179.506 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 93.6 m -94.38 -42.8 8.69 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -0.907 . . . . 0.0 110.517 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.504 ' CE1' HD11 ' A' ' 32' ' ' LEU . 91.4 m-70 -108.54 122.69 47.58 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.187 -0.945 . . . . 0.0 110.023 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 30.9 p -87.8 -24.64 23.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.303 -0.873 . . . . 0.0 109.83 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 t 51.17 36.76 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.223 -0.923 . . . . 0.0 110.127 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -103.52 148.43 25.97 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.193 -0.942 . . . . 0.0 109.357 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 21.7 pttm -60.9 -37.55 82.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.171 -0.956 . . . . 0.0 109.275 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -56.47 -30.6 58.96 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.28 -1.528 . . . . 0.0 109.28 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 64.16 58.58 10.24 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -60.96 -24.58 79.79 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.542 2.161 . . . . 0.0 111.822 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.69 ' H ' HD22 ' A' ' 31' ' ' ASN . 94.3 m-70 55.6 42.28 29.72 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.433 -0.792 . . . . 0.0 110.066 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.4 tttm -56.93 -36.09 69.81 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.158 -0.964 . . . . 0.0 108.847 179.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.59 ' O ' ' CZ ' ' A' ' 46' ' ' TYR . 2.4 t -146.31 -76.44 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.391 -0.818 . . . . 0.0 109.253 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.427 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -72.76 160.31 53.99 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.1 Cg_endo -58.2 1.69 0.23 Allowed 'Trans proline' 0 C--N 1.305 -1.738 0 C-N-CA 123.035 2.49 . . . . 0.0 112.561 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.69 HD22 ' H ' ' A' ' 26' ' ' HIS . 0.7 OUTLIER 66.56 122.09 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.101 -0.999 . . . . 0.0 109.769 179.872 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.824 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.1 mp -93.89 139.8 30.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.276 -0.89 . . . . 0.0 109.852 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -167.32 94.61 0.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 0.0 109.078 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.3 6.4 71.19 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.986 -1.646 . . . . 0.0 108.986 -179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -59.58 -21.3 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.527 -0.984 . . . . 0.0 109.8 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.672 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 76.0 m-85 -64.44 131.47 47.25 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.1 -1.0 . . . . 0.0 109.791 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.93 27.99 73.42 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.689 ' NE ' ' NE2' ' A' ' 42' ' ' GLN . 63.4 mtp85 -144.94 168.89 19.19 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.948 -1.324 . . . . 0.0 110.189 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.7 m80 -94.21 157.76 15.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.945 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.464 ' HB3' ' HE1' ' A' ' 59' ' ' TRP . 59.5 p -67.31 163.71 20.01 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.397 -0.814 . . . . 0.0 109.924 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 97.69 -10.87 64.69 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.689 ' NE2' ' NE ' ' A' ' 38' ' ' ARG . 44.1 tt0 -61.65 -37.71 85.05 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.138 -1.213 . . . . 0.0 109.838 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.748 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -57.62 140.19 51.71 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.222 -0.924 . . . . 0.0 109.715 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 94.3 mt-10 -126.52 148.59 49.69 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.455 -0.778 . . . . 0.0 109.352 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 97.4 -7.78 64.05 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.59 ' CZ ' ' O ' ' A' ' 28' ' ' VAL . 73.9 t80 -129.42 134.59 47.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.177 -1.19 . . . . 0.0 109.426 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 49.8 m -67.73 156.28 37.32 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.238 -0.914 . . . . 0.0 109.655 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.748 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 14.0 m-85 -111.88 140.0 46.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.461 -0.775 . . . . 0.0 109.418 179.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.706 HG21 ' HA ' ' A' ' 78' ' ' THR . 40.7 m -69.35 145.43 52.97 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.242 -0.911 . . . . 0.0 109.348 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' O ' ' C ' ' A' ' 51' ' ' ALA . 92.6 m-20 -51.66 -37.34 50.05 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.191 -0.943 . . . . 0.0 109.785 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -43.06 -74.47 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.065 -1.022 . . . . 0.0 110.314 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.5 t-20 -54.04 -40.9 67.5 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.191 -0.943 . . . . 0.0 110.744 -178.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 71.4 mt -59.83 -48.57 87.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 120.673 -1.267 . . . . 0.0 109.842 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 25.9 mttt -60.22 -33.84 72.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.211 -0.931 . . . . 0.0 109.371 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.7 tttm -127.53 114.88 18.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.582 -0.699 . . . . 0.0 109.305 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.613 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -97.89 140.04 32.84 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.123 -0.986 . . . . 0.0 108.897 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.867 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.2 p -132.45 147.14 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 O-C-N 121.435 -0.79 . . . . 0.0 110.259 -179.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.9 tp -80.78 130.0 34.83 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.5 ' O ' ' OD1' ' A' ' 60' ' ' ASP . 95.6 m95 -92.44 118.46 30.97 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.147 -0.97 . . . . 0.0 110.31 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.5 ' OD1' ' O ' ' A' ' 59' ' ' TRP . 91.4 m-20 -140.86 -178.51 5.58 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.85 -38.3 87.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.007 -1.058 . . . . 0.0 110.033 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.549 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -76.87 -41.95 41.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.16 -0.963 . . . . 0.0 110.259 -179.295 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.5 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 31.8 t30 -59.02 -42.51 90.32 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.879 . . . . 0.0 110.249 -179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.672 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 61.4 mtt -63.11 -39.93 96.13 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.009 -1.057 . . . . 0.0 109.744 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.618 ' CB ' ' NH1' ' A' ' 91' ' ' ARG . 71.0 m -59.07 -40.51 85.41 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.154 -0.966 . . . . 0.0 109.631 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -71.62 -32.72 68.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.154 -0.966 . . . . 0.0 110.452 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 64.5 t60 -56.89 -51.17 70.14 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.198 -0.939 . . . . 0.0 110.416 -178.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.68 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.3 mp -71.05 -28.58 64.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.121 -0.987 . . . . 0.0 109.958 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.4 m -57.74 -38.12 74.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.189 -0.945 . . . . 0.0 110.848 -179.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -163.25 66.5 1.61 Allowed Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.858 -1.151 . . . . 0.0 110.358 -179.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.467 ' O ' ' O ' ' A' ' 74' ' ' TYR . 31.7 Cg_exo -50.92 -18.88 4.78 Favored 'Trans proline' 0 C--N 1.3 -1.994 0 C-N-CA 122.838 2.359 . . . . 0.0 112.464 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.11 -76.06 0.06 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.191 -0.943 . . . . 0.0 110.281 -179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.4 mttp -57.95 -32.88 68.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.92 . . . . 0.0 109.467 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.867 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.4 t80 -79.56 126.68 31.19 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.345 -0.847 . . . . 0.0 108.997 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.78 ' O ' HG22 ' A' ' 75' ' ' ILE . 60.1 mt 44.58 63.12 9.16 Favored Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.209 -0.932 . . . . 0.0 109.416 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -79.05 146.5 20.29 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 C-N-CA 122.923 2.415 . . . . 0.0 112.451 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.19 16.41 47.29 Favored Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.855 -1.164 . . . . 0.0 110.762 179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.706 ' HA ' HG21 ' A' ' 49' ' ' THR . 12.9 t -106.89 151.67 24.93 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.064 -1.257 . . . . 0.0 109.908 179.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -58.78 -29.62 66.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.48 -0.762 . . . . 0.0 109.538 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 22.1 ttp -59.71 140.51 56.41 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.447 -0.783 . . . . 0.0 110.288 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -170.04 92.96 0.22 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.447 -0.783 . . . . 0.0 109.507 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.592 ' CD2' ' N ' ' A' ' 83' ' ' GLY . 0.0 OUTLIER -161.7 -46.67 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.378 -0.826 . . . . 0.0 109.673 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.592 ' N ' ' CD2' ' A' ' 82' ' ' PHE . . . -41.11 164.51 0.01 OUTLIER Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 -179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 126.5 44.29 0.25 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 108.852 -1.699 . . . . 0.0 108.852 -179.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.528 HD11 HD21 ' A' ' 9' ' ' LEU . 43.6 mt -88.25 138.27 31.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.461 -1.023 . . . . 0.0 109.301 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -90.34 -2.99 58.03 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.911 . . . . 0.0 110.134 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -97.89 126.52 43.31 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.961 -1.087 . . . . 0.0 109.956 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -81.54 -40.08 23.68 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.491 -0.755 . . . . 0.0 110.158 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -60.47 -47.98 83.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.163 -0.961 . . . . 0.0 110.207 -179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -64.45 -42.44 95.96 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.042 -1.036 . . . . 0.0 109.493 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.618 ' NH1' ' CB ' ' A' ' 65' ' ' SER . 59.5 ttp85 -61.76 -41.55 97.83 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.3 -0.875 . . . . 0.0 110.164 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -58.15 -41.01 82.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.172 -0.955 . . . . 0.0 110.215 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -63.31 -38.26 90.45 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.137 -0.977 . . . . 0.0 109.849 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.854 HD21 ' CBB' ' A' ' 201' ' ' HEC . 50.9 tp -60.14 -45.82 91.75 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.298 -0.876 . . . . 0.0 110.75 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.4 mt -66.22 -44.35 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.894 -1.129 . . . . 0.0 109.697 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.534 HG21 ' HA3' ' A' ' 1' ' ' GLY . 29.1 m -64.35 -39.8 94.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.145 -0.972 . . . . 0.0 110.352 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.651 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.8 t80 -59.21 -43.77 92.27 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.05 -1.031 . . . . 0.0 110.657 -178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.458 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.1 mt -61.39 -35.82 78.57 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.715 -1.241 . . . . 0.0 109.528 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -56.94 -38.34 72.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.043 -1.036 . . . . 0.0 109.162 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttp -59.76 -45.06 93.4 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.338 -0.851 . . . . 0.0 109.263 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.19 -37.94 84.75 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.477 -0.765 . . . . 0.0 109.296 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.437 ' O ' ' C ' ' A' ' 103' ' ' GLU . 53.1 p -70.22 -30.88 68.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.201 179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.424 -0.798 . . . . 0.0 109.879 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.854 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.2 p . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -110.62 154.05 24.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.807 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -99.96 128.36 46.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.249 -0.907 . . . . 0.0 109.512 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 1' ' ' GLY . 16.0 ttmt -90.67 132.02 36.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.206 -0.933 . . . . 0.0 109.425 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -50.17 99.23 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.191 -0.943 . . . . 0.0 109.249 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -67.2 147.09 48.72 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.702 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 25.4 m -56.61 -33.19 66.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.225 -1.162 . . . . 0.0 109.055 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.702 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 75.97 -32.33 0.21 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.394 -0.816 . . . . 0.0 109.85 179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.427 ' H ' ' C ' ' A' ' 2' ' ' SER . 17.1 mttp -59.67 -51.37 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.085 -1.01 . . . . 0.0 109.203 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -65.04 -40.03 94.19 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.253 -0.904 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.479 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.38 -34.56 89.68 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.38 -46.23 89.26 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.142 -1.211 . . . . 0.0 109.023 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.921 ' O ' HG23 ' A' ' 12' ' ' THR . 55.9 p -75.25 -38.28 60.61 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.275 -0.89 . . . . 0.0 108.963 179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.2 OUTLIER -60.25 -42.76 95.96 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.616 -1.253 . . . . 0.0 107.616 179.152 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 72.1 t80 -65.08 -46.43 81.15 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 23.2 tttt -63.4 -39.22 93.9 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 121.324 0.583 . . . . 0.0 110.25 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.921 HG23 ' O ' ' A' ' 8' ' ' THR . 70.5 p -70.14 -31.27 68.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.368 -0.832 . . . . 0.0 111.448 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 49.2 mtm180 -149.23 56.2 0.99 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.607 -1.308 . . . . 0.0 111.246 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.53 -50.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.769 -1.207 . . . . 0.0 110.585 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 16.1 tp -56.66 -37.23 70.53 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.166 -0.959 . . . . 0.0 110.057 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -56.55 -35.29 67.96 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.114 -0.992 . . . . 0.0 109.89 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 84.0 m -98.31 -44.13 6.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.127 -0.983 . . . . 0.0 110.718 -179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.559 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -103.48 123.95 47.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 110.069 -178.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.572 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 7.0 p -84.2 -24.6 30.03 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.323 -0.861 . . . . 0.0 109.28 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.656 ' O ' HG22 ' A' ' 20' ' ' VAL . 13.9 p 42.24 41.05 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.351 -0.843 . . . . 0.0 110.072 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -100.53 158.27 16.04 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.08 -1.012 . . . . 0.0 109.187 179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -68.44 143.44 55.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.237 -0.915 . . . . 0.0 109.403 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 97.87 -6.91 62.6 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' O ' ' CD2' ' A' ' 26' ' ' HIS . . . 47.22 60.94 4.81 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.983 -1.247 . . . . 0.0 109.983 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -60.89 -28.05 85.76 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.37 2.046 . . . . 0.0 111.823 179.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.769 ' H ' ' ND2' ' A' ' 31' ' ' ASN . 93.5 m-70 55.0 46.74 23.67 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.385 -0.822 . . . . 0.0 110.497 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -57.43 -35.11 69.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.051 -1.031 . . . . 0.0 108.652 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.45 HG12 ' N ' ' A' ' 29' ' ' GLY . 21.7 t -141.96 -114.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' N ' HG12 ' A' ' 28' ' ' VAL . . . -57.56 160.7 10.28 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 108.072 -2.011 . . . . 0.0 108.072 178.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.559 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 2.4 Cg_endo -53.89 137.35 68.25 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 C-N-CA 121.776 1.651 . . . . 0.0 111.517 -179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.769 ' ND2' ' H ' ' A' ' 26' ' ' HIS . 98.2 m-20 -89.37 137.76 32.04 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.246 -0.909 . . . . 0.0 109.293 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.9 mp -92.11 137.76 32.09 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.34 -0.85 . . . . 0.0 110.279 -178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -162.94 90.69 0.7 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.479 ' H ' HG22 ' A' ' 102' ' ' THR . . . 90.58 5.72 68.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 16.1 tt -56.73 -21.91 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.556 -0.967 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -62.64 134.85 56.94 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.127 -0.983 . . . . 0.0 108.989 179.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 70.69 22.35 78.03 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 95.7 mtt180 -134.25 161.39 35.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.351 -1.088 . . . . 0.0 110.147 -179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.42 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.3 m80 -97.6 153.49 18.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.411 -0.806 . . . . 0.0 109.277 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.595 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 26.8 p -66.09 158.39 28.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.196 -0.94 . . . . 0.0 109.888 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 90.34 -21.47 31.71 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.93 -1.268 . . . . 0.0 109.93 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -61.23 -36.08 78.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.233 -1.157 . . . . 0.0 110.138 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.644 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -58.72 -44.81 90.52 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.928 -1.108 . . . . 0.0 109.606 -179.469 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 57.68 -19.86 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.563 -0.71 . . . . 0.0 110.878 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.644 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -58.21 -34.25 73.08 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 68.3 t80 -124.06 142.33 51.28 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.564 -0.962 . . . . 0.0 109.163 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 54.2 p -64.92 160.49 20.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.176 -0.953 . . . . 0.0 109.824 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.511 ' O ' HD11 ' A' ' 53' ' ' ILE . 36.0 m-85 -116.44 149.93 38.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.47 -0.769 . . . . 0.0 109.507 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.645 HG23 HBD2 ' A' ' 201' ' ' HEC . 34.9 p -75.47 162.01 28.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -0.907 . . . . 0.0 109.388 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.05 -32.96 62.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.381 -0.824 . . . . 0.0 109.742 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -53.72 -75.66 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.228 -0.92 . . . . 0.0 110.529 -179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.489 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.4 t-20 -54.0 -41.71 68.25 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.061 -1.024 . . . . 0.0 110.049 -179.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.511 HD11 ' O ' ' A' ' 48' ' ' TYR . 97.4 mt -59.7 -47.19 92.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 120.869 -1.144 . . . . 0.0 109.213 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 26.8 tttp -60.99 -37.36 82.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.359 -0.838 . . . . 0.0 109.258 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.489 ' O ' ' O ' ' A' ' 52' ' ' ASN . 19.5 tttm -125.06 117.07 23.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.536 -0.728 . . . . 0.0 109.415 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.595 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 15.9 t-20 -100.25 137.27 38.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.176 -0.953 . . . . 0.0 109.023 179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' OH ' ' A' ' 74' ' ' TYR . 11.3 p -131.17 147.46 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.446 -0.783 . . . . 0.0 110.196 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.435 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 63.4 tp -77.97 132.95 38.07 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.517 ' O ' ' N ' ' A' ' 37' ' ' GLY . 97.3 m95 -96.59 126.96 42.14 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.213 -0.93 . . . . 0.0 110.133 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 51.5 t0 -156.06 171.66 19.74 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 97.1 mt-10 -58.07 -39.07 77.58 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.916 -1.115 . . . . 0.0 109.547 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.485 ' ND2' ' H ' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -72.52 -48.04 43.54 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.067 -1.02 . . . . 0.0 109.256 179.667 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.449 ' HB3' ' H ' ' A' ' 60' ' ' ASP . 35.5 t30 -60.81 -37.16 81.03 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.453 -0.78 . . . . 0.0 109.937 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 3.8 mmt -58.65 -40.68 84.11 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.323 -0.861 . . . . 0.0 109.702 -179.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.4 ' HB2' ' NH1' ' A' ' 91' ' ' ARG . 98.6 p -64.12 -35.43 80.75 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.114 -0.991 . . . . 0.0 109.339 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -67.22 -35.12 78.92 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 0.0 109.353 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 78.3 t60 -59.05 -47.09 86.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.418 -0.801 . . . . 0.0 109.45 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.501 HD11 HD23 ' A' ' 94' ' ' LEU . 20.7 mt -67.97 -29.57 68.64 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.283 -0.886 . . . . 0.0 109.058 179.635 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 45.6 m -59.28 -37.91 78.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.327 -0.858 . . . . 0.0 111.024 -179.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.417 ' ND2' ' H ' ' A' ' 73' ' ' LYS . 0.9 OUTLIER -161.53 65.49 2.0 Allowed Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 120.931 -1.106 . . . . 0.0 110.238 -179.262 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -52.44 -21.29 13.54 Favored 'Trans proline' 0 C--N 1.3 -1.983 0 C-N-CA 122.609 2.206 . . . . 0.0 112.083 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -70.91 -77.82 0.08 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.193 -0.942 . . . . 0.0 109.954 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.417 ' H ' ' ND2' ' A' ' 70' ' ' ASN . 17.5 tttt -57.45 -36.11 70.99 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.227 -0.921 . . . . 0.0 109.256 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.747 ' OH ' HG11 ' A' ' 57' ' ' VAL . 74.2 t80 -57.22 -51.29 69.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.746 ' O ' HG22 ' A' ' 75' ' ' ILE . 19.3 mt -148.29 76.49 10.17 Favored Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.198 -0.939 . . . . 0.0 108.621 178.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -83.9 148.81 12.28 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.103 2.535 . . . . 0.0 112.262 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.74 9.4 52.66 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.821 -1.18 . . . . 0.0 110.375 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -108.42 169.37 8.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.214 -1.168 . . . . 0.0 109.378 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -84.32 9.18 13.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.263 -0.898 . . . . 0.0 110.927 -178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.512 ' H ' HG23 ' A' ' 78' ' ' THR . 1.4 mtm -69.35 118.32 12.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.631 -1.293 . . . . 0.0 109.657 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.08 28.01 7.64 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.391 -0.818 . . . . 0.0 108.833 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.594 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 66.0 t80 -85.01 131.28 34.49 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.501 -0.749 . . . . 0.0 109.822 -179.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.594 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -75.95 144.12 30.74 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.489 ' CA ' ' O ' ' A' ' 68' ' ' LEU . . . -75.9 142.86 29.22 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 35.0 mt -101.39 141.55 34.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.373 -1.074 . . . . 0.0 108.971 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -82.64 -78.41 0.21 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.079 -1.013 . . . . 0.0 108.784 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 54.3 tttp -142.65 120.33 11.84 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.434 ' HG2' ' H ' ' A' ' 90' ' ' ASP . 82.4 tt0 -161.75 147.33 13.5 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.076 -1.015 . . . . 0.0 109.916 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 70.8 mttt -56.71 -34.58 67.59 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.193 -0.942 . . . . 0.0 108.657 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.434 ' H ' ' HG2' ' A' ' 88' ' ' GLU . 90.5 m-20 -57.39 -38.21 73.91 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.308 -0.87 . . . . 0.0 108.9 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.449 ' HG3' HD12 ' A' ' 68' ' ' LEU . 64.0 ttp85 -57.53 -45.95 84.44 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.149 -0.969 . . . . 0.0 108.992 179.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 16.2 m120 -65.51 -43.45 90.02 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.344 -0.847 . . . . 0.0 109.466 179.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.586 ' OD1' ' N ' ' A' ' 2' ' ' SER . 84.7 m-20 -67.07 -39.56 86.87 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.334 -0.854 . . . . 0.0 109.997 -179.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.501 HD23 HD11 ' A' ' 68' ' ' LEU . 58.5 tp -55.98 -45.87 78.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 109.737 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.5 mt -66.16 -40.56 87.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.042 -1.036 . . . . 0.0 108.903 179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 41.7 m -60.2 -39.66 87.32 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.465 -0.772 . . . . 0.0 109.711 179.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -58.66 -50.31 74.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.018 . . . . 0.0 109.283 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 10' ' ' PHE . 91.8 mt -69.28 -31.98 70.85 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.165 -0.959 . . . . 0.0 108.452 178.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 34.4 tttt -55.99 -46.2 78.77 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.558 -0.714 . . . . 0.0 109.483 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -63.28 -46.64 85.86 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.0 109.892 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.76 -35.62 78.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.597 -0.689 . . . . 0.0 109.67 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.479 HG22 ' H ' ' A' ' 34' ' ' GLY . 70.0 p -93.39 1.89 56.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.213 -0.929 . . . . 0.0 109.521 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.27 -0.894 . . . . 0.0 109.46 179.921 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.661 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.79 144.63 37.75 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.184 -0.947 . . . . 0.0 109.555 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -98.29 129.25 45.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.201 -0.937 . . . . 0.0 109.665 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -86.25 129.47 34.84 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.269 -0.895 . . . . 0.0 109.052 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -57.47 91.84 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.105 -0.997 . . . . 0.0 109.286 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.421 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -104.07 126.43 8.76 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.5 m -61.2 137.9 58.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.14 -1.212 . . . . 0.0 109.296 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.431 ' O ' ' N ' ' A' ' 7' ' ' ALA . . . -78.13 -19.24 54.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.263 -0.898 . . . . 0.0 109.986 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 tttp -58.38 -48.75 79.6 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.133 -0.979 . . . . 0.0 110.066 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -65.69 -50.77 63.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.074 -1.016 . . . . 0.0 109.319 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.533 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.45 -32.1 83.09 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.431 ' N ' ' O ' ' A' ' 3' ' ' ALA . . . -56.68 -43.91 80.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.2 -1.176 . . . . 0.0 109.592 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.85 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -71.87 -37.59 70.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.951 . . . . 0.0 109.053 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.454 HD23 HD22 ' A' ' 94' ' ' LEU . 9.1 tp -58.75 -40.92 85.26 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.665 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.7 t80 -62.82 -47.02 85.24 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 178.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 69.7 tttt -63.42 -38.85 92.72 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-O 121.386 0.613 . . . . 0.0 109.963 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.85 HG23 ' O ' ' A' ' 8' ' ' THR . 59.4 p -69.68 -33.54 72.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.393 -0.817 . . . . 0.0 111.391 -178.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -149.68 58.87 1.0 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.579 -1.326 . . . . 0.0 110.946 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.1 t -172.33 -54.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.832 -1.168 . . . . 0.0 110.291 179.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.16 -38.07 70.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.994 -1.067 . . . . 0.0 109.706 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -58.79 -35.43 72.81 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.18 -0.95 . . . . 0.0 109.832 -179.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 96.1 m -96.07 -43.61 7.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.125 -0.984 . . . . 0.0 110.514 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -105.88 123.73 48.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.341 -0.849 . . . . 0.0 110.2 -178.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.4 p -86.75 -23.37 25.49 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.288 -0.882 . . . . 0.0 109.298 179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.799 HG13 ' O ' ' A' ' 32' ' ' LEU . 16.0 t 40.37 67.27 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.789 . . . . 0.0 109.918 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -110.76 143.92 40.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.448 -0.782 . . . . 0.0 109.317 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -64.23 -35.1 79.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.248 -0.908 . . . . 0.0 109.518 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.05 49.49 0.72 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -115.82 166.99 12.32 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.684 -1.367 . . . . 0.0 109.684 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.485 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.3 Cg_endo -74.1 -171.02 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 123.054 2.503 . . . . 0.0 112.021 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 87.8 m-70 -105.57 134.68 48.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.361 -0.837 . . . . 0.0 109.499 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.586 ' O ' ' N ' ' A' ' 29' ' ' GLY . 79.7 tttt -131.35 129.72 41.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.451 -0.78 . . . . 0.0 109.173 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 81.9 t 53.81 -84.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.222 -179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -101.89 161.54 17.58 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -60.24 154.16 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 123.151 2.567 . . . . 0.0 112.361 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.485 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 13.9 m120 -84.13 133.65 34.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.14 -0.975 . . . . 0.0 109.255 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.799 ' O ' HG13 ' A' ' 20' ' ' VAL . 6.8 mp -99.7 133.99 43.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.183 -0.948 . . . . 0.0 109.927 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -161.44 102.93 1.22 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 108.81 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.548 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 80.46 9.88 85.96 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 108.363 -1.895 . . . . 0.0 108.363 -179.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.2 tt -57.57 -21.32 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.599 -0.942 . . . . 0.0 109.523 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 102' ' ' THR . 90.4 m-85 -64.71 132.98 51.14 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.203 -0.935 . . . . 0.0 109.495 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.04 26.11 73.19 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.548 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 90.2 mtt-85 -134.37 165.0 26.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.338 -1.095 . . . . 0.0 110.021 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -100.04 147.33 25.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.375 -0.828 . . . . 0.0 109.505 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.582 ' OG ' ' NE1' ' A' ' 59' ' ' TRP . 9.5 m -61.3 152.89 27.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.424 -0.797 . . . . 0.0 110.118 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.51 -7.73 74.76 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.444 HE22 HH11 ' A' ' 38' ' ' ARG . 45.0 tt0 -64.03 -39.11 93.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.029 -1.277 . . . . 0.0 110.273 -179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.631 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -59.75 -45.44 92.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.0 -1.063 . . . . 0.0 109.556 -179.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 58.97 -22.73 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.609 -0.682 . . . . 0.0 110.693 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.631 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -60.96 -34.88 89.42 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.402 ' CD2' ' O ' ' A' ' 47' ' ' SER . 64.9 t80 -111.68 135.91 51.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.412 -1.052 . . . . 0.0 109.352 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.402 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 35.0 m -62.57 153.79 30.91 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.711 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.552 ' O ' HD11 ' A' ' 53' ' ' ILE . 87.2 m-85 -116.03 148.95 39.63 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.492 -0.755 . . . . 0.0 109.522 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.417 ' OG1' HG22 ' A' ' 78' ' ' THR . 30.1 p -76.52 164.38 26.01 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.314 -0.866 . . . . 0.0 109.64 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -55.62 -34.28 64.76 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.34 -0.85 . . . . 0.0 110.147 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -52.31 -75.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.095 -1.003 . . . . 0.0 110.442 -179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.487 ' O ' ' O ' ' A' ' 55' ' ' LYS . 22.8 t-20 -55.04 -41.3 71.24 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.971 -1.081 . . . . 0.0 110.271 -179.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.552 HD11 ' O ' ' A' ' 48' ' ' TYR . 96.9 mt -59.88 -54.54 33.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 120.793 -1.192 . . . . 0.0 109.34 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -62.15 -40.39 95.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 0.0 109.084 179.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.487 ' O ' ' O ' ' A' ' 52' ' ' ASN . 56.4 tttm -111.43 111.96 23.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.595 -0.691 . . . . 0.0 109.197 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -100.54 136.73 39.96 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.264 -0.897 . . . . 0.0 109.201 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.848 HG11 ' OH ' ' A' ' 74' ' ' TYR . 13.4 p -131.11 147.37 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.521 -0.737 . . . . 0.0 109.866 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.765 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.2 tt -79.24 128.43 33.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.765 ' N ' HD23 ' A' ' 58' ' ' LEU . 87.8 m95 -91.63 108.22 19.75 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.069 -1.019 . . . . 0.0 110.126 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.489 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 52.4 p30 -136.49 176.25 8.87 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.574 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -61.91 -41.69 98.22 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.084 -1.01 . . . . 0.0 110.357 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 13.5 t30 -64.78 -51.69 60.9 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.0 110.333 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.489 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 38.3 t30 -61.42 -35.89 78.81 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.406 -0.809 . . . . 0.0 110.458 -179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 2.6 mmt -56.63 -41.43 77.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.992 -1.067 . . . . 0.0 109.648 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.425 ' OG ' HD11 ' A' ' 95' ' ' ILE . 35.5 m -63.24 -42.16 99.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.169 -0.957 . . . . 0.0 109.286 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.56 -36.9 83.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.396 179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.471 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 79.6 t60 -57.76 -43.62 85.6 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.259 -0.901 . . . . 0.0 109.22 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.487 HD11 HD23 ' A' ' 94' ' ' LEU . 86.2 mt -63.54 -28.84 70.21 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.464 -0.773 . . . . 0.0 109.68 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.551 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 10.0 m -81.89 125.37 30.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.459 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.2 m-20 37.52 61.55 3.92 Favored Pre-proline 0 N--CA 1.494 1.729 0 O-C-N 121.551 -0.718 . . . . 0.0 110.342 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -62.9 -21.52 73.2 Favored 'Trans proline' 0 C--N 1.307 -1.62 0 C-N-CA 122.645 2.23 . . . . 0.0 112.943 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.82 -56.67 16.98 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.076 -1.015 . . . . 0.0 109.878 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.9 mttt -62.14 -36.32 81.45 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 0.0 109.54 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.848 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.0 t80 -59.9 -51.68 68.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.467 -0.77 . . . . 0.0 110.302 -179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.694 ' O ' HG22 ' A' ' 75' ' ' ILE . 3.0 mm -141.18 79.55 17.74 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.261 -0.899 . . . . 0.0 109.048 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -85.32 152.22 10.64 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 C-N-CA 123.112 2.542 . . . . 0.0 112.735 -179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.17 -1.82 59.31 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.531 HG21 ' CG2' ' A' ' 75' ' ' ILE . 15.0 p -100.57 166.54 10.86 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.981 -1.305 . . . . 0.0 109.949 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -81.67 2.77 28.08 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 109.342 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.6 ttt -83.57 128.38 34.47 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.329 -0.857 . . . . 0.0 109.847 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -131.61 86.78 2.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.483 -0.761 . . . . 0.0 109.212 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -103.07 131.64 49.92 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.411 -0.805 . . . . 0.0 109.316 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.64 145.43 38.64 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.71 144.12 32.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.579 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 52.6 mt -95.87 124.74 40.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.153 -1.204 . . . . 0.0 109.491 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 24.9 mtpt -65.13 -35.94 82.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.795 . . . . 0.0 110.092 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.3 mttm -93.47 129.8 39.52 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.032 -1.043 . . . . 0.0 110.404 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -74.81 -33.9 62.3 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.576 -0.703 . . . . 0.0 109.583 179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -57.2 -39.48 75.49 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.272 -0.893 . . . . 0.0 109.553 -179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -60.02 -38.08 81.63 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.253 -0.904 . . . . 0.0 108.936 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.579 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 85.5 mtt180 -61.47 -39.26 90.25 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.419 -0.8 . . . . 0.0 109.796 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -59.88 -40.5 88.9 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.279 -0.888 . . . . 0.0 110.186 -179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.533 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.6 m-20 -64.63 -41.36 96.21 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.088 -1.008 . . . . 0.0 109.784 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.822 HD21 ' CBB' ' A' ' 201' ' ' HEC . 55.3 tp -61.69 -43.34 99.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 0.0 109.787 -179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.425 HD11 ' OG ' ' A' ' 65' ' ' SER . 89.0 mt -64.78 -35.95 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.114 -0.991 . . . . 0.0 108.899 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.404 HG22 ' HB2' ' A' ' 3' ' ' ALA . 21.2 m -56.51 -41.12 76.16 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 109.913 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 77.3 t80 -64.07 -54.78 28.7 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.082 -1.011 . . . . 0.0 110.299 -179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD23 ' HA ' ' A' ' 98' ' ' LEU . 91.9 mt -68.08 -37.3 81.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.874 -1.141 . . . . 0.0 108.892 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.574 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 29.7 tttt -57.71 -40.03 78.61 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.6 tttp -59.65 -39.92 85.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.403 -0.811 . . . . 0.0 109.413 179.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.12 -32.37 68.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.439 -0.788 . . . . 0.0 109.577 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.402 HG21 ' CD1' ' A' ' 36' ' ' PHE . 44.0 p -66.11 -25.54 67.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.21 -0.931 . . . . 0.0 109.442 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.335 -0.853 . . . . 0.0 109.402 -179.895 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.822 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 6.2 m . . . . . 0 N--CA 1.491 1.582 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.74 -32.98 73.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.277 -0.89 . . . . 0.0 109.465 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -100.55 128.22 46.68 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.246 -0.909 . . . . 0.0 109.577 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -90.48 133.12 35.26 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.291 -0.881 . . . . 0.0 109.405 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 1' ' ' GLY . . . -57.11 127.69 33.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.176 -0.953 . . . . 0.0 109.387 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' -1' ' ' ALA . . . -42.31 137.67 2.97 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 -179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.9 m -58.24 -36.71 73.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.233 -1.157 . . . . 0.0 109.416 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.485 ' O ' ' OD2' ' A' ' 93' ' ' ASP . . . -177.24 -146.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.313 -0.867 . . . . 0.0 109.784 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.453 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 88.3 mttt -87.7 7.5 29.85 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -0.854 . . . . 0.0 109.896 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -54.81 -43.89 73.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.104 -0.997 . . . . 0.0 108.98 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.659 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -62.17 -29.29 72.46 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.064 -1.614 . . . . 0.0 109.064 179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.721 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -58.86 -42.82 90.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.341 -1.094 . . . . 0.0 109.492 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.928 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -67.35 -36.9 82.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.118 -0.989 . . . . 0.0 108.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.589 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -58.84 -40.02 83.0 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 178.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.689 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.6 t80 -66.08 -48.55 70.59 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.0 tttt -62.89 -38.76 92.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.686 -0.634 . . . . 0.0 110.125 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.928 HG23 ' O ' ' A' ' 8' ' ' THR . 68.5 p -68.17 -32.7 73.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.454 -0.779 . . . . 0.0 111.23 -178.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 62.8 mtt85 -151.27 59.2 0.9 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.664 -1.273 . . . . 0.0 111.014 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.689 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.0 t -173.06 -55.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.755 -1.216 . . . . 0.0 110.61 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -53.85 -38.69 64.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.044 -1.035 . . . . 0.0 109.582 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.0 -35.94 67.36 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.063 -1.023 . . . . 0.0 109.801 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 92.4 m -97.04 -43.03 7.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.12 -0.988 . . . . 0.0 110.985 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.465 ' ND1' ' CD1' ' A' ' 32' ' ' LEU . 89.0 m-70 -105.36 129.29 53.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.185 -0.947 . . . . 0.0 110.48 -178.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.45 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 46.8 p -89.9 -19.19 24.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.445 -0.785 . . . . 0.0 109.495 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.547 ' O ' ' ND1' ' A' ' 33' ' ' HIS . 4.3 t 60.93 20.53 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.326 -0.858 . . . . 0.0 110.194 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.417 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.4 tt0 -104.46 138.06 41.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 109.331 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 12.1 pttm -59.67 -39.07 83.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.203 -0.935 . . . . 0.0 109.34 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -107.3 28.78 11.79 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.041 -1.624 . . . . 0.0 109.041 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -61.23 154.22 37.76 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.814 -1.314 . . . . 0.0 109.814 -179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -72.71 -3.22 13.12 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.891 2.394 . . . . 0.0 112.263 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.5 ' O ' ' O ' ' A' ' 27' ' ' LYS . 79.5 m-70 59.01 66.26 1.08 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -178.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.5 ' O ' ' O ' ' A' ' 26' ' ' HIS . 29.9 tttp -58.04 -122.19 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 0.0 109.688 -179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 93.6 t -64.04 -39.78 86.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 120.929 -1.107 . . . . 0.0 109.572 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -121.24 162.79 14.87 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 18.0 Cg_endo -62.59 154.31 65.81 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 C-N-CA 122.966 2.444 . . . . 0.0 112.253 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.45 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 6.8 m120 -86.22 134.19 33.79 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.113 -0.992 . . . . 0.0 109.122 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.61 HD23 HG21 ' A' ' 35' ' ' ILE . 9.7 mp -89.58 -112.89 0.07 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.122 -0.986 . . . . 0.0 109.912 -179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.547 ' ND1' ' O ' ' A' ' 20' ' ' VAL . 10.6 t60 79.33 90.35 0.06 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.494 -0.754 . . . . 0.0 109.797 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 91.73 5.45 66.58 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.61 HG21 HD23 ' A' ' 32' ' ' LEU . 3.2 tp -57.81 -20.2 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.26 -1.141 . . . . 0.0 109.801 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.656 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 90.4 m-85 -63.1 135.36 57.16 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.115 -0.99 . . . . 0.0 109.97 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 68.54 25.56 74.85 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.434 ' HD3' HE22 ' A' ' 42' ' ' GLN . 87.2 mtt180 -135.16 157.96 45.59 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -1.115 . . . . 0.0 110.057 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -91.57 152.09 20.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.327 -0.858 . . . . 0.0 109.361 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.59 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 60.6 p -65.77 157.75 29.47 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.319 -0.863 . . . . 0.0 110.07 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 93.94 -13.59 67.1 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 110.052 -1.219 . . . . 0.0 110.052 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.434 HE22 ' HD3' ' A' ' 38' ' ' ARG . 48.1 tt0 -62.58 -37.51 86.48 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.174 -1.192 . . . . 0.0 110.208 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.71 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -54.5 140.08 35.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.118 -0.988 . . . . 0.0 109.513 -179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -117.92 153.16 34.05 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.56 -0.713 . . . . 0.0 109.314 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 95.15 0.81 63.2 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.3 t80 -140.26 168.22 20.32 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.22 -1.165 . . . . 0.0 109.215 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.55 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -111.86 150.58 30.21 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.406 -0.809 . . . . 0.0 109.956 -179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.71 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 10.8 m-85 -109.19 151.35 26.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.538 -0.726 . . . . 0.0 109.513 179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.705 HG23 HBD2 ' A' ' 201' ' ' HEC . 33.6 p -75.43 157.96 33.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.255 -0.903 . . . . 0.0 109.376 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.08 -33.33 70.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 110.088 -179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -55.31 -63.73 1.07 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.185 -0.947 . . . . 0.0 110.39 -179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.582 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.5 t-20 -55.46 -44.17 76.16 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.04 -1.037 . . . . 0.0 110.164 -179.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 41.5 mm -63.27 -47.11 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 O-C-N 120.948 -1.095 . . . . 0.0 110.056 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 16.4 tttp -60.04 -38.57 83.16 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.222 -0.924 . . . . 0.0 109.372 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -91.75 -66.14 0.95 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.445 -0.784 . . . . 0.0 109.623 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.59 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.7 OUTLIER 66.1 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.32 -0.862 . . . . 0.0 108.922 -179.508 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.819 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.1 p -131.77 149.23 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 110.181 -178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 59.9 tp -74.36 131.55 41.22 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.801 ' CE2' HMA2 ' A' ' 201' ' ' HEC . 98.4 m95 -96.79 125.69 41.42 Favored 'General case' 0 N--CA 1.487 1.394 0 C-N-CA 119.408 -0.917 . . . . 0.0 110.167 -179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.454 ' OD1' ' CB ' ' A' ' 63' ' ' ASN . 50.8 p30 -152.22 179.81 8.19 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 179.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.547 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -59.35 -42.19 90.97 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.729 -1.232 . . . . 0.0 110.647 -178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -67.98 -49.27 62.65 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.024 -1.048 . . . . 0.0 110.869 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.454 ' CB ' ' OD1' ' A' ' 60' ' ' ASP . 58.3 t30 -60.34 -41.41 93.52 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.376 -0.828 . . . . 0.0 111.271 -178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.656 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 61.5 mtt -61.12 -37.62 83.45 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.905 -1.122 . . . . 0.0 110.276 -179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.7 p -60.97 -43.38 98.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.018 -1.051 . . . . 0.0 109.678 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -69.1 -36.7 77.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.013 -1.054 . . . . 0.0 109.169 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -60.01 -46.14 90.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.577 -0.702 . . . . 0.0 110.156 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.503 ' CD1' HD23 ' A' ' 94' ' ' LEU . 90.1 mt -62.53 -31.46 72.24 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.133 -0.979 . . . . 0.0 110.063 -179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.528 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 13.1 m -85.79 127.12 34.47 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.943 -1.098 . . . . 0.0 109.392 179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.438 ' C ' ' O ' ' A' ' 69' ' ' THR . 2.0 m120 39.8 58.61 6.91 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.429 -0.794 . . . . 0.0 110.192 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -58.81 -20.81 53.76 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.792 2.328 . . . . 0.0 112.959 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.51 -58.87 6.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.078 -1.014 . . . . 0.0 110.083 -179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.9 mttt -61.68 -33.52 74.12 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.14 -0.975 . . . . 0.0 109.575 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.819 ' OH ' HG11 ' A' ' 57' ' ' VAL . 71.5 t80 -57.19 -48.74 78.0 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.393 -0.817 . . . . 0.0 110.596 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.794 HG23 ' O ' ' A' ' 75' ' ' ILE . 4.2 tp -152.82 82.08 5.11 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 120.925 -1.109 . . . . 0.0 109.271 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -75.91 151.34 35.44 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.314 2.009 . . . . 0.0 112.338 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.76 1.08 58.82 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 79.6 p -93.21 165.72 12.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.333 -1.098 . . . . 0.0 109.688 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.8 mtmt -92.28 14.58 15.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.383 -0.823 . . . . 0.0 110.143 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 5.3 mtm -78.9 134.46 36.89 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.96 -1.087 . . . . 0.0 110.078 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.05 27.13 9.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.486 -0.759 . . . . 0.0 109.048 179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -77.53 130.56 37.12 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.331 -0.856 . . . . 0.0 108.94 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -89.68 179.29 44.43 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -83.69 146.12 23.17 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.0 mt -96.02 118.14 32.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.168 -1.195 . . . . 0.0 109.338 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.1 ttpm? -64.97 -38.48 91.11 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.388 -0.82 . . . . 0.0 110.167 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -85.78 128.45 34.81 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.128 -0.982 . . . . 0.0 110.351 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.4 -29.27 59.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.67 -0.644 . . . . 0.0 109.895 179.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 56.5 mttp -55.65 -47.11 77.2 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.152 -0.968 . . . . 0.0 110.093 -178.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -63.57 -38.94 93.05 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 120.907 -1.121 . . . . 0.0 108.801 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.528 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 38.5 ttm180 -60.85 -45.19 95.51 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.551 -0.718 . . . . 0.0 110.035 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -66.66 -48.79 68.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.43 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.659 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 45.7 t0 -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.057 -1.027 . . . . 0.0 109.869 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.503 HD23 ' CD1' ' A' ' 68' ' ' LEU . 47.8 tp -54.79 -47.03 74.49 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.165 -0.959 . . . . 0.0 110.108 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 62.8 mt -68.35 -40.77 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.03 -1.044 . . . . 0.0 109.266 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 40.1 m -59.18 -41.83 89.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.413 -0.805 . . . . 0.0 110.078 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.721 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 82.2 t80 -60.4 -49.57 77.04 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.863 -1.148 . . . . 0.0 108.932 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 98' ' ' LEU . 82.9 mt -68.13 -32.06 72.08 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.143 -0.973 . . . . 0.0 108.562 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.547 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 41.3 tttm -54.82 -43.75 73.24 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.505 -0.747 . . . . 0.0 109.041 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -62.02 -43.22 99.29 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.305 -0.872 . . . . 0.0 109.376 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.41 -25.2 65.76 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.645 -0.659 . . . . 0.0 109.899 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.458 ' CG2' ' N ' ' A' ' 103' ' ' GLU . 1.2 t -50.24 -39.71 45.59 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.578 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.458 ' N ' ' CG2' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.445 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.801 HMA2 ' CE2' ' A' ' 59' ' ' TRP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.374 0.607 . . . . 0.0 109.481 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.94 -33.21 73.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 0.0 109.441 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -100.19 131.23 46.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.418 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -111.19 162.19 15.21 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.474 -0.766 . . . . 0.0 109.335 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 109.5 0.39 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.241 -0.912 . . . . 0.0 109.47 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -97.69 125.64 8.58 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.551 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 86.1 p -60.98 -27.75 68.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.248 -1.148 . . . . 0.0 109.171 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.551 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 67.56 -21.34 0.12 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.303 -0.873 . . . . 0.0 110.057 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 2' ' ' SER . 33.8 tttt -58.82 -51.52 69.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.016 -1.053 . . . . 0.0 109.426 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -65.57 -42.23 92.04 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.165 -0.959 . . . . 0.0 109.201 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.509 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -61.72 -34.96 90.45 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.879 -1.288 . . . . 0.0 109.879 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.02 83.28 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.141 -1.211 . . . . 0.0 109.675 -179.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.795 ' O ' HG23 ' A' ' 12' ' ' THR . 52.3 p -74.57 -38.65 62.61 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.124 -0.985 . . . . 0.0 109.402 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 8.7 tp -59.05 -41.8 88.76 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.6 t80 -63.97 -45.91 87.0 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.047 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -62.78 -38.6 91.26 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-O 121.404 0.621 . . . . 0.0 110.267 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.795 HG23 ' O ' ' A' ' 8' ' ' THR . 61.9 p -72.25 -29.6 64.07 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 0.0 111.663 -178.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.8 mtp85 -147.72 53.49 1.05 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.468 -1.395 . . . . 0.0 111.479 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.5 t -173.48 -50.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.724 -1.235 . . . . 0.0 110.774 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.5 tp -56.66 -37.55 70.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.079 -1.013 . . . . 0.0 110.156 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -56.97 -34.8 68.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.12 -0.988 . . . . 0.0 109.769 -179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.5 m -98.14 -43.58 6.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.678 -179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.437 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 88.8 m-70 -104.16 128.51 51.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.234 -0.916 . . . . 0.0 110.411 -178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.413 ' O ' ' C ' ' A' ' 20' ' ' VAL . 44.7 p -93.95 -15.71 24.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.214 -0.929 . . . . 0.0 109.475 179.598 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' C ' ' O ' ' A' ' 19' ' ' THR . 2.5 t 42.26 36.62 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.337 -0.852 . . . . 0.0 109.76 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.404 ' HG2' ' H ' ' A' ' 24' ' ' GLY . 85.3 tt0 -101.16 141.06 34.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.249 -0.907 . . . . 0.0 109.276 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -76.15 -82.68 0.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.295 -0.878 . . . . 0.0 110.203 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.16 -30.58 24.51 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.842 -1.303 . . . . 0.0 109.842 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -63.48 150.84 49.25 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.488 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 72.7 Cg_endo -76.43 -155.58 0.05 OUTLIER 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.676 2.251 . . . . 0.0 111.773 179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -104.03 134.66 46.93 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.285 -0.884 . . . . 0.0 109.027 179.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.554 ' O ' ' N ' ' A' ' 29' ' ' GLY . 46.1 tptt -130.51 133.01 45.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.0 109.307 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.474 HG23 ' HG3' ' A' ' 27' ' ' LYS . 91.6 t 53.9 -86.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.19 -0.944 . . . . 0.0 109.11 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -103.87 158.7 16.9 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.437 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 15.6 Cg_endo -57.01 146.78 78.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.059 2.506 . . . . 0.0 112.341 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 18.6 m120 -74.1 135.55 42.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.334 -0.854 . . . . 0.0 110.001 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.443 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.0 mp -97.17 11.48 36.2 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.266 -0.896 . . . . 0.0 109.569 179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 50.1 p-80 -52.22 -32.39 36.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.188 -0.945 . . . . 0.0 110.197 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -137.42 56.05 0.68 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -111.77 2.34 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.446 -1.032 . . . . 0.0 110.045 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.557 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 48.7 m-85 -82.33 129.18 34.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.893 -1.129 . . . . 0.0 109.985 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 68.24 31.06 73.94 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -145.77 168.25 21.21 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.204 -1.174 . . . . 0.0 110.171 -179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.0 m80 -94.31 156.32 16.57 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.349 -0.844 . . . . 0.0 109.363 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.492 ' O ' ' CZ ' ' A' ' 48' ' ' TYR . 59.5 p -58.71 -39.65 81.42 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.221 -0.924 . . . . 0.0 109.739 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -65.45 -33.18 85.77 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.1 tt0 -58.26 -36.22 72.91 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.304 -1.115 . . . . 0.0 110.737 -179.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.638 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -59.08 -32.02 69.43 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.892 -1.13 . . . . 0.0 109.686 -179.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.494 ' O ' ' O ' ' A' ' 43' ' ' ALA . 78.7 mm-40 42.84 -167.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.227 -0.921 . . . . 0.0 109.512 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 79.98 -41.9 2.45 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 47' ' ' SER . 71.8 t80 -123.53 136.1 54.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.474 -1.015 . . . . 0.0 109.333 -179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.522 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 55.1 p -69.35 159.34 33.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.319 -0.863 . . . . 0.0 109.472 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.638 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 95.4 m-85 -118.27 146.72 44.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.409 -0.807 . . . . 0.0 109.879 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.574 HG21 ' OG1' ' A' ' 78' ' ' THR . 61.4 m -69.75 151.88 45.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.391 -0.818 . . . . 0.0 109.392 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -47.79 -33.27 7.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.438 -0.789 . . . . 0.0 109.777 -179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.49 -68.55 0.17 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.188 -0.945 . . . . 0.0 110.407 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.485 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.7 t-20 -56.58 -41.81 77.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.939 -1.1 . . . . 0.0 110.295 -179.457 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 80.5 mt -60.8 -44.32 97.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 120.852 -1.155 . . . . 0.0 109.693 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.1 tttm -59.11 -37.14 76.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.158 -0.964 . . . . 0.0 108.785 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.0 tttt -127.14 112.3 15.0 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.502 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -97.95 134.79 40.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.278 -0.889 . . . . 0.0 109.287 -179.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.79 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -130.84 145.76 35.02 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.468 -0.77 . . . . 0.0 109.657 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.7 tp -79.89 132.81 36.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.243 -0.91 . . . . 0.0 108.774 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.589 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 99.0 m95 -94.98 124.74 39.2 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.17 -0.956 . . . . 0.0 109.778 -179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.459 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 55.2 t0 -148.18 163.41 37.05 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.471 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.4 mt-10 -52.51 -40.76 62.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.919 -1.113 . . . . 0.0 109.483 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.7 t30 -68.05 -48.19 66.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.229 -0.92 . . . . 0.0 110.164 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -61.52 -38.83 88.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.417 -0.802 . . . . 0.0 110.732 -179.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.557 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 63.1 mtt -59.76 -38.25 81.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.079 -1.013 . . . . 0.0 109.844 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HA ' HD11 ' A' ' 95' ' ' ILE . 90.5 p -60.9 -40.53 93.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.025 -1.047 . . . . 0.0 108.964 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -66.81 -35.12 79.33 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.095 -1.003 . . . . 0.0 109.107 179.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.474 ' ND1' ' CG ' ' A' ' 74' ' ' TYR . 69.8 t60 -61.37 -45.66 93.45 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.385 -0.822 . . . . 0.0 109.792 -179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.63 HD13 HD23 ' A' ' 94' ' ' LEU . 42.0 mt -63.56 -27.01 68.96 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.37 -0.831 . . . . 0.0 109.868 -179.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.536 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 17.6 m -86.01 126.15 33.93 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.85 -1.157 . . . . 0.0 108.725 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.599 HD22 ' N ' ' A' ' 70' ' ' ASN . 0.9 OUTLIER 41.77 59.33 9.46 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.272 -0.892 . . . . 0.0 109.751 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -62.52 -23.21 74.78 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.762 2.308 . . . . 0.0 112.747 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.489 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -60.55 -49.26 78.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.035 -1.041 . . . . 0.0 109.609 -179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 32.9 mttp -64.16 -30.52 71.58 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.19 -0.944 . . . . 0.0 109.387 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.79 ' OH ' HG11 ' A' ' 57' ' ' VAL . 31.2 t80 -52.35 -46.12 66.0 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.318 -0.864 . . . . 0.0 108.936 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 77' ' ' GLY . 1.6 pt -141.05 153.35 66.99 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -45.54 -7.31 0.03 OUTLIER 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.085 1.857 . . . . 0.0 112.018 179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.575 ' N ' ' O ' ' A' ' 75' ' ' ILE . . . 84.02 48.41 5.17 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.671 HG23 ' N ' ' A' ' 79' ' ' LYS . 4.9 t -56.81 -118.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.487 -1.007 . . . . 0.0 109.974 -179.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.671 ' N ' HG23 ' A' ' 78' ' ' THR . 45.4 mtmt -89.64 1.46 55.99 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.188 -0.945 . . . . 0.0 109.668 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 7.3 mmm -75.17 118.54 18.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.219 -0.925 . . . . 0.0 108.959 179.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.13 32.03 5.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.457 -0.777 . . . . 0.0 110.17 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.535 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 60.2 t80 -87.53 130.47 34.71 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.082 -1.011 . . . . 0.0 109.256 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.535 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.41 179.77 49.35 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.424 -1.47 . . . . 0.0 109.424 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.36 157.27 23.85 Favored Glycine 0 N--CA 1.488 2.132 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 57.4 mt -102.46 119.03 38.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.262 -1.14 . . . . 0.0 109.346 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -66.32 -35.72 81.1 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.354 -0.841 . . . . 0.0 110.248 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.494 ' O ' ' OD1' ' A' ' 90' ' ' ASP . 69.0 mttm -90.32 130.76 36.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 0.0 110.294 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.03 -29.56 49.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.472 -0.767 . . . . 0.0 109.999 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 54.7 tttp -56.62 -52.1 66.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.168 -0.958 . . . . 0.0 110.217 -178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . 0.639 ' OD1' ' N ' ' A' ' 91' ' ' ARG . 53.3 p30 -64.47 -30.29 71.33 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.618 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.639 ' N ' ' OD1' ' A' ' 90' ' ' ASP . 39.2 ttm180 -59.45 -43.69 93.11 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.191 -0.943 . . . . 0.0 109.674 179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -62.12 -41.89 98.69 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.142 -0.974 . . . . 0.0 109.859 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.509 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 86.2 m-20 -65.46 -40.5 93.26 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.189 -0.944 . . . . 0.0 110.17 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.63 HD23 HD13 ' A' ' 68' ' ' LEU . 54.5 tp -58.19 -47.0 84.78 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.113 -0.992 . . . . 0.0 110.186 -179.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.48 HD11 ' HA ' ' A' ' 65' ' ' SER . 63.2 mt -67.33 -36.17 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.011 -1.055 . . . . 0.0 108.684 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.425 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.6 m -57.68 -41.43 81.57 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.403 -0.811 . . . . 0.0 109.674 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 79.4 t80 -60.63 -50.87 71.78 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.009 -1.057 . . . . 0.0 109.0 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.607 HD21 ' CE1' ' A' ' 10' ' ' PHE . 88.1 mt -66.74 -32.77 74.29 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.142 -0.974 . . . . 0.0 108.384 178.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 19.2 tttt -57.33 -41.63 80.34 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -60.48 -40.34 90.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.47 -0.769 . . . . 0.0 109.362 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.46 -30.81 67.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.504 -0.748 . . . . 0.0 109.652 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.406 HG22 ' O ' ' A' ' 99' ' ' LYS . 0.6 OUTLIER -63.76 -32.04 73.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.195 -0.941 . . . . 0.0 109.455 179.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.548 0 O-C-N 121.225 -0.922 . . . . 0.0 109.572 179.923 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.642 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 62.3 p . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.94 -32.73 68.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.258 -0.901 . . . . 0.0 109.549 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -97.89 129.03 44.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.368 -0.833 . . . . 0.0 109.608 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.404 ' O ' ' N ' ' A' ' 1' ' ' GLY . 15.5 ttmt -92.27 131.54 37.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.201 -0.937 . . . . 0.0 109.406 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -52.16 97.82 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.132 -0.98 . . . . 0.0 109.265 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -71.11 156.47 53.15 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.609 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 23.7 m -56.28 -33.26 65.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.241 -1.153 . . . . 0.0 109.129 179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 72.05 -41.04 0.49 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.391 -0.818 . . . . 0.0 109.935 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.424 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.8 tttt -58.98 -51.21 71.06 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.041 -1.037 . . . . 0.0 109.414 -179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -64.0 -43.13 96.61 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.098 -1.001 . . . . 0.0 108.984 179.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.44 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.97 -32.73 85.18 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -56.64 -42.65 79.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.192 -1.181 . . . . 0.0 109.007 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.889 ' O ' HG23 ' A' ' 12' ' ' THR . 52.7 p -74.19 -33.48 63.45 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.34 -0.85 . . . . 0.0 109.119 179.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.606 ' O ' HD13 ' A' ' 9' ' ' LEU . 0.3 OUTLIER -60.35 -42.18 95.2 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 179.406 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.685 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.0 t80 -69.07 -47.37 65.45 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 178.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.5 tttm -62.67 -39.24 93.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.67 -0.644 . . . . 0.0 110.421 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.889 HG23 ' O ' ' A' ' 8' ' ' THR . 73.3 p -69.36 -32.53 71.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.347 -0.846 . . . . 0.0 111.399 -178.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -150.76 58.06 0.93 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.53 -1.356 . . . . 0.0 111.526 -178.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.685 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 6.3 t -170.59 -43.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.757 -1.215 . . . . 0.0 110.128 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -58.54 -35.91 73.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.088 -1.007 . . . . 0.0 109.656 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -57.8 -37.21 73.34 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.142 -0.974 . . . . 0.0 109.945 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.5 m -93.25 -41.3 9.96 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.17 -0.956 . . . . 0.0 110.4 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.646 ' ND1' HD11 ' A' ' 32' ' ' LEU . 87.4 m-70 -107.73 127.08 53.36 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.3 -0.875 . . . . 0.0 110.402 -178.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.408 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 43.2 p -87.69 -20.39 26.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.446 -0.784 . . . . 0.0 109.613 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 20' ' ' VAL . 5.7 t 57.65 29.78 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.242 -0.911 . . . . 0.0 110.189 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -104.17 149.06 25.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.132 -0.98 . . . . 0.0 109.303 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -60.47 -36.22 77.75 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.885 . . . . 0.0 109.337 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -125.98 41.31 1.67 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.063 -1.615 . . . . 0.0 109.063 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' C ' ' OD1' ' A' ' 31' ' ' ASN . . . -62.81 156.49 40.11 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 -179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -71.79 -4.74 15.66 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.953 2.435 . . . . 0.0 112.196 179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' O ' ' O ' ' A' ' 27' ' ' LYS . 73.1 m-70 60.49 65.85 1.01 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 -178.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.497 ' O ' ' O ' ' A' ' 26' ' ' HIS . 14.6 tttt -57.04 -118.11 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.425 -0.797 . . . . 0.0 109.773 -179.29 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 91.2 t -63.83 -40.36 88.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.925 -1.109 . . . . 0.0 109.68 -179.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -125.76 162.86 19.91 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 -179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.43 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 16.6 Cg_endo -60.6 150.52 81.46 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.917 2.411 . . . . 0.0 111.952 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.443 ' OD1' ' C ' ' A' ' 24' ' ' GLY . 5.4 m120 -81.24 140.46 34.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.173 -0.954 . . . . 0.0 109.292 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.676 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.9 mp -98.28 140.85 31.95 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.161 -0.962 . . . . 0.0 110.024 -179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -171.18 97.01 0.2 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.427 -0.795 . . . . 0.0 109.064 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.29 6.76 74.0 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.6 tt -58.81 -23.37 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.523 -0.986 . . . . 0.0 109.81 -179.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -65.74 133.74 51.7 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.226 -0.921 . . . . 0.0 109.529 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.48 22.08 78.91 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.242 -1.543 . . . . 0.0 109.242 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.405 ' HG3' HE22 ' A' ' 42' ' ' GLN . 64.5 mmt-85 -135.81 161.55 35.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.346 -1.091 . . . . 0.0 109.711 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.0 m80 -88.78 156.69 18.82 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.6 ' CB ' ' HE1' ' A' ' 59' ' ' TRP . 1.8 t -61.07 149.36 37.3 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.0 109.585 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.83 -4.81 63.57 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.867 -1.293 . . . . 0.0 109.867 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.405 HE22 ' HG3' ' A' ' 38' ' ' ARG . 51.9 tt0 -60.59 -38.34 84.31 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.129 -1.218 . . . . 0.0 109.859 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.752 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.18 139.13 48.63 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.083 -1.01 . . . . 0.0 109.069 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -117.79 150.62 38.83 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.434 -0.791 . . . . 0.0 109.434 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.82 2.45 62.85 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.519 ' CD2' ' O ' ' A' ' 47' ' ' SER . 58.7 t80 -136.25 157.83 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.208 -1.172 . . . . 0.0 109.319 179.912 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.519 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.3 t -98.77 148.52 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.752 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 39.3 m-85 -109.81 141.67 42.16 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.509 -0.744 . . . . 0.0 110.043 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.704 ' H ' ' CGD' ' A' ' 201' ' ' HEC . 51.7 m -73.47 146.94 44.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.321 -0.862 . . . . 0.0 109.333 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.712 ' HA ' HD12 ' A' ' 53' ' ' ILE . 92.2 m-20 -51.7 -36.31 46.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.21 -0.931 . . . . 0.0 109.766 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 50' ' ' ASP . . . -42.71 -71.41 0.08 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.034 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.581 ' O ' ' N ' ' A' ' 56' ' ' ASN . 26.9 t-20 -52.88 -40.12 63.22 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 0.0 110.367 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 50' ' ' ASP . 79.2 mt -56.8 -54.17 32.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 120.862 -1.149 . . . . 0.0 109.415 -179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -62.47 -38.52 90.14 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.239 -0.913 . . . . 0.0 109.084 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.2 mttm -99.26 25.44 6.88 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.475 -0.766 . . . . 0.0 109.611 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.581 ' N ' ' O ' ' A' ' 52' ' ' ASN . 0.5 OUTLIER -43.64 126.55 4.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 109.018 -179.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.854 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.5 p -135.53 152.11 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.391 -0.818 . . . . 0.0 110.122 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.5 tp -71.2 133.63 46.29 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.6 ' HE1' ' CB ' ' A' ' 40' ' ' SER . 98.1 m95 -96.41 123.76 40.17 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.229 -0.92 . . . . 0.0 110.107 -179.411 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.567 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 55.1 p30 -152.93 176.66 11.61 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.578 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -60.11 -39.37 85.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.896 -1.128 . . . . 0.0 110.665 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -70.37 -56.44 6.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.926 -1.109 . . . . 0.0 110.47 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.567 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 46.2 t30 -59.55 -38.8 82.03 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.5 -0.75 . . . . 0.0 110.66 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 4.5 mmt -59.29 -40.53 86.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.069 -1.019 . . . . 0.0 109.961 -179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.428 ' HA ' HD11 ' A' ' 95' ' ' ILE . 43.1 m -60.16 -40.37 89.65 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.187 -0.946 . . . . 0.0 109.523 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -66.17 -33.2 75.23 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.949 -1.095 . . . . 0.0 109.446 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.49 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 71.3 t60 -59.74 -47.72 84.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.479 -0.763 . . . . 0.0 110.376 -179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.1 mp -67.84 -30.54 69.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 110.602 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.584 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 28.1 m -60.74 -38.82 86.46 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.908 -1.12 . . . . 0.0 110.41 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 34.9 p-10 -154.15 67.03 5.62 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.021 -1.049 . . . . 0.0 109.796 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.27 -22.04 72.14 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.571 2.181 . . . . 0.0 113.061 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.65 -71.97 0.13 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.974 -1.079 . . . . 0.0 109.651 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 27.2 mttp -59.7 -24.28 63.84 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -0.856 . . . . 0.0 109.504 179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.854 ' OH ' HG11 ' A' ' 57' ' ' VAL . 18.6 t80 -55.36 -46.29 76.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.417 -0.802 . . . . 0.0 109.922 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.67 HD12 HG21 ' A' ' 78' ' ' THR . 2.1 pt -142.47 78.78 16.07 Favored Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.155 -0.966 . . . . 0.0 109.91 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -69.25 137.42 36.9 Favored 'Trans proline' 0 C--N 1.298 -2.117 0 C-N-CA 123.039 2.492 . . . . 0.0 111.94 179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.71 2.79 62.86 Favored Glycine 0 N--CA 1.489 2.178 0 C-N-CA 120.005 -1.093 . . . . 0.0 110.538 179.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.818 HG23 ' H ' ' A' ' 80' ' ' MET . 8.8 t -98.6 170.4 8.83 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.999 -1.295 . . . . 0.0 109.675 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 48.5 mtmt -90.94 13.89 15.32 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.248 -0.908 . . . . 0.0 110.603 -179.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.818 ' H ' HG23 ' A' ' 78' ' ' THR . 1.0 OUTLIER -74.67 122.48 23.28 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.959 -1.088 . . . . 0.0 109.363 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -112.75 30.59 7.02 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 0.0 110.016 -179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.591 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 63.9 t80 -89.69 131.15 35.81 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.044 -1.035 . . . . 0.0 109.406 -179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.591 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -85.88 176.37 49.12 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.234 -1.546 . . . . 0.0 109.234 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.37 159.45 25.14 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 56.6 mt -100.98 122.98 44.48 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.22 -1.165 . . . . 0.0 109.293 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 25.3 mtmt -64.49 -35.59 81.43 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.326 -0.859 . . . . 0.0 110.08 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.98 128.51 36.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.136 -0.978 . . . . 0.0 110.28 -179.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -75.06 -28.51 60.41 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.595 -0.691 . . . . 0.0 109.889 179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.6 mttt -55.6 -47.33 76.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.895 . . . . 0.0 110.185 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -64.32 -39.16 93.34 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 120.886 -1.134 . . . . 0.0 108.898 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.584 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.6 ttp180 -61.0 -43.41 98.93 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.555 -0.716 . . . . 0.0 110.447 -179.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -58.63 -47.21 85.15 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.009 -1.057 . . . . 0.0 109.62 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 2' ' ' SER . 88.7 m-20 -66.79 -39.42 87.77 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.291 -0.881 . . . . 0.0 109.512 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.67 HD23 ' O ' ' A' ' 94' ' ' LEU . 6.7 tt -57.92 -45.84 85.92 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.235 -0.916 . . . . 0.0 109.71 -179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.428 HD11 ' HA ' ' A' ' 65' ' ' SER . 75.4 mt -65.12 -36.79 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.015 -1.053 . . . . 0.0 108.344 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 27.0 m -57.24 -41.32 79.33 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.594 -0.691 . . . . 0.0 109.59 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -62.29 -52.53 63.33 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.169 -0.957 . . . . 0.0 109.28 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.48 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.4 mt -66.19 -32.92 74.65 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 108.495 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.578 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 13.8 tttp -55.87 -43.47 77.18 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.561 -0.712 . . . . 0.0 109.091 179.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 51.6 tttt -61.15 -39.89 91.8 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.436 -0.79 . . . . 0.0 109.538 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.81 -26.64 64.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.54 -0.725 . . . . 0.0 109.718 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.463 ' CG2' ' N ' ' A' ' 103' ' ' GLU . 1.3 t -52.72 -39.69 62.31 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.138 -0.976 . . . . 0.0 109.569 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' N ' ' CG2' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.52 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.704 ' CGD' ' H ' ' A' ' 49' ' ' THR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 30.8 p . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -61.8 -31.7 71.93 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -0.913 . . . . 0.0 109.441 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 42.0 p90 -123.33 170.21 10.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.487 -0.758 . . . . 0.0 109.823 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.752 ' O ' ' HB2' ' A' ' -1' ' ' ALA . 35.0 ttpt -49.97 -56.82 9.13 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.221 -0.924 . . . . 0.0 111.176 -178.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.752 ' HB2' ' O ' ' A' ' -2' ' ' LYS . . . 160.88 28.17 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.213 -0.929 . . . . 0.0 109.426 -179.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.532 ' CA ' ' OD1' ' A' ' 93' ' ' ASP . . . -39.83 98.08 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' -1' ' ' ALA . 40.4 p -129.25 34.57 4.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.311 -1.111 . . . . 0.0 109.207 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -99.48 149.2 23.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.309 -0.87 . . . . 0.0 110.285 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 53.1 tttp -56.43 -25.73 51.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.584 -0.697 . . . . 0.0 109.762 179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -45.52 -50.92 12.46 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.1 -1.0 . . . . 0.0 109.234 -179.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -60.62 -34.83 87.76 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.589 ' HB2' ' CD1' ' A' ' 97' ' ' TYR . . . -63.37 -49.7 72.8 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.285 -1.126 . . . . 0.0 109.476 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' THR . 25.3 m -61.25 -39.12 89.16 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.274 -0.892 . . . . 0.0 108.761 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.679 HD23 HD22 ' A' ' 94' ' ' LEU . 7.0 tp -53.98 -41.63 68.1 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.683 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.4 t80 -61.25 -47.04 87.87 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -64.44 -38.03 89.58 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.441 0.638 . . . . 0.0 109.933 179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.787 HG23 ' O ' ' A' ' 8' ' ' THR . 49.4 p -68.11 -36.32 79.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.48 -0.763 . . . . 0.0 111.315 -178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 73.0 mtt85 -151.9 61.23 0.86 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.0 110.712 -178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.683 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -172.37 -47.29 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.959 -1.088 . . . . 0.0 110.161 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.2 tp -57.21 -37.67 72.56 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.171 -0.956 . . . . 0.0 109.818 -179.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -58.14 -35.25 71.23 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.132 -0.98 . . . . 0.0 109.866 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 90.2 m -96.57 -42.5 8.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.134 -0.979 . . . . 0.0 110.7 -179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.462 ' CE1' HD11 ' A' ' 32' ' ' LEU . 93.5 m-70 -109.19 124.04 50.2 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.186 -0.947 . . . . 0.0 109.881 -179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.546 ' C ' ' H ' ' A' ' 21' ' ' GLU . 36.3 p -89.03 -18.18 27.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.212 -0.93 . . . . 0.0 109.744 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.8 t 61.84 -8.72 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.221 -0.925 . . . . 0.0 110.136 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.546 ' H ' ' C ' ' A' ' 19' ' ' THR . 97.1 mt-10 -60.67 136.56 58.1 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.924 -1.11 . . . . 0.0 109.579 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -78.54 -39.67 37.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.23 -0.919 . . . . 0.0 109.863 -179.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -98.83 -7.78 55.01 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 -179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.77 155.72 52.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.44 -166.52 0.34 Allowed 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 122.723 2.282 . . . . 0.0 111.987 179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -101.3 90.41 4.1 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.266 -0.896 . . . . 0.0 109.318 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.9 tttp -59.99 -41.7 92.6 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.108 -0.995 . . . . 0.0 108.845 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 t -150.39 -71.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.546 -0.721 . . . . 0.0 109.153 179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.497 ' C ' ' H ' ' A' ' 31' ' ' ASN . . . -76.65 159.62 49.91 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.895 -1.282 . . . . 0.0 109.895 -179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -56.03 5.56 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 123.298 2.665 . . . . 0.0 112.834 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' H ' ' C ' ' A' ' 29' ' ' GLY . 0.4 OUTLIER 64.78 122.63 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.076 -1.015 . . . . 0.0 110.126 179.358 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.71 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.6 mp -95.92 143.48 27.08 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.234 -0.916 . . . . 0.0 109.885 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -172.51 91.47 0.11 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.412 -0.805 . . . . 0.0 109.045 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.38 6.35 74.28 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.0 tp -56.73 -20.19 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.478 -1.013 . . . . 0.0 109.609 -179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.6 m-85 -60.4 131.31 50.37 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.175 -0.953 . . . . 0.0 109.805 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.496 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 67.95 29.45 73.58 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.438 ' HD3' HE22 ' A' ' 42' ' ' GLN . 89.6 mtt180 -140.52 164.41 30.22 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.116 -1.226 . . . . 0.0 110.255 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -92.69 159.59 15.37 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.381 -0.825 . . . . 0.0 109.705 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.48 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 22.6 t -71.03 154.22 41.97 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.318 -0.864 . . . . 0.0 110.073 -179.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.88 -19.96 51.16 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 110.127 -1.189 . . . . 0.0 110.127 179.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.438 HE22 ' HD3' ' A' ' 38' ' ' ARG . 49.7 tt0 -62.54 -36.09 81.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.037 -1.272 . . . . 0.0 109.95 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -58.7 -32.74 69.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.188 -0.945 . . . . 0.0 109.716 -179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.47 ' O ' ' O ' ' A' ' 43' ' ' ALA . 95.6 mt-10 42.04 -165.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.332 -0.855 . . . . 0.0 109.374 -179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 77.17 -39.39 1.63 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 -179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.405 ' H ' ' C ' ' A' ' 44' ' ' GLU . 63.7 t80 -116.15 134.1 55.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.488 -1.007 . . . . 0.0 108.99 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.4 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 45.6 m -63.12 153.16 35.14 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.0 109.967 -179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.426 ' O ' HD11 ' A' ' 53' ' ' ILE . 66.5 m-85 -114.5 145.89 41.36 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.514 -0.741 . . . . 0.0 109.359 179.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -79.39 166.55 21.93 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.226 -0.921 . . . . 0.0 109.629 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.19 -31.7 61.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.353 -0.842 . . . . 0.0 109.771 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.596 ' HB1' ' HA ' ' A' ' 75' ' ' ILE . . . -46.67 -81.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.741 -179.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.481 ' O ' ' O ' ' A' ' 55' ' ' LYS . 23.6 t-20 -55.87 -41.33 74.23 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.12 -0.988 . . . . 0.0 110.79 -178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.426 HD11 ' O ' ' A' ' 48' ' ' TYR . 80.2 mt -59.44 -50.27 80.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.912 -1.118 . . . . 0.0 109.854 -179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.3 tttm -59.89 -36.52 77.11 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.303 -0.873 . . . . 0.0 109.238 179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 20.5 ttpp -128.01 117.43 21.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.536 -0.728 . . . . 0.0 109.338 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -103.64 136.73 42.81 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.295 -0.878 . . . . 0.0 108.932 179.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.938 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.8 p -130.06 147.32 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.498 -0.751 . . . . 0.0 110.072 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 63.3 tp -75.63 132.25 40.49 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.59 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 76.1 m95 -93.69 125.88 38.55 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.052 -1.03 . . . . 0.0 109.841 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.419 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.7 t0 -152.74 170.35 20.49 Favored 'General case' 0 C--N 1.303 -1.443 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.8 mt-10 -55.77 -39.93 71.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.765 -1.21 . . . . 0.0 109.498 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -66.19 -48.25 71.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.329 -0.857 . . . . 0.0 110.368 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -63.97 -40.41 96.35 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.397 -0.815 . . . . 0.0 110.791 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.9 mtt -60.79 -38.7 86.24 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.024 -1.047 . . . . 0.0 110.075 -179.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 30.0 m -60.75 -45.48 94.12 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.057 -1.027 . . . . 0.0 109.216 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -66.69 -33.37 75.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.306 -0.871 . . . . 0.0 108.951 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 57.8 t60 -57.76 -44.04 85.86 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.509 -0.744 . . . . 0.0 109.158 -179.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.585 HD11 HD23 ' A' ' 94' ' ' LEU . 93.3 mt -67.43 -25.38 65.89 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.549 -0.719 . . . . 0.0 109.852 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.589 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 24.5 m -85.43 131.05 34.45 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.013 -1.054 . . . . 0.0 109.836 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.444 ' C ' ' O ' ' A' ' 69' ' ' THR . 9.9 t30 38.8 56.6 5.45 Favored Pre-proline 0 N--CA 1.494 1.732 0 O-C-N 121.492 -0.755 . . . . 0.0 110.713 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -64.76 -14.75 46.58 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.773 2.315 . . . . 0.0 112.222 179.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.98 -36.19 72.25 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.176 -0.953 . . . . 0.0 109.762 -179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -84.83 3.9 35.62 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.144 -0.972 . . . . 0.0 109.04 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.938 ' OH ' HG11 ' A' ' 57' ' ' VAL . 0.3 OUTLIER -108.31 124.52 50.46 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 121.466 -0.771 . . . . 0.0 109.405 -179.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.596 ' HA ' ' HB1' ' A' ' 51' ' ' ALA . 44.7 pt 38.23 54.09 4.0 Favored Pre-proline 0 N--CA 1.495 1.797 0 O-C-N 121.463 -0.773 . . . . 0.0 110.733 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.435 ' CD ' ' N ' ' A' ' 75' ' ' ILE . 18.2 Cg_endo -61.33 -18.65 60.19 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.756 2.304 . . . . 0.0 112.249 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -90.27 21.88 29.4 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.397 -1.081 . . . . 0.0 110.397 -179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.4 p -116.03 156.01 27.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.278 -1.131 . . . . 0.0 110.043 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' C ' ' A' ' 80' ' ' MET . 22.8 mttm -60.31 -29.93 69.16 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.435 ' C ' ' O ' ' A' ' 79' ' ' LYS . 4.7 ttt -38.62 115.21 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 CA-C-O 121.43 0.633 . . . . 0.0 110.351 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -116.17 29.38 8.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.494 -0.754 . . . . 0.0 109.25 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.513 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 54.9 t80 -65.63 134.42 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.331 -0.855 . . . . 0.0 109.434 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.513 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -86.25 179.21 49.47 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -89.56 151.46 21.87 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.507 HD11 HD21 ' A' ' 9' ' ' LEU . 57.2 mt -105.07 121.34 43.58 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.308 -1.113 . . . . 0.0 109.626 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -66.74 -34.03 76.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.257 -0.902 . . . . 0.0 110.071 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.9 mmtm -84.07 116.7 23.0 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.962 . . . . 0.0 109.994 -179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.43 ' HA ' ' HE ' ' A' ' 91' ' ' ARG . 97.3 mt-10 -72.22 -35.88 69.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.371 -0.83 . . . . 0.0 109.776 179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.5 mttp -58.43 -38.74 78.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.248 -0.907 . . . . 0.0 109.687 -179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.19 -37.27 77.0 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.195 -0.941 . . . . 0.0 109.251 179.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.589 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 80.6 mtm180 -60.03 -43.02 95.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.307 -0.871 . . . . 0.0 109.877 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -57.58 -42.61 83.47 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.383 -0.823 . . . . 0.0 110.828 -178.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.532 ' OD1' ' CA ' ' A' ' 1' ' ' GLY . 75.2 m-20 -67.27 -39.92 86.12 Favored 'General case' 0 C--N 1.306 -1.3 0 O-C-N 120.812 -1.18 . . . . 0.0 109.95 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.84 HD21 ' CBB' ' A' ' 201' ' ' HEC . 55.2 tp -61.97 -45.77 92.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 0.0 110.689 -179.2 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 69.4 mt -64.58 -42.17 94.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.09 -1.006 . . . . 0.0 109.618 -179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.517 ' OG1' ' O ' ' A' ' 1' ' ' GLY . 43.8 m -62.78 -39.71 95.06 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.435 -0.79 . . . . 0.0 110.732 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . 0.589 ' CD1' ' HB2' ' A' ' 7' ' ' ALA . 84.0 t80 -60.7 -44.71 96.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.066 -1.021 . . . . 0.0 110.922 -178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.444 HD21 ' CE1' ' A' ' 10' ' ' PHE . 80.2 mt -62.79 -37.68 87.68 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.813 -1.18 . . . . 0.0 109.874 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 9.3 mtpt -58.77 -37.0 75.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.092 -1.005 . . . . 0.0 109.188 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -59.5 -42.34 91.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.265 -0.897 . . . . 0.0 109.357 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.63 -33.78 75.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.509 -0.744 . . . . 0.0 109.569 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.46 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 52.1 p -68.67 -24.66 64.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.189 -0.944 . . . . 0.0 109.569 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.496 -179.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.84 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 78.2 m . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -102.14 140.27 36.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.399 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.598 ' CD2' ' O ' ' A' ' -2' ' ' LYS . 75.8 t80 -100.71 129.52 46.62 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.318 -0.864 . . . . 0.0 109.685 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.598 ' O ' ' CD2' ' A' ' -3' ' ' PHE . 45.6 mtpt -83.24 172.57 12.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.293 -0.879 . . . . 0.0 109.303 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.468 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.09 -25.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.554 -0.716 . . . . 0.0 109.793 -179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.625 ' C ' HG21 ' A' ' 96' ' ' THR . . . 88.02 81.47 1.25 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.4 m -120.2 142.86 48.62 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.454 -1.027 . . . . 0.0 109.147 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.571 ' HB1' ' HB2' ' A' ' 7' ' ' ALA . . . -78.2 -82.46 0.09 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.097 -1.002 . . . . 0.0 109.642 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.422 ' C ' ' O ' ' A' ' 3' ' ' ALA . 47.5 tptt 42.27 -99.96 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.408 -0.808 . . . . 0.0 109.568 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.438 ' N ' ' O ' ' A' ' 3' ' ' ALA . 34.7 mttp -61.9 -42.77 99.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.175 -0.953 . . . . 0.0 109.938 -179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -59.95 -37.93 93.4 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.954 -1.258 . . . . 0.0 109.954 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.571 ' HB2' ' HB1' ' A' ' 3' ' ' ALA . . . -63.39 -51.63 65.03 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.172 -1.193 . . . . 0.0 109.785 -179.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.789 ' O ' HG23 ' A' ' 12' ' ' THR . 52.8 p -71.93 -38.18 69.91 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.269 -0.895 . . . . 0.0 109.198 179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.404 HD21 HD11 ' A' ' 85' ' ' LEU . 8.0 tp -58.35 -41.01 83.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.681 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.4 t80 -63.38 -46.8 84.77 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -62.7 -38.48 90.57 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 121.425 0.631 . . . . 0.0 110.21 -179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 8' ' ' THR . 57.5 p -71.16 -30.43 66.43 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.393 -0.817 . . . . 0.0 111.532 -178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -148.54 55.37 1.02 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.58 -1.325 . . . . 0.0 111.326 -178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -173.52 -52.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.742 -1.224 . . . . 0.0 110.871 179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.1 tp -55.61 -37.12 67.71 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.202 -0.936 . . . . 0.0 109.984 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -57.36 -34.77 69.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.033 -1.042 . . . . 0.0 109.772 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 89.3 m -98.98 -43.52 6.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.235 -0.916 . . . . 0.0 110.896 -179.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.595 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -104.16 130.02 51.91 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.16 -0.963 . . . . 0.0 110.22 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.574 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 19.6 p -91.08 -24.19 20.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.506 -0.746 . . . . 0.0 109.892 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.2 t 54.2 1.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.253 -0.904 . . . . 0.0 110.054 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.528 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.4 tt0 -98.48 124.76 43.38 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.983 -1.073 . . . . 0.0 109.534 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.9 pttt -70.9 -40.23 72.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.263 -0.898 . . . . 0.0 109.524 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -60.23 -37.65 93.3 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.58 155.99 44.04 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.484 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 63.2 Cg_endo -74.3 -156.59 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.746 2.298 . . . . 0.0 111.701 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 78.8 m-70 -104.03 132.28 50.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.239 -0.913 . . . . 0.0 109.302 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD2' HG22 ' A' ' 19' ' ' THR . 26.0 mttt -102.09 -147.96 0.37 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.455 -0.778 . . . . 0.0 109.421 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.406 ' O ' ' OH ' ' A' ' 46' ' ' TYR . 54.7 t -49.82 -41.43 17.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.894 -1.129 . . . . 0.0 109.861 -179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -117.33 159.37 14.09 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.04 152.05 67.88 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.84 2.36 . . . . 0.0 111.922 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.574 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 16.1 m120 -83.84 139.94 32.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.095 -1.003 . . . . 0.0 109.61 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.776 ' N ' HD12 ' A' ' 32' ' ' LEU . 5.3 mp -96.69 139.78 32.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.289 -0.882 . . . . 0.0 109.664 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 52.2 p-80 -173.8 92.99 0.09 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.027 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 89.9 6.77 69.22 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 108.881 -1.688 . . . . 0.0 108.881 -179.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.4 tt -58.72 -23.3 22.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.519 -0.989 . . . . 0.0 109.622 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -64.65 135.81 56.31 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.066 -1.021 . . . . 0.0 109.278 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.67 24.27 72.91 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 60.8 mmt-85 -125.31 151.28 46.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.369 -1.077 . . . . 0.0 109.386 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.543 ' O ' ' CB ' ' A' ' 40' ' ' SER . 1.9 t-160 -120.18 135.64 54.9 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.442 -0.786 . . . . 0.0 109.823 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' HIS . 0.7 OUTLIER 80.52 -176.08 0.06 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.455 -0.778 . . . . 0.0 110.149 179.497 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' ' CE2' ' A' ' 48' ' ' TYR . . . -82.65 70.26 3.21 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 -179.633 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 51.8 tt0 -59.17 -36.68 75.72 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.098 -1.236 . . . . 0.0 110.071 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.509 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -55.66 141.37 38.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.021 -1.05 . . . . 0.0 109.394 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -124.0 164.09 20.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.467 -0.771 . . . . 0.0 109.589 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 101.96 -9.8 56.77 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' OH ' ' O ' ' A' ' 28' ' ' VAL . 59.7 t80 -134.43 141.13 46.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.307 -1.113 . . . . 0.0 109.082 179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 55.6 p -71.62 159.32 34.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 109.991 -179.485 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.603 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 17.6 m-85 -119.09 147.84 43.71 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.564 -0.71 . . . . 0.0 109.52 179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.664 HG23 HBD2 ' A' ' 201' ' ' HEC . 51.8 p -79.16 159.49 27.39 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.175 -0.953 . . . . 0.0 109.299 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.39 -30.78 67.09 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.286 -0.884 . . . . 0.0 109.694 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -50.22 -75.81 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 110.721 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.483 ' O ' ' O ' ' A' ' 55' ' ' LYS . 27.4 t-20 -55.39 -42.98 74.76 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.925 -1.109 . . . . 0.0 110.687 -178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.3 mt -60.33 -49.35 84.58 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 O-C-N 120.714 -1.241 . . . . 0.0 109.271 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -60.59 -37.45 81.39 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 52' ' ' ASN . 16.4 tttt -125.4 113.24 17.27 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -103.5 143.91 32.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.357 -0.839 . . . . 0.0 109.41 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.831 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -132.43 149.47 32.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.611 -0.681 . . . . 0.0 109.841 -178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.437 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 62.1 tp -74.32 128.65 36.08 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.185 -0.947 . . . . 0.0 108.673 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.426 ' CH2' HMA2 ' A' ' 201' ' ' HEC . 97.0 m95 -95.57 123.69 39.24 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.195 -0.941 . . . . 0.0 109.966 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.528 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 48.7 p30 -161.18 -174.43 4.34 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -60.51 -42.8 97.14 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.834 -1.166 . . . . 0.0 110.22 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -70.91 -53.88 13.45 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.148 -0.97 . . . . 0.0 110.518 -179.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.528 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 37.9 t30 -59.08 -38.58 79.81 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.507 -0.746 . . . . 0.0 110.525 -179.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.437 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 7.8 mmt -58.87 -40.91 85.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.071 -1.018 . . . . 0.0 109.662 -179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.8 p -66.25 -34.82 78.87 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.28 -0.887 . . . . 0.0 109.587 179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.7 -35.7 80.75 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.176 -0.953 . . . . 0.0 109.496 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -59.04 -47.03 86.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.35 -0.844 . . . . 0.0 109.554 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.536 ' CD1' HD23 ' A' ' 94' ' ' LEU . 87.2 mt -68.54 -31.44 70.68 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.424 -0.798 . . . . 0.0 109.946 179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.8 m -58.61 -37.89 76.83 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.087 -1.008 . . . . 0.0 110.918 -178.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.5 m120 -162.75 67.02 1.8 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 120.901 -1.124 . . . . 0.0 110.074 -179.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -51.49 -19.34 6.94 Favored 'Trans proline' 0 C--N 1.302 -1.915 0 C-N-CA 122.977 2.451 . . . . 0.0 112.42 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.35 -80.85 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.214 -0.929 . . . . 0.0 110.407 -179.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -56.67 -34.26 67.19 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.183 -0.948 . . . . 0.0 109.56 -179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.831 ' OH ' HG11 ' A' ' 57' ' ' VAL . 65.6 t80 -55.22 -51.04 67.85 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.378 -0.826 . . . . 0.0 109.534 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.729 ' O ' HG22 ' A' ' 75' ' ' ILE . 17.3 mt -147.66 80.14 9.14 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.281 -0.887 . . . . 0.0 108.729 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -83.79 149.52 12.58 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.924 2.416 . . . . 0.0 112.255 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 100.14 0.46 55.98 Favored Glycine 0 N--CA 1.49 2.26 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.41 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.522 HG23 ' H ' ' A' ' 80' ' ' MET . 9.9 t -100.57 171.25 7.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.616 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -84.65 9.37 13.99 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.274 -0.892 . . . . 0.0 110.484 -178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.522 ' H ' HG23 ' A' ' 78' ' ' THR . 3.1 mtm -73.83 119.68 18.37 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.891 -1.131 . . . . 0.0 110.011 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -108.13 26.97 9.75 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 59.3 t80 -76.5 133.05 39.88 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.572 -0.705 . . . . 0.0 109.504 -179.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.9 175.57 50.37 Favored Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -92.71 147.01 18.43 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.793 -1.323 . . . . 0.0 109.793 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.404 HD11 HD21 ' A' ' 9' ' ' LEU . 54.1 mt -99.71 134.82 42.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -1.155 . . . . 0.0 109.261 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -92.04 -4.43 54.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -100.93 127.59 47.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.075 -1.016 . . . . 0.0 109.929 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.61 -38.23 48.52 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.551 -0.718 . . . . 0.0 110.132 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -60.41 -48.79 80.23 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.232 -0.918 . . . . 0.0 110.251 -179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -64.54 -40.23 95.22 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.19 -0.943 . . . . 0.0 109.682 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.4 ttm180 -59.93 -41.73 92.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.411 -0.806 . . . . 0.0 110.104 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.409 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.7 m-20 -61.02 -39.8 91.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.134 -0.979 . . . . 0.0 110.302 -179.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 91.1 m-20 -62.05 -40.73 96.73 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.101 -0.999 . . . . 0.0 109.904 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.66 HD21 ' CBB' ' A' ' 201' ' ' HEC . 55.3 tp -61.22 -43.88 98.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.141 -0.974 . . . . 0.0 110.221 -179.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 77.8 mt -64.57 -42.96 96.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.116 -0.99 . . . . 0.0 109.806 -179.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.625 HG21 ' C ' ' A' ' 1' ' ' GLY . 26.7 m -62.38 -37.75 86.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.379 -0.825 . . . . 0.0 110.27 -179.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -57.55 -46.97 83.28 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.952 -1.092 . . . . 0.0 110.304 -179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.666 HD21 ' CE1' ' A' ' 10' ' ' PHE . 74.4 mt -65.29 -38.38 90.06 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.933 -1.104 . . . . 0.0 109.616 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -60.59 -36.65 79.05 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.227 -0.921 . . . . 0.0 109.342 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.9 tttp -59.05 -42.96 91.55 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.323 -0.861 . . . . 0.0 109.436 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.21 79.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.504 -0.747 . . . . 0.0 109.415 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 54.0 p -70.73 -23.5 62.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.337 -0.852 . . . . 0.0 109.561 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.231 -0.918 . . . . 0.0 109.465 -179.91 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.666 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.291 0.567 . . . . 0.0 109.565 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.78 -33.41 74.05 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.276 -0.89 . . . . 0.0 109.502 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.52 ' CE1' ' O ' ' A' ' -2' ' ' LYS . 52.2 t80 -101.98 131.24 48.51 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.194 -0.941 . . . . 0.0 109.575 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.52 ' O ' ' CE1' ' A' ' -3' ' ' PHE . 12.8 ptmt -104.18 161.6 13.89 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.332 -0.855 . . . . 0.0 109.23 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -56.22 126.12 24.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.235 -0.916 . . . . 0.0 109.514 -179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . -138.73 164.25 25.75 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 32.2 t -110.92 131.14 55.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.326 -1.102 . . . . 0.0 109.295 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.473 ' CB ' ' NZ ' ' A' ' 100' ' ' LYS . . . -74.48 -18.27 60.64 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.327 -0.858 . . . . 0.0 110.042 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.5 tptt -57.52 -48.46 79.21 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.061 -1.024 . . . . 0.0 109.969 -179.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -67.02 -51.92 48.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.926 -1.109 . . . . 0.0 109.748 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -65.35 -30.67 78.23 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.444 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.42 -45.7 87.94 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -1.199 . . . . 0.0 110.054 -179.218 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.916 ' O ' HG23 ' A' ' 12' ' ' THR . 59.6 p -72.71 -37.33 67.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.133 -0.979 . . . . 0.0 109.534 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.662 HD23 HD22 ' A' ' 94' ' ' LEU . 6.9 tp -58.92 -41.63 87.73 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.674 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.5 t80 -62.78 -46.74 86.63 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -63.6 -38.27 90.49 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.421 0.629 . . . . 0.0 110.079 179.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.916 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.47 -34.99 75.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.468 -0.77 . . . . 0.0 111.61 -178.234 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 37.8 mtp180 -149.94 58.17 0.98 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.525 -1.36 . . . . 0.0 111.356 -178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.6 t -172.97 -48.6 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.834 -1.166 . . . . 0.0 110.153 179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.6 tp -56.89 -37.22 71.09 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.197 -0.94 . . . . 0.0 109.6 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -57.39 -34.63 69.08 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.201 -0.937 . . . . 0.0 109.547 -179.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 85.1 m -96.5 -44.21 7.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 110.695 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.637 ' ND1' HD11 ' A' ' 32' ' ' LEU . 89.6 m-70 -105.81 124.8 50.15 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.182 -0.949 . . . . 0.0 110.243 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.554 ' OG1' ' ND2' ' A' ' 31' ' ' ASN . 53.1 p -84.3 -27.06 28.08 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.347 -0.845 . . . . 0.0 109.695 179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG23 ' C ' ' A' ' 19' ' ' THR . 1.9 t 64.22 -7.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.238 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.481 ' H ' ' C ' ' A' ' 19' ' ' THR . 78.2 mm-40 -92.48 120.98 33.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.89 -1.131 . . . . 0.0 109.622 -179.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.401 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 55.2 pttt -69.96 -39.99 75.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.265 -0.897 . . . . 0.0 109.474 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.401 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.4 -36.76 90.43 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -75.43 157.25 49.33 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.495 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 59.1 Cg_endo -73.02 -156.69 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.681 2.254 . . . . 0.0 111.705 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.1 m-70 -105.27 134.57 48.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.297 -0.877 . . . . 0.0 109.37 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 29' ' ' GLY . 36.2 tttt -130.46 127.01 38.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.466 -0.771 . . . . 0.0 109.079 179.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 29' ' ' GLY . 49.4 t 53.42 -84.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.29 -0.881 . . . . 0.0 109.299 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 27' ' ' LYS . . . -100.44 161.76 18.91 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -62.0 152.69 73.71 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.979 2.453 . . . . 0.0 112.203 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.554 ' ND2' ' OG1' ' A' ' 19' ' ' THR . 13.1 m120 -81.71 140.52 34.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.944 . . . . 0.0 109.277 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.69 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.2 mp -98.05 139.41 33.91 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.142 -0.974 . . . . 0.0 109.813 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.2 t60 -172.0 95.89 0.16 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 0.0 109.204 179.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.68 7.02 75.85 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.065 -1.614 . . . . 0.0 109.065 -179.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.0 tt -58.54 -23.77 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.294 -1.121 . . . . 0.0 109.565 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.525 ' CD1' HG21 ' A' ' 102' ' ' THR . 96.2 m-85 -70.41 132.11 45.1 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.212 -0.93 . . . . 0.0 109.58 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 75.13 20.33 79.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.678 ' CZ ' HE21 ' A' ' 42' ' ' GLN . 31.0 mtp180 -140.85 167.0 23.22 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.185 -1.186 . . . . 0.0 110.015 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.1 m80 -93.72 156.73 16.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.336 -0.852 . . . . 0.0 109.861 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.589 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 24.9 p -66.15 167.1 10.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.39 -0.819 . . . . 0.0 109.684 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.5 -8.14 61.97 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.678 HE21 ' CZ ' ' A' ' 38' ' ' ARG . 38.9 tt0 -61.58 -38.3 87.01 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.315 -1.109 . . . . 0.0 109.852 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.676 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.94 75.08 0.47 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.625 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -63.42 -31.76 73.0 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.331 -0.856 . . . . 0.0 109.387 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -55.47 -35.81 62.31 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.941 -1.263 . . . . 0.0 109.941 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.417 ' CD2' ' O ' ' A' ' 47' ' ' SER . 54.9 t80 -112.29 131.99 55.2 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.394 -1.063 . . . . 0.0 109.302 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 50.9 m -67.65 156.77 36.08 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.307 -0.871 . . . . 0.0 109.865 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.676 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 55.4 m-85 -111.21 145.39 38.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.476 -0.765 . . . . 0.0 109.521 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.6 p -75.74 161.65 28.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.254 -0.904 . . . . 0.0 109.377 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.67 -34.66 67.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.253 -0.905 . . . . 0.0 109.762 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.487 ' HB2' ' HA3' ' A' ' 77' ' ' GLY . . . -48.08 -72.58 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.204 -0.935 . . . . 0.0 110.329 -179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.484 ' O ' ' N ' ' A' ' 56' ' ' ASN . 22.2 t-20 -52.62 -41.62 63.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.032 -1.042 . . . . 0.0 110.305 -179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 86.9 mt -59.02 -55.59 22.52 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 120.959 -1.088 . . . . 0.0 109.325 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 31.9 mttm -64.18 -36.69 84.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.369 -0.832 . . . . 0.0 109.296 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.424 ' O ' ' C ' ' A' ' 56' ' ' ASN . 43.7 tttm -102.33 33.34 3.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.427 -0.796 . . . . 0.0 109.295 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.589 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -46.69 131.55 11.44 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 120.848 -1.157 . . . . 0.0 108.694 -179.404 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.927 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.6 p -133.79 150.53 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.374 -0.829 . . . . 0.0 110.251 -178.793 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 61.2 tp -76.47 130.61 38.21 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.488 ' CH2' HMA2 ' A' ' 201' ' ' HEC . 97.5 m95 -97.24 123.23 40.97 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.126 -0.984 . . . . 0.0 110.274 -179.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 56.2 p30 -149.59 176.28 10.78 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 179.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -59.82 -40.46 88.5 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.061 -1.024 . . . . 0.0 111.004 -178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t30 -72.29 -57.2 4.41 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.953 -1.092 . . . . 0.0 110.646 -179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.587 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.7 t30 -60.46 -39.66 88.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.411 -0.805 . . . . 0.0 110.799 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.413 ' SD ' ' CE3' ' A' ' 59' ' ' TRP . 42.8 tpp -59.15 -39.49 82.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.088 -1.008 . . . . 0.0 109.745 -179.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.515 ' OG ' ' CD1' ' A' ' 95' ' ' ILE . 19.1 m -60.76 -40.68 93.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.253 -0.905 . . . . 0.0 109.87 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.72 -33.54 74.21 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.147 -0.971 . . . . 0.0 109.692 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.575 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 77.9 t60 -61.26 -48.0 83.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 110.476 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.596 ' CD2' HD23 ' A' ' 94' ' ' LEU . 6.8 mp -57.81 -31.09 66.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.17 -0.956 . . . . 0.0 109.754 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.539 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 23.5 m -84.99 125.03 32.37 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 120.979 -1.076 . . . . 0.0 109.225 179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 69' ' ' THR . 12.5 m120 41.75 59.6 9.29 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.273 -0.892 . . . . 0.0 110.685 179.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -65.69 -21.32 58.94 Favored 'Trans proline' 0 N--CA 1.497 1.708 0 C-N-CA 122.808 2.339 . . . . 0.0 112.636 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.72 -59.1 5.52 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.12 -0.987 . . . . 0.0 109.981 -179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -62.25 -32.52 73.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.25 -0.907 . . . . 0.0 109.515 179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.927 ' OH ' HG11 ' A' ' 57' ' ' VAL . 66.8 t80 -57.75 -48.73 78.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 110.51 -179.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.807 HG23 ' O ' ' A' ' 75' ' ' ILE . 2.7 tp -163.23 79.9 1.64 Allowed Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 120.983 -1.073 . . . . 0.0 109.265 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -80.89 -21.25 7.04 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.823 2.349 . . . . 0.0 112.769 -179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 51' ' ' ALA . . . -56.55 -27.23 54.1 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 -179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 30.3 p -77.49 163.06 26.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.156 -1.203 . . . . 0.0 110.068 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.0 mttm -78.47 5.36 10.93 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 11.0 ttt -79.7 141.92 35.96 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.507 -0.746 . . . . 0.0 111.145 -178.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -147.79 85.73 1.57 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.844 -0.798 . . . . 0.0 108.844 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.536 ' CE2' ' O ' ' A' ' 83' ' ' GLY . 81.7 t80 -103.36 134.89 45.98 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.403 -0.81 . . . . 0.0 110.094 -179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.536 ' O ' ' CE2' ' A' ' 82' ' ' PHE . . . -72.63 142.02 31.68 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -71.69 152.47 49.19 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.533 HD11 HD21 ' A' ' 9' ' ' LEU . 56.8 mt -97.23 125.2 41.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.075 -1.25 . . . . 0.0 109.477 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.2 ttpm? -64.31 -39.75 94.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.396 -0.815 . . . . 0.0 110.417 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.35 128.42 35.5 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.984 -1.072 . . . . 0.0 110.337 -179.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.15 -34.72 61.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.515 -0.741 . . . . 0.0 109.939 179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -58.22 -45.35 87.85 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.152 -0.968 . . . . 0.0 109.938 -179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -61.91 -38.66 89.23 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.128 -0.982 . . . . 0.0 108.898 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.539 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 58.7 ttp180 -59.06 -41.39 87.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.497 -0.752 . . . . 0.0 110.152 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.41 ' OD1' ' CE2' ' A' ' -3' ' ' PHE . 53.2 t30 -59.12 -41.86 89.19 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.0 110.17 -179.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 89.1 m-20 -62.4 -39.8 94.42 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.043 -1.036 . . . . 0.0 109.964 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.762 HD21 ' CBB' ' A' ' 201' ' ' HEC . 51.9 tp -59.0 -43.61 91.51 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.873 -179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.515 ' CD1' ' OG ' ' A' ' 65' ' ' SER . 85.0 mt -64.65 -37.17 79.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.006 . . . . 0.0 109.24 179.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.2 m -59.52 -40.65 87.83 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.459 -0.775 . . . . 0.0 109.94 -179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -60.94 -46.9 88.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.052 . . . . 0.0 110.644 -179.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.665 ' O ' HG23 ' A' ' 102' ' ' THR . 89.3 mt -67.05 -38.45 85.86 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.953 -1.092 . . . . 0.0 110.318 -179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.406 ' NZ ' ' CB ' ' A' ' 99' ' ' LYS . 9.7 mtpm? -58.3 -40.54 82.23 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.002 -1.061 . . . . 0.0 109.732 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.473 ' NZ ' ' CB ' ' A' ' 3' ' ' ALA . 99.2 mttt -61.64 -45.43 94.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 0.0 109.667 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.52 -33.03 73.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.508 -0.745 . . . . 0.0 109.534 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 98' ' ' LEU . 50.2 p -69.63 -21.14 63.58 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.322 -0.861 . . . . 0.0 109.551 179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.222 -0.924 . . . . 0.0 109.421 179.937 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.762 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . 0.51 ' O ' ' O ' ' A' ' -4' ' ' GLU . 16.9 p . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . 0.51 ' O ' ' O ' ' A' ' -5' ' ' THR . 84.2 tt0 57.29 150.63 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.388 -0.82 . . . . 0.0 109.793 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -128.91 166.29 19.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.39 -0.819 . . . . 0.0 109.566 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.528 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.9 ttpt -63.31 128.15 34.52 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.197 -0.939 . . . . 0.0 110.301 -179.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.457 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.26 94.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.304 -0.872 . . . . 0.0 109.608 179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -92.41 152.38 21.15 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.443 ' O ' ' CG ' ' A' ' 93' ' ' ASP . 53.5 p -69.29 155.51 40.31 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.287 -1.125 . . . . 0.0 109.261 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -100.38 -10.08 21.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.192 -0.942 . . . . 0.0 109.785 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -59.22 -49.48 77.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -0.991 . . . . 0.0 109.857 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -65.01 -46.8 79.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.179 -0.951 . . . . 0.0 109.387 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.489 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.38 -30.87 79.04 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.32 -46.17 89.33 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.203 -1.175 . . . . 0.0 109.891 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.848 ' O ' HG23 ' A' ' 12' ' ' THR . 51.9 p -72.44 -38.74 68.23 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.154 -0.966 . . . . 0.0 109.369 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.481 HD23 HD22 ' A' ' 94' ' ' LEU . 9.0 tp -59.2 -40.9 87.21 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.667 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 66.8 t80 -62.86 -46.7 86.65 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 22.1 tttt -63.14 -38.89 92.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.669 -0.645 . . . . 0.0 109.955 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.848 HG23 ' O ' ' A' ' 8' ' ' THR . 53.0 p -69.97 -33.12 71.68 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.368 -0.833 . . . . 0.0 111.453 -178.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -148.77 57.62 1.04 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.571 -1.331 . . . . 0.0 111.14 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.667 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.2 t -172.56 -53.08 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.854 -1.153 . . . . 0.0 110.28 179.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.7 tp -57.09 -37.63 72.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.014 -1.054 . . . . 0.0 109.811 -179.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -58.33 -35.28 71.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 0.0 109.862 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 91.2 m -96.96 -43.42 7.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.199 -0.938 . . . . 0.0 110.618 -179.432 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.433 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 90.6 m-70 -106.0 125.34 50.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 0.0 110.138 -178.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.446 ' O ' ' C ' ' A' ' 20' ' ' VAL . 52.4 p -89.52 -20.66 23.55 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.201 -0.937 . . . . 0.0 109.47 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.654 HG13 ' O ' ' A' ' 32' ' ' LEU . 8.0 t 40.97 69.1 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.321 -0.862 . . . . 0.0 109.696 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -115.17 155.17 27.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.434 -0.791 . . . . 0.0 109.529 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -61.7 -35.72 78.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 0.0 109.576 179.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -152.29 20.96 0.84 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -70.3 166.49 50.6 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -70.62 -177.82 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 C-N-CA 122.96 2.44 . . . . 0.0 112.12 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -106.34 136.7 45.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.393 -0.817 . . . . 0.0 109.263 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -105.78 -127.97 0.25 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.301 -0.874 . . . . 0.0 109.333 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.6 t -63.27 -39.71 86.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.081 -1.012 . . . . 0.0 109.565 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -123.83 165.21 16.73 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.354 -1.498 . . . . 0.0 109.354 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.433 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 27.5 Cg_endo -63.69 150.46 88.4 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 C-N-CA 122.843 2.362 . . . . 0.0 112.001 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.426 ' C ' HD12 ' A' ' 32' ' ' LEU . 8.7 m120 -80.64 138.63 36.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.073 -1.017 . . . . 0.0 109.268 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.733 ' N ' HD12 ' A' ' 32' ' ' LEU . 6.9 mp -97.89 137.48 36.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.134 -0.979 . . . . 0.0 109.888 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -166.35 100.24 0.61 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.423 -0.798 . . . . 0.0 108.991 179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 86.06 7.89 79.74 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 108.864 -1.694 . . . . 0.0 108.864 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.6 tt -59.5 -22.41 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.555 -0.968 . . . . 0.0 109.716 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.659 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 78.7 m-85 -66.15 133.58 50.98 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.23 -0.919 . . . . 0.0 109.668 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.03 19.51 78.44 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' CD ' HE22 ' A' ' 42' ' ' GLN . 32.8 mmt180 -135.66 163.29 30.48 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.325 -1.103 . . . . 0.0 109.826 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -90.17 161.53 15.7 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.386 -0.821 . . . . 0.0 109.514 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.495 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 24.8 t -63.17 148.71 47.25 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.357 -0.84 . . . . 0.0 109.787 -179.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.6 -10.07 62.65 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.409 HE22 ' CD ' ' A' ' 38' ' ' ARG . 52.6 tt0 -61.39 -38.35 86.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.006 -1.291 . . . . 0.0 109.722 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -61.55 -30.51 70.7 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.136 -0.977 . . . . 0.0 109.47 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 49.96 177.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.364 -0.835 . . . . 0.0 109.287 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.483 ' O ' ' C ' ' A' ' 46' ' ' TYR . . . 80.61 -165.3 47.88 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.281 -1.528 . . . . 0.0 109.281 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.483 ' C ' ' O ' ' A' ' 45' ' ' GLY . 33.3 t80 37.07 -127.77 0.16 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.611 -0.935 . . . . 0.0 109.749 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.441 ' N ' ' CG ' ' A' ' 46' ' ' TYR . 30.1 t -158.44 146.14 18.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.257 -0.902 . . . . 0.0 109.5 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -114.57 138.75 50.25 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.48 -0.762 . . . . 0.0 109.343 179.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.418 ' OG1' HG22 ' A' ' 78' ' ' THR . 41.9 p -79.85 162.54 24.99 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.895 -179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.21 -32.73 68.57 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.528 -0.733 . . . . 0.0 110.071 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.468 ' HB3' ' CG2' ' A' ' 78' ' ' THR . . . -51.59 -75.11 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.045 -1.034 . . . . 0.0 110.487 -179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.495 ' O ' ' O ' ' A' ' 55' ' ' LYS . 26.2 t-20 -54.0 -41.65 68.19 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.933 -1.105 . . . . 0.0 110.319 -179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.05 -51.04 77.58 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 120.78 -1.2 . . . . 0.0 109.53 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.9 tttp -61.0 -38.57 86.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 108.951 179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' O ' ' O ' ' A' ' 52' ' ' ASN . 85.7 tttt -117.96 110.43 17.7 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -98.44 138.77 35.18 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.228 -0.92 . . . . 0.0 109.084 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.743 HG11 ' OH ' ' A' ' 74' ' ' TYR . 10.6 p -130.39 147.03 33.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.565 -0.71 . . . . 0.0 109.948 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 62.1 tp -78.77 131.92 36.72 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.59 ' CZ2' HMA2 ' A' ' 201' ' ' HEC . 88.6 m95 -95.5 124.71 39.66 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.217 -0.927 . . . . 0.0 110.101 -179.674 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.46 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.5 t0 -152.66 166.52 31.87 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.562 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.6 mt-10 -55.17 -39.7 69.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.69 -1.256 . . . . 0.0 109.217 -179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -69.51 -47.97 62.07 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.243 -0.91 . . . . 0.0 110.27 179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -61.31 -40.71 95.2 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.38 -0.825 . . . . 0.0 110.712 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.659 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.5 mtt -60.21 -36.79 78.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.002 -1.061 . . . . 0.0 109.686 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -59.5 -42.97 93.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.988 . . . . 0.0 109.156 179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.18 -34.5 76.41 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.204 -0.935 . . . . 0.0 109.27 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.563 ' ND1' ' CD2' ' A' ' 74' ' ' TYR . 81.9 t60 -58.03 -45.46 86.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.541 ' CD1' HD23 ' A' ' 94' ' ' LEU . 79.9 mt -68.1 -29.88 68.91 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.419 -0.801 . . . . 0.0 110.212 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 70' ' ' ASN . 29.1 m -57.68 -38.12 74.6 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.042 -1.036 . . . . 0.0 110.528 -179.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.43 ' CG ' ' O ' ' A' ' 69' ' ' THR . 15.9 m120 -163.45 67.73 1.67 Allowed Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 120.942 -1.099 . . . . 0.0 109.795 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -51.92 -27.74 29.04 Favored 'Trans proline' 0 C--N 1.303 -1.836 0 C-N-CA 122.975 2.45 . . . . 0.0 112.705 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -62.38 1.84 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.026 -1.046 . . . . 0.0 109.527 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -61.42 -29.88 70.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.246 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.743 ' OH ' HG11 ' A' ' 57' ' ' VAL . 40.4 t80 -58.46 -49.36 77.61 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.464 -0.773 . . . . 0.0 109.858 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.482 HG23 ' HD2' ' A' ' 74' ' ' TYR . 7.9 pt -139.9 75.48 30.13 Favored Pre-proline 0 N--CA 1.499 1.991 0 O-C-N 121.012 -1.055 . . . . 0.0 110.046 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -66.24 138.55 51.76 Favored 'Trans proline' 0 C--N 1.299 -2.064 0 C-N-CA 122.919 2.413 . . . . 0.0 112.576 179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 97.41 -6.81 63.49 Favored Glycine 0 N--CA 1.492 2.391 0 C-N-CA 120.094 -1.05 . . . . 0.0 110.89 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.468 ' CG2' ' HB3' ' A' ' 51' ' ' ALA . 71.5 p -88.64 164.06 15.52 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.879 -1.365 . . . . 0.0 110.415 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 24.2 mtmt -85.12 2.02 45.34 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.577 -0.702 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 10.9 ttt -81.77 127.74 33.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.244 -0.91 . . . . 0.0 109.951 -179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -130.93 87.08 2.44 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.352 -0.842 . . . . 0.0 109.344 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 69.7 t80 -103.34 131.55 50.31 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.392 -0.818 . . . . 0.0 109.335 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.476 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -67.87 142.78 40.58 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -76.63 145.34 31.39 Favored Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.444 HD11 HD21 ' A' ' 9' ' ' LEU . 55.0 mt -98.81 134.21 42.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -1.172 . . . . 0.0 109.468 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.7 mtmt -93.76 -5.81 47.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.947 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.6 tttt -110.32 119.27 38.69 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.189 -0.944 . . . . 0.0 109.478 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.92 -33.57 73.97 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.425 -0.797 . . . . 0.0 110.446 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.1 tttt -57.88 -56.27 24.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.037 -1.04 . . . . 0.0 110.018 -178.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -62.36 -38.9 91.32 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.276 -0.89 . . . . 0.0 109.57 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 39.3 ttm180 -58.65 -42.19 87.77 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.341 -0.85 . . . . 0.0 109.865 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 83.7 m-20 -60.95 -39.14 88.37 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.168 -0.957 . . . . 0.0 110.385 -179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.489 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 83.8 m-20 -62.29 -38.44 89.38 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.108 -0.995 . . . . 0.0 110.102 -179.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.737 HD21 ' CBB' ' A' ' 201' ' ' HEC . 56.1 tp -59.76 -45.17 93.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.084 -1.01 . . . . 0.0 110.383 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 59.8 mt -66.4 -40.84 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.993 -1.067 . . . . 0.0 108.85 179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 26.1 m -59.11 -39.01 80.92 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.512 -0.742 . . . . 0.0 110.004 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.48 -52.2 66.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.946 -1.096 . . . . 0.0 109.424 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.546 HD21 ' CE1' ' A' ' 10' ' ' PHE . 87.0 mt -66.53 -32.94 74.6 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.067 -1.021 . . . . 0.0 108.401 178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.562 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 19.1 tttp -56.65 -42.25 78.59 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 18.5 tptm -60.38 -39.08 85.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.493 -0.755 . . . . 0.0 109.328 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -58.77 -31.19 68.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.518 -0.739 . . . . 0.0 109.554 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.1 p -67.33 -23.9 65.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 0.0 109.459 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.155 -0.966 . . . . 0.0 109.509 179.964 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.737 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -57.64 145.2 34.84 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.284 -0.885 . . . . 0.0 109.435 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.585 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 68.0 t80 -97.28 128.86 44.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.255 -0.903 . . . . 0.0 109.563 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.591 ' O ' ' N ' ' A' ' 1' ' ' GLY . 44.3 mtpt -87.65 172.35 9.78 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.324 -0.86 . . . . 0.0 109.223 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.466 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -40.57 -22.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.271 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 78.08 81.29 0.66 Allowed Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.51 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 49.4 p -72.14 166.76 21.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.19 -1.182 . . . . 0.0 108.738 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -130.04 21.23 5.36 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.362 -0.836 . . . . 0.0 109.781 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 34.4 ttpt -92.53 -70.98 0.67 Allowed 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.255 -0.903 . . . . 0.0 109.725 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -63.86 -45.22 90.45 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 0.0 110.247 -179.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.669 ' H ' ' CG ' ' A' ' 93' ' ' ASP . . . -60.3 -39.39 96.01 Favored Glycine 0 N--CA 1.49 2.238 0 C-N-CA 119.997 -1.097 . . . . 0.0 110.359 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.74 -50.31 71.6 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.174 -1.192 . . . . 0.0 109.948 -179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.812 ' O ' HG23 ' A' ' 12' ' ' THR . 53.5 p -74.46 -35.37 63.31 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.243 -0.911 . . . . 0.0 109.658 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.596 HD21 HD11 ' A' ' 85' ' ' LEU . 7.3 tp -57.28 -40.86 78.61 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.662 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 64.4 t80 -62.88 -46.84 85.98 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 18.9 tttt -63.95 -39.18 93.57 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.742 -0.599 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.812 HG23 ' O ' ' A' ' 8' ' ' THR . 57.4 p -68.8 -35.01 76.49 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.473 -0.767 . . . . 0.0 111.495 -178.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 70.4 mtt85 -151.77 60.53 0.87 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.628 -1.295 . . . . 0.0 110.876 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.662 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -172.84 -47.52 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 0.0 109.625 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.8 tp -59.48 -37.15 77.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.29 -0.881 . . . . 0.0 109.7 -179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -58.54 -37.74 76.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.12 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 87.3 m -93.5 -40.85 10.1 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.129 -0.982 . . . . 0.0 110.17 -179.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.554 ' ND1' HD11 ' A' ' 32' ' ' LEU . 88.4 m-70 -106.91 132.89 52.35 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.397 -0.815 . . . . 0.0 110.099 -178.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.491 ' O ' ' N ' ' A' ' 21' ' ' GLU . 30.0 p -103.41 -4.33 24.25 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.398 -0.814 . . . . 0.0 109.478 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.448 ' HA ' ' H ' ' A' ' 32' ' ' LEU . 2.8 t 45.99 16.78 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 109.999 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' N ' ' O ' ' A' ' 19' ' ' THR . 85.0 tt0 -104.27 137.3 42.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.176 -0.952 . . . . 0.0 109.465 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.1 ttpt -76.83 -88.49 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.284 -0.885 . . . . 0.0 109.891 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 24' ' ' GLY . . . -51.37 -17.01 2.55 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.488 ' O ' ' O ' ' A' ' 23' ' ' GLY . . . -41.18 164.93 0.01 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 -179.79 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -63.16 -12.31 29.44 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.274 2.649 . . . . 0.0 112.084 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.614 ' CE1' ' H ' ' A' ' 31' ' ' ASN . 2.1 m-70 60.97 97.69 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.445 -0.784 . . . . 0.0 109.237 -179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' HG3' HG21 ' A' ' 19' ' ' THR . 51.5 mttm -74.6 -167.8 0.61 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.317 -0.864 . . . . 0.0 110.017 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.636 ' CG1' ' NZ ' ' A' ' 79' ' ' LYS . 55.9 t -50.49 -45.95 26.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.296 -0.878 . . . . 0.0 109.989 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.53 149.2 22.45 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -63.86 148.54 91.8 Favored 'Trans proline' 0 N--CA 1.493 1.458 0 C-N-CA 122.392 2.062 . . . . 0.0 111.741 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.614 ' H ' ' CE1' ' A' ' 26' ' ' HIS . 2.8 m120 -84.35 138.73 32.72 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.997 -1.065 . . . . 0.0 109.48 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.6 mp -93.76 140.45 29.64 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.633 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.583 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 49.5 p-80 -174.07 90.43 0.07 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.415 -0.803 . . . . 0.0 109.102 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.588 ' O ' ' NH1' ' A' ' 38' ' ' ARG . . . 92.58 4.79 65.49 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.062 -1.615 . . . . 0.0 109.062 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.9 tt -58.19 -22.58 19.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.278 -1.131 . . . . 0.0 109.557 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.665 ' CE1' ' SD ' ' A' ' 64' ' ' MET . 82.1 m-85 -65.62 133.99 52.32 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.159 -0.963 . . . . 0.0 109.652 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 73.15 25.81 72.37 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.821 -1.312 . . . . 0.0 109.821 179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.588 ' NH1' ' O ' ' A' ' 34' ' ' GLY . 68.0 mtt85 -145.75 168.75 19.97 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -1.224 . . . . 0.0 110.247 -179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.443 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.8 m80 -97.89 157.5 16.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.373 -0.829 . . . . 0.0 110.119 -179.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.567 ' HG ' ' HE1' ' A' ' 59' ' ' TRP . 2.6 m -61.33 163.91 6.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.474 -0.766 . . . . 0.0 109.662 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.07 -6.08 59.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.464 HE22 ' HD2' ' A' ' 38' ' ' ARG . 39.6 tt0 -62.14 -38.94 90.9 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.192 -1.181 . . . . 0.0 110.101 -179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.636 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -69.93 77.2 0.48 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.108 -0.995 . . . . 0.0 109.57 -179.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.34 -33.05 74.69 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.502 -0.749 . . . . 0.0 109.328 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -57.14 -35.08 68.26 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.509 ' CD2' ' O ' ' A' ' 47' ' ' SER . 65.7 t80 -113.36 135.1 54.23 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.407 -1.055 . . . . 0.0 109.385 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.509 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 57.4 p -72.61 162.35 29.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.21 -0.931 . . . . 0.0 109.93 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.636 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 60.8 m-85 -114.41 148.17 38.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.515 -0.741 . . . . 0.0 109.599 179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 48.2 p -75.26 160.65 30.11 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 109.29 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -56.6 -35.43 68.25 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.266 -0.896 . . . . 0.0 109.788 -179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.648 ' HB2' ' O ' ' A' ' 76' ' ' PRO . . . -46.56 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.269 -0.894 . . . . 0.0 110.4 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 56' ' ' ASN . 27.3 t-20 -52.21 -41.94 63.12 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.038 -1.039 . . . . 0.0 110.538 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 93.6 mt -57.59 -53.44 44.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 O-C-N 120.843 -1.161 . . . . 0.0 109.416 -179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -62.88 -38.79 92.3 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.319 -0.863 . . . . 0.0 109.259 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.437 ' O ' ' C ' ' A' ' 56' ' ' ASN . 68.7 mttm -101.64 28.65 5.42 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.828 . . . . 0.0 109.886 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.552 ' N ' ' O ' ' A' ' 52' ' ' ASN . 2.6 t-20 -43.88 127.55 5.24 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.125 -0.984 . . . . 0.0 108.946 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.898 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.4 p -135.18 153.2 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.375 -0.828 . . . . 0.0 110.333 -178.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.443 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -70.46 136.0 49.12 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.598 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 78.8 m95 -97.75 126.59 43.17 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.231 -0.918 . . . . 0.0 110.34 -179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.438 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.9 t0 -150.9 163.82 37.77 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.543 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.5 mt-10 -54.82 -39.77 68.87 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.868 -1.145 . . . . 0.0 109.376 -179.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -68.51 -47.66 66.4 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.079 -1.013 . . . . 0.0 110.251 179.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -61.24 -39.78 91.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.396 -0.815 . . . . 0.0 110.652 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.665 ' SD ' ' CE1' ' A' ' 36' ' ' PHE . 62.1 mtt -59.89 -37.96 80.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 109.807 -179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 34.5 m -58.98 -41.45 87.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.034 -1.041 . . . . 0.0 109.075 179.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -68.84 -32.77 72.7 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.227 -0.921 . . . . 0.0 109.699 179.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.446 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 77.1 t60 -56.87 -48.88 77.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.419 -0.801 . . . . 0.0 110.279 -179.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.681 ' CD2' HD23 ' A' ' 94' ' ' LEU . 9.4 mp -73.61 -20.79 60.5 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.293 -0.88 . . . . 0.0 110.362 -179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 31.2 m -57.76 -36.41 72.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 120.687 -1.258 . . . . 0.0 109.307 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.92 68.23 3.33 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.206 -0.934 . . . . 0.0 109.945 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -64.3 -18.7 64.16 Favored 'Trans proline' 0 N--CA 1.496 1.641 0 C-N-CA 122.577 2.185 . . . . 0.0 113.031 -179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.64 -51.18 69.55 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.022 -1.049 . . . . 0.0 110.421 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 mttm -94.38 -5.36 46.62 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.994 -1.066 . . . . 0.0 110.192 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.898 ' OH ' HG11 ' A' ' 57' ' ' VAL . 28.0 t80 -63.84 -46.1 86.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.141 -0.974 . . . . 0.0 109.643 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.921 HD12 HG21 ' A' ' 78' ' ' THR . 1.8 pt -136.96 72.88 53.72 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.188 -0.945 . . . . 0.0 109.923 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.648 ' O ' ' HB2' ' A' ' 51' ' ' ALA . 18.2 Cg_exo -62.53 136.84 61.05 Favored 'Trans proline' 0 C--N 1.297 -2.183 0 C-N-CA 122.655 2.237 . . . . 0.0 111.486 179.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 93.48 15.87 48.6 Favored Glycine 0 N--CA 1.49 2.287 0 C-N-CA 119.687 -1.245 . . . . 0.0 110.498 179.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.921 HG21 HD12 ' A' ' 75' ' ' ILE . 6.6 t -117.52 165.84 13.07 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.146 -1.208 . . . . 0.0 109.567 179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.636 ' NZ ' ' CG1' ' A' ' 28' ' ' VAL . 6.4 mtmp? -86.07 6.48 28.8 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.284 -0.885 . . . . 0.0 111.255 -178.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.734 ' H ' HG23 ' A' ' 78' ' ' THR . 3.4 ttt -74.95 116.67 15.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.748 -1.22 . . . . 0.0 109.313 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.72 31.57 6.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.489 -0.757 . . . . 0.0 109.718 -179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 86.5 t80 -84.99 131.96 34.4 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.859 . . . . 0.0 109.614 -179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.582 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -82.73 176.94 53.46 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -96.36 166.55 24.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 119.602 -1.285 . . . . 0.0 109.913 -179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.596 HD11 HD21 ' A' ' 9' ' ' LEU . 63.4 mt -106.66 124.55 49.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.372 -1.076 . . . . 0.0 109.423 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 9.9 ttmt -64.7 -38.13 89.93 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 110.311 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -85.28 128.17 34.59 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.121 -0.987 . . . . 0.0 110.338 -179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -77.55 -33.07 54.2 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.558 -0.714 . . . . 0.0 110.125 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -57.01 -50.1 73.76 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.093 -1.004 . . . . 0.0 110.071 -178.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.82 -39.01 92.97 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.174 -0.954 . . . . 0.0 108.779 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -59.79 -40.68 89.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.756 -0.59 . . . . 0.0 109.947 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.85 -43.55 85.96 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.21 -0.931 . . . . 0.0 110.248 -179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.669 ' CG ' ' H ' ' A' ' 6' ' ' GLY . 58.9 t0 -62.48 -39.25 92.83 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.16 -0.962 . . . . 0.0 110.069 -179.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.878 HD21 ' CBB' ' A' ' 201' ' ' HEC . 57.8 tp -59.04 -45.48 90.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.189 -0.944 . . . . 0.0 110.207 -179.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 65.6 mt -65.54 -38.83 83.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.024 -1.047 . . . . 0.0 108.824 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.551 HG21 ' O ' ' A' ' 1' ' ' GLY . 28.1 m -59.0 -39.76 82.84 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.562 -0.711 . . . . 0.0 109.732 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -59.28 -48.65 80.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.847 -1.158 . . . . 0.0 108.871 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 ' CE1' ' A' ' 10' ' ' PHE . 84.5 mt -69.12 -31.81 70.77 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 178.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.543 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 20.8 tttm -56.01 -43.49 77.76 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -61.55 -43.64 98.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.448 -0.783 . . . . 0.0 109.387 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.29 -29.89 69.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.596 -0.69 . . . . 0.0 109.738 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.403 HG22 ' O ' ' A' ' 99' ' ' LYS . 0.5 OUTLIER -62.23 -32.76 73.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 109.366 -179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.21 -0.931 . . . . 0.0 109.514 -179.914 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.878 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.552 0 N-CA-C 109.412 -0.588 . . . . 0.0 109.412 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -57.93 144.18 40.21 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.292 -0.88 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 93.1 t80 -99.44 129.69 45.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.278 -0.889 . . . . 0.0 109.856 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.589 ' O ' ' N ' ' A' ' 1' ' ' GLY . 14.8 ttmt -82.87 141.95 31.85 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.408 -0.808 . . . . 0.0 109.172 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -44.79 -13.75 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 70.14 126.5 0.05 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.522 ' HG ' ' CG ' ' A' ' 93' ' ' ASP . 84.2 p -63.27 -19.41 64.55 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.317 -1.108 . . . . 0.0 109.177 179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.582 ' O ' ' N ' ' A' ' 5' ' ' LYS . . . 60.11 -143.55 0.53 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.33 -0.856 . . . . 0.0 109.401 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 50.6 tttm 56.06 -79.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.702 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.582 ' N ' ' O ' ' A' ' 3' ' ' ALA . 65.4 mttp -58.31 -43.52 88.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -0.949 . . . . 0.0 109.836 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.449 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -58.98 -33.95 76.54 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.751 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.16 -46.86 88.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.239 -1.154 . . . . 0.0 109.566 -179.672 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.811 ' O ' HG23 ' A' ' 12' ' ' THR . 58.8 p -72.54 -36.21 68.22 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.131 -0.981 . . . . 0.0 109.038 179.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.475 HD21 HD11 ' A' ' 85' ' ' LEU . 8.1 tp -58.14 -40.89 82.47 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 71.2 t80 -63.46 -46.93 83.99 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.004 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -62.92 -38.18 89.95 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.64 -0.663 . . . . 0.0 110.133 -179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.811 HG23 ' O ' ' A' ' 8' ' ' THR . 51.7 p -70.81 -31.16 67.81 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.438 -0.789 . . . . 0.0 111.481 -178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -148.13 54.88 1.04 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.562 -1.336 . . . . 0.0 111.357 -178.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.6 t -173.37 -50.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.677 -1.264 . . . . 0.0 110.829 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.6 tp -56.52 -37.07 69.95 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.04 -1.037 . . . . 0.0 110.074 -179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.4 mt-30 -56.3 -32.88 65.03 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.033 -1.042 . . . . 0.0 109.638 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 97.3 m -101.5 -44.76 5.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 0.0 110.838 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -103.64 121.93 43.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.073 -1.017 . . . . 0.0 110.084 -178.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.535 ' C ' HG23 ' A' ' 20' ' ' VAL . 47.8 p -81.9 -24.64 35.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.904 . . . . 0.0 109.632 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 65.55 -0.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.367 -0.833 . . . . 0.0 110.153 179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -98.86 120.49 39.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.075 -1.016 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.402 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 14.5 pttp -69.85 -40.05 76.03 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.153 -0.967 . . . . 0.0 109.613 179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.402 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -59.92 -36.55 90.5 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -74.15 155.43 49.1 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.54 -156.47 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.688 2.259 . . . . 0.0 111.934 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.61 137.25 47.72 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.454 -0.779 . . . . 0.0 109.276 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 12.9 tttp -110.71 -124.78 0.27 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.429 -0.795 . . . . 0.0 109.114 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.0 t -62.63 -40.73 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.089 -1.007 . . . . 0.0 109.438 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -128.38 163.08 22.0 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -61.17 145.6 98.52 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 C-N-CA 122.883 2.389 . . . . 0.0 112.353 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.0 145.97 53.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.068 -1.02 . . . . 0.0 109.029 179.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.834 ' CD2' HD13 ' A' ' 98' ' ' LEU . 13.3 tp -101.85 119.18 38.38 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.159 -0.963 . . . . 0.0 109.168 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.592 ' O ' ' N ' ' A' ' 35' ' ' ILE . 85.2 t60 -154.1 134.33 13.31 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.041 -1.037 . . . . 0.0 109.875 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 102' ' ' THR . . . 44.43 15.57 0.05 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.592 ' N ' ' O ' ' A' ' 33' ' ' HIS . 3.7 tp -58.22 -22.49 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.427 -1.043 . . . . 0.0 109.614 -179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.664 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 92.2 m-85 -63.64 136.77 57.74 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.172 -0.955 . . . . 0.0 109.283 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.09 32.34 72.84 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.723 ' O ' HD12 ' A' ' 58' ' ' LEU . 60.6 mmt-85 -127.29 152.06 47.92 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -1.14 . . . . 0.0 110.153 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.913 ' CE1' HD13 ' A' ' 58' ' ' LEU . 77.5 m80 -109.49 142.15 40.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.512 -0.742 . . . . 0.0 109.933 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.492 ' OG ' ' O ' ' A' ' 39' ' ' HIS . 7.4 p 49.44 174.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.634 0.731 . . . . 0.0 110.599 179.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -63.7 72.31 0.04 OUTLIER Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.477 ' N ' ' O ' ' A' ' 40' ' ' SER . 44.0 tt0 -60.17 -35.07 74.52 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.194 -1.18 . . . . 0.0 110.003 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' O ' ' O ' ' A' ' 44' ' ' GLU . . . -57.51 -34.78 69.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.232 -0.917 . . . . 0.0 109.899 -179.292 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.5 ' O ' ' O ' ' A' ' 43' ' ' ALA . 96.1 mt-10 46.54 -176.21 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.298 -0.876 . . . . 0.0 109.522 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.24 -13.05 68.11 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -179.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.43 ' CD2' ' O ' ' A' ' 47' ' ' SER . 85.7 t80 -136.63 146.41 45.97 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.517 -0.99 . . . . 0.0 108.962 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.43 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 44.1 m -62.23 147.45 47.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.165 -0.959 . . . . 0.0 109.744 -179.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -119.75 142.37 48.61 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.449 -0.782 . . . . 0.0 109.339 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.587 ' N ' ' O1D' ' A' ' 201' ' ' HEC . 56.9 m -72.84 143.82 47.69 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.179 -0.95 . . . . 0.0 109.072 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -49.29 -33.73 13.76 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.176 -0.952 . . . . 0.0 109.311 -179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.488 ' H ' HG22 ' A' ' 49' ' ' THR . . . -47.99 -71.86 0.06 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.36 -0.837 . . . . 0.0 110.228 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 56' ' ' ASN . 25.6 t-20 -57.51 -40.38 78.59 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.145 -0.972 . . . . 0.0 110.79 -179.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.505 ' O ' ' OD1' ' A' ' 56' ' ' ASN . 67.4 mt -60.99 -49.19 85.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.867 -1.145 . . . . 0.0 109.936 -179.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.0 tttp -64.16 -52.7 57.74 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.971 -1.081 . . . . 0.0 109.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.533 ' O ' ' O ' ' A' ' 56' ' ' ASN . 32.8 tttp -67.68 -47.62 68.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.26 -0.9 . . . . 0.0 109.943 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.533 ' O ' ' O ' ' A' ' 55' ' ' LYS . 1.8 m120 38.42 97.47 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.669 -0.645 . . . . 0.0 109.876 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG11 ' CZ ' ' A' ' 74' ' ' TYR . 7.1 p -123.18 149.82 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.608 -0.683 . . . . 0.0 110.172 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.913 HD13 ' CE1' ' A' ' 39' ' ' HIS . 49.9 tp -66.09 134.13 52.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.548 -0.72 . . . . 0.0 109.395 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.572 ' CZ2' HMA2 ' A' ' 201' ' ' HEC . 92.8 m95 -98.03 130.89 44.83 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.324 -0.86 . . . . 0.0 109.365 179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.442 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 52.3 t0 -156.13 164.84 37.9 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.533 ' OE2' ' CE ' ' A' ' 99' ' ' LYS . 96.7 mt-10 -53.89 -40.17 66.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 109.273 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -67.76 -47.98 67.67 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.246 -0.908 . . . . 0.0 109.855 179.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.574 ' ND2' ' O ' ' A' ' 58' ' ' LEU . 64.7 t30 -63.75 -40.35 96.5 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 110.718 -179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.664 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 62.9 mtt -59.92 -37.9 80.78 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.082 -1.011 . . . . 0.0 109.688 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 38.6 m -60.32 -41.58 93.81 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.081 -1.012 . . . . 0.0 108.974 179.642 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.88 -34.38 77.67 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 121.189 -0.944 . . . . 0.0 109.074 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.472 ' ND1' ' CD1' ' A' ' 74' ' ' TYR . 61.8 t60 -59.57 -47.28 86.19 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.438 -0.789 . . . . 0.0 109.076 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.562 ' CD1' HD23 ' A' ' 94' ' ' LEU . 71.7 mt -71.59 -34.04 69.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.583 -0.698 . . . . 0.0 110.039 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' NH1' ' A' ' 91' ' ' ARG . 30.9 m -58.66 -38.35 77.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.123 -0.986 . . . . 0.0 110.828 -178.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.6 m-80 -161.65 67.76 2.23 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 120.96 -1.087 . . . . 0.0 109.803 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -49.31 -24.71 8.83 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 C-N-CA 122.792 2.328 . . . . 0.0 112.144 179.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.534 ' O ' ' O ' ' A' ' 75' ' ' ILE . . . -63.72 -59.84 4.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.198 -0.939 . . . . 0.0 109.506 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -63.91 -34.12 77.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.028 -1.045 . . . . 0.0 109.429 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.512 ' OH ' ' ND2' ' A' ' 63' ' ' ASN . 21.6 t80 -54.97 -44.74 74.67 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.415 -0.803 . . . . 0.0 109.508 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.569 ' C ' ' H ' ' A' ' 77' ' ' GLY . 0.8 OUTLIER -139.78 154.67 71.13 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.136 -0.977 . . . . 0.0 108.885 179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -52.24 6.36 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 122.573 2.182 . . . . 0.0 112.838 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.569 ' H ' ' C ' ' A' ' 75' ' ' ILE . . . 88.2 50.44 3.44 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.883 HG23 ' H ' ' A' ' 80' ' ' MET . 14.6 t -55.64 -159.36 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -1.091 . . . . 0.0 109.612 179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 42.5 mtmt -59.57 -24.81 64.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.157 -0.965 . . . . 0.0 110.099 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.883 ' H ' HG23 ' A' ' 78' ' ' THR . 63.5 mtm -68.88 120.22 14.44 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.041 -1.037 . . . . 0.0 110.576 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -111.23 26.12 11.02 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 65.0 t80 -55.87 136.23 51.58 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.575 -0.703 . . . . 0.0 109.706 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.556 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -84.03 -179.68 51.87 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.5 146.69 17.72 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.475 HD11 HD21 ' A' ' 9' ' ' LEU . 55.9 mt -97.22 135.96 38.4 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.277 -1.131 . . . . 0.0 109.056 179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.5 mtmp? -91.1 -6.55 53.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.229 -0.919 . . . . 0.0 110.097 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -103.53 127.22 50.97 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.076 -1.015 . . . . 0.0 109.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -76.32 -38.54 55.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.438 -0.789 . . . . 0.0 110.056 179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 55.0 mttm -60.52 -47.93 84.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.241 -0.912 . . . . 0.0 110.125 -179.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -63.99 -39.91 95.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.09 -1.006 . . . . 0.0 109.461 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.55 ' NH1' ' OG1' ' A' ' 69' ' ' THR . 61.7 ttp180 -59.58 -43.62 93.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.421 -0.799 . . . . 0.0 109.994 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -61.52 -37.13 82.61 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.15 -0.969 . . . . 0.0 109.59 -179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' CG ' ' HG ' ' A' ' 2' ' ' SER . 90.4 m-20 -61.0 -40.2 92.61 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.185 -0.947 . . . . 0.0 109.637 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.562 HD23 ' CD1' ' A' ' 68' ' ' LEU . 51.8 tp -61.57 -46.25 90.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.155 -0.966 . . . . 0.0 110.359 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 63.5 mt -66.1 -41.0 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.024 -1.048 . . . . 0.0 109.029 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 33.5 m -59.6 -39.68 85.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.458 -0.776 . . . . 0.0 109.825 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 81.1 t80 -57.74 -49.19 77.4 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.923 -1.11 . . . . 0.0 109.045 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.834 HD13 ' CD2' ' A' ' 32' ' ' LEU . 94.0 mt -68.18 -32.14 72.17 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 178.539 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.533 ' CE ' ' OE2' ' A' ' 61' ' ' GLU . 29.1 tttm -57.71 -42.84 84.58 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.582 -0.699 . . . . 0.0 109.284 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -61.63 -43.71 98.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.398 -0.813 . . . . 0.0 109.769 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.98 -38.93 73.73 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.552 -0.718 . . . . 0.0 109.397 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.524 HG21 ' CD1' ' A' ' 36' ' ' PHE . 51.1 p -72.47 -29.03 63.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.212 -0.93 . . . . 0.0 109.197 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.451 ' C ' ' O ' ' A' ' 102' ' ' THR . 84.4 tt0 . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.539 -0.726 . . . . 0.0 109.831 179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.641 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 75.8 p . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -61.82 -33.53 74.29 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.0 109.462 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.533 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 89.7 t80 -102.41 131.0 49.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.999 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.566 ' O ' ' N ' ' A' ' 1' ' ' GLY . 34.1 ttpt -84.08 139.95 32.14 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.497 ' O ' ' O ' ' A' ' 1' ' ' GLY . . . -39.15 -24.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 0.0 109.827 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.566 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 52.21 169.54 0.02 OUTLIER Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 30.6 t -124.53 125.85 44.88 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.394 -1.063 . . . . 0.0 109.069 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -70.24 -22.82 62.86 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.159 -0.963 . . . . 0.0 110.058 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.6 mttp -57.38 -53.86 53.36 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.988 -1.07 . . . . 0.0 110.208 -179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 57.6 mttt -67.3 -50.57 59.68 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.876 -1.14 . . . . 0.0 109.621 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.525 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.63 -31.04 78.57 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.949 -1.26 . . . . 0.0 109.949 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -58.44 -47.06 85.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.251 -1.146 . . . . 0.0 109.857 -179.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.887 ' O ' HG23 ' A' ' 12' ' ' THR . 66.4 p -73.62 -39.77 64.31 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.142 -0.974 . . . . 0.0 109.42 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.581 HD23 HD13 ' A' ' 94' ' ' LEU . 8.8 tp -59.97 -41.23 91.52 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.67 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 65.6 t80 -62.07 -46.12 90.53 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 179.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -63.47 -37.63 88.02 Favored 'General case' 0 N--CA 1.487 1.413 0 CA-C-O 121.489 0.661 . . . . 0.0 109.967 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.887 HG23 ' O ' ' A' ' 8' ' ' THR . 56.9 p -70.43 -33.9 71.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.469 -0.77 . . . . 0.0 111.74 -178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -149.58 56.89 0.98 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.519 -1.363 . . . . 0.0 111.491 -178.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.67 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.3 t -173.06 -48.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.74 -1.225 . . . . 0.0 110.192 178.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 18.2 tp -57.79 -37.36 73.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.138 -0.976 . . . . 0.0 109.942 -179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -57.72 -35.07 70.17 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.179 -0.95 . . . . 0.0 109.826 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 99.2 m -96.73 -43.11 7.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.243 -0.911 . . . . 0.0 110.658 -179.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -107.21 123.79 48.8 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.135 -0.978 . . . . 0.0 110.145 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 21' ' ' GLU . 44.2 p -86.07 -23.9 26.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.271 -0.893 . . . . 0.0 109.44 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.535 HG13 ' O ' ' A' ' 32' ' ' LEU . 2.4 t 59.28 -1.8 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.294 -0.879 . . . . 0.0 110.298 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 19' ' ' THR . 84.3 tt0 -97.36 124.06 41.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.841 -1.162 . . . . 0.0 109.53 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.422 ' CG ' ' N ' ' A' ' 23' ' ' GLY . 24.6 pttm -68.41 -41.4 80.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.283 -0.885 . . . . 0.0 109.191 179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.422 ' N ' ' CG ' ' A' ' 22' ' ' LYS . . . -63.12 -34.84 91.05 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -67.2 157.56 51.43 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -73.74 -161.34 0.11 Allowed 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.762 2.308 . . . . 0.0 112.043 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' CD2' ' CG ' ' A' ' 46' ' ' TYR . 0.1 OUTLIER -103.64 125.24 50.02 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.398 -0.814 . . . . 0.0 109.106 179.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 30.2 mmtp -101.53 -159.59 0.74 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.301 -0.875 . . . . 0.0 109.589 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 67.5 t -51.3 -41.85 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.164 -0.96 . . . . 0.0 109.418 -179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -109.13 149.98 17.13 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.084 -1.606 . . . . 0.0 109.084 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -60.31 147.36 94.09 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.495 2.13 . . . . 0.0 112.6 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -61.74 138.71 58.35 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.308 -0.87 . . . . 0.0 109.111 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.793 ' CD2' HD13 ' A' ' 98' ' ' LEU . 14.6 tp -106.54 118.67 37.26 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.229 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -158.92 127.16 5.16 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.785 -1.197 . . . . 0.0 110.231 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 55.8 12.17 4.89 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.66 HG21 HD11 ' A' ' 32' ' ' LEU . 2.8 tp -60.07 -21.63 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.362 -1.081 . . . . 0.0 109.835 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.642 ' CE2' ' SD ' ' A' ' 64' ' ' MET . 90.5 m-85 -62.88 139.16 58.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.055 -1.028 . . . . 0.0 109.38 -179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.502 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 69.95 22.73 77.18 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.138 -1.585 . . . . 0.0 109.138 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -136.29 160.09 39.75 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -1.095 . . . . 0.0 109.804 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' CE1' HD13 ' A' ' 58' ' ' LEU . 78.0 m80 -94.34 158.39 15.6 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.385 -0.822 . . . . 0.0 109.443 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.454 ' CB ' ' O2A' ' A' ' 201' ' ' HEC . 77.1 p -62.08 159.41 14.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.328 -0.857 . . . . 0.0 109.853 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 83.76 5.36 88.16 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -60.85 -35.21 75.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.46 -1.024 . . . . 0.0 110.226 -179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 45' ' ' GLY . . . -57.53 -35.05 69.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.112 -0.992 . . . . 0.0 109.719 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.429 ' C ' ' O ' ' A' ' 43' ' ' ALA . 96.0 mt-10 42.2 18.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.583 -179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . -118.65 -36.63 0.89 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.301 -1.519 . . . . 0.0 109.301 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.465 ' CG ' ' CD2' ' A' ' 26' ' ' HIS . 78.9 t80 -110.65 136.41 49.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.544 -0.974 . . . . 0.0 109.14 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.432 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 38.5 m -59.61 153.1 20.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 0.0 109.959 -179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.555 ' CD2' ' O1D' ' A' ' 201' ' ' HEC . 24.2 m-85 -117.5 158.84 23.82 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.515 -0.74 . . . . 0.0 109.356 179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.56 ' H ' ' CGD' ' A' ' 201' ' ' HEC . 26.1 p -74.74 158.51 33.4 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.216 -0.927 . . . . 0.0 109.247 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -58.79 -30.86 67.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.0 109.495 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.67 -78.82 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.333 -0.854 . . . . 0.0 110.532 -179.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.502 ' O ' ' O ' ' A' ' 55' ' ' LYS . 28.5 t-20 -52.35 -44.03 64.98 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.157 -0.964 . . . . 0.0 110.51 -178.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.405 HD13 ' HA ' ' A' ' 53' ' ' ILE . 42.0 mm -59.71 -40.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 120.619 -1.301 . . . . 0.0 109.284 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 64.3 tttm -61.34 -37.75 84.45 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 108.736 179.21 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.502 ' O ' ' O ' ' A' ' 52' ' ' ASN . 43.6 tttp -125.72 114.51 18.74 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.486 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.5 OUTLIER -95.16 134.88 37.41 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.094 -1.004 . . . . 0.0 109.289 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.849 HG11 ' OH ' ' A' ' 74' ' ' TYR . 12.2 p -131.39 146.83 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.463 -0.773 . . . . 0.0 110.046 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 39' ' ' HIS . 63.3 tp -81.59 133.95 35.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 108.968 179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.502 ' O ' ' N ' ' A' ' 37' ' ' GLY . 98.4 m95 -97.95 127.57 43.98 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.195 -0.941 . . . . 0.0 110.207 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.3 t0 -151.92 167.81 27.15 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.08 -1.082 . . . . 0.0 108.08 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -57.47 -36.06 70.97 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.893 -1.13 . . . . 0.0 109.653 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.9 t30 -76.23 -57.5 3.83 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.189 -0.945 . . . . 0.0 109.895 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.0 t30 -63.48 -41.18 98.58 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.297 -0.877 . . . . 0.0 110.371 -179.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.642 ' SD ' ' CE2' ' A' ' 36' ' ' PHE . 59.0 ttm -59.27 -36.31 75.31 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 109.542 -179.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 85.4 p -62.75 -35.88 81.23 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.128 -0.983 . . . . 0.0 109.554 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -64.28 -35.94 82.47 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.233 -0.917 . . . . 0.0 109.718 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -60.45 -43.39 96.93 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.363 -0.836 . . . . 0.0 110.045 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.609 ' CD2' HD23 ' A' ' 94' ' ' LEU . 7.0 mp -62.36 -31.7 72.38 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.219 -0.925 . . . . 0.0 109.873 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.55 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 18.0 m -88.16 129.84 35.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.081 -1.012 . . . . 0.0 109.541 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.436 ' C ' ' O ' ' A' ' 69' ' ' THR . 74.0 m-20 38.64 54.98 4.8 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.504 -0.748 . . . . 0.0 110.496 179.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.42 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 9.5 Cg_endo -54.97 -14.68 8.64 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.568 2.179 . . . . 0.0 111.102 178.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 74' ' ' TYR . . . -63.2 154.17 32.16 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.485 -0.76 . . . . 0.0 109.615 179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.2 tttt 67.23 -36.52 0.29 Allowed 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.858 -0.526 . . . . 0.0 110.004 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.849 ' OH ' HG11 ' A' ' 57' ' ' VAL . 86.5 t80 -60.25 -50.01 75.36 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.073 -1.017 . . . . 0.0 109.579 179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.683 ' O ' HG22 ' A' ' 75' ' ' ILE . 3.8 mm -140.87 77.2 21.71 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.275 -0.891 . . . . 0.0 109.136 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -84.57 151.4 11.69 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 C-N-CA 123.095 2.53 . . . . 0.0 112.276 -179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 21.09 27.82 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 179.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.506 HG23 ' H ' ' A' ' 80' ' ' MET . 12.1 t -123.51 164.7 18.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.303 -1.116 . . . . 0.0 109.797 -179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 5.8 mtmp? -81.77 4.2 22.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.376 -0.827 . . . . 0.0 109.69 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.506 ' H ' HG23 ' A' ' 78' ' ' THR . 11.9 ttp -79.8 131.74 35.97 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.237 -0.914 . . . . 0.0 109.907 -179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -135.08 70.18 1.44 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -0.836 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.588 ' CD2' ' O ' ' A' ' 83' ' ' GLY . 76.6 t80 -102.89 134.44 46.3 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.393 -0.817 . . . . 0.0 109.474 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 82' ' ' PHE . . . -81.83 174.36 53.91 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -91.91 161.89 27.2 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 58.3 mt -102.83 128.07 49.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.303 -1.116 . . . . 0.0 109.194 179.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 70.2 mttt -65.18 -44.21 89.2 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.313 -0.867 . . . . 0.0 109.951 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -90.09 129.52 36.38 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.726 -0.79 . . . . 0.0 110.483 -179.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -73.37 -32.37 64.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.559 -0.713 . . . . 0.0 109.76 179.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 62.0 tttt -56.18 -48.32 76.58 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 0.0 109.464 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.24 -37.6 77.94 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.479 -0.763 . . . . 0.0 109.262 179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.55 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 34.0 ttm180 -57.81 -41.78 82.89 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.516 -0.74 . . . . 0.0 109.694 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -59.49 -40.49 87.17 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.265 -0.897 . . . . 0.0 109.964 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 80.1 m-20 -64.27 -40.05 95.19 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.169 -0.957 . . . . 0.0 109.67 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.716 HD21 ' CBB' ' A' ' 201' ' ' HEC . 46.6 tp -62.62 -44.74 95.54 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.204 -0.935 . . . . 0.0 109.748 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 64.8 mt -67.02 -36.91 78.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.11 -0.994 . . . . 0.0 108.563 179.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 31.6 m -57.31 -40.84 78.71 Favored 'General case' 0 C--N 1.306 -1.317 0 O-C-N 121.552 -0.717 . . . . 0.0 109.646 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -60.06 -51.78 68.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.046 -1.034 . . . . 0.0 109.382 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.793 HD13 ' CD2' ' A' ' 32' ' ' LEU . 91.9 mt -65.31 -35.41 80.91 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 178.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 12.7 tttp -57.28 -40.38 77.62 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 179.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -59.44 -40.3 86.37 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.485 -0.759 . . . . 0.0 109.391 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -57.63 -32.98 67.79 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.474 -0.766 . . . . 0.0 109.466 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.6 p -67.89 -23.13 65.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 109.324 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.243 -0.911 . . . . 0.0 109.532 179.943 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.716 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 41.3 p . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.66 -33.05 73.28 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.445 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -100.4 127.08 46.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.347 -0.846 . . . . 0.0 109.54 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.577 ' O ' ' N ' ' A' ' 1' ' ' GLY . 32.7 ttpt -94.82 130.85 41.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.189 -0.944 . . . . 0.0 109.267 179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . -48.64 90.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.158 -0.964 . . . . 0.0 109.212 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.577 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -105.53 135.19 12.46 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.571 -1.412 . . . . 0.0 109.571 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.8 p -69.58 153.54 43.31 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.116 -1.226 . . . . 0.0 109.203 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 7' ' ' ALA . . . -93.36 -10.23 36.04 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.227 -0.921 . . . . 0.0 109.797 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.9 mttt -59.48 -47.76 84.25 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.109 -0.995 . . . . 0.0 109.923 -179.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -67.2 -50.73 59.83 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.076 -1.015 . . . . 0.0 109.48 179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.514 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -64.59 -32.82 85.46 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 3' ' ' ALA . . . -57.92 -45.26 86.81 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.132 -1.217 . . . . 0.0 109.639 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.759 ' O ' HG23 ' A' ' 12' ' ' THR . 51.8 p -71.95 -37.61 69.93 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.209 -0.932 . . . . 0.0 109.064 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.489 HD23 HD22 ' A' ' 94' ' ' LEU . 9.9 tp -59.45 -41.35 89.45 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 179.179 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.671 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 67.7 t80 -63.74 -45.81 88.2 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 178.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 45.5 tttm -62.61 -39.85 95.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.661 -0.65 . . . . 0.0 110.415 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.759 HG23 ' O ' ' A' ' 8' ' ' THR . 56.6 p -71.58 -37.06 71.06 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 0.0 111.665 -178.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.8 mmt180 -140.49 54.38 1.61 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.775 -1.203 . . . . 0.0 110.899 -178.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.671 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 2.0 t -170.95 -53.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.696 -1.252 . . . . 0.0 110.616 179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 14.9 tp -56.94 -37.9 72.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.034 -1.041 . . . . 0.0 109.687 -179.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -58.25 -35.74 72.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.201 -0.937 . . . . 0.0 109.829 -179.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.2 m -95.73 -43.18 8.01 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.194 -0.941 . . . . 0.0 110.57 -179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.473 ' ND1' HD13 ' A' ' 32' ' ' LEU . 88.4 m-70 -105.32 129.88 53.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.302 -0.874 . . . . 0.0 110.345 -178.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.492 ' O ' ' N ' ' A' ' 21' ' ' GLU . 63.0 p -95.45 -8.13 36.28 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.01 179.306 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG12 ' O ' ' A' ' 32' ' ' LEU . 2.7 m 32.3 36.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 121.209 0.528 . . . . 0.0 110.72 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.492 ' N ' ' O ' ' A' ' 19' ' ' THR . 84.4 tt0 -104.15 133.7 48.64 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.161 -0.962 . . . . 0.0 109.252 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 16.9 ttpt -82.48 139.4 33.96 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.234 -0.916 . . . . 0.0 109.635 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 70.82 25.14 76.27 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.34 165.19 12.81 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -74.14 172.11 16.64 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 123.115 2.543 . . . . 0.0 111.99 179.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 92.7 m-70 -105.15 135.62 46.16 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.351 -0.843 . . . . 0.0 109.153 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' CG ' ' H ' ' A' ' 28' ' ' VAL . 18.0 tptt -104.65 -126.48 0.23 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.275 -0.891 . . . . 0.0 109.005 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.41 ' H ' ' CG ' ' A' ' 27' ' ' LYS . 75.6 t -62.13 -39.66 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.129 -0.982 . . . . 0.0 109.064 179.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.44 160.65 20.82 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 32' ' ' LEU . 20.9 Cg_endo -62.34 149.43 90.78 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 C-N-CA 123.035 2.49 . . . . 0.0 112.498 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.54 ' C ' HD12 ' A' ' 32' ' ' LEU . 2.6 m120 -77.72 126.21 30.52 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.092 -1.005 . . . . 0.0 109.003 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.658 ' N ' HD12 ' A' ' 32' ' ' LEU . 8.2 mp -100.0 132.02 45.61 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 0.0 110.18 -179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -160.97 102.18 1.28 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.81 11.28 77.26 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 108.681 -1.767 . . . . 0.0 108.681 -179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.5 tt -57.7 -21.72 16.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.49 -1.006 . . . . 0.0 109.391 -179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.589 ' CD2' ' OE2' ' A' ' 61' ' ' GLU . 96.0 m-85 -62.86 135.52 57.37 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.303 -0.873 . . . . 0.0 108.932 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.54 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.94 20.67 80.02 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.337 -1.505 . . . . 0.0 109.337 -179.564 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 82.6 mtt180 -133.67 162.4 32.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.353 -1.086 . . . . 0.0 110.035 -179.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 79.4 m80 -94.72 168.6 10.73 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.399 -0.813 . . . . 0.0 109.571 -179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.499 ' OG ' ' O2A' ' A' ' 201' ' ' HEC . 20.8 t -83.96 146.38 28.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.243 -0.911 . . . . 0.0 109.985 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.63 -6.84 70.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.894 -1.283 . . . . 0.0 109.894 179.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -62.75 -37.62 87.3 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 110.138 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.63 ' C ' ' H ' ' A' ' 45' ' ' GLY . . . -60.21 -43.52 95.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.097 -1.002 . . . . 0.0 109.427 -179.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 58.11 -21.17 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.48 -0.762 . . . . 0.0 110.938 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.63 ' H ' ' C ' ' A' ' 43' ' ' ALA . . . -59.91 -33.93 80.79 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.724 -1.351 . . . . 0.0 109.724 -179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.47 ' CD2' ' O ' ' A' ' 47' ' ' SER . 76.6 t80 -115.13 140.29 49.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.481 -1.011 . . . . 0.0 109.524 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.47 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.7 t -65.66 151.99 45.24 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -0.91 . . . . 0.0 109.504 -179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.594 ' CD2' ' O2D' ' A' ' 201' ' ' HEC . 37.0 m-85 -111.73 147.75 34.96 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.564 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.2 p -75.86 164.35 26.3 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.393 -0.817 . . . . 0.0 109.517 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -55.22 -31.22 61.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.392 -0.818 . . . . 0.0 109.258 179.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.433 ' HB2' ' C ' ' A' ' 77' ' ' GLY . . . -48.84 -78.29 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.372 -0.83 . . . . 0.0 110.638 -179.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.606 ' HA ' HD12 ' A' ' 75' ' ' ILE . 23.5 t-20 -57.42 -41.56 80.63 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.952 -1.093 . . . . 0.0 110.641 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.518 HD11 ' O ' ' A' ' 48' ' ' TYR . 84.4 mt -60.25 -44.66 96.05 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 120.845 -1.16 . . . . 0.0 109.83 -179.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.4 tttp -59.35 -37.54 78.13 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.195 -0.94 . . . . 0.0 109.271 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 52' ' ' ASN . 76.6 tttt -132.14 121.33 23.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.444 -0.785 . . . . 0.0 109.215 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -100.81 136.52 40.55 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.313 -0.867 . . . . 0.0 108.998 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.724 HG11 ' OH ' ' A' ' 74' ' ' TYR . 9.5 p -130.93 147.73 33.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.523 -0.736 . . . . 0.0 110.055 -179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.415 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 64.7 tp -77.73 133.78 38.23 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 0.0 108.95 179.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.54 ' O ' ' N ' ' A' ' 37' ' ' GLY . 93.2 m95 -93.86 127.75 39.77 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.375 -0.828 . . . . 0.0 109.856 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.466 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 53.6 t0 -148.96 167.97 24.35 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.589 ' OE2' ' CD2' ' A' ' 36' ' ' PHE . 79.0 mm-40 -58.03 -39.36 78.18 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.988 -1.07 . . . . 0.0 109.422 -179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.578 ' OD1' ' N ' ' A' ' 63' ' ' ASN . 1.0 OUTLIER -78.69 -48.67 14.52 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.117 -0.989 . . . . 0.0 109.543 179.856 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.578 ' N ' ' OD1' ' A' ' 62' ' ' ASN . 33.9 t30 -59.89 -39.23 84.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.271 -0.893 . . . . 0.0 109.573 179.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 42.4 tpp -60.3 -38.92 85.14 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.374 -0.829 . . . . 0.0 109.551 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 86.3 p -61.47 -33.79 74.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 0.0 109.801 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -66.51 -36.03 81.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.212 -0.93 . . . . 0.0 109.885 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.408 ' NE2' ' CE ' ' A' ' 80' ' ' MET . 81.3 t60 -59.31 -43.79 92.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.181 -0.949 . . . . 0.0 109.569 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.565 ' N ' ' CD1' ' A' ' 68' ' ' LEU . 5.3 mp -67.77 -27.15 66.51 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.516 -0.74 . . . . 0.0 109.999 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.546 ' OG1' ' CZ ' ' A' ' 91' ' ' ARG . 25.5 m -81.16 128.48 33.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.144 -0.973 . . . . 0.0 110.379 -179.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.479 ' C ' ' O ' ' A' ' 69' ' ' THR . 11.7 t-20 32.54 59.81 1.42 Allowed Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.849 -0.532 . . . . 0.0 111.312 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.721 ' O ' ' HB2' ' A' ' 72' ' ' ALA . 19.2 Cg_endo -61.8 135.65 57.32 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 C-N-CA 122.329 2.019 . . . . 0.0 111.699 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.721 ' HB2' ' O ' ' A' ' 71' ' ' PRO . . . 162.04 -86.99 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.101 -0.999 . . . . 0.0 109.391 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 18.0 mttp -56.51 -28.96 61.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.373 -0.829 . . . . 0.0 109.013 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.724 ' OH ' HG11 ' A' ' 57' ' ' VAL . 84.8 t80 -54.83 -51.98 64.14 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.436 -0.79 . . . . 0.0 109.53 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.749 ' O ' HG22 ' A' ' 75' ' ' ILE . 9.5 mm -152.08 73.18 7.79 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.136 -0.977 . . . . 0.0 108.787 179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -80.96 150.59 18.2 Favored 'Trans proline' 0 C--N 1.306 -1.709 0 C-N-CA 122.894 2.396 . . . . 0.0 112.34 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.433 ' C ' ' HB2' ' A' ' 51' ' ' ALA . . . 107.01 15.29 16.69 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 110.162 -1.175 . . . . 0.0 110.162 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 14.0 t -124.17 156.99 35.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.359 -1.083 . . . . 0.0 109.414 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.3 pttt -84.6 5.38 28.1 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 0.0 110.948 -179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.474 ' O ' ' C ' ' A' ' 81' ' ' ALA . 4.5 ttt -55.45 -40.14 71.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.793 -1.192 . . . . 0.0 109.636 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.474 ' C ' ' O ' ' A' ' 80' ' ' MET . . . 33.69 75.08 0.05 Allowed 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.722 -0.611 . . . . 0.0 110.593 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 80.9 t80 -106.22 131.44 53.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.828 . . . . 0.0 109.517 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -71.28 140.14 30.44 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -74.98 150.84 41.58 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 51.6 mt -96.19 133.67 40.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.252 -1.146 . . . . 0.0 109.164 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 2.3 pttp -87.5 -12.72 45.11 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.165 -0.96 . . . . 0.0 110.233 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.6 mttt -101.6 126.18 48.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.138 -0.976 . . . . 0.0 109.83 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -75.12 -36.68 61.63 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.469 -0.769 . . . . 0.0 109.932 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 92.0 mttt -60.0 -45.06 93.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.207 -0.933 . . . . 0.0 110.127 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -63.07 -39.35 94.47 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.135 -0.978 . . . . 0.0 109.605 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.546 ' CZ ' ' OG1' ' A' ' 69' ' ' THR . 39.1 ttm180 -59.12 -41.78 88.99 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.453 -0.779 . . . . 0.0 109.966 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -60.9 -40.82 94.56 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.08 -1.013 . . . . 0.0 110.143 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.514 ' HB3' ' H ' ' A' ' 6' ' ' GLY . 84.5 m-20 -64.35 -41.27 96.83 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 120.966 -1.084 . . . . 0.0 109.638 -179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.752 HD21 ' CBB' ' A' ' 201' ' ' HEC . 50.8 tp -59.25 -43.1 92.44 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.082 -1.012 . . . . 0.0 109.376 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.542 ' CG2' ' OE1' ' A' ' 61' ' ' GLU . 81.0 mt -66.19 -36.15 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.186 -0.946 . . . . 0.0 108.78 179.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 11.7 m -57.31 -41.35 79.71 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.604 -0.685 . . . . 0.0 109.843 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 75.5 t80 -63.18 -52.94 60.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.169 -0.957 . . . . 0.0 110.306 -179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.514 HD21 ' CE1' ' A' ' 10' ' ' PHE . 94.3 mt -70.02 -39.85 75.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.85 -1.156 . . . . 0.0 108.965 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.428 ' O ' ' OG1' ' A' ' 102' ' ' THR . 84.0 tttt -58.88 -40.24 83.81 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.555 -0.716 . . . . 0.0 109.347 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -60.39 -40.15 89.87 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.348 -0.845 . . . . 0.0 109.534 179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.64 -30.03 68.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.46 -0.775 . . . . 0.0 109.667 -179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.428 ' OG1' ' O ' ' A' ' 99' ' ' LYS . 38.9 p -64.69 -25.43 67.94 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.219 -0.926 . . . . 0.0 109.464 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.224 -0.922 . . . . 0.0 109.524 179.937 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.752 ' CBB' HD21 ' A' ' 94' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -61.68 -32.96 73.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.353 -0.842 . . . . 0.0 109.455 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . 0.595 ' CE2' ' O ' ' A' ' -2' ' ' LYS . 70.1 t80 -100.61 129.03 46.48 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.233 -0.917 . . . . 0.0 109.517 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.595 ' O ' ' CE2' ' A' ' -3' ' ' PHE . 48.5 mtmt -86.42 170.89 11.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.259 -0.9 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.475 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -38.65 -24.09 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.508 -0.745 . . . . 0.0 109.798 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.594 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . 101.31 97.28 2.29 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.718 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.9 t -119.72 136.93 54.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.534 -0.98 . . . . 0.0 109.07 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.73 131.03 53.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.311 -0.868 . . . . 0.0 109.771 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -175.22 -91.64 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.5 mttp -63.31 -37.66 88.13 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.195 -0.941 . . . . 0.0 108.718 178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -59.9 -36.73 91.05 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.37 -49.81 75.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.271 -1.134 . . . . 0.0 109.588 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.822 ' O ' HG23 ' A' ' 12' ' ' THR . 52.0 p -74.0 -32.27 63.32 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.159 -0.963 . . . . 0.0 109.126 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.644 HD23 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -56.65 -41.8 77.83 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.668 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 68.0 t80 -63.5 -47.08 83.17 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 179.038 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.6 tttt -63.27 -38.74 92.33 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-O 121.434 0.635 . . . . 0.0 110.127 179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 8' ' ' THR . 57.3 p -70.4 -32.92 70.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.421 -0.799 . . . . 0.0 111.483 -178.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 83.3 mtp180 -148.58 57.44 1.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.667 -1.271 . . . . 0.0 111.166 -178.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.668 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 3.3 t -173.33 -51.58 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.854 -1.153 . . . . 0.0 110.322 179.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.7 tp -56.87 -37.7 71.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.098 -1.001 . . . . 0.0 109.799 -179.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -57.52 -34.92 69.61 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.163 -0.96 . . . . 0.0 109.718 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 98.0 m -97.41 -43.67 7.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.185 -0.947 . . . . 0.0 110.681 -179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.456 ' ND1' ' O ' ' A' ' 30' ' ' PRO . 89.8 m-70 -105.11 124.43 49.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.177 -0.952 . . . . 0.0 110.203 -178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.44 ' C ' HG23 ' A' ' 20' ' ' VAL . 52.4 p -87.22 -18.34 30.53 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.448 -0.782 . . . . 0.0 109.31 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.44 HG23 ' C ' ' A' ' 19' ' ' THR . 2.1 t 61.57 19.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.246 -0.909 . . . . 0.0 109.571 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.499 ' HG3' ' H ' ' A' ' 24' ' ' GLY . 49.0 tp10 -99.82 140.6 33.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.942 . . . . 0.0 109.348 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -82.2 -81.7 0.14 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.832 . . . . 0.0 110.065 -179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -51.14 -28.61 19.03 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.672 -1.371 . . . . 0.0 109.672 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.499 ' H ' ' HG3' ' A' ' 21' ' ' GLU . . . -59.22 156.05 26.31 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.487 ' O ' ' OD1' ' A' ' 31' ' ' ASN . 60.2 Cg_endo -73.3 -174.48 1.62 Allowed 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.84 2.36 . . . . 0.0 111.948 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -105.72 135.13 47.69 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.374 -0.829 . . . . 0.0 109.251 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.3 tttm -97.86 -126.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.202 -0.936 . . . . 0.0 108.908 179.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 70.0 t -63.34 -39.4 85.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.109 -0.995 . . . . 0.0 109.044 179.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -126.2 165.56 19.33 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.456 ' O ' ' ND1' ' A' ' 18' ' ' HIS . 22.9 Cg_endo -62.68 148.23 93.66 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 C-N-CA 122.968 2.445 . . . . 0.0 111.991 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' PRO . 9.4 m120 -80.13 137.48 36.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.088 -1.007 . . . . 0.0 109.46 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.679 ' N ' HD12 ' A' ' 32' ' ' LEU . 7.8 mp -100.08 135.57 41.3 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.222 -0.923 . . . . 0.0 109.835 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 56.6 t-80 -164.14 98.41 0.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.838 . . . . 0.0 108.975 179.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.94 8.61 82.17 Favored Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.804 -1.718 . . . . 0.0 108.804 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 17.4 tt -57.28 -23.16 18.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.479 -1.012 . . . . 0.0 109.494 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CD1' HG21 ' A' ' 102' ' ' THR . 96.2 m-85 -67.17 135.34 53.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.246 -0.909 . . . . 0.0 109.475 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 73.95 20.73 79.71 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.432 ' HD3' HE22 ' A' ' 42' ' ' GLN . 95.0 mtt180 -137.01 165.22 26.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -1.194 . . . . 0.0 109.936 -179.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.3 m80 -97.38 154.54 17.39 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.318 -0.864 . . . . 0.0 109.526 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.583 ' OG ' ' ND2' ' A' ' 56' ' ' ASN . 37.1 p -65.88 160.88 22.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.171 -0.956 . . . . 0.0 109.899 -179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 96.57 -18.61 57.18 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.432 HE22 ' HD3' ' A' ' 38' ' ' ARG . 52.0 tt0 -62.23 -36.73 82.89 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.055 -1.262 . . . . 0.0 109.931 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.818 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -56.57 140.24 47.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.117 -0.99 . . . . 0.0 109.381 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -123.97 153.37 41.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.443 -0.786 . . . . 0.0 109.354 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 94.87 0.42 64.05 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.537 ' CD2' ' O ' ' A' ' 47' ' ' SER . 59.8 t80 -136.38 156.04 49.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.308 -1.113 . . . . 0.0 109.205 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.537 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 29.9 t -95.55 147.3 23.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.645 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.818 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 49.4 m-85 -103.21 141.99 34.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.378 -0.826 . . . . 0.0 109.785 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.721 HG21 ' HA ' ' A' ' 78' ' ' THR . 47.2 m -74.4 149.98 40.23 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.479 -0.763 . . . . 0.0 109.548 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.64 -33.73 23.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.361 -0.837 . . . . 0.0 109.809 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -49.38 -73.14 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.125 -0.985 . . . . 0.0 110.455 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.494 ' O ' ' O ' ' A' ' 55' ' ' LYS . 25.5 t-20 -54.51 -41.0 69.13 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.053 -1.029 . . . . 0.0 110.306 -179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 75.7 mt -60.11 -46.4 94.48 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 O-C-N 120.838 -1.164 . . . . 0.0 109.456 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -60.48 -37.21 80.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 108.94 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.494 ' O ' ' O ' ' A' ' 52' ' ' ASN . 25.9 tttt -127.84 116.9 20.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.569 -0.707 . . . . 0.0 109.272 179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.583 ' ND2' ' OG ' ' A' ' 40' ' ' SER . 0.4 OUTLIER -101.87 134.99 44.18 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.312 -0.867 . . . . 0.0 109.12 179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.65 HG11 ' OH ' ' A' ' 74' ' ' TYR . 8.9 p -131.99 148.24 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.438 -0.788 . . . . 0.0 109.892 -179.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.794 HD23 ' N ' ' A' ' 59' ' ' TRP . 6.5 tt -79.66 132.26 36.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.328 -0.858 . . . . 0.0 109.069 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.794 ' N ' HD23 ' A' ' 58' ' ' LEU . 99.7 m95 -92.88 110.08 21.53 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.056 -1.027 . . . . 0.0 109.688 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 61' ' ' GLU . 54.8 t0 -136.31 168.92 18.52 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 179.388 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.564 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -56.02 -37.36 69.07 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.902 -1.124 . . . . 0.0 109.293 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 20.6 t30 -70.75 -56.57 6.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.289 -0.882 . . . . 0.0 109.9 179.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.458 ' ND2' ' OH ' ' A' ' 74' ' ' TYR . 41.0 t30 -62.34 -38.96 91.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.376 -0.828 . . . . 0.0 110.397 -179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.5 tpp -58.75 -40.56 84.2 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.0 109.543 -179.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.691 ' HA ' HD11 ' A' ' 95' ' ' ILE . 19.7 m -62.08 -42.51 99.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 0.0 109.276 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.13 -31.44 72.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.184 -0.948 . . . . 0.0 109.047 179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.474 ' CE1' ' CD1' ' A' ' 74' ' ' TYR . 75.2 t60 -57.48 -47.49 81.75 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.439 -0.788 . . . . 0.0 109.597 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.523 ' CD1' HD23 ' A' ' 94' ' ' LEU . 72.8 mt -68.37 -30.52 69.47 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.497 -0.752 . . . . 0.0 110.028 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 34.7 m -62.46 -39.81 94.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.015 -1.053 . . . . 0.0 110.641 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -150.95 65.93 7.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.073 -1.017 . . . . 0.0 110.056 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.63 -20.74 69.76 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.572 2.181 . . . . 0.0 112.776 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.9 -50.38 64.67 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.149 -0.969 . . . . 0.0 110.652 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.6 pttp -86.62 -6.36 58.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.97 -1.081 . . . . 0.0 110.046 -179.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.65 ' OH ' HG11 ' A' ' 57' ' ' VAL . 44.6 t80 -62.47 -49.67 74.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.561 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.492 HG23 ' CD1' ' A' ' 74' ' ' TYR . 6.7 pt -140.7 72.26 29.79 Favored Pre-proline 0 N--CA 1.499 1.992 0 O-C-N 121.09 -1.006 . . . . 0.0 109.622 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -54.04 135.67 64.69 Favored 'Trans proline' 0 C--N 1.297 -2.166 0 C-N-CA 122.49 2.127 . . . . 0.0 112.204 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.44 14.62 50.09 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.884 -1.15 . . . . 0.0 111.15 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.721 ' HA ' HG21 ' A' ' 49' ' ' THR . 14.9 t -104.61 171.44 7.33 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.816 -1.403 . . . . 0.0 110.064 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 46.5 mtmt -94.61 14.06 22.22 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.266 -0.896 . . . . 0.0 110.318 -179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . 0.625 ' H ' HG23 ' A' ' 78' ' ' THR . 2.1 mmm -67.5 135.05 52.44 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 0.0 109.889 -179.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -117.25 26.01 10.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 0.0 109.428 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' A' ' 83' ' ' GLY . 57.2 t80 -91.79 130.16 37.62 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.225 -0.922 . . . . 0.0 109.179 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.601 ' O ' ' CD1' ' A' ' 82' ' ' PHE . . . -85.48 177.05 50.09 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -86.91 158.07 30.21 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 59.8 mt -102.95 135.05 45.34 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.229 -1.16 . . . . 0.0 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -92.65 -4.62 53.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.115 -0.991 . . . . 0.0 109.795 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -103.02 130.81 50.25 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.092 -1.005 . . . . 0.0 109.805 -179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -82.31 -44.87 15.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.412 -0.805 . . . . 0.0 110.454 -179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 28.7 mttp -60.17 -48.26 82.47 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.072 -1.018 . . . . 0.0 110.301 -178.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -63.63 -39.04 93.36 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.089 -1.007 . . . . 0.0 109.364 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -58.92 -42.31 89.38 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.476 -0.765 . . . . 0.0 110.055 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.414 HD22 ' HG3' ' A' ' -2' ' ' LYS . 90.3 m-20 -61.62 -40.37 94.62 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.07 -1.019 . . . . 0.0 110.384 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -63.37 -40.08 96.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.026 -1.046 . . . . 0.0 110.001 -179.443 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.644 HD22 HD23 ' A' ' 9' ' ' LEU . 59.0 tp -57.26 -45.75 83.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.04 -1.038 . . . . 0.0 109.848 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.691 HD11 ' HA ' ' A' ' 65' ' ' SER . 77.3 mt -66.53 -43.64 90.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.145 -0.972 . . . . 0.0 109.652 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . . . . . . . . . 25.3 m -60.71 -39.74 89.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.352 -0.843 . . . . 0.0 109.917 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -58.09 -49.18 77.83 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.03 -1.043 . . . . 0.0 109.729 -179.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.733 ' O ' HG23 ' A' ' 102' ' ' THR . 85.8 mt -69.09 -35.59 76.65 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.04 -1.038 . . . . 0.0 109.169 179.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.564 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 10.9 tptm -57.84 -43.34 85.78 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.388 -0.82 . . . . 0.0 109.517 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 65.6 mttt -61.04 -45.44 94.78 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.176 -0.952 . . . . 0.0 109.693 179.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.28 -34.0 74.47 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.557 -0.714 . . . . 0.0 109.511 -179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 98' ' ' LEU . 54.8 p -70.28 -21.01 63.0 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.457 -179.982 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.656 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -5' ' ' THR . . . . . 0.448 ' O ' ' C ' ' A' ' -4' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' GLU . . . . . 0.448 ' C ' ' O ' ' A' ' -5' ' ' THR . 95.5 mt-10 41.97 -154.32 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.32 -0.863 . . . . 0.0 109.462 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' PHE . . . . . . . . . . . . . 52.6 t80 -96.4 127.48 42.43 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.289 -0.882 . . . . 0.0 109.53 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' LYS . . . . . 0.445 ' O ' ' C ' ' A' ' -1' ' ' ALA . 34.6 ttpt -102.54 136.36 42.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.431 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.445 ' C ' ' O ' ' A' ' -2' ' ' LYS . . . -41.99 101.69 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 0.0 109.277 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' -2' ' ' LYS . . . -98.23 134.27 11.65 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.661 ' O ' ' HB3' ' A' ' 3' ' ' ALA . 22.8 t -57.19 -33.48 67.53 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.29 -1.123 . . . . 0.0 109.288 179.759 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.661 ' HB3' ' O ' ' A' ' 2' ' ' SER . . . 73.32 -35.77 0.33 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.233 -0.917 . . . . 0.0 110.066 179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.447 ' H ' ' C ' ' A' ' 2' ' ' SER . 20.2 tttt -59.14 -48.9 79.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.095 -1.003 . . . . 0.0 109.52 -179.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 69.4 mttt -63.62 -42.81 98.17 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.283 -0.886 . . . . 0.0 109.072 179.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' H ' ' HB3' ' A' ' 93' ' ' ASP . . . -62.36 -32.16 81.9 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.63 -43.9 93.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.21 -1.17 . . . . 0.0 109.474 -179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.79 ' O ' HG23 ' A' ' 12' ' ' THR . 47.4 p -72.51 -36.38 68.35 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.304 -0.872 . . . . 0.0 109.159 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.572 HD23 HD13 ' A' ' 94' ' ' LEU . 7.1 tp -58.33 -41.49 84.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 179.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.615 ' CE1' ' SG ' ' A' ' 14' ' ' CYS . 70.3 t80 -63.54 -46.85 84.11 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 14.6 tttt -63.31 -39.65 95.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.778 -0.576 . . . . 0.0 110.326 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 8' ' ' THR . 65.3 p -70.41 -34.43 72.52 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.419 -0.8 . . . . 0.0 111.7 -178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -150.27 59.97 0.97 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.626 -1.296 . . . . 0.0 110.933 -178.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.615 ' SG ' ' CE1' ' A' ' 10' ' ' PHE . 4.1 t -173.08 -48.64 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.962 -1.086 . . . . 0.0 109.997 179.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.06 -36.32 72.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.261 -0.9 . . . . 0.0 109.967 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -56.45 -35.35 67.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.024 -1.048 . . . . 0.0 109.496 -179.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 95.9 m -97.26 -48.84 5.18 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.259 -0.9 . . . . 0.0 110.263 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . 0.574 ' ND1' HD11 ' A' ' 32' ' ' LEU . 91.2 m-70 -99.3 113.43 25.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 0.0 109.741 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.477 ' O ' ' C ' ' A' ' 20' ' ' VAL . 50.0 p -82.58 -19.15 39.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.369 -0.832 . . . . 0.0 109.62 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.73 ' O ' HG22 ' A' ' 20' ' ' VAL . 8.0 p 36.86 41.8 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.607 -0.683 . . . . 0.0 109.834 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.415 ' HG2' ' H ' ' A' ' 23' ' ' GLY . 84.6 tt0 -101.67 147.95 25.83 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.489 -179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -56.57 -36.58 69.48 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.179 -0.951 . . . . 0.0 109.554 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.415 ' H ' ' HG2' ' A' ' 21' ' ' GLU . . . -55.44 -30.94 56.61 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.412 ' N ' ' CD ' ' A' ' 25' ' ' PRO . . . 64.66 56.54 16.33 Favored Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 24' ' ' GLY . 33.1 Cg_endo -67.79 -23.78 41.35 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.787 2.325 . . . . 0.0 112.019 179.553 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.497 ' N ' ' OD1' ' A' ' 31' ' ' ASN . 93.1 m-70 54.77 57.9 5.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.317 -0.864 . . . . 0.0 109.644 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.483 ' O ' ' O ' ' A' ' 26' ' ' HIS . 45.1 tttm -58.98 -122.84 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.371 -0.831 . . . . 0.0 109.342 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 73.8 t -66.05 -40.14 86.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 0.0 109.883 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -122.52 167.47 14.95 Favored Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.761 -1.335 . . . . 0.0 109.761 -179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 12.7 Cg_endo -59.29 152.29 61.49 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 123.004 2.469 . . . . 0.0 112.263 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 26' ' ' HIS . 16.2 m120 -89.17 140.83 29.07 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.273 -0.892 . . . . 0.0 109.044 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.817 ' N ' HD12 ' A' ' 32' ' ' LEU . 4.8 mp -92.83 140.39 29.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.932 -179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 33' ' ' HIS . 47.6 p-80 -176.06 86.45 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.441 ' O ' ' NE ' ' A' ' 38' ' ' ARG . . . 93.98 3.8 63.62 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.7 tt -56.19 -21.56 12.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.449 -1.03 . . . . 0.0 109.524 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' CD1' HG21 ' A' ' 102' ' ' THR . 82.3 m-85 -66.94 132.32 47.71 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.179 -0.951 . . . . 0.0 109.556 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 59' ' ' TRP . . . 72.8 24.33 76.26 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' NE ' ' O ' ' A' ' 34' ' ' GLY . 86.3 mtt-85 -133.12 159.1 41.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.274 -1.133 . . . . 0.0 109.95 -179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 77.1 m80 -90.93 147.38 23.16 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.45 ' HB2' ' HE1' ' A' ' 59' ' ' TRP . 3.4 t -63.13 155.91 26.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.354 -0.842 . . . . 0.0 109.79 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 100.79 -13.92 59.08 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.766 -1.333 . . . . 0.0 109.766 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.511 ' O ' ' N ' ' A' ' 44' ' ' GLU . 51.4 tt0 -62.3 -37.1 84.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.255 -1.144 . . . . 0.0 109.804 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.469 ' HB3' ' OH ' ' A' ' 48' ' ' TYR . . . -64.85 70.53 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.14 -0.975 . . . . 0.0 109.897 -179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.511 ' N ' ' O ' ' A' ' 42' ' ' GLN . 97.2 mt-10 -60.51 -31.28 70.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.439 -0.788 . . . . 0.0 109.396 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -54.11 -32.84 50.64 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 47' ' ' SER . 60.3 t80 -122.3 142.03 50.9 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.432 -1.04 . . . . 0.0 109.572 -179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.441 ' O ' ' CD2' ' A' ' 46' ' ' TYR . 22.9 t -74.04 158.17 34.79 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.321 -0.862 . . . . 0.0 110.071 -179.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.469 ' OH ' ' HB3' ' A' ' 43' ' ' ALA . 19.4 m-85 -106.12 150.27 25.97 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.279 -0.888 . . . . 0.0 109.835 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.44 HG23 ' N ' ' A' ' 51' ' ' ALA . 2.0 t -63.58 155.21 30.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.202 -0.936 . . . . 0.0 109.258 179.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -55.52 -35.49 65.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -0.903 . . . . 0.0 110.567 -179.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.44 ' N ' HG23 ' A' ' 49' ' ' THR . . . -59.53 -58.23 9.49 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.994 -1.066 . . . . 0.0 110.185 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.477 ' O ' ' O ' ' A' ' 55' ' ' LYS . 17.5 t-20 -57.88 -40.81 81.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.922 -1.111 . . . . 0.0 109.469 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.0 mt -62.77 -43.13 98.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.145 -0.972 . . . . 0.0 109.426 179.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.6 ttpp -60.34 -40.99 92.66 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 0.0 109.331 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.477 ' O ' ' O ' ' A' ' 52' ' ' ASN . 6.7 tptm -128.39 125.17 38.07 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.621 HD22 ' H ' ' A' ' 57' ' ' VAL . 0.4 OUTLIER -98.05 140.89 31.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.245 -0.909 . . . . 0.0 109.086 179.833 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.806 HG11 ' OH ' ' A' ' 74' ' ' TYR . 14.3 p -130.94 148.86 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.357 -0.839 . . . . 0.0 110.053 -179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 60.0 tp -82.28 130.89 35.2 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.597 ' NE1' ' O2A' ' A' ' 201' ' ' HEC . 97.4 m95 -98.95 125.15 44.33 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.247 -0.908 . . . . 0.0 110.829 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 60' ' ' ASP . 55.0 p30 -157.95 -170.21 3.08 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.463 ' OE2' ' NZ ' ' A' ' 99' ' ' LYS . 96.9 mt-10 -62.31 -43.12 99.55 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.763 -1.21 . . . . 0.0 110.439 -179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -68.39 -54.1 19.46 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 0.0 110.714 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 40.7 t30 -57.1 -38.7 73.77 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.44 -0.787 . . . . 0.0 110.902 -179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.415 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 6.6 mmt -58.04 -41.99 84.43 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.001 -1.062 . . . . 0.0 109.425 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 87.1 p -65.88 -32.96 74.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.191 -0.943 . . . . 0.0 109.458 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -67.03 -37.59 84.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.148 -179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 79.0 t60 -59.04 -49.21 78.76 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.032 -1.043 . . . . 0.0 109.496 -179.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.691 ' N ' HD12 ' A' ' 68' ' ' LEU . 8.4 mp -72.23 -26.95 62.22 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.325 -0.859 . . . . 0.0 109.77 179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 70' ' ' ASN . 27.2 m -87.51 129.66 35.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.075 -1.015 . . . . 0.0 109.629 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . 0.455 ' C ' ' O ' ' A' ' 69' ' ' THR . 1.5 m120 38.75 55.94 5.2 Favored Pre-proline 0 N--CA 1.494 1.749 0 O-C-N 121.564 -0.71 . . . . 0.0 110.355 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 70' ' ' ASN . 11.1 Cg_endo -58.44 -18.49 39.16 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 122.84 2.36 . . . . 0.0 112.649 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.95 -39.77 90.79 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.074 -1.016 . . . . 0.0 110.529 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -91.47 4.73 51.81 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.943 -1.098 . . . . 0.0 110.272 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' TYR . . . . . 0.806 ' OH ' HG11 ' A' ' 57' ' ' VAL . 50.9 t80 -116.39 119.35 35.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.275 -0.891 . . . . 0.0 109.957 -179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.7 ' O ' HG23 ' A' ' 78' ' ' THR . 45.7 mm 40.23 59.25 7.39 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.483 -0.761 . . . . 0.0 109.783 179.105 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -69.99 147.8 62.19 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.903 2.402 . . . . 0.0 112.139 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 98.7 2.91 57.34 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 75' ' ' ILE . 51.9 p -75.48 163.59 27.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.968 -1.313 . . . . 0.0 109.448 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -85.07 5.99 27.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' MET . . . . . . . . . . . . . 69.1 mtm -86.7 126.69 34.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.988 -1.07 . . . . 0.0 110.371 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -105.65 6.87 32.38 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -102.83 134.07 46.85 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.339 -0.851 . . . . 0.0 109.811 -179.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 149.55 -175.32 28.77 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.482 -1.447 . . . . 0.0 109.482 179.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.56 ' N ' ' O ' ' A' ' 68' ' ' LEU . . . 76.71 36.32 37.73 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.545 ' O ' ' NH2' ' A' ' 91' ' ' ARG . 62.7 mt -82.26 143.27 31.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.24 -1.153 . . . . 0.0 109.443 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 87' ' ' LYS . 20.3 ttpp -73.3 145.64 45.89 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.432 ' C ' ' O ' ' A' ' 86' ' ' LYS . 17.5 mttp -44.19 130.76 6.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.033 -1.042 . . . . 0.0 109.197 -179.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.401 ' HG2' ' N ' ' A' ' 89' ' ' LYS . 85.6 tt0 -172.19 158.53 4.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.385 -0.822 . . . . 0.0 109.444 -179.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' N ' ' HG2' ' A' ' 88' ' ' GLU . 18.6 mttt -55.38 -32.3 62.49 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.144 -0.973 . . . . 0.0 109.231 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -56.04 -41.26 74.73 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.156 -0.965 . . . . 0.0 109.251 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.545 ' NH2' ' O ' ' A' ' 85' ' ' LEU . 38.3 ttm180 -61.21 -46.46 90.35 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.267 -0.896 . . . . 0.0 109.292 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -67.25 -40.94 86.32 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.334 -0.854 . . . . 0.0 109.775 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' CG ' ' H ' ' A' ' 3' ' ' ALA . 89.2 m-20 -62.93 -40.22 96.94 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.116 -0.99 . . . . 0.0 109.607 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.602 HD23 HD21 ' A' ' 68' ' ' LEU . 53.5 tp -58.18 -44.78 88.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.122 -0.986 . . . . 0.0 109.52 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 80.8 mt -67.16 -40.54 85.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.209 -0.932 . . . . 0.0 108.789 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.505 ' CG2' ' HB2' ' A' ' 3' ' ' ALA . 14.1 m -57.99 -40.15 79.99 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.735 -0.603 . . . . 0.0 109.77 -179.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -59.83 -51.36 70.05 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.082 -1.011 . . . . 0.0 109.687 -179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.409 HD21 ' CE1' ' A' ' 10' ' ' PHE . 92.3 mt -66.92 -35.61 80.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.057 -1.027 . . . . 0.0 108.33 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' NZ ' ' OE2' ' A' ' 61' ' ' GLU . 82.8 tttt -58.09 -42.39 85.52 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 109.152 -0.685 . . . . 0.0 109.152 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 40.7 tttp -60.79 -39.89 90.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.47 -0.769 . . . . 0.0 109.742 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -56.55 -34.85 67.48 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.456 -0.778 . . . . 0.0 109.421 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.401 HG21 ' CD1' ' A' ' 36' ' ' PHE . 68.8 p -69.8 -22.33 63.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.078 -1.014 . . . . 0.0 109.133 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.245 -0.909 . . . . 0.0 109.468 -179.988 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' HEC . . . . . 0.645 ' CBB' HMB1 ' A' ' 201' ' ' HEC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_